data_1bmr_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1bmr _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 4.8 m . . . . . 0 N--CA 1.483 1.185 0 CA-C-O 122.443 1.116 . . . . 0.0 111.065 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 34.6 mtp85 -97.26 151.38 19.93 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 -171.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -130.63 125.3 33.71 Favored 'General case' 0 CA--C 1.485 -1.519 1 N-CA-C 96.597 -5.335 . . . . 0.0 96.597 165.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.76 -178.12 35.41 Favored Glycine 0 CA--C 1.477 -2.32 0 N-CA-C 103.162 -3.975 . . . . 0.0 103.162 176.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -76.88 133.33 39.32 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 168.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 17.4 tt -91.34 147.49 5.22 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 CA-C-N 120.163 1.347 . . . . 0.0 108.406 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -134.87 -150.98 0.41 Allowed 'General case' 0 N--CA 1.426 -1.654 0 C-N-CA 127.657 2.383 . . . . 0.0 106.869 -177.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -125.67 144.96 49.85 Favored Pre-proline 0 N--CA 1.426 -1.668 1 N-CA-C 94.661 -6.052 . . . . 0.0 94.661 162.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -80.6 -1.77 11.49 Favored 'Trans proline' 0 CA--C 1.501 -1.143 0 CA-C-N 123.165 2.166 . . . . 0.0 112.714 -143.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 48.8 mm-40 -86.37 46.85 1.39 Allowed 'General case' 0 N--CA 1.438 -1.043 0 C-N-CA 124.574 1.15 . . . . 0.0 109.874 -167.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.417 ' O ' ' HE1' ' A' ' 43' ' ' HIS . 0.2 OUTLIER 65.59 45.87 2.6 Favored 'General case' 0 C--N 1.356 0.889 0 C-N-CA 126.343 1.857 . . . . 0.0 107.598 177.355 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 94.9 m -122.38 -162.64 1.02 Allowed 'General case' 0 CA--C 1.486 -1.502 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 -169.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -141.59 170.26 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.838 1 N-CA-C 96.897 -5.223 . . . . 0.0 96.897 173.137 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -98.2 -163.95 1.09 Allowed 'General case' 0 CA--C 1.5 -0.966 0 N-CA-C 101.254 -3.61 . . . . 0.0 101.254 163.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 69.8 m80 -139.56 162.67 34.5 Favored 'General case' 0 CA--C 1.482 -1.672 1 N-CA-C 96.085 -5.524 . . . . 0.0 96.085 166.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 8.4 t -123.03 164.36 18.72 Favored 'General case' 0 CA--C 1.477 -1.837 0 N-CA-C 101.965 -3.346 . . . . 0.0 101.965 -167.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -112.53 122.06 37.32 Favored Pre-proline 0 N--CA 1.425 -1.693 1 N-CA-C 97.341 -5.059 . . . . 0.0 97.341 166.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_exo -56.34 96.47 0.06 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.578 0 CA-C-N 123.823 2.401 . . . . 0.0 117.081 -169.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 162.28 -161.06 33.23 Favored Glycine 0 N--CA 1.417 -2.568 1 N-CA-C 97.597 -6.201 . . . . 0.0 97.597 -179.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -84.86 -45.35 12.37 Favored 'General case' 0 N--CA 1.426 -1.652 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 176.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.9 m -39.29 -56.22 1.57 Allowed 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 117.356 2.354 . . . . 0.0 117.356 -145.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -68.34 -74.74 0.57 Allowed Glycine 0 C--N 1.351 1.363 0 O-C-N 121.606 -0.683 . . . . 0.0 111.815 -176.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.6 p -87.0 -6.02 58.89 Favored 'General case' 0 CA--C 1.497 -1.073 0 O-C-N 121.219 -1.165 . . . . 0.0 113.048 -166.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -69.88 -33.72 72.6 Favored 'General case' 0 C--N 1.359 0.983 0 CA-C-N 119.774 1.17 . . . . 0.0 108.276 166.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 26.6 m -70.27 -42.02 72.68 Favored 'General case' 0 N--CA 1.447 -0.624 0 O-C-N 120.936 -1.102 . . . . 0.0 108.679 177.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 96.3 mt -61.31 -40.41 94.06 Favored 'General case' 0 C--N 1.355 0.824 0 CA-C-O 121.73 0.776 . . . . 0.0 110.734 175.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.0 t -55.13 -43.34 74.03 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 123.841 0.856 . . . . 0.0 111.256 174.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -60.51 -46.55 89.73 Favored 'General case' 0 C--N 1.356 0.884 0 CA-C-N 118.361 0.528 . . . . 0.0 111.877 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -76.83 -23.57 52.75 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -174.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -80.79 -30.93 35.88 Favored 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 173.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 117.56 35.59 1.07 Allowed Glycine 0 CA--C 1.487 -1.67 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 162.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.58 142.89 15.72 Favored Glycine 0 CA--C 1.488 -1.638 0 N-CA-C 105.097 -3.201 . . . . 0.0 105.097 173.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.3 p -105.17 15.4 27.54 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-O 121.657 0.741 . . . . 0.0 109.798 -167.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 65.8 m -158.39 154.92 27.75 Favored 'General case' 0 CA--C 1.475 -1.92 1 N-CA-C 98.405 -4.665 . . . . 0.0 98.405 159.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -153.87 147.85 17.72 Favored Glycine 0 CA--C 1.468 -2.853 1 N-CA-C 97.491 -6.243 . . . . 0.0 97.491 -170.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -156.61 -171.37 3.66 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 101.566 -3.494 . . . . 0.0 101.566 -171.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 79.3 m -103.36 -179.38 3.93 Favored 'General case' 0 CA--C 1.491 -1.307 0 N-CA-C 104.278 -2.49 . . . . 0.0 104.278 174.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.17 178.29 45.2 Favored Glycine 0 N--CA 1.421 -2.347 0 N-CA-C 103.505 -3.838 . . . . 0.0 103.505 170.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -131.45 133.4 45.13 Favored 'General case' 0 CA--C 1.488 -1.418 1 N-CA-C 98.912 -4.477 . . . . 0.0 98.912 172.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -118.93 99.25 6.63 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 102.2 -3.259 . . . . 0.0 102.2 178.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.0 t -69.34 129.91 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 -175.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 124.75 -41.55 1.69 Allowed Glycine 0 CA--C 1.488 -1.649 0 N-CA-C 104.516 -3.434 . . . . 0.0 104.516 -168.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.417 ' HE1' ' O ' ' A' ' 11' ' ' ASN . 14.2 m-70 -108.94 -69.85 0.84 Allowed 'General case' 0 CA--C 1.496 -1.102 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 176.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 158.39 -155.49 26.51 Favored Glycine 0 N--CA 1.429 -1.823 0 N-CA-C 103.915 -3.674 . . . . 0.0 103.915 -170.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.1 tt -73.43 141.66 46.91 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 105.953 -1.869 . . . . 0.0 105.953 -178.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.78 -172.75 3.46 Favored 'General case' 0 CA--C 1.489 -1.394 0 N-CA-C 104.116 -2.55 . . . . 0.0 104.116 -168.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 45.5 m -117.5 176.61 5.09 Favored 'General case' 0 CA--C 1.477 -1.838 0 N-CA-C 103.001 -2.963 . . . . 0.0 103.001 170.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 8.1 t-105 -138.79 151.89 47.43 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 102.89 -3.004 . . . . 0.0 102.89 -178.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 4.4 m -143.78 156.18 44.41 Favored 'General case' 0 CA--C 1.486 -1.517 0 N-CA-C 104.927 -2.249 . . . . 0.0 104.927 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -127.77 136.87 52.09 Favored 'General case' 0 CA--C 1.49 -1.36 0 N-CA-C 104.219 -2.511 . . . . 0.0 104.219 175.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 73.9 49.73 0.12 Allowed 'General case' 0 CA--C 1.493 -1.233 0 C-N-CA 126.671 1.988 . . . . 0.0 110.549 170.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 50.2 mt -89.33 141.83 29.31 Favored Pre-proline 0 CA--C 1.504 -0.803 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 177.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -66.1 162.51 35.3 Favored 'Trans proline' 0 N--CA 1.448 -1.175 0 C-N-CA 122.222 1.948 . . . . 0.0 111.906 177.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -60.2 -17.11 38.94 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -86.2 -1.02 57.07 Favored 'General case' 0 CA--C 1.504 -0.825 0 O-C-N 121.55 -0.719 . . . . 0.0 111.208 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.1 t -94.14 156.72 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 N-CA-C 103.472 -2.788 . . . . 0.0 103.472 177.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -141.28 152.81 23.56 Favored Glycine 0 CA--C 1.48 -2.122 1 N-CA-C 98.103 -5.999 . . . . 0.0 98.103 -177.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 21.4 pt -146.21 -144.25 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 N-CA-C 104.66 -2.348 . . . . 0.0 104.66 -156.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.9 mm -68.74 147.06 12.42 Favored 'Isoleucine or valine' 0 C--N 1.359 0.98 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 178.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 15.5 t . . . . . 0 N--CA 1.427 -1.596 1 N-CA-C 94.511 -6.107 . . . . 0.0 94.511 177.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 30.3 m . . . . . 0 N--CA 1.481 1.093 0 CA-C-O 121.228 0.537 . . . . 0.0 110.089 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -83.52 157.34 22.4 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 173.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -124.71 125.8 44.67 Favored 'General case' 0 CA--C 1.49 -1.337 1 N-CA-C 92.769 -6.752 . . . . 0.0 92.769 151.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.54 178.54 37.4 Favored Glycine 0 CA--C 1.473 -2.568 0 N-CA-C 106.022 -2.831 . . . . 0.0 106.022 -170.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 48' ' ' TRP . 65.0 m-85 -87.12 125.03 33.88 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 171.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.6 tt -90.51 152.07 3.4 Favored 'Isoleucine or valine' 0 C--N 1.357 0.93 0 CA-C-N 120.272 1.396 . . . . 0.0 108.143 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -144.09 -159.19 0.96 Allowed 'General case' 0 N--CA 1.418 -2.053 0 C-N-CA 126.426 1.89 . . . . 0.0 107.83 -167.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 -105.48 144.29 28.52 Favored Pre-proline 0 N--CA 1.432 -1.356 1 N-CA-C 99.345 -4.317 . . . . 0.0 99.345 158.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -79.04 -12.34 14.56 Favored 'Trans proline' 0 CA--C 1.503 -1.052 0 CA-C-N 122.236 1.834 . . . . 0.0 112.544 -153.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -87.59 55.49 3.52 Favored 'General case' 0 C--N 1.36 1.022 0 CA-C-N 120.591 1.541 . . . . 0.0 108.666 -173.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.5 t30 73.24 37.4 0.75 Allowed 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 128.075 2.55 . . . . 0.0 110.993 168.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -108.94 -162.33 0.81 Allowed 'General case' 0 CA--C 1.504 -0.816 0 O-C-N 121.053 -1.029 . . . . 0.0 111.693 -167.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.539 HG11 ' HD1' ' A' ' 43' ' ' HIS . 3.7 m -133.96 170.46 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.225 1 N-CA-C 98.662 -4.569 . . . . 0.0 98.662 162.241 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . 0.313 1.3 m-85 -111.15 151.17 28.48 Favored 'General case' 0 CA--C 1.487 -1.456 1 N-CA-C 95.1 -5.889 . . . . 0.0 95.1 166.041 . . . . . . . . 3 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 34.8 m80 -92.21 144.65 25.2 Favored 'General case' 0 CA--C 1.496 -1.109 0 N-CA-C 102.772 -3.047 . . . . 0.0 102.772 171.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 39.0 t -92.41 164.77 13.36 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 -177.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -108.29 101.78 43.69 Favored Pre-proline 0 N--CA 1.425 -1.712 1 N-CA-C 98.959 -4.46 . . . . 0.0 98.959 169.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -68.18 107.78 1.62 Allowed 'Trans proline' 0 CA--C 1.501 -1.147 0 C-N-CA 122.367 2.045 . . . . 0.0 110.58 -161.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 160.79 -45.2 0.41 Allowed Glycine 0 CA--C 1.48 -2.104 1 N-CA-C 97.972 -6.051 . . . . 0.0 97.972 -169.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.2 m 122.8 -34.91 0.01 OUTLIER 'General case' 0 CA--C 1.487 -1.47 0 C-N-CA 128.8 2.84 . . . . 0.0 107.898 161.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 m -38.9 -51.92 1.76 Allowed 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 127.644 2.377 . . . . 0.0 116.377 -160.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.14 -41.99 68.53 Favored Glycine 0 C--N 1.355 1.594 0 O-C-N 121.287 -0.883 . . . . 0.0 111.513 -176.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.8 t -88.09 -24.88 23.29 Favored 'General case' 0 CA--C 1.496 -1.105 0 O-C-N 121.562 -0.964 . . . . 0.0 109.037 -171.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -65.83 -36.51 83.68 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 170.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 44.0 m -64.42 -37.85 88.95 Favored 'General case' 0 C--N 1.348 0.517 0 O-C-N 121.055 -1.028 . . . . 0.0 110.635 174.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 78.8 mt -63.96 -40.04 95.51 Favored 'General case' 0 C--N 1.357 0.931 0 CA-C-O 122.192 0.996 . . . . 0.0 110.559 175.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 38.3 t -58.17 -46.04 86.43 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.109 1.363 . . . . 0.0 110.347 174.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.17 -49.22 76.69 Favored 'General case' 0 C--N 1.359 0.984 0 O-C-N 121.752 -0.592 . . . . 0.0 110.613 -178.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -70.1 -21.18 63.15 Favored 'General case' 0 C--N 1.354 0.802 0 O-C-N 121.688 -0.632 . . . . 0.0 112.626 -173.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -96.5 5.79 50.09 Favored 'General case' 0 C--N 1.355 0.846 0 O-C-N 121.671 -0.643 . . . . 0.0 110.52 177.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.37 36.94 19.18 Favored Glycine 0 CA--C 1.493 -1.311 0 O-C-N 121.847 -0.533 . . . . 0.0 111.937 169.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -97.27 138.91 14.18 Favored Glycine 0 CA--C 1.487 -1.672 1 N-CA-C 102.862 -4.095 . . . . 0.0 102.862 164.196 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.4 m -105.96 -5.12 19.86 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -156.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 71.5 m -160.72 177.74 10.16 Favored 'General case' 0 CA--C 1.496 -1.121 1 N-CA-C 97.948 -4.834 . . . . 0.0 97.948 163.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -176.3 -170.88 39.49 Favored Glycine 0 CA--C 1.476 -2.369 1 N-CA-C 102.112 -4.395 . . . . 0.0 102.112 178.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -177.76 -154.51 0.03 OUTLIER 'General case' 0 N--CA 1.426 -1.634 1 N-CA-C 95.504 -5.739 . . . . 0.0 95.504 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 98.2 m -146.37 -176.6 5.24 Favored 'General case' 0 CA--C 1.48 -1.717 0 N-CA-C 101.24 -3.615 . . . . 0.0 101.24 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -175.66 -164.13 29.58 Favored Glycine 0 N--CA 1.422 -2.258 1 N-CA-C 99.971 -5.251 . . . . 0.0 99.971 -177.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -126.44 148.83 49.58 Favored 'General case' 0 N--CA 1.431 -1.385 1 N-CA-C 100.124 -4.028 . . . . 0.0 100.124 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -129.33 106.84 9.08 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 103.451 -2.796 . . . . 0.0 103.451 174.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.3 t -73.21 124.83 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 -174.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 134.95 -43.86 1.22 Allowed Glycine 0 CA--C 1.483 -1.944 0 N-CA-C 104.863 -3.295 . . . . 0.0 104.863 -171.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.539 ' HD1' HG11 ' A' ' 13' ' ' VAL . 38.9 m170 -114.97 -71.67 0.73 Allowed 'General case' 0 CA--C 1.498 -1.047 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 175.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 166.83 -145.25 9.74 Favored Glycine 0 N--CA 1.429 -1.78 0 N-CA-C 106.678 -2.569 . . . . 0.0 106.678 -177.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 45.9 tp -66.42 133.39 50.35 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 126.448 1.899 . . . . 0.0 106.458 177.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -138.49 171.86 13.75 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 102.84 -3.022 . . . . 0.0 102.84 -167.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 63.3 m -114.93 -179.94 3.77 Favored 'General case' 0 CA--C 1.484 -1.591 0 N-CA-C 102.991 -2.966 . . . . 0.0 102.991 176.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.425 ' HA ' ' HA ' ' A' ' 5' ' ' TYR . 9.8 t-105 -144.94 151.38 38.57 Favored 'General case' 0 CA--C 1.493 -1.239 0 N-CA-C 102.932 -2.988 . . . . 0.0 102.932 -174.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 45.8 m -137.26 151.73 49.02 Favored 'General case' 0 CA--C 1.487 -1.466 0 N-CA-C 104.697 -2.335 . . . . 0.0 104.697 172.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -115.57 130.7 56.96 Favored 'General case' 0 CA--C 1.495 -1.144 0 N-CA-C 103.794 -2.669 . . . . 0.0 103.794 170.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 65.01 72.58 0.43 Allowed 'General case' 0 CA--C 1.498 -1.041 0 C-N-CA 126.449 1.9 . . . . 0.0 110.685 175.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 20.9 mt -104.46 139.35 20.02 Favored Pre-proline 0 CA--C 1.492 -1.26 0 N-CA-C 102.197 -3.26 . . . . 0.0 102.197 166.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -70.67 168.48 22.62 Favored 'Trans proline' 0 N--CA 1.447 -1.24 0 C-N-CA 122.605 2.204 . . . . 0.0 110.114 175.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -84.07 5.42 26.03 Favored 'General case' 0 N--CA 1.443 -0.822 0 O-C-N 121.634 -0.666 . . . . 0.0 112.787 -164.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 -92.3 0.31 57.44 Favored 'General case' 0 CA--C 1.502 -0.876 0 O-C-N 121.638 -0.664 . . . . 0.0 109.584 176.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.1 t -91.65 163.12 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 N-CA-C 104.764 -2.31 . . . . 0.0 104.764 178.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -141.41 150.45 21.89 Favored Glycine 0 CA--C 1.483 -1.935 1 N-CA-C 97.552 -6.219 . . . . 0.0 97.552 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 16.6 pt -152.32 -140.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 N-CA-C 104.216 -2.513 . . . . 0.0 104.216 -155.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.06 126.52 24.22 Favored 'Isoleucine or valine' 0 C--N 1.362 1.128 0 N-CA-C 104.792 -2.299 . . . . 0.0 104.792 163.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.7 t . . . . . 0 N--CA 1.422 -1.839 1 N-CA-C 95.568 -5.716 . . . . 0.0 95.568 -178.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 27.2 m . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 121.272 0.558 . . . . 0.0 109.728 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.02 169.07 17.35 Favored 'General case' 0 N--CA 1.434 -1.23 1 N-CA-C 98.578 -4.601 . . . . 0.0 98.578 167.618 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 -130.63 133.06 45.82 Favored 'General case' 0 CA--C 1.48 -1.737 1 N-CA-C 94.366 -6.161 . . . . 0.0 94.366 169.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.66 -178.23 35.4 Favored Glycine 0 CA--C 1.474 -2.528 0 C-N-CA 117.397 -2.335 . . . . 0.0 107.411 -173.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.411 ' HA ' ' HA ' ' A' ' 48' ' ' TRP . 42.2 m-85 -78.45 130.46 36.09 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 102.713 -3.069 . . . . 0.0 102.713 158.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.7 tt -90.47 137.29 21.9 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 N-CA-C 105.331 -2.1 . . . . 0.0 105.331 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -94.3 -144.76 0.25 Allowed 'General case' 0 N--CA 1.424 -1.734 0 CA-C-N 112.319 -2.219 . . . . 0.0 107.79 177.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 62.7 mt-30 -109.57 147.02 35.23 Favored Pre-proline 0 N--CA 1.43 -1.464 1 N-CA-C 96.068 -5.53 . . . . 0.0 96.068 165.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -76.34 7.59 3.31 Favored 'Trans proline' 0 CA--C 1.506 -0.888 0 C-N-CA 122.671 2.247 . . . . 0.0 113.883 -145.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 18.1 mp0 -88.4 -76.35 0.4 Allowed 'General case' 0 N--CA 1.426 -1.643 0 N-CA-C 103.234 -2.876 . . . . 0.0 103.234 176.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -176.84 144.02 0.45 Allowed 'General case' 0 N--CA 1.419 -2.003 1 N-CA-C 93.64 -6.429 . . . . 0.0 93.64 -178.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 160.69 -153.48 0.0 OUTLIER 'General case' 0 CA--C 1.493 -1.237 0 N-CA-C 101.705 -3.443 . . . . 0.0 101.705 173.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -126.1 165.15 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.33 1 N-CA-C 99.477 -4.268 . . . . 0.0 99.477 159.649 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -86.01 -148.89 0.13 Allowed 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 164.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 46.4 m80 -142.33 176.29 9.1 Favored 'General case' 0 CA--C 1.483 -1.632 1 N-CA-C 97.209 -5.108 . . . . 0.0 97.209 164.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 8.2 t -136.18 159.97 40.09 Favored 'General case' 0 N--CA 1.426 -1.644 1 N-CA-C 96.482 -5.377 . . . . 0.0 96.482 -177.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -111.19 107.75 57.32 Favored Pre-proline 0 N--CA 1.428 -1.557 1 N-CA-C 97.529 -4.989 . . . . 0.0 97.529 170.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_exo -53.03 103.82 0.09 OUTLIER 'Trans proline' 0 CA--C 1.513 -0.557 0 CA-C-N 124.439 2.621 . . . . 0.0 116.871 -155.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 161.69 -170.33 37.38 Favored Glycine 0 N--CA 1.426 -2.011 1 N-CA-C 97.228 -6.349 . . . . 0.0 97.228 -172.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.2 m -86.98 -42.47 13.1 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 118.82 1.31 . . . . 0.0 109.566 179.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -40.1 -55.18 2.15 Favored 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 129.08 2.952 . . . . 0.0 117.231 -156.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.27 -48.79 43.57 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 111.074 -0.811 . . . . 0.0 111.074 -174.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 68.4 m -71.85 -34.04 68.92 Favored 'General case' 0 CA--C 1.49 -1.363 0 O-C-N 121.71 -0.876 . . . . 0.0 111.13 -176.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -59.16 -46.56 88.07 Favored 'General case' 0 C--N 1.35 0.597 0 CA-C-O 121.351 0.596 . . . . 0.0 109.422 173.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.0 m -64.45 -48.1 76.55 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 123.044 0.538 . . . . 0.0 111.031 177.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 75.5 mt -60.76 -43.6 97.8 Favored 'General case' 0 C--N 1.362 1.149 0 CA-C-O 121.846 0.831 . . . . 0.0 109.964 -177.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.8 t -56.9 -44.16 82.07 Favored 'General case' 0 N--CA 1.437 -1.092 0 C-N-CA 123.322 0.649 . . . . 0.0 111.46 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -77.35 -31.41 54.41 Favored 'General case' 0 C--N 1.353 0.735 0 C-N-CA 121.149 -0.22 . . . . 0.0 111.533 -173.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -76.75 -30.77 56.7 Favored 'General case' 0 CA--C 1.506 -0.727 0 O-C-N 121.58 -0.7 . . . . 0.0 110.71 177.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -78.24 -49.62 13.39 Favored 'General case' 0 C--N 1.359 1.013 0 CA-C-N 118.974 0.806 . . . . 0.0 109.816 177.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 131.67 47.99 0.11 Allowed Glycine 0 CA--C 1.488 -1.647 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 173.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -117.48 160.85 13.45 Favored Glycine 0 CA--C 1.484 -1.881 0 N-CA-C 104.077 -3.609 . . . . 0.0 104.077 161.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -64.68 -54.9 24.34 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 124.88 1.272 . . . . 0.0 110.621 -164.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.9 m -160.79 177.63 10.24 Favored 'General case' 0 N--CA 1.423 -1.813 1 N-CA-C 97.199 -5.111 . . . . 0.0 97.199 170.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -161.48 174.76 38.06 Favored Glycine 0 CA--C 1.474 -2.501 1 N-CA-C 101.346 -4.701 . . . . 0.0 101.346 -163.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 53.8 m80 -156.66 -153.04 0.4 Allowed 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 100.348 -3.945 . . . . 0.0 100.348 -168.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 81.6 m -147.53 177.64 9.09 Favored 'General case' 0 CA--C 1.483 -1.627 0 N-CA-C 103.762 -2.681 . . . . 0.0 103.762 -174.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 171.53 -157.14 27.37 Favored Glycine 0 N--CA 1.423 -2.215 1 N-CA-C 95.9 -6.88 . . . . 0.0 95.9 178.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -140.44 146.51 38.37 Favored 'General case' 0 CA--C 1.489 -1.385 1 N-CA-C 98.091 -4.781 . . . . 0.0 98.091 -174.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 9.7 tmtt? -115.75 97.29 6.04 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 103.144 -2.91 . . . . 0.0 103.144 174.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.4 t -70.86 120.37 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 -176.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 136.86 -37.38 1.87 Allowed Glycine 0 CA--C 1.486 -1.78 0 N-CA-C 103.949 -3.66 . . . . 0.0 103.949 -167.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 15.6 m170 -125.1 -64.71 1.07 Allowed 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 165.89 -161.22 34.8 Favored Glycine 0 N--CA 1.432 -1.626 0 N-CA-C 107.219 -2.353 . . . . 0.0 107.219 -171.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.7 tp -69.43 143.49 53.58 Favored 'General case' 0 CA--C 1.502 -0.904 0 C-N-CA 127.969 2.508 . . . . 0.0 105.725 177.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -153.05 178.3 9.86 Favored 'General case' 0 CA--C 1.488 -1.428 0 N-CA-C 103.759 -2.682 . . . . 0.0 103.759 -168.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 50.8 m -112.16 161.72 16.23 Favored 'General case' 0 CA--C 1.493 -1.25 0 N-CA-C 103.135 -2.913 . . . . 0.0 103.135 177.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.411 ' HA ' ' HA ' ' A' ' 5' ' ' TYR . 61.1 t-105 -101.83 152.18 21.2 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 104.598 -2.371 . . . . 0.0 104.598 166.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.8 m -141.4 141.17 33.77 Favored 'General case' 0 CA--C 1.491 -1.31 0 N-CA-C 104.568 -2.382 . . . . 0.0 104.568 164.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -105.67 107.9 19.13 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 102.606 -3.109 . . . . 0.0 102.606 174.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 90.06 135.4 0.03 OUTLIER 'General case' 0 N--CA 1.432 -1.365 0 C-N-CA 128.243 2.617 . . . . 0.0 106.068 -173.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -145.13 155.89 54.73 Favored Pre-proline 0 N--CA 1.426 -1.668 1 N-CA-C 96.335 -5.431 . . . . 0.0 96.335 149.166 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -70.16 165.06 32.68 Favored 'Trans proline' 0 N--CA 1.445 -1.346 0 C-N-CA 122.404 2.069 . . . . 0.0 109.139 164.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -74.7 -9.04 58.18 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 114.12 1.155 . . . . 0.0 114.12 -163.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 -84.35 -12.35 54.68 Favored 'General case' 0 CA--C 1.507 -0.696 0 O-C-N 121.397 -0.814 . . . . 0.0 110.176 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.2 t -87.29 118.39 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -87.45 147.01 20.45 Favored Glycine 0 CA--C 1.487 -1.702 0 N-CA-C 106.934 -2.467 . . . . 0.0 106.934 -178.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 46.1 pt -117.97 -153.81 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 -173.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 9.2 mm -66.77 -30.27 49.13 Favored 'Isoleucine or valine' 0 C--N 1.357 0.894 0 O-C-N 121.412 -0.805 . . . . 0.0 111.949 -165.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.426 -1.658 1 N-CA-C 99.058 -4.423 . . . . 0.0 99.058 175.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 9.9 m . . . . . 0 N--CA 1.483 1.221 0 CA-C-O 122.441 1.115 . . . . 0.0 110.913 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 16.2 mtp85 -100.64 158.03 16.24 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 -174.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -130.47 128.71 41.79 Favored 'General case' 0 CA--C 1.486 -1.481 1 N-CA-C 97.124 -5.139 . . . . 0.0 97.124 168.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.82 178.31 37.73 Favored Glycine 0 CA--C 1.481 -2.037 0 N-CA-C 107.272 -2.331 . . . . 0.0 107.272 -177.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -79.64 127.95 32.8 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 104.034 -2.58 . . . . 0.0 104.034 164.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.26 11.6 tt -91.51 147.6 5.16 Favored 'Isoleucine or valine' 0 C--O 1.243 0.737 0 CA-C-N 120.487 1.494 . . . . 0.0 108.879 178.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -135.77 -128.61 0.15 Allowed 'General case' 0 N--CA 1.426 -1.663 0 C-N-CA 128.035 2.534 . . . . 0.0 104.548 172.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -139.71 152.02 67.39 Favored Pre-proline 0 N--CA 1.424 -1.743 1 N-CA-C 96.513 -5.365 . . . . 0.0 96.513 176.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -74.89 35.14 0.4 Allowed 'Trans proline' 0 CA--C 1.514 -0.504 0 CA-C-N 124.241 2.55 . . . . 0.0 117.096 -159.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 53.0 mm-40 -124.53 32.79 5.39 Favored 'General case' 0 CA--C 1.497 -1.083 0 CA-C-N 120.202 1.364 . . . . 0.0 107.635 -169.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 48.99 58.1 5.73 Favored 'General case' 0 CA--C 1.489 -1.382 0 C-N-CA 128.686 2.794 . . . . 0.0 112.196 -174.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 91.3 m -116.89 -160.26 0.76 Allowed 'General case' 0 CA--C 1.482 -1.649 0 N-CA-C 103.285 -2.857 . . . . 0.0 103.285 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -134.85 169.39 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.827 1 N-CA-C 96.059 -5.534 . . . . 0.0 96.059 170.697 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -96.62 -154.27 0.44 Allowed 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 101.711 -3.44 . . . . 0.0 101.711 163.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 33.4 m80 -137.43 172.62 12.71 Favored 'General case' 0 CA--C 1.478 -1.792 1 N-CA-C 97.457 -5.016 . . . . 0.0 97.457 166.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 29.3 t -132.11 158.39 41.77 Favored 'General case' 0 N--CA 1.422 -1.868 1 N-CA-C 97.497 -5.001 . . . . 0.0 97.497 -175.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -112.45 104.78 56.13 Favored Pre-proline 0 N--CA 1.428 -1.546 1 N-CA-C 98.232 -4.729 . . . . 0.0 98.232 168.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -51.43 98.69 0.04 OUTLIER 'Trans proline' 0 CA--C 1.51 -0.708 0 C-N-CA 123.473 2.782 . . . . 0.0 117.07 -154.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 163.21 -171.48 38.95 Favored Glycine 0 N--CA 1.423 -2.227 1 N-CA-C 96.704 -6.558 . . . . 0.0 96.704 -172.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 38.1 m -82.46 -31.12 29.56 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 118.682 1.241 . . . . 0.0 111.154 -177.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.2 m -39.59 -71.48 0.08 Allowed 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 117.006 2.224 . . . . 0.0 117.006 -151.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.44 -43.82 52.67 Favored Glycine 0 C--N 1.347 1.153 0 O-C-N 121.198 -0.939 . . . . 0.0 111.113 -173.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 35.2 m -67.24 -43.98 80.59 Favored 'General case' 0 CA--C 1.486 -1.504 0 O-C-N 122.039 -0.683 . . . . 0.0 112.1 -173.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -66.35 -35.3 80.0 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -178.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.3 m -63.18 -50.41 70.45 Favored 'General case' 0 N--CA 1.445 -0.695 0 O-C-N 121.78 -0.575 . . . . 0.0 110.023 174.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.9 mt -63.56 -40.15 96.23 Favored 'General case' 0 C--N 1.359 0.998 0 CA-C-O 122.052 0.93 . . . . 0.0 110.923 -177.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 19.5 t -57.11 -47.6 80.68 Favored 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 125.775 1.63 . . . . 0.0 110.115 177.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 50.3 mttp -74.36 -34.63 63.42 Favored 'General case' 0 C--N 1.353 0.718 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.519 -173.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -77.43 -20.78 54.02 Favored 'General case' 0 C--N 1.354 0.771 0 O-C-N 121.712 -0.617 . . . . 0.0 111.407 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.6 mmtm -76.6 -59.09 2.92 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 168.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 134.64 48.77 0.08 OUTLIER Glycine 0 CA--C 1.489 -1.548 0 N-CA-C 108.896 -1.682 . . . . 0.0 108.896 170.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -107.18 139.97 15.14 Favored Glycine 0 CA--C 1.482 -1.976 1 N-CA-C 101.549 -4.62 . . . . 0.0 101.549 164.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.6 p -80.02 -49.5 11.72 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-N 118.587 1.193 . . . . 0.0 108.528 -170.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.3 m -103.41 139.84 38.26 Favored 'General case' 0 CA--C 1.487 -1.478 0 N-CA-C 102.101 -3.296 . . . . 0.0 102.101 -172.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -146.48 142.65 10.65 Favored Glycine 0 CA--C 1.473 -2.58 1 N-CA-C 101.215 -4.754 . . . . 0.0 101.215 -168.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 66.4 m80 -155.86 -157.43 0.72 Allowed 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 100.286 -3.968 . . . . 0.0 100.286 -173.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 85.5 m -143.73 177.36 8.56 Favored 'General case' 0 CA--C 1.476 -1.893 1 N-CA-C 99.099 -4.408 . . . . 0.0 99.099 177.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -179.27 -175.99 46.63 Favored Glycine 0 N--CA 1.419 -2.476 1 N-CA-C 98.092 -6.003 . . . . 0.0 98.092 177.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -116.68 139.44 50.54 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 102.048 -3.316 . . . . 0.0 102.048 177.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.9 94.27 4.96 Favored 'General case' 0 CA--C 1.498 -1.038 0 N-CA-C 103.506 -2.776 . . . . 0.0 103.506 178.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.7 t -70.76 116.82 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 -174.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 136.83 -39.59 1.62 Allowed Glycine 0 CA--C 1.488 -1.642 0 N-CA-C 105.929 -2.868 . . . . 0.0 105.929 -169.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 27.0 m170 -119.25 -66.85 1.03 Allowed 'General case' 0 CA--C 1.499 -0.992 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 178.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 167.04 -159.89 33.41 Favored Glycine 0 N--CA 1.432 -1.631 0 N-CA-C 106.262 -2.735 . . . . 0.0 106.262 -173.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 57.8 tp -68.21 142.28 55.71 Favored 'General case' 0 C--N 1.351 0.665 0 C-N-CA 126.779 2.032 . . . . 0.0 106.175 175.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -150.19 -178.04 6.28 Favored 'General case' 0 CA--C 1.485 -1.528 0 N-CA-C 104.046 -2.575 . . . . 0.0 104.046 -167.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 67.3 m -107.02 163.63 12.82 Favored 'General case' 0 CA--C 1.492 -1.287 0 N-CA-C 102.689 -3.078 . . . . 0.0 102.689 176.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 14.6 t-105 -128.14 146.67 50.64 Favored 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 104.435 -2.432 . . . . 0.0 104.435 177.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 61.2 m -140.43 151.49 44.93 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 174.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -118.95 143.44 47.03 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 103.806 -2.665 . . . . 0.0 103.806 166.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 77.02 54.94 0.04 OUTLIER 'General case' 0 CA--C 1.497 -1.075 0 C-N-CA 127.018 2.127 . . . . 0.0 110.883 171.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 33.5 mt -97.77 135.67 21.47 Favored Pre-proline 0 CA--C 1.5 -0.948 0 N-CA-C 105.12 -2.178 . . . . 0.0 105.12 173.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -74.46 167.92 26.01 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 CA-C-N 122.628 1.974 . . . . 0.0 111.103 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -61.28 -19.86 62.21 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 126.561 1.944 . . . . 0.0 114.686 -170.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.4 p-10 -86.54 -2.2 58.28 Favored 'General case' 0 CA--C 1.505 -0.767 0 C-N-CA 123.722 0.809 . . . . 0.0 110.628 -176.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.5 t -91.09 163.32 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 N-CA-C 104.078 -2.564 . . . . 0.0 104.078 177.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -145.84 154.53 26.0 Favored Glycine 0 CA--C 1.48 -2.132 1 N-CA-C 96.668 -6.573 . . . . 0.0 96.668 179.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 16.1 pt -139.66 -126.65 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 N-CA-C 104.885 -2.265 . . . . 0.0 104.885 -158.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.0 mm -74.5 62.28 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.582 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 169.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.425 -1.682 0 N-CA-C 103.008 -2.96 . . . . 0.0 103.008 -167.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 18.6 m . . . . . 0 N--CA 1.486 1.325 0 CA-C-O 121.898 0.856 . . . . 0.0 110.649 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 22.6 mtp85 -121.71 154.81 36.38 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 104.669 -2.345 . . . . 0.0 104.669 -172.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -137.48 132.71 33.7 Favored 'General case' 0 CA--C 1.486 -1.481 1 N-CA-C 97.273 -5.084 . . . . 0.0 97.273 166.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.29 -166.29 20.79 Favored Glycine 0 CA--C 1.477 -2.34 1 N-CA-C 101.948 -4.461 . . . . 0.0 101.948 172.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -74.81 142.14 44.25 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 103.872 -2.64 . . . . 0.0 103.872 161.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.1 tt -90.24 136.26 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.125 0 N-CA-C 105.018 -2.215 . . . . 0.0 105.018 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.406 ' HB3' ' H ' ' A' ' 8' ' ' GLN . . . -109.59 -149.94 0.45 Allowed 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 127.385 2.274 . . . . 0.0 106.255 179.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.406 ' H ' ' HB3' ' A' ' 7' ' ' ALA . 58.6 mt-30 -115.13 142.87 29.22 Favored Pre-proline 0 N--CA 1.426 -1.669 1 N-CA-C 97.454 -5.017 . . . . 0.0 97.454 171.108 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -75.58 29.81 0.38 Allowed 'Trans proline' 0 CA--C 1.503 -1.042 0 N-CA-C 117.764 2.179 . . . . 0.0 117.764 -141.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -120.35 -78.74 0.59 Allowed 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 101.733 -3.432 . . . . 0.0 101.733 -178.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 53.6 t-20 -160.92 142.72 12.17 Favored 'General case' 0 N--CA 1.423 -1.803 1 N-CA-C 93.932 -6.322 . . . . 0.0 93.932 166.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 19.0 m 173.42 -157.09 0.01 OUTLIER 'General case' 0 CA--C 1.496 -1.122 1 N-CA-C 98.743 -4.54 . . . . 0.0 98.743 172.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -126.8 167.68 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.575 1 N-CA-C 98.372 -4.677 . . . . 0.0 98.372 158.956 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -87.04 -162.7 0.82 Allowed 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 103.126 -2.916 . . . . 0.0 103.126 163.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 47.4 m80 -143.16 168.62 19.32 Favored 'General case' 0 N--CA 1.417 -2.114 1 N-CA-C 94.198 -6.223 . . . . 0.0 94.198 165.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.4 t -160.45 -151.01 0.23 Allowed 'General case' 0 N--CA 1.418 -2.037 1 N-CA-C 95.894 -5.595 . . . . 0.0 95.894 -176.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -148.44 147.77 26.5 Favored Pre-proline 0 N--CA 1.409 -2.493 1 N-CA-C 95.198 -5.853 . . . . 0.0 95.198 -167.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -71.23 73.8 2.04 Favored 'Trans proline' 0 C--N 1.32 -0.939 0 CA-C-N 125.383 2.958 . . . . 0.0 114.134 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -172.82 162.74 34.4 Favored Glycine 0 N--CA 1.425 -2.071 1 N-CA-C 98.704 -5.759 . . . . 0.0 98.704 175.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.2 m -81.65 -7.88 59.64 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 118.752 1.276 . . . . 0.0 111.775 -172.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -53.55 -28.38 31.41 Favored 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 128.448 2.699 . . . . 0.0 115.417 -169.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -87.06 -73.48 1.28 Allowed Glycine 0 C--N 1.348 1.211 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 176.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 75.6 m -79.99 -12.57 59.7 Favored 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 -162.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -63.17 -44.97 93.96 Favored 'General case' 0 C--N 1.358 0.972 0 CA-C-N 121.65 2.023 . . . . 0.0 108.38 173.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -57.67 -51.22 70.4 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 127.1 2.16 . . . . 0.0 110.794 174.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 84.6 mt -64.85 -40.1 94.61 Favored 'General case' 0 CA--C 1.497 -1.077 0 C-N-CA 124.088 0.955 . . . . 0.0 111.133 -177.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.7 t -56.77 -44.24 81.64 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 124.556 1.143 . . . . 0.0 109.847 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 52.0 mttp -71.15 -34.93 71.45 Favored 'General case' 0 N--CA 1.443 -0.801 0 O-C-N 122.151 -0.343 . . . . 0.0 111.54 -174.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -78.58 -26.67 45.55 Favored 'General case' 0 C--N 1.355 0.821 0 O-C-N 121.543 -0.723 . . . . 0.0 112.359 177.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.4 mmtm -80.54 -26.07 38.26 Favored 'General case' 0 C--N 1.357 0.92 0 CA-C-N 118.911 0.778 . . . . 0.0 109.843 176.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.53 37.64 1.88 Allowed Glycine 0 CA--C 1.486 -1.765 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 163.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -108.27 143.86 16.16 Favored Glycine 0 CA--C 1.485 -1.84 0 N-CA-C 103.226 -3.95 . . . . 0.0 103.226 168.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.4 m -73.5 -29.82 62.73 Favored 'General case' 0 N--CA 1.437 -1.084 0 O-C-N 122.074 -0.662 . . . . 0.0 110.473 -167.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.1 m -159.74 161.6 34.77 Favored 'General case' 0 CA--C 1.481 -1.704 0 N-CA-C 102.734 -3.062 . . . . 0.0 102.734 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -171.38 175.25 44.97 Favored Glycine 0 N--CA 1.419 -2.441 1 N-CA-C 99.944 -5.262 . . . . 0.0 99.944 -172.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 44.2 p-80 -169.67 -171.71 1.27 Allowed 'General case' 0 N--CA 1.431 -1.418 1 N-CA-C 98.224 -4.732 . . . . 0.0 98.224 -174.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 73.8 m -127.41 153.07 46.71 Favored 'General case' 0 CA--C 1.486 -1.498 0 N-CA-C 104.433 -2.432 . . . . 0.0 104.433 -173.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -172.18 167.17 40.1 Favored Glycine 0 CA--C 1.477 -2.316 1 N-CA-C 100.004 -5.238 . . . . 0.0 100.004 -173.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -98.67 161.18 13.8 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 104.741 -2.318 . . . . 0.0 104.741 -172.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.99 173.36 13.44 Favored 'General case' 0 N--CA 1.428 -1.55 1 N-CA-C 96.009 -5.552 . . . . 0.0 96.009 163.5 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -132.34 155.81 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.548 1 N-CA-C 97.607 -4.96 . . . . 0.0 97.607 177.928 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 130.34 -52.18 0.84 Allowed Glycine 0 CA--C 1.485 -1.789 1 N-CA-C 101.535 -4.626 . . . . 0.0 101.535 -170.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 66.9 m170 -117.48 -73.88 0.63 Allowed 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 104.318 -2.475 . . . . 0.0 104.318 168.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 164.45 -145.67 10.58 Favored Glycine 0 CA--C 1.472 -2.63 1 N-CA-C 100.876 -4.89 . . . . 0.0 100.876 178.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 33.2 tp -62.97 137.77 58.37 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 125.304 1.442 . . . . 0.0 107.388 -173.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -152.04 -171.12 3.84 Favored 'General case' 0 CA--C 1.479 -1.764 1 N-CA-C 97.556 -4.979 . . . . 0.0 97.556 -160.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 3.0 p -147.11 -174.15 4.43 Favored 'General case' 0 CA--C 1.478 -1.824 0 C-N-CA 115.734 -2.386 . . . . 0.0 104.616 169.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 43.7 t-105 -127.73 157.1 41.26 Favored 'General case' 0 CA--C 1.505 -0.785 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 -167.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 6.0 m -150.15 152.31 34.5 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 168.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -118.94 140.1 50.56 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 104.478 -2.416 . . . . 0.0 104.478 168.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 77.36 47.67 0.06 Allowed 'General case' 0 CA--C 1.496 -1.108 0 C-N-CA 127.451 2.301 . . . . 0.0 111.378 166.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 38.4 mt -91.48 137.14 26.07 Favored Pre-proline 0 CA--C 1.503 -0.862 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 178.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -77.94 174.71 12.13 Favored 'Trans proline' 0 N--CA 1.447 -1.217 0 C-N-CA 122.274 1.983 . . . . 0.0 111.494 -179.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -69.49 -9.05 52.15 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 125.254 1.421 . . . . 0.0 114.203 -171.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -92.73 -0.15 57.32 Favored 'General case' 0 CA--C 1.501 -0.934 0 O-C-N 121.667 -0.646 . . . . 0.0 110.008 -179.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.5 t -99.05 179.13 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 N-CA-C 102.49 -3.152 . . . . 0.0 102.49 174.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -152.12 159.4 28.33 Favored Glycine 0 CA--C 1.479 -2.216 1 N-CA-C 97.258 -6.337 . . . . 0.0 97.258 -178.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 18.2 pt -146.81 -156.46 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.271 0 N-CA-C 103.296 -2.853 . . . . 0.0 103.296 -165.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.1 mm -73.02 129.86 35.9 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.094 0 N-CA-C 104.839 -2.282 . . . . 0.0 104.839 176.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.9 t . . . . . 0 N--CA 1.426 -1.653 0 N-CA-C 100.687 -3.82 . . . . 0.0 100.687 172.974 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 26.7 m . . . . . 0 N--CA 1.483 1.184 0 CA-C-O 121.578 0.704 . . . . 0.0 109.798 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -100.31 156.2 17.37 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 104.136 -2.542 . . . . 0.0 104.136 166.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -123.99 122.04 36.87 Favored 'General case' 0 CA--C 1.487 -1.468 1 N-CA-C 95.705 -5.665 . . . . 0.0 95.705 164.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.55 -175.7 32.85 Favored Glycine 0 CA--C 1.477 -2.324 0 N-CA-C 105.01 -3.236 . . . . 0.0 105.01 -171.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -88.3 135.71 33.32 Favored 'General case' 0 CA--C 1.491 -1.319 0 N-CA-C 103.524 -2.769 . . . . 0.0 103.524 170.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 17.0 tt -90.25 139.34 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 N-CA-C 106.854 -1.535 . . . . 0.0 106.854 -177.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -111.16 -161.44 0.75 Allowed 'General case' 0 N--CA 1.426 -1.632 0 C-N-CA 127.536 2.334 . . . . 0.0 106.412 178.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -107.02 146.36 33.0 Favored Pre-proline 0 N--CA 1.427 -1.583 1 N-CA-C 97.985 -4.82 . . . . 0.0 97.985 164.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -80.22 -3.47 12.64 Favored 'Trans proline' 0 CA--C 1.5 -1.225 0 C-N-CA 121.183 1.256 . . . . 0.0 114.125 -135.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -91.28 -46.59 7.97 Favored 'General case' 0 CA--C 1.5 -0.98 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 49.8 t-20 171.1 142.53 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.465 1 N-CA-C 97.962 -4.829 . . . . 0.0 97.962 167.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 171.31 -157.2 0.01 OUTLIER 'General case' 0 CA--C 1.488 -1.419 0 C-N-CA 126.986 2.114 . . . . 0.0 105.587 178.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.5 m -125.83 155.81 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.775 1 N-CA-C 96.772 -5.27 . . . . 0.0 96.772 155.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -98.91 141.78 31.24 Favored 'General case' 0 CA--C 1.482 -1.636 1 N-CA-C 97.506 -4.998 . . . . 0.0 97.506 165.098 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -84.31 178.79 7.63 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 105.33 -2.1 . . . . 0.0 105.33 179.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 36.4 t -146.79 163.28 36.52 Favored 'General case' 0 N--CA 1.419 -1.979 1 N-CA-C 96.76 -5.274 . . . . 0.0 96.76 -173.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -126.27 132.57 24.36 Favored Pre-proline 0 N--CA 1.417 -2.11 1 N-CA-C 98.383 -4.673 . . . . 0.0 98.383 -173.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -65.53 -6.64 14.1 Favored 'Trans proline' 0 CA--C 1.514 -0.479 0 CA-C-N 123.576 2.313 . . . . 0.0 113.518 177.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -95.55 89.35 1.15 Allowed Glycine 0 C--N 1.352 1.426 1 N-CA-C 101.216 -4.754 . . . . 0.0 101.216 158.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.9 m -60.04 -15.56 23.78 Favored 'General case' 0 CA--C 1.498 -1.057 0 C-N-CA 127.404 2.281 . . . . 0.0 115.868 -159.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -44.41 -45.0 8.76 Favored 'General case' 0 N--CA 1.436 -1.155 0 C-N-CA 128.618 2.767 . . . . 0.0 114.087 -175.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.73 -50.28 65.51 Favored Glycine 0 C--N 1.355 1.587 0 N-CA-C 111.972 -0.451 . . . . 0.0 111.972 -175.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 19.5 t -76.14 -24.23 54.86 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -177.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -61.37 -48.24 82.19 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 175.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -60.57 -40.06 90.26 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 172.197 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 96.1 mt -64.96 -44.12 90.44 Favored 'General case' 0 C--N 1.357 0.928 0 CA-C-N 119.321 0.964 . . . . 0.0 110.551 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 9.1 t -58.23 -46.85 85.17 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 125.257 1.423 . . . . 0.0 109.632 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -67.75 -37.18 81.79 Favored 'General case' 0 C--N 1.354 0.766 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -177.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -77.11 -22.76 52.22 Favored 'General case' 0 C--N 1.354 0.794 0 O-C-N 121.192 -0.942 . . . . 0.0 111.397 -176.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -85.99 -34.29 20.86 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 175.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 114.89 44.03 0.71 Allowed Glycine 0 CA--C 1.482 -1.978 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 164.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.13 149.08 16.59 Favored Glycine 0 CA--C 1.487 -1.715 1 N-CA-C 102.322 -4.311 . . . . 0.0 102.322 163.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.1 m -70.61 -47.45 60.03 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 122.265 1.031 . . . . 0.0 110.203 -165.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 33.8 m -160.82 -174.0 4.2 Favored 'General case' 0 N--CA 1.422 -1.849 1 N-CA-C 97.802 -4.888 . . . . 0.0 97.802 167.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -175.92 -177.96 45.35 Favored Glycine 0 N--CA 1.418 -2.543 1 N-CA-C 99.329 -5.508 . . . . 0.0 99.329 -169.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 68.4 m80 -155.96 176.98 11.94 Favored 'General case' 0 N--CA 1.425 -1.71 1 N-CA-C 99.421 -4.288 . . . . 0.0 99.421 -172.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 68.0 m -88.38 164.31 15.59 Favored 'General case' 0 CA--C 1.49 -1.361 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -179.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -167.68 -169.84 31.71 Favored Glycine 0 N--CA 1.414 -2.815 1 N-CA-C 100.45 -5.06 . . . . 0.0 100.45 176.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -152.61 156.65 39.69 Favored 'General case' 0 N--CA 1.417 -2.09 1 N-CA-C 94.132 -6.247 . . . . 0.0 94.132 -176.816 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 16.8 ptmt -136.86 17.43 3.05 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 104.248 -2.501 . . . . 0.0 104.248 163.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . 0.276 1.8 t 50.01 -138.24 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.358 0.974 0 C-N-CA 126.764 2.026 . . . . 0.0 107.534 -160.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.43 -72.35 2.17 Favored Glycine 0 CA--C 1.495 -1.217 0 C-N-CA 123.787 0.708 . . . . 0.0 111.652 163.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 9.5 m170 -98.79 -64.41 1.04 Allowed 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 105.127 -2.175 . . . . 0.0 105.127 176.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 174.64 -169.23 42.16 Favored Glycine 0 CA--C 1.473 -2.531 1 N-CA-C 100.478 -5.049 . . . . 0.0 100.478 -169.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.2 tt -70.2 132.27 45.51 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 105.504 -2.035 . . . . 0.0 105.504 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -133.63 165.85 23.96 Favored 'General case' 0 CA--C 1.474 -1.954 0 N-CA-C 101.273 -3.603 . . . . 0.0 101.273 -159.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 49.7 t -120.2 151.61 38.88 Favored 'General case' 0 CA--C 1.488 -1.422 0 N-CA-C 102.482 -3.155 . . . . 0.0 102.482 -174.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 62.1 t-105 -97.95 149.72 22.11 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 104.108 -2.553 . . . . 0.0 104.108 175.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.8 m -141.35 143.95 34.28 Favored 'General case' 0 CA--C 1.481 -1.688 0 N-CA-C 100.949 -3.723 . . . . 0.0 100.949 170.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -108.55 124.6 50.73 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 104.14 -2.541 . . . . 0.0 104.14 179.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 76.37 73.59 0.08 Allowed 'General case' 0 CA--C 1.498 -1.025 0 C-N-CA 127.093 2.157 . . . . 0.0 110.939 171.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 35.9 mt -103.53 131.47 22.01 Favored Pre-proline 0 CA--C 1.498 -1.041 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 174.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -72.05 174.09 11.85 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 CA-C-N 122.515 1.934 . . . . 0.0 110.28 176.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -69.15 -8.35 44.71 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 -172.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 17.7 p-10 -81.91 -10.69 59.21 Favored 'General case' 0 CA--C 1.505 -0.786 0 O-C-N 121.093 -1.004 . . . . 0.0 109.438 -177.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.8 t -100.24 132.52 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.374 0 N-CA-C 104.538 -2.393 . . . . 0.0 104.538 -176.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -103.77 151.05 17.65 Favored Glycine 0 CA--C 1.485 -1.829 0 N-CA-C 103.099 -4.0 . . . . 0.0 103.099 176.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 24.7 pt -136.14 -152.96 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 N-CA-C 104.823 -2.288 . . . . 0.0 104.823 -164.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.8 mm -67.98 133.46 31.63 Favored 'Isoleucine or valine' 0 C--N 1.358 0.956 0 N-CA-C 107.497 -1.298 . . . . 0.0 107.497 -178.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.2 t . . . . . 0 N--CA 1.426 -1.663 1 N-CA-C 96.444 -5.391 . . . . 0.0 96.444 169.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 33.2 m . . . . . 0 N--CA 1.485 1.303 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -107.52 159.2 16.61 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 170.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -130.37 120.72 24.73 Favored 'General case' 0 CA--C 1.49 -1.333 1 N-CA-C 96.218 -5.475 . . . . 0.0 96.218 161.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.02 -175.06 32.64 Favored Glycine 0 CA--C 1.477 -2.325 0 N-CA-C 105.456 -3.058 . . . . 0.0 105.456 -176.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -79.53 136.17 36.82 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 104.121 -2.548 . . . . 0.0 104.121 165.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 14.4 tt -90.82 146.73 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 N-CA-C 105.663 -1.977 . . . . 0.0 105.663 178.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -131.38 -178.06 4.68 Favored 'General case' 0 N--CA 1.414 -2.273 0 N-CA-C 105.165 -2.161 . . . . 0.0 105.165 -178.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -86.6 149.05 47.89 Favored Pre-proline 0 N--CA 1.435 -1.208 0 N-CA-C 103.225 -2.88 . . . . 0.0 103.225 159.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_exo -71.48 0.56 6.69 Favored 'Trans proline' 0 CA--C 1.504 -0.994 0 CA-C-N 123.222 2.186 . . . . 0.0 115.691 -154.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.7 mp0 -94.44 19.19 9.97 Favored 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 126.039 1.736 . . . . 0.0 109.227 -170.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 67.2 t30 66.25 61.54 0.6 Allowed 'General case' 0 CA--C 1.497 -1.083 0 C-N-CA 127.543 2.337 . . . . 0.0 108.803 -178.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 85.4 m -122.13 -137.58 0.31 Allowed 'General case' 0 CA--C 1.481 -1.699 0 N-CA-C 103.307 -2.849 . . . . 0.0 103.307 -178.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -136.56 173.24 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.923 1 N-CA-C 99.855 -4.128 . . . . 0.0 99.855 164.279 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -124.59 138.82 54.29 Favored 'General case' 0 N--CA 1.414 -2.268 1 N-CA-C 93.555 -6.461 . . . . 0.0 93.555 174.26 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 54.6 m80 -87.26 -178.32 6.18 Favored 'General case' 0 CA--C 1.492 -1.268 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 -173.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.2 t -153.43 173.37 15.76 Favored 'General case' 0 N--CA 1.412 -2.341 1 N-CA-C 95.361 -5.792 . . . . 0.0 95.361 -168.014 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -140.52 142.15 28.04 Favored Pre-proline 0 N--CA 1.409 -2.501 1 N-CA-C 95.352 -5.796 . . . . 0.0 95.352 -177.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -75.06 64.81 6.12 Favored 'Trans proline' 0 C--N 1.326 -0.613 0 C-N-CA 123.698 2.932 . . . . 0.0 109.369 172.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 156.99 60.82 0.01 OUTLIER Glycine 0 CA--C 1.482 -1.988 1 N-CA-C 97.82 -6.112 . . . . 0.0 97.82 -170.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 m -84.09 46.34 1.19 Allowed 'General case' 0 N--CA 1.436 -1.16 0 C-N-CA 124.994 1.318 . . . . 0.0 113.403 -154.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.9 p -70.5 -38.88 74.39 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 124.63 1.172 . . . . 0.0 108.951 -178.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.94 -37.1 92.92 Favored Glycine 0 C--N 1.351 1.379 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 177.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 38.7 t -72.75 -31.04 64.64 Favored 'General case' 0 C--N 1.358 0.952 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -57.23 -44.89 84.21 Favored 'General case' 0 C--N 1.354 0.764 0 CA-C-N 119.827 1.194 . . . . 0.0 110.267 178.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -58.2 -48.1 81.39 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 171.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 95.9 mt -65.64 -41.09 93.0 Favored 'General case' 0 C--N 1.359 0.991 0 CA-C-O 122.651 1.215 . . . . 0.0 110.813 -176.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 9.0 t -62.99 -46.07 89.4 Favored 'General case' 0 CA--C 1.495 -1.148 0 C-N-CA 125.301 1.44 . . . . 0.0 108.871 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.7 mmtm -65.29 -43.71 90.31 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-O 119.327 -0.368 . . . . 0.0 111.423 -178.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 25.8 pt-20 -72.3 -19.05 61.73 Favored 'General case' 0 C--N 1.354 0.8 0 CA-C-N 118.76 0.709 . . . . 0.0 112.351 -174.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -88.45 -17.69 29.87 Favored 'General case' 0 CA--C 1.506 -0.731 0 C-N-CA 123.244 0.618 . . . . 0.0 110.199 175.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.88 27.06 5.56 Favored Glycine 0 CA--C 1.489 -1.553 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 169.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -95.69 123.08 7.53 Favored Glycine 0 CA--C 1.49 -1.499 0 N-CA-C 105.467 -3.053 . . . . 0.0 105.467 174.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.8 p -97.28 -4.64 38.38 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -167.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.8 p -159.11 169.94 23.11 Favored 'General case' 0 N--CA 1.427 -1.576 1 N-CA-C 97.859 -4.867 . . . . 0.0 97.859 172.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -176.09 179.65 47.07 Favored Glycine 0 CA--C 1.474 -2.498 1 N-CA-C 102.007 -4.437 . . . . 0.0 102.007 -172.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -154.12 -161.22 1.2 Allowed 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 100.821 -3.77 . . . . 0.0 100.821 -174.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 12.5 t -147.87 161.88 40.39 Favored 'General case' 0 N--CA 1.431 -1.396 1 N-CA-C 98.994 -4.447 . . . . 0.0 98.994 -172.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 170.03 -160.23 33.07 Favored Glycine 0 N--CA 1.428 -1.858 1 N-CA-C 102.285 -4.326 . . . . 0.0 102.285 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -134.53 143.13 47.25 Favored 'General case' 0 N--CA 1.433 -1.3 1 N-CA-C 99.482 -4.266 . . . . 0.0 99.482 -176.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.47 105.2 11.85 Favored 'General case' 0 CA--C 1.491 -1.322 0 N-CA-C 101.533 -3.506 . . . . 0.0 101.533 174.137 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.5 t -41.64 -71.59 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.496 -1.109 0 C-N-CA 127.114 2.165 . . . . 0.0 115.136 -163.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -77.25 53.03 3.45 Favored Glycine 0 CA--C 1.501 -0.785 0 C-N-CA 126.413 1.958 . . . . 0.0 111.485 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 41.9 m-70 -167.59 -60.52 0.03 OUTLIER 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 105.093 -2.188 . . . . 0.0 105.093 171.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 150.46 -154.05 25.41 Favored Glycine 0 C--N 1.352 1.463 0 N-CA-C 108.397 -1.881 . . . . 0.0 108.397 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 63.2 tp -71.91 125.85 28.25 Favored 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 178.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -131.5 172.46 12.19 Favored 'General case' 0 CA--C 1.476 -1.867 0 N-CA-C 103.684 -2.71 . . . . 0.0 103.684 -163.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 38.6 t -125.68 167.91 14.48 Favored 'General case' 0 CA--C 1.486 -1.515 0 N-CA-C 101.508 -3.516 . . . . 0.0 101.508 176.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 11.0 t-105 -124.56 147.03 48.69 Favored 'General case' 0 CA--C 1.484 -1.572 0 N-CA-C 101.542 -3.503 . . . . 0.0 101.542 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 22.0 m -139.5 148.72 43.04 Favored 'General case' 0 CA--C 1.486 -1.506 0 N-CA-C 100.516 -3.883 . . . . 0.0 100.516 176.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -122.59 136.56 54.91 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 102.703 -3.073 . . . . 0.0 102.703 -174.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 71.16 49.76 0.32 Allowed 'General case' 0 CA--C 1.499 -1.006 0 C-N-CA 127.313 2.245 . . . . 0.0 110.928 176.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 20.0 mt -88.43 135.1 33.12 Favored Pre-proline 0 CA--C 1.498 -1.047 0 N-CA-C 105.344 -2.095 . . . . 0.0 105.344 177.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -73.15 170.59 19.48 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 122.241 1.961 . . . . 0.0 110.315 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -77.36 -3.94 42.64 Favored 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 -164.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -92.96 1.8 57.12 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 123.944 0.898 . . . . 0.0 109.885 -178.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.5 t -102.61 137.2 31.54 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.146 0 N-CA-C 103.386 -2.82 . . . . 0.0 103.386 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -108.14 144.52 16.2 Favored Glycine 0 CA--C 1.481 -2.091 0 N-CA-C 103.376 -3.889 . . . . 0.0 103.376 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 27.3 pt -139.18 -147.46 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.379 0 N-CA-C 103.529 -2.767 . . . . 0.0 103.529 -166.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.8 mm -69.73 121.11 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 175.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.496 -1.101 0 C-N-CA 124.554 1.141 . . . . 0.0 109.171 -164.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 27.5 m . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 121.11 0.481 . . . . 0.0 110.038 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.31 173.02 9.11 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 106.163 -1.792 . . . . 0.0 106.163 175.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -134.53 140.97 46.54 Favored 'General case' 0 N--CA 1.431 -1.398 1 N-CA-C 95.4 -5.778 . . . . 0.0 95.4 164.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.65 -175.77 33.03 Favored Glycine 0 CA--C 1.475 -2.42 1 N-CA-C 101.56 -4.616 . . . . 0.0 101.56 176.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -82.95 136.8 34.43 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 101.16 -3.644 . . . . 0.0 101.16 158.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 13.5 tt -87.29 132.98 31.29 Favored 'Isoleucine or valine' 0 C--O 1.252 1.19 0 N-CA-C 105.612 -1.995 . . . . 0.0 105.612 -174.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -107.56 -179.68 3.98 Favored 'General case' 0 C--N 1.366 1.314 0 O-C-N 127.691 3.119 . . . . 0.0 108.702 175.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -95.37 135.98 22.87 Favored Pre-proline 0 N--CA 1.433 -1.307 0 N-CA-C 100.508 -3.886 . . . . 0.0 100.508 167.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -78.15 60.42 7.39 Favored 'Trans proline' 0 CA--C 1.514 -0.519 0 C-N-CA 123.836 3.024 . . . . 0.0 112.49 -163.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -118.13 -83.28 0.64 Allowed 'General case' 0 N--CA 1.422 -1.827 1 N-CA-C 96.686 -5.302 . . . . 0.0 96.686 159.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 19.8 t30 -166.17 143.48 5.3 Favored 'General case' 0 N--CA 1.419 -1.976 1 N-CA-C 92.616 -6.809 . . . . 0.0 92.616 159.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.1 m 176.3 -157.11 0.02 OUTLIER 'General case' 0 CA--C 1.49 -1.333 1 N-CA-C 99.737 -4.172 . . . . 0.0 99.737 178.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -120.83 155.95 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.913 1 N-CA-C 97.46 -5.015 . . . . 0.0 97.46 160.592 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -93.64 136.88 33.47 Favored 'General case' 0 CA--C 1.48 -1.724 1 N-CA-C 96.895 -5.224 . . . . 0.0 96.895 162.595 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 79.0 m80 -85.85 176.27 8.19 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 -169.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 12.2 t -140.67 158.23 44.29 Favored 'General case' 0 N--CA 1.413 -2.31 1 N-CA-C 94.056 -6.276 . . . . 0.0 94.056 178.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -124.93 138.69 31.94 Favored Pre-proline 0 N--CA 1.419 -1.986 1 N-CA-C 95.654 -5.684 . . . . 0.0 95.654 177.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_exo -63.53 94.94 0.18 Allowed 'Trans proline' 0 CA--C 1.512 -0.598 0 CA-C-N 124.71 2.718 . . . . 0.0 114.182 -171.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 164.64 -173.51 40.57 Favored Glycine 0 N--CA 1.421 -2.308 1 N-CA-C 97.927 -6.069 . . . . 0.0 97.927 -176.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.1 m -84.49 -32.59 23.88 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 117.333 0.566 . . . . 0.0 110.421 -177.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.5 m -46.7 -59.68 2.88 Favored 'General case' 0 N--CA 1.439 -0.984 0 C-N-CA 127.594 2.358 . . . . 0.0 116.582 -156.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -72.82 -54.69 7.04 Favored Glycine 0 C--N 1.349 1.286 0 N-CA-C 110.179 -1.169 . . . . 0.0 110.179 -174.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 49.1 t -61.29 -48.39 81.62 Favored 'General case' 0 CA--C 1.499 -1.016 0 C-N-CA 125.418 1.487 . . . . 0.0 111.473 -171.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -62.34 -42.78 99.67 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 118.729 0.695 . . . . 0.0 109.543 -175.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.0 m -66.5 -50.86 61.85 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 123.567 0.747 . . . . 0.0 110.639 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 55.7 mt -64.09 -41.83 97.15 Favored 'General case' 0 C--N 1.362 1.124 0 C-N-CA 124.697 1.199 . . . . 0.0 110.35 -175.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 15.9 t -62.35 -46.44 88.65 Favored 'General case' 0 CA--C 1.5 -0.967 0 C-N-CA 123.649 0.779 . . . . 0.0 108.98 177.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -66.82 -45.0 79.68 Favored 'General case' 0 CA--C 1.504 -0.802 0 O-C-N 121.76 -0.587 . . . . 0.0 110.899 -173.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -72.33 -23.58 61.18 Favored 'General case' 0 C--N 1.354 0.774 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -174.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 42.6 mmtm -88.22 -18.82 27.82 Favored 'General case' 0 C--N 1.354 0.772 0 CA-C-N 118.673 0.669 . . . . 0.0 109.393 175.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.35 41.66 1.35 Allowed Glycine 0 CA--C 1.483 -1.952 0 N-CA-C 109.331 -1.507 . . . . 0.0 109.331 161.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -103.79 128.5 9.52 Favored Glycine 0 CA--C 1.486 -1.76 0 N-CA-C 103.56 -3.816 . . . . 0.0 103.56 171.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.7 p -99.87 4.49 45.17 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 122.339 1.066 . . . . 0.0 108.725 -166.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 46.4 m -160.3 165.12 31.92 Favored 'General case' 0 N--CA 1.421 -1.893 1 N-CA-C 98.66 -4.571 . . . . 0.0 98.66 166.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 179.69 -173.72 45.44 Favored Glycine 0 N--CA 1.414 -2.801 1 N-CA-C 99.563 -5.415 . . . . 0.0 99.563 -176.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 10.1 p-80 -171.42 173.65 4.73 Favored 'General case' 0 N--CA 1.43 -1.428 1 N-CA-C 99.463 -4.273 . . . . 0.0 99.463 172.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 49.0 t -94.32 153.92 17.76 Favored 'General case' 0 CA--C 1.502 -0.878 0 N-CA-C 105.361 -2.088 . . . . 0.0 105.361 -176.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.63 -165.3 28.65 Favored Glycine 0 N--CA 1.431 -1.659 0 N-CA-C 104.927 -3.269 . . . . 0.0 104.927 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -148.42 147.58 29.34 Favored 'General case' 0 N--CA 1.429 -1.495 1 N-CA-C 98.012 -4.811 . . . . 0.0 98.012 -170.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -130.17 100.7 5.5 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 102.106 -3.294 . . . . 0.0 102.106 167.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.9 t -70.22 120.08 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 -173.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 141.07 -48.4 0.82 Allowed Glycine 0 CA--C 1.484 -1.865 1 N-CA-C 102.019 -4.433 . . . . 0.0 102.019 -164.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 18.3 m-70 -106.69 -74.93 0.64 Allowed 'General case' 0 CA--C 1.501 -0.934 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 173.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 169.16 -156.53 27.82 Favored Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 105.427 -3.069 . . . . 0.0 105.427 -173.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.78 130.11 42.13 Favored 'General case' 0 C--N 1.358 0.939 0 C-N-CA 127.809 2.443 . . . . 0.0 104.819 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -130.5 174.81 9.53 Favored 'General case' 0 CA--C 1.478 -1.792 0 N-CA-C 104.734 -2.321 . . . . 0.0 104.734 -168.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 19.3 t -121.38 158.16 28.9 Favored 'General case' 0 CA--C 1.492 -1.263 1 N-CA-C 99.575 -4.231 . . . . 0.0 99.575 172.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 12.3 t-105 -117.81 150.5 39.04 Favored 'General case' 0 CA--C 1.495 -1.173 0 N-CA-C 102.233 -3.247 . . . . 0.0 102.233 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 59.1 m -147.47 152.01 37.35 Favored 'General case' 0 CA--C 1.492 -1.272 0 N-CA-C 105.057 -2.201 . . . . 0.0 105.057 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -119.79 145.14 46.87 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 104.636 -2.357 . . . . 0.0 104.636 171.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 65.2 53.02 1.38 Allowed 'General case' 0 CA--C 1.49 -1.331 0 C-N-CA 127.283 2.233 . . . . 0.0 110.461 170.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 31.2 mt -91.31 139.95 25.53 Favored Pre-proline 0 CA--C 1.498 -1.028 0 N-CA-C 103.602 -2.74 . . . . 0.0 103.602 175.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -72.17 169.96 20.23 Favored 'Trans proline' 0 N--CA 1.447 -1.233 0 C-N-CA 122.544 2.163 . . . . 0.0 109.456 176.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -83.0 13.65 3.85 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -165.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -103.7 4.28 35.19 Favored 'General case' 0 CA--C 1.501 -0.922 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 177.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.0 t -104.85 154.53 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 N-CA-C 103.181 -2.896 . . . . 0.0 103.181 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -122.94 158.62 17.59 Favored Glycine 0 CA--C 1.483 -1.954 1 N-CA-C 102.731 -4.147 . . . . 0.0 102.731 -175.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 28.4 pt -151.18 -178.81 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.594 0 N-CA-C 102.469 -3.16 . . . . 0.0 102.469 -163.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.5 mm -69.61 131.9 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.045 0 O-C-N 123.974 0.796 . . . . 0.0 109.813 -166.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.6 t . . . . . 0 N--CA 1.429 -1.516 1 N-CA-C 98.98 -4.452 . . . . 0.0 98.98 173.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 5.7 m . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 121.811 0.815 . . . . 0.0 111.343 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 20.5 mtp85 -106.27 147.93 28.56 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 104.834 -2.284 . . . . 0.0 104.834 177.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -129.51 120.1 24.83 Favored 'General case' 0 CA--C 1.489 -1.378 1 N-CA-C 98.044 -4.798 . . . . 0.0 98.044 166.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.78 -170.62 26.76 Favored Glycine 0 CA--C 1.481 -2.058 0 N-CA-C 104.89 -3.284 . . . . 0.0 104.89 -169.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -96.6 140.25 31.5 Favored 'General case' 0 CA--C 1.491 -1.321 0 N-CA-C 101.73 -3.433 . . . . 0.0 101.73 168.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.7 tt -91.07 149.21 4.14 Favored 'Isoleucine or valine' 0 C--O 1.246 0.894 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 178.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.406 ' HB3' HD12 ' A' ' 59' ' ' ILE . . . -141.32 173.0 11.9 Favored 'General case' 0 N--CA 1.413 -2.304 1 N-CA-C 99.457 -4.275 . . . . 0.0 99.457 175.42 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -79.97 149.95 71.09 Favored Pre-proline 0 N--CA 1.434 -1.226 0 N-CA-C 103.14 -2.911 . . . . 0.0 103.14 165.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -79.95 -1.87 11.71 Favored 'Trans proline' 0 CA--C 1.499 -1.246 0 CA-C-N 121.113 1.433 . . . . 0.0 112.484 -142.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -96.33 13.79 26.49 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 -177.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 53.5 t30 77.28 44.89 0.09 Allowed 'General case' 0 CA--C 1.5 -0.951 0 C-N-CA 127.693 2.397 . . . . 0.0 108.354 178.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.3 m -122.82 110.73 15.82 Favored 'General case' 0 CA--C 1.482 -1.664 1 N-CA-C 99.42 -4.289 . . . . 0.0 99.42 -176.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 18.0 m -67.22 160.33 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.234 0 CA-C-N 119.652 1.115 . . . . 0.0 112.925 -163.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -101.71 117.49 34.98 Favored 'General case' 0 CA--C 1.479 -1.772 1 N-CA-C 97.341 -5.059 . . . . 0.0 97.341 179.645 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -83.15 125.85 31.97 Favored 'General case' 0 CA--C 1.486 -1.496 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 -158.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 40.4 t -92.24 149.59 21.37 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 104.026 -2.583 . . . . 0.0 104.026 175.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -134.45 140.0 34.41 Favored Pre-proline 0 N--CA 1.416 -2.141 1 N-CA-C 96.977 -5.194 . . . . 0.0 96.977 172.455 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -68.65 67.67 1.16 Allowed 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 124.124 3.216 . . . . 0.0 113.431 174.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -178.13 50.86 0.1 OUTLIER Glycine 0 CA--C 1.487 -1.656 1 N-CA-C 99.41 -5.476 . . . . 0.0 99.41 177.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.0 m -86.25 45.02 1.18 Allowed 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 114.104 -1.048 . . . . 0.0 112.909 -147.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.5 p -72.93 -42.63 63.27 Favored 'General case' 0 N--CA 1.444 -0.756 0 O-C-N 121.372 -0.83 . . . . 0.0 109.379 -175.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -68.97 -43.71 71.67 Favored Glycine 0 C--N 1.349 1.289 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 177.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.7 t -59.73 -44.4 93.79 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 125.455 1.502 . . . . 0.0 111.754 178.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -67.5 -35.32 78.9 Favored 'General case' 0 C--N 1.353 0.737 0 O-C-N 120.974 -1.079 . . . . 0.0 110.596 177.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 40.7 m -70.05 -33.69 72.27 Favored 'General case' 0 N--CA 1.45 -0.448 0 O-C-N 121.052 -1.03 . . . . 0.0 109.955 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 20.3 mt -66.89 -38.38 86.15 Favored 'General case' 0 CA--C 1.496 -1.129 0 O-C-N 121.518 -0.739 . . . . 0.0 109.705 177.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 36.8 t -54.82 -47.89 73.51 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 122.149 -0.344 . . . . 0.0 111.699 170.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.5 mmtm -63.06 -50.32 71.05 Favored 'General case' 0 C--N 1.354 0.784 0 O-C-N 121.394 -0.816 . . . . 0.0 111.276 -178.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -70.71 -8.91 55.53 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 112.897 0.702 . . . . 0.0 112.897 -173.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.9 mmmp? -102.69 2.9 36.44 Favored 'General case' 0 C--N 1.354 0.785 0 O-C-N 121.469 -0.769 . . . . 0.0 111.239 173.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 93.96 29.0 10.17 Favored Glycine 0 C--N 1.35 1.341 0 N-CA-C 111.436 -0.666 . . . . 0.0 111.436 169.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -91.93 140.97 15.42 Favored Glycine 0 C--N 1.354 1.578 0 N-CA-C 106.851 -2.5 . . . . 0.0 106.851 171.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.4 m -99.11 -26.38 14.23 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 -165.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.6 m -147.93 175.64 10.8 Favored 'General case' 0 CA--C 1.482 -1.661 1 N-CA-C 99.92 -4.104 . . . . 0.0 99.92 171.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -171.68 -176.44 40.66 Favored Glycine 0 N--CA 1.42 -2.382 1 N-CA-C 100.579 -5.008 . . . . 0.0 100.579 -173.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.444 ' CE1' ' CD1' ' A' ' 48' ' ' TRP . 16.2 p-80 -177.91 -152.5 0.03 OUTLIER 'General case' 0 N--CA 1.434 -1.254 1 N-CA-C 97.687 -4.931 . . . . 0.0 97.687 173.101 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 24.8 t -149.5 154.77 39.29 Favored 'General case' 0 N--CA 1.425 -1.723 1 N-CA-C 97.904 -4.85 . . . . 0.0 97.904 -173.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 178.76 -179.29 48.82 Favored Glycine 0 N--CA 1.425 -2.092 1 N-CA-C 96.8 -6.52 . . . . 0.0 96.8 -178.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.45 ' CD1' ' HA ' ' A' ' 45' ' ' LEU . 61.3 t80 -158.25 134.34 9.26 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 101.295 -3.595 . . . . 0.0 101.295 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.454 ' H ' HG22 ' A' ' 41' ' ' VAL . 28.7 mmmt -168.72 57.35 0.05 Allowed 'General case' 0 CA--C 1.499 -1.005 1 N-CA-C 97.747 -4.909 . . . . 0.0 97.747 172.545 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.454 HG22 ' H ' ' A' ' 40' ' ' LYS . 13.7 t -134.89 163.94 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.369 1 N-CA-C 99.579 -4.23 . . . . 0.0 99.579 -169.125 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -116.45 89.46 0.49 Allowed Glycine 0 CA--C 1.487 -1.69 1 N-CA-C 101.822 -4.511 . . . . 0.0 101.822 170.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 60.9 m-70 -175.01 -154.63 0.05 Allowed 'General case' 0 N--CA 1.429 -1.507 1 N-CA-C 96.779 -5.267 . . . . 0.0 96.779 -175.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -83.72 -69.86 1.37 Allowed Glycine 0 C--N 1.351 1.395 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -176.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.45 ' HA ' ' CD1' ' A' ' 39' ' ' PHE . 0.1 OUTLIER -167.54 152.7 7.12 Favored 'General case' 0 CA--C 1.489 -1.383 1 N-CA-C 96.363 -5.421 . . . . 0.0 96.363 178.61 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.19 166.06 25.54 Favored 'General case' 0 CA--C 1.486 -1.49 0 N-CA-C 102.521 -3.141 . . . . 0.0 102.521 -167.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 99.6 m -101.84 150.96 22.64 Favored 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 104.318 -2.475 . . . . 0.0 104.318 -178.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.444 ' CD1' ' CE1' ' A' ' 36' ' ' HIS . 44.0 t-105 -93.75 146.33 23.93 Favored 'General case' 0 CA--C 1.496 -1.125 0 N-CA-C 104.327 -2.471 . . . . 0.0 104.327 177.006 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 60.6 m -133.95 141.14 47.18 Favored 'General case' 0 CA--C 1.48 -1.744 0 N-CA-C 104.651 -2.351 . . . . 0.0 104.651 169.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -113.46 128.63 56.51 Favored 'General case' 0 N--CA 1.427 -1.596 0 N-CA-C 101.843 -3.392 . . . . 0.0 101.843 176.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 63.33 74.1 0.43 Allowed 'General case' 0 N--CA 1.434 -1.245 0 C-N-CA 126.571 1.948 . . . . 0.0 110.823 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 17.8 mt -97.99 141.9 23.71 Favored Pre-proline 0 CA--C 1.496 -1.122 0 N-CA-C 103.006 -2.961 . . . . 0.0 103.006 164.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -72.85 166.43 30.02 Favored 'Trans proline' 0 N--CA 1.443 -1.476 0 C-N-CA 122.382 2.054 . . . . 0.0 109.186 178.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -77.28 1.25 19.22 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -164.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -101.86 5.83 41.2 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 123.855 0.862 . . . . 0.0 109.594 -177.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.9 t -97.6 163.93 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 103.428 -2.804 . . . . 0.0 103.428 178.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -142.98 150.79 22.62 Favored Glycine 0 CA--C 1.475 -2.426 1 N-CA-C 97.247 -6.341 . . . . 0.0 97.247 -178.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 18.8 pt -153.77 -147.65 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.49 -1.358 0 N-CA-C 101.553 -3.499 . . . . 0.0 101.553 -154.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.406 HD12 ' HB3' ' A' ' 7' ' ' ALA . 7.3 mm -59.51 119.37 3.81 Favored 'Isoleucine or valine' 0 C--N 1.36 1.045 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 174.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.496 -1.126 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.491 -162.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 24.1 m . . . . . 0 N--CA 1.484 1.263 0 CA-C-O 120.999 0.428 . . . . 0.0 110.455 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.67 173.34 6.92 Favored 'General case' 0 CA--C 1.5 -0.957 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 173.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -130.0 140.08 50.94 Favored 'General case' 0 CA--C 1.488 -1.43 1 N-CA-C 94.563 -6.088 . . . . 0.0 94.563 163.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.72 176.07 38.22 Favored Glycine 0 CA--C 1.476 -2.346 0 N-CA-C 104.901 -3.279 . . . . 0.0 104.901 -178.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -83.62 126.93 33.35 Favored 'General case' 0 CA--C 1.497 -1.067 0 N-CA-C 101.184 -3.636 . . . . 0.0 101.184 157.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.4 tt -90.3 137.39 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 -172.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.68 -150.92 0.34 Allowed 'General case' 0 N--CA 1.427 -1.589 0 C-N-CA 127.605 2.362 . . . . 0.0 107.606 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -119.52 139.54 27.98 Favored Pre-proline 0 N--CA 1.424 -1.769 1 N-CA-C 93.847 -6.353 . . . . 0.0 93.847 165.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -83.0 30.81 0.53 Allowed 'Trans proline' 0 CA--C 1.505 -0.966 0 C-N-CA 122.306 2.004 . . . . 0.0 113.916 -135.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -106.25 -89.45 0.43 Allowed 'General case' 0 N--CA 1.424 -1.727 0 N-CA-C 101.43 -3.544 . . . . 0.0 101.43 177.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -157.16 138.07 13.39 Favored 'General case' 0 N--CA 1.417 -2.091 1 N-CA-C 92.377 -6.898 . . . . 0.0 92.377 164.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 5.5 m 176.59 -163.54 0.03 OUTLIER 'General case' 0 CA--C 1.489 -1.4 1 N-CA-C 97.414 -5.032 . . . . 0.0 97.414 178.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 15.4 m -119.73 163.08 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.626 1 N-CA-C 99.19 -4.374 . . . . 0.0 99.19 159.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -83.44 164.75 19.71 Favored 'General case' 0 CA--C 1.501 -0.925 0 N-CA-C 102.722 -3.066 . . . . 0.0 102.722 162.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 22.8 m80 -90.29 158.12 17.33 Favored 'General case' 0 CA--C 1.484 -1.595 0 N-CA-C 101.538 -3.504 . . . . 0.0 101.538 178.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -160.19 177.48 10.63 Favored 'General case' 0 N--CA 1.41 -2.432 1 N-CA-C 95.92 -5.585 . . . . 0.0 95.92 -174.48 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -147.06 167.29 13.94 Favored Pre-proline 0 N--CA 1.412 -2.331 1 N-CA-C 96.019 -5.548 . . . . 0.0 96.019 -161.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.05 49.67 2.33 Favored 'Trans proline' 0 C--N 1.316 -1.169 0 CA-C-N 124.752 2.733 . . . . 0.0 110.61 169.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -172.68 139.34 5.17 Favored Glycine 0 CA--C 1.478 -2.234 1 N-CA-C 99.702 -5.359 . . . . 0.0 99.702 -177.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.0 m -92.15 11.04 26.88 Favored 'General case' 0 CA--C 1.499 -0.994 0 C-N-CA 123.673 0.789 . . . . 0.0 112.27 -165.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.4 m -51.14 -53.74 31.73 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 126.29 1.836 . . . . 0.0 113.871 -168.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.93 -35.52 27.61 Favored Glycine 0 C--N 1.352 1.427 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -177.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 44.1 t -59.95 -44.61 94.3 Favored 'General case' 0 CA--C 1.499 -0.989 0 C-N-CA 125.379 1.471 . . . . 0.0 110.769 -174.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -59.13 -44.3 92.02 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 124.478 1.111 . . . . 0.0 110.329 178.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -68.87 -38.17 79.54 Favored 'General case' 0 N--CA 1.443 -0.787 0 O-C-N 121.018 -1.051 . . . . 0.0 112.848 175.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 85.8 mt -65.03 -40.33 94.69 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-O 122.29 1.043 . . . . 0.0 109.742 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.6 t -60.14 -46.99 87.78 Favored 'General case' 0 N--CA 1.433 -1.286 0 C-N-CA 123.895 0.878 . . . . 0.0 110.404 -178.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -74.26 -29.34 61.63 Favored 'General case' 0 N--CA 1.444 -0.762 0 O-C-N 121.725 -0.609 . . . . 0.0 112.433 -176.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -79.04 -25.33 43.2 Favored 'General case' 0 C--N 1.357 0.918 0 O-C-N 121.023 -1.048 . . . . 0.0 111.094 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.1 mmmp? -82.53 -29.3 30.51 Favored 'General case' 0 C--N 1.358 0.935 0 O-C-N 121.451 -0.781 . . . . 0.0 109.381 172.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 110.25 43.68 1.06 Allowed Glycine 0 CA--C 1.485 -1.793 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 164.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -104.06 161.3 15.69 Favored Glycine 0 CA--C 1.488 -1.608 0 N-CA-C 103.394 -3.883 . . . . 0.0 103.394 166.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.1 p -71.94 -52.34 17.68 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-O 122.281 1.039 . . . . 0.0 109.924 -168.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 39.3 m -160.85 -176.55 5.59 Favored 'General case' 0 N--CA 1.421 -1.924 1 N-CA-C 98.002 -4.814 . . . . 0.0 98.002 170.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -172.67 -176.17 41.14 Favored Glycine 0 N--CA 1.416 -2.673 1 N-CA-C 98.766 -5.734 . . . . 0.0 98.766 -169.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 39.6 m80 -157.96 169.42 24.62 Favored 'General case' 0 N--CA 1.432 -1.366 1 N-CA-C 99.504 -4.258 . . . . 0.0 99.504 -176.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 64.1 m -84.22 159.92 20.9 Favored 'General case' 0 CA--C 1.499 -0.992 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 172.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -170.02 -178.51 41.05 Favored Glycine 0 N--CA 1.423 -2.19 1 N-CA-C 99.186 -5.566 . . . . 0.0 99.186 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -151.82 -169.33 3.33 Favored 'General case' 0 N--CA 1.422 -1.849 1 N-CA-C 99.224 -4.362 . . . . 0.0 99.224 174.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -154.21 -141.86 0.11 Allowed 'General case' 0 N--CA 1.424 -1.747 1 N-CA-C 93.637 -6.431 . . . . 0.0 93.637 -168.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.2 t -124.95 151.62 30.7 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.293 1 N-CA-C 96.995 -5.187 . . . . 0.0 96.995 149.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 160.49 -137.14 4.84 Favored Glycine 0 N--CA 1.42 -2.398 1 N-CA-C 98.683 -5.767 . . . . 0.0 98.683 -163.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 33.2 m170 -87.49 -35.08 18.41 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -160.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -169.92 -65.14 0.04 OUTLIER Glycine 0 C--N 1.357 1.73 0 C-N-CA 118.031 -2.033 . . . . 0.0 110.692 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.26 -178.08 6.43 Favored 'General case' 0 N--CA 1.434 -1.242 1 N-CA-C 94.784 -6.006 . . . . 0.0 94.784 167.786 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -150.36 171.72 16.54 Favored 'General case' 0 CA--C 1.482 -1.667 0 N-CA-C 102.206 -3.257 . . . . 0.0 102.206 174.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 8.5 t -110.13 155.61 21.69 Favored 'General case' 0 CA--C 1.489 -1.396 1 N-CA-C 99.378 -4.304 . . . . 0.0 99.378 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 6.5 t-105 -118.57 154.45 32.58 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 102.454 -3.165 . . . . 0.0 102.454 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 9.8 m -151.06 154.86 37.81 Favored 'General case' 0 CA--C 1.49 -1.365 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 176.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -117.81 143.42 46.28 Favored 'General case' 0 CA--C 1.495 -1.145 0 N-CA-C 104.689 -2.338 . . . . 0.0 104.689 169.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 65.02 58.27 0.92 Allowed 'General case' 0 CA--C 1.498 -1.023 0 C-N-CA 127.681 2.392 . . . . 0.0 112.507 171.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 31.3 mt -97.03 146.57 31.53 Favored Pre-proline 0 CA--C 1.502 -0.872 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 177.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -64.25 162.51 29.76 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 123.167 2.578 . . . . 0.0 111.244 174.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -68.88 -22.79 64.17 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -169.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 18.5 p-10 -94.66 19.82 9.42 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 124.345 1.058 . . . . 0.0 110.376 -176.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.3 t -106.91 126.2 62.91 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.274 0 N-CA-C 101.596 -3.483 . . . . 0.0 101.596 169.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -90.95 154.55 23.11 Favored Glycine 0 CA--C 1.492 -1.385 0 N-CA-C 107.923 -2.071 . . . . 0.0 107.923 -174.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 45.8 pt -136.68 -171.84 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 -170.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.3 mm -69.77 127.55 31.83 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.275 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 -174.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 42.6 t . . . . . 0 N--CA 1.426 -1.632 0 N-CA-C 101.81 -3.404 . . . . 0.0 101.81 177.908 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 15.2 m . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 121.565 0.698 . . . . 0.0 110.515 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 6.1 mmm180 -101.66 141.89 33.84 Favored 'General case' 0 CA--C 1.495 -1.169 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 -178.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -130.19 116.51 18.53 Favored 'General case' 0 CA--C 1.489 -1.403 1 N-CA-C 95.815 -5.624 . . . . 0.0 95.815 158.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.86 -172.2 28.94 Favored Glycine 0 CA--C 1.476 -2.405 1 N-CA-C 100.981 -4.848 . . . . 0.0 100.981 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -76.86 144.87 38.72 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 104.359 -2.46 . . . . 0.0 104.359 161.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.5 tt -91.23 140.99 15.1 Favored 'Isoleucine or valine' 0 C--O 1.249 1.046 0 N-CA-C 104.617 -2.364 . . . . 0.0 104.617 171.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -141.29 176.99 8.4 Favored 'General case' 0 N--CA 1.41 -2.457 1 N-CA-C 98.875 -4.491 . . . . 0.0 98.875 177.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -85.44 153.38 58.8 Favored Pre-proline 0 N--CA 1.431 -1.386 0 N-CA-C 103.705 -2.702 . . . . 0.0 103.705 172.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -68.1 -16.93 45.53 Favored 'Trans proline' 0 CA--C 1.502 -1.121 0 N-CA-C 117.625 2.125 . . . . 0.0 117.625 -149.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.4 mp0 -95.37 18.47 12.48 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-N 119.317 0.962 . . . . 0.0 108.52 -175.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 58.3 t-20 82.06 48.19 0.02 OUTLIER 'General case' 0 C--N 1.356 0.853 0 C-N-CA 125.85 1.66 . . . . 0.0 107.841 168.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.3 m -125.49 122.19 35.9 Favored 'General case' 0 CA--C 1.487 -1.477 0 N-CA-C 101.001 -3.703 . . . . 0.0 101.001 178.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.1 m -56.88 155.16 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.057 0 CA-C-N 120.858 1.663 . . . . 0.0 113.437 -170.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.64 131.84 54.71 Favored 'General case' 0 CA--C 1.468 -2.205 1 N-CA-C 93.344 -6.539 . . . . 0.0 93.344 177.464 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 66.7 m80 -92.83 -156.65 0.49 Allowed 'General case' 0 CA--C 1.49 -1.362 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 -164.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 5.6 t -155.11 168.39 27.17 Favored 'General case' 0 N--CA 1.417 -2.111 1 N-CA-C 94.399 -6.149 . . . . 0.0 94.399 -173.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -122.81 121.45 27.38 Favored Pre-proline 0 N--CA 1.42 -1.935 1 N-CA-C 94.694 -6.039 . . . . 0.0 94.694 175.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -62.45 99.33 0.2 Allowed 'Trans proline' 0 CA--C 1.51 -0.686 0 CA-C-N 123.106 2.145 . . . . 0.0 116.709 -158.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 169.91 -175.6 43.95 Favored Glycine 0 N--CA 1.422 -2.245 1 N-CA-C 96.168 -6.773 . . . . 0.0 96.168 176.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -69.95 -39.03 76.27 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 119.433 1.617 . . . . 0.0 109.124 178.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -45.63 -49.02 14.69 Favored 'General case' 0 N--CA 1.437 -1.122 0 C-N-CA 130.746 3.619 . . . . 0.0 115.566 -171.401 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.5 -40.88 59.05 Favored Glycine 0 CA--C 1.49 -1.499 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -172.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 43.3 t -70.33 -48.1 58.04 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -52.99 -44.21 67.05 Favored 'General case' 0 C--N 1.354 0.797 0 C-N-CA 124.512 1.125 . . . . 0.0 111.487 -178.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 34.2 m -60.6 -53.84 52.63 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 123.524 0.73 . . . . 0.0 111.142 177.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 83.8 mt -71.86 -40.16 69.17 Favored 'General case' 0 CA--C 1.5 -0.971 0 CA-C-O 122.104 0.955 . . . . 0.0 110.19 -172.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 33.7 t -61.07 -44.28 97.62 Favored 'General case' 0 CA--C 1.5 -0.98 0 C-N-CA 124.932 1.293 . . . . 0.0 109.372 178.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm -68.01 -43.89 77.78 Favored 'General case' 0 CA--C 1.502 -0.892 0 O-C-N 121.986 -0.446 . . . . 0.0 110.1 -173.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.458 ' HG3' ' HZ2' ' A' ' 30' ' ' LYS . 12.1 pt-20 -71.67 -13.0 61.61 Favored 'General case' 0 C--N 1.351 0.663 0 O-C-N 121.691 -0.63 . . . . 0.0 112.512 -175.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.458 ' HZ2' ' HG3' ' A' ' 29' ' ' GLU . 11.4 mmtm -98.43 -2.81 38.18 Favored 'General case' 0 CA--C 1.504 -0.79 0 C-N-CA 123.23 0.612 . . . . 0.0 110.056 176.03 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.0 32.72 8.73 Favored Glycine 0 CA--C 1.491 -1.416 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 172.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -91.44 142.1 15.95 Favored Glycine 0 C--N 1.354 1.556 0 N-CA-C 106.642 -2.583 . . . . 0.0 106.642 171.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.1 m -98.35 -17.24 18.97 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 -163.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 59.5 m -159.93 167.5 27.87 Favored 'General case' 0 CA--C 1.482 -1.639 1 N-CA-C 99.226 -4.361 . . . . 0.0 99.226 171.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -171.34 174.77 44.99 Favored Glycine 0 CA--C 1.476 -2.365 1 N-CA-C 100.328 -5.109 . . . . 0.0 100.328 -179.219 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 32.1 p-80 -158.5 159.49 35.68 Favored 'General case' 0 N--CA 1.426 -1.637 1 N-CA-C 98.452 -4.648 . . . . 0.0 98.452 176.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 42.3 t -87.03 159.04 19.1 Favored 'General case' 0 CA--C 1.501 -0.942 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 -173.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -174.68 -172.05 39.39 Favored Glycine 0 N--CA 1.423 -2.221 0 N-CA-C 103.861 -3.696 . . . . 0.0 103.861 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -130.08 148.97 51.98 Favored 'General case' 0 N--CA 1.426 -1.636 1 N-CA-C 97.202 -5.11 . . . . 0.0 97.202 -175.168 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.0 tptm -115.24 112.68 22.83 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 100.61 -3.848 . . . . 0.0 100.61 175.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.7 t -82.06 117.24 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 -173.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 119.79 -13.0 10.78 Favored Glycine 0 C--N 1.347 1.163 0 N-CA-C 107.856 -2.097 . . . . 0.0 107.856 -169.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -128.77 -78.83 0.56 Allowed 'General case' 0 CA--C 1.501 -0.929 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 175.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 168.11 -162.18 35.96 Favored Glycine 0 N--CA 1.427 -1.915 0 N-CA-C 103.808 -3.717 . . . . 0.0 103.808 -168.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 41.1 tp -63.17 131.08 47.28 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 127.448 2.299 . . . . 0.0 107.123 176.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -136.48 -171.72 2.97 Favored 'General case' 0 CA--C 1.492 -1.286 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 -165.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 4.2 t -139.19 156.73 46.9 Favored 'General case' 0 CA--C 1.488 -1.409 0 N-CA-C 100.594 -3.854 . . . . 0.0 100.594 173.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 15.6 t-105 -115.06 147.59 39.98 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 103.423 -2.806 . . . . 0.0 103.423 178.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 63.4 m -136.44 143.93 44.17 Favored 'General case' 0 CA--C 1.489 -1.384 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 172.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -113.64 131.05 56.28 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 102.309 -3.219 . . . . 0.0 102.309 177.218 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 57.86 71.26 0.59 Allowed 'General case' 0 CA--C 1.498 -1.046 0 C-N-CA 126.877 2.071 . . . . 0.0 110.946 178.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 15.9 mt -96.03 145.94 30.43 Favored Pre-proline 0 CA--C 1.499 -1.005 0 N-CA-C 102.78 -3.045 . . . . 0.0 102.78 164.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.06 166.7 28.33 Favored 'Trans proline' 0 N--CA 1.447 -1.236 0 C-N-CA 122.295 1.997 . . . . 0.0 109.527 172.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -77.86 -9.65 59.16 Favored 'General case' 0 CA--C 1.5 -0.973 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -163.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -85.65 7.33 23.77 Favored 'General case' 0 CA--C 1.506 -0.737 0 C-N-CA 123.996 0.918 . . . . 0.0 109.95 -179.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.0 t -104.35 113.46 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.636 0 N-CA-C 103.877 -2.638 . . . . 0.0 103.877 172.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -84.38 155.5 31.11 Favored Glycine 0 CA--C 1.493 -1.334 0 N-CA-C 104.604 -3.399 . . . . 0.0 104.604 169.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 15.1 pt -144.1 -134.59 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 N-CA-C 102.674 -3.084 . . . . 0.0 102.674 -166.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.2 mp -74.41 112.35 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 N-CA-C 102.39 -3.189 . . . . 0.0 102.39 168.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.425 -1.694 0 N-CA-C 100.8 -3.778 . . . . 0.0 100.8 -158.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 28.1 m . . . . . 0 N--CA 1.483 1.176 0 CA-C-O 120.977 0.418 . . . . 0.0 110.528 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -102.16 162.79 12.64 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 172.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -125.19 132.12 53.07 Favored 'General case' 0 CA--C 1.493 -1.217 1 N-CA-C 96.192 -5.484 . . . . 0.0 96.192 158.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.1 -170.13 26.43 Favored Glycine 0 CA--C 1.481 -2.055 0 N-CA-C 103.979 -3.648 . . . . 0.0 103.979 176.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -83.29 135.82 34.6 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 103.765 -2.679 . . . . 0.0 103.765 162.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.8 tt -91.47 147.52 5.21 Favored 'Isoleucine or valine' 0 C--O 1.244 0.814 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 175.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -149.3 -169.24 3.32 Favored 'General case' 0 N--CA 1.42 -1.952 0 N-CA-C 104.632 -2.358 . . . . 0.0 104.632 178.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -88.57 150.45 46.32 Favored Pre-proline 0 N--CA 1.432 -1.365 0 N-CA-C 104.624 -2.362 . . . . 0.0 104.624 169.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -70.57 32.47 0.22 Allowed 'Trans proline' 0 CA--C 1.517 -0.347 0 C-N-CA 123.911 3.074 . . . . 0.0 116.029 -174.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -109.54 11.05 25.02 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 106.957 -1.498 . . . . 0.0 106.957 -176.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 50.1 t30 67.66 53.65 0.7 Allowed 'General case' 0 CA--C 1.5 -0.949 0 C-N-CA 127.798 2.439 . . . . 0.0 108.285 -172.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -110.93 -154.72 0.55 Allowed 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -167.026 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.8 m -135.51 161.35 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.592 1 N-CA-C 98.021 -4.807 . . . . 0.0 98.021 163.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -113.64 130.79 56.34 Favored 'General case' 0 CA--C 1.479 -1.76 1 N-CA-C 96.683 -5.302 . . . . 0.0 96.683 173.918 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 27.7 m80 -82.98 141.88 31.78 Favored 'General case' 0 CA--C 1.493 -1.236 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 -173.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.423 ' H ' ' HG ' ' A' ' 45' ' ' LEU . 1.8 t -91.39 -179.18 5.32 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 -178.182 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -131.49 126.04 20.97 Favored Pre-proline 0 N--CA 1.412 -2.332 1 N-CA-C 97.073 -5.158 . . . . 0.0 97.073 -174.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_exo -62.96 67.97 0.14 Allowed 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.402 2.735 . . . . 0.0 112.029 164.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 171.96 77.21 0.05 OUTLIER Glycine 0 N--CA 1.423 -2.204 1 N-CA-C 95.346 -7.102 . . . . 0.0 95.346 -172.656 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.2 m -49.24 -38.1 25.51 Favored 'General case' 0 N--CA 1.438 -1.045 0 C-N-CA 128.532 2.733 . . . . 0.0 113.404 -159.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.5 m -61.05 -17.4 52.19 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 -177.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.8 -52.11 50.81 Favored Glycine 0 C--N 1.35 1.333 0 CA-C-N 119.982 1.265 . . . . 0.0 110.384 173.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -88.23 -20.99 24.77 Favored 'General case' 0 CA--C 1.496 -1.114 0 O-C-N 121.465 -1.021 . . . . 0.0 109.488 -175.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -64.28 -34.66 78.63 Favored 'General case' 0 C--N 1.355 0.818 0 O-C-N 121.232 -0.917 . . . . 0.0 109.515 170.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 33.4 m -64.88 -44.79 88.52 Favored 'General case' 0 C--N 1.354 0.771 0 O-C-N 120.8 -1.188 . . . . 0.0 109.862 172.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 84.1 mt -62.4 -43.33 99.08 Favored 'General case' 0 C--N 1.361 1.109 0 CA-C-O 121.732 0.777 . . . . 0.0 110.897 178.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 41.7 t -54.37 -48.86 71.03 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 125.132 1.373 . . . . 0.0 109.875 173.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.6 tptp -66.13 -40.55 90.74 Favored 'General case' 0 N--CA 1.441 -0.911 0 O-C-N 121.837 -0.539 . . . . 0.0 111.783 -174.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -76.94 -24.57 52.37 Favored 'General case' 0 C--N 1.354 0.773 0 O-C-N 121.772 -0.58 . . . . 0.0 112.455 -177.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -75.43 -39.16 59.24 Favored 'General case' 0 C--N 1.361 1.081 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 171.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 120.7 44.05 0.43 Allowed Glycine 0 CA--C 1.483 -1.963 0 N-CA-C 108.066 -2.014 . . . . 0.0 108.066 166.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -95.84 136.97 13.14 Favored Glycine 0 CA--C 1.486 -1.767 0 N-CA-C 103.159 -3.976 . . . . 0.0 103.159 167.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.0 m -102.38 2.87 37.24 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 -158.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.3 m -160.64 165.42 30.64 Favored 'General case' 0 CA--C 1.488 -1.441 1 N-CA-C 99.517 -4.253 . . . . 0.0 99.517 159.433 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -175.67 168.85 41.4 Favored Glycine 0 CA--C 1.48 -2.117 0 N-CA-C 103.513 -3.835 . . . . 0.0 103.513 -177.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.472 ' CE1' ' CD1' ' A' ' 48' ' ' TRP . 35.1 p-80 -174.1 -178.86 1.55 Allowed 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 100.619 -3.845 . . . . 0.0 100.619 -176.22 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 74.4 m -87.47 163.44 16.7 Favored 'General case' 0 CA--C 1.495 -1.157 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -164.07 -177.71 37.03 Favored Glycine 0 N--CA 1.423 -2.209 1 N-CA-C 99.641 -5.384 . . . . 0.0 99.641 176.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -136.35 140.24 43.14 Favored 'General case' 0 N--CA 1.431 -1.403 1 N-CA-C 96.929 -5.211 . . . . 0.0 96.929 177.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.4 tmtt? -108.99 100.68 9.84 Favored 'General case' 0 CA--C 1.492 -1.265 0 N-CA-C 101.625 -3.472 . . . . 0.0 101.625 178.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.1 t -71.42 117.4 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 -178.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 135.46 -38.18 1.83 Allowed Glycine 0 CA--C 1.489 -1.571 0 N-CA-C 105.648 -2.981 . . . . 0.0 105.648 -167.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 30.7 m170 -121.07 -74.41 0.61 Allowed 'General case' 0 CA--C 1.498 -1.033 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 177.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 171.71 -158.82 30.0 Favored Glycine 0 N--CA 1.427 -1.918 0 N-CA-C 104.812 -3.315 . . . . 0.0 104.812 -169.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.423 ' HG ' ' H ' ' A' ' 16' ' ' CYS . 43.8 tp -67.19 129.84 41.19 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 126.67 1.988 . . . . 0.0 106.249 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -137.23 175.27 9.76 Favored 'General case' 0 CA--C 1.484 -1.581 0 N-CA-C 102.006 -3.331 . . . . 0.0 102.006 -167.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 64.0 m -117.95 160.65 21.1 Favored 'General case' 0 CA--C 1.476 -1.884 0 N-CA-C 102.582 -3.118 . . . . 0.0 102.582 174.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.472 ' CD1' ' CE1' ' A' ' 36' ' ' HIS . 30.7 t-105 -117.52 148.52 41.78 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 103.531 -2.766 . . . . 0.0 103.531 -176.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 67.9 m -142.09 148.2 38.0 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 104.602 -2.369 . . . . 0.0 104.602 172.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -112.77 140.28 47.69 Favored 'General case' 0 CA--C 1.492 -1.272 0 N-CA-C 101.499 -3.519 . . . . 0.0 101.499 168.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 66.66 66.12 0.45 Allowed 'General case' 0 CA--C 1.498 -1.035 0 C-N-CA 126.222 1.809 . . . . 0.0 110.691 169.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 14.4 mt -103.74 138.99 19.69 Favored Pre-proline 0 CA--C 1.498 -1.047 0 N-CA-C 104.609 -2.367 . . . . 0.0 104.609 172.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.9 170.05 20.64 Favored 'Trans proline' 0 N--CA 1.447 -1.241 0 C-N-CA 122.542 2.161 . . . . 0.0 110.751 177.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -76.96 -0.45 24.38 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -172.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -87.3 3.35 47.12 Favored 'General case' 0 CA--C 1.505 -0.781 0 O-C-N 121.455 -0.778 . . . . 0.0 110.253 177.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.0 t -103.83 148.08 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.278 0 N-CA-C 102.582 -3.118 . . . . 0.0 102.582 178.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -129.19 144.38 15.37 Favored Glycine 0 CA--C 1.476 -2.372 1 N-CA-C 97.034 -6.426 . . . . 0.0 97.034 174.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 27.4 pt -142.31 -141.7 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.32 0 N-CA-C 104.305 -2.479 . . . . 0.0 104.305 -154.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.7 mp -70.25 113.6 6.53 Favored 'Isoleucine or valine' 0 C--N 1.352 0.691 0 N-CA-C 104.548 -2.39 . . . . 0.0 104.548 168.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.496 -1.109 0 CA-C-O 122.655 1.217 . . . . 0.0 108.272 -160.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 29.8 m . . . . . 0 N--CA 1.484 1.252 0 CA-C-O 121.129 0.49 . . . . 0.0 110.079 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.5 171.97 7.97 Favored 'General case' 0 CA--C 1.493 -1.219 0 N-CA-C 101.116 -3.661 . . . . 0.0 101.116 161.282 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -129.35 135.25 48.49 Favored 'General case' 0 CA--C 1.485 -1.526 1 N-CA-C 94.007 -6.294 . . . . 0.0 94.007 169.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.81 -177.27 34.73 Favored Glycine 0 CA--C 1.473 -2.556 1 N-CA-C 102.957 -4.057 . . . . 0.0 102.957 -177.014 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -87.97 136.53 32.92 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 101.954 -3.35 . . . . 0.0 101.954 164.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 16.1 tt -90.62 144.26 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.366 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 -177.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -126.26 -148.42 0.39 Allowed 'General case' 0 N--CA 1.423 -1.779 0 C-N-CA 128.674 2.79 . . . . 0.0 106.68 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -133.22 148.78 70.48 Favored Pre-proline 0 N--CA 1.422 -1.857 1 N-CA-C 95.572 -5.714 . . . . 0.0 95.572 166.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -82.01 39.9 0.91 Allowed 'Trans proline' 0 CA--C 1.513 -0.543 0 C-N-CA 123.601 2.867 . . . . 0.0 112.151 -154.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -111.64 17.03 20.32 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 106.557 -1.646 . . . . 0.0 106.557 -178.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.43 ' O ' ' HE1' ' A' ' 43' ' ' HIS . 49.9 t30 64.56 60.23 0.91 Allowed 'General case' 0 CA--C 1.497 -1.063 0 C-N-CA 128.265 2.626 . . . . 0.0 108.583 -172.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -117.9 -158.37 0.71 Allowed 'General case' 0 CA--C 1.493 -1.224 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -166.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.1 m -137.26 156.79 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.687 1 N-CA-C 96.103 -5.517 . . . . 0.0 96.103 167.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -93.73 121.04 34.76 Favored 'General case' 0 CA--C 1.486 -1.51 0 N-CA-C 100.529 -3.878 . . . . 0.0 100.529 170.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -74.88 107.74 7.16 Favored 'General case' 0 CA--C 1.492 -1.26 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 -168.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.3 t -83.65 150.14 26.08 Favored 'General case' 0 CA--C 1.485 -1.54 0 CA-C-N 114.399 -1.273 . . . . 0.0 107.68 -164.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -112.04 112.99 52.38 Favored Pre-proline 0 N--CA 1.428 -1.572 0 N-CA-C 102.046 -3.316 . . . . 0.0 102.046 178.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_exo -59.41 137.59 79.06 Favored 'Trans proline' 0 CA--C 1.503 -1.047 0 C-N-CA 122.625 2.216 . . . . 0.0 110.677 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 119.83 -54.95 0.63 Allowed Glycine 0 CA--C 1.488 -1.607 1 N-CA-C 101.617 -4.593 . . . . 0.0 101.617 -157.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.0 m 91.24 12.04 0.04 OUTLIER 'General case' 0 CA--C 1.496 -1.105 0 C-N-CA 127.518 2.327 . . . . 0.0 111.224 174.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.7 m -56.65 -53.88 52.6 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 124.473 1.109 . . . . 0.0 113.047 -172.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -74.8 -31.81 57.81 Favored Glycine 0 C--N 1.35 1.342 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.7 t -67.03 -51.68 51.79 Favored 'General case' 0 CA--C 1.488 -1.419 0 C-N-CA 124.174 0.99 . . . . 0.0 109.602 -174.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -65.44 -36.74 84.82 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -176.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.8 m -60.33 -50.5 73.38 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 121.52 -0.738 . . . . 0.0 111.137 173.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 32.3 mt -64.5 -42.0 96.09 Favored 'General case' 0 CA--C 1.498 -1.046 0 C-N-CA 123.9 0.88 . . . . 0.0 109.99 -179.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 19.5 t -55.91 -46.0 78.53 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 124.123 0.969 . . . . 0.0 110.82 176.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 37.5 mtmm -63.55 -46.67 84.89 Favored 'General case' 0 C--N 1.356 0.864 0 CA-C-N 118.213 0.461 . . . . 0.0 111.259 -177.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -73.13 -21.95 60.63 Favored 'General case' 0 C--N 1.351 0.636 0 O-C-N 121.666 -0.646 . . . . 0.0 112.267 -175.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 48.9 mmtm -86.14 -10.39 54.91 Favored 'General case' 0 C--N 1.355 0.844 0 O-C-N 121.855 -0.528 . . . . 0.0 110.907 174.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.57 28.85 7.72 Favored Glycine 0 CA--C 1.489 -1.535 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 168.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -94.83 146.46 18.18 Favored Glycine 0 CA--C 1.487 -1.68 0 N-CA-C 105.037 -3.225 . . . . 0.0 105.037 165.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.5 p -72.58 -43.33 63.52 Favored 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 124.483 1.113 . . . . 0.0 110.354 -166.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 34.9 m -160.63 -178.59 6.98 Favored 'General case' 0 N--CA 1.422 -1.863 1 N-CA-C 97.8 -4.889 . . . . 0.0 97.8 165.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -174.7 177.35 46.84 Favored Glycine 0 N--CA 1.417 -2.605 1 N-CA-C 98.947 -5.661 . . . . 0.0 98.947 -167.294 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 81.8 m-70 -164.52 171.28 14.77 Favored 'General case' 0 CA--C 1.492 -1.257 1 N-CA-C 98.621 -4.585 . . . . 0.0 98.621 -171.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 72.5 m -81.16 160.52 24.35 Favored 'General case' 0 CA--C 1.502 -0.881 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 165.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -167.34 171.77 42.1 Favored Glycine 0 CA--C 1.481 -2.084 1 N-CA-C 98.58 -5.808 . . . . 0.0 98.58 173.239 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -156.26 140.38 16.45 Favored 'General case' 0 N--CA 1.426 -1.628 1 N-CA-C 97.82 -4.882 . . . . 0.0 97.82 -176.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -155.42 47.96 0.52 Allowed 'General case' 0 CA--C 1.491 -1.298 1 N-CA-C 99.514 -4.254 . . . . 0.0 99.514 174.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . 0.276 2.1 t 61.68 -147.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 N-CA-C 105.482 -2.044 . . . . 0.0 105.482 -152.271 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 142.93 -88.11 0.18 Allowed Glycine 0 CA--C 1.48 -2.109 1 N-CA-C 100.853 -4.899 . . . . 0.0 100.853 -178.455 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.43 ' HE1' ' O ' ' A' ' 11' ' ' ASN . 47.0 m170 -150.26 -69.57 0.19 Allowed 'General case' 0 CA--C 1.493 -1.223 1 N-CA-C 98.215 -4.735 . . . . 0.0 98.215 168.179 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -115.01 -159.37 12.29 Favored Glycine 0 N--CA 1.437 -1.267 0 N-CA-C 103.304 -3.918 . . . . 0.0 103.304 168.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -83.18 110.98 18.51 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 -174.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -98.77 175.39 5.98 Favored 'General case' 0 CA--C 1.492 -1.28 0 C-N-CA 124.649 1.18 . . . . 0.0 108.182 -167.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 10.8 t -111.12 148.65 32.24 Favored 'General case' 0 CA--C 1.499 -1.018 0 N-CA-C 102.387 -3.19 . . . . 0.0 102.387 -174.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 70.0 t-105 -100.19 150.64 22.31 Favored 'General case' 0 CA--C 1.492 -1.286 0 N-CA-C 104.355 -2.461 . . . . 0.0 104.355 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 26.1 m -141.01 143.72 34.59 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 101.422 -3.547 . . . . 0.0 101.422 166.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -110.11 23.34 14.45 Favored 'General case' 0 CA--C 1.503 -0.862 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -167.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -177.29 156.44 1.23 Allowed 'General case' 0 N--CA 1.418 -2.037 1 N-CA-C 94.321 -6.177 . . . . 0.0 94.321 170.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 14.8 mt -159.41 154.22 21.15 Favored Pre-proline 0 CA--C 1.488 -1.437 1 N-CA-C 96.128 -5.508 . . . . 0.0 96.128 157.53 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.18 161.39 46.18 Favored 'Trans proline' 0 N--CA 1.446 -1.287 0 C-N-CA 122.006 1.804 . . . . 0.0 108.328 165.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -77.92 -6.52 54.6 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -165.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -86.91 -1.79 58.1 Favored 'General case' 0 CA--C 1.506 -0.73 0 O-C-N 121.439 -0.788 . . . . 0.0 109.629 -178.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.1 t -94.16 111.01 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.16 0 N-CA-C 104.287 -2.486 . . . . 0.0 104.287 177.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -84.98 143.65 20.59 Favored Glycine 0 CA--C 1.492 -1.382 0 N-CA-C 106.627 -2.589 . . . . 0.0 106.627 176.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 13.6 pt -125.34 -134.65 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.276 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 -162.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.1 mp -76.18 119.45 24.29 Favored 'Isoleucine or valine' 0 C--N 1.354 0.784 0 N-CA-C 102.884 -3.006 . . . . 0.0 102.884 165.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.9 t . . . . . 0 CA--C 1.497 -1.065 0 C-N-CA 124.954 1.302 . . . . 0.0 109.175 -163.496 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 34.1 m . . . . . 0 N--CA 1.485 1.284 0 CA-C-O 121.17 0.509 . . . . 0.0 109.903 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -106.11 157.95 17.18 Favored 'General case' 0 CA--C 1.499 -0.987 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 171.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -126.44 125.73 42.63 Favored 'General case' 0 CA--C 1.484 -1.589 1 N-CA-C 94.386 -6.153 . . . . 0.0 94.386 156.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.72 178.34 37.64 Favored Glycine 0 CA--C 1.475 -2.41 0 N-CA-C 107.601 -2.2 . . . . 0.0 107.601 -171.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -82.65 129.79 35.01 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 166.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 14.0 tt -91.05 144.18 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -144.85 179.34 7.39 Favored 'General case' 0 N--CA 1.417 -2.078 1 N-CA-C 98.731 -4.544 . . . . 0.0 98.731 -177.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -79.64 156.2 75.55 Favored Pre-proline 0 N--CA 1.437 -1.12 0 CA-C-O 116.735 -1.603 . . . . 0.0 106.836 178.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -67.9 -18.82 46.85 Favored 'Trans proline' 0 CA--C 1.504 -0.999 0 CA-C-N 122.989 2.103 . . . . 0.0 116.709 -152.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -101.21 7.12 43.19 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -177.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 86.73 126.62 0.03 OUTLIER 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 128.822 2.849 . . . . 0.0 107.112 176.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 156.9 126.47 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.345 1 N-CA-C 99.16 -4.385 . . . . 0.0 99.16 172.294 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.402 HG11 ' HD1' ' A' ' 43' ' ' HIS . 12.0 m -63.36 156.46 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.23 0 CA-C-O 123.011 1.386 . . . . 0.0 112.705 -162.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -100.52 121.16 41.12 Favored 'General case' 0 N--CA 1.42 -1.947 1 N-CA-C 97.317 -5.068 . . . . 0.0 97.317 176.609 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 45.6 m80 -80.83 126.04 30.84 Favored 'General case' 0 CA--C 1.487 -1.472 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 -166.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 9.2 t -94.11 174.05 7.35 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 -176.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -146.31 156.71 49.88 Favored Pre-proline 0 N--CA 1.417 -2.093 1 N-CA-C 97.311 -5.07 . . . . 0.0 97.311 -177.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_exo -69.65 -14.94 37.18 Favored 'Trans proline' 0 CA--C 1.511 -0.653 0 CA-C-N 122.977 2.099 . . . . 0.0 111.715 175.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -113.18 81.84 0.3 Allowed Glycine 0 CA--C 1.486 -1.778 1 N-CA-C 101.162 -4.775 . . . . 0.0 101.162 169.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 m -82.09 29.07 0.42 Allowed 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 125.647 1.579 . . . . 0.0 113.1 -160.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.5 m -56.65 -50.98 70.47 Favored 'General case' 0 N--CA 1.435 -1.193 0 C-N-CA 126.879 2.072 . . . . 0.0 113.737 -161.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.03 -31.87 72.69 Favored Glycine 0 C--N 1.352 1.439 0 N-CA-C 111.374 -0.69 . . . . 0.0 111.374 -176.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.3 t -78.49 -31.8 47.91 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -174.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -62.08 -41.83 98.59 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 123.708 0.803 . . . . 0.0 110.436 174.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.02 -35.31 80.3 Favored 'General case' 0 C--N 1.352 0.707 0 O-C-N 121.048 -1.032 . . . . 0.0 112.196 174.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 92.0 mt -67.45 -41.76 84.21 Favored 'General case' 0 C--N 1.357 0.893 0 CA-C-O 121.938 0.875 . . . . 0.0 109.663 176.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 27.2 t -55.41 -47.57 75.71 Favored 'General case' 0 CA--C 1.507 -0.691 0 C-N-CA 125.027 1.331 . . . . 0.0 110.135 177.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -59.04 -50.79 72.73 Favored 'General case' 0 C--N 1.354 0.797 0 C-N-CA 122.827 0.451 . . . . 0.0 111.697 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -71.16 -23.11 62.0 Favored 'General case' 0 C--N 1.356 0.871 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -174.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.0 mmtp -81.92 -14.8 55.63 Favored 'General case' 0 C--N 1.355 0.805 0 C-N-CA 123.147 0.579 . . . . 0.0 110.713 175.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 110.26 24.39 5.7 Favored Glycine 0 CA--C 1.49 -1.472 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 167.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -97.11 122.31 7.38 Favored Glycine 0 C--N 1.353 1.484 0 N-CA-C 105.899 -2.88 . . . . 0.0 105.899 177.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.7 p -99.57 9.2 43.62 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 122.225 1.012 . . . . 0.0 109.162 -168.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 57.9 m -160.11 164.85 32.69 Favored 'General case' 0 CA--C 1.479 -1.786 1 N-CA-C 97.598 -4.964 . . . . 0.0 97.598 164.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -158.15 164.95 33.59 Favored Glycine 0 CA--C 1.465 -3.07 1 N-CA-C 99.605 -5.398 . . . . 0.0 99.605 -173.427 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -156.76 -159.18 0.84 Allowed 'General case' 0 N--CA 1.421 -1.88 1 N-CA-C 98.185 -4.746 . . . . 0.0 98.185 -177.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 34.0 t -148.13 166.43 27.88 Favored 'General case' 0 N--CA 1.424 -1.733 1 N-CA-C 97.798 -4.89 . . . . 0.0 97.798 -170.264 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -179.7 -161.83 27.67 Favored Glycine 0 N--CA 1.421 -2.306 1 N-CA-C 100.571 -5.012 . . . . 0.0 100.571 176.149 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -140.55 148.27 40.75 Favored 'General case' 0 N--CA 1.432 -1.358 1 N-CA-C 100.072 -4.047 . . . . 0.0 100.072 -178.035 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.9 mmpt? -123.74 103.06 8.16 Favored 'General case' 0 CA--C 1.491 -1.295 0 N-CA-C 104.027 -2.583 . . . . 0.0 104.027 173.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.7 t -74.06 118.71 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 136.65 -36.72 1.95 Allowed Glycine 0 CA--C 1.487 -1.712 0 N-CA-C 104.131 -3.587 . . . . 0.0 104.131 -165.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.402 ' HD1' HG11 ' A' ' 13' ' ' VAL . 39.1 m170 -125.56 -68.89 0.81 Allowed 'General case' 0 CA--C 1.499 -0.99 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 178.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 162.02 -150.58 20.07 Favored Glycine 0 N--CA 1.429 -1.774 0 N-CA-C 105.297 -3.121 . . . . 0.0 105.297 -175.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -70.78 127.72 33.61 Favored 'General case' 0 C--N 1.353 0.745 0 N-CA-C 103.66 -2.718 . . . . 0.0 103.66 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.67 155.77 49.89 Favored 'General case' 0 CA--C 1.479 -1.759 0 N-CA-C 101.235 -3.617 . . . . 0.0 101.235 -168.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 58.0 m -100.44 177.67 4.96 Favored 'General case' 0 CA--C 1.49 -1.334 0 N-CA-C 103.663 -2.717 . . . . 0.0 103.663 -176.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 3.8 t-105 -140.92 150.08 42.7 Favored 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 101.507 -3.516 . . . . 0.0 101.507 -177.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 56.1 m -142.85 154.4 44.12 Favored 'General case' 0 CA--C 1.493 -1.224 0 N-CA-C 104.667 -2.346 . . . . 0.0 104.667 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -123.34 135.47 54.19 Favored 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 175.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 77.7 41.89 0.13 Allowed 'General case' 0 CA--C 1.493 -1.215 0 C-N-CA 127.428 2.291 . . . . 0.0 110.612 169.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 49.2 mt -80.69 135.57 52.47 Favored Pre-proline 0 CA--C 1.502 -0.876 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 177.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -72.02 169.61 20.94 Favored 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 122.416 2.077 . . . . 0.0 109.513 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -76.44 -5.79 48.93 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -163.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -86.17 -7.7 58.37 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 123.432 0.693 . . . . 0.0 110.208 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.0 t -93.17 126.93 45.54 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.045 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 -176.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -97.29 150.89 19.65 Favored Glycine 0 CA--C 1.485 -1.842 0 N-CA-C 104.075 -3.61 . . . . 0.0 104.075 178.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 20.2 pt -148.25 -143.74 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 N-CA-C 102.032 -3.321 . . . . 0.0 102.032 -166.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.9 mp -71.8 119.78 18.89 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 104.881 -2.266 . . . . 0.0 104.881 168.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.426 -1.658 0 N-CA-C 102.198 -3.26 . . . . 0.0 102.198 -156.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 25.3 m . . . . . 0 N--CA 1.488 1.459 0 CA-C-O 121.107 0.479 . . . . 0.0 110.962 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.53 166.22 16.43 Favored 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 170.085 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -130.1 131.81 45.88 Favored 'General case' 0 CA--C 1.492 -1.276 1 N-CA-C 95.173 -5.862 . . . . 0.0 95.173 165.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.86 -173.34 30.4 Favored Glycine 0 CA--C 1.476 -2.372 0 N-CA-C 104.24 -3.544 . . . . 0.0 104.24 178.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -80.04 131.83 35.86 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 102.156 -3.275 . . . . 0.0 102.156 157.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.2 tt -90.72 145.79 6.99 Favored 'Isoleucine or valine' 0 C--O 1.243 0.756 0 N-CA-C 105.52 -2.03 . . . . 0.0 105.52 -177.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -126.28 -176.17 3.58 Favored 'General case' 0 N--CA 1.424 -1.742 0 C-N-CA 126.165 1.786 . . . . 0.0 106.748 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -82.95 145.31 49.43 Favored Pre-proline 0 N--CA 1.437 -1.119 0 N-CA-C 104.548 -2.389 . . . . 0.0 104.548 157.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_exo -67.28 -22.06 46.87 Favored 'Trans proline' 0 CA--C 1.502 -1.107 0 CA-C-N 122.827 2.045 . . . . 0.0 116.295 -149.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -84.67 38.7 0.71 Allowed 'General case' 0 N--CA 1.438 -1.035 0 C-N-CA 124.825 1.25 . . . . 0.0 110.784 -167.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 50.7 t30 63.85 48.46 3.17 Favored 'General case' 0 C--N 1.354 0.782 0 C-N-CA 127.812 2.445 . . . . 0.0 110.143 -178.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -104.15 -146.68 0.38 Allowed 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 -177.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.1 m -133.11 -166.01 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.338 1 N-CA-C 97.653 -4.943 . . . . 0.0 97.653 164.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -120.41 155.41 33.52 Favored 'General case' 0 CA--C 1.491 -1.315 1 N-CA-C 95.704 -5.665 . . . . 0.0 95.704 170.845 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 33.4 m80 -91.1 99.2 12.26 Favored 'General case' 0 CA--C 1.486 -1.481 0 N-CA-C 102.846 -3.02 . . . . 0.0 102.846 175.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 7.2 t -104.94 -176.02 2.96 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 104.273 -2.492 . . . . 0.0 104.273 174.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -137.85 164.55 40.23 Favored Pre-proline 0 N--CA 1.417 -2.084 1 N-CA-C 99.15 -4.389 . . . . 0.0 99.15 -158.266 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.25 55.87 3.65 Favored 'Trans proline' 0 C--N 1.322 -0.863 0 C-N-CA 123.263 2.642 . . . . 0.0 111.063 171.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -173.47 146.31 8.81 Favored Glycine 0 N--CA 1.421 -2.362 1 N-CA-C 99.577 -5.409 . . . . 0.0 99.577 175.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.4 m -93.35 8.77 39.13 Favored 'General case' 0 N--CA 1.438 -1.068 0 C-N-CA 123.92 0.888 . . . . 0.0 110.397 -174.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -50.38 -51.64 44.24 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 128.492 2.717 . . . . 0.0 114.131 -164.426 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -89.97 -22.01 37.29 Favored Glycine 0 C--N 1.351 1.365 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.9 t -81.28 -12.49 59.06 Favored 'General case' 0 C--N 1.355 0.835 0 O-C-N 121.046 -1.267 . . . . 0.0 109.592 -172.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -51.79 -55.21 21.16 Favored 'General case' 0 C--N 1.352 0.694 0 C-N-CA 124.584 1.154 . . . . 0.0 109.793 166.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.74 -44.98 96.01 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 123.965 0.906 . . . . 0.0 112.131 175.09 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.52 -39.02 93.01 Favored 'General case' 0 C--N 1.361 1.073 0 CA-C-N 118.977 0.808 . . . . 0.0 111.232 -177.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.6 t -68.05 -42.74 80.06 Favored 'General case' 0 N--CA 1.439 -0.987 0 O-C-N 121.301 -0.874 . . . . 0.0 109.51 -178.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -77.89 -26.41 49.13 Favored 'General case' 0 CA--C 1.505 -0.77 0 O-C-N 121.007 -1.058 . . . . 0.0 111.963 -174.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -76.66 -21.55 55.28 Favored 'General case' 0 C--N 1.355 0.815 0 O-C-N 121.243 -0.911 . . . . 0.0 110.988 179.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -79.93 -48.82 12.8 Favored 'General case' 0 CA--C 1.494 -1.174 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 168.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 120.83 48.36 0.3 Allowed Glycine 0 CA--C 1.489 -1.576 0 N-CA-C 108.214 -1.954 . . . . 0.0 108.214 177.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.07 139.29 14.73 Favored Glycine 0 N--CA 1.433 -1.531 0 N-CA-C 103.689 -3.764 . . . . 0.0 103.689 164.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -98.6 2.87 47.77 Favored 'General case' 0 N--CA 1.438 -1.05 0 C-N-CA 124.258 1.023 . . . . 0.0 109.607 -169.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 24.1 m -160.42 159.25 30.76 Favored 'General case' 0 CA--C 1.474 -1.954 0 N-CA-C 100.529 -3.878 . . . . 0.0 100.529 165.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -165.82 169.79 40.31 Favored Glycine 0 N--CA 1.418 -2.555 1 N-CA-C 101.407 -4.677 . . . . 0.0 101.407 -179.146 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 78.7 m-70 -161.4 -170.16 2.54 Favored 'General case' 0 CA--C 1.491 -1.295 1 N-CA-C 98.558 -4.608 . . . . 0.0 98.558 -174.098 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 73.1 m -145.87 162.57 37.42 Favored 'General case' 0 CA--C 1.485 -1.553 1 N-CA-C 98.852 -4.499 . . . . 0.0 98.852 172.17 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 173.29 179.97 44.31 Favored Glycine 0 N--CA 1.425 -2.049 1 N-CA-C 100.072 -5.211 . . . . 0.0 100.072 -177.099 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -151.1 141.91 22.84 Favored 'General case' 0 N--CA 1.426 -1.674 1 N-CA-C 96.407 -5.405 . . . . 0.0 96.407 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.9 mttp -157.74 58.22 0.49 Allowed 'General case' 0 CA--C 1.488 -1.434 1 N-CA-C 98.303 -4.703 . . . . 0.0 98.303 173.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.522 HG13 ' H ' ' A' ' 42' ' ' GLY 0.272 2.9 t 69.77 -172.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 C-N-CA 127.054 2.142 . . . . 0.0 105.543 -158.264 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.522 ' H ' HG13 ' A' ' 41' ' ' VAL . . . 145.04 -127.96 3.03 Favored Glycine 0 N--CA 1.421 -2.338 1 N-CA-C 97.716 -6.153 . . . . 0.0 97.716 -173.031 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 59.3 m170 -130.37 -39.16 1.33 Allowed 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 104.515 -2.402 . . . . 0.0 104.515 175.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -158.09 -177.0 30.78 Favored Glycine 0 N--CA 1.425 -2.051 1 N-CA-C 95.798 -6.921 . . . . 0.0 95.798 176.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.2 tt -72.25 114.94 10.91 Favored 'General case' 0 C--N 1.351 0.666 0 CA-C-N 118.693 1.247 . . . . 0.0 108.177 -171.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -105.85 -177.81 3.47 Favored 'General case' 0 CA--C 1.485 -1.529 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 -164.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 34.6 t -115.0 161.56 18.17 Favored 'General case' 0 CA--C 1.493 -1.236 0 N-CA-C 102.432 -3.173 . . . . 0.0 102.432 -175.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 33.0 t-105 -117.57 151.75 36.52 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 102.878 -3.008 . . . . 0.0 102.878 178.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 15.0 m -148.21 149.79 32.58 Favored 'General case' 0 CA--C 1.495 -1.157 0 N-CA-C 103.428 -2.805 . . . . 0.0 103.428 171.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -111.3 141.99 44.11 Favored 'General case' 0 CA--C 1.495 -1.15 0 N-CA-C 104.212 -2.514 . . . . 0.0 104.212 171.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 66.01 53.28 1.11 Allowed 'General case' 0 CA--C 1.491 -1.298 0 C-N-CA 127.488 2.315 . . . . 0.0 111.164 167.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 40.0 mt -94.81 142.93 25.35 Favored Pre-proline 0 CA--C 1.495 -1.147 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 177.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -72.01 166.74 28.7 Favored 'Trans proline' 0 N--CA 1.447 -1.258 0 C-N-CA 122.61 2.206 . . . . 0.0 110.134 175.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -68.99 -17.07 63.88 Favored 'General case' 0 CA--C 1.506 -0.728 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -167.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -76.48 -6.82 53.45 Favored 'General case' 0 CA--C 1.504 -0.81 0 O-C-N 121.439 -0.788 . . . . 0.0 110.942 -178.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.3 t -94.09 107.96 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 N-CA-C 104.474 -2.417 . . . . 0.0 104.474 178.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -81.63 148.39 27.6 Favored Glycine 0 CA--C 1.489 -1.549 0 N-CA-C 106.393 -2.683 . . . . 0.0 106.393 178.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 41.0 pt -133.66 -160.05 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.303 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 -165.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -73.7 121.15 24.07 Favored 'Isoleucine or valine' 0 C--N 1.362 1.146 0 N-CA-C 104.829 -2.286 . . . . 0.0 104.829 176.042 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.4 t . . . . . 0 N--CA 1.44 -0.943 0 N-CA-C 101.899 -3.371 . . . . 0.0 101.899 -162.567 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 33.5 m . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 121.354 0.597 . . . . 0.0 109.629 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -94.24 148.46 22.17 Favored 'General case' 0 CA--C 1.502 -0.879 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 173.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -122.37 118.19 27.84 Favored 'General case' 0 CA--C 1.489 -1.399 1 N-CA-C 94.394 -6.15 . . . . 0.0 94.394 154.23 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.61 -174.13 31.1 Favored Glycine 0 CA--C 1.479 -2.214 0 N-CA-C 106.196 -2.762 . . . . 0.0 106.196 -171.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -86.22 134.96 33.74 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 104.872 -2.27 . . . . 0.0 104.872 167.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 16.9 tt -90.63 151.23 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 176.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -156.3 -177.81 6.86 Favored 'General case' 0 N--CA 1.416 -2.144 1 N-CA-C 98.949 -4.463 . . . . 0.0 98.949 -177.142 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -93.53 156.91 39.31 Favored Pre-proline 0 N--CA 1.435 -1.186 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 178.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -77.36 -1.96 12.14 Favored 'Trans proline' 0 CA--C 1.509 -0.745 0 CA-C-N 121.283 1.494 . . . . 0.0 115.254 -155.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -95.13 13.41 25.39 Favored 'General case' 0 C--N 1.358 0.96 0 CA-C-N 121.214 1.825 . . . . 0.0 107.498 176.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 43.4 t30 83.23 43.44 0.02 OUTLIER 'General case' 0 C--N 1.361 1.102 0 C-N-CA 126.081 1.752 . . . . 0.0 107.494 168.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -131.36 132.18 44.25 Favored 'General case' 0 CA--C 1.487 -1.462 0 N-CA-C 102.374 -3.195 . . . . 0.0 102.374 -173.148 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . 0.253 1.7 m -60.57 159.25 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 CA-C-O 123.435 1.588 . . . . 0.0 115.228 -173.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -114.73 139.97 49.26 Favored 'General case' 0 N--CA 1.416 -2.157 1 N-CA-C 92.687 -6.783 . . . . 0.0 92.687 169.554 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 66.1 m170 -90.42 -162.28 0.88 Allowed 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 178.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 25.4 t -150.06 171.62 16.57 Favored 'General case' 0 N--CA 1.417 -2.121 1 N-CA-C 97.52 -4.993 . . . . 0.0 97.52 -172.244 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -127.28 123.68 23.42 Favored Pre-proline 0 N--CA 1.419 -2.018 1 N-CA-C 95.925 -5.583 . . . . 0.0 95.925 -178.125 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -55.88 96.6 0.06 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.604 0 CA-C-N 124.224 2.544 . . . . 0.0 116.691 -168.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 159.92 -159.36 30.61 Favored Glycine 0 N--CA 1.422 -2.267 1 N-CA-C 98.07 -6.012 . . . . 0.0 98.07 -178.166 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.8 p -94.25 -43.67 8.33 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 170.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -39.74 -61.95 0.77 Allowed 'General case' 0 N--CA 1.442 -0.875 0 C-N-CA 128.812 2.845 . . . . 0.0 118.243 -150.287 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -72.09 -39.5 58.28 Favored Glycine 0 C--N 1.348 1.227 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -173.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 9.6 t -83.65 -28.45 28.39 Favored 'General case' 0 CA--C 1.5 -0.962 0 O-C-N 121.277 -1.131 . . . . 0.0 109.329 -177.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -60.81 -46.52 90.2 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-N 119.353 0.979 . . . . 0.0 109.679 175.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.9 p -67.06 -39.15 86.83 Favored 'General case' 0 N--CA 1.44 -0.941 0 O-C-N 121.894 -0.504 . . . . 0.0 111.721 179.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 40.7 mt -63.22 -47.61 81.77 Favored 'General case' 0 C--N 1.357 0.899 0 O-C-N 121.032 -1.043 . . . . 0.0 111.127 172.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 3.0 t -66.01 -32.33 73.75 Favored 'General case' 0 CA--C 1.501 -0.911 0 O-C-N 120.155 -1.59 . . . . 0.0 110.827 -175.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -65.41 -35.26 80.41 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 122.943 0.497 . . . . 0.0 111.488 176.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -75.93 -34.18 59.87 Favored 'General case' 0 C--N 1.359 0.999 0 O-C-N 121.559 -0.713 . . . . 0.0 111.108 177.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.2 mmmp? -72.15 -40.23 68.17 Favored 'General case' 0 C--N 1.36 1.026 0 C-N-CA 123.535 0.734 . . . . 0.0 110.519 178.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 128.41 43.57 0.23 Allowed Glycine 0 CA--C 1.492 -1.368 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 162.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -111.12 145.32 17.55 Favored Glycine 0 CA--C 1.491 -1.415 0 N-CA-C 105.512 -3.035 . . . . 0.0 105.512 169.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.4 p -92.23 4.61 52.89 Favored 'General case' 0 C--N 1.352 0.676 0 CA-C-N 118.053 0.926 . . . . 0.0 110.154 -171.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 57.4 m -157.13 156.66 33.09 Favored 'General case' 0 CA--C 1.483 -1.603 0 N-CA-C 100.981 -3.711 . . . . 0.0 100.981 168.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -152.98 141.17 8.16 Favored Glycine 0 N--CA 1.422 -2.278 1 N-CA-C 97.782 -6.127 . . . . 0.0 97.782 -178.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 15.1 t-80 -159.94 175.6 12.84 Favored 'General case' 0 N--CA 1.429 -1.495 1 N-CA-C 99.692 -4.188 . . . . 0.0 99.692 -169.263 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 63.2 m -95.22 -174.93 3.36 Favored 'General case' 0 CA--C 1.491 -1.296 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 176.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 177.13 -166.56 37.25 Favored Glycine 0 N--CA 1.417 -2.604 1 N-CA-C 96.196 -6.762 . . . . 0.0 96.196 179.282 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -144.51 138.82 27.84 Favored 'General case' 0 N--CA 1.43 -1.437 1 N-CA-C 96.098 -5.519 . . . . 0.0 96.098 173.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 26.2 tptp -120.69 100.14 6.94 Favored 'General case' 0 CA--C 1.487 -1.471 0 N-CA-C 102.358 -3.201 . . . . 0.0 102.358 -179.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.5 t -68.45 134.1 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 -175.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 115.67 -36.83 3.69 Favored Glycine 0 CA--C 1.492 -1.387 0 N-CA-C 105.951 -2.86 . . . . 0.0 105.951 -171.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 57.9 m-70 -106.19 -66.85 0.97 Allowed 'General case' 0 CA--C 1.494 -1.177 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 174.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 150.1 -143.26 10.51 Favored Glycine 0 CA--C 1.481 -2.054 0 N-CA-C 103.826 -3.71 . . . . 0.0 103.826 -174.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.9 tp -65.58 135.98 55.78 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 105.124 -2.176 . . . . 0.0 105.124 172.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -155.04 172.6 17.85 Favored 'General case' 0 CA--C 1.475 -1.917 1 N-CA-C 97.98 -4.822 . . . . 0.0 97.98 -168.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 9.1 t -118.34 159.78 22.8 Favored 'General case' 0 CA--C 1.487 -1.444 0 N-CA-C 103.089 -2.93 . . . . 0.0 103.089 -173.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 19.0 t-105 -118.83 146.18 45.06 Favored 'General case' 0 CA--C 1.496 -1.116 0 N-CA-C 103.288 -2.856 . . . . 0.0 103.288 -176.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 79.5 m -146.26 157.78 43.83 Favored 'General case' 0 CA--C 1.487 -1.457 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 173.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -118.06 138.88 51.93 Favored 'General case' 0 CA--C 1.495 -1.15 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 176.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 64.62 61.89 0.81 Allowed 'General case' 0 CA--C 1.494 -1.191 0 C-N-CA 128.102 2.561 . . . . 0.0 111.646 173.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 28.6 mt -96.04 133.45 25.2 Favored Pre-proline 0 CA--C 1.502 -0.882 0 N-CA-C 104.015 -2.587 . . . . 0.0 104.015 172.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -75.32 173.97 13.6 Favored 'Trans proline' 0 N--CA 1.447 -1.247 0 CA-C-N 122.057 1.771 . . . . 0.0 109.768 -178.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -74.3 -5.53 42.69 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -169.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -90.61 -0.93 57.86 Favored 'General case' 0 CA--C 1.502 -0.872 0 O-C-N 121.239 -0.913 . . . . 0.0 110.015 -178.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.5 t -97.88 152.01 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 N-CA-C 102.677 -3.083 . . . . 0.0 102.677 178.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -123.01 153.28 16.96 Favored Glycine 0 CA--C 1.481 -2.045 1 N-CA-C 98.767 -5.733 . . . . 0.0 98.767 177.153 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 19.5 pt -152.82 -154.63 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 N-CA-C 101.258 -3.608 . . . . 0.0 101.258 -163.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.5 mp -73.76 119.28 20.61 Favored 'Isoleucine or valine' 0 C--N 1.362 1.11 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 169.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.428 -1.537 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 -157.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 27.3 m . . . . . 0 N--CA 1.485 1.29 0 CA-C-O 121.413 0.625 . . . . 0.0 110.646 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -99.25 155.62 17.4 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 105.318 -2.105 . . . . 0.0 105.318 166.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -122.16 126.32 48.06 Favored 'General case' 0 CA--C 1.486 -1.488 1 N-CA-C 94.331 -6.174 . . . . 0.0 94.331 153.19 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.55 179.91 36.65 Favored Glycine 0 CA--C 1.475 -2.466 0 N-CA-C 104.345 -3.502 . . . . 0.0 104.345 -174.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -79.89 134.05 36.28 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 104.461 -2.422 . . . . 0.0 104.461 168.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 16.4 tt -90.36 149.4 4.06 Favored 'Isoleucine or valine' 0 C--N 1.355 0.808 0 N-CA-C 105.62 -1.992 . . . . 0.0 105.62 -178.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -139.96 -173.07 3.54 Favored 'General case' 0 N--CA 1.417 -2.113 0 C-N-CA 126.255 1.822 . . . . 0.0 106.898 -170.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -95.18 148.33 34.48 Favored Pre-proline 0 N--CA 1.432 -1.36 0 N-CA-C 102.085 -3.302 . . . . 0.0 102.085 163.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_exo -69.62 -26.86 27.8 Favored 'Trans proline' 0 CA--C 1.501 -1.144 0 CA-C-N 123.034 2.119 . . . . 0.0 115.52 -153.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -88.76 53.78 2.81 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-N 119.224 0.92 . . . . 0.0 110.483 -167.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 75.32 41.34 0.29 Allowed 'General case' 0 C--N 1.354 0.786 0 C-N-CA 125.793 1.637 . . . . 0.0 110.121 167.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 55.6 m -117.05 -154.86 0.57 Allowed 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -168.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.6 m -133.01 175.57 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.4 1 N-CA-C 98.433 -4.655 . . . . 0.0 98.433 166.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . 0.31 0.2 OUTLIER -119.62 141.14 49.57 Favored 'General case' 0 CA--C 1.477 -1.861 1 N-CA-C 92.684 -6.784 . . . . 0.0 92.684 170.045 . . . . . . . . 4 3 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.409 ' CD2' ' HB3' ' A' ' 45' ' ' LEU . 21.5 m80 -90.46 145.66 24.74 Favored 'General case' 0 CA--C 1.491 -1.306 0 N-CA-C 103.558 -2.756 . . . . 0.0 103.558 174.135 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.7 t -90.48 167.71 12.39 Favored 'General case' 0 CA--C 1.483 -1.606 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 -176.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -114.38 113.44 45.75 Favored Pre-proline 0 N--CA 1.42 -1.952 1 N-CA-C 98.424 -4.658 . . . . 0.0 98.424 168.427 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -57.59 129.59 34.53 Favored 'Trans proline' 0 CA--C 1.507 -0.87 0 CA-C-N 123.154 2.162 . . . . 0.0 111.351 178.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 126.61 -56.98 0.71 Allowed Glycine 0 CA--C 1.49 -1.5 1 N-CA-C 101.853 -4.499 . . . . 0.0 101.853 -157.62 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.5 m 107.3 -6.1 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.321 0 C-N-CA 129.25 3.02 . . . . 0.0 110.932 174.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.1 m -42.42 -55.36 3.45 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 127.625 2.37 . . . . 0.0 115.275 -166.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -72.26 -45.86 37.2 Favored Glycine 0 C--N 1.351 1.378 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 -176.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.9 m -72.89 -32.59 65.48 Favored 'General case' 0 CA--C 1.492 -1.269 0 O-C-N 121.474 -1.015 . . . . 0.0 112.003 -174.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -65.78 -38.32 88.7 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 174.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 32.2 m -65.29 -43.35 91.42 Favored 'General case' 0 C--N 1.35 0.603 0 O-C-N 120.733 -1.23 . . . . 0.0 110.144 176.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 33.9 mt -63.69 -40.39 96.69 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-O 122.17 0.986 . . . . 0.0 110.474 178.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.4 t -57.14 -43.8 82.77 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 124.6 1.16 . . . . 0.0 110.79 175.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -64.03 -43.61 95.05 Favored 'General case' 0 C--N 1.355 0.84 0 CA-C-N 118.494 0.588 . . . . 0.0 111.633 -178.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -79.04 -30.63 44.23 Favored 'General case' 0 CA--C 1.507 -0.674 0 O-C-N 122.039 -0.413 . . . . 0.0 111.27 -172.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -83.77 -22.11 31.99 Favored 'General case' 0 C--N 1.355 0.843 0 O-C-N 121.774 -0.579 . . . . 0.0 109.847 177.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 108.65 48.27 0.86 Allowed Glycine 0 CA--C 1.491 -1.439 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 159.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.23 154.27 16.9 Favored Glycine 0 C--N 1.35 1.326 0 N-CA-C 106.582 -2.607 . . . . 0.0 106.582 170.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 39.3 p -90.81 -20.53 22.23 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-O 122.341 1.067 . . . . 0.0 109.927 -165.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.9 m -160.22 159.75 31.9 Favored 'General case' 0 N--CA 1.423 -1.818 1 N-CA-C 98.122 -4.77 . . . . 0.0 98.122 179.237 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -178.6 172.52 44.87 Favored Glycine 0 CA--C 1.467 -2.944 1 N-CA-C 100.039 -5.224 . . . . 0.0 100.039 -179.347 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 177.95 -160.07 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 100.262 -3.977 . . . . 0.0 100.262 -174.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 61.6 m -76.77 177.49 7.56 Favored 'General case' 0 CA--C 1.504 -0.821 0 CA-C-O 121.898 0.856 . . . . 0.0 110.704 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -164.05 -179.11 38.1 Favored Glycine 0 N--CA 1.42 -2.426 1 N-CA-C 98.663 -5.775 . . . . 0.0 98.663 178.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -143.7 159.99 41.5 Favored 'General case' 0 N--CA 1.422 -1.833 1 N-CA-C 97.623 -4.955 . . . . 0.0 97.623 -177.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.1 mmmm -148.95 167.08 26.72 Favored 'General case' 0 N--CA 1.421 -1.886 1 N-CA-C 95.995 -5.557 . . . . 0.0 95.995 169.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -133.43 156.77 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.685 1 N-CA-C 94.391 -6.151 . . . . 0.0 94.391 173.228 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.89 -60.53 0.73 Allowed Glycine 0 CA--C 1.492 -1.394 0 N-CA-C 104.771 -3.331 . . . . 0.0 104.771 -170.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 23.4 m170 -90.24 -90.61 0.15 Allowed 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 166.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 163.86 -156.61 28.54 Favored Glycine 0 CA--C 1.479 -2.194 1 N-CA-C 99.399 -5.48 . . . . 0.0 99.399 179.033 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.409 ' HB3' ' CD2' ' A' ' 15' ' ' HIS . 54.0 tp -43.52 126.73 4.53 Favored 'General case' 0 C--N 1.352 0.712 0 C-N-CA 128.001 2.521 . . . . 0.0 111.646 -179.49 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -127.67 -171.19 2.38 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 105.416 -2.068 . . . . 0.0 105.416 -168.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 63.7 m -131.23 176.21 8.47 Favored 'General case' 0 CA--C 1.482 -1.641 0 N-CA-C 102.746 -3.057 . . . . 0.0 102.746 171.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 12.5 t-105 -137.58 154.03 49.85 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 -177.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 22.6 m -145.59 152.84 40.34 Favored 'General case' 0 CA--C 1.493 -1.25 0 N-CA-C 104.269 -2.493 . . . . 0.0 104.269 171.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -109.53 143.54 39.05 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 104.31 -2.478 . . . . 0.0 104.31 168.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 55.9 62.48 2.37 Favored 'General case' 0 CA--C 1.499 -1.017 0 C-N-CA 127.871 2.469 . . . . 0.0 113.128 173.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 33.5 mt -95.61 134.74 23.77 Favored Pre-proline 0 CA--C 1.498 -1.021 0 N-CA-C 103.614 -2.735 . . . . 0.0 103.614 171.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -71.53 176.54 7.93 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 CA-C-N 122.375 1.884 . . . . 0.0 111.72 178.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -75.02 -8.76 57.45 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 113.65 0.982 . . . . 0.0 113.65 -167.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.8 p-10 -85.99 -8.24 58.1 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 121.605 -0.684 . . . . 0.0 110.069 -179.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.0 t -92.9 127.78 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 -175.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -97.32 140.69 15.19 Favored Glycine 0 CA--C 1.484 -1.898 0 N-CA-C 104.424 -3.47 . . . . 0.0 104.424 177.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 24.4 pt -139.09 -151.8 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 N-CA-C 104.157 -2.535 . . . . 0.0 104.157 -165.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.8 mp -66.41 118.77 10.27 Favored 'Isoleucine or valine' 0 C--N 1.364 1.209 0 N-CA-C 103.501 -2.778 . . . . 0.0 103.501 168.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.4 t . . . . . 0 N--CA 1.422 -1.843 1 N-CA-C 96.95 -5.204 . . . . 0.0 96.95 -168.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 27.4 m . . . . . 0 N--CA 1.484 1.265 0 CA-C-O 121.174 0.512 . . . . 0.0 110.26 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -105.03 160.34 15.12 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 106.109 -1.811 . . . . 0.0 106.109 168.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -127.69 126.62 42.24 Favored 'General case' 0 CA--C 1.49 -1.357 1 N-CA-C 96.636 -5.32 . . . . 0.0 96.636 158.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.04 -170.83 27.35 Favored Glycine 0 CA--C 1.477 -2.328 1 N-CA-C 102.084 -4.407 . . . . 0.0 102.084 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -81.08 141.68 34.07 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 103.611 -2.737 . . . . 0.0 103.611 164.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 11.5 tt -90.4 142.14 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 N-CA-C 104.903 -2.258 . . . . 0.0 104.903 175.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -130.52 175.65 8.81 Favored 'General case' 0 N--CA 1.414 -2.233 0 N-CA-C 103.919 -2.622 . . . . 0.0 103.919 -175.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -79.6 154.21 76.11 Favored Pre-proline 0 N--CA 1.432 -1.34 0 N-CA-C 105.032 -2.21 . . . . 0.0 105.032 166.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -68.96 0.34 5.18 Favored 'Trans proline' 0 CA--C 1.511 -0.627 0 C-N-CA 121.94 1.76 . . . . 0.0 116.609 -168.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -102.28 9.56 39.85 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 119.773 1.169 . . . . 0.0 108.525 -175.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 66.3 t30 73.34 57.54 0.11 Allowed 'General case' 0 CA--C 1.497 -1.096 0 C-N-CA 126.278 1.831 . . . . 0.0 107.951 -177.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 30.5 m -142.01 135.71 29.55 Favored 'General case' 0 CA--C 1.485 -1.541 1 N-CA-C 99.01 -4.441 . . . . 0.0 99.01 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.7 m -60.95 148.47 9.07 Favored 'Isoleucine or valine' 0 C--N 1.354 0.764 0 CA-C-N 120.463 1.483 . . . . 0.0 112.35 -172.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -98.02 132.09 43.88 Favored 'General case' 0 CA--C 1.483 -1.623 1 N-CA-C 97.97 -4.826 . . . . 0.0 97.97 177.211 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 66.9 m80 -90.38 -175.58 4.52 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 -166.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 5.7 t -147.03 157.55 43.65 Favored 'General case' 0 N--CA 1.413 -2.305 1 N-CA-C 96.392 -5.41 . . . . 0.0 96.392 -175.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -117.34 110.92 40.51 Favored Pre-proline 0 N--CA 1.419 -2.008 1 N-CA-C 96.906 -5.22 . . . . 0.0 96.906 172.405 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_exo -60.1 114.57 2.15 Favored 'Trans proline' 0 CA--C 1.506 -0.899 0 CA-C-N 123.324 2.223 . . . . 0.0 113.811 -162.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 154.45 -42.98 0.59 Allowed Glycine 0 N--CA 1.432 -1.568 1 N-CA-C 100.584 -5.006 . . . . 0.0 100.584 -163.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.6 m 95.84 21.84 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.31 0 C-N-CA 127.329 2.251 . . . . 0.0 111.071 167.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 p -68.13 -52.29 36.47 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 125.493 1.517 . . . . 0.0 110.302 -174.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.62 -38.39 90.17 Favored Glycine 0 C--N 1.347 1.192 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 178.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 41.9 t -66.15 -48.33 71.13 Favored 'General case' 0 CA--C 1.502 -0.872 0 C-N-CA 124.283 1.033 . . . . 0.0 110.013 -177.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -53.34 -49.91 66.11 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 125.539 1.536 . . . . 0.0 109.925 175.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.4 m -60.51 -53.09 61.75 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 124.105 0.962 . . . . 0.0 111.299 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 37.4 mt -65.47 -44.45 87.13 Favored 'General case' 0 CA--C 1.492 -1.257 0 C-N-CA 125.068 1.347 . . . . 0.0 110.234 -175.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.8 t -62.56 -44.97 95.0 Favored 'General case' 0 N--CA 1.435 -1.189 0 C-N-CA 123.021 0.528 . . . . 0.0 109.788 179.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -69.25 -41.94 76.27 Favored 'General case' 0 CA--C 1.503 -0.856 0 O-C-N 122.247 -0.283 . . . . 0.0 110.402 -174.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -74.73 -27.36 60.33 Favored 'General case' 0 CA--C 1.505 -0.777 0 O-C-N 121.715 -0.616 . . . . 0.0 111.621 -176.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.36 -23.53 27.97 Favored 'General case' 0 C--N 1.358 0.966 0 CA-C-O 121.571 0.7 . . . . 0.0 109.331 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.08 43.05 1.23 Allowed Glycine 0 CA--C 1.484 -1.859 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 162.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -98.91 152.09 19.61 Favored Glycine 0 CA--C 1.491 -1.461 0 N-CA-C 104.278 -3.529 . . . . 0.0 104.278 165.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 23.5 p -87.77 -44.53 11.06 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -168.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 18.3 m -129.06 157.23 42.32 Favored 'General case' 0 CA--C 1.485 -1.547 0 N-CA-C 102.14 -3.282 . . . . 0.0 102.14 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -161.26 160.19 31.9 Favored Glycine 0 N--CA 1.416 -2.683 1 N-CA-C 98.473 -5.851 . . . . 0.0 98.473 178.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 9.0 p-80 -164.21 176.53 9.12 Favored 'General case' 0 N--CA 1.427 -1.594 1 N-CA-C 96.719 -5.289 . . . . 0.0 96.719 -178.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 70.3 m -110.58 165.76 11.55 Favored 'General case' 0 CA--C 1.481 -1.69 0 CA-C-N 119.566 1.075 . . . . 0.0 108.256 -173.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -175.6 -169.05 36.83 Favored Glycine 0 N--CA 1.424 -2.154 1 N-CA-C 100.649 -4.981 . . . . 0.0 100.649 -179.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -130.32 138.88 50.67 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 101.605 -3.48 . . . . 0.0 101.605 -172.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -108.1 111.89 24.16 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 102.855 -3.017 . . . . 0.0 102.855 174.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.8 t -80.81 120.66 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 -175.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 119.93 -7.12 12.03 Favored Glycine 0 CA--C 1.494 -1.267 0 N-CA-C 106.838 -2.505 . . . . 0.0 106.838 -166.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 44.8 m-70 -139.69 -79.56 0.31 Allowed 'General case' 0 CA--C 1.497 -1.067 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 167.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 170.4 -161.52 34.55 Favored Glycine 0 N--CA 1.426 -2.023 0 N-CA-C 104.188 -3.565 . . . . 0.0 104.188 -166.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 30.8 tp -65.57 133.44 51.19 Favored 'General case' 0 CA--C 1.505 -0.77 0 C-N-CA 127.197 2.199 . . . . 0.0 107.275 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.25 -176.41 4.25 Favored 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 -166.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.2 t -125.13 151.16 46.13 Favored 'General case' 0 CA--C 1.491 -1.323 1 N-CA-C 98.631 -4.581 . . . . 0.0 98.631 175.226 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 38.0 t-105 -107.15 152.8 23.58 Favored 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 103.941 -2.614 . . . . 0.0 103.941 179.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 22.9 m -143.77 150.57 38.78 Favored 'General case' 0 CA--C 1.483 -1.621 0 N-CA-C 104.307 -2.479 . . . . 0.0 104.307 170.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -116.09 140.44 49.28 Favored 'General case' 0 CA--C 1.492 -1.277 0 N-CA-C 102.464 -3.161 . . . . 0.0 102.464 171.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 67.21 56.67 0.62 Allowed 'General case' 0 CA--C 1.496 -1.112 0 C-N-CA 127.103 2.161 . . . . 0.0 111.601 172.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 25.1 mt -93.96 134.04 26.7 Favored Pre-proline 0 CA--C 1.496 -1.12 0 N-CA-C 104.411 -2.44 . . . . 0.0 104.411 174.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -75.06 173.61 14.22 Favored 'Trans proline' 0 N--CA 1.445 -1.327 0 C-N-CA 122.236 1.958 . . . . 0.0 110.236 178.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -64.75 -13.21 54.22 Favored 'General case' 0 CA--C 1.506 -0.744 0 C-N-CA 125.795 1.638 . . . . 0.0 114.477 -173.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -89.88 8.76 30.48 Favored 'General case' 0 CA--C 1.504 -0.807 0 O-C-N 121.503 -0.748 . . . . 0.0 110.247 -176.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.7 t -110.54 141.93 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.339 0 N-CA-C 102.552 -3.129 . . . . 0.0 102.552 177.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -115.79 148.14 18.91 Favored Glycine 0 CA--C 1.479 -2.21 1 N-CA-C 100.3 -5.12 . . . . 0.0 100.3 175.176 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 24.2 pt -147.28 -151.22 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.426 -1.635 0 N-CA-C 102.34 -3.207 . . . . 0.0 102.34 -163.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 7.5 mm -71.65 122.55 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 178.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.431 -1.404 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 -163.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.2 m . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 121.164 0.507 . . . . 0.0 110.411 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -109.94 159.26 17.41 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 175.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -126.99 127.13 44.33 Favored 'General case' 0 CA--C 1.488 -1.41 1 N-CA-C 95.21 -5.848 . . . . 0.0 95.21 158.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.82 -169.14 24.73 Favored Glycine 0 CA--C 1.474 -2.53 1 N-CA-C 102.372 -4.291 . . . . 0.0 102.372 -179.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -83.71 143.85 29.76 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 103.859 -2.645 . . . . 0.0 103.859 161.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.0 tt -90.79 141.49 14.33 Favored 'Isoleucine or valine' 0 C--O 1.25 1.102 0 N-CA-C 105.939 -1.875 . . . . 0.0 105.939 174.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -140.18 174.41 10.54 Favored 'General case' 0 N--CA 1.42 -1.966 1 N-CA-C 99.915 -4.106 . . . . 0.0 99.915 175.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -85.2 160.25 55.02 Favored Pre-proline 0 N--CA 1.432 -1.36 0 C-N-CA 126.983 2.113 . . . . 0.0 106.014 178.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -70.23 -11.98 31.19 Favored 'Trans proline' 0 CA--C 1.505 -0.95 0 CA-C-N 121.4 1.536 . . . . 0.0 116.024 -160.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -99.58 15.02 27.98 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -178.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 63.7 t30 74.43 54.64 0.09 Allowed 'General case' 0 CA--C 1.501 -0.929 0 C-N-CA 125.706 1.603 . . . . 0.0 110.052 172.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.2 m -133.86 136.59 44.47 Favored 'General case' 0 CA--C 1.478 -1.823 1 N-CA-C 98.909 -4.478 . . . . 0.0 98.909 176.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -64.35 155.18 6.35 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.932 0 CA-C-N 120.186 1.357 . . . . 0.0 112.224 -172.16 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -104.8 128.2 52.87 Favored 'General case' 0 CA--C 1.473 -1.997 1 N-CA-C 91.416 -7.253 . . . . 0.0 91.416 177.154 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 41.1 m80 -88.5 -150.57 0.19 Allowed 'General case' 0 CA--C 1.491 -1.291 0 N-CA-C 105.41 -2.07 . . . . 0.0 105.41 -167.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 8.0 t -153.19 161.99 41.81 Favored 'General case' 0 N--CA 1.413 -2.303 1 N-CA-C 94.094 -6.262 . . . . 0.0 94.094 -176.006 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -111.73 112.82 53.34 Favored Pre-proline 0 N--CA 1.422 -1.847 1 N-CA-C 95.907 -5.59 . . . . 0.0 95.907 171.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo -60.39 101.06 0.16 Allowed 'Trans proline' 0 CA--C 1.508 -0.811 0 C-N-CA 122.457 2.105 . . . . 0.0 116.449 -157.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 169.16 -178.33 42.42 Favored Glycine 0 N--CA 1.422 -2.247 1 N-CA-C 95.893 -6.883 . . . . 0.0 95.893 178.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.3 m -69.78 -39.24 76.77 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 119.45 1.625 . . . . 0.0 109.234 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -43.87 -53.03 6.39 Favored 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 130.653 3.581 . . . . 0.0 115.607 -173.278 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.71 -39.7 66.29 Favored Glycine 0 C--N 1.353 1.473 0 O-C-N 120.998 -1.064 . . . . 0.0 111.441 -171.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 38.9 t -70.92 -47.24 60.19 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -54.91 -44.14 73.92 Favored 'General case' 0 C--N 1.354 0.769 0 C-N-CA 123.267 0.627 . . . . 0.0 110.845 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 26.6 m -59.92 -50.13 74.97 Favored 'General case' 0 C--N 1.35 0.601 0 C-N-CA 123.193 0.597 . . . . 0.0 111.509 177.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 50.3 mt -67.77 -40.43 84.03 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-O 122.437 1.113 . . . . 0.0 110.43 -176.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.0 t -62.44 -42.75 99.69 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 124.64 1.176 . . . . 0.0 109.419 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 24.0 mtpp -68.44 -42.57 78.65 Favored 'General case' 0 C--N 1.355 0.831 0 C-N-CA 123.072 0.549 . . . . 0.0 111.674 -179.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -75.07 -22.16 58.51 Favored 'General case' 0 C--N 1.354 0.782 0 O-C-N 121.455 -0.778 . . . . 0.0 111.24 -174.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.3 mmtm -79.86 -60.33 2.38 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 170.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 135.39 50.12 0.07 OUTLIER Glycine 0 CA--C 1.489 -1.577 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 171.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.5 141.95 15.57 Favored Glycine 0 CA--C 1.491 -1.442 0 N-CA-C 103.839 -3.704 . . . . 0.0 103.839 164.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.1 p -100.11 3.32 43.85 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 123.813 0.845 . . . . 0.0 110.334 -165.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.4 m -160.1 158.53 30.49 Favored 'General case' 0 CA--C 1.476 -1.894 1 N-CA-C 97.773 -4.899 . . . . 0.0 97.773 168.069 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -170.76 164.76 37.97 Favored Glycine 0 CA--C 1.469 -2.817 1 N-CA-C 99.56 -5.416 . . . . 0.0 99.56 -176.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 59.9 m80 -155.05 152.98 30.25 Favored 'General case' 0 N--CA 1.43 -1.45 1 N-CA-C 100.049 -4.056 . . . . 0.0 100.049 -175.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 44.9 t -85.1 153.76 22.49 Favored 'General case' 0 CA--C 1.505 -0.778 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 -175.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -174.55 -177.1 43.42 Favored Glycine 0 CA--C 1.482 -2.017 0 N-CA-C 105.061 -3.216 . . . . 0.0 105.061 179.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -119.98 142.61 48.62 Favored 'General case' 0 N--CA 1.431 -1.42 1 N-CA-C 99.547 -4.242 . . . . 0.0 99.547 -179.003 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 24.8 tptp -119.31 103.91 9.91 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 101.457 -3.534 . . . . 0.0 101.457 175.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.9 t -73.07 136.9 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 N-CA-C 105.868 -1.901 . . . . 0.0 105.868 -178.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 113.34 -24.75 12.01 Favored Glycine 0 CA--C 1.491 -1.435 0 N-CA-C 106.23 -2.748 . . . . 0.0 106.23 -168.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 60.8 m-70 -127.98 -81.11 0.59 Allowed 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 174.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 168.17 -151.76 19.14 Favored Glycine 0 N--CA 1.429 -1.798 0 N-CA-C 105.169 -3.172 . . . . 0.0 105.169 -171.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 49.1 tp -65.41 126.14 27.33 Favored 'General case' 0 CA--C 1.506 -0.721 0 C-N-CA 126.634 1.974 . . . . 0.0 106.856 178.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -134.27 -167.99 2.06 Favored 'General case' 0 CA--C 1.489 -1.372 0 N-CA-C 105.369 -2.085 . . . . 0.0 105.369 -166.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.7 t -136.86 148.23 46.97 Favored 'General case' 0 CA--C 1.489 -1.369 0 N-CA-C 100.349 -3.945 . . . . 0.0 100.349 172.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 20.3 t-105 -102.89 148.69 25.33 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 104.111 -2.552 . . . . 0.0 104.111 177.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 50.2 m -144.77 149.2 35.1 Favored 'General case' 0 CA--C 1.498 -1.052 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 176.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -113.62 142.84 45.51 Favored 'General case' 0 CA--C 1.495 -1.164 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 172.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 62.69 57.03 1.85 Allowed 'General case' 0 CA--C 1.494 -1.191 0 C-N-CA 127.985 2.514 . . . . 0.0 111.103 172.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 17.8 mt -90.07 137.28 28.09 Favored Pre-proline 0 N--CA 1.44 -0.959 0 N-CA-C 104.899 -2.26 . . . . 0.0 104.899 174.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_exo -69.02 171.88 12.88 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 122.036 1.824 . . . . 0.0 113.047 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -76.25 -13.16 60.17 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 123.39 0.676 . . . . 0.0 112.203 -171.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -91.64 13.3 18.37 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 124.122 0.969 . . . . 0.0 110.426 178.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.3 t -104.22 160.9 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 N-CA-C 101.535 -3.506 . . . . 0.0 101.535 171.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -138.05 150.52 20.97 Favored Glycine 0 CA--C 1.481 -2.09 1 N-CA-C 96.986 -6.446 . . . . 0.0 96.986 178.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 29.4 pt -156.68 -155.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 N-CA-C 101.586 -3.487 . . . . 0.0 101.586 -158.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.2 mm -63.08 137.51 24.48 Favored 'Isoleucine or valine' 0 C--N 1.363 1.163 0 C-N-CA 123.943 0.897 . . . . 0.0 109.556 -177.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.419 -1.986 1 N-CA-C 96.295 -5.446 . . . . 0.0 96.295 -178.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 17.3 m . . . . . 0 N--CA 1.481 1.121 0 CA-C-O 121.621 0.724 . . . . 0.0 110.56 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -100.6 174.06 6.25 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 102.654 -3.091 . . . . 0.0 102.654 159.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -119.16 150.17 40.49 Favored 'General case' 0 CA--C 1.487 -1.464 1 N-CA-C 94.262 -6.199 . . . . 0.0 94.262 155.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -160.7 165.12 34.97 Favored Glycine 0 CA--C 1.471 -2.691 0 C-N-CA 116.618 -2.706 . . . . 0.0 108.822 -172.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -87.87 116.24 25.88 Favored 'General case' 0 N--CA 1.429 -1.504 1 N-CA-C 99.51 -4.255 . . . . 0.0 99.51 160.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 13.8 tt -75.72 135.0 27.98 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.419 0 N-CA-C 104.524 -2.399 . . . . 0.0 104.524 -172.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -125.89 -172.99 2.73 Favored 'General case' 0 N--CA 1.419 -2.01 0 O-C-N 126.309 2.256 . . . . 0.0 107.793 -178.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -101.54 139.52 20.47 Favored Pre-proline 0 N--CA 1.424 -1.753 1 N-CA-C 98.126 -4.768 . . . . 0.0 98.126 164.297 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -76.78 -0.31 10.38 Favored 'Trans proline' 0 CA--C 1.504 -1.008 0 C-N-CA 122.457 2.104 . . . . 0.0 112.501 -152.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 84.5 mt-10 -95.28 45.35 1.1 Allowed 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 124.756 1.222 . . . . 0.0 108.322 -165.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 66.49 49.31 1.39 Allowed 'General case' 0 C--N 1.355 0.806 0 C-N-CA 126.555 1.942 . . . . 0.0 108.174 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -128.29 -160.59 1.03 Allowed 'General case' 0 CA--C 1.492 -1.269 0 O-C-N 120.651 -1.281 . . . . 0.0 110.91 -171.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.7 m -125.37 -171.23 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.435 1 N-CA-C 99.618 -4.216 . . . . 0.0 99.618 167.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -126.89 150.44 49.28 Favored 'General case' 0 CA--C 1.477 -1.827 1 N-CA-C 95.338 -5.801 . . . . 0.0 95.338 173.755 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 61.0 m170 -99.08 122.91 42.93 Favored 'General case' 0 CA--C 1.485 -1.535 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 -178.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 41.9 t -83.54 151.08 25.56 Favored 'General case' 0 N--CA 1.427 -1.597 0 N-CA-C 105.95 -1.871 . . . . 0.0 105.95 176.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -98.44 118.41 63.38 Favored Pre-proline 0 N--CA 1.428 -1.528 1 N-CA-C 100.148 -4.019 . . . . 0.0 100.148 175.253 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -62.7 103.15 0.32 Allowed 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.687 2.258 . . . . 0.0 112.849 -165.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 168.59 -52.59 0.22 Allowed Glycine 0 N--CA 1.427 -1.902 1 N-CA-C 100.238 -5.145 . . . . 0.0 100.238 -175.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.8 m 134.11 -42.92 0.01 OUTLIER 'General case' 0 CA--C 1.489 -1.403 0 C-N-CA 128.953 2.901 . . . . 0.0 105.81 174.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.6 m -39.66 -55.53 1.87 Allowed 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 128.311 2.645 . . . . 0.0 117.165 -150.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.89 -34.64 71.64 Favored Glycine 0 C--N 1.346 1.103 0 O-C-N 121.478 -0.764 . . . . 0.0 111.723 -175.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.7 t -86.51 -18.31 31.91 Favored 'General case' 0 CA--C 1.5 -0.953 0 O-C-N 121.46 -1.023 . . . . 0.0 108.4 -176.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -66.1 -44.06 85.45 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 170.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -62.94 -33.3 75.06 Favored 'General case' 0 C--N 1.353 0.758 0 O-C-N 121.123 -0.986 . . . . 0.0 113.019 172.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 86.3 mt -66.76 -41.42 87.79 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-N 119.1 0.864 . . . . 0.0 110.212 175.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 11.4 t -56.41 -50.42 71.66 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 123.763 0.825 . . . . 0.0 110.337 174.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -56.89 -51.48 68.94 Favored 'General case' 0 C--N 1.359 0.979 0 C-N-CA 123.621 0.769 . . . . 0.0 111.888 -179.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -69.57 -19.28 63.68 Favored 'General case' 0 C--N 1.354 0.78 0 O-C-N 121.519 -0.738 . . . . 0.0 112.976 -173.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 48.6 mmtm -96.46 0.44 50.36 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 177.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.11 21.34 23.16 Favored Glycine 0 C--N 1.352 1.428 0 O-C-N 121.416 -0.803 . . . . 0.0 111.582 168.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -88.48 124.02 7.03 Favored Glycine 0 CA--C 1.485 -1.82 0 N-CA-C 106.466 -2.653 . . . . 0.0 106.466 169.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -77.17 -56.39 4.61 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 124.947 1.299 . . . . 0.0 108.435 -173.015 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.2 m -114.17 156.94 23.34 Favored 'General case' 0 CA--C 1.484 -1.584 0 N-CA-C 103.883 -2.636 . . . . 0.0 103.883 178.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -168.13 177.72 42.16 Favored Glycine 0 N--CA 1.416 -2.696 1 N-CA-C 99.926 -5.27 . . . . 0.0 99.926 -177.217 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 31.6 p-80 -171.97 -172.99 1.06 Allowed 'General case' 0 N--CA 1.425 -1.69 1 N-CA-C 95.955 -5.572 . . . . 0.0 95.955 173.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 88.1 m -122.58 158.88 28.96 Favored 'General case' 0 CA--C 1.48 -1.734 0 N-CA-C 102.509 -3.145 . . . . 0.0 102.509 174.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.42 174.42 46.67 Favored Glycine 0 CA--C 1.481 -2.058 1 N-CA-C 100.741 -4.944 . . . . 0.0 100.741 -174.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -146.16 127.7 15.09 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 102.638 -3.097 . . . . 0.0 102.638 -178.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 35.5 mmtm -156.83 82.37 0.95 Allowed 'General case' 0 CA--C 1.493 -1.241 1 N-CA-C 96.417 -5.401 . . . . 0.0 96.417 153.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.8 t -143.57 -178.1 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.071 1 N-CA-C 99.702 -4.184 . . . . 0.0 99.702 -169.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -135.04 26.95 3.21 Favored Glycine 0 C--N 1.349 1.27 0 N-CA-C 108.022 -2.031 . . . . 0.0 108.022 177.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 39.4 m170 -116.22 -75.34 0.58 Allowed 'General case' 0 CA--C 1.5 -0.969 0 N-CA-C 104.346 -2.465 . . . . 0.0 104.346 173.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -171.75 -169.31 34.44 Favored Glycine 0 CA--C 1.478 -2.247 1 N-CA-C 98.312 -5.915 . . . . 0.0 98.312 -175.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . 0.256 0.2 OUTLIER -65.39 147.49 53.34 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 123.817 0.847 . . . . 0.0 111.066 -178.072 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -141.22 175.63 9.49 Favored 'General case' 0 CA--C 1.485 -1.551 0 N-CA-C 101.984 -3.339 . . . . 0.0 101.984 -166.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.5 m -120.05 155.38 33.04 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 104.407 -2.442 . . . . 0.0 104.407 178.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 73.5 t-105 -102.08 148.89 24.84 Favored 'General case' 0 CA--C 1.489 -1.391 0 N-CA-C 104.35 -2.463 . . . . 0.0 104.35 -177.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 69.2 m -140.09 140.91 36.18 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 102.174 -3.269 . . . . 0.0 102.174 168.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -106.73 19.11 20.95 Favored 'General case' 0 C--N 1.352 0.714 0 CA-C-O 121.413 0.625 . . . . 0.0 110.127 -169.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -166.77 144.27 4.95 Favored 'General case' 0 N--CA 1.422 -1.825 1 N-CA-C 93.573 -6.454 . . . . 0.0 93.573 169.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 21.5 mt -150.58 142.11 15.27 Favored Pre-proline 0 CA--C 1.486 -1.518 1 N-CA-C 99.13 -4.396 . . . . 0.0 99.13 153.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -74.06 172.13 16.58 Favored 'Trans proline' 0 N--CA 1.444 -1.402 0 C-N-CA 122.19 1.927 . . . . 0.0 110.14 174.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -75.48 -1.99 26.74 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 -166.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -92.0 -7.73 48.05 Favored 'General case' 0 CA--C 1.505 -0.765 0 O-C-N 121.57 -0.707 . . . . 0.0 109.573 179.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.8 t -101.47 129.71 52.18 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.308 0 N-CA-C 103.748 -2.686 . . . . 0.0 103.748 -174.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -98.45 160.19 20.49 Favored Glycine 0 CA--C 1.485 -1.804 0 N-CA-C 106.133 -2.787 . . . . 0.0 106.133 -178.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 23.2 pt -146.56 -162.67 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.549 0 N-CA-C 103.543 -2.762 . . . . 0.0 103.543 -165.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.8 mm -63.51 137.4 24.75 Favored 'Isoleucine or valine' 0 C--N 1.361 1.084 0 C-N-CA 124.074 0.95 . . . . 0.0 109.167 -176.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 55.3 t . . . . . 0 N--CA 1.442 -0.843 0 N-CA-C 103.643 -2.725 . . . . 0.0 103.643 178.813 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 34.8 m . . . . . 0 N--CA 1.485 1.303 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.52 165.48 27.46 Favored 'General case' 0 N--CA 1.426 -1.63 1 N-CA-C 100.071 -4.048 . . . . 0.0 100.071 165.753 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -133.41 128.21 35.05 Favored 'General case' 0 N--CA 1.429 -1.522 1 N-CA-C 93.867 -6.345 . . . . 0.0 93.867 166.649 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.03 -175.31 32.93 Favored Glycine 0 CA--C 1.47 -2.748 1 N-CA-C 102.064 -4.414 . . . . 0.0 102.064 176.477 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -75.34 133.1 41.32 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 104.555 -2.387 . . . . 0.0 104.555 163.533 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.9 tt -89.87 137.99 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.315 0 N-CA-C 104.611 -2.366 . . . . 0.0 104.611 -175.436 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -100.97 -144.81 0.34 Allowed 'General case' 0 N--CA 1.426 -1.674 0 C-N-CA 127.185 2.194 . . . . 0.0 106.717 -178.283 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -128.91 143.03 47.12 Favored Pre-proline 0 N--CA 1.421 -1.895 1 N-CA-C 93.47 -6.493 . . . . 0.0 93.47 163.577 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -82.57 27.27 0.61 Allowed 'Trans proline' 0 CA--C 1.506 -0.917 0 C-N-CA 122.651 2.234 . . . . 0.0 113.731 -141.248 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 41.4 mp0 -104.38 -78.52 0.56 Allowed 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 102.589 -3.115 . . . . 0.0 102.589 -178.156 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -161.33 142.97 11.71 Favored 'General case' 0 N--CA 1.425 -1.699 1 N-CA-C 92.464 -6.865 . . . . 0.0 92.464 156.188 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER 176.29 -166.68 0.04 OUTLIER 'General case' 0 CA--C 1.486 -1.513 0 N-CA-C 101.485 -3.524 . . . . 0.0 101.485 179.816 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.601 HG11 ' HD1' ' A' ' 43' ' ' HIS . 1.0 OUTLIER -121.29 160.56 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.725 1 N-CA-C 99.006 -4.442 . . . . 0.0 99.006 156.929 . . . . . . . . 4 4 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -82.71 -168.87 2.21 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 104.798 -2.297 . . . . 0.0 104.798 161.074 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 42.9 m170 -134.61 177.76 7.53 Favored 'General case' 0 N--CA 1.422 -1.858 1 N-CA-C 95.271 -5.826 . . . . 0.0 95.271 168.291 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 40.9 t -154.89 169.31 24.32 Favored 'General case' 0 N--CA 1.416 -2.148 1 N-CA-C 96.088 -5.523 . . . . 0.0 96.088 -168.275 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -126.3 120.41 23.58 Favored Pre-proline 0 N--CA 1.42 -1.931 1 N-CA-C 98.795 -4.52 . . . . 0.0 98.795 178.768 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 0.8 OUTLIER -55.56 135.2 68.2 Favored 'Trans proline' 0 CA--C 1.505 -0.951 0 C-N-CA 122.568 2.179 . . . . 0.0 112.384 -178.452 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 116.27 -43.55 1.64 Allowed Glycine 0 N--CA 1.438 -1.231 0 N-CA-C 103.989 -3.644 . . . . 0.0 103.989 -158.322 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.0 m 82.56 23.85 0.18 Allowed 'General case' 0 CA--C 1.496 -1.111 0 C-N-CA 128.105 2.562 . . . . 0.0 110.647 175.836 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.7 -61.2 2.68 Favored 'General case' 0 N--CA 1.44 -0.933 0 C-N-CA 126.808 2.043 . . . . 0.0 110.998 -168.995 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.14 -32.23 72.6 Favored Glycine 0 C--N 1.347 1.187 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 -175.468 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 11.5 t -78.45 -21.38 49.22 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-O 119.302 -0.38 . . . . 0.0 110.054 -173.482 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -60.43 -46.96 88.16 Favored 'General case' 0 C--N 1.352 0.692 0 CA-C-N 119.585 1.084 . . . . 0.0 109.409 173.394 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.13 -49.26 75.06 Favored 'General case' 0 N--CA 1.44 -0.934 0 O-C-N 121.537 -0.727 . . . . 0.0 112.521 171.09 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 73.8 mt -63.91 -44.28 93.39 Favored 'General case' 0 C--N 1.358 0.96 0 CA-C-O 121.722 0.772 . . . . 0.0 111.59 -173.882 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 13.7 t -60.0 -42.54 94.47 Favored 'General case' 0 CA--C 1.503 -0.855 0 C-N-CA 123.589 0.756 . . . . 0.0 109.558 179.175 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.6 mtmm -74.47 -35.05 63.28 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-N 119.211 0.914 . . . . 0.0 112.801 -177.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -70.75 -24.71 62.66 Favored 'General case' 0 C--N 1.358 0.941 0 CA-C-N 120.13 1.332 . . . . 0.0 111.536 178.628 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 48.4 mmtm -85.12 -13.58 49.8 Favored 'General case' 0 C--N 1.355 0.822 0 O-C-N 121.882 -0.512 . . . . 0.0 110.067 173.933 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.89 32.0 5.79 Favored Glycine 0 CA--C 1.492 -1.385 0 CA-C-O 119.375 -0.68 . . . . 0.0 111.636 166.718 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.3 138.29 14.29 Favored Glycine 0 CA--C 1.488 -1.653 0 N-CA-C 105.379 -3.089 . . . . 0.0 105.379 174.247 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 18.0 p -100.67 2.76 41.83 Favored 'General case' 0 N--CA 1.44 -0.97 0 O-C-N 122.063 -0.669 . . . . 0.0 110.042 -163.723 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.5 m -160.17 153.41 21.94 Favored 'General case' 0 CA--C 1.483 -1.6 1 N-CA-C 99.225 -4.361 . . . . 0.0 99.225 168.621 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -171.31 161.97 34.56 Favored Glycine 0 CA--C 1.474 -2.526 1 N-CA-C 100.022 -5.231 . . . . 0.0 100.022 178.296 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 14.8 p80 -165.81 170.71 13.61 Favored 'General case' 0 CA--C 1.488 -1.417 0 N-CA-C 100.215 -3.994 . . . . 0.0 100.215 -177.05 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 62.9 m -77.53 147.63 35.68 Favored 'General case' 0 CA--C 1.491 -1.29 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 177.843 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -163.88 173.43 39.93 Favored Glycine 0 CA--C 1.476 -2.404 1 N-CA-C 98.493 -5.843 . . . . 0.0 98.493 179.9 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -168.89 -169.33 0.98 Allowed 'General case' 0 N--CA 1.422 -1.867 1 N-CA-C 97.01 -5.182 . . . . 0.0 97.01 178.142 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.6 mptt 97.65 61.29 0.0 OUTLIER 'General case' 0 CA--C 1.492 -1.251 0 C-N-CA 131.186 3.794 . . . . 0.0 101.753 -164.692 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 19.3 t -143.21 172.92 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.738 1 N-CA-C 96.501 -5.37 . . . . 0.0 96.501 -177.743 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -113.21 89.57 0.52 Allowed Glycine 0 CA--C 1.486 -1.77 0 N-CA-C 104.329 -3.509 . . . . 0.0 104.329 176.643 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.601 ' HD1' HG11 ' A' ' 13' ' ' VAL . 17.4 m170 -172.09 -132.21 0.01 OUTLIER 'General case' 0 N--CA 1.438 -1.041 1 N-CA-C 99.422 -4.288 . . . . 0.0 99.422 172.741 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -110.87 -41.03 1.23 Allowed Glycine 0 C--N 1.358 1.758 0 CA-C-N 120.843 1.656 . . . . 0.0 113.317 -170.32 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 13.6 tp -165.63 177.4 7.35 Favored 'General case' 0 N--CA 1.434 -1.236 1 N-CA-C 95.769 -5.641 . . . . 0.0 95.769 -173.385 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -159.02 -174.86 4.95 Favored 'General case' 0 CA--C 1.478 -1.822 1 N-CA-C 98.288 -4.708 . . . . 0.0 98.288 175.409 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 46.8 t -130.25 164.51 24.4 Favored 'General case' 0 CA--C 1.492 -1.286 1 N-CA-C 99.943 -4.095 . . . . 0.0 99.943 167.872 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 24.9 t-105 -111.99 152.23 28.35 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 104.231 -2.507 . . . . 0.0 104.231 176.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 15.3 m -145.55 150.69 36.88 Favored 'General case' 0 C--N 1.36 1.032 0 N-CA-C 104.797 -2.297 . . . . 0.0 104.797 173.73 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -113.15 138.5 49.85 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 104.878 -2.268 . . . . 0.0 104.878 171.178 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 64.79 58.4 0.97 Allowed 'General case' 0 CA--C 1.491 -1.297 0 C-N-CA 127.199 2.2 . . . . 0.0 111.697 166.505 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 20.4 mt -89.11 143.91 31.85 Favored Pre-proline 0 N--CA 1.441 -0.912 0 N-CA-C 104.21 -2.515 . . . . 0.0 104.21 170.788 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -73.11 170.37 19.98 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.574 2.183 . . . . 0.0 109.773 177.573 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -70.47 -12.16 61.39 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -167.293 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -84.61 -9.06 58.63 Favored 'General case' 0 CA--C 1.506 -0.744 0 O-C-N 121.381 -0.825 . . . . 0.0 110.27 -176.469 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.5 t -92.35 133.92 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 -176.39 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -98.2 150.03 19.31 Favored Glycine 0 CA--C 1.487 -1.698 0 N-CA-C 105.193 -3.163 . . . . 0.0 105.193 179.273 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 28.4 pt -135.29 -166.43 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 103.459 -2.793 . . . . 0.0 103.459 -172.707 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.3 mm -66.45 130.06 31.45 Favored 'Isoleucine or valine' 0 C--N 1.362 1.11 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 -173.256 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 77.4 t . . . . . 0 N--CA 1.427 -1.612 0 N-CA-C 102.101 -3.296 . . . . 0.0 102.101 171.477 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 27.0 m . . . . . 0 N--CA 1.485 1.285 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -105.41 157.25 17.47 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 171.667 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -131.04 123.8 29.48 Favored 'General case' 0 N--CA 1.431 -1.386 1 N-CA-C 93.459 -6.497 . . . . 0.0 93.459 155.518 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.81 -173.61 30.68 Favored Glycine 0 CA--C 1.478 -2.28 1 N-CA-C 101.705 -4.558 . . . . 0.0 101.705 -177.426 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -79.93 137.69 36.94 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 103.673 -2.714 . . . . 0.0 103.673 166.683 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.2 tt -90.72 150.84 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.976 0 N-CA-C 105.171 -2.159 . . . . 0.0 105.171 179.489 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -143.88 179.68 7.02 Favored 'General case' 0 N--CA 1.411 -2.386 0 N-CA-C 101.309 -3.589 . . . . 0.0 101.309 -173.093 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -86.08 145.8 41.49 Favored Pre-proline 0 N--CA 1.427 -1.597 0 N-CA-C 102.559 -3.126 . . . . 0.0 102.559 171.33 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.11 5.42 5.76 Favored 'Trans proline' 0 CA--C 1.501 -1.157 0 C-N-CA 122.249 1.966 . . . . 0.0 112.491 -151.27 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -107.99 21.53 17.26 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 -179.919 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 62.4 t30 76.18 52.65 0.05 Allowed 'General case' 0 CA--C 1.496 -1.125 0 C-N-CA 126.903 2.081 . . . . 0.0 109.627 167.512 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 26.0 m -140.47 138.72 34.86 Favored 'General case' 0 CA--C 1.478 -1.806 0 N-CA-C 100.636 -3.839 . . . . 0.0 100.636 -175.937 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.0 m -66.95 152.19 9.83 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.94 0 CA-C-N 120.544 1.52 . . . . 0.0 111.058 -173.188 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -89.43 122.52 32.71 Favored 'General case' 0 CA--C 1.484 -1.565 1 N-CA-C 100.01 -4.07 . . . . 0.0 100.01 176.018 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 58.6 m80 -86.02 138.34 32.04 Favored 'General case' 0 CA--C 1.478 -1.794 0 N-CA-C 102.427 -3.175 . . . . 0.0 102.427 -174.561 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.0 t -148.53 -179.02 6.65 Favored 'General case' 0 N--CA 1.411 -2.413 1 N-CA-C 93.666 -6.42 . . . . 0.0 93.666 -170.122 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -147.36 171.67 6.07 Favored Pre-proline 0 N--CA 1.412 -2.344 1 N-CA-C 97.515 -4.995 . . . . 0.0 97.515 -157.79 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -66.7 44.58 0.21 Allowed 'Trans proline' 0 C--N 1.324 -0.738 0 C-N-CA 123.307 2.672 . . . . 0.0 116.79 -178.912 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -174.93 148.5 9.69 Favored Glycine 0 N--CA 1.42 -2.427 1 N-CA-C 98.202 -5.959 . . . . 0.0 98.202 172.973 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -78.25 38.12 0.28 Allowed 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 124.813 1.245 . . . . 0.0 112.389 -174.881 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.6 m -54.47 -62.46 1.64 Allowed 'General case' 0 N--CA 1.44 -0.947 0 C-N-CA 127.577 2.351 . . . . 0.0 112.447 -162.816 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -90.16 -19.7 45.31 Favored Glycine 0 C--N 1.35 1.338 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 179.901 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.4 t -80.58 -15.22 57.17 Favored 'General case' 0 N--CA 1.442 -0.837 0 O-C-N 121.679 -0.895 . . . . 0.0 110.462 -167.455 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -54.68 -54.51 40.8 Favored 'General case' 0 C--N 1.353 0.743 0 C-N-CA 125.334 1.454 . . . . 0.0 109.594 172.152 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -61.24 -48.43 81.48 Favored 'General case' 0 N--CA 1.435 -1.184 0 C-N-CA 125.233 1.413 . . . . 0.0 112.111 172.518 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 96.3 mt -65.53 -42.19 92.26 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-O 122.192 0.996 . . . . 0.0 111.368 -171.31 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 14.2 t -61.71 -44.39 97.02 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 124.19 0.996 . . . . 0.0 108.491 179.059 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -68.07 -40.2 82.79 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -179.267 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -72.53 -20.37 61.36 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 120.122 1.328 . . . . 0.0 112.371 -179.114 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.8 mmtm -85.82 -16.34 39.04 Favored 'General case' 0 C--N 1.354 0.783 0 C-N-CA 123.349 0.659 . . . . 0.0 109.947 173.07 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.23 29.63 6.66 Favored Glycine 0 CA--C 1.487 -1.682 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 168.743 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -93.85 142.95 16.25 Favored Glycine 0 N--CA 1.435 -1.386 0 N-CA-C 105.792 -2.923 . . . . 0.0 105.792 172.987 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.1 m -109.84 -3.86 16.39 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 122.866 1.317 . . . . 0.0 108.211 -160.84 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 43.1 m -160.49 165.83 30.25 Favored 'General case' 0 CA--C 1.483 -1.633 1 N-CA-C 98.027 -4.805 . . . . 0.0 98.027 166.232 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -166.33 174.99 41.87 Favored Glycine 0 CA--C 1.473 -2.536 1 N-CA-C 101.561 -4.616 . . . . 0.0 101.561 -176.457 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -166.42 -175.15 3.11 Favored 'General case' 0 N--CA 1.431 -1.415 1 N-CA-C 97.604 -4.961 . . . . 0.0 97.604 -172.505 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 86.4 m -146.06 161.35 40.32 Favored 'General case' 0 CA--C 1.487 -1.468 1 N-CA-C 99.531 -4.248 . . . . 0.0 99.531 172.178 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 179.65 -176.89 47.92 Favored Glycine 0 N--CA 1.426 -1.991 1 N-CA-C 101.837 -4.505 . . . . 0.0 101.837 -177.197 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -99.36 161.14 13.79 Favored 'General case' 0 N--CA 1.436 -1.175 0 N-CA-C 104.829 -2.286 . . . . 0.0 104.829 -178.256 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.46 ' HZ2' HG22 ' A' ' 59' ' ' ILE . 0.1 OUTLIER -154.26 158.81 40.79 Favored 'General case' 0 N--CA 1.425 -1.707 1 N-CA-C 96.047 -5.538 . . . . 0.0 96.047 163.869 . . . . . . . . 4 4 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.4 t -111.7 141.07 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.16 0 N-CA-C 103.505 -2.776 . . . . 0.0 103.505 -170.364 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 145.22 -66.41 0.43 Allowed Glycine 0 CA--C 1.482 -2.024 1 N-CA-C 103.054 -4.018 . . . . 0.0 103.054 179.857 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 60.6 m170 -97.31 -75.86 0.53 Allowed 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 172.49 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 171.46 -158.84 30.23 Favored Glycine 0 CA--C 1.477 -2.287 1 N-CA-C 102.562 -4.215 . . . . 0.0 102.562 -173.901 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.3 tt -69.01 137.16 53.45 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 -173.436 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -137.98 -179.01 5.52 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 104.346 -2.465 . . . . 0.0 104.346 -162.432 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 30.6 t -117.32 169.81 9.19 Favored 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 101.142 -3.651 . . . . 0.0 101.142 179.204 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 7.8 t-105 -131.44 150.42 52.16 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 102.452 -3.166 . . . . 0.0 102.452 -177.842 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 22.2 m -146.64 153.97 40.93 Favored 'General case' 0 CA--C 1.493 -1.25 0 N-CA-C 103.743 -2.688 . . . . 0.0 103.743 176.441 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -121.09 134.6 55.26 Favored 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 104.756 -2.313 . . . . 0.0 104.756 175.331 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 73.08 57.84 0.11 Allowed 'General case' 0 CA--C 1.492 -1.279 0 C-N-CA 126.941 2.096 . . . . 0.0 109.799 170.382 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 31.4 mt -96.32 144.25 27.51 Favored Pre-proline 0 CA--C 1.499 -0.987 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 176.967 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -66.6 164.37 29.19 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.562 2.174 . . . . 0.0 112.552 173.815 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -63.95 -27.58 69.24 Favored 'General case' 0 N--CA 1.442 -0.875 0 C-N-CA 125.224 1.409 . . . . 0.0 113.859 -173.455 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -94.97 17.25 14.23 Favored 'General case' 0 CA--C 1.503 -0.85 0 O-C-N 121.237 -0.915 . . . . 0.0 110.288 -174.796 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 20.4 t -97.21 122.84 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 N-CA-C 102.125 -3.287 . . . . 0.0 102.125 168.758 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -91.87 148.19 19.11 Favored Glycine 0 CA--C 1.488 -1.637 0 N-CA-C 104.817 -3.313 . . . . 0.0 104.817 179.272 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 25.5 pt -140.83 -149.68 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 N-CA-C 103.762 -2.681 . . . . 0.0 103.762 -169.284 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.46 HG22 ' HZ2' ' A' ' 40' ' ' LYS . 5.7 mm -71.24 115.42 11.16 Favored 'Isoleucine or valine' 0 C--N 1.357 0.9 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 177.272 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.257 1.2 t . . . . . 0 N--CA 1.438 -1.07 0 N-CA-C 102.519 -3.141 . . . . 0.0 102.519 -166.394 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 17.0 m . . . . . 0 N--CA 1.485 1.312 0 CA-C-O 121.709 0.766 . . . . 0.0 110.864 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.488 HH21 HG12 ' A' ' 58' ' ' ILE . 21.1 mtp85 -115.67 159.8 20.87 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 -173.298 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -135.89 134.31 38.63 Favored 'General case' 0 CA--C 1.489 -1.402 1 N-CA-C 96.674 -5.306 . . . . 0.0 96.674 164.071 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.01 -178.22 35.72 Favored Glycine 0 CA--C 1.48 -2.108 0 N-CA-C 106.687 -2.565 . . . . 0.0 106.687 175.558 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -75.36 128.7 35.98 Favored 'General case' 0 CA--C 1.497 -1.076 0 N-CA-C 104.386 -2.45 . . . . 0.0 104.386 158.745 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.7 tt -89.85 136.92 22.54 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.975 0 N-CA-C 105.444 -2.058 . . . . 0.0 105.444 -173.733 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -97.39 -147.11 0.31 Allowed 'General case' 0 N--CA 1.423 -1.806 0 CA-C-N 112.067 -2.333 . . . . 0.0 106.938 174.622 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -125.07 141.21 37.85 Favored Pre-proline 0 N--CA 1.42 -1.968 1 N-CA-C 93.575 -6.454 . . . . 0.0 93.575 168.831 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -80.54 23.38 0.71 Allowed 'Trans proline' 0 C--N 1.323 -0.769 0 C-N-CA 122.707 2.271 . . . . 0.0 114.276 -145.443 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -95.48 -82.0 0.39 Allowed 'General case' 0 CA--C 1.489 -1.368 0 N-CA-C 103.043 -2.947 . . . . 0.0 103.043 -179.965 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -165.38 123.78 1.64 Allowed 'General case' 0 N--CA 1.425 -1.698 1 N-CA-C 91.584 -7.191 . . . . 0.0 91.584 169.05 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.3 m -174.59 -166.14 0.24 Allowed 'General case' 0 CA--C 1.496 -1.127 0 N-CA-C 101.825 -3.398 . . . . 0.0 101.825 -179.163 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.497 HG11 ' HD1' ' A' ' 43' ' ' HIS . 0.9 OUTLIER -125.24 167.32 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.387 1 N-CA-C 96.829 -5.248 . . . . 0.0 96.829 160.039 . . . . . . . . 4 4 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -88.83 -159.01 0.53 Allowed 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 104.718 -2.327 . . . . 0.0 104.718 163.236 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 51.5 m80 -140.46 160.65 39.53 Favored 'General case' 0 N--CA 1.417 -2.112 1 N-CA-C 94.982 -5.932 . . . . 0.0 94.982 168.796 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.4 t -161.23 -153.63 0.31 Allowed 'General case' 0 N--CA 1.415 -2.191 1 N-CA-C 94.188 -6.227 . . . . 0.0 94.188 -178.896 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -147.33 174.2 3.58 Favored Pre-proline 0 N--CA 1.414 -2.238 1 N-CA-C 99.201 -4.37 . . . . 0.0 99.201 -166.069 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_exo -67.82 44.06 0.26 Allowed 'Trans proline' 0 C--N 1.321 -0.883 0 C-N-CA 123.635 2.89 . . . . 0.0 114.245 168.047 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -176.07 147.66 8.78 Favored Glycine 0 N--CA 1.425 -2.094 1 N-CA-C 98.884 -5.686 . . . . 0.0 98.884 179.232 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.3 m -79.36 -16.11 56.8 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -164.182 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.6 m -39.86 -56.75 1.72 Allowed 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 117.264 2.32 . . . . 0.0 117.264 -151.561 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -77.61 -34.59 39.07 Favored Glycine 0 C--N 1.349 1.301 0 O-C-N 121.291 -0.881 . . . . 0.0 111.131 -174.432 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.3 t -84.24 -12.32 54.95 Favored 'General case' 0 CA--C 1.499 -0.999 0 O-C-N 121.695 -0.885 . . . . 0.0 109.065 -172.792 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -62.88 -48.29 79.64 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 172.787 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -58.54 -48.28 81.38 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 123.235 0.614 . . . . 0.0 112.318 171.334 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 90.8 mt -63.97 -42.41 97.26 Favored 'General case' 0 C--N 1.357 0.934 0 CA-C-O 121.895 0.855 . . . . 0.0 111.445 -175.603 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 24.9 t -59.67 -46.97 87.45 Favored 'General case' 0 CA--C 1.5 -0.954 0 C-N-CA 125.304 1.442 . . . . 0.0 108.998 177.253 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 45.3 mttp -70.79 -40.57 72.5 Favored 'General case' 0 N--CA 1.438 -1.064 0 O-C-N 121.683 -0.635 . . . . 0.0 111.405 -173.568 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -71.05 -18.11 62.58 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 118.914 0.779 . . . . 0.0 112.601 -179.111 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -97.57 -1.84 43.03 Favored 'General case' 0 C--N 1.355 0.822 0 O-C-N 121.731 -0.606 . . . . 0.0 110.478 175.152 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.97 33.72 6.51 Favored Glycine 0 C--N 1.352 1.422 0 CA-C-O 119.762 -0.465 . . . . 0.0 112.122 167.209 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -104.79 125.58 8.39 Favored Glycine 0 CA--C 1.49 -1.506 0 N-CA-C 104.826 -3.309 . . . . 0.0 104.826 168.582 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.9 p -100.54 6.08 44.17 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-O 122.139 0.971 . . . . 0.0 109.694 -164.557 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 26.9 m -160.17 159.11 31.25 Favored 'General case' 0 CA--C 1.476 -1.87 1 N-CA-C 98.503 -4.629 . . . . 0.0 98.503 167.289 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -170.89 177.32 43.97 Favored Glycine 0 N--CA 1.418 -2.539 1 N-CA-C 99.421 -5.472 . . . . 0.0 99.421 -176.012 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 52.6 m80 -165.33 -172.96 2.65 Favored 'General case' 0 N--CA 1.431 -1.404 1 N-CA-C 97.18 -5.119 . . . . 0.0 97.18 -177.724 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 100.0 m -140.61 156.51 46.25 Favored 'General case' 0 CA--C 1.477 -1.84 0 N-CA-C 100.503 -3.888 . . . . 0.0 100.503 174.684 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 170.22 -168.74 41.69 Favored Glycine 0 N--CA 1.424 -2.108 1 N-CA-C 98.373 -5.891 . . . . 0.0 98.373 -169.128 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -152.85 -177.95 6.59 Favored 'General case' 0 N--CA 1.427 -1.611 1 N-CA-C 98.921 -4.474 . . . . 0.0 98.921 -177.591 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 25.2 tptp 128.11 63.66 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.149 2 C-N-CA 133.38 4.672 . . . . 0.0 99.372 -179.602 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.432 HG13 ' H ' ' A' ' 42' ' ' GLY . 2.7 t -146.17 -167.08 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.518 1 N-CA-C 97.277 -5.083 . . . . 0.0 97.277 -172.867 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.432 ' H ' HG13 ' A' ' 41' ' ' VAL . . . -139.81 68.77 0.48 Allowed Glycine 0 CA--C 1.487 -1.7 0 N-CA-C 105.616 -2.994 . . . . 0.0 105.616 -176.383 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.497 ' HD1' HG11 ' A' ' 13' ' ' VAL . 21.7 m170 -158.33 -107.43 0.02 OUTLIER 'General case' 0 N--CA 1.434 -1.272 0 N-CA-C 100.894 -3.743 . . . . 0.0 100.894 173.172 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -121.21 -70.39 0.28 Allowed Glycine 0 C--N 1.355 1.587 0 CA-C-N 120.111 1.323 . . . . 0.0 111.932 -170.559 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -149.53 179.78 7.7 Favored 'General case' 0 N--CA 1.434 -1.245 1 N-CA-C 95.328 -5.805 . . . . 0.0 95.328 176.499 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -157.03 -174.48 4.94 Favored 'General case' 0 CA--C 1.486 -1.498 1 N-CA-C 99.936 -4.098 . . . . 0.0 99.936 -179.81 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.6 m -116.31 -179.13 3.58 Favored 'General case' 0 CA--C 1.486 -1.484 0 N-CA-C 102.308 -3.219 . . . . 0.0 102.308 165.814 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 32.2 t-105 -122.07 153.53 38.52 Favored 'General case' 0 CA--C 1.496 -1.121 0 N-CA-C 102.885 -3.006 . . . . 0.0 102.885 174.275 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 37.3 m -145.64 147.46 32.04 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 170.457 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -114.08 144.24 43.45 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 105.024 -2.213 . . . . 0.0 105.024 173.572 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 69.7 42.9 1.03 Allowed 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 127.289 2.236 . . . . 0.0 111.602 167.215 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 38.7 mt -84.04 137.95 40.09 Favored Pre-proline 0 CA--C 1.504 -0.825 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 178.391 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -73.6 168.91 23.58 Favored 'Trans proline' 0 N--CA 1.447 -1.208 0 C-N-CA 122.187 1.925 . . . . 0.0 110.333 177.514 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -67.78 -9.22 42.3 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 124.652 1.181 . . . . 0.0 114.054 -171.317 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 -91.15 -0.12 57.64 Favored 'General case' 0 CA--C 1.507 -0.709 0 O-C-N 121.557 -0.715 . . . . 0.0 110.923 -176.946 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.0 t -99.93 178.12 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 N-CA-C 103.755 -2.683 . . . . 0.0 103.755 179.463 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -143.61 161.58 27.72 Favored Glycine 0 CA--C 1.479 -2.205 1 N-CA-C 100.086 -5.206 . . . . 0.0 100.086 -176.035 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.488 HG12 HH21 ' A' ' 2' ' ' ARG . 17.8 pt -152.99 -166.94 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.627 1 N-CA-C 99.32 -4.326 . . . . 0.0 99.32 -167.655 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.9 mm -63.7 134.28 28.79 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 179.146 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.8 t . . . . . 0 N--CA 1.423 -1.822 1 N-CA-C 93.404 -6.517 . . . . 0.0 93.404 -179.183 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 19.1 m . . . . . 0 N--CA 1.485 1.295 0 CA-C-O 121.403 0.621 . . . . 0.0 110.424 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -103.97 167.71 9.59 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 104.637 -2.357 . . . . 0.0 104.637 163.551 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -125.86 140.45 52.64 Favored 'General case' 0 CA--C 1.485 -1.556 1 N-CA-C 93.75 -6.389 . . . . 0.0 93.75 156.714 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.79 178.94 37.46 Favored Glycine 0 CA--C 1.474 -2.523 0 C-N-CA 116.904 -2.569 . . . . 0.0 107.513 -178.479 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -73.87 130.16 39.35 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 104.075 -2.565 . . . . 0.0 104.075 155.409 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.8 tt -90.63 137.81 20.86 Favored 'Isoleucine or valine' 0 C--O 1.253 1.275 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 179.247 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -100.24 -158.38 0.67 Allowed 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 112.755 -2.021 . . . . 0.0 107.484 176.062 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -98.87 142.39 24.52 Favored Pre-proline 0 CA--C 1.49 -1.344 1 N-CA-C 97.422 -5.029 . . . . 0.0 97.422 163.815 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -78.49 26.47 0.52 Allowed 'Trans proline' 0 CA--C 1.509 -0.759 0 C-N-CA 123.07 2.514 . . . . 0.0 114.654 -136.292 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -115.5 -78.95 0.58 Allowed 'General case' 0 N--CA 1.425 -1.704 0 N-CA-C 102.415 -3.18 . . . . 0.0 102.415 177.65 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -165.89 147.83 7.14 Favored 'General case' 0 N--CA 1.429 -1.513 1 N-CA-C 96.544 -5.354 . . . . 0.0 96.544 164.958 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 20.3 m 164.91 -152.73 0.0 OUTLIER 'General case' 0 CA--C 1.499 -1.017 1 N-CA-C 97.308 -5.071 . . . . 0.0 97.308 179.238 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -126.77 163.69 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 1 N-CA-C 98.844 -4.502 . . . . 0.0 98.844 160.111 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -87.8 -158.87 0.49 Allowed 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 104.79 -2.3 . . . . 0.0 104.79 164.447 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 71.4 m80 -142.82 -178.46 5.82 Favored 'General case' 0 N--CA 1.424 -1.735 1 N-CA-C 97.032 -5.173 . . . . 0.0 97.032 166.739 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.3 t -155.05 166.13 34.56 Favored 'General case' 0 N--CA 1.415 -2.19 1 N-CA-C 96.643 -5.318 . . . . 0.0 96.643 -171.513 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -121.84 125.24 26.78 Favored Pre-proline 0 N--CA 1.42 -1.951 1 N-CA-C 99.841 -4.133 . . . . 0.0 99.841 179.251 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -58.4 111.72 0.96 Allowed 'Trans proline' 0 CA--C 1.503 -1.046 0 C-N-CA 123.327 2.684 . . . . 0.0 112.653 -174.0 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 140.06 -36.79 1.78 Allowed Glycine 0 CA--C 1.49 -1.522 1 N-CA-C 102.739 -4.144 . . . . 0.0 102.739 -166.937 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.3 m 85.23 11.85 0.26 Allowed 'General case' 0 CA--C 1.496 -1.096 0 C-N-CA 128.187 2.595 . . . . 0.0 111.04 172.384 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -48.87 -55.17 12.5 Favored 'General case' 0 N--CA 1.436 -1.148 0 C-N-CA 129.4 3.08 . . . . 0.0 113.526 -169.822 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -85.95 -26.28 35.04 Favored Glycine 0 C--N 1.35 1.359 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 -172.75 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 15.7 t -79.53 -17.09 54.8 Favored 'General case' 0 C--N 1.354 0.78 0 O-C-N 122.238 -0.566 . . . . 0.0 110.187 -172.412 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -62.45 -43.09 99.64 Favored 'General case' 0 C--N 1.354 0.801 0 O-C-N 120.973 -1.079 . . . . 0.0 109.364 174.118 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -56.14 -54.24 47.42 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 124.262 1.025 . . . . 0.0 111.132 169.794 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 91.1 mt -61.75 -45.43 93.93 Favored 'General case' 0 CA--C 1.496 -1.122 0 C-N-CA 123.49 0.716 . . . . 0.0 111.036 -172.739 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.8 t -60.28 -46.5 89.63 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 123.711 0.805 . . . . 0.0 109.407 179.381 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 78.7 mttt -67.31 -43.0 82.74 Favored 'General case' 0 CA--C 1.502 -0.884 0 O-C-N 121.956 -0.465 . . . . 0.0 111.629 -177.329 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -75.26 -21.08 58.8 Favored 'General case' 0 CA--C 1.508 -0.641 0 O-C-N 121.606 -0.684 . . . . 0.0 112.432 -176.5 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -87.94 -15.94 35.19 Favored 'General case' 0 C--N 1.356 0.865 0 CA-C-N 118.971 0.805 . . . . 0.0 109.875 172.822 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.2 34.33 3.98 Favored Glycine 0 CA--C 1.492 -1.366 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 166.655 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -96.83 157.26 21.15 Favored Glycine 0 CA--C 1.491 -1.42 0 N-CA-C 105.535 -3.026 . . . . 0.0 105.535 164.786 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 30.4 m -85.09 -42.38 14.86 Favored 'General case' 0 CA--C 1.497 -1.063 0 CA-C-O 123.119 1.438 . . . . 0.0 107.988 -168.628 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.5 m -158.99 166.59 31.43 Favored 'General case' 0 N--CA 1.417 -2.104 1 N-CA-C 97.083 -5.155 . . . . 0.0 97.083 -178.9 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -175.11 175.6 47.13 Favored Glycine 0 N--CA 1.421 -2.312 1 N-CA-C 98.545 -5.822 . . . . 0.0 98.545 -169.459 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 34.2 p-80 -167.11 -179.35 4.56 Favored 'General case' 0 N--CA 1.428 -1.54 1 N-CA-C 98.575 -4.602 . . . . 0.0 98.575 -173.695 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 80.2 m -74.08 171.29 13.8 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-N 119.476 1.035 . . . . 0.0 111.13 -178.842 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.86 170.34 43.31 Favored Glycine 0 N--CA 1.422 -2.237 1 N-CA-C 99.466 -5.454 . . . . 0.0 99.466 178.525 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -138.39 136.23 36.09 Favored 'General case' 0 N--CA 1.429 -1.489 1 N-CA-C 97.258 -5.09 . . . . 0.0 97.258 177.796 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.5 tmtm? -118.61 102.27 8.75 Favored 'General case' 0 CA--C 1.494 -1.189 0 N-CA-C 102.341 -3.207 . . . . 0.0 102.341 -177.477 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.6 t -73.87 122.28 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 -172.407 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 139.86 -43.26 1.15 Allowed Glycine 0 CA--C 1.484 -1.897 0 N-CA-C 103.115 -3.994 . . . . 0.0 103.115 -171.687 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -113.42 -63.96 1.37 Allowed 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 178.488 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 164.1 -162.65 35.4 Favored Glycine 0 CA--C 1.489 -1.547 0 N-CA-C 108.112 -1.995 . . . . 0.0 108.112 -170.452 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 28.8 tp -63.5 133.96 54.78 Favored 'General case' 0 CA--C 1.501 -0.936 0 C-N-CA 127.768 2.427 . . . . 0.0 105.657 173.515 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -136.59 -158.28 0.85 Allowed 'General case' 0 CA--C 1.483 -1.597 0 N-CA-C 103.289 -2.856 . . . . 0.0 103.289 -167.253 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 52.9 t -138.52 168.72 19.16 Favored 'General case' 0 CA--C 1.49 -1.336 0 N-CA-C 101.683 -3.451 . . . . 0.0 101.683 163.322 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 42.0 t-105 -121.16 145.89 47.34 Favored 'General case' 0 CA--C 1.499 -1.0 0 N-CA-C 103.418 -2.808 . . . . 0.0 103.418 -177.444 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 6.9 m -141.06 146.29 36.96 Favored 'General case' 0 CA--C 1.49 -1.33 0 N-CA-C 105.623 -1.991 . . . . 0.0 105.623 177.159 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -113.51 130.99 56.23 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 179.066 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 65.64 78.65 0.27 Allowed 'General case' 0 CA--C 1.491 -1.318 0 C-N-CA 129.378 3.071 . . . . 0.0 110.422 178.462 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -104.98 125.71 32.98 Favored Pre-proline 0 CA--C 1.496 -1.111 0 N-CA-C 102.216 -3.253 . . . . 0.0 102.216 177.9 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -72.06 170.74 18.25 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 CA-C-N 123.514 2.291 . . . . 0.0 110.126 174.169 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -85.67 18.15 2.99 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -165.64 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -100.92 1.28 39.68 Favored 'General case' 0 CA--C 1.502 -0.885 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 174.045 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.2 t -110.69 133.7 55.32 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.082 0 N-CA-C 103.68 -2.711 . . . . 0.0 103.68 -174.669 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -100.58 148.77 18.41 Favored Glycine 0 CA--C 1.489 -1.579 0 N-CA-C 106.097 -2.801 . . . . 0.0 106.097 178.611 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 25.3 pt -129.83 -146.57 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.492 -1.265 0 N-CA-C 104.222 -2.51 . . . . 0.0 104.222 -169.213 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.1 mm -73.03 1.42 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.747 0 CA-C-N 118.904 0.774 . . . . 0.0 112.194 -172.484 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.491 -1.298 0 O-C-N 119.109 -2.244 . . . . 0.0 105.853 161.353 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 22.8 m . . . . . 0 N--CA 1.484 1.252 0 CA-C-O 121.202 0.525 . . . . 0.0 110.512 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.46 174.97 5.65 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 103.439 -2.8 . . . . 0.0 103.439 160.798 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -126.22 142.02 51.69 Favored 'General case' 0 CA--C 1.489 -1.399 1 N-CA-C 93.354 -6.535 . . . . 0.0 93.354 162.716 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.28 170.74 37.14 Favored Glycine 0 CA--C 1.47 -2.732 0 N-CA-C 106.446 -2.662 . . . . 0.0 106.446 -174.292 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -88.77 125.22 34.78 Favored 'General case' 0 CA--C 1.488 -1.411 0 N-CA-C 100.708 -3.812 . . . . 0.0 100.708 162.611 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.9 tt -87.84 140.72 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.088 0 N-CA-C 105.58 -2.007 . . . . 0.0 105.58 -174.271 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -116.41 -158.55 0.69 Allowed 'General case' 0 N--CA 1.424 -1.727 0 C-N-CA 128.12 2.568 . . . . 0.0 107.55 -175.118 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -88.3 144.5 34.16 Favored Pre-proline 0 N--CA 1.44 -0.928 0 N-CA-C 100.493 -3.891 . . . . 0.0 100.493 162.239 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -78.36 27.16 0.5 Allowed 'Trans proline' 0 CA--C 1.511 -0.637 0 C-N-CA 123.322 2.681 . . . . 0.0 113.811 -152.897 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 53.6 mp0 -111.37 -82.07 0.58 Allowed 'General case' 0 N--CA 1.425 -1.699 0 N-CA-C 101.912 -3.366 . . . . 0.0 101.912 178.955 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -163.47 143.95 8.92 Favored 'General case' 0 N--CA 1.424 -1.754 1 N-CA-C 93.521 -6.474 . . . . 0.0 93.521 167.496 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 9.1 m 170.66 -156.21 0.01 OUTLIER 'General case' 0 CA--C 1.494 -1.178 1 N-CA-C 98.166 -4.753 . . . . 0.0 98.166 175.203 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.413 HG11 ' HD1' ' A' ' 43' ' ' HIS . 7.8 m -130.98 168.4 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.531 1 N-CA-C 96.815 -5.254 . . . . 0.0 96.815 160.284 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -89.89 163.55 14.95 Favored 'General case' 0 CA--C 1.499 -1.018 0 N-CA-C 100.957 -3.72 . . . . 0.0 100.957 161.915 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 71.3 m80 -108.13 101.2 10.45 Favored 'General case' 0 CA--C 1.48 -1.727 0 N-CA-C 102.74 -3.059 . . . . 0.0 102.74 -174.654 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.8 t -107.44 -171.51 1.89 Allowed 'General case' 0 N--CA 1.425 -1.7 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 -177.896 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -142.43 167.9 15.02 Favored Pre-proline 0 N--CA 1.416 -2.148 1 N-CA-C 98.552 -4.61 . . . . 0.0 98.552 -160.289 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.94 54.23 2.09 Favored 'Trans proline' 0 C--N 1.327 -0.588 0 C-N-CA 123.259 2.639 . . . . 0.0 110.749 166.497 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -178.51 134.16 2.3 Favored Glycine 0 N--CA 1.425 -2.068 1 N-CA-C 99.403 -5.479 . . . . 0.0 99.403 -178.519 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.98 26.06 9.17 Favored 'General case' 0 N--CA 1.434 -1.249 0 C-N-CA 124.305 1.042 . . . . 0.0 109.722 -168.938 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.5 m -49.68 -48.26 49.67 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 126.73 2.012 . . . . 0.0 115.37 -169.759 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -90.1 -26.35 24.18 Favored Glycine 0 C--N 1.351 1.364 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 -179.374 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -85.88 -14.69 44.12 Favored 'General case' 0 CA--C 1.5 -0.976 0 O-C-N 121.53 -0.982 . . . . 0.0 109.989 -167.946 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -58.9 -49.54 77.4 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 125.724 1.61 . . . . 0.0 108.113 171.979 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.4 -45.25 93.98 Favored 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 124.599 1.16 . . . . 0.0 112.162 174.173 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 95.9 mt -64.34 -41.29 96.84 Favored 'General case' 0 C--N 1.357 0.933 0 CA-C-O 121.69 0.757 . . . . 0.0 111.9 -178.064 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 13.2 t -59.79 -44.72 93.81 Favored 'General case' 0 N--CA 1.443 -0.799 0 O-C-N 121.59 -0.694 . . . . 0.0 109.815 176.776 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 46.1 mttp -63.66 -50.9 67.44 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 123.129 0.571 . . . . 0.0 111.163 -177.581 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -67.71 -23.57 65.29 Favored 'General case' 0 C--N 1.351 0.674 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -175.549 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -91.71 -5.72 53.22 Favored 'General case' 0 C--N 1.357 0.902 0 O-C-N 121.728 -0.607 . . . . 0.0 110.701 177.718 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.25 32.37 5.82 Favored Glycine 0 CA--C 1.492 -1.386 0 N-CA-C 111.579 -0.608 . . . . 0.0 111.579 165.713 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -108.75 140.26 15.51 Favored Glycine 0 CA--C 1.486 -1.735 0 N-CA-C 106.173 -2.771 . . . . 0.0 106.173 170.857 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.78 -76.29 0.34 Allowed 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 -171.814 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.8 m -85.85 151.83 23.48 Favored 'General case' 0 CA--C 1.491 -1.293 0 N-CA-C 105.496 -2.038 . . . . 0.0 105.496 176.706 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -158.41 171.61 35.26 Favored Glycine 0 N--CA 1.414 -2.787 1 N-CA-C 99.246 -5.542 . . . . 0.0 99.246 -175.936 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 52.9 m80 -168.0 -170.38 1.33 Allowed 'General case' 0 N--CA 1.426 -1.662 1 N-CA-C 95.982 -5.562 . . . . 0.0 95.982 -176.156 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 46.8 m -138.09 161.47 36.69 Favored 'General case' 0 N--CA 1.427 -1.579 1 N-CA-C 97.465 -5.013 . . . . 0.0 97.465 167.602 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 178.29 179.49 48.25 Favored Glycine 0 CA--C 1.481 -2.06 1 N-CA-C 100.779 -4.928 . . . . 0.0 100.779 -174.018 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -144.46 138.83 27.93 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 100.228 -3.989 . . . . 0.0 100.228 -170.294 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -148.11 50.39 1.03 Allowed 'General case' 0 CA--C 1.491 -1.302 1 N-CA-C 99.599 -4.223 . . . . 0.0 99.599 170.549 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . 0.275 2.2 t 60.61 -142.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.142 0 C-N-CA 125.84 1.656 . . . . 0.0 106.84 -160.288 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 121.55 -86.09 0.39 Allowed Glycine 0 CA--C 1.484 -1.899 1 N-CA-C 102.894 -4.082 . . . . 0.0 102.894 -176.714 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.413 ' HD1' HG11 ' A' ' 13' ' ' VAL . 26.1 m170 -159.93 -47.9 0.05 Allowed 'General case' 0 CA--C 1.498 -1.033 0 N-CA-C 104.726 -2.324 . . . . 0.0 104.726 -175.486 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -160.07 -176.89 32.65 Favored Glycine 0 N--CA 1.428 -1.878 1 N-CA-C 97.119 -6.393 . . . . 0.0 97.119 -178.508 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.7 tt -73.33 120.63 19.21 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 118.61 1.205 . . . . 0.0 108.689 -169.567 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -105.22 179.01 4.4 Favored 'General case' 0 CA--C 1.491 -1.308 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -162.82 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 58.9 m -109.46 157.13 19.26 Favored 'General case' 0 CA--C 1.486 -1.486 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 179.79 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 65.7 t-105 -109.88 148.93 30.65 Favored 'General case' 0 CA--C 1.487 -1.479 0 N-CA-C 103.717 -2.697 . . . . 0.0 103.717 179.591 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 45.1 m -140.94 141.81 34.45 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 101.72 -3.437 . . . . 0.0 101.72 167.382 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -108.61 17.12 22.33 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-O 121.396 0.617 . . . . 0.0 109.653 -166.679 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -171.0 144.52 2.15 Favored 'General case' 0 N--CA 1.418 -2.042 1 N-CA-C 93.624 -6.436 . . . . 0.0 93.624 172.364 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 17.0 mt -153.48 146.22 17.54 Favored Pre-proline 0 CA--C 1.487 -1.445 1 N-CA-C 97.325 -5.065 . . . . 0.0 97.325 155.61 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.38 170.21 19.8 Favored 'Trans proline' 0 N--CA 1.447 -1.207 0 C-N-CA 122.6 2.2 . . . . 0.0 109.221 173.33 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -65.89 -19.79 66.0 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -167.259 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -83.61 -2.37 55.94 Favored 'General case' 0 CA--C 1.501 -0.923 0 C-N-CA 124.18 0.992 . . . . 0.0 111.289 -172.923 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.8 t -100.09 126.31 53.62 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.303 0 N-CA-C 103.753 -2.684 . . . . 0.0 103.753 -177.67 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -92.68 158.71 24.4 Favored Glycine 0 CA--C 1.485 -1.8 0 N-CA-C 105.324 -3.11 . . . . 0.0 105.324 178.559 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 25.8 pt -144.89 -156.99 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.517 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 -166.491 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -71.93 128.03 34.51 Favored 'Isoleucine or valine' 0 C--N 1.365 1.247 0 N-CA-C 104.967 -2.234 . . . . 0.0 104.967 176.085 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.6 t . . . . . 0 N--CA 1.427 -1.596 0 N-CA-C 101.292 -3.596 . . . . 0.0 101.292 176.886 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 4.8 m . . . . . 0 N--CA 1.483 1.185 0 CA-C-O 122.443 1.116 . . . . 0.0 111.065 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 34.6 mtp85 -97.26 151.38 19.93 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 -171.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -130.63 125.3 33.71 Favored 'General case' 0 CA--C 1.485 -1.519 1 N-CA-C 96.597 -5.335 . . . . 0.0 96.597 165.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.76 -178.12 35.41 Favored Glycine 0 CA--C 1.477 -2.32 0 N-CA-C 103.162 -3.975 . . . . 0.0 103.162 176.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -76.88 133.33 39.32 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 168.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 17.4 tt -91.34 147.49 5.22 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 CA-C-N 120.163 1.347 . . . . 0.0 108.406 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -134.87 -150.98 0.41 Allowed 'General case' 0 N--CA 1.426 -1.654 0 C-N-CA 127.657 2.383 . . . . 0.0 106.869 -177.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -125.67 144.96 49.85 Favored Pre-proline 0 N--CA 1.426 -1.668 1 N-CA-C 94.661 -6.052 . . . . 0.0 94.661 162.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -80.6 -1.77 11.49 Favored 'Trans proline' 0 CA--C 1.501 -1.143 0 CA-C-N 123.165 2.166 . . . . 0.0 112.714 -143.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 48.8 mm-40 -86.37 46.85 1.39 Allowed 'General case' 0 N--CA 1.438 -1.043 0 C-N-CA 124.574 1.15 . . . . 0.0 109.874 -167.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.417 ' O ' ' HE1' ' A' ' 43' ' ' HIS . 0.2 OUTLIER 65.59 45.87 2.6 Favored 'General case' 0 C--N 1.356 0.889 0 C-N-CA 126.343 1.857 . . . . 0.0 107.598 177.355 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 94.9 m -122.38 -162.64 1.02 Allowed 'General case' 0 CA--C 1.486 -1.502 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 -169.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -141.59 170.26 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.838 1 N-CA-C 96.897 -5.223 . . . . 0.0 96.897 173.137 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -98.2 -163.95 1.09 Allowed 'General case' 0 CA--C 1.5 -0.966 0 N-CA-C 101.254 -3.61 . . . . 0.0 101.254 163.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 69.8 m80 -139.56 162.67 34.5 Favored 'General case' 0 CA--C 1.482 -1.672 1 N-CA-C 96.085 -5.524 . . . . 0.0 96.085 166.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 8.4 t -123.03 164.36 18.72 Favored 'General case' 0 CA--C 1.477 -1.837 0 N-CA-C 101.965 -3.346 . . . . 0.0 101.965 -167.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -112.53 122.06 37.32 Favored Pre-proline 0 N--CA 1.425 -1.693 1 N-CA-C 97.341 -5.059 . . . . 0.0 97.341 166.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_exo -56.34 96.47 0.06 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.578 0 CA-C-N 123.823 2.401 . . . . 0.0 117.081 -169.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 162.28 -161.06 33.23 Favored Glycine 0 N--CA 1.417 -2.568 1 N-CA-C 97.597 -6.201 . . . . 0.0 97.597 -179.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -84.86 -45.35 12.37 Favored 'General case' 0 N--CA 1.426 -1.652 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 176.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.9 m -39.29 -56.22 1.57 Allowed 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 117.356 2.354 . . . . 0.0 117.356 -145.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -68.34 -74.74 0.57 Allowed Glycine 0 C--N 1.351 1.363 0 O-C-N 121.606 -0.683 . . . . 0.0 111.815 -176.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.6 p -87.0 -6.02 58.89 Favored 'General case' 0 CA--C 1.497 -1.073 0 O-C-N 121.219 -1.165 . . . . 0.0 113.048 -166.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -69.88 -33.72 72.6 Favored 'General case' 0 C--N 1.359 0.983 0 CA-C-N 119.774 1.17 . . . . 0.0 108.276 166.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 26.6 m -70.27 -42.02 72.68 Favored 'General case' 0 N--CA 1.447 -0.624 0 O-C-N 120.936 -1.102 . . . . 0.0 108.679 177.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 96.3 mt -61.31 -40.41 94.06 Favored 'General case' 0 C--N 1.355 0.824 0 CA-C-O 121.73 0.776 . . . . 0.0 110.734 175.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.0 t -55.13 -43.34 74.03 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 123.841 0.856 . . . . 0.0 111.256 174.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -60.51 -46.55 89.73 Favored 'General case' 0 C--N 1.356 0.884 0 CA-C-N 118.361 0.528 . . . . 0.0 111.877 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -76.83 -23.57 52.75 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -174.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -80.79 -30.93 35.88 Favored 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 173.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 117.56 35.59 1.07 Allowed Glycine 0 CA--C 1.487 -1.67 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 162.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.58 142.89 15.72 Favored Glycine 0 CA--C 1.488 -1.638 0 N-CA-C 105.097 -3.201 . . . . 0.0 105.097 173.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.3 p -105.17 15.4 27.54 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-O 121.657 0.741 . . . . 0.0 109.798 -167.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 65.8 m -158.39 154.92 27.75 Favored 'General case' 0 CA--C 1.475 -1.92 1 N-CA-C 98.405 -4.665 . . . . 0.0 98.405 159.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -153.87 147.85 17.72 Favored Glycine 0 CA--C 1.468 -2.853 1 N-CA-C 97.491 -6.243 . . . . 0.0 97.491 -170.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -156.61 -171.37 3.66 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 101.566 -3.494 . . . . 0.0 101.566 -171.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 79.3 m -103.36 -179.38 3.93 Favored 'General case' 0 CA--C 1.491 -1.307 0 N-CA-C 104.278 -2.49 . . . . 0.0 104.278 174.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.17 178.29 45.2 Favored Glycine 0 N--CA 1.421 -2.347 0 N-CA-C 103.505 -3.838 . . . . 0.0 103.505 170.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -131.45 133.4 45.13 Favored 'General case' 0 CA--C 1.488 -1.418 1 N-CA-C 98.912 -4.477 . . . . 0.0 98.912 172.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -118.93 99.25 6.63 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 102.2 -3.259 . . . . 0.0 102.2 178.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.0 t -69.34 129.91 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 -175.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 124.75 -41.55 1.69 Allowed Glycine 0 CA--C 1.488 -1.649 0 N-CA-C 104.516 -3.434 . . . . 0.0 104.516 -168.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.417 ' HE1' ' O ' ' A' ' 11' ' ' ASN . 14.2 m-70 -108.94 -69.85 0.84 Allowed 'General case' 0 CA--C 1.496 -1.102 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 176.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 158.39 -155.49 26.51 Favored Glycine 0 N--CA 1.429 -1.823 0 N-CA-C 103.915 -3.674 . . . . 0.0 103.915 -170.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.1 tt -73.43 141.66 46.91 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 105.953 -1.869 . . . . 0.0 105.953 -178.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.78 -172.75 3.46 Favored 'General case' 0 CA--C 1.489 -1.394 0 N-CA-C 104.116 -2.55 . . . . 0.0 104.116 -168.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 45.5 m -117.5 176.61 5.09 Favored 'General case' 0 CA--C 1.477 -1.838 0 N-CA-C 103.001 -2.963 . . . . 0.0 103.001 170.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 8.1 t-105 -138.79 151.89 47.43 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 102.89 -3.004 . . . . 0.0 102.89 -178.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 4.4 m -143.78 156.18 44.41 Favored 'General case' 0 CA--C 1.486 -1.517 0 N-CA-C 104.927 -2.249 . . . . 0.0 104.927 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -127.77 136.87 52.09 Favored 'General case' 0 CA--C 1.49 -1.36 0 N-CA-C 104.219 -2.511 . . . . 0.0 104.219 175.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 73.9 49.73 0.12 Allowed 'General case' 0 CA--C 1.493 -1.233 0 C-N-CA 126.671 1.988 . . . . 0.0 110.549 170.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 50.2 mt -89.33 141.83 29.31 Favored Pre-proline 0 CA--C 1.504 -0.803 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 177.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -66.1 162.51 35.3 Favored 'Trans proline' 0 N--CA 1.448 -1.175 0 C-N-CA 122.222 1.948 . . . . 0.0 111.906 177.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -60.2 -17.11 38.94 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -86.2 -1.02 57.07 Favored 'General case' 0 CA--C 1.504 -0.825 0 O-C-N 121.55 -0.719 . . . . 0.0 111.208 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.1 t -94.14 156.72 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 N-CA-C 103.472 -2.788 . . . . 0.0 103.472 177.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -141.28 152.81 23.56 Favored Glycine 0 CA--C 1.48 -2.122 1 N-CA-C 98.103 -5.999 . . . . 0.0 98.103 -177.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 21.4 pt -146.21 -144.25 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 N-CA-C 104.66 -2.348 . . . . 0.0 104.66 -156.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.9 mm -68.74 147.06 12.42 Favored 'Isoleucine or valine' 0 C--N 1.359 0.98 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 178.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 15.5 t -144.09 163.92 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.596 1 N-CA-C 94.511 -6.107 . . . . 0.0 94.511 177.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -158.38 155.5 28.8 Favored 'General case' 0 CA--C 1.478 -1.791 1 N-CA-C 98.31 -4.7 . . . . 0.0 98.31 164.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 137.24 -47.42 0.95 Allowed Glycine 0 CA--C 1.485 -1.793 1 N-CA-C 99.385 -5.486 . . . . 0.0 99.385 -157.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -102.32 -144.8 0.36 Allowed 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 104.854 -2.276 . . . . 0.0 104.854 165.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -155.96 177.42 11.43 Favored 'General case' 0 N--CA 1.423 -1.808 1 N-CA-C 95.505 -5.739 . . . . 0.0 95.505 -173.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 45.8 t -76.79 142.67 40.26 Favored 'General case' 0 CA--C 1.497 -1.069 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -172.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 36.0 p-80 -146.92 161.31 41.01 Favored 'General case' 0 N--CA 1.424 -1.743 1 N-CA-C 97.683 -4.932 . . . . 0.0 97.683 173.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.7 m -179.13 175.48 0.96 Allowed 'General case' 0 N--CA 1.425 -1.704 1 N-CA-C 95.45 -5.759 . . . . 0.0 95.45 176.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.357 0.907 0 O-C-N 123.838 0.711 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 30.3 m . . . . . 0 N--CA 1.481 1.093 0 CA-C-O 121.228 0.537 . . . . 0.0 110.089 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -83.52 157.34 22.4 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 173.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -124.71 125.8 44.67 Favored 'General case' 0 CA--C 1.49 -1.337 1 N-CA-C 92.769 -6.752 . . . . 0.0 92.769 151.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.54 178.54 37.4 Favored Glycine 0 CA--C 1.473 -2.568 0 N-CA-C 106.022 -2.831 . . . . 0.0 106.022 -170.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 48' ' ' TRP . 65.0 m-85 -87.12 125.03 33.88 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 171.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.6 tt -90.51 152.07 3.4 Favored 'Isoleucine or valine' 0 C--N 1.357 0.93 0 CA-C-N 120.272 1.396 . . . . 0.0 108.143 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -144.09 -159.19 0.96 Allowed 'General case' 0 N--CA 1.418 -2.053 0 C-N-CA 126.426 1.89 . . . . 0.0 107.83 -167.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 -105.48 144.29 28.52 Favored Pre-proline 0 N--CA 1.432 -1.356 1 N-CA-C 99.345 -4.317 . . . . 0.0 99.345 158.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -79.04 -12.34 14.56 Favored 'Trans proline' 0 CA--C 1.503 -1.052 0 CA-C-N 122.236 1.834 . . . . 0.0 112.544 -153.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -87.59 55.49 3.52 Favored 'General case' 0 C--N 1.36 1.022 0 CA-C-N 120.591 1.541 . . . . 0.0 108.666 -173.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.5 t30 73.24 37.4 0.75 Allowed 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 128.075 2.55 . . . . 0.0 110.993 168.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -108.94 -162.33 0.81 Allowed 'General case' 0 CA--C 1.504 -0.816 0 O-C-N 121.053 -1.029 . . . . 0.0 111.693 -167.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.539 HG11 ' HD1' ' A' ' 43' ' ' HIS . 3.7 m -133.96 170.46 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.225 1 N-CA-C 98.662 -4.569 . . . . 0.0 98.662 162.241 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . 0.313 1.3 m-85 -111.15 151.17 28.48 Favored 'General case' 0 CA--C 1.487 -1.456 1 N-CA-C 95.1 -5.889 . . . . 0.0 95.1 166.041 . . . . . . . . 3 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 34.8 m80 -92.21 144.65 25.2 Favored 'General case' 0 CA--C 1.496 -1.109 0 N-CA-C 102.772 -3.047 . . . . 0.0 102.772 171.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 39.0 t -92.41 164.77 13.36 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 -177.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -108.29 101.78 43.69 Favored Pre-proline 0 N--CA 1.425 -1.712 1 N-CA-C 98.959 -4.46 . . . . 0.0 98.959 169.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -68.18 107.78 1.62 Allowed 'Trans proline' 0 CA--C 1.501 -1.147 0 C-N-CA 122.367 2.045 . . . . 0.0 110.58 -161.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 160.79 -45.2 0.41 Allowed Glycine 0 CA--C 1.48 -2.104 1 N-CA-C 97.972 -6.051 . . . . 0.0 97.972 -169.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.2 m 122.8 -34.91 0.01 OUTLIER 'General case' 0 CA--C 1.487 -1.47 0 C-N-CA 128.8 2.84 . . . . 0.0 107.898 161.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 m -38.9 -51.92 1.76 Allowed 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 127.644 2.377 . . . . 0.0 116.377 -160.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.14 -41.99 68.53 Favored Glycine 0 C--N 1.355 1.594 0 O-C-N 121.287 -0.883 . . . . 0.0 111.513 -176.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.8 t -88.09 -24.88 23.29 Favored 'General case' 0 CA--C 1.496 -1.105 0 O-C-N 121.562 -0.964 . . . . 0.0 109.037 -171.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -65.83 -36.51 83.68 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 170.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 44.0 m -64.42 -37.85 88.95 Favored 'General case' 0 C--N 1.348 0.517 0 O-C-N 121.055 -1.028 . . . . 0.0 110.635 174.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 78.8 mt -63.96 -40.04 95.51 Favored 'General case' 0 C--N 1.357 0.931 0 CA-C-O 122.192 0.996 . . . . 0.0 110.559 175.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 38.3 t -58.17 -46.04 86.43 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.109 1.363 . . . . 0.0 110.347 174.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.17 -49.22 76.69 Favored 'General case' 0 C--N 1.359 0.984 0 O-C-N 121.752 -0.592 . . . . 0.0 110.613 -178.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -70.1 -21.18 63.15 Favored 'General case' 0 C--N 1.354 0.802 0 O-C-N 121.688 -0.632 . . . . 0.0 112.626 -173.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -96.5 5.79 50.09 Favored 'General case' 0 C--N 1.355 0.846 0 O-C-N 121.671 -0.643 . . . . 0.0 110.52 177.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.37 36.94 19.18 Favored Glycine 0 CA--C 1.493 -1.311 0 O-C-N 121.847 -0.533 . . . . 0.0 111.937 169.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -97.27 138.91 14.18 Favored Glycine 0 CA--C 1.487 -1.672 1 N-CA-C 102.862 -4.095 . . . . 0.0 102.862 164.196 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.4 m -105.96 -5.12 19.86 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -156.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 71.5 m -160.72 177.74 10.16 Favored 'General case' 0 CA--C 1.496 -1.121 1 N-CA-C 97.948 -4.834 . . . . 0.0 97.948 163.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -176.3 -170.88 39.49 Favored Glycine 0 CA--C 1.476 -2.369 1 N-CA-C 102.112 -4.395 . . . . 0.0 102.112 178.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -177.76 -154.51 0.03 OUTLIER 'General case' 0 N--CA 1.426 -1.634 1 N-CA-C 95.504 -5.739 . . . . 0.0 95.504 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 98.2 m -146.37 -176.6 5.24 Favored 'General case' 0 CA--C 1.48 -1.717 0 N-CA-C 101.24 -3.615 . . . . 0.0 101.24 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -175.66 -164.13 29.58 Favored Glycine 0 N--CA 1.422 -2.258 1 N-CA-C 99.971 -5.251 . . . . 0.0 99.971 -177.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -126.44 148.83 49.58 Favored 'General case' 0 N--CA 1.431 -1.385 1 N-CA-C 100.124 -4.028 . . . . 0.0 100.124 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -129.33 106.84 9.08 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 103.451 -2.796 . . . . 0.0 103.451 174.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.3 t -73.21 124.83 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 -174.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 134.95 -43.86 1.22 Allowed Glycine 0 CA--C 1.483 -1.944 0 N-CA-C 104.863 -3.295 . . . . 0.0 104.863 -171.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.539 ' HD1' HG11 ' A' ' 13' ' ' VAL . 38.9 m170 -114.97 -71.67 0.73 Allowed 'General case' 0 CA--C 1.498 -1.047 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 175.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 166.83 -145.25 9.74 Favored Glycine 0 N--CA 1.429 -1.78 0 N-CA-C 106.678 -2.569 . . . . 0.0 106.678 -177.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 45.9 tp -66.42 133.39 50.35 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 126.448 1.899 . . . . 0.0 106.458 177.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -138.49 171.86 13.75 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 102.84 -3.022 . . . . 0.0 102.84 -167.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 63.3 m -114.93 -179.94 3.77 Favored 'General case' 0 CA--C 1.484 -1.591 0 N-CA-C 102.991 -2.966 . . . . 0.0 102.991 176.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.425 ' HA ' ' HA ' ' A' ' 5' ' ' TYR . 9.8 t-105 -144.94 151.38 38.57 Favored 'General case' 0 CA--C 1.493 -1.239 0 N-CA-C 102.932 -2.988 . . . . 0.0 102.932 -174.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 45.8 m -137.26 151.73 49.02 Favored 'General case' 0 CA--C 1.487 -1.466 0 N-CA-C 104.697 -2.335 . . . . 0.0 104.697 172.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -115.57 130.7 56.96 Favored 'General case' 0 CA--C 1.495 -1.144 0 N-CA-C 103.794 -2.669 . . . . 0.0 103.794 170.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 65.01 72.58 0.43 Allowed 'General case' 0 CA--C 1.498 -1.041 0 C-N-CA 126.449 1.9 . . . . 0.0 110.685 175.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 20.9 mt -104.46 139.35 20.02 Favored Pre-proline 0 CA--C 1.492 -1.26 0 N-CA-C 102.197 -3.26 . . . . 0.0 102.197 166.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -70.67 168.48 22.62 Favored 'Trans proline' 0 N--CA 1.447 -1.24 0 C-N-CA 122.605 2.204 . . . . 0.0 110.114 175.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -84.07 5.42 26.03 Favored 'General case' 0 N--CA 1.443 -0.822 0 O-C-N 121.634 -0.666 . . . . 0.0 112.787 -164.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 -92.3 0.31 57.44 Favored 'General case' 0 CA--C 1.502 -0.876 0 O-C-N 121.638 -0.664 . . . . 0.0 109.584 176.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.1 t -91.65 163.12 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 N-CA-C 104.764 -2.31 . . . . 0.0 104.764 178.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -141.41 150.45 21.89 Favored Glycine 0 CA--C 1.483 -1.935 1 N-CA-C 97.552 -6.219 . . . . 0.0 97.552 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 16.6 pt -152.32 -140.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 N-CA-C 104.216 -2.513 . . . . 0.0 104.216 -155.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.06 126.52 24.22 Favored 'Isoleucine or valine' 0 C--N 1.362 1.128 0 N-CA-C 104.792 -2.299 . . . . 0.0 104.792 163.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.7 t -133.76 142.33 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.839 1 N-CA-C 95.568 -5.716 . . . . 0.0 95.568 -178.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 62.41 -54.8 0.15 Allowed 'General case' 0 C--N 1.359 1.019 0 C-N-CA 128.244 2.618 . . . . 0.0 117.448 164.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.08 15.0 59.74 Favored Glycine 0 N--CA 1.438 -1.202 0 C-N-CA 125.476 1.512 . . . . 0.0 112.98 176.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -81.71 -52.7 6.89 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-N 118.534 1.167 . . . . 0.0 112.248 -171.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -161.7 -178.53 6.6 Favored 'General case' 0 N--CA 1.434 -1.234 1 N-CA-C 97.766 -4.901 . . . . 0.0 97.766 -171.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 16.0 t -130.4 154.65 47.48 Favored 'General case' 0 CA--C 1.482 -1.636 1 N-CA-C 97.874 -4.861 . . . . 0.0 97.874 173.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -137.22 127.1 25.7 Favored 'General case' 0 CA--C 1.487 -1.454 0 N-CA-C 101.295 -3.595 . . . . 0.0 101.295 175.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.9 m -171.71 172.51 4.9 Favored 'General case' 0 N--CA 1.425 -1.712 1 N-CA-C 96.054 -5.535 . . . . 0.0 96.054 -177.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.359 1.007 0 CA-C-N 119.258 0.936 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 27.2 m . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 121.272 0.558 . . . . 0.0 109.728 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.02 169.07 17.35 Favored 'General case' 0 N--CA 1.434 -1.23 1 N-CA-C 98.578 -4.601 . . . . 0.0 98.578 167.618 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 -130.63 133.06 45.82 Favored 'General case' 0 CA--C 1.48 -1.737 1 N-CA-C 94.366 -6.161 . . . . 0.0 94.366 169.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.66 -178.23 35.4 Favored Glycine 0 CA--C 1.474 -2.528 0 C-N-CA 117.397 -2.335 . . . . 0.0 107.411 -173.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.411 ' HA ' ' HA ' ' A' ' 48' ' ' TRP . 42.2 m-85 -78.45 130.46 36.09 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 102.713 -3.069 . . . . 0.0 102.713 158.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.7 tt -90.47 137.29 21.9 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 N-CA-C 105.331 -2.1 . . . . 0.0 105.331 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -94.3 -144.76 0.25 Allowed 'General case' 0 N--CA 1.424 -1.734 0 CA-C-N 112.319 -2.219 . . . . 0.0 107.79 177.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 62.7 mt-30 -109.57 147.02 35.23 Favored Pre-proline 0 N--CA 1.43 -1.464 1 N-CA-C 96.068 -5.53 . . . . 0.0 96.068 165.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -76.34 7.59 3.31 Favored 'Trans proline' 0 CA--C 1.506 -0.888 0 C-N-CA 122.671 2.247 . . . . 0.0 113.883 -145.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.424 ' HB3' ' CE1' ' A' ' 66' ' ' HIS . 18.1 mp0 -88.4 -76.35 0.4 Allowed 'General case' 0 N--CA 1.426 -1.643 0 N-CA-C 103.234 -2.876 . . . . 0.0 103.234 176.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -176.84 144.02 0.45 Allowed 'General case' 0 N--CA 1.419 -2.003 1 N-CA-C 93.64 -6.429 . . . . 0.0 93.64 -178.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 160.69 -153.48 0.0 OUTLIER 'General case' 0 CA--C 1.493 -1.237 0 N-CA-C 101.705 -3.443 . . . . 0.0 101.705 173.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -126.1 165.15 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.33 1 N-CA-C 99.477 -4.268 . . . . 0.0 99.477 159.649 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -86.01 -148.89 0.13 Allowed 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 164.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 46.4 m80 -142.33 176.29 9.1 Favored 'General case' 0 CA--C 1.483 -1.632 1 N-CA-C 97.209 -5.108 . . . . 0.0 97.209 164.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 8.2 t -136.18 159.97 40.09 Favored 'General case' 0 N--CA 1.426 -1.644 1 N-CA-C 96.482 -5.377 . . . . 0.0 96.482 -177.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -111.19 107.75 57.32 Favored Pre-proline 0 N--CA 1.428 -1.557 1 N-CA-C 97.529 -4.989 . . . . 0.0 97.529 170.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_exo -53.03 103.82 0.09 OUTLIER 'Trans proline' 0 CA--C 1.513 -0.557 0 CA-C-N 124.439 2.621 . . . . 0.0 116.871 -155.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 161.69 -170.33 37.38 Favored Glycine 0 N--CA 1.426 -2.011 1 N-CA-C 97.228 -6.349 . . . . 0.0 97.228 -172.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.2 m -86.98 -42.47 13.1 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 118.82 1.31 . . . . 0.0 109.566 179.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -40.1 -55.18 2.15 Favored 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 129.08 2.952 . . . . 0.0 117.231 -156.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.27 -48.79 43.57 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 111.074 -0.811 . . . . 0.0 111.074 -174.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 68.4 m -71.85 -34.04 68.92 Favored 'General case' 0 CA--C 1.49 -1.363 0 O-C-N 121.71 -0.876 . . . . 0.0 111.13 -176.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -59.16 -46.56 88.07 Favored 'General case' 0 C--N 1.35 0.597 0 CA-C-O 121.351 0.596 . . . . 0.0 109.422 173.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.0 m -64.45 -48.1 76.55 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 123.044 0.538 . . . . 0.0 111.031 177.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 75.5 mt -60.76 -43.6 97.8 Favored 'General case' 0 C--N 1.362 1.149 0 CA-C-O 121.846 0.831 . . . . 0.0 109.964 -177.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.8 t -56.9 -44.16 82.07 Favored 'General case' 0 N--CA 1.437 -1.092 0 C-N-CA 123.322 0.649 . . . . 0.0 111.46 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -77.35 -31.41 54.41 Favored 'General case' 0 C--N 1.353 0.735 0 C-N-CA 121.149 -0.22 . . . . 0.0 111.533 -173.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -76.75 -30.77 56.7 Favored 'General case' 0 CA--C 1.506 -0.727 0 O-C-N 121.58 -0.7 . . . . 0.0 110.71 177.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -78.24 -49.62 13.39 Favored 'General case' 0 C--N 1.359 1.013 0 CA-C-N 118.974 0.806 . . . . 0.0 109.816 177.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 131.67 47.99 0.11 Allowed Glycine 0 CA--C 1.488 -1.647 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 173.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -117.48 160.85 13.45 Favored Glycine 0 CA--C 1.484 -1.881 0 N-CA-C 104.077 -3.609 . . . . 0.0 104.077 161.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -64.68 -54.9 24.34 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 124.88 1.272 . . . . 0.0 110.621 -164.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.9 m -160.79 177.63 10.24 Favored 'General case' 0 N--CA 1.423 -1.813 1 N-CA-C 97.199 -5.111 . . . . 0.0 97.199 170.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -161.48 174.76 38.06 Favored Glycine 0 CA--C 1.474 -2.501 1 N-CA-C 101.346 -4.701 . . . . 0.0 101.346 -163.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 53.8 m80 -156.66 -153.04 0.4 Allowed 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 100.348 -3.945 . . . . 0.0 100.348 -168.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 81.6 m -147.53 177.64 9.09 Favored 'General case' 0 CA--C 1.483 -1.627 0 N-CA-C 103.762 -2.681 . . . . 0.0 103.762 -174.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 171.53 -157.14 27.37 Favored Glycine 0 N--CA 1.423 -2.215 1 N-CA-C 95.9 -6.88 . . . . 0.0 95.9 178.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -140.44 146.51 38.37 Favored 'General case' 0 CA--C 1.489 -1.385 1 N-CA-C 98.091 -4.781 . . . . 0.0 98.091 -174.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 9.7 tmtt? -115.75 97.29 6.04 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 103.144 -2.91 . . . . 0.0 103.144 174.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.4 t -70.86 120.37 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 -176.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 136.86 -37.38 1.87 Allowed Glycine 0 CA--C 1.486 -1.78 0 N-CA-C 103.949 -3.66 . . . . 0.0 103.949 -167.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 15.6 m170 -125.1 -64.71 1.07 Allowed 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 165.89 -161.22 34.8 Favored Glycine 0 N--CA 1.432 -1.626 0 N-CA-C 107.219 -2.353 . . . . 0.0 107.219 -171.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.7 tp -69.43 143.49 53.58 Favored 'General case' 0 CA--C 1.502 -0.904 0 C-N-CA 127.969 2.508 . . . . 0.0 105.725 177.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -153.05 178.3 9.86 Favored 'General case' 0 CA--C 1.488 -1.428 0 N-CA-C 103.759 -2.682 . . . . 0.0 103.759 -168.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 50.8 m -112.16 161.72 16.23 Favored 'General case' 0 CA--C 1.493 -1.25 0 N-CA-C 103.135 -2.913 . . . . 0.0 103.135 177.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.411 ' HA ' ' HA ' ' A' ' 5' ' ' TYR . 61.1 t-105 -101.83 152.18 21.2 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 104.598 -2.371 . . . . 0.0 104.598 166.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.8 m -141.4 141.17 33.77 Favored 'General case' 0 CA--C 1.491 -1.31 0 N-CA-C 104.568 -2.382 . . . . 0.0 104.568 164.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -105.67 107.9 19.13 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 102.606 -3.109 . . . . 0.0 102.606 174.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 90.06 135.4 0.03 OUTLIER 'General case' 0 N--CA 1.432 -1.365 0 C-N-CA 128.243 2.617 . . . . 0.0 106.068 -173.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -145.13 155.89 54.73 Favored Pre-proline 0 N--CA 1.426 -1.668 1 N-CA-C 96.335 -5.431 . . . . 0.0 96.335 149.166 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -70.16 165.06 32.68 Favored 'Trans proline' 0 N--CA 1.445 -1.346 0 C-N-CA 122.404 2.069 . . . . 0.0 109.139 164.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -74.7 -9.04 58.18 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 114.12 1.155 . . . . 0.0 114.12 -163.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 -84.35 -12.35 54.68 Favored 'General case' 0 CA--C 1.507 -0.696 0 O-C-N 121.397 -0.814 . . . . 0.0 110.176 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.2 t -87.29 118.39 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -87.45 147.01 20.45 Favored Glycine 0 CA--C 1.487 -1.702 0 N-CA-C 106.934 -2.467 . . . . 0.0 106.934 -178.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 46.1 pt -117.97 -153.81 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 -173.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 9.2 mm -66.77 -30.27 49.13 Favored 'Isoleucine or valine' 0 C--N 1.357 0.894 0 O-C-N 121.412 -0.805 . . . . 0.0 111.949 -165.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -127.79 153.12 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.658 1 N-CA-C 99.058 -4.423 . . . . 0.0 99.058 175.074 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -166.5 176.76 7.11 Favored 'General case' 0 N--CA 1.423 -1.791 1 N-CA-C 95.499 -5.741 . . . . 0.0 95.499 -172.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -90.73 72.6 1.89 Allowed Glycine 0 CA--C 1.491 -1.45 0 N-CA-C 104.615 -3.394 . . . . 0.0 104.615 171.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -168.89 -169.4 0.99 Allowed 'General case' 0 N--CA 1.423 -1.779 1 N-CA-C 99.632 -4.21 . . . . 0.0 99.632 -166.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 28.9 ttpp -156.35 162.73 40.05 Favored 'General case' 0 N--CA 1.426 -1.629 1 N-CA-C 96.128 -5.508 . . . . 0.0 96.128 171.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 41.6 t -68.95 139.19 55.05 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-O 121.751 0.786 . . . . 0.0 111.962 -166.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.424 ' CE1' ' HB3' ' A' ' 10' ' ' GLU . 16.7 p-80 -142.6 151.55 41.61 Favored 'General case' 0 N--CA 1.424 -1.768 1 N-CA-C 95.648 -5.686 . . . . 0.0 95.648 164.739 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 40.5 t 176.23 -173.38 0.09 Allowed 'General case' 0 N--CA 1.431 -1.402 1 N-CA-C 95.166 -5.865 . . . . 0.0 95.166 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.357 0.898 0 O-C-N 124.469 1.106 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 9.9 m . . . . . 0 N--CA 1.483 1.221 0 CA-C-O 122.441 1.115 . . . . 0.0 110.913 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 16.2 mtp85 -100.64 158.03 16.24 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 -174.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -130.47 128.71 41.79 Favored 'General case' 0 CA--C 1.486 -1.481 1 N-CA-C 97.124 -5.139 . . . . 0.0 97.124 168.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.82 178.31 37.73 Favored Glycine 0 CA--C 1.481 -2.037 0 N-CA-C 107.272 -2.331 . . . . 0.0 107.272 -177.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -79.64 127.95 32.8 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 104.034 -2.58 . . . . 0.0 104.034 164.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.26 11.6 tt -91.51 147.6 5.16 Favored 'Isoleucine or valine' 0 C--O 1.243 0.737 0 CA-C-N 120.487 1.494 . . . . 0.0 108.879 178.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -135.77 -128.61 0.15 Allowed 'General case' 0 N--CA 1.426 -1.663 0 C-N-CA 128.035 2.534 . . . . 0.0 104.548 172.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -139.71 152.02 67.39 Favored Pre-proline 0 N--CA 1.424 -1.743 1 N-CA-C 96.513 -5.365 . . . . 0.0 96.513 176.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -74.89 35.14 0.4 Allowed 'Trans proline' 0 CA--C 1.514 -0.504 0 CA-C-N 124.241 2.55 . . . . 0.0 117.096 -159.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 53.0 mm-40 -124.53 32.79 5.39 Favored 'General case' 0 CA--C 1.497 -1.083 0 CA-C-N 120.202 1.364 . . . . 0.0 107.635 -169.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 48.99 58.1 5.73 Favored 'General case' 0 CA--C 1.489 -1.382 0 C-N-CA 128.686 2.794 . . . . 0.0 112.196 -174.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 91.3 m -116.89 -160.26 0.76 Allowed 'General case' 0 CA--C 1.482 -1.649 0 N-CA-C 103.285 -2.857 . . . . 0.0 103.285 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -134.85 169.39 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.827 1 N-CA-C 96.059 -5.534 . . . . 0.0 96.059 170.697 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -96.62 -154.27 0.44 Allowed 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 101.711 -3.44 . . . . 0.0 101.711 163.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 33.4 m80 -137.43 172.62 12.71 Favored 'General case' 0 CA--C 1.478 -1.792 1 N-CA-C 97.457 -5.016 . . . . 0.0 97.457 166.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 29.3 t -132.11 158.39 41.77 Favored 'General case' 0 N--CA 1.422 -1.868 1 N-CA-C 97.497 -5.001 . . . . 0.0 97.497 -175.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -112.45 104.78 56.13 Favored Pre-proline 0 N--CA 1.428 -1.546 1 N-CA-C 98.232 -4.729 . . . . 0.0 98.232 168.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -51.43 98.69 0.04 OUTLIER 'Trans proline' 0 CA--C 1.51 -0.708 0 C-N-CA 123.473 2.782 . . . . 0.0 117.07 -154.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 163.21 -171.48 38.95 Favored Glycine 0 N--CA 1.423 -2.227 1 N-CA-C 96.704 -6.558 . . . . 0.0 96.704 -172.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 38.1 m -82.46 -31.12 29.56 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 118.682 1.241 . . . . 0.0 111.154 -177.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.2 m -39.59 -71.48 0.08 Allowed 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 117.006 2.224 . . . . 0.0 117.006 -151.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.44 -43.82 52.67 Favored Glycine 0 C--N 1.347 1.153 0 O-C-N 121.198 -0.939 . . . . 0.0 111.113 -173.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 35.2 m -67.24 -43.98 80.59 Favored 'General case' 0 CA--C 1.486 -1.504 0 O-C-N 122.039 -0.683 . . . . 0.0 112.1 -173.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -66.35 -35.3 80.0 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -178.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.3 m -63.18 -50.41 70.45 Favored 'General case' 0 N--CA 1.445 -0.695 0 O-C-N 121.78 -0.575 . . . . 0.0 110.023 174.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.9 mt -63.56 -40.15 96.23 Favored 'General case' 0 C--N 1.359 0.998 0 CA-C-O 122.052 0.93 . . . . 0.0 110.923 -177.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 19.5 t -57.11 -47.6 80.68 Favored 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 125.775 1.63 . . . . 0.0 110.115 177.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 50.3 mttp -74.36 -34.63 63.42 Favored 'General case' 0 C--N 1.353 0.718 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.519 -173.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -77.43 -20.78 54.02 Favored 'General case' 0 C--N 1.354 0.771 0 O-C-N 121.712 -0.617 . . . . 0.0 111.407 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.6 mmtm -76.6 -59.09 2.92 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 168.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 134.64 48.77 0.08 OUTLIER Glycine 0 CA--C 1.489 -1.548 0 N-CA-C 108.896 -1.682 . . . . 0.0 108.896 170.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -107.18 139.97 15.14 Favored Glycine 0 CA--C 1.482 -1.976 1 N-CA-C 101.549 -4.62 . . . . 0.0 101.549 164.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.6 p -80.02 -49.5 11.72 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-N 118.587 1.193 . . . . 0.0 108.528 -170.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.3 m -103.41 139.84 38.26 Favored 'General case' 0 CA--C 1.487 -1.478 0 N-CA-C 102.101 -3.296 . . . . 0.0 102.101 -172.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -146.48 142.65 10.65 Favored Glycine 0 CA--C 1.473 -2.58 1 N-CA-C 101.215 -4.754 . . . . 0.0 101.215 -168.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 66.4 m80 -155.86 -157.43 0.72 Allowed 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 100.286 -3.968 . . . . 0.0 100.286 -173.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 85.5 m -143.73 177.36 8.56 Favored 'General case' 0 CA--C 1.476 -1.893 1 N-CA-C 99.099 -4.408 . . . . 0.0 99.099 177.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -179.27 -175.99 46.63 Favored Glycine 0 N--CA 1.419 -2.476 1 N-CA-C 98.092 -6.003 . . . . 0.0 98.092 177.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -116.68 139.44 50.54 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 102.048 -3.316 . . . . 0.0 102.048 177.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.9 94.27 4.96 Favored 'General case' 0 CA--C 1.498 -1.038 0 N-CA-C 103.506 -2.776 . . . . 0.0 103.506 178.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.7 t -70.76 116.82 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 -174.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 136.83 -39.59 1.62 Allowed Glycine 0 CA--C 1.488 -1.642 0 N-CA-C 105.929 -2.868 . . . . 0.0 105.929 -169.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 27.0 m170 -119.25 -66.85 1.03 Allowed 'General case' 0 CA--C 1.499 -0.992 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 178.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 167.04 -159.89 33.41 Favored Glycine 0 N--CA 1.432 -1.631 0 N-CA-C 106.262 -2.735 . . . . 0.0 106.262 -173.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 57.8 tp -68.21 142.28 55.71 Favored 'General case' 0 C--N 1.351 0.665 0 C-N-CA 126.779 2.032 . . . . 0.0 106.175 175.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -150.19 -178.04 6.28 Favored 'General case' 0 CA--C 1.485 -1.528 0 N-CA-C 104.046 -2.575 . . . . 0.0 104.046 -167.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 67.3 m -107.02 163.63 12.82 Favored 'General case' 0 CA--C 1.492 -1.287 0 N-CA-C 102.689 -3.078 . . . . 0.0 102.689 176.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 14.6 t-105 -128.14 146.67 50.64 Favored 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 104.435 -2.432 . . . . 0.0 104.435 177.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 61.2 m -140.43 151.49 44.93 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 174.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -118.95 143.44 47.03 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 103.806 -2.665 . . . . 0.0 103.806 166.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 77.02 54.94 0.04 OUTLIER 'General case' 0 CA--C 1.497 -1.075 0 C-N-CA 127.018 2.127 . . . . 0.0 110.883 171.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 33.5 mt -97.77 135.67 21.47 Favored Pre-proline 0 CA--C 1.5 -0.948 0 N-CA-C 105.12 -2.178 . . . . 0.0 105.12 173.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -74.46 167.92 26.01 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 CA-C-N 122.628 1.974 . . . . 0.0 111.103 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -61.28 -19.86 62.21 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 126.561 1.944 . . . . 0.0 114.686 -170.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.4 p-10 -86.54 -2.2 58.28 Favored 'General case' 0 CA--C 1.505 -0.767 0 C-N-CA 123.722 0.809 . . . . 0.0 110.628 -176.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.5 t -91.09 163.32 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 N-CA-C 104.078 -2.564 . . . . 0.0 104.078 177.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -145.84 154.53 26.0 Favored Glycine 0 CA--C 1.48 -2.132 1 N-CA-C 96.668 -6.573 . . . . 0.0 96.668 179.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 16.1 pt -139.66 -126.65 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 N-CA-C 104.885 -2.265 . . . . 0.0 104.885 -158.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.0 mm -74.5 62.28 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.582 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 169.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -155.13 142.4 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.682 0 N-CA-C 103.008 -2.96 . . . . 0.0 103.008 -167.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.47 ' HG3' ' H ' ' A' ' 62' ' ' GLY . 11.0 tp10 150.31 -166.22 0.0 OUTLIER 'General case' 0 CA--C 1.5 -0.95 2 N-CA-C 95.629 -5.693 . . . . 0.0 95.629 175.666 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.47 ' H ' ' HG3' ' A' ' 61' ' ' GLU . . . -80.11 70.31 2.96 Favored Glycine 0 C--N 1.347 1.171 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 -177.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 69.54 -47.44 0.6 Allowed 'General case' 0 C--N 1.352 0.703 0 C-N-CA 128.638 2.775 . . . . 0.0 115.014 167.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 15.4 tptm -98.25 151.64 20.26 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -164.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 38.9 t -87.79 145.11 26.26 Favored 'General case' 0 CA--C 1.492 -1.28 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 179.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -169.26 -172.08 1.42 Allowed 'General case' 0 N--CA 1.421 -1.888 1 N-CA-C 97.862 -4.866 . . . . 0.0 97.862 179.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 36.0 m -172.84 171.99 4.19 Favored 'General case' 0 N--CA 1.425 -1.712 1 N-CA-C 95.937 -5.579 . . . . 0.0 95.937 173.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.359 0.981 0 O-C-N 124.294 0.996 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 18.6 m . . . . . 0 N--CA 1.486 1.325 0 CA-C-O 121.898 0.856 . . . . 0.0 110.649 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 22.6 mtp85 -121.71 154.81 36.38 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 104.669 -2.345 . . . . 0.0 104.669 -172.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -137.48 132.71 33.7 Favored 'General case' 0 CA--C 1.486 -1.481 1 N-CA-C 97.273 -5.084 . . . . 0.0 97.273 166.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.29 -166.29 20.79 Favored Glycine 0 CA--C 1.477 -2.34 1 N-CA-C 101.948 -4.461 . . . . 0.0 101.948 172.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -74.81 142.14 44.25 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 103.872 -2.64 . . . . 0.0 103.872 161.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.1 tt -90.24 136.26 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.125 0 N-CA-C 105.018 -2.215 . . . . 0.0 105.018 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.406 ' HB3' ' H ' ' A' ' 8' ' ' GLN . . . -109.59 -149.94 0.45 Allowed 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 127.385 2.274 . . . . 0.0 106.255 179.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.406 ' H ' ' HB3' ' A' ' 7' ' ' ALA . 58.6 mt-30 -115.13 142.87 29.22 Favored Pre-proline 0 N--CA 1.426 -1.669 1 N-CA-C 97.454 -5.017 . . . . 0.0 97.454 171.108 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -75.58 29.81 0.38 Allowed 'Trans proline' 0 CA--C 1.503 -1.042 0 N-CA-C 117.764 2.179 . . . . 0.0 117.764 -141.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -120.35 -78.74 0.59 Allowed 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 101.733 -3.432 . . . . 0.0 101.733 -178.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 53.6 t-20 -160.92 142.72 12.17 Favored 'General case' 0 N--CA 1.423 -1.803 1 N-CA-C 93.932 -6.322 . . . . 0.0 93.932 166.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 19.0 m 173.42 -157.09 0.01 OUTLIER 'General case' 0 CA--C 1.496 -1.122 1 N-CA-C 98.743 -4.54 . . . . 0.0 98.743 172.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -126.8 167.68 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.575 1 N-CA-C 98.372 -4.677 . . . . 0.0 98.372 158.956 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -87.04 -162.7 0.82 Allowed 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 103.126 -2.916 . . . . 0.0 103.126 163.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 47.4 m80 -143.16 168.62 19.32 Favored 'General case' 0 N--CA 1.417 -2.114 1 N-CA-C 94.198 -6.223 . . . . 0.0 94.198 165.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.4 t -160.45 -151.01 0.23 Allowed 'General case' 0 N--CA 1.418 -2.037 1 N-CA-C 95.894 -5.595 . . . . 0.0 95.894 -176.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -148.44 147.77 26.5 Favored Pre-proline 0 N--CA 1.409 -2.493 1 N-CA-C 95.198 -5.853 . . . . 0.0 95.198 -167.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -71.23 73.8 2.04 Favored 'Trans proline' 0 C--N 1.32 -0.939 0 CA-C-N 125.383 2.958 . . . . 0.0 114.134 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -172.82 162.74 34.4 Favored Glycine 0 N--CA 1.425 -2.071 1 N-CA-C 98.704 -5.759 . . . . 0.0 98.704 175.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.2 m -81.65 -7.88 59.64 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 118.752 1.276 . . . . 0.0 111.775 -172.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -53.55 -28.38 31.41 Favored 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 128.448 2.699 . . . . 0.0 115.417 -169.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -87.06 -73.48 1.28 Allowed Glycine 0 C--N 1.348 1.211 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 176.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 75.6 m -79.99 -12.57 59.7 Favored 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 -162.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -63.17 -44.97 93.96 Favored 'General case' 0 C--N 1.358 0.972 0 CA-C-N 121.65 2.023 . . . . 0.0 108.38 173.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -57.67 -51.22 70.4 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 127.1 2.16 . . . . 0.0 110.794 174.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 84.6 mt -64.85 -40.1 94.61 Favored 'General case' 0 CA--C 1.497 -1.077 0 C-N-CA 124.088 0.955 . . . . 0.0 111.133 -177.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.7 t -56.77 -44.24 81.64 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 124.556 1.143 . . . . 0.0 109.847 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 52.0 mttp -71.15 -34.93 71.45 Favored 'General case' 0 N--CA 1.443 -0.801 0 O-C-N 122.151 -0.343 . . . . 0.0 111.54 -174.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -78.58 -26.67 45.55 Favored 'General case' 0 C--N 1.355 0.821 0 O-C-N 121.543 -0.723 . . . . 0.0 112.359 177.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.4 mmtm -80.54 -26.07 38.26 Favored 'General case' 0 C--N 1.357 0.92 0 CA-C-N 118.911 0.778 . . . . 0.0 109.843 176.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.53 37.64 1.88 Allowed Glycine 0 CA--C 1.486 -1.765 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 163.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -108.27 143.86 16.16 Favored Glycine 0 CA--C 1.485 -1.84 0 N-CA-C 103.226 -3.95 . . . . 0.0 103.226 168.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.4 m -73.5 -29.82 62.73 Favored 'General case' 0 N--CA 1.437 -1.084 0 O-C-N 122.074 -0.662 . . . . 0.0 110.473 -167.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.1 m -159.74 161.6 34.77 Favored 'General case' 0 CA--C 1.481 -1.704 0 N-CA-C 102.734 -3.062 . . . . 0.0 102.734 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -171.38 175.25 44.97 Favored Glycine 0 N--CA 1.419 -2.441 1 N-CA-C 99.944 -5.262 . . . . 0.0 99.944 -172.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 44.2 p-80 -169.67 -171.71 1.27 Allowed 'General case' 0 N--CA 1.431 -1.418 1 N-CA-C 98.224 -4.732 . . . . 0.0 98.224 -174.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 73.8 m -127.41 153.07 46.71 Favored 'General case' 0 CA--C 1.486 -1.498 0 N-CA-C 104.433 -2.432 . . . . 0.0 104.433 -173.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -172.18 167.17 40.1 Favored Glycine 0 CA--C 1.477 -2.316 1 N-CA-C 100.004 -5.238 . . . . 0.0 100.004 -173.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -98.67 161.18 13.8 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 104.741 -2.318 . . . . 0.0 104.741 -172.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.99 173.36 13.44 Favored 'General case' 0 N--CA 1.428 -1.55 1 N-CA-C 96.009 -5.552 . . . . 0.0 96.009 163.5 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -132.34 155.81 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.548 1 N-CA-C 97.607 -4.96 . . . . 0.0 97.607 177.928 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 130.34 -52.18 0.84 Allowed Glycine 0 CA--C 1.485 -1.789 1 N-CA-C 101.535 -4.626 . . . . 0.0 101.535 -170.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 66.9 m170 -117.48 -73.88 0.63 Allowed 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 104.318 -2.475 . . . . 0.0 104.318 168.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 164.45 -145.67 10.58 Favored Glycine 0 CA--C 1.472 -2.63 1 N-CA-C 100.876 -4.89 . . . . 0.0 100.876 178.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 33.2 tp -62.97 137.77 58.37 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 125.304 1.442 . . . . 0.0 107.388 -173.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -152.04 -171.12 3.84 Favored 'General case' 0 CA--C 1.479 -1.764 1 N-CA-C 97.556 -4.979 . . . . 0.0 97.556 -160.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 3.0 p -147.11 -174.15 4.43 Favored 'General case' 0 CA--C 1.478 -1.824 0 C-N-CA 115.734 -2.386 . . . . 0.0 104.616 169.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 43.7 t-105 -127.73 157.1 41.26 Favored 'General case' 0 CA--C 1.505 -0.785 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 -167.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 6.0 m -150.15 152.31 34.5 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 168.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -118.94 140.1 50.56 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 104.478 -2.416 . . . . 0.0 104.478 168.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 77.36 47.67 0.06 Allowed 'General case' 0 CA--C 1.496 -1.108 0 C-N-CA 127.451 2.301 . . . . 0.0 111.378 166.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 38.4 mt -91.48 137.14 26.07 Favored Pre-proline 0 CA--C 1.503 -0.862 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 178.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -77.94 174.71 12.13 Favored 'Trans proline' 0 N--CA 1.447 -1.217 0 C-N-CA 122.274 1.983 . . . . 0.0 111.494 -179.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -69.49 -9.05 52.15 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 125.254 1.421 . . . . 0.0 114.203 -171.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -92.73 -0.15 57.32 Favored 'General case' 0 CA--C 1.501 -0.934 0 O-C-N 121.667 -0.646 . . . . 0.0 110.008 -179.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.5 t -99.05 179.13 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 N-CA-C 102.49 -3.152 . . . . 0.0 102.49 174.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -152.12 159.4 28.33 Favored Glycine 0 CA--C 1.479 -2.216 1 N-CA-C 97.258 -6.337 . . . . 0.0 97.258 -178.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 18.2 pt -146.81 -156.46 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.271 0 N-CA-C 103.296 -2.853 . . . . 0.0 103.296 -165.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.1 mm -73.02 129.86 35.9 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.094 0 N-CA-C 104.839 -2.282 . . . . 0.0 104.839 176.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.9 t -106.62 108.86 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.653 0 N-CA-C 100.687 -3.82 . . . . 0.0 100.687 172.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 64.08 -110.51 0.27 Allowed 'General case' 0 C--N 1.359 0.992 0 C-N-CA 125.374 1.47 . . . . 0.0 107.906 -171.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -169.53 38.9 0.2 Allowed Glycine 0 CA--C 1.48 -2.139 1 N-CA-C 100.453 -5.059 . . . . 0.0 100.453 173.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -101.18 -71.4 0.71 Allowed 'General case' 0 CA--C 1.495 -1.164 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -163.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 6.7 tppt? -105.3 169.67 8.32 Favored 'General case' 0 CA--C 1.502 -0.871 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 -162.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 35.7 t -144.85 137.58 26.42 Favored 'General case' 0 N--CA 1.422 -1.866 1 N-CA-C 95.013 -5.921 . . . . 0.0 95.013 170.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -165.68 173.02 11.2 Favored 'General case' 0 CA--C 1.485 -1.54 0 N-CA-C 100.413 -3.921 . . . . 0.0 100.413 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 38.7 m -167.66 173.93 8.11 Favored 'General case' 0 N--CA 1.421 -1.906 1 N-CA-C 96.271 -5.455 . . . . 0.0 96.271 178.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.358 0.939 0 O-C-N 124.111 0.882 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 26.7 m . . . . . 0 N--CA 1.483 1.184 0 CA-C-O 121.578 0.704 . . . . 0.0 109.798 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -100.31 156.2 17.37 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 104.136 -2.542 . . . . 0.0 104.136 166.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -123.99 122.04 36.87 Favored 'General case' 0 CA--C 1.487 -1.468 1 N-CA-C 95.705 -5.665 . . . . 0.0 95.705 164.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.55 -175.7 32.85 Favored Glycine 0 CA--C 1.477 -2.324 0 N-CA-C 105.01 -3.236 . . . . 0.0 105.01 -171.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -88.3 135.71 33.32 Favored 'General case' 0 CA--C 1.491 -1.319 0 N-CA-C 103.524 -2.769 . . . . 0.0 103.524 170.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 17.0 tt -90.25 139.34 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 N-CA-C 106.854 -1.535 . . . . 0.0 106.854 -177.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -111.16 -161.44 0.75 Allowed 'General case' 0 N--CA 1.426 -1.632 0 C-N-CA 127.536 2.334 . . . . 0.0 106.412 178.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -107.02 146.36 33.0 Favored Pre-proline 0 N--CA 1.427 -1.583 1 N-CA-C 97.985 -4.82 . . . . 0.0 97.985 164.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -80.22 -3.47 12.64 Favored 'Trans proline' 0 CA--C 1.5 -1.225 0 C-N-CA 121.183 1.256 . . . . 0.0 114.125 -135.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -91.28 -46.59 7.97 Favored 'General case' 0 CA--C 1.5 -0.98 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 49.8 t-20 171.1 142.53 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.465 1 N-CA-C 97.962 -4.829 . . . . 0.0 97.962 167.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 171.31 -157.2 0.01 OUTLIER 'General case' 0 CA--C 1.488 -1.419 0 C-N-CA 126.986 2.114 . . . . 0.0 105.587 178.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.5 m -125.83 155.81 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.775 1 N-CA-C 96.772 -5.27 . . . . 0.0 96.772 155.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -98.91 141.78 31.24 Favored 'General case' 0 CA--C 1.482 -1.636 1 N-CA-C 97.506 -4.998 . . . . 0.0 97.506 165.098 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -84.31 178.79 7.63 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 105.33 -2.1 . . . . 0.0 105.33 179.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 36.4 t -146.79 163.28 36.52 Favored 'General case' 0 N--CA 1.419 -1.979 1 N-CA-C 96.76 -5.274 . . . . 0.0 96.76 -173.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -126.27 132.57 24.36 Favored Pre-proline 0 N--CA 1.417 -2.11 1 N-CA-C 98.383 -4.673 . . . . 0.0 98.383 -173.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -65.53 -6.64 14.1 Favored 'Trans proline' 0 CA--C 1.514 -0.479 0 CA-C-N 123.576 2.313 . . . . 0.0 113.518 177.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -95.55 89.35 1.15 Allowed Glycine 0 C--N 1.352 1.426 1 N-CA-C 101.216 -4.754 . . . . 0.0 101.216 158.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.9 m -60.04 -15.56 23.78 Favored 'General case' 0 CA--C 1.498 -1.057 0 C-N-CA 127.404 2.281 . . . . 0.0 115.868 -159.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -44.41 -45.0 8.76 Favored 'General case' 0 N--CA 1.436 -1.155 0 C-N-CA 128.618 2.767 . . . . 0.0 114.087 -175.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.73 -50.28 65.51 Favored Glycine 0 C--N 1.355 1.587 0 N-CA-C 111.972 -0.451 . . . . 0.0 111.972 -175.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 19.5 t -76.14 -24.23 54.86 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -177.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -61.37 -48.24 82.19 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 175.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -60.57 -40.06 90.26 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 172.197 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 96.1 mt -64.96 -44.12 90.44 Favored 'General case' 0 C--N 1.357 0.928 0 CA-C-N 119.321 0.964 . . . . 0.0 110.551 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 9.1 t -58.23 -46.85 85.17 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 125.257 1.423 . . . . 0.0 109.632 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -67.75 -37.18 81.79 Favored 'General case' 0 C--N 1.354 0.766 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -177.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -77.11 -22.76 52.22 Favored 'General case' 0 C--N 1.354 0.794 0 O-C-N 121.192 -0.942 . . . . 0.0 111.397 -176.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -85.99 -34.29 20.86 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 175.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 114.89 44.03 0.71 Allowed Glycine 0 CA--C 1.482 -1.978 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 164.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.13 149.08 16.59 Favored Glycine 0 CA--C 1.487 -1.715 1 N-CA-C 102.322 -4.311 . . . . 0.0 102.322 163.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.1 m -70.61 -47.45 60.03 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 122.265 1.031 . . . . 0.0 110.203 -165.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 33.8 m -160.82 -174.0 4.2 Favored 'General case' 0 N--CA 1.422 -1.849 1 N-CA-C 97.802 -4.888 . . . . 0.0 97.802 167.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -175.92 -177.96 45.35 Favored Glycine 0 N--CA 1.418 -2.543 1 N-CA-C 99.329 -5.508 . . . . 0.0 99.329 -169.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 68.4 m80 -155.96 176.98 11.94 Favored 'General case' 0 N--CA 1.425 -1.71 1 N-CA-C 99.421 -4.288 . . . . 0.0 99.421 -172.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 68.0 m -88.38 164.31 15.59 Favored 'General case' 0 CA--C 1.49 -1.361 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -179.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -167.68 -169.84 31.71 Favored Glycine 0 N--CA 1.414 -2.815 1 N-CA-C 100.45 -5.06 . . . . 0.0 100.45 176.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -152.61 156.65 39.69 Favored 'General case' 0 N--CA 1.417 -2.09 1 N-CA-C 94.132 -6.247 . . . . 0.0 94.132 -176.816 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 16.8 ptmt -136.86 17.43 3.05 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 104.248 -2.501 . . . . 0.0 104.248 163.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . 0.276 1.8 t 50.01 -138.24 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.358 0.974 0 C-N-CA 126.764 2.026 . . . . 0.0 107.534 -160.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.43 -72.35 2.17 Favored Glycine 0 CA--C 1.495 -1.217 0 C-N-CA 123.787 0.708 . . . . 0.0 111.652 163.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 9.5 m170 -98.79 -64.41 1.04 Allowed 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 105.127 -2.175 . . . . 0.0 105.127 176.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 174.64 -169.23 42.16 Favored Glycine 0 CA--C 1.473 -2.531 1 N-CA-C 100.478 -5.049 . . . . 0.0 100.478 -169.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.2 tt -70.2 132.27 45.51 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 105.504 -2.035 . . . . 0.0 105.504 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -133.63 165.85 23.96 Favored 'General case' 0 CA--C 1.474 -1.954 0 N-CA-C 101.273 -3.603 . . . . 0.0 101.273 -159.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 49.7 t -120.2 151.61 38.88 Favored 'General case' 0 CA--C 1.488 -1.422 0 N-CA-C 102.482 -3.155 . . . . 0.0 102.482 -174.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 62.1 t-105 -97.95 149.72 22.11 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 104.108 -2.553 . . . . 0.0 104.108 175.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.8 m -141.35 143.95 34.28 Favored 'General case' 0 CA--C 1.481 -1.688 0 N-CA-C 100.949 -3.723 . . . . 0.0 100.949 170.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -108.55 124.6 50.73 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 104.14 -2.541 . . . . 0.0 104.14 179.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 76.37 73.59 0.08 Allowed 'General case' 0 CA--C 1.498 -1.025 0 C-N-CA 127.093 2.157 . . . . 0.0 110.939 171.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 35.9 mt -103.53 131.47 22.01 Favored Pre-proline 0 CA--C 1.498 -1.041 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 174.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -72.05 174.09 11.85 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 CA-C-N 122.515 1.934 . . . . 0.0 110.28 176.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -69.15 -8.35 44.71 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 -172.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 17.7 p-10 -81.91 -10.69 59.21 Favored 'General case' 0 CA--C 1.505 -0.786 0 O-C-N 121.093 -1.004 . . . . 0.0 109.438 -177.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.8 t -100.24 132.52 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.374 0 N-CA-C 104.538 -2.393 . . . . 0.0 104.538 -176.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -103.77 151.05 17.65 Favored Glycine 0 CA--C 1.485 -1.829 0 N-CA-C 103.099 -4.0 . . . . 0.0 103.099 176.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 24.7 pt -136.14 -152.96 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 N-CA-C 104.823 -2.288 . . . . 0.0 104.823 -164.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.8 mm -67.98 133.46 31.63 Favored 'Isoleucine or valine' 0 C--N 1.358 0.956 0 N-CA-C 107.497 -1.298 . . . . 0.0 107.497 -178.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.2 t -129.72 150.99 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.663 1 N-CA-C 96.444 -5.391 . . . . 0.0 96.444 169.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -155.19 152.94 29.98 Favored 'General case' 0 CA--C 1.482 -1.67 1 N-CA-C 97.172 -5.122 . . . . 0.0 97.172 178.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 129.9 -44.95 1.17 Allowed Glycine 0 CA--C 1.489 -1.571 1 N-CA-C 100.26 -5.136 . . . . 0.0 100.26 -159.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -106.31 -138.36 0.37 Allowed 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 101.477 -3.527 . . . . 0.0 101.477 159.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 18.0 ttmm -166.14 -163.04 0.58 Allowed 'General case' 0 N--CA 1.423 -1.795 1 N-CA-C 96.366 -5.42 . . . . 0.0 96.366 -179.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 52.4 t -57.09 140.91 47.84 Favored 'General case' 0 CA--C 1.501 -0.913 0 C-N-CA 126.478 1.911 . . . . 0.0 112.161 -170.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 9.1 p-80 -145.48 25.03 1.37 Allowed 'General case' 0 CA--C 1.499 -1.008 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 169.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.5 m -82.68 75.73 9.57 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 172.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.363 1.161 0 CA-C-N 116.209 -0.45 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 33.2 m . . . . . 0 N--CA 1.485 1.303 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -107.52 159.2 16.61 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 170.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -130.37 120.72 24.73 Favored 'General case' 0 CA--C 1.49 -1.333 1 N-CA-C 96.218 -5.475 . . . . 0.0 96.218 161.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.02 -175.06 32.64 Favored Glycine 0 CA--C 1.477 -2.325 0 N-CA-C 105.456 -3.058 . . . . 0.0 105.456 -176.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -79.53 136.17 36.82 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 104.121 -2.548 . . . . 0.0 104.121 165.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 14.4 tt -90.82 146.73 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 N-CA-C 105.663 -1.977 . . . . 0.0 105.663 178.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -131.38 -178.06 4.68 Favored 'General case' 0 N--CA 1.414 -2.273 0 N-CA-C 105.165 -2.161 . . . . 0.0 105.165 -178.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -86.6 149.05 47.89 Favored Pre-proline 0 N--CA 1.435 -1.208 0 N-CA-C 103.225 -2.88 . . . . 0.0 103.225 159.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_exo -71.48 0.56 6.69 Favored 'Trans proline' 0 CA--C 1.504 -0.994 0 CA-C-N 123.222 2.186 . . . . 0.0 115.691 -154.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.7 mp0 -94.44 19.19 9.97 Favored 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 126.039 1.736 . . . . 0.0 109.227 -170.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 67.2 t30 66.25 61.54 0.6 Allowed 'General case' 0 CA--C 1.497 -1.083 0 C-N-CA 127.543 2.337 . . . . 0.0 108.803 -178.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 85.4 m -122.13 -137.58 0.31 Allowed 'General case' 0 CA--C 1.481 -1.699 0 N-CA-C 103.307 -2.849 . . . . 0.0 103.307 -178.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -136.56 173.24 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.923 1 N-CA-C 99.855 -4.128 . . . . 0.0 99.855 164.279 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -124.59 138.82 54.29 Favored 'General case' 0 N--CA 1.414 -2.268 1 N-CA-C 93.555 -6.461 . . . . 0.0 93.555 174.26 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 54.6 m80 -87.26 -178.32 6.18 Favored 'General case' 0 CA--C 1.492 -1.268 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 -173.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.2 t -153.43 173.37 15.76 Favored 'General case' 0 N--CA 1.412 -2.341 1 N-CA-C 95.361 -5.792 . . . . 0.0 95.361 -168.014 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -140.52 142.15 28.04 Favored Pre-proline 0 N--CA 1.409 -2.501 1 N-CA-C 95.352 -5.796 . . . . 0.0 95.352 -177.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -75.06 64.81 6.12 Favored 'Trans proline' 0 C--N 1.326 -0.613 0 C-N-CA 123.698 2.932 . . . . 0.0 109.369 172.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 156.99 60.82 0.01 OUTLIER Glycine 0 CA--C 1.482 -1.988 1 N-CA-C 97.82 -6.112 . . . . 0.0 97.82 -170.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 m -84.09 46.34 1.19 Allowed 'General case' 0 N--CA 1.436 -1.16 0 C-N-CA 124.994 1.318 . . . . 0.0 113.403 -154.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.9 p -70.5 -38.88 74.39 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 124.63 1.172 . . . . 0.0 108.951 -178.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.94 -37.1 92.92 Favored Glycine 0 C--N 1.351 1.379 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 177.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 38.7 t -72.75 -31.04 64.64 Favored 'General case' 0 C--N 1.358 0.952 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -57.23 -44.89 84.21 Favored 'General case' 0 C--N 1.354 0.764 0 CA-C-N 119.827 1.194 . . . . 0.0 110.267 178.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -58.2 -48.1 81.39 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 171.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 95.9 mt -65.64 -41.09 93.0 Favored 'General case' 0 C--N 1.359 0.991 0 CA-C-O 122.651 1.215 . . . . 0.0 110.813 -176.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 9.0 t -62.99 -46.07 89.4 Favored 'General case' 0 CA--C 1.495 -1.148 0 C-N-CA 125.301 1.44 . . . . 0.0 108.871 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.7 mmtm -65.29 -43.71 90.31 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-O 119.327 -0.368 . . . . 0.0 111.423 -178.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 25.8 pt-20 -72.3 -19.05 61.73 Favored 'General case' 0 C--N 1.354 0.8 0 CA-C-N 118.76 0.709 . . . . 0.0 112.351 -174.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -88.45 -17.69 29.87 Favored 'General case' 0 CA--C 1.506 -0.731 0 C-N-CA 123.244 0.618 . . . . 0.0 110.199 175.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.88 27.06 5.56 Favored Glycine 0 CA--C 1.489 -1.553 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 169.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -95.69 123.08 7.53 Favored Glycine 0 CA--C 1.49 -1.499 0 N-CA-C 105.467 -3.053 . . . . 0.0 105.467 174.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.8 p -97.28 -4.64 38.38 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -167.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.8 p -159.11 169.94 23.11 Favored 'General case' 0 N--CA 1.427 -1.576 1 N-CA-C 97.859 -4.867 . . . . 0.0 97.859 172.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -176.09 179.65 47.07 Favored Glycine 0 CA--C 1.474 -2.498 1 N-CA-C 102.007 -4.437 . . . . 0.0 102.007 -172.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -154.12 -161.22 1.2 Allowed 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 100.821 -3.77 . . . . 0.0 100.821 -174.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 12.5 t -147.87 161.88 40.39 Favored 'General case' 0 N--CA 1.431 -1.396 1 N-CA-C 98.994 -4.447 . . . . 0.0 98.994 -172.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 170.03 -160.23 33.07 Favored Glycine 0 N--CA 1.428 -1.858 1 N-CA-C 102.285 -4.326 . . . . 0.0 102.285 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -134.53 143.13 47.25 Favored 'General case' 0 N--CA 1.433 -1.3 1 N-CA-C 99.482 -4.266 . . . . 0.0 99.482 -176.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.47 105.2 11.85 Favored 'General case' 0 CA--C 1.491 -1.322 0 N-CA-C 101.533 -3.506 . . . . 0.0 101.533 174.137 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.5 t -41.64 -71.59 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.496 -1.109 0 C-N-CA 127.114 2.165 . . . . 0.0 115.136 -163.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -77.25 53.03 3.45 Favored Glycine 0 CA--C 1.501 -0.785 0 C-N-CA 126.413 1.958 . . . . 0.0 111.485 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 41.9 m-70 -167.59 -60.52 0.03 OUTLIER 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 105.093 -2.188 . . . . 0.0 105.093 171.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 150.46 -154.05 25.41 Favored Glycine 0 C--N 1.352 1.463 0 N-CA-C 108.397 -1.881 . . . . 0.0 108.397 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 63.2 tp -71.91 125.85 28.25 Favored 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 178.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -131.5 172.46 12.19 Favored 'General case' 0 CA--C 1.476 -1.867 0 N-CA-C 103.684 -2.71 . . . . 0.0 103.684 -163.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 38.6 t -125.68 167.91 14.48 Favored 'General case' 0 CA--C 1.486 -1.515 0 N-CA-C 101.508 -3.516 . . . . 0.0 101.508 176.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 11.0 t-105 -124.56 147.03 48.69 Favored 'General case' 0 CA--C 1.484 -1.572 0 N-CA-C 101.542 -3.503 . . . . 0.0 101.542 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 22.0 m -139.5 148.72 43.04 Favored 'General case' 0 CA--C 1.486 -1.506 0 N-CA-C 100.516 -3.883 . . . . 0.0 100.516 176.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -122.59 136.56 54.91 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 102.703 -3.073 . . . . 0.0 102.703 -174.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 71.16 49.76 0.32 Allowed 'General case' 0 CA--C 1.499 -1.006 0 C-N-CA 127.313 2.245 . . . . 0.0 110.928 176.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 20.0 mt -88.43 135.1 33.12 Favored Pre-proline 0 CA--C 1.498 -1.047 0 N-CA-C 105.344 -2.095 . . . . 0.0 105.344 177.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -73.15 170.59 19.48 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 122.241 1.961 . . . . 0.0 110.315 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -77.36 -3.94 42.64 Favored 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 -164.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -92.96 1.8 57.12 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 123.944 0.898 . . . . 0.0 109.885 -178.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.5 t -102.61 137.2 31.54 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.146 0 N-CA-C 103.386 -2.82 . . . . 0.0 103.386 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -108.14 144.52 16.2 Favored Glycine 0 CA--C 1.481 -2.091 0 N-CA-C 103.376 -3.889 . . . . 0.0 103.376 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 27.3 pt -139.18 -147.46 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.379 0 N-CA-C 103.529 -2.767 . . . . 0.0 103.529 -166.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.8 mm -69.73 121.11 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 175.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -108.65 -21.88 5.32 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.101 0 C-N-CA 124.554 1.141 . . . . 0.0 109.171 -164.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.455 ' HG3' ' H ' ' A' ' 62' ' ' GLY . 36.3 tp10 173.71 -167.05 0.03 OUTLIER 'General case' 0 N--CA 1.433 -1.32 1 N-CA-C 95.393 -5.78 . . . . 0.0 95.393 178.127 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.455 ' H ' ' HG3' ' A' ' 61' ' ' GLU . . . -125.06 121.15 4.2 Favored Glycine 0 CA--C 1.479 -2.194 1 N-CA-C 94.824 -7.311 . . . . 0.0 94.824 162.826 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -163.72 -61.53 0.04 OUTLIER 'General case' 0 CA--C 1.487 -1.477 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 -164.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -153.4 158.66 41.8 Favored 'General case' 0 N--CA 1.427 -1.621 1 N-CA-C 98.916 -4.475 . . . . 0.0 98.916 -173.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 1.2 t -145.62 154.92 42.66 Favored 'General case' 0 N--CA 1.43 -1.427 1 N-CA-C 94.718 -6.03 . . . . 0.0 94.718 177.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 38.0 p-80 -157.84 177.91 10.82 Favored 'General case' 0 N--CA 1.429 -1.509 1 N-CA-C 99.87 -4.122 . . . . 0.0 99.87 175.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 30.3 m -172.94 175.78 3.21 Favored 'General case' 0 N--CA 1.426 -1.637 1 N-CA-C 96.166 -5.494 . . . . 0.0 96.166 177.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.358 0.948 0 O-C-N 124.405 1.066 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 27.5 m . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 121.11 0.481 . . . . 0.0 110.038 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.31 173.02 9.11 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 106.163 -1.792 . . . . 0.0 106.163 175.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -134.53 140.97 46.54 Favored 'General case' 0 N--CA 1.431 -1.398 1 N-CA-C 95.4 -5.778 . . . . 0.0 95.4 164.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.65 -175.77 33.03 Favored Glycine 0 CA--C 1.475 -2.42 1 N-CA-C 101.56 -4.616 . . . . 0.0 101.56 176.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -82.95 136.8 34.43 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 101.16 -3.644 . . . . 0.0 101.16 158.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 13.5 tt -87.29 132.98 31.29 Favored 'Isoleucine or valine' 0 C--O 1.252 1.19 0 N-CA-C 105.612 -1.995 . . . . 0.0 105.612 -174.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -107.56 -179.68 3.98 Favored 'General case' 0 C--N 1.366 1.314 0 O-C-N 127.691 3.119 . . . . 0.0 108.702 175.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -95.37 135.98 22.87 Favored Pre-proline 0 N--CA 1.433 -1.307 0 N-CA-C 100.508 -3.886 . . . . 0.0 100.508 167.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -78.15 60.42 7.39 Favored 'Trans proline' 0 CA--C 1.514 -0.519 0 C-N-CA 123.836 3.024 . . . . 0.0 112.49 -163.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -118.13 -83.28 0.64 Allowed 'General case' 0 N--CA 1.422 -1.827 1 N-CA-C 96.686 -5.302 . . . . 0.0 96.686 159.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 19.8 t30 -166.17 143.48 5.3 Favored 'General case' 0 N--CA 1.419 -1.976 1 N-CA-C 92.616 -6.809 . . . . 0.0 92.616 159.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.1 m 176.3 -157.11 0.02 OUTLIER 'General case' 0 CA--C 1.49 -1.333 1 N-CA-C 99.737 -4.172 . . . . 0.0 99.737 178.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -120.83 155.95 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.913 1 N-CA-C 97.46 -5.015 . . . . 0.0 97.46 160.592 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -93.64 136.88 33.47 Favored 'General case' 0 CA--C 1.48 -1.724 1 N-CA-C 96.895 -5.224 . . . . 0.0 96.895 162.595 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 79.0 m80 -85.85 176.27 8.19 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 -169.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 12.2 t -140.67 158.23 44.29 Favored 'General case' 0 N--CA 1.413 -2.31 1 N-CA-C 94.056 -6.276 . . . . 0.0 94.056 178.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -124.93 138.69 31.94 Favored Pre-proline 0 N--CA 1.419 -1.986 1 N-CA-C 95.654 -5.684 . . . . 0.0 95.654 177.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_exo -63.53 94.94 0.18 Allowed 'Trans proline' 0 CA--C 1.512 -0.598 0 CA-C-N 124.71 2.718 . . . . 0.0 114.182 -171.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 164.64 -173.51 40.57 Favored Glycine 0 N--CA 1.421 -2.308 1 N-CA-C 97.927 -6.069 . . . . 0.0 97.927 -176.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.1 m -84.49 -32.59 23.88 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 117.333 0.566 . . . . 0.0 110.421 -177.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.5 m -46.7 -59.68 2.88 Favored 'General case' 0 N--CA 1.439 -0.984 0 C-N-CA 127.594 2.358 . . . . 0.0 116.582 -156.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -72.82 -54.69 7.04 Favored Glycine 0 C--N 1.349 1.286 0 N-CA-C 110.179 -1.169 . . . . 0.0 110.179 -174.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 49.1 t -61.29 -48.39 81.62 Favored 'General case' 0 CA--C 1.499 -1.016 0 C-N-CA 125.418 1.487 . . . . 0.0 111.473 -171.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -62.34 -42.78 99.67 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 118.729 0.695 . . . . 0.0 109.543 -175.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.0 m -66.5 -50.86 61.85 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 123.567 0.747 . . . . 0.0 110.639 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 55.7 mt -64.09 -41.83 97.15 Favored 'General case' 0 C--N 1.362 1.124 0 C-N-CA 124.697 1.199 . . . . 0.0 110.35 -175.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 15.9 t -62.35 -46.44 88.65 Favored 'General case' 0 CA--C 1.5 -0.967 0 C-N-CA 123.649 0.779 . . . . 0.0 108.98 177.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -66.82 -45.0 79.68 Favored 'General case' 0 CA--C 1.504 -0.802 0 O-C-N 121.76 -0.587 . . . . 0.0 110.899 -173.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -72.33 -23.58 61.18 Favored 'General case' 0 C--N 1.354 0.774 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -174.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 42.6 mmtm -88.22 -18.82 27.82 Favored 'General case' 0 C--N 1.354 0.772 0 CA-C-N 118.673 0.669 . . . . 0.0 109.393 175.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.35 41.66 1.35 Allowed Glycine 0 CA--C 1.483 -1.952 0 N-CA-C 109.331 -1.507 . . . . 0.0 109.331 161.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -103.79 128.5 9.52 Favored Glycine 0 CA--C 1.486 -1.76 0 N-CA-C 103.56 -3.816 . . . . 0.0 103.56 171.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.7 p -99.87 4.49 45.17 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 122.339 1.066 . . . . 0.0 108.725 -166.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 46.4 m -160.3 165.12 31.92 Favored 'General case' 0 N--CA 1.421 -1.893 1 N-CA-C 98.66 -4.571 . . . . 0.0 98.66 166.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 179.69 -173.72 45.44 Favored Glycine 0 N--CA 1.414 -2.801 1 N-CA-C 99.563 -5.415 . . . . 0.0 99.563 -176.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 10.1 p-80 -171.42 173.65 4.73 Favored 'General case' 0 N--CA 1.43 -1.428 1 N-CA-C 99.463 -4.273 . . . . 0.0 99.463 172.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 49.0 t -94.32 153.92 17.76 Favored 'General case' 0 CA--C 1.502 -0.878 0 N-CA-C 105.361 -2.088 . . . . 0.0 105.361 -176.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.63 -165.3 28.65 Favored Glycine 0 N--CA 1.431 -1.659 0 N-CA-C 104.927 -3.269 . . . . 0.0 104.927 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -148.42 147.58 29.34 Favored 'General case' 0 N--CA 1.429 -1.495 1 N-CA-C 98.012 -4.811 . . . . 0.0 98.012 -170.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -130.17 100.7 5.5 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 102.106 -3.294 . . . . 0.0 102.106 167.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.9 t -70.22 120.08 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 -173.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 141.07 -48.4 0.82 Allowed Glycine 0 CA--C 1.484 -1.865 1 N-CA-C 102.019 -4.433 . . . . 0.0 102.019 -164.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 18.3 m-70 -106.69 -74.93 0.64 Allowed 'General case' 0 CA--C 1.501 -0.934 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 173.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 169.16 -156.53 27.82 Favored Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 105.427 -3.069 . . . . 0.0 105.427 -173.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.78 130.11 42.13 Favored 'General case' 0 C--N 1.358 0.939 0 C-N-CA 127.809 2.443 . . . . 0.0 104.819 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -130.5 174.81 9.53 Favored 'General case' 0 CA--C 1.478 -1.792 0 N-CA-C 104.734 -2.321 . . . . 0.0 104.734 -168.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 19.3 t -121.38 158.16 28.9 Favored 'General case' 0 CA--C 1.492 -1.263 1 N-CA-C 99.575 -4.231 . . . . 0.0 99.575 172.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 12.3 t-105 -117.81 150.5 39.04 Favored 'General case' 0 CA--C 1.495 -1.173 0 N-CA-C 102.233 -3.247 . . . . 0.0 102.233 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 59.1 m -147.47 152.01 37.35 Favored 'General case' 0 CA--C 1.492 -1.272 0 N-CA-C 105.057 -2.201 . . . . 0.0 105.057 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -119.79 145.14 46.87 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 104.636 -2.357 . . . . 0.0 104.636 171.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 65.2 53.02 1.38 Allowed 'General case' 0 CA--C 1.49 -1.331 0 C-N-CA 127.283 2.233 . . . . 0.0 110.461 170.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 31.2 mt -91.31 139.95 25.53 Favored Pre-proline 0 CA--C 1.498 -1.028 0 N-CA-C 103.602 -2.74 . . . . 0.0 103.602 175.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -72.17 169.96 20.23 Favored 'Trans proline' 0 N--CA 1.447 -1.233 0 C-N-CA 122.544 2.163 . . . . 0.0 109.456 176.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -83.0 13.65 3.85 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -165.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -103.7 4.28 35.19 Favored 'General case' 0 CA--C 1.501 -0.922 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 177.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.0 t -104.85 154.53 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 N-CA-C 103.181 -2.896 . . . . 0.0 103.181 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -122.94 158.62 17.59 Favored Glycine 0 CA--C 1.483 -1.954 1 N-CA-C 102.731 -4.147 . . . . 0.0 102.731 -175.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 28.4 pt -151.18 -178.81 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.594 0 N-CA-C 102.469 -3.16 . . . . 0.0 102.469 -163.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.5 mm -69.61 131.9 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.045 0 O-C-N 123.974 0.796 . . . . 0.0 109.813 -166.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.6 t -123.93 160.98 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.516 1 N-CA-C 98.98 -4.452 . . . . 0.0 98.98 173.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -157.72 160.61 38.09 Favored 'General case' 0 N--CA 1.426 -1.654 1 N-CA-C 97.429 -5.026 . . . . 0.0 97.429 173.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 114.67 -30.14 7.09 Favored Glycine 0 C--N 1.347 1.171 0 N-CA-C 103.459 -3.857 . . . . 0.0 103.459 -157.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -123.44 -149.82 0.43 Allowed 'General case' 0 N--CA 1.43 -1.435 1 N-CA-C 97.965 -4.828 . . . . 0.0 97.965 164.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 21.8 ttmt -167.09 -161.94 0.45 Allowed 'General case' 0 N--CA 1.43 -1.448 1 N-CA-C 97.763 -4.903 . . . . 0.0 97.763 -179.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 42.3 t -60.71 126.73 28.51 Favored 'General case' 0 CA--C 1.49 -1.349 0 C-N-CA 126.888 2.075 . . . . 0.0 108.201 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 20.4 p-80 -146.81 171.72 14.75 Favored 'General case' 0 CA--C 1.481 -1.685 0 N-CA-C 101.141 -3.652 . . . . 0.0 101.141 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 58.2 m -171.5 173.08 4.86 Favored 'General case' 0 N--CA 1.422 -1.834 1 N-CA-C 95.712 -5.662 . . . . 0.0 95.712 175.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.358 0.958 0 O-C-N 124.229 0.956 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 5.7 m . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 121.811 0.815 . . . . 0.0 111.343 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 20.5 mtp85 -106.27 147.93 28.56 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 104.834 -2.284 . . . . 0.0 104.834 177.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -129.51 120.1 24.83 Favored 'General case' 0 CA--C 1.489 -1.378 1 N-CA-C 98.044 -4.798 . . . . 0.0 98.044 166.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.78 -170.62 26.76 Favored Glycine 0 CA--C 1.481 -2.058 0 N-CA-C 104.89 -3.284 . . . . 0.0 104.89 -169.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -96.6 140.25 31.5 Favored 'General case' 0 CA--C 1.491 -1.321 0 N-CA-C 101.73 -3.433 . . . . 0.0 101.73 168.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.7 tt -91.07 149.21 4.14 Favored 'Isoleucine or valine' 0 C--O 1.246 0.894 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 178.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.406 ' HB3' HD12 ' A' ' 59' ' ' ILE . . . -141.32 173.0 11.9 Favored 'General case' 0 N--CA 1.413 -2.304 1 N-CA-C 99.457 -4.275 . . . . 0.0 99.457 175.42 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -79.97 149.95 71.09 Favored Pre-proline 0 N--CA 1.434 -1.226 0 N-CA-C 103.14 -2.911 . . . . 0.0 103.14 165.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -79.95 -1.87 11.71 Favored 'Trans proline' 0 CA--C 1.499 -1.246 0 CA-C-N 121.113 1.433 . . . . 0.0 112.484 -142.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -96.33 13.79 26.49 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 -177.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 53.5 t30 77.28 44.89 0.09 Allowed 'General case' 0 CA--C 1.5 -0.951 0 C-N-CA 127.693 2.397 . . . . 0.0 108.354 178.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.3 m -122.82 110.73 15.82 Favored 'General case' 0 CA--C 1.482 -1.664 1 N-CA-C 99.42 -4.289 . . . . 0.0 99.42 -176.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 18.0 m -67.22 160.33 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.234 0 CA-C-N 119.652 1.115 . . . . 0.0 112.925 -163.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -101.71 117.49 34.98 Favored 'General case' 0 CA--C 1.479 -1.772 1 N-CA-C 97.341 -5.059 . . . . 0.0 97.341 179.645 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -83.15 125.85 31.97 Favored 'General case' 0 CA--C 1.486 -1.496 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 -158.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 40.4 t -92.24 149.59 21.37 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 104.026 -2.583 . . . . 0.0 104.026 175.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -134.45 140.0 34.41 Favored Pre-proline 0 N--CA 1.416 -2.141 1 N-CA-C 96.977 -5.194 . . . . 0.0 96.977 172.455 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -68.65 67.67 1.16 Allowed 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 124.124 3.216 . . . . 0.0 113.431 174.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -178.13 50.86 0.1 OUTLIER Glycine 0 CA--C 1.487 -1.656 1 N-CA-C 99.41 -5.476 . . . . 0.0 99.41 177.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.0 m -86.25 45.02 1.18 Allowed 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 114.104 -1.048 . . . . 0.0 112.909 -147.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.5 p -72.93 -42.63 63.27 Favored 'General case' 0 N--CA 1.444 -0.756 0 O-C-N 121.372 -0.83 . . . . 0.0 109.379 -175.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -68.97 -43.71 71.67 Favored Glycine 0 C--N 1.349 1.289 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 177.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.7 t -59.73 -44.4 93.79 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 125.455 1.502 . . . . 0.0 111.754 178.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -67.5 -35.32 78.9 Favored 'General case' 0 C--N 1.353 0.737 0 O-C-N 120.974 -1.079 . . . . 0.0 110.596 177.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 40.7 m -70.05 -33.69 72.27 Favored 'General case' 0 N--CA 1.45 -0.448 0 O-C-N 121.052 -1.03 . . . . 0.0 109.955 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 20.3 mt -66.89 -38.38 86.15 Favored 'General case' 0 CA--C 1.496 -1.129 0 O-C-N 121.518 -0.739 . . . . 0.0 109.705 177.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 36.8 t -54.82 -47.89 73.51 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 122.149 -0.344 . . . . 0.0 111.699 170.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.5 mmtm -63.06 -50.32 71.05 Favored 'General case' 0 C--N 1.354 0.784 0 O-C-N 121.394 -0.816 . . . . 0.0 111.276 -178.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -70.71 -8.91 55.53 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 112.897 0.702 . . . . 0.0 112.897 -173.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.9 mmmp? -102.69 2.9 36.44 Favored 'General case' 0 C--N 1.354 0.785 0 O-C-N 121.469 -0.769 . . . . 0.0 111.239 173.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 93.96 29.0 10.17 Favored Glycine 0 C--N 1.35 1.341 0 N-CA-C 111.436 -0.666 . . . . 0.0 111.436 169.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -91.93 140.97 15.42 Favored Glycine 0 C--N 1.354 1.578 0 N-CA-C 106.851 -2.5 . . . . 0.0 106.851 171.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.4 m -99.11 -26.38 14.23 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 -165.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.6 m -147.93 175.64 10.8 Favored 'General case' 0 CA--C 1.482 -1.661 1 N-CA-C 99.92 -4.104 . . . . 0.0 99.92 171.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -171.68 -176.44 40.66 Favored Glycine 0 N--CA 1.42 -2.382 1 N-CA-C 100.579 -5.008 . . . . 0.0 100.579 -173.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.444 ' CE1' ' CD1' ' A' ' 48' ' ' TRP . 16.2 p-80 -177.91 -152.5 0.03 OUTLIER 'General case' 0 N--CA 1.434 -1.254 1 N-CA-C 97.687 -4.931 . . . . 0.0 97.687 173.101 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 24.8 t -149.5 154.77 39.29 Favored 'General case' 0 N--CA 1.425 -1.723 1 N-CA-C 97.904 -4.85 . . . . 0.0 97.904 -173.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 178.76 -179.29 48.82 Favored Glycine 0 N--CA 1.425 -2.092 1 N-CA-C 96.8 -6.52 . . . . 0.0 96.8 -178.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.45 ' CD1' ' HA ' ' A' ' 45' ' ' LEU . 61.3 t80 -158.25 134.34 9.26 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 101.295 -3.595 . . . . 0.0 101.295 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.454 ' H ' HG22 ' A' ' 41' ' ' VAL . 28.7 mmmt -168.72 57.35 0.05 Allowed 'General case' 0 CA--C 1.499 -1.005 1 N-CA-C 97.747 -4.909 . . . . 0.0 97.747 172.545 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.454 HG22 ' H ' ' A' ' 40' ' ' LYS . 13.7 t -134.89 163.94 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.369 1 N-CA-C 99.579 -4.23 . . . . 0.0 99.579 -169.125 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -116.45 89.46 0.49 Allowed Glycine 0 CA--C 1.487 -1.69 1 N-CA-C 101.822 -4.511 . . . . 0.0 101.822 170.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 60.9 m-70 -175.01 -154.63 0.05 Allowed 'General case' 0 N--CA 1.429 -1.507 1 N-CA-C 96.779 -5.267 . . . . 0.0 96.779 -175.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -83.72 -69.86 1.37 Allowed Glycine 0 C--N 1.351 1.395 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -176.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.45 ' HA ' ' CD1' ' A' ' 39' ' ' PHE . 0.1 OUTLIER -167.54 152.7 7.12 Favored 'General case' 0 CA--C 1.489 -1.383 1 N-CA-C 96.363 -5.421 . . . . 0.0 96.363 178.61 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.19 166.06 25.54 Favored 'General case' 0 CA--C 1.486 -1.49 0 N-CA-C 102.521 -3.141 . . . . 0.0 102.521 -167.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 99.6 m -101.84 150.96 22.64 Favored 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 104.318 -2.475 . . . . 0.0 104.318 -178.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.444 ' CD1' ' CE1' ' A' ' 36' ' ' HIS . 44.0 t-105 -93.75 146.33 23.93 Favored 'General case' 0 CA--C 1.496 -1.125 0 N-CA-C 104.327 -2.471 . . . . 0.0 104.327 177.006 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 60.6 m -133.95 141.14 47.18 Favored 'General case' 0 CA--C 1.48 -1.744 0 N-CA-C 104.651 -2.351 . . . . 0.0 104.651 169.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -113.46 128.63 56.51 Favored 'General case' 0 N--CA 1.427 -1.596 0 N-CA-C 101.843 -3.392 . . . . 0.0 101.843 176.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 63.33 74.1 0.43 Allowed 'General case' 0 N--CA 1.434 -1.245 0 C-N-CA 126.571 1.948 . . . . 0.0 110.823 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 17.8 mt -97.99 141.9 23.71 Favored Pre-proline 0 CA--C 1.496 -1.122 0 N-CA-C 103.006 -2.961 . . . . 0.0 103.006 164.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -72.85 166.43 30.02 Favored 'Trans proline' 0 N--CA 1.443 -1.476 0 C-N-CA 122.382 2.054 . . . . 0.0 109.186 178.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -77.28 1.25 19.22 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -164.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -101.86 5.83 41.2 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 123.855 0.862 . . . . 0.0 109.594 -177.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.9 t -97.6 163.93 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 103.428 -2.804 . . . . 0.0 103.428 178.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -142.98 150.79 22.62 Favored Glycine 0 CA--C 1.475 -2.426 1 N-CA-C 97.247 -6.341 . . . . 0.0 97.247 -178.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 18.8 pt -153.77 -147.65 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.49 -1.358 0 N-CA-C 101.553 -3.499 . . . . 0.0 101.553 -154.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.406 HD12 ' HB3' ' A' ' 7' ' ' ALA . 7.3 mm -59.51 119.37 3.81 Favored 'Isoleucine or valine' 0 C--N 1.36 1.045 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 174.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -114.52 -15.62 9.92 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.126 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.491 -162.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -173.97 167.68 4.26 Favored 'General case' 0 N--CA 1.434 -1.252 1 N-CA-C 97.49 -5.004 . . . . 0.0 97.49 177.871 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -108.41 83.22 0.32 Allowed Glycine 0 CA--C 1.487 -1.718 1 N-CA-C 102.992 -4.043 . . . . 0.0 102.992 172.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -149.24 -87.07 0.08 Allowed 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 -171.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.419 ' HG2' ' H ' ' A' ' 65' ' ' CYS . 2.4 ttpm? -162.61 -167.13 1.48 Allowed 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 102.647 -3.094 . . . . 0.0 102.647 -173.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . 0.419 ' H ' ' HG2' ' A' ' 64' ' ' LYS . 52.8 t -117.4 152.86 34.1 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 -165.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 45.0 p-80 -116.25 -152.22 0.5 Allowed 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 175.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 31.5 m -171.33 174.57 4.47 Favored 'General case' 0 N--CA 1.424 -1.737 1 N-CA-C 95.7 -5.667 . . . . 0.0 95.7 176.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.354 0.798 0 O-C-N 124.456 1.098 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 24.1 m . . . . . 0 N--CA 1.484 1.263 0 CA-C-O 120.999 0.428 . . . . 0.0 110.455 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.67 173.34 6.92 Favored 'General case' 0 CA--C 1.5 -0.957 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 173.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -130.0 140.08 50.94 Favored 'General case' 0 CA--C 1.488 -1.43 1 N-CA-C 94.563 -6.088 . . . . 0.0 94.563 163.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.72 176.07 38.22 Favored Glycine 0 CA--C 1.476 -2.346 0 N-CA-C 104.901 -3.279 . . . . 0.0 104.901 -178.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -83.62 126.93 33.35 Favored 'General case' 0 CA--C 1.497 -1.067 0 N-CA-C 101.184 -3.636 . . . . 0.0 101.184 157.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.4 tt -90.3 137.39 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 -172.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.68 -150.92 0.34 Allowed 'General case' 0 N--CA 1.427 -1.589 0 C-N-CA 127.605 2.362 . . . . 0.0 107.606 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -119.52 139.54 27.98 Favored Pre-proline 0 N--CA 1.424 -1.769 1 N-CA-C 93.847 -6.353 . . . . 0.0 93.847 165.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -83.0 30.81 0.53 Allowed 'Trans proline' 0 CA--C 1.505 -0.966 0 C-N-CA 122.306 2.004 . . . . 0.0 113.916 -135.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.584 ' HB3' ' CE1' ' A' ' 66' ' ' HIS . 15.4 mm-40 -106.25 -89.45 0.43 Allowed 'General case' 0 N--CA 1.424 -1.727 0 N-CA-C 101.43 -3.544 . . . . 0.0 101.43 177.041 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -157.16 138.07 13.39 Favored 'General case' 0 N--CA 1.417 -2.091 1 N-CA-C 92.377 -6.898 . . . . 0.0 92.377 164.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 5.5 m 176.59 -163.54 0.03 OUTLIER 'General case' 0 CA--C 1.489 -1.4 1 N-CA-C 97.414 -5.032 . . . . 0.0 97.414 178.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 15.4 m -119.73 163.08 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.626 1 N-CA-C 99.19 -4.374 . . . . 0.0 99.19 159.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -83.44 164.75 19.71 Favored 'General case' 0 CA--C 1.501 -0.925 0 N-CA-C 102.722 -3.066 . . . . 0.0 102.722 162.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 22.8 m80 -90.29 158.12 17.33 Favored 'General case' 0 CA--C 1.484 -1.595 0 N-CA-C 101.538 -3.504 . . . . 0.0 101.538 178.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -160.19 177.48 10.63 Favored 'General case' 0 N--CA 1.41 -2.432 1 N-CA-C 95.92 -5.585 . . . . 0.0 95.92 -174.48 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -147.06 167.29 13.94 Favored Pre-proline 0 N--CA 1.412 -2.331 1 N-CA-C 96.019 -5.548 . . . . 0.0 96.019 -161.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.05 49.67 2.33 Favored 'Trans proline' 0 C--N 1.316 -1.169 0 CA-C-N 124.752 2.733 . . . . 0.0 110.61 169.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -172.68 139.34 5.17 Favored Glycine 0 CA--C 1.478 -2.234 1 N-CA-C 99.702 -5.359 . . . . 0.0 99.702 -177.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.0 m -92.15 11.04 26.88 Favored 'General case' 0 CA--C 1.499 -0.994 0 C-N-CA 123.673 0.789 . . . . 0.0 112.27 -165.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.4 m -51.14 -53.74 31.73 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 126.29 1.836 . . . . 0.0 113.871 -168.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.93 -35.52 27.61 Favored Glycine 0 C--N 1.352 1.427 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -177.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 44.1 t -59.95 -44.61 94.3 Favored 'General case' 0 CA--C 1.499 -0.989 0 C-N-CA 125.379 1.471 . . . . 0.0 110.769 -174.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -59.13 -44.3 92.02 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 124.478 1.111 . . . . 0.0 110.329 178.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -68.87 -38.17 79.54 Favored 'General case' 0 N--CA 1.443 -0.787 0 O-C-N 121.018 -1.051 . . . . 0.0 112.848 175.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 85.8 mt -65.03 -40.33 94.69 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-O 122.29 1.043 . . . . 0.0 109.742 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.6 t -60.14 -46.99 87.78 Favored 'General case' 0 N--CA 1.433 -1.286 0 C-N-CA 123.895 0.878 . . . . 0.0 110.404 -178.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -74.26 -29.34 61.63 Favored 'General case' 0 N--CA 1.444 -0.762 0 O-C-N 121.725 -0.609 . . . . 0.0 112.433 -176.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -79.04 -25.33 43.2 Favored 'General case' 0 C--N 1.357 0.918 0 O-C-N 121.023 -1.048 . . . . 0.0 111.094 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.1 mmmp? -82.53 -29.3 30.51 Favored 'General case' 0 C--N 1.358 0.935 0 O-C-N 121.451 -0.781 . . . . 0.0 109.381 172.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 110.25 43.68 1.06 Allowed Glycine 0 CA--C 1.485 -1.793 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 164.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -104.06 161.3 15.69 Favored Glycine 0 CA--C 1.488 -1.608 0 N-CA-C 103.394 -3.883 . . . . 0.0 103.394 166.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.1 p -71.94 -52.34 17.68 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-O 122.281 1.039 . . . . 0.0 109.924 -168.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 39.3 m -160.85 -176.55 5.59 Favored 'General case' 0 N--CA 1.421 -1.924 1 N-CA-C 98.002 -4.814 . . . . 0.0 98.002 170.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -172.67 -176.17 41.14 Favored Glycine 0 N--CA 1.416 -2.673 1 N-CA-C 98.766 -5.734 . . . . 0.0 98.766 -169.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 39.6 m80 -157.96 169.42 24.62 Favored 'General case' 0 N--CA 1.432 -1.366 1 N-CA-C 99.504 -4.258 . . . . 0.0 99.504 -176.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 64.1 m -84.22 159.92 20.9 Favored 'General case' 0 CA--C 1.499 -0.992 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 172.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -170.02 -178.51 41.05 Favored Glycine 0 N--CA 1.423 -2.19 1 N-CA-C 99.186 -5.566 . . . . 0.0 99.186 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -151.82 -169.33 3.33 Favored 'General case' 0 N--CA 1.422 -1.849 1 N-CA-C 99.224 -4.362 . . . . 0.0 99.224 174.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -154.21 -141.86 0.11 Allowed 'General case' 0 N--CA 1.424 -1.747 1 N-CA-C 93.637 -6.431 . . . . 0.0 93.637 -168.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.2 t -124.95 151.62 30.7 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.293 1 N-CA-C 96.995 -5.187 . . . . 0.0 96.995 149.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 160.49 -137.14 4.84 Favored Glycine 0 N--CA 1.42 -2.398 1 N-CA-C 98.683 -5.767 . . . . 0.0 98.683 -163.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 33.2 m170 -87.49 -35.08 18.41 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -160.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -169.92 -65.14 0.04 OUTLIER Glycine 0 C--N 1.357 1.73 0 C-N-CA 118.031 -2.033 . . . . 0.0 110.692 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.26 -178.08 6.43 Favored 'General case' 0 N--CA 1.434 -1.242 1 N-CA-C 94.784 -6.006 . . . . 0.0 94.784 167.786 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -150.36 171.72 16.54 Favored 'General case' 0 CA--C 1.482 -1.667 0 N-CA-C 102.206 -3.257 . . . . 0.0 102.206 174.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 8.5 t -110.13 155.61 21.69 Favored 'General case' 0 CA--C 1.489 -1.396 1 N-CA-C 99.378 -4.304 . . . . 0.0 99.378 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 6.5 t-105 -118.57 154.45 32.58 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 102.454 -3.165 . . . . 0.0 102.454 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 9.8 m -151.06 154.86 37.81 Favored 'General case' 0 CA--C 1.49 -1.365 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 176.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -117.81 143.42 46.28 Favored 'General case' 0 CA--C 1.495 -1.145 0 N-CA-C 104.689 -2.338 . . . . 0.0 104.689 169.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 65.02 58.27 0.92 Allowed 'General case' 0 CA--C 1.498 -1.023 0 C-N-CA 127.681 2.392 . . . . 0.0 112.507 171.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 31.3 mt -97.03 146.57 31.53 Favored Pre-proline 0 CA--C 1.502 -0.872 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 177.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -64.25 162.51 29.76 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 123.167 2.578 . . . . 0.0 111.244 174.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -68.88 -22.79 64.17 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -169.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 18.5 p-10 -94.66 19.82 9.42 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 124.345 1.058 . . . . 0.0 110.376 -176.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.3 t -106.91 126.2 62.91 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.274 0 N-CA-C 101.596 -3.483 . . . . 0.0 101.596 169.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -90.95 154.55 23.11 Favored Glycine 0 CA--C 1.492 -1.385 0 N-CA-C 107.923 -2.071 . . . . 0.0 107.923 -174.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 45.8 pt -136.68 -171.84 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 -170.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.3 mm -69.77 127.55 31.83 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.275 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 -174.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 42.6 t -113.41 103.57 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.632 0 N-CA-C 101.81 -3.404 . . . . 0.0 101.81 177.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 64.8 -117.25 0.4 Allowed 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 124.686 1.195 . . . . 0.0 108.469 -177.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -168.1 45.46 0.24 Allowed Glycine 0 N--CA 1.431 -1.68 1 N-CA-C 99.542 -5.423 . . . . 0.0 99.542 168.412 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -84.09 -51.78 6.81 Favored 'General case' 0 CA--C 1.493 -1.235 0 CA-C-O 121.523 0.678 . . . . 0.0 109.416 -164.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 24.8 tptt -149.37 166.37 29.25 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 103.976 -2.601 . . . . 0.0 103.976 -171.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 18.0 t -129.25 136.4 50.05 Favored 'General case' 0 N--CA 1.423 -1.797 1 N-CA-C 93.599 -6.445 . . . . 0.0 93.599 166.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.584 ' CE1' ' HB3' ' A' ' 10' ' ' GLU . 13.6 p-80 -157.09 159.36 37.81 Favored 'General case' 0 CA--C 1.484 -1.579 1 N-CA-C 99.889 -4.115 . . . . 0.0 99.889 -175.324 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 59.2 m -131.78 135.51 46.84 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 100.594 -3.854 . . . . 0.0 100.594 -173.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.36 1.052 0 O-C-N 124.046 0.842 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 15.2 m . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 121.565 0.698 . . . . 0.0 110.515 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 6.1 mmm180 -101.66 141.89 33.84 Favored 'General case' 0 CA--C 1.495 -1.169 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 -178.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -130.19 116.51 18.53 Favored 'General case' 0 CA--C 1.489 -1.403 1 N-CA-C 95.815 -5.624 . . . . 0.0 95.815 158.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.86 -172.2 28.94 Favored Glycine 0 CA--C 1.476 -2.405 1 N-CA-C 100.981 -4.848 . . . . 0.0 100.981 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -76.86 144.87 38.72 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 104.359 -2.46 . . . . 0.0 104.359 161.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.5 tt -91.23 140.99 15.1 Favored 'Isoleucine or valine' 0 C--O 1.249 1.046 0 N-CA-C 104.617 -2.364 . . . . 0.0 104.617 171.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -141.29 176.99 8.4 Favored 'General case' 0 N--CA 1.41 -2.457 1 N-CA-C 98.875 -4.491 . . . . 0.0 98.875 177.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -85.44 153.38 58.8 Favored Pre-proline 0 N--CA 1.431 -1.386 0 N-CA-C 103.705 -2.702 . . . . 0.0 103.705 172.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -68.1 -16.93 45.53 Favored 'Trans proline' 0 CA--C 1.502 -1.121 0 N-CA-C 117.625 2.125 . . . . 0.0 117.625 -149.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.4 mp0 -95.37 18.47 12.48 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-N 119.317 0.962 . . . . 0.0 108.52 -175.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 58.3 t-20 82.06 48.19 0.02 OUTLIER 'General case' 0 C--N 1.356 0.853 0 C-N-CA 125.85 1.66 . . . . 0.0 107.841 168.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.3 m -125.49 122.19 35.9 Favored 'General case' 0 CA--C 1.487 -1.477 0 N-CA-C 101.001 -3.703 . . . . 0.0 101.001 178.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.1 m -56.88 155.16 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.057 0 CA-C-N 120.858 1.663 . . . . 0.0 113.437 -170.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.64 131.84 54.71 Favored 'General case' 0 CA--C 1.468 -2.205 1 N-CA-C 93.344 -6.539 . . . . 0.0 93.344 177.464 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 66.7 m80 -92.83 -156.65 0.49 Allowed 'General case' 0 CA--C 1.49 -1.362 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 -164.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 5.6 t -155.11 168.39 27.17 Favored 'General case' 0 N--CA 1.417 -2.111 1 N-CA-C 94.399 -6.149 . . . . 0.0 94.399 -173.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -122.81 121.45 27.38 Favored Pre-proline 0 N--CA 1.42 -1.935 1 N-CA-C 94.694 -6.039 . . . . 0.0 94.694 175.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -62.45 99.33 0.2 Allowed 'Trans proline' 0 CA--C 1.51 -0.686 0 CA-C-N 123.106 2.145 . . . . 0.0 116.709 -158.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 169.91 -175.6 43.95 Favored Glycine 0 N--CA 1.422 -2.245 1 N-CA-C 96.168 -6.773 . . . . 0.0 96.168 176.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -69.95 -39.03 76.27 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 119.433 1.617 . . . . 0.0 109.124 178.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -45.63 -49.02 14.69 Favored 'General case' 0 N--CA 1.437 -1.122 0 C-N-CA 130.746 3.619 . . . . 0.0 115.566 -171.401 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.5 -40.88 59.05 Favored Glycine 0 CA--C 1.49 -1.499 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -172.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 43.3 t -70.33 -48.1 58.04 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -52.99 -44.21 67.05 Favored 'General case' 0 C--N 1.354 0.797 0 C-N-CA 124.512 1.125 . . . . 0.0 111.487 -178.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 34.2 m -60.6 -53.84 52.63 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 123.524 0.73 . . . . 0.0 111.142 177.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 83.8 mt -71.86 -40.16 69.17 Favored 'General case' 0 CA--C 1.5 -0.971 0 CA-C-O 122.104 0.955 . . . . 0.0 110.19 -172.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 33.7 t -61.07 -44.28 97.62 Favored 'General case' 0 CA--C 1.5 -0.98 0 C-N-CA 124.932 1.293 . . . . 0.0 109.372 178.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm -68.01 -43.89 77.78 Favored 'General case' 0 CA--C 1.502 -0.892 0 O-C-N 121.986 -0.446 . . . . 0.0 110.1 -173.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.458 ' HG3' ' HZ2' ' A' ' 30' ' ' LYS . 12.1 pt-20 -71.67 -13.0 61.61 Favored 'General case' 0 C--N 1.351 0.663 0 O-C-N 121.691 -0.63 . . . . 0.0 112.512 -175.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.458 ' HZ2' ' HG3' ' A' ' 29' ' ' GLU . 11.4 mmtm -98.43 -2.81 38.18 Favored 'General case' 0 CA--C 1.504 -0.79 0 C-N-CA 123.23 0.612 . . . . 0.0 110.056 176.03 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.0 32.72 8.73 Favored Glycine 0 CA--C 1.491 -1.416 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 172.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -91.44 142.1 15.95 Favored Glycine 0 C--N 1.354 1.556 0 N-CA-C 106.642 -2.583 . . . . 0.0 106.642 171.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.1 m -98.35 -17.24 18.97 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 -163.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 59.5 m -159.93 167.5 27.87 Favored 'General case' 0 CA--C 1.482 -1.639 1 N-CA-C 99.226 -4.361 . . . . 0.0 99.226 171.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -171.34 174.77 44.99 Favored Glycine 0 CA--C 1.476 -2.365 1 N-CA-C 100.328 -5.109 . . . . 0.0 100.328 -179.219 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 32.1 p-80 -158.5 159.49 35.68 Favored 'General case' 0 N--CA 1.426 -1.637 1 N-CA-C 98.452 -4.648 . . . . 0.0 98.452 176.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 42.3 t -87.03 159.04 19.1 Favored 'General case' 0 CA--C 1.501 -0.942 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 -173.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -174.68 -172.05 39.39 Favored Glycine 0 N--CA 1.423 -2.221 0 N-CA-C 103.861 -3.696 . . . . 0.0 103.861 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -130.08 148.97 51.98 Favored 'General case' 0 N--CA 1.426 -1.636 1 N-CA-C 97.202 -5.11 . . . . 0.0 97.202 -175.168 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.0 tptm -115.24 112.68 22.83 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 100.61 -3.848 . . . . 0.0 100.61 175.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.7 t -82.06 117.24 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 -173.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 119.79 -13.0 10.78 Favored Glycine 0 C--N 1.347 1.163 0 N-CA-C 107.856 -2.097 . . . . 0.0 107.856 -169.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -128.77 -78.83 0.56 Allowed 'General case' 0 CA--C 1.501 -0.929 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 175.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 168.11 -162.18 35.96 Favored Glycine 0 N--CA 1.427 -1.915 0 N-CA-C 103.808 -3.717 . . . . 0.0 103.808 -168.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 41.1 tp -63.17 131.08 47.28 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 127.448 2.299 . . . . 0.0 107.123 176.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -136.48 -171.72 2.97 Favored 'General case' 0 CA--C 1.492 -1.286 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 -165.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 4.2 t -139.19 156.73 46.9 Favored 'General case' 0 CA--C 1.488 -1.409 0 N-CA-C 100.594 -3.854 . . . . 0.0 100.594 173.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 15.6 t-105 -115.06 147.59 39.98 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 103.423 -2.806 . . . . 0.0 103.423 178.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 63.4 m -136.44 143.93 44.17 Favored 'General case' 0 CA--C 1.489 -1.384 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 172.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -113.64 131.05 56.28 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 102.309 -3.219 . . . . 0.0 102.309 177.218 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 57.86 71.26 0.59 Allowed 'General case' 0 CA--C 1.498 -1.046 0 C-N-CA 126.877 2.071 . . . . 0.0 110.946 178.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 15.9 mt -96.03 145.94 30.43 Favored Pre-proline 0 CA--C 1.499 -1.005 0 N-CA-C 102.78 -3.045 . . . . 0.0 102.78 164.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.06 166.7 28.33 Favored 'Trans proline' 0 N--CA 1.447 -1.236 0 C-N-CA 122.295 1.997 . . . . 0.0 109.527 172.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -77.86 -9.65 59.16 Favored 'General case' 0 CA--C 1.5 -0.973 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -163.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -85.65 7.33 23.77 Favored 'General case' 0 CA--C 1.506 -0.737 0 C-N-CA 123.996 0.918 . . . . 0.0 109.95 -179.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.0 t -104.35 113.46 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.636 0 N-CA-C 103.877 -2.638 . . . . 0.0 103.877 172.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -84.38 155.5 31.11 Favored Glycine 0 CA--C 1.493 -1.334 0 N-CA-C 104.604 -3.399 . . . . 0.0 104.604 169.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 15.1 pt -144.1 -134.59 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 N-CA-C 102.674 -3.084 . . . . 0.0 102.674 -166.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.2 mp -74.41 112.35 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 N-CA-C 102.39 -3.189 . . . . 0.0 102.39 168.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.453 HG11 ' HE2' ' A' ' 66' ' ' HIS . 0.5 OUTLIER -130.44 138.71 53.13 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.694 0 N-CA-C 100.8 -3.778 . . . . 0.0 100.8 -158.991 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 67.85 -70.3 0.13 Allowed 'General case' 0 C--N 1.356 0.883 0 C-N-CA 126.679 1.992 . . . . 0.0 109.015 -165.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 152.52 -53.46 0.47 Allowed Glycine 0 CA--C 1.483 -1.913 0 N-CA-C 104.424 -3.471 . . . . 0.0 104.424 175.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 78.1 tt0 -31.2 -83.24 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.854 0 C-N-CA 129.604 3.161 . . . . 0.0 116.821 -164.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 42.6 tttm -169.26 -167.65 0.74 Allowed 'General case' 0 N--CA 1.426 -1.651 1 N-CA-C 98.056 -4.794 . . . . 0.0 98.056 -175.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 19.6 t -86.96 148.93 25.12 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 -171.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.453 ' HE2' HG11 ' A' ' 60' ' ' VAL . 11.5 p80 -135.38 -162.34 1.25 Allowed 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 -178.184 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 18.9 m -174.95 176.98 2.06 Favored 'General case' 0 N--CA 1.427 -1.62 1 N-CA-C 95.771 -5.64 . . . . 0.0 95.771 178.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.359 1.004 0 O-C-N 124.255 0.972 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 28.1 m . . . . . 0 N--CA 1.483 1.176 0 CA-C-O 120.977 0.418 . . . . 0.0 110.528 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -102.16 162.79 12.64 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 172.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -125.19 132.12 53.07 Favored 'General case' 0 CA--C 1.493 -1.217 1 N-CA-C 96.192 -5.484 . . . . 0.0 96.192 158.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.1 -170.13 26.43 Favored Glycine 0 CA--C 1.481 -2.055 0 N-CA-C 103.979 -3.648 . . . . 0.0 103.979 176.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -83.29 135.82 34.6 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 103.765 -2.679 . . . . 0.0 103.765 162.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.8 tt -91.47 147.52 5.21 Favored 'Isoleucine or valine' 0 C--O 1.244 0.814 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 175.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -149.3 -169.24 3.32 Favored 'General case' 0 N--CA 1.42 -1.952 0 N-CA-C 104.632 -2.358 . . . . 0.0 104.632 178.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -88.57 150.45 46.32 Favored Pre-proline 0 N--CA 1.432 -1.365 0 N-CA-C 104.624 -2.362 . . . . 0.0 104.624 169.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -70.57 32.47 0.22 Allowed 'Trans proline' 0 CA--C 1.517 -0.347 0 C-N-CA 123.911 3.074 . . . . 0.0 116.029 -174.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -109.54 11.05 25.02 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 106.957 -1.498 . . . . 0.0 106.957 -176.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 50.1 t30 67.66 53.65 0.7 Allowed 'General case' 0 CA--C 1.5 -0.949 0 C-N-CA 127.798 2.439 . . . . 0.0 108.285 -172.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -110.93 -154.72 0.55 Allowed 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -167.026 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.8 m -135.51 161.35 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.592 1 N-CA-C 98.021 -4.807 . . . . 0.0 98.021 163.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -113.64 130.79 56.34 Favored 'General case' 0 CA--C 1.479 -1.76 1 N-CA-C 96.683 -5.302 . . . . 0.0 96.683 173.918 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 27.7 m80 -82.98 141.88 31.78 Favored 'General case' 0 CA--C 1.493 -1.236 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 -173.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.423 ' H ' ' HG ' ' A' ' 45' ' ' LEU . 1.8 t -91.39 -179.18 5.32 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 -178.182 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -131.49 126.04 20.97 Favored Pre-proline 0 N--CA 1.412 -2.332 1 N-CA-C 97.073 -5.158 . . . . 0.0 97.073 -174.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_exo -62.96 67.97 0.14 Allowed 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.402 2.735 . . . . 0.0 112.029 164.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 171.96 77.21 0.05 OUTLIER Glycine 0 N--CA 1.423 -2.204 1 N-CA-C 95.346 -7.102 . . . . 0.0 95.346 -172.656 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.2 m -49.24 -38.1 25.51 Favored 'General case' 0 N--CA 1.438 -1.045 0 C-N-CA 128.532 2.733 . . . . 0.0 113.404 -159.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.5 m -61.05 -17.4 52.19 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 -177.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.8 -52.11 50.81 Favored Glycine 0 C--N 1.35 1.333 0 CA-C-N 119.982 1.265 . . . . 0.0 110.384 173.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -88.23 -20.99 24.77 Favored 'General case' 0 CA--C 1.496 -1.114 0 O-C-N 121.465 -1.021 . . . . 0.0 109.488 -175.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -64.28 -34.66 78.63 Favored 'General case' 0 C--N 1.355 0.818 0 O-C-N 121.232 -0.917 . . . . 0.0 109.515 170.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 33.4 m -64.88 -44.79 88.52 Favored 'General case' 0 C--N 1.354 0.771 0 O-C-N 120.8 -1.188 . . . . 0.0 109.862 172.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 84.1 mt -62.4 -43.33 99.08 Favored 'General case' 0 C--N 1.361 1.109 0 CA-C-O 121.732 0.777 . . . . 0.0 110.897 178.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 41.7 t -54.37 -48.86 71.03 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 125.132 1.373 . . . . 0.0 109.875 173.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.6 tptp -66.13 -40.55 90.74 Favored 'General case' 0 N--CA 1.441 -0.911 0 O-C-N 121.837 -0.539 . . . . 0.0 111.783 -174.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -76.94 -24.57 52.37 Favored 'General case' 0 C--N 1.354 0.773 0 O-C-N 121.772 -0.58 . . . . 0.0 112.455 -177.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -75.43 -39.16 59.24 Favored 'General case' 0 C--N 1.361 1.081 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 171.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 120.7 44.05 0.43 Allowed Glycine 0 CA--C 1.483 -1.963 0 N-CA-C 108.066 -2.014 . . . . 0.0 108.066 166.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -95.84 136.97 13.14 Favored Glycine 0 CA--C 1.486 -1.767 0 N-CA-C 103.159 -3.976 . . . . 0.0 103.159 167.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.0 m -102.38 2.87 37.24 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 -158.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.3 m -160.64 165.42 30.64 Favored 'General case' 0 CA--C 1.488 -1.441 1 N-CA-C 99.517 -4.253 . . . . 0.0 99.517 159.433 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -175.67 168.85 41.4 Favored Glycine 0 CA--C 1.48 -2.117 0 N-CA-C 103.513 -3.835 . . . . 0.0 103.513 -177.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.472 ' CE1' ' CD1' ' A' ' 48' ' ' TRP . 35.1 p-80 -174.1 -178.86 1.55 Allowed 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 100.619 -3.845 . . . . 0.0 100.619 -176.22 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 74.4 m -87.47 163.44 16.7 Favored 'General case' 0 CA--C 1.495 -1.157 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -164.07 -177.71 37.03 Favored Glycine 0 N--CA 1.423 -2.209 1 N-CA-C 99.641 -5.384 . . . . 0.0 99.641 176.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -136.35 140.24 43.14 Favored 'General case' 0 N--CA 1.431 -1.403 1 N-CA-C 96.929 -5.211 . . . . 0.0 96.929 177.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.4 tmtt? -108.99 100.68 9.84 Favored 'General case' 0 CA--C 1.492 -1.265 0 N-CA-C 101.625 -3.472 . . . . 0.0 101.625 178.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.1 t -71.42 117.4 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 -178.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 135.46 -38.18 1.83 Allowed Glycine 0 CA--C 1.489 -1.571 0 N-CA-C 105.648 -2.981 . . . . 0.0 105.648 -167.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 30.7 m170 -121.07 -74.41 0.61 Allowed 'General case' 0 CA--C 1.498 -1.033 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 177.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 171.71 -158.82 30.0 Favored Glycine 0 N--CA 1.427 -1.918 0 N-CA-C 104.812 -3.315 . . . . 0.0 104.812 -169.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.423 ' HG ' ' H ' ' A' ' 16' ' ' CYS . 43.8 tp -67.19 129.84 41.19 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 126.67 1.988 . . . . 0.0 106.249 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -137.23 175.27 9.76 Favored 'General case' 0 CA--C 1.484 -1.581 0 N-CA-C 102.006 -3.331 . . . . 0.0 102.006 -167.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 64.0 m -117.95 160.65 21.1 Favored 'General case' 0 CA--C 1.476 -1.884 0 N-CA-C 102.582 -3.118 . . . . 0.0 102.582 174.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.472 ' CD1' ' CE1' ' A' ' 36' ' ' HIS . 30.7 t-105 -117.52 148.52 41.78 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 103.531 -2.766 . . . . 0.0 103.531 -176.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 67.9 m -142.09 148.2 38.0 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 104.602 -2.369 . . . . 0.0 104.602 172.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -112.77 140.28 47.69 Favored 'General case' 0 CA--C 1.492 -1.272 0 N-CA-C 101.499 -3.519 . . . . 0.0 101.499 168.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 66.66 66.12 0.45 Allowed 'General case' 0 CA--C 1.498 -1.035 0 C-N-CA 126.222 1.809 . . . . 0.0 110.691 169.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 14.4 mt -103.74 138.99 19.69 Favored Pre-proline 0 CA--C 1.498 -1.047 0 N-CA-C 104.609 -2.367 . . . . 0.0 104.609 172.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.9 170.05 20.64 Favored 'Trans proline' 0 N--CA 1.447 -1.241 0 C-N-CA 122.542 2.161 . . . . 0.0 110.751 177.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -76.96 -0.45 24.38 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -172.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -87.3 3.35 47.12 Favored 'General case' 0 CA--C 1.505 -0.781 0 O-C-N 121.455 -0.778 . . . . 0.0 110.253 177.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.0 t -103.83 148.08 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.278 0 N-CA-C 102.582 -3.118 . . . . 0.0 102.582 178.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -129.19 144.38 15.37 Favored Glycine 0 CA--C 1.476 -2.372 1 N-CA-C 97.034 -6.426 . . . . 0.0 97.034 174.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 27.4 pt -142.31 -141.7 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.32 0 N-CA-C 104.305 -2.479 . . . . 0.0 104.305 -154.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.7 mp -70.25 113.6 6.53 Favored 'Isoleucine or valine' 0 C--N 1.352 0.691 0 N-CA-C 104.548 -2.39 . . . . 0.0 104.548 168.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -111.76 -17.71 8.18 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.109 0 CA-C-O 122.655 1.217 . . . . 0.0 108.272 -160.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -170.68 -173.4 1.38 Allowed 'General case' 0 N--CA 1.424 -1.755 1 N-CA-C 96.192 -5.485 . . . . 0.0 96.192 171.433 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -129.14 73.01 0.47 Allowed Glycine 0 CA--C 1.482 -2.014 1 N-CA-C 101.568 -4.613 . . . . 0.0 101.568 170.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -105.49 -71.48 0.74 Allowed 'General case' 0 CA--C 1.492 -1.288 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 -174.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -165.1 177.67 7.56 Favored 'General case' 0 N--CA 1.426 -1.666 1 N-CA-C 96.575 -5.343 . . . . 0.0 96.575 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 35.9 t -112.49 149.7 32.27 Favored 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 102.433 -3.173 . . . . 0.0 102.433 176.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 14.7 p80 -113.42 62.45 0.65 Allowed 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 176.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.45 67.01 1.94 Allowed 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 126.219 1.808 . . . . 0.0 110.326 -178.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.365 1.262 0 CA-C-N 115.317 -0.856 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 29.8 m . . . . . 0 N--CA 1.484 1.252 0 CA-C-O 121.129 0.49 . . . . 0.0 110.079 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.5 171.97 7.97 Favored 'General case' 0 CA--C 1.493 -1.219 0 N-CA-C 101.116 -3.661 . . . . 0.0 101.116 161.282 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -129.35 135.25 48.49 Favored 'General case' 0 CA--C 1.485 -1.526 1 N-CA-C 94.007 -6.294 . . . . 0.0 94.007 169.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.81 -177.27 34.73 Favored Glycine 0 CA--C 1.473 -2.556 1 N-CA-C 102.957 -4.057 . . . . 0.0 102.957 -177.014 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -87.97 136.53 32.92 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 101.954 -3.35 . . . . 0.0 101.954 164.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 16.1 tt -90.62 144.26 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.366 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 -177.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -126.26 -148.42 0.39 Allowed 'General case' 0 N--CA 1.423 -1.779 0 C-N-CA 128.674 2.79 . . . . 0.0 106.68 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -133.22 148.78 70.48 Favored Pre-proline 0 N--CA 1.422 -1.857 1 N-CA-C 95.572 -5.714 . . . . 0.0 95.572 166.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -82.01 39.9 0.91 Allowed 'Trans proline' 0 CA--C 1.513 -0.543 0 C-N-CA 123.601 2.867 . . . . 0.0 112.151 -154.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -111.64 17.03 20.32 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 106.557 -1.646 . . . . 0.0 106.557 -178.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.43 ' O ' ' HE1' ' A' ' 43' ' ' HIS . 49.9 t30 64.56 60.23 0.91 Allowed 'General case' 0 CA--C 1.497 -1.063 0 C-N-CA 128.265 2.626 . . . . 0.0 108.583 -172.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -117.9 -158.37 0.71 Allowed 'General case' 0 CA--C 1.493 -1.224 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -166.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.1 m -137.26 156.79 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.687 1 N-CA-C 96.103 -5.517 . . . . 0.0 96.103 167.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -93.73 121.04 34.76 Favored 'General case' 0 CA--C 1.486 -1.51 0 N-CA-C 100.529 -3.878 . . . . 0.0 100.529 170.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -74.88 107.74 7.16 Favored 'General case' 0 CA--C 1.492 -1.26 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 -168.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.3 t -83.65 150.14 26.08 Favored 'General case' 0 CA--C 1.485 -1.54 0 CA-C-N 114.399 -1.273 . . . . 0.0 107.68 -164.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -112.04 112.99 52.38 Favored Pre-proline 0 N--CA 1.428 -1.572 0 N-CA-C 102.046 -3.316 . . . . 0.0 102.046 178.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_exo -59.41 137.59 79.06 Favored 'Trans proline' 0 CA--C 1.503 -1.047 0 C-N-CA 122.625 2.216 . . . . 0.0 110.677 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 119.83 -54.95 0.63 Allowed Glycine 0 CA--C 1.488 -1.607 1 N-CA-C 101.617 -4.593 . . . . 0.0 101.617 -157.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.0 m 91.24 12.04 0.04 OUTLIER 'General case' 0 CA--C 1.496 -1.105 0 C-N-CA 127.518 2.327 . . . . 0.0 111.224 174.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.7 m -56.65 -53.88 52.6 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 124.473 1.109 . . . . 0.0 113.047 -172.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -74.8 -31.81 57.81 Favored Glycine 0 C--N 1.35 1.342 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.7 t -67.03 -51.68 51.79 Favored 'General case' 0 CA--C 1.488 -1.419 0 C-N-CA 124.174 0.99 . . . . 0.0 109.602 -174.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -65.44 -36.74 84.82 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -176.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.8 m -60.33 -50.5 73.38 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 121.52 -0.738 . . . . 0.0 111.137 173.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 32.3 mt -64.5 -42.0 96.09 Favored 'General case' 0 CA--C 1.498 -1.046 0 C-N-CA 123.9 0.88 . . . . 0.0 109.99 -179.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 19.5 t -55.91 -46.0 78.53 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 124.123 0.969 . . . . 0.0 110.82 176.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 37.5 mtmm -63.55 -46.67 84.89 Favored 'General case' 0 C--N 1.356 0.864 0 CA-C-N 118.213 0.461 . . . . 0.0 111.259 -177.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -73.13 -21.95 60.63 Favored 'General case' 0 C--N 1.351 0.636 0 O-C-N 121.666 -0.646 . . . . 0.0 112.267 -175.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 48.9 mmtm -86.14 -10.39 54.91 Favored 'General case' 0 C--N 1.355 0.844 0 O-C-N 121.855 -0.528 . . . . 0.0 110.907 174.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.57 28.85 7.72 Favored Glycine 0 CA--C 1.489 -1.535 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 168.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -94.83 146.46 18.18 Favored Glycine 0 CA--C 1.487 -1.68 0 N-CA-C 105.037 -3.225 . . . . 0.0 105.037 165.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.5 p -72.58 -43.33 63.52 Favored 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 124.483 1.113 . . . . 0.0 110.354 -166.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 34.9 m -160.63 -178.59 6.98 Favored 'General case' 0 N--CA 1.422 -1.863 1 N-CA-C 97.8 -4.889 . . . . 0.0 97.8 165.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -174.7 177.35 46.84 Favored Glycine 0 N--CA 1.417 -2.605 1 N-CA-C 98.947 -5.661 . . . . 0.0 98.947 -167.294 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 81.8 m-70 -164.52 171.28 14.77 Favored 'General case' 0 CA--C 1.492 -1.257 1 N-CA-C 98.621 -4.585 . . . . 0.0 98.621 -171.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 72.5 m -81.16 160.52 24.35 Favored 'General case' 0 CA--C 1.502 -0.881 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 165.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -167.34 171.77 42.1 Favored Glycine 0 CA--C 1.481 -2.084 1 N-CA-C 98.58 -5.808 . . . . 0.0 98.58 173.239 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -156.26 140.38 16.45 Favored 'General case' 0 N--CA 1.426 -1.628 1 N-CA-C 97.82 -4.882 . . . . 0.0 97.82 -176.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -155.42 47.96 0.52 Allowed 'General case' 0 CA--C 1.491 -1.298 1 N-CA-C 99.514 -4.254 . . . . 0.0 99.514 174.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . 0.276 2.1 t 61.68 -147.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 N-CA-C 105.482 -2.044 . . . . 0.0 105.482 -152.271 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 142.93 -88.11 0.18 Allowed Glycine 0 CA--C 1.48 -2.109 1 N-CA-C 100.853 -4.899 . . . . 0.0 100.853 -178.455 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.43 ' HE1' ' O ' ' A' ' 11' ' ' ASN . 47.0 m170 -150.26 -69.57 0.19 Allowed 'General case' 0 CA--C 1.493 -1.223 1 N-CA-C 98.215 -4.735 . . . . 0.0 98.215 168.179 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -115.01 -159.37 12.29 Favored Glycine 0 N--CA 1.437 -1.267 0 N-CA-C 103.304 -3.918 . . . . 0.0 103.304 168.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -83.18 110.98 18.51 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 -174.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -98.77 175.39 5.98 Favored 'General case' 0 CA--C 1.492 -1.28 0 C-N-CA 124.649 1.18 . . . . 0.0 108.182 -167.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 10.8 t -111.12 148.65 32.24 Favored 'General case' 0 CA--C 1.499 -1.018 0 N-CA-C 102.387 -3.19 . . . . 0.0 102.387 -174.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 70.0 t-105 -100.19 150.64 22.31 Favored 'General case' 0 CA--C 1.492 -1.286 0 N-CA-C 104.355 -2.461 . . . . 0.0 104.355 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 26.1 m -141.01 143.72 34.59 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 101.422 -3.547 . . . . 0.0 101.422 166.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -110.11 23.34 14.45 Favored 'General case' 0 CA--C 1.503 -0.862 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -167.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -177.29 156.44 1.23 Allowed 'General case' 0 N--CA 1.418 -2.037 1 N-CA-C 94.321 -6.177 . . . . 0.0 94.321 170.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 14.8 mt -159.41 154.22 21.15 Favored Pre-proline 0 CA--C 1.488 -1.437 1 N-CA-C 96.128 -5.508 . . . . 0.0 96.128 157.53 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.18 161.39 46.18 Favored 'Trans proline' 0 N--CA 1.446 -1.287 0 C-N-CA 122.006 1.804 . . . . 0.0 108.328 165.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -77.92 -6.52 54.6 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -165.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -86.91 -1.79 58.1 Favored 'General case' 0 CA--C 1.506 -0.73 0 O-C-N 121.439 -0.788 . . . . 0.0 109.629 -178.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.1 t -94.16 111.01 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.16 0 N-CA-C 104.287 -2.486 . . . . 0.0 104.287 177.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -84.98 143.65 20.59 Favored Glycine 0 CA--C 1.492 -1.382 0 N-CA-C 106.627 -2.589 . . . . 0.0 106.627 176.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 13.6 pt -125.34 -134.65 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.276 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 -162.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.1 mp -76.18 119.45 24.29 Favored 'Isoleucine or valine' 0 C--N 1.354 0.784 0 N-CA-C 102.884 -3.006 . . . . 0.0 102.884 165.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.9 t -104.76 -22.78 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.065 0 C-N-CA 124.954 1.302 . . . . 0.0 109.175 -163.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -171.39 163.58 6.93 Favored 'General case' 0 N--CA 1.431 -1.409 1 N-CA-C 99.188 -4.375 . . . . 0.0 99.188 173.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -92.94 65.17 2.0 Allowed Glycine 0 CA--C 1.496 -1.127 0 N-CA-C 105.52 -3.032 . . . . 0.0 105.52 171.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -104.91 -84.91 0.48 Allowed 'General case' 0 CA--C 1.496 -1.097 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 -172.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -166.98 164.19 16.05 Favored 'General case' 0 N--CA 1.424 -1.735 1 N-CA-C 98.2 -4.741 . . . . 0.0 98.2 -176.253 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 51.4 t -106.33 144.62 32.77 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 176.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 25.1 p-80 -102.53 74.33 1.37 Allowed 'General case' 0 CA--C 1.498 -1.036 0 N-CA-C 105.207 -2.146 . . . . 0.0 105.207 172.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.2 m -69.05 57.63 0.1 Allowed 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 127.077 2.151 . . . . 0.0 114.219 -173.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.358 0.962 0 CA-C-N 116.857 -0.156 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 34.1 m . . . . . 0 N--CA 1.485 1.284 0 CA-C-O 121.17 0.509 . . . . 0.0 109.903 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -106.11 157.95 17.18 Favored 'General case' 0 CA--C 1.499 -0.987 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 171.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -126.44 125.73 42.63 Favored 'General case' 0 CA--C 1.484 -1.589 1 N-CA-C 94.386 -6.153 . . . . 0.0 94.386 156.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.72 178.34 37.64 Favored Glycine 0 CA--C 1.475 -2.41 0 N-CA-C 107.601 -2.2 . . . . 0.0 107.601 -171.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -82.65 129.79 35.01 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 166.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 14.0 tt -91.05 144.18 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -144.85 179.34 7.39 Favored 'General case' 0 N--CA 1.417 -2.078 1 N-CA-C 98.731 -4.544 . . . . 0.0 98.731 -177.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -79.64 156.2 75.55 Favored Pre-proline 0 N--CA 1.437 -1.12 0 CA-C-O 116.735 -1.603 . . . . 0.0 106.836 178.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -67.9 -18.82 46.85 Favored 'Trans proline' 0 CA--C 1.504 -0.999 0 CA-C-N 122.989 2.103 . . . . 0.0 116.709 -152.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -101.21 7.12 43.19 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -177.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 86.73 126.62 0.03 OUTLIER 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 128.822 2.849 . . . . 0.0 107.112 176.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 156.9 126.47 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.345 1 N-CA-C 99.16 -4.385 . . . . 0.0 99.16 172.294 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.402 HG11 ' HD1' ' A' ' 43' ' ' HIS . 12.0 m -63.36 156.46 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.23 0 CA-C-O 123.011 1.386 . . . . 0.0 112.705 -162.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -100.52 121.16 41.12 Favored 'General case' 0 N--CA 1.42 -1.947 1 N-CA-C 97.317 -5.068 . . . . 0.0 97.317 176.609 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 45.6 m80 -80.83 126.04 30.84 Favored 'General case' 0 CA--C 1.487 -1.472 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 -166.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 9.2 t -94.11 174.05 7.35 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 -176.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -146.31 156.71 49.88 Favored Pre-proline 0 N--CA 1.417 -2.093 1 N-CA-C 97.311 -5.07 . . . . 0.0 97.311 -177.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_exo -69.65 -14.94 37.18 Favored 'Trans proline' 0 CA--C 1.511 -0.653 0 CA-C-N 122.977 2.099 . . . . 0.0 111.715 175.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -113.18 81.84 0.3 Allowed Glycine 0 CA--C 1.486 -1.778 1 N-CA-C 101.162 -4.775 . . . . 0.0 101.162 169.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 m -82.09 29.07 0.42 Allowed 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 125.647 1.579 . . . . 0.0 113.1 -160.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.5 m -56.65 -50.98 70.47 Favored 'General case' 0 N--CA 1.435 -1.193 0 C-N-CA 126.879 2.072 . . . . 0.0 113.737 -161.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.03 -31.87 72.69 Favored Glycine 0 C--N 1.352 1.439 0 N-CA-C 111.374 -0.69 . . . . 0.0 111.374 -176.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.3 t -78.49 -31.8 47.91 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -174.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -62.08 -41.83 98.59 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 123.708 0.803 . . . . 0.0 110.436 174.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.02 -35.31 80.3 Favored 'General case' 0 C--N 1.352 0.707 0 O-C-N 121.048 -1.032 . . . . 0.0 112.196 174.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 92.0 mt -67.45 -41.76 84.21 Favored 'General case' 0 C--N 1.357 0.893 0 CA-C-O 121.938 0.875 . . . . 0.0 109.663 176.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 27.2 t -55.41 -47.57 75.71 Favored 'General case' 0 CA--C 1.507 -0.691 0 C-N-CA 125.027 1.331 . . . . 0.0 110.135 177.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -59.04 -50.79 72.73 Favored 'General case' 0 C--N 1.354 0.797 0 C-N-CA 122.827 0.451 . . . . 0.0 111.697 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -71.16 -23.11 62.0 Favored 'General case' 0 C--N 1.356 0.871 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -174.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.0 mmtp -81.92 -14.8 55.63 Favored 'General case' 0 C--N 1.355 0.805 0 C-N-CA 123.147 0.579 . . . . 0.0 110.713 175.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 110.26 24.39 5.7 Favored Glycine 0 CA--C 1.49 -1.472 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 167.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -97.11 122.31 7.38 Favored Glycine 0 C--N 1.353 1.484 0 N-CA-C 105.899 -2.88 . . . . 0.0 105.899 177.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.7 p -99.57 9.2 43.62 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 122.225 1.012 . . . . 0.0 109.162 -168.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 57.9 m -160.11 164.85 32.69 Favored 'General case' 0 CA--C 1.479 -1.786 1 N-CA-C 97.598 -4.964 . . . . 0.0 97.598 164.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -158.15 164.95 33.59 Favored Glycine 0 CA--C 1.465 -3.07 1 N-CA-C 99.605 -5.398 . . . . 0.0 99.605 -173.427 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -156.76 -159.18 0.84 Allowed 'General case' 0 N--CA 1.421 -1.88 1 N-CA-C 98.185 -4.746 . . . . 0.0 98.185 -177.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 34.0 t -148.13 166.43 27.88 Favored 'General case' 0 N--CA 1.424 -1.733 1 N-CA-C 97.798 -4.89 . . . . 0.0 97.798 -170.264 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -179.7 -161.83 27.67 Favored Glycine 0 N--CA 1.421 -2.306 1 N-CA-C 100.571 -5.012 . . . . 0.0 100.571 176.149 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -140.55 148.27 40.75 Favored 'General case' 0 N--CA 1.432 -1.358 1 N-CA-C 100.072 -4.047 . . . . 0.0 100.072 -178.035 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.9 mmpt? -123.74 103.06 8.16 Favored 'General case' 0 CA--C 1.491 -1.295 0 N-CA-C 104.027 -2.583 . . . . 0.0 104.027 173.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.7 t -74.06 118.71 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 136.65 -36.72 1.95 Allowed Glycine 0 CA--C 1.487 -1.712 0 N-CA-C 104.131 -3.587 . . . . 0.0 104.131 -165.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.402 ' HD1' HG11 ' A' ' 13' ' ' VAL . 39.1 m170 -125.56 -68.89 0.81 Allowed 'General case' 0 CA--C 1.499 -0.99 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 178.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 162.02 -150.58 20.07 Favored Glycine 0 N--CA 1.429 -1.774 0 N-CA-C 105.297 -3.121 . . . . 0.0 105.297 -175.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -70.78 127.72 33.61 Favored 'General case' 0 C--N 1.353 0.745 0 N-CA-C 103.66 -2.718 . . . . 0.0 103.66 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.67 155.77 49.89 Favored 'General case' 0 CA--C 1.479 -1.759 0 N-CA-C 101.235 -3.617 . . . . 0.0 101.235 -168.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 58.0 m -100.44 177.67 4.96 Favored 'General case' 0 CA--C 1.49 -1.334 0 N-CA-C 103.663 -2.717 . . . . 0.0 103.663 -176.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 3.8 t-105 -140.92 150.08 42.7 Favored 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 101.507 -3.516 . . . . 0.0 101.507 -177.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 56.1 m -142.85 154.4 44.12 Favored 'General case' 0 CA--C 1.493 -1.224 0 N-CA-C 104.667 -2.346 . . . . 0.0 104.667 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -123.34 135.47 54.19 Favored 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 175.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 77.7 41.89 0.13 Allowed 'General case' 0 CA--C 1.493 -1.215 0 C-N-CA 127.428 2.291 . . . . 0.0 110.612 169.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 49.2 mt -80.69 135.57 52.47 Favored Pre-proline 0 CA--C 1.502 -0.876 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 177.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -72.02 169.61 20.94 Favored 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 122.416 2.077 . . . . 0.0 109.513 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -76.44 -5.79 48.93 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -163.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -86.17 -7.7 58.37 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 123.432 0.693 . . . . 0.0 110.208 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.0 t -93.17 126.93 45.54 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.045 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 -176.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -97.29 150.89 19.65 Favored Glycine 0 CA--C 1.485 -1.842 0 N-CA-C 104.075 -3.61 . . . . 0.0 104.075 178.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 20.2 pt -148.25 -143.74 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 N-CA-C 102.032 -3.321 . . . . 0.0 102.032 -166.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.9 mp -71.8 119.78 18.89 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 104.881 -2.266 . . . . 0.0 104.881 168.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -152.46 159.78 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.658 0 N-CA-C 102.198 -3.26 . . . . 0.0 102.198 -156.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 80.39 -115.82 0.02 OUTLIER 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 103.093 -2.929 . . . . 0.0 103.093 -170.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -107.19 -60.16 0.57 Allowed Glycine 0 CA--C 1.486 -1.766 1 N-CA-C 101.271 -4.732 . . . . 0.0 101.271 161.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -156.67 159.3 38.27 Favored 'General case' 0 N--CA 1.419 -1.99 1 N-CA-C 95.278 -5.823 . . . . 0.0 95.278 161.007 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.1 tppt? -173.56 -177.2 1.4 Allowed 'General case' 0 N--CA 1.429 -1.524 1 N-CA-C 96.057 -5.534 . . . . 0.0 96.057 -177.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 2.3 t -147.49 145.97 29.34 Favored 'General case' 0 N--CA 1.424 -1.735 1 N-CA-C 95.586 -5.709 . . . . 0.0 95.586 163.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -163.43 173.62 12.94 Favored 'General case' 0 N--CA 1.426 -1.632 1 N-CA-C 98.405 -4.665 . . . . 0.0 98.405 165.033 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.6 m -174.87 172.61 2.89 Favored 'General case' 0 N--CA 1.425 -1.724 1 N-CA-C 96.052 -5.536 . . . . 0.0 96.052 -178.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.358 0.969 0 O-C-N 124.101 0.876 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 25.3 m . . . . . 0 N--CA 1.488 1.459 0 CA-C-O 121.107 0.479 . . . . 0.0 110.962 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.53 166.22 16.43 Favored 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 170.085 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -130.1 131.81 45.88 Favored 'General case' 0 CA--C 1.492 -1.276 1 N-CA-C 95.173 -5.862 . . . . 0.0 95.173 165.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.86 -173.34 30.4 Favored Glycine 0 CA--C 1.476 -2.372 0 N-CA-C 104.24 -3.544 . . . . 0.0 104.24 178.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -80.04 131.83 35.86 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 102.156 -3.275 . . . . 0.0 102.156 157.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.2 tt -90.72 145.79 6.99 Favored 'Isoleucine or valine' 0 C--O 1.243 0.756 0 N-CA-C 105.52 -2.03 . . . . 0.0 105.52 -177.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -126.28 -176.17 3.58 Favored 'General case' 0 N--CA 1.424 -1.742 0 C-N-CA 126.165 1.786 . . . . 0.0 106.748 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -82.95 145.31 49.43 Favored Pre-proline 0 N--CA 1.437 -1.119 0 N-CA-C 104.548 -2.389 . . . . 0.0 104.548 157.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_exo -67.28 -22.06 46.87 Favored 'Trans proline' 0 CA--C 1.502 -1.107 0 CA-C-N 122.827 2.045 . . . . 0.0 116.295 -149.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -84.67 38.7 0.71 Allowed 'General case' 0 N--CA 1.438 -1.035 0 C-N-CA 124.825 1.25 . . . . 0.0 110.784 -167.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 50.7 t30 63.85 48.46 3.17 Favored 'General case' 0 C--N 1.354 0.782 0 C-N-CA 127.812 2.445 . . . . 0.0 110.143 -178.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -104.15 -146.68 0.38 Allowed 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 -177.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.1 m -133.11 -166.01 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.338 1 N-CA-C 97.653 -4.943 . . . . 0.0 97.653 164.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -120.41 155.41 33.52 Favored 'General case' 0 CA--C 1.491 -1.315 1 N-CA-C 95.704 -5.665 . . . . 0.0 95.704 170.845 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 33.4 m80 -91.1 99.2 12.26 Favored 'General case' 0 CA--C 1.486 -1.481 0 N-CA-C 102.846 -3.02 . . . . 0.0 102.846 175.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 7.2 t -104.94 -176.02 2.96 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 104.273 -2.492 . . . . 0.0 104.273 174.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -137.85 164.55 40.23 Favored Pre-proline 0 N--CA 1.417 -2.084 1 N-CA-C 99.15 -4.389 . . . . 0.0 99.15 -158.266 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.25 55.87 3.65 Favored 'Trans proline' 0 C--N 1.322 -0.863 0 C-N-CA 123.263 2.642 . . . . 0.0 111.063 171.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -173.47 146.31 8.81 Favored Glycine 0 N--CA 1.421 -2.362 1 N-CA-C 99.577 -5.409 . . . . 0.0 99.577 175.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.4 m -93.35 8.77 39.13 Favored 'General case' 0 N--CA 1.438 -1.068 0 C-N-CA 123.92 0.888 . . . . 0.0 110.397 -174.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -50.38 -51.64 44.24 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 128.492 2.717 . . . . 0.0 114.131 -164.426 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -89.97 -22.01 37.29 Favored Glycine 0 C--N 1.351 1.365 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.9 t -81.28 -12.49 59.06 Favored 'General case' 0 C--N 1.355 0.835 0 O-C-N 121.046 -1.267 . . . . 0.0 109.592 -172.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -51.79 -55.21 21.16 Favored 'General case' 0 C--N 1.352 0.694 0 C-N-CA 124.584 1.154 . . . . 0.0 109.793 166.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.74 -44.98 96.01 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 123.965 0.906 . . . . 0.0 112.131 175.09 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.52 -39.02 93.01 Favored 'General case' 0 C--N 1.361 1.073 0 CA-C-N 118.977 0.808 . . . . 0.0 111.232 -177.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.6 t -68.05 -42.74 80.06 Favored 'General case' 0 N--CA 1.439 -0.987 0 O-C-N 121.301 -0.874 . . . . 0.0 109.51 -178.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -77.89 -26.41 49.13 Favored 'General case' 0 CA--C 1.505 -0.77 0 O-C-N 121.007 -1.058 . . . . 0.0 111.963 -174.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -76.66 -21.55 55.28 Favored 'General case' 0 C--N 1.355 0.815 0 O-C-N 121.243 -0.911 . . . . 0.0 110.988 179.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -79.93 -48.82 12.8 Favored 'General case' 0 CA--C 1.494 -1.174 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 168.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 120.83 48.36 0.3 Allowed Glycine 0 CA--C 1.489 -1.576 0 N-CA-C 108.214 -1.954 . . . . 0.0 108.214 177.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.07 139.29 14.73 Favored Glycine 0 N--CA 1.433 -1.531 0 N-CA-C 103.689 -3.764 . . . . 0.0 103.689 164.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -98.6 2.87 47.77 Favored 'General case' 0 N--CA 1.438 -1.05 0 C-N-CA 124.258 1.023 . . . . 0.0 109.607 -169.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 24.1 m -160.42 159.25 30.76 Favored 'General case' 0 CA--C 1.474 -1.954 0 N-CA-C 100.529 -3.878 . . . . 0.0 100.529 165.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -165.82 169.79 40.31 Favored Glycine 0 N--CA 1.418 -2.555 1 N-CA-C 101.407 -4.677 . . . . 0.0 101.407 -179.146 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 78.7 m-70 -161.4 -170.16 2.54 Favored 'General case' 0 CA--C 1.491 -1.295 1 N-CA-C 98.558 -4.608 . . . . 0.0 98.558 -174.098 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 73.1 m -145.87 162.57 37.42 Favored 'General case' 0 CA--C 1.485 -1.553 1 N-CA-C 98.852 -4.499 . . . . 0.0 98.852 172.17 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 173.29 179.97 44.31 Favored Glycine 0 N--CA 1.425 -2.049 1 N-CA-C 100.072 -5.211 . . . . 0.0 100.072 -177.099 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -151.1 141.91 22.84 Favored 'General case' 0 N--CA 1.426 -1.674 1 N-CA-C 96.407 -5.405 . . . . 0.0 96.407 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.9 mttp -157.74 58.22 0.49 Allowed 'General case' 0 CA--C 1.488 -1.434 1 N-CA-C 98.303 -4.703 . . . . 0.0 98.303 173.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.522 HG13 ' H ' ' A' ' 42' ' ' GLY 0.272 2.9 t 69.77 -172.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 C-N-CA 127.054 2.142 . . . . 0.0 105.543 -158.264 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.522 ' H ' HG13 ' A' ' 41' ' ' VAL . . . 145.04 -127.96 3.03 Favored Glycine 0 N--CA 1.421 -2.338 1 N-CA-C 97.716 -6.153 . . . . 0.0 97.716 -173.031 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 59.3 m170 -130.37 -39.16 1.33 Allowed 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 104.515 -2.402 . . . . 0.0 104.515 175.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -158.09 -177.0 30.78 Favored Glycine 0 N--CA 1.425 -2.051 1 N-CA-C 95.798 -6.921 . . . . 0.0 95.798 176.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.2 tt -72.25 114.94 10.91 Favored 'General case' 0 C--N 1.351 0.666 0 CA-C-N 118.693 1.247 . . . . 0.0 108.177 -171.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -105.85 -177.81 3.47 Favored 'General case' 0 CA--C 1.485 -1.529 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 -164.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 34.6 t -115.0 161.56 18.17 Favored 'General case' 0 CA--C 1.493 -1.236 0 N-CA-C 102.432 -3.173 . . . . 0.0 102.432 -175.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 33.0 t-105 -117.57 151.75 36.52 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 102.878 -3.008 . . . . 0.0 102.878 178.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 15.0 m -148.21 149.79 32.58 Favored 'General case' 0 CA--C 1.495 -1.157 0 N-CA-C 103.428 -2.805 . . . . 0.0 103.428 171.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -111.3 141.99 44.11 Favored 'General case' 0 CA--C 1.495 -1.15 0 N-CA-C 104.212 -2.514 . . . . 0.0 104.212 171.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 66.01 53.28 1.11 Allowed 'General case' 0 CA--C 1.491 -1.298 0 C-N-CA 127.488 2.315 . . . . 0.0 111.164 167.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 40.0 mt -94.81 142.93 25.35 Favored Pre-proline 0 CA--C 1.495 -1.147 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 177.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -72.01 166.74 28.7 Favored 'Trans proline' 0 N--CA 1.447 -1.258 0 C-N-CA 122.61 2.206 . . . . 0.0 110.134 175.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -68.99 -17.07 63.88 Favored 'General case' 0 CA--C 1.506 -0.728 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -167.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -76.48 -6.82 53.45 Favored 'General case' 0 CA--C 1.504 -0.81 0 O-C-N 121.439 -0.788 . . . . 0.0 110.942 -178.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.3 t -94.09 107.96 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 N-CA-C 104.474 -2.417 . . . . 0.0 104.474 178.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -81.63 148.39 27.6 Favored Glycine 0 CA--C 1.489 -1.549 0 N-CA-C 106.393 -2.683 . . . . 0.0 106.393 178.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 41.0 pt -133.66 -160.05 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.303 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 -165.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -73.7 121.15 24.07 Favored 'Isoleucine or valine' 0 C--N 1.362 1.146 0 N-CA-C 104.829 -2.286 . . . . 0.0 104.829 176.042 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.4 t -133.06 34.35 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 N-CA-C 101.899 -3.371 . . . . 0.0 101.899 -162.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -72.16 94.28 1.52 Allowed 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 112.782 -2.008 . . . . 0.0 112.875 -169.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -143.42 31.68 1.91 Allowed Glycine 0 N--CA 1.437 -1.234 1 N-CA-C 101.8 -4.52 . . . . 0.0 101.8 155.116 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 178.48 -178.86 0.29 Allowed 'General case' 0 N--CA 1.432 -1.33 1 N-CA-C 95.093 -5.891 . . . . 0.0 95.093 -170.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 54.5 tttt -127.09 -154.64 0.64 Allowed 'General case' 0 CA--C 1.502 -0.881 0 N-CA-C 105.013 -2.217 . . . . 0.0 105.013 177.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 16.1 t -81.69 152.52 27.03 Favored 'General case' 0 CA--C 1.496 -1.129 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 -169.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 28.0 p-80 -131.05 169.14 16.27 Favored 'General case' 0 CA--C 1.487 -1.451 0 N-CA-C 100.822 -3.77 . . . . 0.0 100.822 174.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.6 m -171.29 174.06 4.68 Favored 'General case' 0 N--CA 1.424 -1.767 1 N-CA-C 96.096 -5.52 . . . . 0.0 96.096 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.357 0.921 0 O-C-N 124.301 1.0 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 33.5 m . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 121.354 0.597 . . . . 0.0 109.629 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -94.24 148.46 22.17 Favored 'General case' 0 CA--C 1.502 -0.879 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 173.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -122.37 118.19 27.84 Favored 'General case' 0 CA--C 1.489 -1.399 1 N-CA-C 94.394 -6.15 . . . . 0.0 94.394 154.23 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.61 -174.13 31.1 Favored Glycine 0 CA--C 1.479 -2.214 0 N-CA-C 106.196 -2.762 . . . . 0.0 106.196 -171.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -86.22 134.96 33.74 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 104.872 -2.27 . . . . 0.0 104.872 167.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 16.9 tt -90.63 151.23 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 176.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -156.3 -177.81 6.86 Favored 'General case' 0 N--CA 1.416 -2.144 1 N-CA-C 98.949 -4.463 . . . . 0.0 98.949 -177.142 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -93.53 156.91 39.31 Favored Pre-proline 0 N--CA 1.435 -1.186 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 178.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -77.36 -1.96 12.14 Favored 'Trans proline' 0 CA--C 1.509 -0.745 0 CA-C-N 121.283 1.494 . . . . 0.0 115.254 -155.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -95.13 13.41 25.39 Favored 'General case' 0 C--N 1.358 0.96 0 CA-C-N 121.214 1.825 . . . . 0.0 107.498 176.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 43.4 t30 83.23 43.44 0.02 OUTLIER 'General case' 0 C--N 1.361 1.102 0 C-N-CA 126.081 1.752 . . . . 0.0 107.494 168.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -131.36 132.18 44.25 Favored 'General case' 0 CA--C 1.487 -1.462 0 N-CA-C 102.374 -3.195 . . . . 0.0 102.374 -173.148 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . 0.253 1.7 m -60.57 159.25 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 CA-C-O 123.435 1.588 . . . . 0.0 115.228 -173.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -114.73 139.97 49.26 Favored 'General case' 0 N--CA 1.416 -2.157 1 N-CA-C 92.687 -6.783 . . . . 0.0 92.687 169.554 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 66.1 m170 -90.42 -162.28 0.88 Allowed 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 178.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 25.4 t -150.06 171.62 16.57 Favored 'General case' 0 N--CA 1.417 -2.121 1 N-CA-C 97.52 -4.993 . . . . 0.0 97.52 -172.244 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -127.28 123.68 23.42 Favored Pre-proline 0 N--CA 1.419 -2.018 1 N-CA-C 95.925 -5.583 . . . . 0.0 95.925 -178.125 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -55.88 96.6 0.06 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.604 0 CA-C-N 124.224 2.544 . . . . 0.0 116.691 -168.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 159.92 -159.36 30.61 Favored Glycine 0 N--CA 1.422 -2.267 1 N-CA-C 98.07 -6.012 . . . . 0.0 98.07 -178.166 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.8 p -94.25 -43.67 8.33 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 170.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -39.74 -61.95 0.77 Allowed 'General case' 0 N--CA 1.442 -0.875 0 C-N-CA 128.812 2.845 . . . . 0.0 118.243 -150.287 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -72.09 -39.5 58.28 Favored Glycine 0 C--N 1.348 1.227 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -173.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 9.6 t -83.65 -28.45 28.39 Favored 'General case' 0 CA--C 1.5 -0.962 0 O-C-N 121.277 -1.131 . . . . 0.0 109.329 -177.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -60.81 -46.52 90.2 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-N 119.353 0.979 . . . . 0.0 109.679 175.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.9 p -67.06 -39.15 86.83 Favored 'General case' 0 N--CA 1.44 -0.941 0 O-C-N 121.894 -0.504 . . . . 0.0 111.721 179.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 40.7 mt -63.22 -47.61 81.77 Favored 'General case' 0 C--N 1.357 0.899 0 O-C-N 121.032 -1.043 . . . . 0.0 111.127 172.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 3.0 t -66.01 -32.33 73.75 Favored 'General case' 0 CA--C 1.501 -0.911 0 O-C-N 120.155 -1.59 . . . . 0.0 110.827 -175.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -65.41 -35.26 80.41 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 122.943 0.497 . . . . 0.0 111.488 176.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -75.93 -34.18 59.87 Favored 'General case' 0 C--N 1.359 0.999 0 O-C-N 121.559 -0.713 . . . . 0.0 111.108 177.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.2 mmmp? -72.15 -40.23 68.17 Favored 'General case' 0 C--N 1.36 1.026 0 C-N-CA 123.535 0.734 . . . . 0.0 110.519 178.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 128.41 43.57 0.23 Allowed Glycine 0 CA--C 1.492 -1.368 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 162.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -111.12 145.32 17.55 Favored Glycine 0 CA--C 1.491 -1.415 0 N-CA-C 105.512 -3.035 . . . . 0.0 105.512 169.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.4 p -92.23 4.61 52.89 Favored 'General case' 0 C--N 1.352 0.676 0 CA-C-N 118.053 0.926 . . . . 0.0 110.154 -171.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 57.4 m -157.13 156.66 33.09 Favored 'General case' 0 CA--C 1.483 -1.603 0 N-CA-C 100.981 -3.711 . . . . 0.0 100.981 168.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -152.98 141.17 8.16 Favored Glycine 0 N--CA 1.422 -2.278 1 N-CA-C 97.782 -6.127 . . . . 0.0 97.782 -178.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 15.1 t-80 -159.94 175.6 12.84 Favored 'General case' 0 N--CA 1.429 -1.495 1 N-CA-C 99.692 -4.188 . . . . 0.0 99.692 -169.263 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 63.2 m -95.22 -174.93 3.36 Favored 'General case' 0 CA--C 1.491 -1.296 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 176.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 177.13 -166.56 37.25 Favored Glycine 0 N--CA 1.417 -2.604 1 N-CA-C 96.196 -6.762 . . . . 0.0 96.196 179.282 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -144.51 138.82 27.84 Favored 'General case' 0 N--CA 1.43 -1.437 1 N-CA-C 96.098 -5.519 . . . . 0.0 96.098 173.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 26.2 tptp -120.69 100.14 6.94 Favored 'General case' 0 CA--C 1.487 -1.471 0 N-CA-C 102.358 -3.201 . . . . 0.0 102.358 -179.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.5 t -68.45 134.1 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 -175.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 115.67 -36.83 3.69 Favored Glycine 0 CA--C 1.492 -1.387 0 N-CA-C 105.951 -2.86 . . . . 0.0 105.951 -171.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 57.9 m-70 -106.19 -66.85 0.97 Allowed 'General case' 0 CA--C 1.494 -1.177 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 174.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 150.1 -143.26 10.51 Favored Glycine 0 CA--C 1.481 -2.054 0 N-CA-C 103.826 -3.71 . . . . 0.0 103.826 -174.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.9 tp -65.58 135.98 55.78 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 105.124 -2.176 . . . . 0.0 105.124 172.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -155.04 172.6 17.85 Favored 'General case' 0 CA--C 1.475 -1.917 1 N-CA-C 97.98 -4.822 . . . . 0.0 97.98 -168.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 9.1 t -118.34 159.78 22.8 Favored 'General case' 0 CA--C 1.487 -1.444 0 N-CA-C 103.089 -2.93 . . . . 0.0 103.089 -173.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 19.0 t-105 -118.83 146.18 45.06 Favored 'General case' 0 CA--C 1.496 -1.116 0 N-CA-C 103.288 -2.856 . . . . 0.0 103.288 -176.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 79.5 m -146.26 157.78 43.83 Favored 'General case' 0 CA--C 1.487 -1.457 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 173.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -118.06 138.88 51.93 Favored 'General case' 0 CA--C 1.495 -1.15 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 176.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 64.62 61.89 0.81 Allowed 'General case' 0 CA--C 1.494 -1.191 0 C-N-CA 128.102 2.561 . . . . 0.0 111.646 173.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 28.6 mt -96.04 133.45 25.2 Favored Pre-proline 0 CA--C 1.502 -0.882 0 N-CA-C 104.015 -2.587 . . . . 0.0 104.015 172.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -75.32 173.97 13.6 Favored 'Trans proline' 0 N--CA 1.447 -1.247 0 CA-C-N 122.057 1.771 . . . . 0.0 109.768 -178.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -74.3 -5.53 42.69 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -169.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -90.61 -0.93 57.86 Favored 'General case' 0 CA--C 1.502 -0.872 0 O-C-N 121.239 -0.913 . . . . 0.0 110.015 -178.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.5 t -97.88 152.01 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 N-CA-C 102.677 -3.083 . . . . 0.0 102.677 178.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -123.01 153.28 16.96 Favored Glycine 0 CA--C 1.481 -2.045 1 N-CA-C 98.767 -5.733 . . . . 0.0 98.767 177.153 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 19.5 pt -152.82 -154.63 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 N-CA-C 101.258 -3.608 . . . . 0.0 101.258 -163.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.5 mp -73.76 119.28 20.61 Favored 'Isoleucine or valine' 0 C--N 1.362 1.11 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 169.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -149.77 -175.42 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.537 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 -157.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 75.92 -56.54 0.59 Allowed 'General case' 0 CA--C 1.503 -0.852 0 C-N-CA 127.437 2.295 . . . . 0.0 112.702 167.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 108.87 -10.56 34.66 Favored Glycine 0 CA--C 1.492 -1.35 0 N-CA-C 107.309 -2.316 . . . . 0.0 107.309 -175.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -105.36 -165.32 1.11 Allowed 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 103.634 -2.728 . . . . 0.0 103.634 168.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 31.2 tttp -109.97 -149.9 0.45 Allowed 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 -170.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 29.5 t -81.26 153.73 26.97 Favored 'General case' 0 CA--C 1.496 -1.13 0 C-N-CA 124.951 1.301 . . . . 0.0 108.795 -168.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -138.41 179.81 6.24 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 101.961 -3.348 . . . . 0.0 101.961 176.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.4 m -171.99 172.71 4.63 Favored 'General case' 0 N--CA 1.425 -1.72 1 N-CA-C 95.8 -5.63 . . . . 0.0 95.8 179.034 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.358 0.969 0 O-C-N 124.202 0.939 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 27.3 m . . . . . 0 N--CA 1.485 1.29 0 CA-C-O 121.413 0.625 . . . . 0.0 110.646 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -99.25 155.62 17.4 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 105.318 -2.105 . . . . 0.0 105.318 166.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -122.16 126.32 48.06 Favored 'General case' 0 CA--C 1.486 -1.488 1 N-CA-C 94.331 -6.174 . . . . 0.0 94.331 153.19 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.55 179.91 36.65 Favored Glycine 0 CA--C 1.475 -2.466 0 N-CA-C 104.345 -3.502 . . . . 0.0 104.345 -174.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -79.89 134.05 36.28 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 104.461 -2.422 . . . . 0.0 104.461 168.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 16.4 tt -90.36 149.4 4.06 Favored 'Isoleucine or valine' 0 C--N 1.355 0.808 0 N-CA-C 105.62 -1.992 . . . . 0.0 105.62 -178.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -139.96 -173.07 3.54 Favored 'General case' 0 N--CA 1.417 -2.113 0 C-N-CA 126.255 1.822 . . . . 0.0 106.898 -170.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -95.18 148.33 34.48 Favored Pre-proline 0 N--CA 1.432 -1.36 0 N-CA-C 102.085 -3.302 . . . . 0.0 102.085 163.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_exo -69.62 -26.86 27.8 Favored 'Trans proline' 0 CA--C 1.501 -1.144 0 CA-C-N 123.034 2.119 . . . . 0.0 115.52 -153.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -88.76 53.78 2.81 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-N 119.224 0.92 . . . . 0.0 110.483 -167.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 75.32 41.34 0.29 Allowed 'General case' 0 C--N 1.354 0.786 0 C-N-CA 125.793 1.637 . . . . 0.0 110.121 167.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 55.6 m -117.05 -154.86 0.57 Allowed 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -168.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.6 m -133.01 175.57 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.4 1 N-CA-C 98.433 -4.655 . . . . 0.0 98.433 166.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . 0.31 0.2 OUTLIER -119.62 141.14 49.57 Favored 'General case' 0 CA--C 1.477 -1.861 1 N-CA-C 92.684 -6.784 . . . . 0.0 92.684 170.045 . . . . . . . . 4 3 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.409 ' CD2' ' HB3' ' A' ' 45' ' ' LEU . 21.5 m80 -90.46 145.66 24.74 Favored 'General case' 0 CA--C 1.491 -1.306 0 N-CA-C 103.558 -2.756 . . . . 0.0 103.558 174.135 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.7 t -90.48 167.71 12.39 Favored 'General case' 0 CA--C 1.483 -1.606 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 -176.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -114.38 113.44 45.75 Favored Pre-proline 0 N--CA 1.42 -1.952 1 N-CA-C 98.424 -4.658 . . . . 0.0 98.424 168.427 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -57.59 129.59 34.53 Favored 'Trans proline' 0 CA--C 1.507 -0.87 0 CA-C-N 123.154 2.162 . . . . 0.0 111.351 178.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 126.61 -56.98 0.71 Allowed Glycine 0 CA--C 1.49 -1.5 1 N-CA-C 101.853 -4.499 . . . . 0.0 101.853 -157.62 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.5 m 107.3 -6.1 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.321 0 C-N-CA 129.25 3.02 . . . . 0.0 110.932 174.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.1 m -42.42 -55.36 3.45 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 127.625 2.37 . . . . 0.0 115.275 -166.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -72.26 -45.86 37.2 Favored Glycine 0 C--N 1.351 1.378 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 -176.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.9 m -72.89 -32.59 65.48 Favored 'General case' 0 CA--C 1.492 -1.269 0 O-C-N 121.474 -1.015 . . . . 0.0 112.003 -174.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -65.78 -38.32 88.7 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 174.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 32.2 m -65.29 -43.35 91.42 Favored 'General case' 0 C--N 1.35 0.603 0 O-C-N 120.733 -1.23 . . . . 0.0 110.144 176.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 33.9 mt -63.69 -40.39 96.69 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-O 122.17 0.986 . . . . 0.0 110.474 178.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.4 t -57.14 -43.8 82.77 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 124.6 1.16 . . . . 0.0 110.79 175.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -64.03 -43.61 95.05 Favored 'General case' 0 C--N 1.355 0.84 0 CA-C-N 118.494 0.588 . . . . 0.0 111.633 -178.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -79.04 -30.63 44.23 Favored 'General case' 0 CA--C 1.507 -0.674 0 O-C-N 122.039 -0.413 . . . . 0.0 111.27 -172.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -83.77 -22.11 31.99 Favored 'General case' 0 C--N 1.355 0.843 0 O-C-N 121.774 -0.579 . . . . 0.0 109.847 177.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 108.65 48.27 0.86 Allowed Glycine 0 CA--C 1.491 -1.439 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 159.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.23 154.27 16.9 Favored Glycine 0 C--N 1.35 1.326 0 N-CA-C 106.582 -2.607 . . . . 0.0 106.582 170.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 39.3 p -90.81 -20.53 22.23 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-O 122.341 1.067 . . . . 0.0 109.927 -165.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.9 m -160.22 159.75 31.9 Favored 'General case' 0 N--CA 1.423 -1.818 1 N-CA-C 98.122 -4.77 . . . . 0.0 98.122 179.237 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -178.6 172.52 44.87 Favored Glycine 0 CA--C 1.467 -2.944 1 N-CA-C 100.039 -5.224 . . . . 0.0 100.039 -179.347 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 177.95 -160.07 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 100.262 -3.977 . . . . 0.0 100.262 -174.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 61.6 m -76.77 177.49 7.56 Favored 'General case' 0 CA--C 1.504 -0.821 0 CA-C-O 121.898 0.856 . . . . 0.0 110.704 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -164.05 -179.11 38.1 Favored Glycine 0 N--CA 1.42 -2.426 1 N-CA-C 98.663 -5.775 . . . . 0.0 98.663 178.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -143.7 159.99 41.5 Favored 'General case' 0 N--CA 1.422 -1.833 1 N-CA-C 97.623 -4.955 . . . . 0.0 97.623 -177.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.1 mmmm -148.95 167.08 26.72 Favored 'General case' 0 N--CA 1.421 -1.886 1 N-CA-C 95.995 -5.557 . . . . 0.0 95.995 169.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -133.43 156.77 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.685 1 N-CA-C 94.391 -6.151 . . . . 0.0 94.391 173.228 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.89 -60.53 0.73 Allowed Glycine 0 CA--C 1.492 -1.394 0 N-CA-C 104.771 -3.331 . . . . 0.0 104.771 -170.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 23.4 m170 -90.24 -90.61 0.15 Allowed 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 166.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 163.86 -156.61 28.54 Favored Glycine 0 CA--C 1.479 -2.194 1 N-CA-C 99.399 -5.48 . . . . 0.0 99.399 179.033 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.409 ' HB3' ' CD2' ' A' ' 15' ' ' HIS . 54.0 tp -43.52 126.73 4.53 Favored 'General case' 0 C--N 1.352 0.712 0 C-N-CA 128.001 2.521 . . . . 0.0 111.646 -179.49 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -127.67 -171.19 2.38 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 105.416 -2.068 . . . . 0.0 105.416 -168.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 63.7 m -131.23 176.21 8.47 Favored 'General case' 0 CA--C 1.482 -1.641 0 N-CA-C 102.746 -3.057 . . . . 0.0 102.746 171.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 12.5 t-105 -137.58 154.03 49.85 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 -177.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 22.6 m -145.59 152.84 40.34 Favored 'General case' 0 CA--C 1.493 -1.25 0 N-CA-C 104.269 -2.493 . . . . 0.0 104.269 171.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -109.53 143.54 39.05 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 104.31 -2.478 . . . . 0.0 104.31 168.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 55.9 62.48 2.37 Favored 'General case' 0 CA--C 1.499 -1.017 0 C-N-CA 127.871 2.469 . . . . 0.0 113.128 173.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 33.5 mt -95.61 134.74 23.77 Favored Pre-proline 0 CA--C 1.498 -1.021 0 N-CA-C 103.614 -2.735 . . . . 0.0 103.614 171.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -71.53 176.54 7.93 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 CA-C-N 122.375 1.884 . . . . 0.0 111.72 178.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -75.02 -8.76 57.45 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 113.65 0.982 . . . . 0.0 113.65 -167.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.8 p-10 -85.99 -8.24 58.1 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 121.605 -0.684 . . . . 0.0 110.069 -179.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.0 t -92.9 127.78 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 -175.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -97.32 140.69 15.19 Favored Glycine 0 CA--C 1.484 -1.898 0 N-CA-C 104.424 -3.47 . . . . 0.0 104.424 177.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 24.4 pt -139.09 -151.8 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 N-CA-C 104.157 -2.535 . . . . 0.0 104.157 -165.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.8 mp -66.41 118.77 10.27 Favored 'Isoleucine or valine' 0 C--N 1.364 1.209 0 N-CA-C 103.501 -2.778 . . . . 0.0 103.501 168.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.4 t -137.86 148.63 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.843 1 N-CA-C 96.95 -5.204 . . . . 0.0 96.95 -168.285 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 60.37 -64.42 0.06 Allowed 'General case' 0 CA--C 1.504 -0.791 0 C-N-CA 130.169 3.388 . . . . 0.0 115.321 173.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.77 58.88 1.56 Allowed Glycine 0 N--CA 1.437 -1.239 0 N-CA-C 104.924 -3.27 . . . . 0.0 104.924 -160.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -102.82 -90.09 0.37 Allowed 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 103.575 -2.75 . . . . 0.0 103.575 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 53.2 tptt -173.76 160.97 3.77 Favored 'General case' 0 N--CA 1.423 -1.801 1 N-CA-C 96.996 -5.187 . . . . 0.0 96.996 176.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 41.4 t -83.21 135.61 34.72 Favored 'General case' 0 CA--C 1.5 -0.955 0 N-CA-C 103.501 -2.777 . . . . 0.0 103.501 178.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 46.6 p-80 -149.59 159.82 44.0 Favored 'General case' 0 CA--C 1.484 -1.59 0 N-CA-C 102.812 -3.033 . . . . 0.0 102.812 -170.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.0 m -80.4 56.72 2.62 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 118.665 0.666 . . . . 0.0 111.258 -177.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.361 1.079 0 CA-C-N 116.223 -0.444 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 27.4 m . . . . . 0 N--CA 1.484 1.265 0 CA-C-O 121.174 0.512 . . . . 0.0 110.26 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -105.03 160.34 15.12 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 106.109 -1.811 . . . . 0.0 106.109 168.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -127.69 126.62 42.24 Favored 'General case' 0 CA--C 1.49 -1.357 1 N-CA-C 96.636 -5.32 . . . . 0.0 96.636 158.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.04 -170.83 27.35 Favored Glycine 0 CA--C 1.477 -2.328 1 N-CA-C 102.084 -4.407 . . . . 0.0 102.084 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -81.08 141.68 34.07 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 103.611 -2.737 . . . . 0.0 103.611 164.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 11.5 tt -90.4 142.14 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 N-CA-C 104.903 -2.258 . . . . 0.0 104.903 175.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -130.52 175.65 8.81 Favored 'General case' 0 N--CA 1.414 -2.233 0 N-CA-C 103.919 -2.622 . . . . 0.0 103.919 -175.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -79.6 154.21 76.11 Favored Pre-proline 0 N--CA 1.432 -1.34 0 N-CA-C 105.032 -2.21 . . . . 0.0 105.032 166.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -68.96 0.34 5.18 Favored 'Trans proline' 0 CA--C 1.511 -0.627 0 C-N-CA 121.94 1.76 . . . . 0.0 116.609 -168.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -102.28 9.56 39.85 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 119.773 1.169 . . . . 0.0 108.525 -175.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 66.3 t30 73.34 57.54 0.11 Allowed 'General case' 0 CA--C 1.497 -1.096 0 C-N-CA 126.278 1.831 . . . . 0.0 107.951 -177.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 30.5 m -142.01 135.71 29.55 Favored 'General case' 0 CA--C 1.485 -1.541 1 N-CA-C 99.01 -4.441 . . . . 0.0 99.01 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.7 m -60.95 148.47 9.07 Favored 'Isoleucine or valine' 0 C--N 1.354 0.764 0 CA-C-N 120.463 1.483 . . . . 0.0 112.35 -172.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -98.02 132.09 43.88 Favored 'General case' 0 CA--C 1.483 -1.623 1 N-CA-C 97.97 -4.826 . . . . 0.0 97.97 177.211 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 66.9 m80 -90.38 -175.58 4.52 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 -166.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 5.7 t -147.03 157.55 43.65 Favored 'General case' 0 N--CA 1.413 -2.305 1 N-CA-C 96.392 -5.41 . . . . 0.0 96.392 -175.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -117.34 110.92 40.51 Favored Pre-proline 0 N--CA 1.419 -2.008 1 N-CA-C 96.906 -5.22 . . . . 0.0 96.906 172.405 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_exo -60.1 114.57 2.15 Favored 'Trans proline' 0 CA--C 1.506 -0.899 0 CA-C-N 123.324 2.223 . . . . 0.0 113.811 -162.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 154.45 -42.98 0.59 Allowed Glycine 0 N--CA 1.432 -1.568 1 N-CA-C 100.584 -5.006 . . . . 0.0 100.584 -163.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.6 m 95.84 21.84 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.31 0 C-N-CA 127.329 2.251 . . . . 0.0 111.071 167.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 p -68.13 -52.29 36.47 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 125.493 1.517 . . . . 0.0 110.302 -174.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.62 -38.39 90.17 Favored Glycine 0 C--N 1.347 1.192 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 178.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 41.9 t -66.15 -48.33 71.13 Favored 'General case' 0 CA--C 1.502 -0.872 0 C-N-CA 124.283 1.033 . . . . 0.0 110.013 -177.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -53.34 -49.91 66.11 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 125.539 1.536 . . . . 0.0 109.925 175.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.4 m -60.51 -53.09 61.75 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 124.105 0.962 . . . . 0.0 111.299 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 37.4 mt -65.47 -44.45 87.13 Favored 'General case' 0 CA--C 1.492 -1.257 0 C-N-CA 125.068 1.347 . . . . 0.0 110.234 -175.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.8 t -62.56 -44.97 95.0 Favored 'General case' 0 N--CA 1.435 -1.189 0 C-N-CA 123.021 0.528 . . . . 0.0 109.788 179.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -69.25 -41.94 76.27 Favored 'General case' 0 CA--C 1.503 -0.856 0 O-C-N 122.247 -0.283 . . . . 0.0 110.402 -174.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -74.73 -27.36 60.33 Favored 'General case' 0 CA--C 1.505 -0.777 0 O-C-N 121.715 -0.616 . . . . 0.0 111.621 -176.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.36 -23.53 27.97 Favored 'General case' 0 C--N 1.358 0.966 0 CA-C-O 121.571 0.7 . . . . 0.0 109.331 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.08 43.05 1.23 Allowed Glycine 0 CA--C 1.484 -1.859 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 162.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -98.91 152.09 19.61 Favored Glycine 0 CA--C 1.491 -1.461 0 N-CA-C 104.278 -3.529 . . . . 0.0 104.278 165.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 23.5 p -87.77 -44.53 11.06 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -168.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 18.3 m -129.06 157.23 42.32 Favored 'General case' 0 CA--C 1.485 -1.547 0 N-CA-C 102.14 -3.282 . . . . 0.0 102.14 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -161.26 160.19 31.9 Favored Glycine 0 N--CA 1.416 -2.683 1 N-CA-C 98.473 -5.851 . . . . 0.0 98.473 178.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 9.0 p-80 -164.21 176.53 9.12 Favored 'General case' 0 N--CA 1.427 -1.594 1 N-CA-C 96.719 -5.289 . . . . 0.0 96.719 -178.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 70.3 m -110.58 165.76 11.55 Favored 'General case' 0 CA--C 1.481 -1.69 0 CA-C-N 119.566 1.075 . . . . 0.0 108.256 -173.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -175.6 -169.05 36.83 Favored Glycine 0 N--CA 1.424 -2.154 1 N-CA-C 100.649 -4.981 . . . . 0.0 100.649 -179.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -130.32 138.88 50.67 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 101.605 -3.48 . . . . 0.0 101.605 -172.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -108.1 111.89 24.16 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 102.855 -3.017 . . . . 0.0 102.855 174.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.8 t -80.81 120.66 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 -175.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 119.93 -7.12 12.03 Favored Glycine 0 CA--C 1.494 -1.267 0 N-CA-C 106.838 -2.505 . . . . 0.0 106.838 -166.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.442 ' HE1' ' O ' ' A' ' 64' ' ' LYS . 44.8 m-70 -139.69 -79.56 0.31 Allowed 'General case' 0 CA--C 1.497 -1.067 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 167.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 170.4 -161.52 34.55 Favored Glycine 0 N--CA 1.426 -2.023 0 N-CA-C 104.188 -3.565 . . . . 0.0 104.188 -166.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 30.8 tp -65.57 133.44 51.19 Favored 'General case' 0 CA--C 1.505 -0.77 0 C-N-CA 127.197 2.199 . . . . 0.0 107.275 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.25 -176.41 4.25 Favored 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 -166.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.2 t -125.13 151.16 46.13 Favored 'General case' 0 CA--C 1.491 -1.323 1 N-CA-C 98.631 -4.581 . . . . 0.0 98.631 175.226 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 38.0 t-105 -107.15 152.8 23.58 Favored 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 103.941 -2.614 . . . . 0.0 103.941 179.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 22.9 m -143.77 150.57 38.78 Favored 'General case' 0 CA--C 1.483 -1.621 0 N-CA-C 104.307 -2.479 . . . . 0.0 104.307 170.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -116.09 140.44 49.28 Favored 'General case' 0 CA--C 1.492 -1.277 0 N-CA-C 102.464 -3.161 . . . . 0.0 102.464 171.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 67.21 56.67 0.62 Allowed 'General case' 0 CA--C 1.496 -1.112 0 C-N-CA 127.103 2.161 . . . . 0.0 111.601 172.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 25.1 mt -93.96 134.04 26.7 Favored Pre-proline 0 CA--C 1.496 -1.12 0 N-CA-C 104.411 -2.44 . . . . 0.0 104.411 174.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -75.06 173.61 14.22 Favored 'Trans proline' 0 N--CA 1.445 -1.327 0 C-N-CA 122.236 1.958 . . . . 0.0 110.236 178.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -64.75 -13.21 54.22 Favored 'General case' 0 CA--C 1.506 -0.744 0 C-N-CA 125.795 1.638 . . . . 0.0 114.477 -173.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -89.88 8.76 30.48 Favored 'General case' 0 CA--C 1.504 -0.807 0 O-C-N 121.503 -0.748 . . . . 0.0 110.247 -176.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.7 t -110.54 141.93 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.339 0 N-CA-C 102.552 -3.129 . . . . 0.0 102.552 177.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -115.79 148.14 18.91 Favored Glycine 0 CA--C 1.479 -2.21 1 N-CA-C 100.3 -5.12 . . . . 0.0 100.3 175.176 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 24.2 pt -147.28 -151.22 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.426 -1.635 0 N-CA-C 102.34 -3.207 . . . . 0.0 102.34 -163.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 7.5 mm -71.65 122.55 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 178.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -142.77 171.41 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.404 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 -163.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 71.67 -57.86 0.6 Allowed 'General case' 0 C--N 1.362 1.115 0 C-N-CA 126.925 2.09 . . . . 0.0 113.161 169.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 155.18 -69.03 0.29 Allowed Glycine 0 N--CA 1.424 -2.142 1 N-CA-C 100.416 -5.074 . . . . 0.0 100.416 -170.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 73.6 tt0 -166.79 153.35 8.64 Favored 'General case' 0 N--CA 1.423 -1.814 1 N-CA-C 97.286 -5.079 . . . . 0.0 97.286 179.559 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.442 ' O ' ' HE1' ' A' ' 43' ' ' HIS . 18.6 ttmm -179.71 -173.06 0.23 Allowed 'General case' 0 N--CA 1.429 -1.514 1 N-CA-C 95.031 -5.915 . . . . 0.0 95.031 167.07 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 34.9 t -166.0 156.78 13.14 Favored 'General case' 0 N--CA 1.429 -1.484 1 N-CA-C 95.298 -5.816 . . . . 0.0 95.298 160.273 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 29.7 p-80 -162.13 -173.51 3.68 Favored 'General case' 0 CA--C 1.486 -1.509 0 N-CA-C 100.418 -3.919 . . . . 0.0 100.418 173.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 39.0 m -172.72 173.77 3.82 Favored 'General case' 0 N--CA 1.424 -1.727 1 N-CA-C 95.921 -5.585 . . . . 0.0 95.921 179.372 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.358 0.96 0 O-C-N 124.018 0.824 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.2 m . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 121.164 0.507 . . . . 0.0 110.411 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -109.94 159.26 17.41 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 175.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -126.99 127.13 44.33 Favored 'General case' 0 CA--C 1.488 -1.41 1 N-CA-C 95.21 -5.848 . . . . 0.0 95.21 158.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.82 -169.14 24.73 Favored Glycine 0 CA--C 1.474 -2.53 1 N-CA-C 102.372 -4.291 . . . . 0.0 102.372 -179.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -83.71 143.85 29.76 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 103.859 -2.645 . . . . 0.0 103.859 161.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.0 tt -90.79 141.49 14.33 Favored 'Isoleucine or valine' 0 C--O 1.25 1.102 0 N-CA-C 105.939 -1.875 . . . . 0.0 105.939 174.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -140.18 174.41 10.54 Favored 'General case' 0 N--CA 1.42 -1.966 1 N-CA-C 99.915 -4.106 . . . . 0.0 99.915 175.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -85.2 160.25 55.02 Favored Pre-proline 0 N--CA 1.432 -1.36 0 C-N-CA 126.983 2.113 . . . . 0.0 106.014 178.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -70.23 -11.98 31.19 Favored 'Trans proline' 0 CA--C 1.505 -0.95 0 CA-C-N 121.4 1.536 . . . . 0.0 116.024 -160.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -99.58 15.02 27.98 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -178.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 63.7 t30 74.43 54.64 0.09 Allowed 'General case' 0 CA--C 1.501 -0.929 0 C-N-CA 125.706 1.603 . . . . 0.0 110.052 172.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.2 m -133.86 136.59 44.47 Favored 'General case' 0 CA--C 1.478 -1.823 1 N-CA-C 98.909 -4.478 . . . . 0.0 98.909 176.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -64.35 155.18 6.35 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.932 0 CA-C-N 120.186 1.357 . . . . 0.0 112.224 -172.16 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -104.8 128.2 52.87 Favored 'General case' 0 CA--C 1.473 -1.997 1 N-CA-C 91.416 -7.253 . . . . 0.0 91.416 177.154 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 41.1 m80 -88.5 -150.57 0.19 Allowed 'General case' 0 CA--C 1.491 -1.291 0 N-CA-C 105.41 -2.07 . . . . 0.0 105.41 -167.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 8.0 t -153.19 161.99 41.81 Favored 'General case' 0 N--CA 1.413 -2.303 1 N-CA-C 94.094 -6.262 . . . . 0.0 94.094 -176.006 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -111.73 112.82 53.34 Favored Pre-proline 0 N--CA 1.422 -1.847 1 N-CA-C 95.907 -5.59 . . . . 0.0 95.907 171.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo -60.39 101.06 0.16 Allowed 'Trans proline' 0 CA--C 1.508 -0.811 0 C-N-CA 122.457 2.105 . . . . 0.0 116.449 -157.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 169.16 -178.33 42.42 Favored Glycine 0 N--CA 1.422 -2.247 1 N-CA-C 95.893 -6.883 . . . . 0.0 95.893 178.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.3 m -69.78 -39.24 76.77 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 119.45 1.625 . . . . 0.0 109.234 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -43.87 -53.03 6.39 Favored 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 130.653 3.581 . . . . 0.0 115.607 -173.278 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.71 -39.7 66.29 Favored Glycine 0 C--N 1.353 1.473 0 O-C-N 120.998 -1.064 . . . . 0.0 111.441 -171.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 38.9 t -70.92 -47.24 60.19 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -54.91 -44.14 73.92 Favored 'General case' 0 C--N 1.354 0.769 0 C-N-CA 123.267 0.627 . . . . 0.0 110.845 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 26.6 m -59.92 -50.13 74.97 Favored 'General case' 0 C--N 1.35 0.601 0 C-N-CA 123.193 0.597 . . . . 0.0 111.509 177.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 50.3 mt -67.77 -40.43 84.03 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-O 122.437 1.113 . . . . 0.0 110.43 -176.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.0 t -62.44 -42.75 99.69 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 124.64 1.176 . . . . 0.0 109.419 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 24.0 mtpp -68.44 -42.57 78.65 Favored 'General case' 0 C--N 1.355 0.831 0 C-N-CA 123.072 0.549 . . . . 0.0 111.674 -179.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -75.07 -22.16 58.51 Favored 'General case' 0 C--N 1.354 0.782 0 O-C-N 121.455 -0.778 . . . . 0.0 111.24 -174.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.3 mmtm -79.86 -60.33 2.38 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 170.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 135.39 50.12 0.07 OUTLIER Glycine 0 CA--C 1.489 -1.577 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 171.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.5 141.95 15.57 Favored Glycine 0 CA--C 1.491 -1.442 0 N-CA-C 103.839 -3.704 . . . . 0.0 103.839 164.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.1 p -100.11 3.32 43.85 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 123.813 0.845 . . . . 0.0 110.334 -165.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.4 m -160.1 158.53 30.49 Favored 'General case' 0 CA--C 1.476 -1.894 1 N-CA-C 97.773 -4.899 . . . . 0.0 97.773 168.069 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -170.76 164.76 37.97 Favored Glycine 0 CA--C 1.469 -2.817 1 N-CA-C 99.56 -5.416 . . . . 0.0 99.56 -176.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 59.9 m80 -155.05 152.98 30.25 Favored 'General case' 0 N--CA 1.43 -1.45 1 N-CA-C 100.049 -4.056 . . . . 0.0 100.049 -175.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 44.9 t -85.1 153.76 22.49 Favored 'General case' 0 CA--C 1.505 -0.778 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 -175.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -174.55 -177.1 43.42 Favored Glycine 0 CA--C 1.482 -2.017 0 N-CA-C 105.061 -3.216 . . . . 0.0 105.061 179.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -119.98 142.61 48.62 Favored 'General case' 0 N--CA 1.431 -1.42 1 N-CA-C 99.547 -4.242 . . . . 0.0 99.547 -179.003 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 24.8 tptp -119.31 103.91 9.91 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 101.457 -3.534 . . . . 0.0 101.457 175.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.9 t -73.07 136.9 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 N-CA-C 105.868 -1.901 . . . . 0.0 105.868 -178.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 113.34 -24.75 12.01 Favored Glycine 0 CA--C 1.491 -1.435 0 N-CA-C 106.23 -2.748 . . . . 0.0 106.23 -168.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 60.8 m-70 -127.98 -81.11 0.59 Allowed 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 174.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 168.17 -151.76 19.14 Favored Glycine 0 N--CA 1.429 -1.798 0 N-CA-C 105.169 -3.172 . . . . 0.0 105.169 -171.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 49.1 tp -65.41 126.14 27.33 Favored 'General case' 0 CA--C 1.506 -0.721 0 C-N-CA 126.634 1.974 . . . . 0.0 106.856 178.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -134.27 -167.99 2.06 Favored 'General case' 0 CA--C 1.489 -1.372 0 N-CA-C 105.369 -2.085 . . . . 0.0 105.369 -166.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.7 t -136.86 148.23 46.97 Favored 'General case' 0 CA--C 1.489 -1.369 0 N-CA-C 100.349 -3.945 . . . . 0.0 100.349 172.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 20.3 t-105 -102.89 148.69 25.33 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 104.111 -2.552 . . . . 0.0 104.111 177.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 50.2 m -144.77 149.2 35.1 Favored 'General case' 0 CA--C 1.498 -1.052 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 176.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -113.62 142.84 45.51 Favored 'General case' 0 CA--C 1.495 -1.164 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 172.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 62.69 57.03 1.85 Allowed 'General case' 0 CA--C 1.494 -1.191 0 C-N-CA 127.985 2.514 . . . . 0.0 111.103 172.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 17.8 mt -90.07 137.28 28.09 Favored Pre-proline 0 N--CA 1.44 -0.959 0 N-CA-C 104.899 -2.26 . . . . 0.0 104.899 174.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_exo -69.02 171.88 12.88 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 122.036 1.824 . . . . 0.0 113.047 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -76.25 -13.16 60.17 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 123.39 0.676 . . . . 0.0 112.203 -171.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -91.64 13.3 18.37 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 124.122 0.969 . . . . 0.0 110.426 178.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.3 t -104.22 160.9 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 N-CA-C 101.535 -3.506 . . . . 0.0 101.535 171.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -138.05 150.52 20.97 Favored Glycine 0 CA--C 1.481 -2.09 1 N-CA-C 96.986 -6.446 . . . . 0.0 96.986 178.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 29.4 pt -156.68 -155.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 N-CA-C 101.586 -3.487 . . . . 0.0 101.586 -158.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.2 mm -63.08 137.51 24.48 Favored 'Isoleucine or valine' 0 C--N 1.363 1.163 0 C-N-CA 123.943 0.897 . . . . 0.0 109.556 -177.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -149.46 166.71 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.986 1 N-CA-C 96.295 -5.446 . . . . 0.0 96.295 -178.68 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -170.0 174.55 5.47 Favored 'General case' 0 N--CA 1.428 -1.545 1 N-CA-C 97.686 -4.931 . . . . 0.0 97.686 177.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 79.52 35.94 27.78 Favored Glycine 0 C--N 1.349 1.268 0 N-CA-C 104.971 -3.252 . . . . 0.0 104.971 -159.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 178.59 -154.03 0.02 OUTLIER 'General case' 0 N--CA 1.42 -1.948 1 N-CA-C 95.712 -5.662 . . . . 0.0 95.712 -159.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -168.76 -156.69 0.17 Allowed 'General case' 0 N--CA 1.427 -1.61 1 N-CA-C 95.877 -5.601 . . . . 0.0 95.877 -168.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 42.3 t -101.81 157.81 16.57 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 102.948 -2.982 . . . . 0.0 102.948 170.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 9.1 p80 -142.82 -168.46 2.78 Favored 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 102.598 -3.112 . . . . 0.0 102.598 175.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 42.1 m -169.74 171.82 7.14 Favored 'General case' 0 N--CA 1.425 -1.692 1 N-CA-C 96.237 -5.468 . . . . 0.0 96.237 176.361 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.357 0.9 0 O-C-N 124.457 1.098 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 17.3 m . . . . . 0 N--CA 1.481 1.121 0 CA-C-O 121.621 0.724 . . . . 0.0 110.56 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -100.6 174.06 6.25 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 102.654 -3.091 . . . . 0.0 102.654 159.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -119.16 150.17 40.49 Favored 'General case' 0 CA--C 1.487 -1.464 1 N-CA-C 94.262 -6.199 . . . . 0.0 94.262 155.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -160.7 165.12 34.97 Favored Glycine 0 CA--C 1.471 -2.691 0 C-N-CA 116.618 -2.706 . . . . 0.0 108.822 -172.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -87.87 116.24 25.88 Favored 'General case' 0 N--CA 1.429 -1.504 1 N-CA-C 99.51 -4.255 . . . . 0.0 99.51 160.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 13.8 tt -75.72 135.0 27.98 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.419 0 N-CA-C 104.524 -2.399 . . . . 0.0 104.524 -172.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -125.89 -172.99 2.73 Favored 'General case' 0 N--CA 1.419 -2.01 0 O-C-N 126.309 2.256 . . . . 0.0 107.793 -178.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -101.54 139.52 20.47 Favored Pre-proline 0 N--CA 1.424 -1.753 1 N-CA-C 98.126 -4.768 . . . . 0.0 98.126 164.297 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -76.78 -0.31 10.38 Favored 'Trans proline' 0 CA--C 1.504 -1.008 0 C-N-CA 122.457 2.104 . . . . 0.0 112.501 -152.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 84.5 mt-10 -95.28 45.35 1.1 Allowed 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 124.756 1.222 . . . . 0.0 108.322 -165.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 66.49 49.31 1.39 Allowed 'General case' 0 C--N 1.355 0.806 0 C-N-CA 126.555 1.942 . . . . 0.0 108.174 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -128.29 -160.59 1.03 Allowed 'General case' 0 CA--C 1.492 -1.269 0 O-C-N 120.651 -1.281 . . . . 0.0 110.91 -171.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.7 m -125.37 -171.23 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.435 1 N-CA-C 99.618 -4.216 . . . . 0.0 99.618 167.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -126.89 150.44 49.28 Favored 'General case' 0 CA--C 1.477 -1.827 1 N-CA-C 95.338 -5.801 . . . . 0.0 95.338 173.755 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 61.0 m170 -99.08 122.91 42.93 Favored 'General case' 0 CA--C 1.485 -1.535 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 -178.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 41.9 t -83.54 151.08 25.56 Favored 'General case' 0 N--CA 1.427 -1.597 0 N-CA-C 105.95 -1.871 . . . . 0.0 105.95 176.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -98.44 118.41 63.38 Favored Pre-proline 0 N--CA 1.428 -1.528 1 N-CA-C 100.148 -4.019 . . . . 0.0 100.148 175.253 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -62.7 103.15 0.32 Allowed 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.687 2.258 . . . . 0.0 112.849 -165.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 168.59 -52.59 0.22 Allowed Glycine 0 N--CA 1.427 -1.902 1 N-CA-C 100.238 -5.145 . . . . 0.0 100.238 -175.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.8 m 134.11 -42.92 0.01 OUTLIER 'General case' 0 CA--C 1.489 -1.403 0 C-N-CA 128.953 2.901 . . . . 0.0 105.81 174.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.6 m -39.66 -55.53 1.87 Allowed 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 128.311 2.645 . . . . 0.0 117.165 -150.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.89 -34.64 71.64 Favored Glycine 0 C--N 1.346 1.103 0 O-C-N 121.478 -0.764 . . . . 0.0 111.723 -175.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.7 t -86.51 -18.31 31.91 Favored 'General case' 0 CA--C 1.5 -0.953 0 O-C-N 121.46 -1.023 . . . . 0.0 108.4 -176.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -66.1 -44.06 85.45 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 170.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -62.94 -33.3 75.06 Favored 'General case' 0 C--N 1.353 0.758 0 O-C-N 121.123 -0.986 . . . . 0.0 113.019 172.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 86.3 mt -66.76 -41.42 87.79 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-N 119.1 0.864 . . . . 0.0 110.212 175.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 11.4 t -56.41 -50.42 71.66 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 123.763 0.825 . . . . 0.0 110.337 174.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -56.89 -51.48 68.94 Favored 'General case' 0 C--N 1.359 0.979 0 C-N-CA 123.621 0.769 . . . . 0.0 111.888 -179.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -69.57 -19.28 63.68 Favored 'General case' 0 C--N 1.354 0.78 0 O-C-N 121.519 -0.738 . . . . 0.0 112.976 -173.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 48.6 mmtm -96.46 0.44 50.36 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 177.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.11 21.34 23.16 Favored Glycine 0 C--N 1.352 1.428 0 O-C-N 121.416 -0.803 . . . . 0.0 111.582 168.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -88.48 124.02 7.03 Favored Glycine 0 CA--C 1.485 -1.82 0 N-CA-C 106.466 -2.653 . . . . 0.0 106.466 169.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -77.17 -56.39 4.61 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 124.947 1.299 . . . . 0.0 108.435 -173.015 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.2 m -114.17 156.94 23.34 Favored 'General case' 0 CA--C 1.484 -1.584 0 N-CA-C 103.883 -2.636 . . . . 0.0 103.883 178.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -168.13 177.72 42.16 Favored Glycine 0 N--CA 1.416 -2.696 1 N-CA-C 99.926 -5.27 . . . . 0.0 99.926 -177.217 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 31.6 p-80 -171.97 -172.99 1.06 Allowed 'General case' 0 N--CA 1.425 -1.69 1 N-CA-C 95.955 -5.572 . . . . 0.0 95.955 173.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 88.1 m -122.58 158.88 28.96 Favored 'General case' 0 CA--C 1.48 -1.734 0 N-CA-C 102.509 -3.145 . . . . 0.0 102.509 174.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.42 174.42 46.67 Favored Glycine 0 CA--C 1.481 -2.058 1 N-CA-C 100.741 -4.944 . . . . 0.0 100.741 -174.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -146.16 127.7 15.09 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 102.638 -3.097 . . . . 0.0 102.638 -178.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 35.5 mmtm -156.83 82.37 0.95 Allowed 'General case' 0 CA--C 1.493 -1.241 1 N-CA-C 96.417 -5.401 . . . . 0.0 96.417 153.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.8 t -143.57 -178.1 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.071 1 N-CA-C 99.702 -4.184 . . . . 0.0 99.702 -169.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -135.04 26.95 3.21 Favored Glycine 0 C--N 1.349 1.27 0 N-CA-C 108.022 -2.031 . . . . 0.0 108.022 177.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 39.4 m170 -116.22 -75.34 0.58 Allowed 'General case' 0 CA--C 1.5 -0.969 0 N-CA-C 104.346 -2.465 . . . . 0.0 104.346 173.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -171.75 -169.31 34.44 Favored Glycine 0 CA--C 1.478 -2.247 1 N-CA-C 98.312 -5.915 . . . . 0.0 98.312 -175.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . 0.256 0.2 OUTLIER -65.39 147.49 53.34 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 123.817 0.847 . . . . 0.0 111.066 -178.072 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -141.22 175.63 9.49 Favored 'General case' 0 CA--C 1.485 -1.551 0 N-CA-C 101.984 -3.339 . . . . 0.0 101.984 -166.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.5 m -120.05 155.38 33.04 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 104.407 -2.442 . . . . 0.0 104.407 178.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 73.5 t-105 -102.08 148.89 24.84 Favored 'General case' 0 CA--C 1.489 -1.391 0 N-CA-C 104.35 -2.463 . . . . 0.0 104.35 -177.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 69.2 m -140.09 140.91 36.18 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 102.174 -3.269 . . . . 0.0 102.174 168.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -106.73 19.11 20.95 Favored 'General case' 0 C--N 1.352 0.714 0 CA-C-O 121.413 0.625 . . . . 0.0 110.127 -169.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -166.77 144.27 4.95 Favored 'General case' 0 N--CA 1.422 -1.825 1 N-CA-C 93.573 -6.454 . . . . 0.0 93.573 169.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 21.5 mt -150.58 142.11 15.27 Favored Pre-proline 0 CA--C 1.486 -1.518 1 N-CA-C 99.13 -4.396 . . . . 0.0 99.13 153.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -74.06 172.13 16.58 Favored 'Trans proline' 0 N--CA 1.444 -1.402 0 C-N-CA 122.19 1.927 . . . . 0.0 110.14 174.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -75.48 -1.99 26.74 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 -166.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -92.0 -7.73 48.05 Favored 'General case' 0 CA--C 1.505 -0.765 0 O-C-N 121.57 -0.707 . . . . 0.0 109.573 179.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.8 t -101.47 129.71 52.18 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.308 0 N-CA-C 103.748 -2.686 . . . . 0.0 103.748 -174.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -98.45 160.19 20.49 Favored Glycine 0 CA--C 1.485 -1.804 0 N-CA-C 106.133 -2.787 . . . . 0.0 106.133 -178.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 23.2 pt -146.56 -162.67 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.549 0 N-CA-C 103.543 -2.762 . . . . 0.0 103.543 -165.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.8 mm -63.51 137.4 24.75 Favored 'Isoleucine or valine' 0 C--N 1.361 1.084 0 C-N-CA 124.074 0.95 . . . . 0.0 109.167 -176.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 55.3 t -118.36 -92.82 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 N-CA-C 103.643 -2.725 . . . . 0.0 103.643 178.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . 0.343 34.0 tt0 77.8 59.27 0.03 OUTLIER 'General case' 0 CA--C 1.499 -1.01 0 CA-C-O 124.214 1.959 . . . . 0.0 111.009 172.145 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -126.63 43.09 1.38 Allowed Glycine 0 CA--C 1.491 -1.433 1 N-CA-C 100.911 -4.876 . . . . 0.0 100.911 157.388 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 179.92 -158.08 0.03 OUTLIER 'General case' 0 N--CA 1.426 -1.673 1 N-CA-C 96.05 -5.537 . . . . 0.0 96.05 -174.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 35.6 tptt -142.04 178.09 7.77 Favored 'General case' 0 N--CA 1.425 -1.716 1 N-CA-C 96.864 -5.236 . . . . 0.0 96.864 175.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 41.6 t -77.22 150.41 35.42 Favored 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 123.319 0.648 . . . . 0.0 109.347 -168.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -134.89 149.37 50.29 Favored 'General case' 0 N--CA 1.428 -1.545 1 N-CA-C 96.978 -5.193 . . . . 0.0 96.978 165.077 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.7 m 176.42 175.14 0.33 Allowed 'General case' 0 N--CA 1.43 -1.454 1 N-CA-C 96.012 -5.551 . . . . 0.0 96.012 -173.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.359 1.008 0 O-C-N 124.095 0.872 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 34.8 m . . . . . 0 N--CA 1.485 1.303 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.52 165.48 27.46 Favored 'General case' 0 N--CA 1.426 -1.63 1 N-CA-C 100.071 -4.048 . . . . 0.0 100.071 165.753 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -133.41 128.21 35.05 Favored 'General case' 0 N--CA 1.429 -1.522 1 N-CA-C 93.867 -6.345 . . . . 0.0 93.867 166.649 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.03 -175.31 32.93 Favored Glycine 0 CA--C 1.47 -2.748 1 N-CA-C 102.064 -4.414 . . . . 0.0 102.064 176.477 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -75.34 133.1 41.32 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 104.555 -2.387 . . . . 0.0 104.555 163.533 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.9 tt -89.87 137.99 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.315 0 N-CA-C 104.611 -2.366 . . . . 0.0 104.611 -175.436 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -100.97 -144.81 0.34 Allowed 'General case' 0 N--CA 1.426 -1.674 0 C-N-CA 127.185 2.194 . . . . 0.0 106.717 -178.283 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -128.91 143.03 47.12 Favored Pre-proline 0 N--CA 1.421 -1.895 1 N-CA-C 93.47 -6.493 . . . . 0.0 93.47 163.577 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -82.57 27.27 0.61 Allowed 'Trans proline' 0 CA--C 1.506 -0.917 0 C-N-CA 122.651 2.234 . . . . 0.0 113.731 -141.248 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.517 ' HB3' ' CE1' ' A' ' 66' ' ' HIS . 41.4 mp0 -104.38 -78.52 0.56 Allowed 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 102.589 -3.115 . . . . 0.0 102.589 -178.156 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -161.33 142.97 11.71 Favored 'General case' 0 N--CA 1.425 -1.699 1 N-CA-C 92.464 -6.865 . . . . 0.0 92.464 156.188 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER 176.29 -166.68 0.04 OUTLIER 'General case' 0 CA--C 1.486 -1.513 0 N-CA-C 101.485 -3.524 . . . . 0.0 101.485 179.816 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.601 HG11 ' HD1' ' A' ' 43' ' ' HIS . 1.0 OUTLIER -121.29 160.56 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.725 1 N-CA-C 99.006 -4.442 . . . . 0.0 99.006 156.929 . . . . . . . . 4 4 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -82.71 -168.87 2.21 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 104.798 -2.297 . . . . 0.0 104.798 161.074 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 42.9 m170 -134.61 177.76 7.53 Favored 'General case' 0 N--CA 1.422 -1.858 1 N-CA-C 95.271 -5.826 . . . . 0.0 95.271 168.291 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 40.9 t -154.89 169.31 24.32 Favored 'General case' 0 N--CA 1.416 -2.148 1 N-CA-C 96.088 -5.523 . . . . 0.0 96.088 -168.275 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -126.3 120.41 23.58 Favored Pre-proline 0 N--CA 1.42 -1.931 1 N-CA-C 98.795 -4.52 . . . . 0.0 98.795 178.768 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 0.8 OUTLIER -55.56 135.2 68.2 Favored 'Trans proline' 0 CA--C 1.505 -0.951 0 C-N-CA 122.568 2.179 . . . . 0.0 112.384 -178.452 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 116.27 -43.55 1.64 Allowed Glycine 0 N--CA 1.438 -1.231 0 N-CA-C 103.989 -3.644 . . . . 0.0 103.989 -158.322 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.0 m 82.56 23.85 0.18 Allowed 'General case' 0 CA--C 1.496 -1.111 0 C-N-CA 128.105 2.562 . . . . 0.0 110.647 175.836 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.7 -61.2 2.68 Favored 'General case' 0 N--CA 1.44 -0.933 0 C-N-CA 126.808 2.043 . . . . 0.0 110.998 -168.995 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.14 -32.23 72.6 Favored Glycine 0 C--N 1.347 1.187 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 -175.468 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 11.5 t -78.45 -21.38 49.22 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-O 119.302 -0.38 . . . . 0.0 110.054 -173.482 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -60.43 -46.96 88.16 Favored 'General case' 0 C--N 1.352 0.692 0 CA-C-N 119.585 1.084 . . . . 0.0 109.409 173.394 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.13 -49.26 75.06 Favored 'General case' 0 N--CA 1.44 -0.934 0 O-C-N 121.537 -0.727 . . . . 0.0 112.521 171.09 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 73.8 mt -63.91 -44.28 93.39 Favored 'General case' 0 C--N 1.358 0.96 0 CA-C-O 121.722 0.772 . . . . 0.0 111.59 -173.882 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 13.7 t -60.0 -42.54 94.47 Favored 'General case' 0 CA--C 1.503 -0.855 0 C-N-CA 123.589 0.756 . . . . 0.0 109.558 179.175 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.6 mtmm -74.47 -35.05 63.28 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-N 119.211 0.914 . . . . 0.0 112.801 -177.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -70.75 -24.71 62.66 Favored 'General case' 0 C--N 1.358 0.941 0 CA-C-N 120.13 1.332 . . . . 0.0 111.536 178.628 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 48.4 mmtm -85.12 -13.58 49.8 Favored 'General case' 0 C--N 1.355 0.822 0 O-C-N 121.882 -0.512 . . . . 0.0 110.067 173.933 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.89 32.0 5.79 Favored Glycine 0 CA--C 1.492 -1.385 0 CA-C-O 119.375 -0.68 . . . . 0.0 111.636 166.718 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.3 138.29 14.29 Favored Glycine 0 CA--C 1.488 -1.653 0 N-CA-C 105.379 -3.089 . . . . 0.0 105.379 174.247 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 18.0 p -100.67 2.76 41.83 Favored 'General case' 0 N--CA 1.44 -0.97 0 O-C-N 122.063 -0.669 . . . . 0.0 110.042 -163.723 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.5 m -160.17 153.41 21.94 Favored 'General case' 0 CA--C 1.483 -1.6 1 N-CA-C 99.225 -4.361 . . . . 0.0 99.225 168.621 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -171.31 161.97 34.56 Favored Glycine 0 CA--C 1.474 -2.526 1 N-CA-C 100.022 -5.231 . . . . 0.0 100.022 178.296 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 14.8 p80 -165.81 170.71 13.61 Favored 'General case' 0 CA--C 1.488 -1.417 0 N-CA-C 100.215 -3.994 . . . . 0.0 100.215 -177.05 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 62.9 m -77.53 147.63 35.68 Favored 'General case' 0 CA--C 1.491 -1.29 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 177.843 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -163.88 173.43 39.93 Favored Glycine 0 CA--C 1.476 -2.404 1 N-CA-C 98.493 -5.843 . . . . 0.0 98.493 179.9 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -168.89 -169.33 0.98 Allowed 'General case' 0 N--CA 1.422 -1.867 1 N-CA-C 97.01 -5.182 . . . . 0.0 97.01 178.142 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.6 mptt 97.65 61.29 0.0 OUTLIER 'General case' 0 CA--C 1.492 -1.251 0 C-N-CA 131.186 3.794 . . . . 0.0 101.753 -164.692 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 19.3 t -143.21 172.92 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.738 1 N-CA-C 96.501 -5.37 . . . . 0.0 96.501 -177.743 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -113.21 89.57 0.52 Allowed Glycine 0 CA--C 1.486 -1.77 0 N-CA-C 104.329 -3.509 . . . . 0.0 104.329 176.643 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.601 ' HD1' HG11 ' A' ' 13' ' ' VAL . 17.4 m170 -172.09 -132.21 0.01 OUTLIER 'General case' 0 N--CA 1.438 -1.041 1 N-CA-C 99.422 -4.288 . . . . 0.0 99.422 172.741 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -110.87 -41.03 1.23 Allowed Glycine 0 C--N 1.358 1.758 0 CA-C-N 120.843 1.656 . . . . 0.0 113.317 -170.32 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 13.6 tp -165.63 177.4 7.35 Favored 'General case' 0 N--CA 1.434 -1.236 1 N-CA-C 95.769 -5.641 . . . . 0.0 95.769 -173.385 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -159.02 -174.86 4.95 Favored 'General case' 0 CA--C 1.478 -1.822 1 N-CA-C 98.288 -4.708 . . . . 0.0 98.288 175.409 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 46.8 t -130.25 164.51 24.4 Favored 'General case' 0 CA--C 1.492 -1.286 1 N-CA-C 99.943 -4.095 . . . . 0.0 99.943 167.872 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 24.9 t-105 -111.99 152.23 28.35 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 104.231 -2.507 . . . . 0.0 104.231 176.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 15.3 m -145.55 150.69 36.88 Favored 'General case' 0 C--N 1.36 1.032 0 N-CA-C 104.797 -2.297 . . . . 0.0 104.797 173.73 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -113.15 138.5 49.85 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 104.878 -2.268 . . . . 0.0 104.878 171.178 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 64.79 58.4 0.97 Allowed 'General case' 0 CA--C 1.491 -1.297 0 C-N-CA 127.199 2.2 . . . . 0.0 111.697 166.505 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 20.4 mt -89.11 143.91 31.85 Favored Pre-proline 0 N--CA 1.441 -0.912 0 N-CA-C 104.21 -2.515 . . . . 0.0 104.21 170.788 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -73.11 170.37 19.98 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.574 2.183 . . . . 0.0 109.773 177.573 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -70.47 -12.16 61.39 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -167.293 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -84.61 -9.06 58.63 Favored 'General case' 0 CA--C 1.506 -0.744 0 O-C-N 121.381 -0.825 . . . . 0.0 110.27 -176.469 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.5 t -92.35 133.92 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 -176.39 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -98.2 150.03 19.31 Favored Glycine 0 CA--C 1.487 -1.698 0 N-CA-C 105.193 -3.163 . . . . 0.0 105.193 179.273 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 28.4 pt -135.29 -166.43 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 103.459 -2.793 . . . . 0.0 103.459 -172.707 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.3 mm -66.45 130.06 31.45 Favored 'Isoleucine or valine' 0 C--N 1.362 1.11 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 -173.256 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 77.4 t -110.63 101.4 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.612 0 N-CA-C 102.101 -3.296 . . . . 0.0 102.101 171.477 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 65.59 -114.58 0.29 Allowed 'General case' 0 C--N 1.355 0.832 0 C-N-CA 125.401 1.48 . . . . 0.0 109.626 -179.281 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -173.88 44.49 0.15 Allowed Glycine 0 CA--C 1.491 -1.464 1 N-CA-C 100.15 -5.18 . . . . 0.0 100.15 171.387 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -95.93 -36.68 10.99 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -162.418 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -149.35 160.36 43.49 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 102.993 -2.965 . . . . 0.0 102.993 -174.605 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 29.0 t -139.86 133.52 30.4 Favored 'General case' 0 N--CA 1.423 -1.809 1 N-CA-C 92.895 -6.706 . . . . 0.0 92.895 167.718 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.517 ' CE1' ' HB3' ' A' ' 10' ' ' GLU . 14.7 p80 -160.08 169.05 24.17 Favored 'General case' 0 CA--C 1.48 -1.744 0 N-CA-C 100.972 -3.714 . . . . 0.0 100.972 -173.807 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.3 m -171.43 174.5 4.44 Favored 'General case' 0 N--CA 1.421 -1.893 1 N-CA-C 95.41 -5.774 . . . . 0.0 95.41 177.884 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.356 0.857 0 O-C-N 124.239 0.962 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 27.0 m . . . . . 0 N--CA 1.485 1.285 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -105.41 157.25 17.47 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 171.667 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -131.04 123.8 29.48 Favored 'General case' 0 N--CA 1.431 -1.386 1 N-CA-C 93.459 -6.497 . . . . 0.0 93.459 155.518 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.81 -173.61 30.68 Favored Glycine 0 CA--C 1.478 -2.28 1 N-CA-C 101.705 -4.558 . . . . 0.0 101.705 -177.426 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -79.93 137.69 36.94 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 103.673 -2.714 . . . . 0.0 103.673 166.683 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.2 tt -90.72 150.84 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.976 0 N-CA-C 105.171 -2.159 . . . . 0.0 105.171 179.489 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -143.88 179.68 7.02 Favored 'General case' 0 N--CA 1.411 -2.386 0 N-CA-C 101.309 -3.589 . . . . 0.0 101.309 -173.093 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -86.08 145.8 41.49 Favored Pre-proline 0 N--CA 1.427 -1.597 0 N-CA-C 102.559 -3.126 . . . . 0.0 102.559 171.33 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.11 5.42 5.76 Favored 'Trans proline' 0 CA--C 1.501 -1.157 0 C-N-CA 122.249 1.966 . . . . 0.0 112.491 -151.27 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -107.99 21.53 17.26 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 -179.919 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.493 HD22 ' HA ' ' A' ' 61' ' ' GLU . 62.4 t30 76.18 52.65 0.05 Allowed 'General case' 0 CA--C 1.496 -1.125 0 C-N-CA 126.903 2.081 . . . . 0.0 109.627 167.512 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 26.0 m -140.47 138.72 34.86 Favored 'General case' 0 CA--C 1.478 -1.806 0 N-CA-C 100.636 -3.839 . . . . 0.0 100.636 -175.937 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.0 m -66.95 152.19 9.83 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.94 0 CA-C-N 120.544 1.52 . . . . 0.0 111.058 -173.188 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -89.43 122.52 32.71 Favored 'General case' 0 CA--C 1.484 -1.565 1 N-CA-C 100.01 -4.07 . . . . 0.0 100.01 176.018 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 58.6 m80 -86.02 138.34 32.04 Favored 'General case' 0 CA--C 1.478 -1.794 0 N-CA-C 102.427 -3.175 . . . . 0.0 102.427 -174.561 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.0 t -148.53 -179.02 6.65 Favored 'General case' 0 N--CA 1.411 -2.413 1 N-CA-C 93.666 -6.42 . . . . 0.0 93.666 -170.122 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -147.36 171.67 6.07 Favored Pre-proline 0 N--CA 1.412 -2.344 1 N-CA-C 97.515 -4.995 . . . . 0.0 97.515 -157.79 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -66.7 44.58 0.21 Allowed 'Trans proline' 0 C--N 1.324 -0.738 0 C-N-CA 123.307 2.672 . . . . 0.0 116.79 -178.912 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -174.93 148.5 9.69 Favored Glycine 0 N--CA 1.42 -2.427 1 N-CA-C 98.202 -5.959 . . . . 0.0 98.202 172.973 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -78.25 38.12 0.28 Allowed 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 124.813 1.245 . . . . 0.0 112.389 -174.881 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.6 m -54.47 -62.46 1.64 Allowed 'General case' 0 N--CA 1.44 -0.947 0 C-N-CA 127.577 2.351 . . . . 0.0 112.447 -162.816 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -90.16 -19.7 45.31 Favored Glycine 0 C--N 1.35 1.338 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 179.901 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.4 t -80.58 -15.22 57.17 Favored 'General case' 0 N--CA 1.442 -0.837 0 O-C-N 121.679 -0.895 . . . . 0.0 110.462 -167.455 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -54.68 -54.51 40.8 Favored 'General case' 0 C--N 1.353 0.743 0 C-N-CA 125.334 1.454 . . . . 0.0 109.594 172.152 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -61.24 -48.43 81.48 Favored 'General case' 0 N--CA 1.435 -1.184 0 C-N-CA 125.233 1.413 . . . . 0.0 112.111 172.518 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 96.3 mt -65.53 -42.19 92.26 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-O 122.192 0.996 . . . . 0.0 111.368 -171.31 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 14.2 t -61.71 -44.39 97.02 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 124.19 0.996 . . . . 0.0 108.491 179.059 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -68.07 -40.2 82.79 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -179.267 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -72.53 -20.37 61.36 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 120.122 1.328 . . . . 0.0 112.371 -179.114 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.8 mmtm -85.82 -16.34 39.04 Favored 'General case' 0 C--N 1.354 0.783 0 C-N-CA 123.349 0.659 . . . . 0.0 109.947 173.07 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.23 29.63 6.66 Favored Glycine 0 CA--C 1.487 -1.682 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 168.743 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -93.85 142.95 16.25 Favored Glycine 0 N--CA 1.435 -1.386 0 N-CA-C 105.792 -2.923 . . . . 0.0 105.792 172.987 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.1 m -109.84 -3.86 16.39 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 122.866 1.317 . . . . 0.0 108.211 -160.84 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 43.1 m -160.49 165.83 30.25 Favored 'General case' 0 CA--C 1.483 -1.633 1 N-CA-C 98.027 -4.805 . . . . 0.0 98.027 166.232 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -166.33 174.99 41.87 Favored Glycine 0 CA--C 1.473 -2.536 1 N-CA-C 101.561 -4.616 . . . . 0.0 101.561 -176.457 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -166.42 -175.15 3.11 Favored 'General case' 0 N--CA 1.431 -1.415 1 N-CA-C 97.604 -4.961 . . . . 0.0 97.604 -172.505 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 86.4 m -146.06 161.35 40.32 Favored 'General case' 0 CA--C 1.487 -1.468 1 N-CA-C 99.531 -4.248 . . . . 0.0 99.531 172.178 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 179.65 -176.89 47.92 Favored Glycine 0 N--CA 1.426 -1.991 1 N-CA-C 101.837 -4.505 . . . . 0.0 101.837 -177.197 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -99.36 161.14 13.79 Favored 'General case' 0 N--CA 1.436 -1.175 0 N-CA-C 104.829 -2.286 . . . . 0.0 104.829 -178.256 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.46 ' HZ2' HG22 ' A' ' 59' ' ' ILE . 0.1 OUTLIER -154.26 158.81 40.79 Favored 'General case' 0 N--CA 1.425 -1.707 1 N-CA-C 96.047 -5.538 . . . . 0.0 96.047 163.869 . . . . . . . . 4 4 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.4 t -111.7 141.07 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.16 0 N-CA-C 103.505 -2.776 . . . . 0.0 103.505 -170.364 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 145.22 -66.41 0.43 Allowed Glycine 0 CA--C 1.482 -2.024 1 N-CA-C 103.054 -4.018 . . . . 0.0 103.054 179.857 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 60.6 m170 -97.31 -75.86 0.53 Allowed 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 172.49 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 171.46 -158.84 30.23 Favored Glycine 0 CA--C 1.477 -2.287 1 N-CA-C 102.562 -4.215 . . . . 0.0 102.562 -173.901 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.3 tt -69.01 137.16 53.45 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 -173.436 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -137.98 -179.01 5.52 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 104.346 -2.465 . . . . 0.0 104.346 -162.432 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 30.6 t -117.32 169.81 9.19 Favored 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 101.142 -3.651 . . . . 0.0 101.142 179.204 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 7.8 t-105 -131.44 150.42 52.16 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 102.452 -3.166 . . . . 0.0 102.452 -177.842 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 22.2 m -146.64 153.97 40.93 Favored 'General case' 0 CA--C 1.493 -1.25 0 N-CA-C 103.743 -2.688 . . . . 0.0 103.743 176.441 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -121.09 134.6 55.26 Favored 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 104.756 -2.313 . . . . 0.0 104.756 175.331 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 73.08 57.84 0.11 Allowed 'General case' 0 CA--C 1.492 -1.279 0 C-N-CA 126.941 2.096 . . . . 0.0 109.799 170.382 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 31.4 mt -96.32 144.25 27.51 Favored Pre-proline 0 CA--C 1.499 -0.987 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 176.967 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -66.6 164.37 29.19 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.562 2.174 . . . . 0.0 112.552 173.815 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -63.95 -27.58 69.24 Favored 'General case' 0 N--CA 1.442 -0.875 0 C-N-CA 125.224 1.409 . . . . 0.0 113.859 -173.455 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -94.97 17.25 14.23 Favored 'General case' 0 CA--C 1.503 -0.85 0 O-C-N 121.237 -0.915 . . . . 0.0 110.288 -174.796 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 20.4 t -97.21 122.84 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 N-CA-C 102.125 -3.287 . . . . 0.0 102.125 168.758 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -91.87 148.19 19.11 Favored Glycine 0 CA--C 1.488 -1.637 0 N-CA-C 104.817 -3.313 . . . . 0.0 104.817 179.272 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 25.5 pt -140.83 -149.68 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 N-CA-C 103.762 -2.681 . . . . 0.0 103.762 -169.284 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.46 HG22 ' HZ2' ' A' ' 40' ' ' LYS . 5.7 mm -71.24 115.42 11.16 Favored 'Isoleucine or valine' 0 C--N 1.357 0.9 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 177.272 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.257 1.2 t -132.14 21.78 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.07 0 N-CA-C 102.519 -3.141 . . . . 0.0 102.519 -166.394 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.493 ' HA ' HD22 ' A' ' 11' ' ' ASN . 43.0 tt0 -65.28 134.85 54.5 Favored 'General case' 0 CA--C 1.498 -1.045 0 C-N-CA 127.034 2.134 . . . . 0.0 109.912 -175.071 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.89 -45.56 0.74 Allowed Glycine 0 N--CA 1.433 -1.566 1 N-CA-C 98.634 -5.787 . . . . 0.0 98.634 -158.426 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.441 ' HG3' ' H ' ' A' ' 64' ' ' LYS . 12.0 tp10 -98.99 -159.18 0.72 Allowed 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 102.73 -3.063 . . . . 0.0 102.73 156.594 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.441 ' H ' ' HG3' ' A' ' 63' ' ' GLU . 9.7 tptm -137.58 -165.55 1.79 Allowed 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 104.532 -2.396 . . . . 0.0 104.532 -170.846 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 37.7 t -82.13 147.85 28.83 Favored 'General case' 0 CA--C 1.496 -1.102 0 C-N-CA 126.465 1.906 . . . . 0.0 107.249 -177.174 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 10.3 p80 -141.96 156.21 45.46 Favored 'General case' 0 N--CA 1.427 -1.607 1 N-CA-C 97.413 -5.032 . . . . 0.0 97.413 165.491 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.4 m 179.53 177.7 0.57 Allowed 'General case' 0 N--CA 1.429 -1.511 1 N-CA-C 96.136 -5.505 . . . . 0.0 96.136 -179.815 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.357 0.901 0 O-C-N 124.429 1.081 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 17.0 m . . . . . 0 N--CA 1.485 1.312 0 CA-C-O 121.709 0.766 . . . . 0.0 110.864 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.488 HH21 HG12 ' A' ' 58' ' ' ILE . 21.1 mtp85 -115.67 159.8 20.87 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 -173.298 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -135.89 134.31 38.63 Favored 'General case' 0 CA--C 1.489 -1.402 1 N-CA-C 96.674 -5.306 . . . . 0.0 96.674 164.071 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.01 -178.22 35.72 Favored Glycine 0 CA--C 1.48 -2.108 0 N-CA-C 106.687 -2.565 . . . . 0.0 106.687 175.558 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -75.36 128.7 35.98 Favored 'General case' 0 CA--C 1.497 -1.076 0 N-CA-C 104.386 -2.45 . . . . 0.0 104.386 158.745 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.7 tt -89.85 136.92 22.54 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.975 0 N-CA-C 105.444 -2.058 . . . . 0.0 105.444 -173.733 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -97.39 -147.11 0.31 Allowed 'General case' 0 N--CA 1.423 -1.806 0 CA-C-N 112.067 -2.333 . . . . 0.0 106.938 174.622 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -125.07 141.21 37.85 Favored Pre-proline 0 N--CA 1.42 -1.968 1 N-CA-C 93.575 -6.454 . . . . 0.0 93.575 168.831 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -80.54 23.38 0.71 Allowed 'Trans proline' 0 C--N 1.323 -0.769 0 C-N-CA 122.707 2.271 . . . . 0.0 114.276 -145.443 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.475 ' HB3' ' CE1' ' A' ' 66' ' ' HIS . 17.5 mm-40 -95.48 -82.0 0.39 Allowed 'General case' 0 CA--C 1.489 -1.368 0 N-CA-C 103.043 -2.947 . . . . 0.0 103.043 -179.965 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -165.38 123.78 1.64 Allowed 'General case' 0 N--CA 1.425 -1.698 1 N-CA-C 91.584 -7.191 . . . . 0.0 91.584 169.05 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.3 m -174.59 -166.14 0.24 Allowed 'General case' 0 CA--C 1.496 -1.127 0 N-CA-C 101.825 -3.398 . . . . 0.0 101.825 -179.163 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.497 HG11 ' HD1' ' A' ' 43' ' ' HIS . 0.9 OUTLIER -125.24 167.32 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.387 1 N-CA-C 96.829 -5.248 . . . . 0.0 96.829 160.039 . . . . . . . . 4 4 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -88.83 -159.01 0.53 Allowed 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 104.718 -2.327 . . . . 0.0 104.718 163.236 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 51.5 m80 -140.46 160.65 39.53 Favored 'General case' 0 N--CA 1.417 -2.112 1 N-CA-C 94.982 -5.932 . . . . 0.0 94.982 168.796 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.4 t -161.23 -153.63 0.31 Allowed 'General case' 0 N--CA 1.415 -2.191 1 N-CA-C 94.188 -6.227 . . . . 0.0 94.188 -178.896 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -147.33 174.2 3.58 Favored Pre-proline 0 N--CA 1.414 -2.238 1 N-CA-C 99.201 -4.37 . . . . 0.0 99.201 -166.069 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_exo -67.82 44.06 0.26 Allowed 'Trans proline' 0 C--N 1.321 -0.883 0 C-N-CA 123.635 2.89 . . . . 0.0 114.245 168.047 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -176.07 147.66 8.78 Favored Glycine 0 N--CA 1.425 -2.094 1 N-CA-C 98.884 -5.686 . . . . 0.0 98.884 179.232 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.3 m -79.36 -16.11 56.8 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -164.182 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.6 m -39.86 -56.75 1.72 Allowed 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 117.264 2.32 . . . . 0.0 117.264 -151.561 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -77.61 -34.59 39.07 Favored Glycine 0 C--N 1.349 1.301 0 O-C-N 121.291 -0.881 . . . . 0.0 111.131 -174.432 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.3 t -84.24 -12.32 54.95 Favored 'General case' 0 CA--C 1.499 -0.999 0 O-C-N 121.695 -0.885 . . . . 0.0 109.065 -172.792 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -62.88 -48.29 79.64 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 172.787 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -58.54 -48.28 81.38 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 123.235 0.614 . . . . 0.0 112.318 171.334 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 90.8 mt -63.97 -42.41 97.26 Favored 'General case' 0 C--N 1.357 0.934 0 CA-C-O 121.895 0.855 . . . . 0.0 111.445 -175.603 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 24.9 t -59.67 -46.97 87.45 Favored 'General case' 0 CA--C 1.5 -0.954 0 C-N-CA 125.304 1.442 . . . . 0.0 108.998 177.253 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 45.3 mttp -70.79 -40.57 72.5 Favored 'General case' 0 N--CA 1.438 -1.064 0 O-C-N 121.683 -0.635 . . . . 0.0 111.405 -173.568 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -71.05 -18.11 62.58 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 118.914 0.779 . . . . 0.0 112.601 -179.111 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -97.57 -1.84 43.03 Favored 'General case' 0 C--N 1.355 0.822 0 O-C-N 121.731 -0.606 . . . . 0.0 110.478 175.152 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.97 33.72 6.51 Favored Glycine 0 C--N 1.352 1.422 0 CA-C-O 119.762 -0.465 . . . . 0.0 112.122 167.209 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -104.79 125.58 8.39 Favored Glycine 0 CA--C 1.49 -1.506 0 N-CA-C 104.826 -3.309 . . . . 0.0 104.826 168.582 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.9 p -100.54 6.08 44.17 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-O 122.139 0.971 . . . . 0.0 109.694 -164.557 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 26.9 m -160.17 159.11 31.25 Favored 'General case' 0 CA--C 1.476 -1.87 1 N-CA-C 98.503 -4.629 . . . . 0.0 98.503 167.289 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -170.89 177.32 43.97 Favored Glycine 0 N--CA 1.418 -2.539 1 N-CA-C 99.421 -5.472 . . . . 0.0 99.421 -176.012 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 52.6 m80 -165.33 -172.96 2.65 Favored 'General case' 0 N--CA 1.431 -1.404 1 N-CA-C 97.18 -5.119 . . . . 0.0 97.18 -177.724 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 100.0 m -140.61 156.51 46.25 Favored 'General case' 0 CA--C 1.477 -1.84 0 N-CA-C 100.503 -3.888 . . . . 0.0 100.503 174.684 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 170.22 -168.74 41.69 Favored Glycine 0 N--CA 1.424 -2.108 1 N-CA-C 98.373 -5.891 . . . . 0.0 98.373 -169.128 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -152.85 -177.95 6.59 Favored 'General case' 0 N--CA 1.427 -1.611 1 N-CA-C 98.921 -4.474 . . . . 0.0 98.921 -177.591 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 25.2 tptp 128.11 63.66 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.149 2 C-N-CA 133.38 4.672 . . . . 0.0 99.372 -179.602 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.432 HG13 ' H ' ' A' ' 42' ' ' GLY . 2.7 t -146.17 -167.08 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.518 1 N-CA-C 97.277 -5.083 . . . . 0.0 97.277 -172.867 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.432 ' H ' HG13 ' A' ' 41' ' ' VAL . . . -139.81 68.77 0.48 Allowed Glycine 0 CA--C 1.487 -1.7 0 N-CA-C 105.616 -2.994 . . . . 0.0 105.616 -176.383 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.497 ' HD1' HG11 ' A' ' 13' ' ' VAL . 21.7 m170 -158.33 -107.43 0.02 OUTLIER 'General case' 0 N--CA 1.434 -1.272 0 N-CA-C 100.894 -3.743 . . . . 0.0 100.894 173.172 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -121.21 -70.39 0.28 Allowed Glycine 0 C--N 1.355 1.587 0 CA-C-N 120.111 1.323 . . . . 0.0 111.932 -170.559 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -149.53 179.78 7.7 Favored 'General case' 0 N--CA 1.434 -1.245 1 N-CA-C 95.328 -5.805 . . . . 0.0 95.328 176.499 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -157.03 -174.48 4.94 Favored 'General case' 0 CA--C 1.486 -1.498 1 N-CA-C 99.936 -4.098 . . . . 0.0 99.936 -179.81 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.6 m -116.31 -179.13 3.58 Favored 'General case' 0 CA--C 1.486 -1.484 0 N-CA-C 102.308 -3.219 . . . . 0.0 102.308 165.814 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 32.2 t-105 -122.07 153.53 38.52 Favored 'General case' 0 CA--C 1.496 -1.121 0 N-CA-C 102.885 -3.006 . . . . 0.0 102.885 174.275 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 37.3 m -145.64 147.46 32.04 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 170.457 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -114.08 144.24 43.45 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 105.024 -2.213 . . . . 0.0 105.024 173.572 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 69.7 42.9 1.03 Allowed 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 127.289 2.236 . . . . 0.0 111.602 167.215 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 38.7 mt -84.04 137.95 40.09 Favored Pre-proline 0 CA--C 1.504 -0.825 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 178.391 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -73.6 168.91 23.58 Favored 'Trans proline' 0 N--CA 1.447 -1.208 0 C-N-CA 122.187 1.925 . . . . 0.0 110.333 177.514 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -67.78 -9.22 42.3 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 124.652 1.181 . . . . 0.0 114.054 -171.317 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 -91.15 -0.12 57.64 Favored 'General case' 0 CA--C 1.507 -0.709 0 O-C-N 121.557 -0.715 . . . . 0.0 110.923 -176.946 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.0 t -99.93 178.12 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 N-CA-C 103.755 -2.683 . . . . 0.0 103.755 179.463 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -143.61 161.58 27.72 Favored Glycine 0 CA--C 1.479 -2.205 1 N-CA-C 100.086 -5.206 . . . . 0.0 100.086 -176.035 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.488 HG12 HH21 ' A' ' 2' ' ' ARG . 17.8 pt -152.99 -166.94 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.627 1 N-CA-C 99.32 -4.326 . . . . 0.0 99.32 -167.655 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.9 mm -63.7 134.28 28.79 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 179.146 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.8 t -144.0 169.21 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.822 1 N-CA-C 93.404 -6.517 . . . . 0.0 93.404 -179.183 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 24.6 tp10 -150.43 159.25 44.61 Favored 'General case' 0 N--CA 1.428 -1.556 1 N-CA-C 98.363 -4.681 . . . . 0.0 98.363 171.4 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 136.95 -41.6 1.39 Allowed Glycine 0 CA--C 1.489 -1.582 1 N-CA-C 102.42 -4.272 . . . . 0.0 102.42 -164.527 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -97.04 -106.42 0.17 Allowed 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 174.402 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 19.7 tptm 174.07 -140.63 0.0 OUTLIER 'General case' 0 CA--C 1.491 -1.31 1 N-CA-C 98.629 -4.582 . . . . 0.0 98.629 -167.508 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 43.3 t -110.52 129.17 55.85 Favored 'General case' 0 CA--C 1.485 -1.536 0 N-CA-C 100.515 -3.884 . . . . 0.0 100.515 165.155 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.475 ' CE1' ' HB3' ' A' ' 10' ' ' GLU . 8.2 p-80 -154.28 166.13 34.12 Favored 'General case' 0 CA--C 1.481 -1.704 0 N-CA-C 100.652 -3.833 . . . . 0.0 100.652 -176.677 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 28.7 m -174.38 176.5 2.4 Favored 'General case' 0 N--CA 1.425 -1.705 1 N-CA-C 96.198 -5.482 . . . . 0.0 96.198 175.326 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.356 0.855 0 O-C-N 124.591 1.182 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 19.1 m . . . . . 0 N--CA 1.485 1.295 0 CA-C-O 121.403 0.621 . . . . 0.0 110.424 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -103.97 167.71 9.59 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 104.637 -2.357 . . . . 0.0 104.637 163.551 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -125.86 140.45 52.64 Favored 'General case' 0 CA--C 1.485 -1.556 1 N-CA-C 93.75 -6.389 . . . . 0.0 93.75 156.714 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.79 178.94 37.46 Favored Glycine 0 CA--C 1.474 -2.523 0 C-N-CA 116.904 -2.569 . . . . 0.0 107.513 -178.479 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -73.87 130.16 39.35 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 104.075 -2.565 . . . . 0.0 104.075 155.409 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.8 tt -90.63 137.81 20.86 Favored 'Isoleucine or valine' 0 C--O 1.253 1.275 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 179.247 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -100.24 -158.38 0.67 Allowed 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 112.755 -2.021 . . . . 0.0 107.484 176.062 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -98.87 142.39 24.52 Favored Pre-proline 0 CA--C 1.49 -1.344 1 N-CA-C 97.422 -5.029 . . . . 0.0 97.422 163.815 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -78.49 26.47 0.52 Allowed 'Trans proline' 0 CA--C 1.509 -0.759 0 C-N-CA 123.07 2.514 . . . . 0.0 114.654 -136.292 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -115.5 -78.95 0.58 Allowed 'General case' 0 N--CA 1.425 -1.704 0 N-CA-C 102.415 -3.18 . . . . 0.0 102.415 177.65 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -165.89 147.83 7.14 Favored 'General case' 0 N--CA 1.429 -1.513 1 N-CA-C 96.544 -5.354 . . . . 0.0 96.544 164.958 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 20.3 m 164.91 -152.73 0.0 OUTLIER 'General case' 0 CA--C 1.499 -1.017 1 N-CA-C 97.308 -5.071 . . . . 0.0 97.308 179.238 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -126.77 163.69 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 1 N-CA-C 98.844 -4.502 . . . . 0.0 98.844 160.111 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -87.8 -158.87 0.49 Allowed 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 104.79 -2.3 . . . . 0.0 104.79 164.447 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 71.4 m80 -142.82 -178.46 5.82 Favored 'General case' 0 N--CA 1.424 -1.735 1 N-CA-C 97.032 -5.173 . . . . 0.0 97.032 166.739 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.3 t -155.05 166.13 34.56 Favored 'General case' 0 N--CA 1.415 -2.19 1 N-CA-C 96.643 -5.318 . . . . 0.0 96.643 -171.513 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -121.84 125.24 26.78 Favored Pre-proline 0 N--CA 1.42 -1.951 1 N-CA-C 99.841 -4.133 . . . . 0.0 99.841 179.251 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -58.4 111.72 0.96 Allowed 'Trans proline' 0 CA--C 1.503 -1.046 0 C-N-CA 123.327 2.684 . . . . 0.0 112.653 -174.0 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 140.06 -36.79 1.78 Allowed Glycine 0 CA--C 1.49 -1.522 1 N-CA-C 102.739 -4.144 . . . . 0.0 102.739 -166.937 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.3 m 85.23 11.85 0.26 Allowed 'General case' 0 CA--C 1.496 -1.096 0 C-N-CA 128.187 2.595 . . . . 0.0 111.04 172.384 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -48.87 -55.17 12.5 Favored 'General case' 0 N--CA 1.436 -1.148 0 C-N-CA 129.4 3.08 . . . . 0.0 113.526 -169.822 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -85.95 -26.28 35.04 Favored Glycine 0 C--N 1.35 1.359 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 -172.75 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 15.7 t -79.53 -17.09 54.8 Favored 'General case' 0 C--N 1.354 0.78 0 O-C-N 122.238 -0.566 . . . . 0.0 110.187 -172.412 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -62.45 -43.09 99.64 Favored 'General case' 0 C--N 1.354 0.801 0 O-C-N 120.973 -1.079 . . . . 0.0 109.364 174.118 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -56.14 -54.24 47.42 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 124.262 1.025 . . . . 0.0 111.132 169.794 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 91.1 mt -61.75 -45.43 93.93 Favored 'General case' 0 CA--C 1.496 -1.122 0 C-N-CA 123.49 0.716 . . . . 0.0 111.036 -172.739 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.8 t -60.28 -46.5 89.63 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 123.711 0.805 . . . . 0.0 109.407 179.381 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 78.7 mttt -67.31 -43.0 82.74 Favored 'General case' 0 CA--C 1.502 -0.884 0 O-C-N 121.956 -0.465 . . . . 0.0 111.629 -177.329 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -75.26 -21.08 58.8 Favored 'General case' 0 CA--C 1.508 -0.641 0 O-C-N 121.606 -0.684 . . . . 0.0 112.432 -176.5 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -87.94 -15.94 35.19 Favored 'General case' 0 C--N 1.356 0.865 0 CA-C-N 118.971 0.805 . . . . 0.0 109.875 172.822 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.2 34.33 3.98 Favored Glycine 0 CA--C 1.492 -1.366 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 166.655 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -96.83 157.26 21.15 Favored Glycine 0 CA--C 1.491 -1.42 0 N-CA-C 105.535 -3.026 . . . . 0.0 105.535 164.786 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 30.4 m -85.09 -42.38 14.86 Favored 'General case' 0 CA--C 1.497 -1.063 0 CA-C-O 123.119 1.438 . . . . 0.0 107.988 -168.628 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.5 m -158.99 166.59 31.43 Favored 'General case' 0 N--CA 1.417 -2.104 1 N-CA-C 97.083 -5.155 . . . . 0.0 97.083 -178.9 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -175.11 175.6 47.13 Favored Glycine 0 N--CA 1.421 -2.312 1 N-CA-C 98.545 -5.822 . . . . 0.0 98.545 -169.459 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 34.2 p-80 -167.11 -179.35 4.56 Favored 'General case' 0 N--CA 1.428 -1.54 1 N-CA-C 98.575 -4.602 . . . . 0.0 98.575 -173.695 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 80.2 m -74.08 171.29 13.8 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-N 119.476 1.035 . . . . 0.0 111.13 -178.842 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.86 170.34 43.31 Favored Glycine 0 N--CA 1.422 -2.237 1 N-CA-C 99.466 -5.454 . . . . 0.0 99.466 178.525 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -138.39 136.23 36.09 Favored 'General case' 0 N--CA 1.429 -1.489 1 N-CA-C 97.258 -5.09 . . . . 0.0 97.258 177.796 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.5 tmtm? -118.61 102.27 8.75 Favored 'General case' 0 CA--C 1.494 -1.189 0 N-CA-C 102.341 -3.207 . . . . 0.0 102.341 -177.477 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.6 t -73.87 122.28 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 -172.407 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 139.86 -43.26 1.15 Allowed Glycine 0 CA--C 1.484 -1.897 0 N-CA-C 103.115 -3.994 . . . . 0.0 103.115 -171.687 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -113.42 -63.96 1.37 Allowed 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 178.488 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 164.1 -162.65 35.4 Favored Glycine 0 CA--C 1.489 -1.547 0 N-CA-C 108.112 -1.995 . . . . 0.0 108.112 -170.452 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 28.8 tp -63.5 133.96 54.78 Favored 'General case' 0 CA--C 1.501 -0.936 0 C-N-CA 127.768 2.427 . . . . 0.0 105.657 173.515 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -136.59 -158.28 0.85 Allowed 'General case' 0 CA--C 1.483 -1.597 0 N-CA-C 103.289 -2.856 . . . . 0.0 103.289 -167.253 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 52.9 t -138.52 168.72 19.16 Favored 'General case' 0 CA--C 1.49 -1.336 0 N-CA-C 101.683 -3.451 . . . . 0.0 101.683 163.322 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 42.0 t-105 -121.16 145.89 47.34 Favored 'General case' 0 CA--C 1.499 -1.0 0 N-CA-C 103.418 -2.808 . . . . 0.0 103.418 -177.444 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 6.9 m -141.06 146.29 36.96 Favored 'General case' 0 CA--C 1.49 -1.33 0 N-CA-C 105.623 -1.991 . . . . 0.0 105.623 177.159 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -113.51 130.99 56.23 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 179.066 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 65.64 78.65 0.27 Allowed 'General case' 0 CA--C 1.491 -1.318 0 C-N-CA 129.378 3.071 . . . . 0.0 110.422 178.462 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -104.98 125.71 32.98 Favored Pre-proline 0 CA--C 1.496 -1.111 0 N-CA-C 102.216 -3.253 . . . . 0.0 102.216 177.9 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -72.06 170.74 18.25 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 CA-C-N 123.514 2.291 . . . . 0.0 110.126 174.169 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -85.67 18.15 2.99 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -165.64 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -100.92 1.28 39.68 Favored 'General case' 0 CA--C 1.502 -0.885 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 174.045 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.2 t -110.69 133.7 55.32 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.082 0 N-CA-C 103.68 -2.711 . . . . 0.0 103.68 -174.669 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -100.58 148.77 18.41 Favored Glycine 0 CA--C 1.489 -1.579 0 N-CA-C 106.097 -2.801 . . . . 0.0 106.097 178.611 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 25.3 pt -129.83 -146.57 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.492 -1.265 0 N-CA-C 104.222 -2.51 . . . . 0.0 104.222 -169.213 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.1 mm -73.03 1.42 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.747 0 CA-C-N 118.904 0.774 . . . . 0.0 112.194 -172.484 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.37 164.69 15.52 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.298 0 O-C-N 119.109 -2.244 . . . . 0.0 105.853 161.353 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -179.22 -62.75 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.274 1 N-CA-C 97.571 -4.974 . . . . 0.0 97.571 -161.544 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -156.36 157.34 27.82 Favored Glycine 0 N--CA 1.424 -2.147 1 N-CA-C 93.655 -7.778 . . . . 0.0 93.655 165.566 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -88.59 95.07 10.1 Favored 'General case' 0 CA--C 1.499 -0.988 0 CA-C-N 119.714 1.757 . . . . 0.0 108.096 -170.37 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -165.66 176.77 7.79 Favored 'General case' 0 N--CA 1.429 -1.49 1 N-CA-C 98.795 -4.52 . . . . 0.0 98.795 174.152 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 1.8 t -128.36 135.23 49.29 Favored 'General case' 0 CA--C 1.487 -1.48 1 N-CA-C 98.754 -4.536 . . . . 0.0 98.754 -179.243 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 3.4 p80 -168.61 146.56 4.04 Favored 'General case' 0 N--CA 1.427 -1.606 1 N-CA-C 98.097 -4.779 . . . . 0.0 98.097 -175.736 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 60.2 m -153.3 158.37 41.5 Favored 'General case' 0 N--CA 1.427 -1.615 1 N-CA-C 95.053 -5.906 . . . . 0.0 95.053 -178.832 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.36 1.028 0 O-C-N 124.258 0.974 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 22.8 m . . . . . 0 N--CA 1.484 1.252 0 CA-C-O 121.202 0.525 . . . . 0.0 110.512 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.46 174.97 5.65 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 103.439 -2.8 . . . . 0.0 103.439 160.798 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -126.22 142.02 51.69 Favored 'General case' 0 CA--C 1.489 -1.399 1 N-CA-C 93.354 -6.535 . . . . 0.0 93.354 162.716 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.28 170.74 37.14 Favored Glycine 0 CA--C 1.47 -2.732 0 N-CA-C 106.446 -2.662 . . . . 0.0 106.446 -174.292 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -88.77 125.22 34.78 Favored 'General case' 0 CA--C 1.488 -1.411 0 N-CA-C 100.708 -3.812 . . . . 0.0 100.708 162.611 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.9 tt -87.84 140.72 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.088 0 N-CA-C 105.58 -2.007 . . . . 0.0 105.58 -174.271 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -116.41 -158.55 0.69 Allowed 'General case' 0 N--CA 1.424 -1.727 0 C-N-CA 128.12 2.568 . . . . 0.0 107.55 -175.118 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -88.3 144.5 34.16 Favored Pre-proline 0 N--CA 1.44 -0.928 0 N-CA-C 100.493 -3.891 . . . . 0.0 100.493 162.239 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -78.36 27.16 0.5 Allowed 'Trans proline' 0 CA--C 1.511 -0.637 0 C-N-CA 123.322 2.681 . . . . 0.0 113.811 -152.897 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.582 ' HB3' ' CE1' ' A' ' 66' ' ' HIS . 53.6 mp0 -111.37 -82.07 0.58 Allowed 'General case' 0 N--CA 1.425 -1.699 0 N-CA-C 101.912 -3.366 . . . . 0.0 101.912 178.955 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -163.47 143.95 8.92 Favored 'General case' 0 N--CA 1.424 -1.754 1 N-CA-C 93.521 -6.474 . . . . 0.0 93.521 167.496 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 9.1 m 170.66 -156.21 0.01 OUTLIER 'General case' 0 CA--C 1.494 -1.178 1 N-CA-C 98.166 -4.753 . . . . 0.0 98.166 175.203 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.413 HG11 ' HD1' ' A' ' 43' ' ' HIS . 7.8 m -130.98 168.4 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.531 1 N-CA-C 96.815 -5.254 . . . . 0.0 96.815 160.284 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -89.89 163.55 14.95 Favored 'General case' 0 CA--C 1.499 -1.018 0 N-CA-C 100.957 -3.72 . . . . 0.0 100.957 161.915 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 71.3 m80 -108.13 101.2 10.45 Favored 'General case' 0 CA--C 1.48 -1.727 0 N-CA-C 102.74 -3.059 . . . . 0.0 102.74 -174.654 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.8 t -107.44 -171.51 1.89 Allowed 'General case' 0 N--CA 1.425 -1.7 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 -177.896 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -142.43 167.9 15.02 Favored Pre-proline 0 N--CA 1.416 -2.148 1 N-CA-C 98.552 -4.61 . . . . 0.0 98.552 -160.289 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.94 54.23 2.09 Favored 'Trans proline' 0 C--N 1.327 -0.588 0 C-N-CA 123.259 2.639 . . . . 0.0 110.749 166.497 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -178.51 134.16 2.3 Favored Glycine 0 N--CA 1.425 -2.068 1 N-CA-C 99.403 -5.479 . . . . 0.0 99.403 -178.519 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.98 26.06 9.17 Favored 'General case' 0 N--CA 1.434 -1.249 0 C-N-CA 124.305 1.042 . . . . 0.0 109.722 -168.938 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.5 m -49.68 -48.26 49.67 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 126.73 2.012 . . . . 0.0 115.37 -169.759 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -90.1 -26.35 24.18 Favored Glycine 0 C--N 1.351 1.364 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 -179.374 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -85.88 -14.69 44.12 Favored 'General case' 0 CA--C 1.5 -0.976 0 O-C-N 121.53 -0.982 . . . . 0.0 109.989 -167.946 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -58.9 -49.54 77.4 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 125.724 1.61 . . . . 0.0 108.113 171.979 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.4 -45.25 93.98 Favored 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 124.599 1.16 . . . . 0.0 112.162 174.173 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 95.9 mt -64.34 -41.29 96.84 Favored 'General case' 0 C--N 1.357 0.933 0 CA-C-O 121.69 0.757 . . . . 0.0 111.9 -178.064 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 13.2 t -59.79 -44.72 93.81 Favored 'General case' 0 N--CA 1.443 -0.799 0 O-C-N 121.59 -0.694 . . . . 0.0 109.815 176.776 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 46.1 mttp -63.66 -50.9 67.44 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 123.129 0.571 . . . . 0.0 111.163 -177.581 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -67.71 -23.57 65.29 Favored 'General case' 0 C--N 1.351 0.674 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -175.549 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -91.71 -5.72 53.22 Favored 'General case' 0 C--N 1.357 0.902 0 O-C-N 121.728 -0.607 . . . . 0.0 110.701 177.718 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.25 32.37 5.82 Favored Glycine 0 CA--C 1.492 -1.386 0 N-CA-C 111.579 -0.608 . . . . 0.0 111.579 165.713 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -108.75 140.26 15.51 Favored Glycine 0 CA--C 1.486 -1.735 0 N-CA-C 106.173 -2.771 . . . . 0.0 106.173 170.857 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.78 -76.29 0.34 Allowed 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 -171.814 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.8 m -85.85 151.83 23.48 Favored 'General case' 0 CA--C 1.491 -1.293 0 N-CA-C 105.496 -2.038 . . . . 0.0 105.496 176.706 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -158.41 171.61 35.26 Favored Glycine 0 N--CA 1.414 -2.787 1 N-CA-C 99.246 -5.542 . . . . 0.0 99.246 -175.936 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 52.9 m80 -168.0 -170.38 1.33 Allowed 'General case' 0 N--CA 1.426 -1.662 1 N-CA-C 95.982 -5.562 . . . . 0.0 95.982 -176.156 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 46.8 m -138.09 161.47 36.69 Favored 'General case' 0 N--CA 1.427 -1.579 1 N-CA-C 97.465 -5.013 . . . . 0.0 97.465 167.602 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 178.29 179.49 48.25 Favored Glycine 0 CA--C 1.481 -2.06 1 N-CA-C 100.779 -4.928 . . . . 0.0 100.779 -174.018 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -144.46 138.83 27.93 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 100.228 -3.989 . . . . 0.0 100.228 -170.294 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -148.11 50.39 1.03 Allowed 'General case' 0 CA--C 1.491 -1.302 1 N-CA-C 99.599 -4.223 . . . . 0.0 99.599 170.549 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . 0.275 2.2 t 60.61 -142.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.142 0 C-N-CA 125.84 1.656 . . . . 0.0 106.84 -160.288 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 121.55 -86.09 0.39 Allowed Glycine 0 CA--C 1.484 -1.899 1 N-CA-C 102.894 -4.082 . . . . 0.0 102.894 -176.714 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.413 ' HD1' HG11 ' A' ' 13' ' ' VAL . 26.1 m170 -159.93 -47.9 0.05 Allowed 'General case' 0 CA--C 1.498 -1.033 0 N-CA-C 104.726 -2.324 . . . . 0.0 104.726 -175.486 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -160.07 -176.89 32.65 Favored Glycine 0 N--CA 1.428 -1.878 1 N-CA-C 97.119 -6.393 . . . . 0.0 97.119 -178.508 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.7 tt -73.33 120.63 19.21 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 118.61 1.205 . . . . 0.0 108.689 -169.567 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -105.22 179.01 4.4 Favored 'General case' 0 CA--C 1.491 -1.308 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -162.82 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 58.9 m -109.46 157.13 19.26 Favored 'General case' 0 CA--C 1.486 -1.486 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 179.79 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 65.7 t-105 -109.88 148.93 30.65 Favored 'General case' 0 CA--C 1.487 -1.479 0 N-CA-C 103.717 -2.697 . . . . 0.0 103.717 179.591 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 45.1 m -140.94 141.81 34.45 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 101.72 -3.437 . . . . 0.0 101.72 167.382 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -108.61 17.12 22.33 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-O 121.396 0.617 . . . . 0.0 109.653 -166.679 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -171.0 144.52 2.15 Favored 'General case' 0 N--CA 1.418 -2.042 1 N-CA-C 93.624 -6.436 . . . . 0.0 93.624 172.364 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 17.0 mt -153.48 146.22 17.54 Favored Pre-proline 0 CA--C 1.487 -1.445 1 N-CA-C 97.325 -5.065 . . . . 0.0 97.325 155.61 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.38 170.21 19.8 Favored 'Trans proline' 0 N--CA 1.447 -1.207 0 C-N-CA 122.6 2.2 . . . . 0.0 109.221 173.33 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -65.89 -19.79 66.0 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -167.259 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -83.61 -2.37 55.94 Favored 'General case' 0 CA--C 1.501 -0.923 0 C-N-CA 124.18 0.992 . . . . 0.0 111.289 -172.923 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.8 t -100.09 126.31 53.62 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.303 0 N-CA-C 103.753 -2.684 . . . . 0.0 103.753 -177.67 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -92.68 158.71 24.4 Favored Glycine 0 CA--C 1.485 -1.8 0 N-CA-C 105.324 -3.11 . . . . 0.0 105.324 178.559 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 25.8 pt -144.89 -156.99 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.517 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 -166.491 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -71.93 128.03 34.51 Favored 'Isoleucine or valine' 0 C--N 1.365 1.247 0 N-CA-C 104.967 -2.234 . . . . 0.0 104.967 176.085 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.6 t -110.91 109.49 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.596 0 N-CA-C 101.292 -3.596 . . . . 0.0 101.292 176.886 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.442 ' HG3' ' H ' ' A' ' 62' ' ' GLY . 17.4 tp10 60.47 -120.21 0.88 Allowed 'General case' 0 C--N 1.361 1.076 0 C-N-CA 125.712 1.605 . . . . 0.0 106.961 -173.911 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.442 ' H ' ' HG3' ' A' ' 61' ' ' GLU . . . -145.72 50.78 0.61 Allowed Glycine 0 N--CA 1.431 -1.668 1 N-CA-C 98.567 -5.813 . . . . 0.0 98.567 156.655 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -79.82 -58.5 3.14 Favored 'General case' 0 CA--C 1.493 -1.234 0 O-C-N 122.278 -0.542 . . . . 0.0 110.192 -164.854 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 19.9 tttm -147.64 177.91 8.89 Favored 'General case' 0 CA--C 1.489 -1.378 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 -171.781 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 24.8 t -142.72 138.82 30.82 Favored 'General case' 0 N--CA 1.416 -2.13 1 N-CA-C 94.451 -6.129 . . . . 0.0 94.451 175.834 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.582 ' CE1' ' HB3' ' A' ' 10' ' ' GLU . 2.9 p-80 -163.48 157.06 19.28 Favored 'General case' 0 N--CA 1.43 -1.465 1 N-CA-C 97.637 -4.949 . . . . 0.0 97.637 176.907 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.1 m -142.55 143.18 32.37 Favored 'General case' 0 N--CA 1.428 -1.534 1 N-CA-C 98.017 -4.809 . . . . 0.0 98.017 -168.353 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.359 1.01 0 O-C-N 124.448 1.092 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 4.8 m . . . . . 0 N--CA 1.483 1.185 0 CA-C-O 122.443 1.116 . . . . 0.0 111.065 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 34.6 mtp85 -97.26 151.38 19.93 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 -171.199 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -130.63 125.3 33.71 Favored 'General case' 0 CA--C 1.485 -1.519 1 N-CA-C 96.597 -5.335 . . . . 0.0 96.597 165.037 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.76 -178.12 35.41 Favored Glycine 0 CA--C 1.477 -2.32 0 N-CA-C 103.162 -3.975 . . . . 0.0 103.162 176.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 48' ' ' TRP . 85.3 m-85 -76.88 133.33 39.32 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 168.246 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 17.4 tt -91.34 147.49 5.22 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 CA-C-N 120.163 1.347 . . . . 0.0 108.406 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.664 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -134.87 -150.98 0.41 Allowed 'General case' 0 N--CA 1.426 -1.654 0 C-N-CA 127.657 2.383 . . . . 0.0 106.869 -177.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -125.67 144.96 49.85 Favored Pre-proline 0 N--CA 1.426 -1.668 1 N-CA-C 94.661 -6.052 . . . . 0.0 94.661 162.377 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -80.6 -1.77 11.49 Favored 'Trans proline' 0 CA--C 1.501 -1.143 0 CA-C-N 123.165 2.166 . . . . 0.0 112.714 -143.155 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 48.8 mm-40 -86.37 46.85 1.39 Allowed 'General case' 0 N--CA 1.438 -1.043 0 C-N-CA 124.574 1.15 . . . . 0.0 109.874 -167.066 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 65.59 45.87 2.6 Favored 'General case' 0 C--N 1.356 0.889 0 C-N-CA 126.343 1.857 . . . . 0.0 107.598 177.355 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 94.9 m -122.38 -162.64 1.02 Allowed 'General case' 0 CA--C 1.486 -1.502 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 -169.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.671 HG12 HD12 ' A' ' 59' ' ' ILE . 0.6 OUTLIER -141.59 170.26 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.838 1 N-CA-C 96.897 -5.223 . . . . 0.0 96.897 173.137 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -98.2 -163.95 1.09 Allowed 'General case' 0 CA--C 1.5 -0.966 0 N-CA-C 101.254 -3.61 . . . . 0.0 101.254 163.462 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 69.8 m80 -139.56 162.67 34.5 Favored 'General case' 0 CA--C 1.482 -1.672 1 N-CA-C 96.085 -5.524 . . . . 0.0 96.085 166.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 8.4 t -123.03 164.36 18.72 Favored 'General case' 0 CA--C 1.477 -1.837 0 N-CA-C 101.965 -3.346 . . . . 0.0 101.965 -167.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -112.53 122.06 37.32 Favored Pre-proline 0 N--CA 1.425 -1.693 1 N-CA-C 97.341 -5.059 . . . . 0.0 97.341 166.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_exo -56.34 96.47 0.06 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.578 0 CA-C-N 123.823 2.401 . . . . 0.0 117.081 -169.493 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 162.28 -161.06 33.23 Favored Glycine 0 N--CA 1.417 -2.568 1 N-CA-C 97.597 -6.201 . . . . 0.0 97.597 -179.342 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -84.86 -45.35 12.37 Favored 'General case' 0 N--CA 1.426 -1.652 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 176.207 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.9 m -39.29 -56.22 1.57 Allowed 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 117.356 2.354 . . . . 0.0 117.356 -145.3 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -68.34 -74.74 0.57 Allowed Glycine 0 C--N 1.351 1.363 0 O-C-N 121.606 -0.683 . . . . 0.0 111.815 -176.033 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.6 p -87.0 -6.02 58.89 Favored 'General case' 0 CA--C 1.497 -1.073 0 O-C-N 121.219 -1.165 . . . . 0.0 113.048 -166.41 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -69.88 -33.72 72.6 Favored 'General case' 0 C--N 1.359 0.983 0 CA-C-N 119.774 1.17 . . . . 0.0 108.276 166.099 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 26.6 m -70.27 -42.02 72.68 Favored 'General case' 0 N--CA 1.447 -0.624 0 O-C-N 120.936 -1.102 . . . . 0.0 108.679 177.196 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 96.3 mt -61.31 -40.41 94.06 Favored 'General case' 0 C--N 1.355 0.824 0 CA-C-O 121.73 0.776 . . . . 0.0 110.734 175.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.0 t -55.13 -43.34 74.03 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 123.841 0.856 . . . . 0.0 111.256 174.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -60.51 -46.55 89.73 Favored 'General case' 0 C--N 1.356 0.884 0 CA-C-N 118.361 0.528 . . . . 0.0 111.877 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -76.83 -23.57 52.75 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -174.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -80.79 -30.93 35.88 Favored 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 173.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 117.56 35.59 1.07 Allowed Glycine 0 CA--C 1.487 -1.67 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 162.152 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.58 142.89 15.72 Favored Glycine 0 CA--C 1.488 -1.638 0 N-CA-C 105.097 -3.201 . . . . 0.0 105.097 173.131 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.3 p -105.17 15.4 27.54 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-O 121.657 0.741 . . . . 0.0 109.798 -167.044 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 65.8 m -158.39 154.92 27.75 Favored 'General case' 0 CA--C 1.475 -1.92 1 N-CA-C 98.405 -4.665 . . . . 0.0 98.405 159.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -153.87 147.85 17.72 Favored Glycine 0 CA--C 1.468 -2.853 1 N-CA-C 97.491 -6.243 . . . . 0.0 97.491 -170.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -156.61 -171.37 3.66 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 101.566 -3.494 . . . . 0.0 101.566 -171.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 79.3 m -103.36 -179.38 3.93 Favored 'General case' 0 CA--C 1.491 -1.307 0 N-CA-C 104.278 -2.49 . . . . 0.0 104.278 174.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.17 178.29 45.2 Favored Glycine 0 N--CA 1.421 -2.347 0 N-CA-C 103.505 -3.838 . . . . 0.0 103.505 170.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -131.45 133.4 45.13 Favored 'General case' 0 CA--C 1.488 -1.418 1 N-CA-C 98.912 -4.477 . . . . 0.0 98.912 172.362 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -118.93 99.25 6.63 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 102.2 -3.259 . . . . 0.0 102.2 178.293 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.0 t -69.34 129.91 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 -175.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 124.75 -41.55 1.69 Allowed Glycine 0 CA--C 1.488 -1.649 0 N-CA-C 104.516 -3.434 . . . . 0.0 104.516 -168.219 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 30.5 m80 -108.94 -69.85 0.84 Allowed 'General case' 0 CA--C 1.496 -1.102 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 176.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 158.39 -155.49 26.51 Favored Glycine 0 N--CA 1.429 -1.823 0 N-CA-C 103.915 -3.674 . . . . 0.0 103.915 -170.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.1 tt -73.43 141.66 46.91 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 105.953 -1.869 . . . . 0.0 105.953 -178.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.78 -172.75 3.46 Favored 'General case' 0 CA--C 1.489 -1.394 0 N-CA-C 104.116 -2.55 . . . . 0.0 104.116 -168.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 45.5 m -117.5 176.61 5.09 Favored 'General case' 0 CA--C 1.477 -1.838 0 N-CA-C 103.001 -2.963 . . . . 0.0 103.001 170.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.428 ' HA ' ' HA ' ' A' ' 5' ' ' TYR . 8.1 t-105 -138.79 151.89 47.43 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 102.89 -3.004 . . . . 0.0 102.89 -178.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 4.4 m -143.78 156.18 44.41 Favored 'General case' 0 CA--C 1.486 -1.517 0 N-CA-C 104.927 -2.249 . . . . 0.0 104.927 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -127.77 136.87 52.09 Favored 'General case' 0 CA--C 1.49 -1.36 0 N-CA-C 104.219 -2.511 . . . . 0.0 104.219 175.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 73.9 49.73 0.12 Allowed 'General case' 0 CA--C 1.493 -1.233 0 C-N-CA 126.671 1.988 . . . . 0.0 110.549 170.018 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 50.2 mt -89.33 141.83 29.31 Favored Pre-proline 0 CA--C 1.504 -0.803 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 177.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -66.1 162.51 35.3 Favored 'Trans proline' 0 N--CA 1.448 -1.175 0 C-N-CA 122.222 1.948 . . . . 0.0 111.906 177.009 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -60.2 -17.11 38.94 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -86.2 -1.02 57.07 Favored 'General case' 0 CA--C 1.504 -0.825 0 O-C-N 121.55 -0.719 . . . . 0.0 111.208 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.1 t -94.14 156.72 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 N-CA-C 103.472 -2.788 . . . . 0.0 103.472 177.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -141.28 152.81 23.56 Favored Glycine 0 CA--C 1.48 -2.122 1 N-CA-C 98.103 -5.999 . . . . 0.0 98.103 -177.321 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 21.4 pt -146.21 -144.25 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 N-CA-C 104.66 -2.348 . . . . 0.0 104.66 -156.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.671 HD12 HG12 ' A' ' 13' ' ' VAL . 1.9 mm -68.74 147.06 12.42 Favored 'Isoleucine or valine' 0 C--N 1.359 0.98 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 178.707 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 15.5 t . . . . . 0 N--CA 1.427 -1.596 1 N-CA-C 94.511 -6.107 . . . . 0.0 94.511 177.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 30.3 m . . . . . 0 N--CA 1.481 1.093 0 CA-C-O 121.228 0.537 . . . . 0.0 110.089 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -83.52 157.34 22.4 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 173.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -124.71 125.8 44.67 Favored 'General case' 0 CA--C 1.49 -1.337 1 N-CA-C 92.769 -6.752 . . . . 0.0 92.769 151.713 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.54 178.54 37.4 Favored Glycine 0 CA--C 1.473 -2.568 0 N-CA-C 106.022 -2.831 . . . . 0.0 106.022 -170.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 48' ' ' TRP . 65.0 m-85 -87.12 125.03 33.88 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 171.072 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.467 HG13 HG22 ' A' ' 58' ' ' ILE . 18.6 tt -90.51 152.07 3.4 Favored 'Isoleucine or valine' 0 C--N 1.357 0.93 0 CA-C-N 120.272 1.396 . . . . 0.0 108.143 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.808 ' HB2' HD12 ' A' ' 59' ' ' ILE . . . -144.09 -159.19 0.96 Allowed 'General case' 0 N--CA 1.418 -2.053 0 C-N-CA 126.426 1.89 . . . . 0.0 107.83 -167.61 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 -105.48 144.29 28.52 Favored Pre-proline 0 N--CA 1.432 -1.356 1 N-CA-C 99.345 -4.317 . . . . 0.0 99.345 158.332 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -79.04 -12.34 14.56 Favored 'Trans proline' 0 CA--C 1.503 -1.052 0 CA-C-N 122.236 1.834 . . . . 0.0 112.544 -153.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -87.59 55.49 3.52 Favored 'General case' 0 C--N 1.36 1.022 0 CA-C-N 120.591 1.541 . . . . 0.0 108.666 -173.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.5 t30 73.24 37.4 0.75 Allowed 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 128.075 2.55 . . . . 0.0 110.993 168.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -108.94 -162.33 0.81 Allowed 'General case' 0 CA--C 1.504 -0.816 0 O-C-N 121.053 -1.029 . . . . 0.0 111.693 -167.009 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.754 HG12 HD11 ' A' ' 59' ' ' ILE . 3.7 m -133.96 170.46 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.225 1 N-CA-C 98.662 -4.569 . . . . 0.0 98.662 162.241 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . 0.313 1.3 m-85 -111.15 151.17 28.48 Favored 'General case' 0 CA--C 1.487 -1.456 1 N-CA-C 95.1 -5.889 . . . . 0.0 95.1 166.041 . . . . . . . . 3 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 34.8 m80 -92.21 144.65 25.2 Favored 'General case' 0 CA--C 1.496 -1.109 0 N-CA-C 102.772 -3.047 . . . . 0.0 102.772 171.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 39.0 t -92.41 164.77 13.36 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 -177.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -108.29 101.78 43.69 Favored Pre-proline 0 N--CA 1.425 -1.712 1 N-CA-C 98.959 -4.46 . . . . 0.0 98.959 169.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -68.18 107.78 1.62 Allowed 'Trans proline' 0 CA--C 1.501 -1.147 0 C-N-CA 122.367 2.045 . . . . 0.0 110.58 -161.292 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 160.79 -45.2 0.41 Allowed Glycine 0 CA--C 1.48 -2.104 1 N-CA-C 97.972 -6.051 . . . . 0.0 97.972 -169.135 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.2 m 122.8 -34.91 0.01 OUTLIER 'General case' 0 CA--C 1.487 -1.47 0 C-N-CA 128.8 2.84 . . . . 0.0 107.898 161.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 m -38.9 -51.92 1.76 Allowed 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 127.644 2.377 . . . . 0.0 116.377 -160.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.14 -41.99 68.53 Favored Glycine 0 C--N 1.355 1.594 0 O-C-N 121.287 -0.883 . . . . 0.0 111.513 -176.576 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.8 t -88.09 -24.88 23.29 Favored 'General case' 0 CA--C 1.496 -1.105 0 O-C-N 121.562 -0.964 . . . . 0.0 109.037 -171.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -65.83 -36.51 83.68 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 170.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 44.0 m -64.42 -37.85 88.95 Favored 'General case' 0 C--N 1.348 0.517 0 O-C-N 121.055 -1.028 . . . . 0.0 110.635 174.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 78.8 mt -63.96 -40.04 95.51 Favored 'General case' 0 C--N 1.357 0.931 0 CA-C-O 122.192 0.996 . . . . 0.0 110.559 175.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 38.3 t -58.17 -46.04 86.43 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.109 1.363 . . . . 0.0 110.347 174.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.17 -49.22 76.69 Favored 'General case' 0 C--N 1.359 0.984 0 O-C-N 121.752 -0.592 . . . . 0.0 110.613 -178.067 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -70.1 -21.18 63.15 Favored 'General case' 0 C--N 1.354 0.802 0 O-C-N 121.688 -0.632 . . . . 0.0 112.626 -173.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -96.5 5.79 50.09 Favored 'General case' 0 C--N 1.355 0.846 0 O-C-N 121.671 -0.643 . . . . 0.0 110.52 177.339 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.37 36.94 19.18 Favored Glycine 0 CA--C 1.493 -1.311 0 O-C-N 121.847 -0.533 . . . . 0.0 111.937 169.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -97.27 138.91 14.18 Favored Glycine 0 CA--C 1.487 -1.672 1 N-CA-C 102.862 -4.095 . . . . 0.0 102.862 164.196 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.4 m -105.96 -5.12 19.86 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -156.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 71.5 m -160.72 177.74 10.16 Favored 'General case' 0 CA--C 1.496 -1.121 1 N-CA-C 97.948 -4.834 . . . . 0.0 97.948 163.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -176.3 -170.88 39.49 Favored Glycine 0 CA--C 1.476 -2.369 1 N-CA-C 102.112 -4.395 . . . . 0.0 102.112 178.297 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -177.76 -154.51 0.03 OUTLIER 'General case' 0 N--CA 1.426 -1.634 1 N-CA-C 95.504 -5.739 . . . . 0.0 95.504 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 98.2 m -146.37 -176.6 5.24 Favored 'General case' 0 CA--C 1.48 -1.717 0 N-CA-C 101.24 -3.615 . . . . 0.0 101.24 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -175.66 -164.13 29.58 Favored Glycine 0 N--CA 1.422 -2.258 1 N-CA-C 99.971 -5.251 . . . . 0.0 99.971 -177.26 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -126.44 148.83 49.58 Favored 'General case' 0 N--CA 1.431 -1.385 1 N-CA-C 100.124 -4.028 . . . . 0.0 100.124 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -129.33 106.84 9.08 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 103.451 -2.796 . . . . 0.0 103.451 174.286 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.3 t -73.21 124.83 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 -174.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 134.95 -43.86 1.22 Allowed Glycine 0 CA--C 1.483 -1.944 0 N-CA-C 104.863 -3.295 . . . . 0.0 104.863 -171.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 38.9 m170 -114.97 -71.67 0.73 Allowed 'General case' 0 CA--C 1.498 -1.047 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 175.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 166.83 -145.25 9.74 Favored Glycine 0 N--CA 1.429 -1.78 0 N-CA-C 106.678 -2.569 . . . . 0.0 106.678 -177.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 45.9 tp -66.42 133.39 50.35 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 126.448 1.899 . . . . 0.0 106.458 177.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -138.49 171.86 13.75 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 102.84 -3.022 . . . . 0.0 102.84 -167.172 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 63.3 m -114.93 -179.94 3.77 Favored 'General case' 0 CA--C 1.484 -1.591 0 N-CA-C 102.991 -2.966 . . . . 0.0 102.991 176.342 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.461 ' HA ' ' HA ' ' A' ' 5' ' ' TYR . 9.8 t-105 -144.94 151.38 38.57 Favored 'General case' 0 CA--C 1.493 -1.239 0 N-CA-C 102.932 -2.988 . . . . 0.0 102.932 -174.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 45.8 m -137.26 151.73 49.02 Favored 'General case' 0 CA--C 1.487 -1.466 0 N-CA-C 104.697 -2.335 . . . . 0.0 104.697 172.104 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -115.57 130.7 56.96 Favored 'General case' 0 CA--C 1.495 -1.144 0 N-CA-C 103.794 -2.669 . . . . 0.0 103.794 170.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 65.01 72.58 0.43 Allowed 'General case' 0 CA--C 1.498 -1.041 0 C-N-CA 126.449 1.9 . . . . 0.0 110.685 175.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 20.9 mt -104.46 139.35 20.02 Favored Pre-proline 0 CA--C 1.492 -1.26 0 N-CA-C 102.197 -3.26 . . . . 0.0 102.197 166.064 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -70.67 168.48 22.62 Favored 'Trans proline' 0 N--CA 1.447 -1.24 0 C-N-CA 122.605 2.204 . . . . 0.0 110.114 175.145 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -84.07 5.42 26.03 Favored 'General case' 0 N--CA 1.443 -0.822 0 O-C-N 121.634 -0.666 . . . . 0.0 112.787 -164.535 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 -92.3 0.31 57.44 Favored 'General case' 0 CA--C 1.502 -0.876 0 O-C-N 121.638 -0.664 . . . . 0.0 109.584 176.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.1 t -91.65 163.12 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 N-CA-C 104.764 -2.31 . . . . 0.0 104.764 178.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -141.41 150.45 21.89 Favored Glycine 0 CA--C 1.483 -1.935 1 N-CA-C 97.552 -6.219 . . . . 0.0 97.552 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.467 HG22 HG13 ' A' ' 6' ' ' ILE . 16.6 pt -152.32 -140.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 N-CA-C 104.216 -2.513 . . . . 0.0 104.216 -155.338 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.808 HD12 ' HB2' ' A' ' 7' ' ' ALA . 1.7 mp -65.06 126.52 24.22 Favored 'Isoleucine or valine' 0 C--N 1.362 1.128 0 N-CA-C 104.792 -2.299 . . . . 0.0 104.792 163.69 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.7 t . . . . . 0 N--CA 1.422 -1.839 1 N-CA-C 95.568 -5.716 . . . . 0.0 95.568 -178.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 27.2 m . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 121.272 0.558 . . . . 0.0 109.728 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.02 169.07 17.35 Favored 'General case' 0 N--CA 1.434 -1.23 1 N-CA-C 98.578 -4.601 . . . . 0.0 98.578 167.618 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 -130.63 133.06 45.82 Favored 'General case' 0 CA--C 1.48 -1.737 1 N-CA-C 94.366 -6.161 . . . . 0.0 94.366 169.327 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.66 -178.23 35.4 Favored Glycine 0 CA--C 1.474 -2.528 0 C-N-CA 117.397 -2.335 . . . . 0.0 107.411 -173.044 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 48' ' ' TRP . 42.2 m-85 -78.45 130.46 36.09 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 102.713 -3.069 . . . . 0.0 102.713 158.343 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.7 tt -90.47 137.29 21.9 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 N-CA-C 105.331 -2.1 . . . . 0.0 105.331 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.547 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -94.3 -144.76 0.25 Allowed 'General case' 0 N--CA 1.424 -1.734 0 CA-C-N 112.319 -2.219 . . . . 0.0 107.79 177.417 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 62.7 mt-30 -109.57 147.02 35.23 Favored Pre-proline 0 N--CA 1.43 -1.464 1 N-CA-C 96.068 -5.53 . . . . 0.0 96.068 165.372 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -76.34 7.59 3.31 Favored 'Trans proline' 0 CA--C 1.506 -0.888 0 C-N-CA 122.671 2.247 . . . . 0.0 113.883 -145.174 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 18.1 mp0 -88.4 -76.35 0.4 Allowed 'General case' 0 N--CA 1.426 -1.643 0 N-CA-C 103.234 -2.876 . . . . 0.0 103.234 176.298 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -176.84 144.02 0.45 Allowed 'General case' 0 N--CA 1.419 -2.003 1 N-CA-C 93.64 -6.429 . . . . 0.0 93.64 -178.155 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 160.69 -153.48 0.0 OUTLIER 'General case' 0 CA--C 1.493 -1.237 0 N-CA-C 101.705 -3.443 . . . . 0.0 101.705 173.494 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.612 HG12 HD12 ' A' ' 59' ' ' ILE . 0.3 OUTLIER -126.1 165.15 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.33 1 N-CA-C 99.477 -4.268 . . . . 0.0 99.477 159.649 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -86.01 -148.89 0.13 Allowed 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 164.436 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 46.4 m80 -142.33 176.29 9.1 Favored 'General case' 0 CA--C 1.483 -1.632 1 N-CA-C 97.209 -5.108 . . . . 0.0 97.209 164.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 8.2 t -136.18 159.97 40.09 Favored 'General case' 0 N--CA 1.426 -1.644 1 N-CA-C 96.482 -5.377 . . . . 0.0 96.482 -177.118 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -111.19 107.75 57.32 Favored Pre-proline 0 N--CA 1.428 -1.557 1 N-CA-C 97.529 -4.989 . . . . 0.0 97.529 170.104 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_exo -53.03 103.82 0.09 OUTLIER 'Trans proline' 0 CA--C 1.513 -0.557 0 CA-C-N 124.439 2.621 . . . . 0.0 116.871 -155.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 161.69 -170.33 37.38 Favored Glycine 0 N--CA 1.426 -2.011 1 N-CA-C 97.228 -6.349 . . . . 0.0 97.228 -172.064 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.2 m -86.98 -42.47 13.1 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 118.82 1.31 . . . . 0.0 109.566 179.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -40.1 -55.18 2.15 Favored 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 129.08 2.952 . . . . 0.0 117.231 -156.51 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.27 -48.79 43.57 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 111.074 -0.811 . . . . 0.0 111.074 -174.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 68.4 m -71.85 -34.04 68.92 Favored 'General case' 0 CA--C 1.49 -1.363 0 O-C-N 121.71 -0.876 . . . . 0.0 111.13 -176.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -59.16 -46.56 88.07 Favored 'General case' 0 C--N 1.35 0.597 0 CA-C-O 121.351 0.596 . . . . 0.0 109.422 173.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.0 m -64.45 -48.1 76.55 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 123.044 0.538 . . . . 0.0 111.031 177.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 75.5 mt -60.76 -43.6 97.8 Favored 'General case' 0 C--N 1.362 1.149 0 CA-C-O 121.846 0.831 . . . . 0.0 109.964 -177.083 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.8 t -56.9 -44.16 82.07 Favored 'General case' 0 N--CA 1.437 -1.092 0 C-N-CA 123.322 0.649 . . . . 0.0 111.46 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -77.35 -31.41 54.41 Favored 'General case' 0 C--N 1.353 0.735 0 C-N-CA 121.149 -0.22 . . . . 0.0 111.533 -173.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -76.75 -30.77 56.7 Favored 'General case' 0 CA--C 1.506 -0.727 0 O-C-N 121.58 -0.7 . . . . 0.0 110.71 177.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -78.24 -49.62 13.39 Favored 'General case' 0 C--N 1.359 1.013 0 CA-C-N 118.974 0.806 . . . . 0.0 109.816 177.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 131.67 47.99 0.11 Allowed Glycine 0 CA--C 1.488 -1.647 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 173.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -117.48 160.85 13.45 Favored Glycine 0 CA--C 1.484 -1.881 0 N-CA-C 104.077 -3.609 . . . . 0.0 104.077 161.416 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -64.68 -54.9 24.34 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 124.88 1.272 . . . . 0.0 110.621 -164.606 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.9 m -160.79 177.63 10.24 Favored 'General case' 0 N--CA 1.423 -1.813 1 N-CA-C 97.199 -5.111 . . . . 0.0 97.199 170.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -161.48 174.76 38.06 Favored Glycine 0 CA--C 1.474 -2.501 1 N-CA-C 101.346 -4.701 . . . . 0.0 101.346 -163.106 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 53.8 m80 -156.66 -153.04 0.4 Allowed 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 100.348 -3.945 . . . . 0.0 100.348 -168.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 81.6 m -147.53 177.64 9.09 Favored 'General case' 0 CA--C 1.483 -1.627 0 N-CA-C 103.762 -2.681 . . . . 0.0 103.762 -174.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 171.53 -157.14 27.37 Favored Glycine 0 N--CA 1.423 -2.215 1 N-CA-C 95.9 -6.88 . . . . 0.0 95.9 178.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -140.44 146.51 38.37 Favored 'General case' 0 CA--C 1.489 -1.385 1 N-CA-C 98.091 -4.781 . . . . 0.0 98.091 -174.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 9.7 tmtt? -115.75 97.29 6.04 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 103.144 -2.91 . . . . 0.0 103.144 174.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.4 t -70.86 120.37 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 -176.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 136.86 -37.38 1.87 Allowed Glycine 0 CA--C 1.486 -1.78 0 N-CA-C 103.949 -3.66 . . . . 0.0 103.949 -167.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 15.6 m170 -125.1 -64.71 1.07 Allowed 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.11 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 165.89 -161.22 34.8 Favored Glycine 0 N--CA 1.432 -1.626 0 N-CA-C 107.219 -2.353 . . . . 0.0 107.219 -171.141 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.7 tp -69.43 143.49 53.58 Favored 'General case' 0 CA--C 1.502 -0.904 0 C-N-CA 127.969 2.508 . . . . 0.0 105.725 177.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -153.05 178.3 9.86 Favored 'General case' 0 CA--C 1.488 -1.428 0 N-CA-C 103.759 -2.682 . . . . 0.0 103.759 -168.33 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 50.8 m -112.16 161.72 16.23 Favored 'General case' 0 CA--C 1.493 -1.25 0 N-CA-C 103.135 -2.913 . . . . 0.0 103.135 177.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.414 ' HA ' ' HA ' ' A' ' 5' ' ' TYR . 61.1 t-105 -101.83 152.18 21.2 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 104.598 -2.371 . . . . 0.0 104.598 166.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.8 m -141.4 141.17 33.77 Favored 'General case' 0 CA--C 1.491 -1.31 0 N-CA-C 104.568 -2.382 . . . . 0.0 104.568 164.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -105.67 107.9 19.13 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 102.606 -3.109 . . . . 0.0 102.606 174.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 90.06 135.4 0.03 OUTLIER 'General case' 0 N--CA 1.432 -1.365 0 C-N-CA 128.243 2.617 . . . . 0.0 106.068 -173.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -145.13 155.89 54.73 Favored Pre-proline 0 N--CA 1.426 -1.668 1 N-CA-C 96.335 -5.431 . . . . 0.0 96.335 149.166 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -70.16 165.06 32.68 Favored 'Trans proline' 0 N--CA 1.445 -1.346 0 C-N-CA 122.404 2.069 . . . . 0.0 109.139 164.232 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -74.7 -9.04 58.18 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 114.12 1.155 . . . . 0.0 114.12 -163.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 -84.35 -12.35 54.68 Favored 'General case' 0 CA--C 1.507 -0.696 0 O-C-N 121.397 -0.814 . . . . 0.0 110.176 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.2 t -87.29 118.39 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -87.45 147.01 20.45 Favored Glycine 0 CA--C 1.487 -1.702 0 N-CA-C 106.934 -2.467 . . . . 0.0 106.934 -178.161 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 46.1 pt -117.97 -153.81 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 -173.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.612 HD12 HG12 ' A' ' 13' ' ' VAL . 9.2 mm -66.77 -30.27 49.13 Favored 'Isoleucine or valine' 0 C--N 1.357 0.894 0 O-C-N 121.412 -0.805 . . . . 0.0 111.949 -165.331 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.426 -1.658 1 N-CA-C 99.058 -4.423 . . . . 0.0 99.058 175.074 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 9.9 m . . . . . 0 N--CA 1.483 1.221 0 CA-C-O 122.441 1.115 . . . . 0.0 110.913 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 16.2 mtp85 -100.64 158.03 16.24 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 -174.169 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -130.47 128.71 41.79 Favored 'General case' 0 CA--C 1.486 -1.481 1 N-CA-C 97.124 -5.139 . . . . 0.0 97.124 168.269 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.82 178.31 37.73 Favored Glycine 0 CA--C 1.481 -2.037 0 N-CA-C 107.272 -2.331 . . . . 0.0 107.272 -177.058 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -79.64 127.95 32.8 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 104.034 -2.58 . . . . 0.0 104.034 164.103 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.26 11.6 tt -91.51 147.6 5.16 Favored 'Isoleucine or valine' 0 C--O 1.243 0.737 0 CA-C-N 120.487 1.494 . . . . 0.0 108.879 178.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -135.77 -128.61 0.15 Allowed 'General case' 0 N--CA 1.426 -1.663 0 C-N-CA 128.035 2.534 . . . . 0.0 104.548 172.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -139.71 152.02 67.39 Favored Pre-proline 0 N--CA 1.424 -1.743 1 N-CA-C 96.513 -5.365 . . . . 0.0 96.513 176.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -74.89 35.14 0.4 Allowed 'Trans proline' 0 CA--C 1.514 -0.504 0 CA-C-N 124.241 2.55 . . . . 0.0 117.096 -159.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 53.0 mm-40 -124.53 32.79 5.39 Favored 'General case' 0 CA--C 1.497 -1.083 0 CA-C-N 120.202 1.364 . . . . 0.0 107.635 -169.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 48.99 58.1 5.73 Favored 'General case' 0 CA--C 1.489 -1.382 0 C-N-CA 128.686 2.794 . . . . 0.0 112.196 -174.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 91.3 m -116.89 -160.26 0.76 Allowed 'General case' 0 CA--C 1.482 -1.649 0 N-CA-C 103.285 -2.857 . . . . 0.0 103.285 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -134.85 169.39 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.827 1 N-CA-C 96.059 -5.534 . . . . 0.0 96.059 170.697 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -96.62 -154.27 0.44 Allowed 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 101.711 -3.44 . . . . 0.0 101.711 163.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 33.4 m80 -137.43 172.62 12.71 Favored 'General case' 0 CA--C 1.478 -1.792 1 N-CA-C 97.457 -5.016 . . . . 0.0 97.457 166.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 29.3 t -132.11 158.39 41.77 Favored 'General case' 0 N--CA 1.422 -1.868 1 N-CA-C 97.497 -5.001 . . . . 0.0 97.497 -175.689 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -112.45 104.78 56.13 Favored Pre-proline 0 N--CA 1.428 -1.546 1 N-CA-C 98.232 -4.729 . . . . 0.0 98.232 168.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -51.43 98.69 0.04 OUTLIER 'Trans proline' 0 CA--C 1.51 -0.708 0 C-N-CA 123.473 2.782 . . . . 0.0 117.07 -154.615 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 163.21 -171.48 38.95 Favored Glycine 0 N--CA 1.423 -2.227 1 N-CA-C 96.704 -6.558 . . . . 0.0 96.704 -172.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 38.1 m -82.46 -31.12 29.56 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 118.682 1.241 . . . . 0.0 111.154 -177.016 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.2 m -39.59 -71.48 0.08 Allowed 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 117.006 2.224 . . . . 0.0 117.006 -151.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.44 -43.82 52.67 Favored Glycine 0 C--N 1.347 1.153 0 O-C-N 121.198 -0.939 . . . . 0.0 111.113 -173.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 35.2 m -67.24 -43.98 80.59 Favored 'General case' 0 CA--C 1.486 -1.504 0 O-C-N 122.039 -0.683 . . . . 0.0 112.1 -173.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -66.35 -35.3 80.0 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -178.167 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.3 m -63.18 -50.41 70.45 Favored 'General case' 0 N--CA 1.445 -0.695 0 O-C-N 121.78 -0.575 . . . . 0.0 110.023 174.015 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.9 mt -63.56 -40.15 96.23 Favored 'General case' 0 C--N 1.359 0.998 0 CA-C-O 122.052 0.93 . . . . 0.0 110.923 -177.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 19.5 t -57.11 -47.6 80.68 Favored 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 125.775 1.63 . . . . 0.0 110.115 177.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 50.3 mttp -74.36 -34.63 63.42 Favored 'General case' 0 C--N 1.353 0.718 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.519 -173.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -77.43 -20.78 54.02 Favored 'General case' 0 C--N 1.354 0.771 0 O-C-N 121.712 -0.617 . . . . 0.0 111.407 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.6 mmtm -76.6 -59.09 2.92 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 168.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 134.64 48.77 0.08 OUTLIER Glycine 0 CA--C 1.489 -1.548 0 N-CA-C 108.896 -1.682 . . . . 0.0 108.896 170.315 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -107.18 139.97 15.14 Favored Glycine 0 CA--C 1.482 -1.976 1 N-CA-C 101.549 -4.62 . . . . 0.0 101.549 164.196 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.6 p -80.02 -49.5 11.72 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-N 118.587 1.193 . . . . 0.0 108.528 -170.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.3 m -103.41 139.84 38.26 Favored 'General case' 0 CA--C 1.487 -1.478 0 N-CA-C 102.101 -3.296 . . . . 0.0 102.101 -172.392 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -146.48 142.65 10.65 Favored Glycine 0 CA--C 1.473 -2.58 1 N-CA-C 101.215 -4.754 . . . . 0.0 101.215 -168.313 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 66.4 m80 -155.86 -157.43 0.72 Allowed 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 100.286 -3.968 . . . . 0.0 100.286 -173.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 85.5 m -143.73 177.36 8.56 Favored 'General case' 0 CA--C 1.476 -1.893 1 N-CA-C 99.099 -4.408 . . . . 0.0 99.099 177.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -179.27 -175.99 46.63 Favored Glycine 0 N--CA 1.419 -2.476 1 N-CA-C 98.092 -6.003 . . . . 0.0 98.092 177.12 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -116.68 139.44 50.54 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 102.048 -3.316 . . . . 0.0 102.048 177.518 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.9 94.27 4.96 Favored 'General case' 0 CA--C 1.498 -1.038 0 N-CA-C 103.506 -2.776 . . . . 0.0 103.506 178.26 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.7 t -70.76 116.82 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 -174.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 136.83 -39.59 1.62 Allowed Glycine 0 CA--C 1.488 -1.642 0 N-CA-C 105.929 -2.868 . . . . 0.0 105.929 -169.095 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 27.0 m170 -119.25 -66.85 1.03 Allowed 'General case' 0 CA--C 1.499 -0.992 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 178.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 167.04 -159.89 33.41 Favored Glycine 0 N--CA 1.432 -1.631 0 N-CA-C 106.262 -2.735 . . . . 0.0 106.262 -173.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 57.8 tp -68.21 142.28 55.71 Favored 'General case' 0 C--N 1.351 0.665 0 C-N-CA 126.779 2.032 . . . . 0.0 106.175 175.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -150.19 -178.04 6.28 Favored 'General case' 0 CA--C 1.485 -1.528 0 N-CA-C 104.046 -2.575 . . . . 0.0 104.046 -167.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 67.3 m -107.02 163.63 12.82 Favored 'General case' 0 CA--C 1.492 -1.287 0 N-CA-C 102.689 -3.078 . . . . 0.0 102.689 176.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 14.6 t-105 -128.14 146.67 50.64 Favored 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 104.435 -2.432 . . . . 0.0 104.435 177.054 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 61.2 m -140.43 151.49 44.93 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 174.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -118.95 143.44 47.03 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 103.806 -2.665 . . . . 0.0 103.806 166.298 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 77.02 54.94 0.04 OUTLIER 'General case' 0 CA--C 1.497 -1.075 0 C-N-CA 127.018 2.127 . . . . 0.0 110.883 171.128 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 33.5 mt -97.77 135.67 21.47 Favored Pre-proline 0 CA--C 1.5 -0.948 0 N-CA-C 105.12 -2.178 . . . . 0.0 105.12 173.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -74.46 167.92 26.01 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 CA-C-N 122.628 1.974 . . . . 0.0 111.103 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -61.28 -19.86 62.21 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 126.561 1.944 . . . . 0.0 114.686 -170.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.4 p-10 -86.54 -2.2 58.28 Favored 'General case' 0 CA--C 1.505 -0.767 0 C-N-CA 123.722 0.809 . . . . 0.0 110.628 -176.118 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.5 t -91.09 163.32 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 N-CA-C 104.078 -2.564 . . . . 0.0 104.078 177.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -145.84 154.53 26.0 Favored Glycine 0 CA--C 1.48 -2.132 1 N-CA-C 96.668 -6.573 . . . . 0.0 96.668 179.255 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 16.1 pt -139.66 -126.65 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 N-CA-C 104.885 -2.265 . . . . 0.0 104.885 -158.006 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.0 mm -74.5 62.28 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.582 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 169.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.425 -1.682 0 N-CA-C 103.008 -2.96 . . . . 0.0 103.008 -167.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 18.6 m . . . . . 0 N--CA 1.486 1.325 0 CA-C-O 121.898 0.856 . . . . 0.0 110.649 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 22.6 mtp85 -121.71 154.81 36.38 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 104.669 -2.345 . . . . 0.0 104.669 -172.461 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -137.48 132.71 33.7 Favored 'General case' 0 CA--C 1.486 -1.481 1 N-CA-C 97.273 -5.084 . . . . 0.0 97.273 166.566 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.29 -166.29 20.79 Favored Glycine 0 CA--C 1.477 -2.34 1 N-CA-C 101.948 -4.461 . . . . 0.0 101.948 172.145 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -74.81 142.14 44.25 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 103.872 -2.64 . . . . 0.0 103.872 161.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.1 tt -90.24 136.26 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.125 0 N-CA-C 105.018 -2.215 . . . . 0.0 105.018 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.657 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -109.59 -149.94 0.45 Allowed 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 127.385 2.274 . . . . 0.0 106.255 179.447 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.415 ' H ' ' HB1' ' A' ' 7' ' ' ALA . 58.6 mt-30 -115.13 142.87 29.22 Favored Pre-proline 0 N--CA 1.426 -1.669 1 N-CA-C 97.454 -5.017 . . . . 0.0 97.454 171.108 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -75.58 29.81 0.38 Allowed 'Trans proline' 0 CA--C 1.503 -1.042 0 N-CA-C 117.764 2.179 . . . . 0.0 117.764 -141.286 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -120.35 -78.74 0.59 Allowed 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 101.733 -3.432 . . . . 0.0 101.733 -178.045 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 53.6 t-20 -160.92 142.72 12.17 Favored 'General case' 0 N--CA 1.423 -1.803 1 N-CA-C 93.932 -6.322 . . . . 0.0 93.932 166.24 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 19.0 m 173.42 -157.09 0.01 OUTLIER 'General case' 0 CA--C 1.496 -1.122 1 N-CA-C 98.743 -4.54 . . . . 0.0 98.743 172.613 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.609 HG12 HD12 ' A' ' 59' ' ' ILE . 0.4 OUTLIER -126.8 167.68 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.575 1 N-CA-C 98.372 -4.677 . . . . 0.0 98.372 158.956 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -87.04 -162.7 0.82 Allowed 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 103.126 -2.916 . . . . 0.0 103.126 163.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 47.4 m80 -143.16 168.62 19.32 Favored 'General case' 0 N--CA 1.417 -2.114 1 N-CA-C 94.198 -6.223 . . . . 0.0 94.198 165.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.4 t -160.45 -151.01 0.23 Allowed 'General case' 0 N--CA 1.418 -2.037 1 N-CA-C 95.894 -5.595 . . . . 0.0 95.894 -176.485 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -148.44 147.77 26.5 Favored Pre-proline 0 N--CA 1.409 -2.493 1 N-CA-C 95.198 -5.853 . . . . 0.0 95.198 -167.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -71.23 73.8 2.04 Favored 'Trans proline' 0 C--N 1.32 -0.939 0 CA-C-N 125.383 2.958 . . . . 0.0 114.134 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -172.82 162.74 34.4 Favored Glycine 0 N--CA 1.425 -2.071 1 N-CA-C 98.704 -5.759 . . . . 0.0 98.704 175.062 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.2 m -81.65 -7.88 59.64 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 118.752 1.276 . . . . 0.0 111.775 -172.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -53.55 -28.38 31.41 Favored 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 128.448 2.699 . . . . 0.0 115.417 -169.401 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -87.06 -73.48 1.28 Allowed Glycine 0 C--N 1.348 1.211 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 176.047 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 75.6 m -79.99 -12.57 59.7 Favored 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 -162.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -63.17 -44.97 93.96 Favored 'General case' 0 C--N 1.358 0.972 0 CA-C-N 121.65 2.023 . . . . 0.0 108.38 173.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -57.67 -51.22 70.4 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 127.1 2.16 . . . . 0.0 110.794 174.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 84.6 mt -64.85 -40.1 94.61 Favored 'General case' 0 CA--C 1.497 -1.077 0 C-N-CA 124.088 0.955 . . . . 0.0 111.133 -177.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.7 t -56.77 -44.24 81.64 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 124.556 1.143 . . . . 0.0 109.847 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 52.0 mttp -71.15 -34.93 71.45 Favored 'General case' 0 N--CA 1.443 -0.801 0 O-C-N 122.151 -0.343 . . . . 0.0 111.54 -174.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -78.58 -26.67 45.55 Favored 'General case' 0 C--N 1.355 0.821 0 O-C-N 121.543 -0.723 . . . . 0.0 112.359 177.068 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.4 mmtm -80.54 -26.07 38.26 Favored 'General case' 0 C--N 1.357 0.92 0 CA-C-N 118.911 0.778 . . . . 0.0 109.843 176.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.53 37.64 1.88 Allowed Glycine 0 CA--C 1.486 -1.765 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 163.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -108.27 143.86 16.16 Favored Glycine 0 CA--C 1.485 -1.84 0 N-CA-C 103.226 -3.95 . . . . 0.0 103.226 168.266 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.4 m -73.5 -29.82 62.73 Favored 'General case' 0 N--CA 1.437 -1.084 0 O-C-N 122.074 -0.662 . . . . 0.0 110.473 -167.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.1 m -159.74 161.6 34.77 Favored 'General case' 0 CA--C 1.481 -1.704 0 N-CA-C 102.734 -3.062 . . . . 0.0 102.734 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -171.38 175.25 44.97 Favored Glycine 0 N--CA 1.419 -2.441 1 N-CA-C 99.944 -5.262 . . . . 0.0 99.944 -172.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 12.6 p80 -169.67 -171.71 1.27 Allowed 'General case' 0 N--CA 1.431 -1.418 1 N-CA-C 98.224 -4.732 . . . . 0.0 98.224 -174.461 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 73.8 m -127.41 153.07 46.71 Favored 'General case' 0 CA--C 1.486 -1.498 0 N-CA-C 104.433 -2.432 . . . . 0.0 104.433 -173.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -172.18 167.17 40.1 Favored Glycine 0 CA--C 1.477 -2.316 1 N-CA-C 100.004 -5.238 . . . . 0.0 100.004 -173.352 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -98.67 161.18 13.8 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 104.741 -2.318 . . . . 0.0 104.741 -172.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.99 173.36 13.44 Favored 'General case' 0 N--CA 1.428 -1.55 1 N-CA-C 96.009 -5.552 . . . . 0.0 96.009 163.5 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -132.34 155.81 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.548 1 N-CA-C 97.607 -4.96 . . . . 0.0 97.607 177.928 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 130.34 -52.18 0.84 Allowed Glycine 0 CA--C 1.485 -1.789 1 N-CA-C 101.535 -4.626 . . . . 0.0 101.535 -170.186 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 66.9 m170 -117.48 -73.88 0.63 Allowed 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 104.318 -2.475 . . . . 0.0 104.318 168.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 164.45 -145.67 10.58 Favored Glycine 0 CA--C 1.472 -2.63 1 N-CA-C 100.876 -4.89 . . . . 0.0 100.876 178.644 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 33.2 tp -62.97 137.77 58.37 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 125.304 1.442 . . . . 0.0 107.388 -173.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -152.04 -171.12 3.84 Favored 'General case' 0 CA--C 1.479 -1.764 1 N-CA-C 97.556 -4.979 . . . . 0.0 97.556 -160.515 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 3.0 p -147.11 -174.15 4.43 Favored 'General case' 0 CA--C 1.478 -1.824 0 C-N-CA 115.734 -2.386 . . . . 0.0 104.616 169.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 43.7 t-105 -127.73 157.1 41.26 Favored 'General case' 0 CA--C 1.505 -0.785 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 -167.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 6.0 m -150.15 152.31 34.5 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 168.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -118.94 140.1 50.56 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 104.478 -2.416 . . . . 0.0 104.478 168.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 77.36 47.67 0.06 Allowed 'General case' 0 CA--C 1.496 -1.108 0 C-N-CA 127.451 2.301 . . . . 0.0 111.378 166.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 38.4 mt -91.48 137.14 26.07 Favored Pre-proline 0 CA--C 1.503 -0.862 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 178.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -77.94 174.71 12.13 Favored 'Trans proline' 0 N--CA 1.447 -1.217 0 C-N-CA 122.274 1.983 . . . . 0.0 111.494 -179.006 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -69.49 -9.05 52.15 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 125.254 1.421 . . . . 0.0 114.203 -171.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -92.73 -0.15 57.32 Favored 'General case' 0 CA--C 1.501 -0.934 0 O-C-N 121.667 -0.646 . . . . 0.0 110.008 -179.387 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.408 HG12 ' H ' ' A' ' 57' ' ' GLY . 1.5 t -99.05 179.13 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 N-CA-C 102.49 -3.152 . . . . 0.0 102.49 174.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.408 ' H ' HG12 ' A' ' 56' ' ' VAL . . . -152.12 159.4 28.33 Favored Glycine 0 CA--C 1.479 -2.216 1 N-CA-C 97.258 -6.337 . . . . 0.0 97.258 -178.528 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 18.2 pt -146.81 -156.46 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.271 0 N-CA-C 103.296 -2.853 . . . . 0.0 103.296 -165.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.657 HD13 ' HB2' ' A' ' 7' ' ' ALA . 1.1 mm -73.02 129.86 35.9 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.094 0 N-CA-C 104.839 -2.282 . . . . 0.0 104.839 176.395 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.9 t . . . . . 0 N--CA 1.426 -1.653 0 N-CA-C 100.687 -3.82 . . . . 0.0 100.687 172.974 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 26.7 m . . . . . 0 N--CA 1.483 1.184 0 CA-C-O 121.578 0.704 . . . . 0.0 109.798 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -100.31 156.2 17.37 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 104.136 -2.542 . . . . 0.0 104.136 166.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -123.99 122.04 36.87 Favored 'General case' 0 CA--C 1.487 -1.468 1 N-CA-C 95.705 -5.665 . . . . 0.0 95.705 164.499 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.55 -175.7 32.85 Favored Glycine 0 CA--C 1.477 -2.324 0 N-CA-C 105.01 -3.236 . . . . 0.0 105.01 -171.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -88.3 135.71 33.32 Favored 'General case' 0 CA--C 1.491 -1.319 0 N-CA-C 103.524 -2.769 . . . . 0.0 103.524 170.056 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 17.0 tt -90.25 139.34 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 N-CA-C 106.854 -1.535 . . . . 0.0 106.854 -177.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.506 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -111.16 -161.44 0.75 Allowed 'General case' 0 N--CA 1.426 -1.632 0 C-N-CA 127.536 2.334 . . . . 0.0 106.412 178.126 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -107.02 146.36 33.0 Favored Pre-proline 0 N--CA 1.427 -1.583 1 N-CA-C 97.985 -4.82 . . . . 0.0 97.985 164.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -80.22 -3.47 12.64 Favored 'Trans proline' 0 CA--C 1.5 -1.225 0 C-N-CA 121.183 1.256 . . . . 0.0 114.125 -135.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -91.28 -46.59 7.97 Favored 'General case' 0 CA--C 1.5 -0.98 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 49.8 t-20 171.1 142.53 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.465 1 N-CA-C 97.962 -4.829 . . . . 0.0 97.962 167.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 171.31 -157.2 0.01 OUTLIER 'General case' 0 CA--C 1.488 -1.419 0 C-N-CA 126.986 2.114 . . . . 0.0 105.587 178.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.461 HG12 HD12 ' A' ' 59' ' ' ILE . 1.5 m -125.83 155.81 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.775 1 N-CA-C 96.772 -5.27 . . . . 0.0 96.772 155.293 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -98.91 141.78 31.24 Favored 'General case' 0 CA--C 1.482 -1.636 1 N-CA-C 97.506 -4.998 . . . . 0.0 97.506 165.098 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -84.31 178.79 7.63 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 105.33 -2.1 . . . . 0.0 105.33 179.064 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 36.4 t -146.79 163.28 36.52 Favored 'General case' 0 N--CA 1.419 -1.979 1 N-CA-C 96.76 -5.274 . . . . 0.0 96.76 -173.161 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -126.27 132.57 24.36 Favored Pre-proline 0 N--CA 1.417 -2.11 1 N-CA-C 98.383 -4.673 . . . . 0.0 98.383 -173.126 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -65.53 -6.64 14.1 Favored 'Trans proline' 0 CA--C 1.514 -0.479 0 CA-C-N 123.576 2.313 . . . . 0.0 113.518 177.303 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -95.55 89.35 1.15 Allowed Glycine 0 C--N 1.352 1.426 1 N-CA-C 101.216 -4.754 . . . . 0.0 101.216 158.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.9 m -60.04 -15.56 23.78 Favored 'General case' 0 CA--C 1.498 -1.057 0 C-N-CA 127.404 2.281 . . . . 0.0 115.868 -159.302 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -44.41 -45.0 8.76 Favored 'General case' 0 N--CA 1.436 -1.155 0 C-N-CA 128.618 2.767 . . . . 0.0 114.087 -175.621 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.73 -50.28 65.51 Favored Glycine 0 C--N 1.355 1.587 0 N-CA-C 111.972 -0.451 . . . . 0.0 111.972 -175.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 19.5 t -76.14 -24.23 54.86 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -177.283 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -61.37 -48.24 82.19 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 175.125 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -60.57 -40.06 90.26 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 172.197 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 96.1 mt -64.96 -44.12 90.44 Favored 'General case' 0 C--N 1.357 0.928 0 CA-C-N 119.321 0.964 . . . . 0.0 110.551 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 9.1 t -58.23 -46.85 85.17 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 125.257 1.423 . . . . 0.0 109.632 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -67.75 -37.18 81.79 Favored 'General case' 0 C--N 1.354 0.766 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -177.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -77.11 -22.76 52.22 Favored 'General case' 0 C--N 1.354 0.794 0 O-C-N 121.192 -0.942 . . . . 0.0 111.397 -176.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -85.99 -34.29 20.86 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 175.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 114.89 44.03 0.71 Allowed Glycine 0 CA--C 1.482 -1.978 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 164.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.13 149.08 16.59 Favored Glycine 0 CA--C 1.487 -1.715 1 N-CA-C 102.322 -4.311 . . . . 0.0 102.322 163.32 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.1 m -70.61 -47.45 60.03 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 122.265 1.031 . . . . 0.0 110.203 -165.467 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 33.8 m -160.82 -174.0 4.2 Favored 'General case' 0 N--CA 1.422 -1.849 1 N-CA-C 97.802 -4.888 . . . . 0.0 97.802 167.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -175.92 -177.96 45.35 Favored Glycine 0 N--CA 1.418 -2.543 1 N-CA-C 99.329 -5.508 . . . . 0.0 99.329 -169.123 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 68.4 m80 -155.96 176.98 11.94 Favored 'General case' 0 N--CA 1.425 -1.71 1 N-CA-C 99.421 -4.288 . . . . 0.0 99.421 -172.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 68.0 m -88.38 164.31 15.59 Favored 'General case' 0 CA--C 1.49 -1.361 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -179.222 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -167.68 -169.84 31.71 Favored Glycine 0 N--CA 1.414 -2.815 1 N-CA-C 100.45 -5.06 . . . . 0.0 100.45 176.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -152.61 156.65 39.69 Favored 'General case' 0 N--CA 1.417 -2.09 1 N-CA-C 94.132 -6.247 . . . . 0.0 94.132 -176.816 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 16.8 ptmt -136.86 17.43 3.05 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 104.248 -2.501 . . . . 0.0 104.248 163.147 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . 0.276 1.8 t 50.01 -138.24 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.358 0.974 0 C-N-CA 126.764 2.026 . . . . 0.0 107.534 -160.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.43 -72.35 2.17 Favored Glycine 0 CA--C 1.495 -1.217 0 C-N-CA 123.787 0.708 . . . . 0.0 111.652 163.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 9.5 m170 -98.79 -64.41 1.04 Allowed 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 105.127 -2.175 . . . . 0.0 105.127 176.136 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 174.64 -169.23 42.16 Favored Glycine 0 CA--C 1.473 -2.531 1 N-CA-C 100.478 -5.049 . . . . 0.0 100.478 -169.513 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.2 tt -70.2 132.27 45.51 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 105.504 -2.035 . . . . 0.0 105.504 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.404 ' HA ' ' HB ' ' A' ' 13' ' ' VAL . . . -133.63 165.85 23.96 Favored 'General case' 0 CA--C 1.474 -1.954 0 N-CA-C 101.273 -3.603 . . . . 0.0 101.273 -159.067 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 49.7 t -120.2 151.61 38.88 Favored 'General case' 0 CA--C 1.488 -1.422 0 N-CA-C 102.482 -3.155 . . . . 0.0 102.482 -174.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 62.1 t-105 -97.95 149.72 22.11 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 104.108 -2.553 . . . . 0.0 104.108 175.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.8 m -141.35 143.95 34.28 Favored 'General case' 0 CA--C 1.481 -1.688 0 N-CA-C 100.949 -3.723 . . . . 0.0 100.949 170.102 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -108.55 124.6 50.73 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 104.14 -2.541 . . . . 0.0 104.14 179.487 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 76.37 73.59 0.08 Allowed 'General case' 0 CA--C 1.498 -1.025 0 C-N-CA 127.093 2.157 . . . . 0.0 110.939 171.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 35.9 mt -103.53 131.47 22.01 Favored Pre-proline 0 CA--C 1.498 -1.041 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 174.256 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -72.05 174.09 11.85 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 CA-C-N 122.515 1.934 . . . . 0.0 110.28 176.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -69.15 -8.35 44.71 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 -172.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 17.7 p-10 -81.91 -10.69 59.21 Favored 'General case' 0 CA--C 1.505 -0.786 0 O-C-N 121.093 -1.004 . . . . 0.0 109.438 -177.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.8 t -100.24 132.52 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.374 0 N-CA-C 104.538 -2.393 . . . . 0.0 104.538 -176.247 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -103.77 151.05 17.65 Favored Glycine 0 CA--C 1.485 -1.829 0 N-CA-C 103.099 -4.0 . . . . 0.0 103.099 176.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 24.7 pt -136.14 -152.96 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 N-CA-C 104.823 -2.288 . . . . 0.0 104.823 -164.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.506 HD13 ' HB2' ' A' ' 7' ' ' ALA . 3.8 mm -67.98 133.46 31.63 Favored 'Isoleucine or valine' 0 C--N 1.358 0.956 0 N-CA-C 107.497 -1.298 . . . . 0.0 107.497 -178.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.2 t . . . . . 0 N--CA 1.426 -1.663 1 N-CA-C 96.444 -5.391 . . . . 0.0 96.444 169.095 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 33.2 m . . . . . 0 N--CA 1.485 1.303 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -107.52 159.2 16.61 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 170.156 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -130.37 120.72 24.73 Favored 'General case' 0 CA--C 1.49 -1.333 1 N-CA-C 96.218 -5.475 . . . . 0.0 96.218 161.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.02 -175.06 32.64 Favored Glycine 0 CA--C 1.477 -2.325 0 N-CA-C 105.456 -3.058 . . . . 0.0 105.456 -176.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 48' ' ' TRP . 46.6 m-85 -79.53 136.17 36.82 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 104.121 -2.548 . . . . 0.0 104.121 165.076 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 14.4 tt -90.82 146.73 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 N-CA-C 105.663 -1.977 . . . . 0.0 105.663 178.05 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.701 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -131.38 -178.06 4.68 Favored 'General case' 0 N--CA 1.414 -2.273 0 N-CA-C 105.165 -2.161 . . . . 0.0 105.165 -178.072 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -86.6 149.05 47.89 Favored Pre-proline 0 N--CA 1.435 -1.208 0 N-CA-C 103.225 -2.88 . . . . 0.0 103.225 159.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_exo -71.48 0.56 6.69 Favored 'Trans proline' 0 CA--C 1.504 -0.994 0 CA-C-N 123.222 2.186 . . . . 0.0 115.691 -154.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.7 mp0 -94.44 19.19 9.97 Favored 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 126.039 1.736 . . . . 0.0 109.227 -170.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 67.2 t30 66.25 61.54 0.6 Allowed 'General case' 0 CA--C 1.497 -1.083 0 C-N-CA 127.543 2.337 . . . . 0.0 108.803 -178.005 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 85.4 m -122.13 -137.58 0.31 Allowed 'General case' 0 CA--C 1.481 -1.699 0 N-CA-C 103.307 -2.849 . . . . 0.0 103.307 -178.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -136.56 173.24 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.923 1 N-CA-C 99.855 -4.128 . . . . 0.0 99.855 164.279 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -124.59 138.82 54.29 Favored 'General case' 0 N--CA 1.414 -2.268 1 N-CA-C 93.555 -6.461 . . . . 0.0 93.555 174.26 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 54.6 m80 -87.26 -178.32 6.18 Favored 'General case' 0 CA--C 1.492 -1.268 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 -173.023 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.2 t -153.43 173.37 15.76 Favored 'General case' 0 N--CA 1.412 -2.341 1 N-CA-C 95.361 -5.792 . . . . 0.0 95.361 -168.014 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -140.52 142.15 28.04 Favored Pre-proline 0 N--CA 1.409 -2.501 1 N-CA-C 95.352 -5.796 . . . . 0.0 95.352 -177.073 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -75.06 64.81 6.12 Favored 'Trans proline' 0 C--N 1.326 -0.613 0 C-N-CA 123.698 2.932 . . . . 0.0 109.369 172.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 156.99 60.82 0.01 OUTLIER Glycine 0 CA--C 1.482 -1.988 1 N-CA-C 97.82 -6.112 . . . . 0.0 97.82 -170.411 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 m -84.09 46.34 1.19 Allowed 'General case' 0 N--CA 1.436 -1.16 0 C-N-CA 124.994 1.318 . . . . 0.0 113.403 -154.156 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.9 p -70.5 -38.88 74.39 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 124.63 1.172 . . . . 0.0 108.951 -178.171 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.94 -37.1 92.92 Favored Glycine 0 C--N 1.351 1.379 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 177.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 38.7 t -72.75 -31.04 64.64 Favored 'General case' 0 C--N 1.358 0.952 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -57.23 -44.89 84.21 Favored 'General case' 0 C--N 1.354 0.764 0 CA-C-N 119.827 1.194 . . . . 0.0 110.267 178.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -58.2 -48.1 81.39 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 171.091 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 95.9 mt -65.64 -41.09 93.0 Favored 'General case' 0 C--N 1.359 0.991 0 CA-C-O 122.651 1.215 . . . . 0.0 110.813 -176.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 9.0 t -62.99 -46.07 89.4 Favored 'General case' 0 CA--C 1.495 -1.148 0 C-N-CA 125.301 1.44 . . . . 0.0 108.871 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.7 mmtm -65.29 -43.71 90.31 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-O 119.327 -0.368 . . . . 0.0 111.423 -178.138 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 25.8 pt-20 -72.3 -19.05 61.73 Favored 'General case' 0 C--N 1.354 0.8 0 CA-C-N 118.76 0.709 . . . . 0.0 112.351 -174.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -88.45 -17.69 29.87 Favored 'General case' 0 CA--C 1.506 -0.731 0 C-N-CA 123.244 0.618 . . . . 0.0 110.199 175.042 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.88 27.06 5.56 Favored Glycine 0 CA--C 1.489 -1.553 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 169.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -95.69 123.08 7.53 Favored Glycine 0 CA--C 1.49 -1.499 0 N-CA-C 105.467 -3.053 . . . . 0.0 105.467 174.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.8 p -97.28 -4.64 38.38 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -167.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.8 p -159.11 169.94 23.11 Favored 'General case' 0 N--CA 1.427 -1.576 1 N-CA-C 97.859 -4.867 . . . . 0.0 97.859 172.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -176.09 179.65 47.07 Favored Glycine 0 CA--C 1.474 -2.498 1 N-CA-C 102.007 -4.437 . . . . 0.0 102.007 -172.456 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 38.8 m80 -154.12 -161.22 1.2 Allowed 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 100.821 -3.77 . . . . 0.0 100.821 -174.075 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 12.5 t -147.87 161.88 40.39 Favored 'General case' 0 N--CA 1.431 -1.396 1 N-CA-C 98.994 -4.447 . . . . 0.0 98.994 -172.149 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 170.03 -160.23 33.07 Favored Glycine 0 N--CA 1.428 -1.858 1 N-CA-C 102.285 -4.326 . . . . 0.0 102.285 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -134.53 143.13 47.25 Favored 'General case' 0 N--CA 1.433 -1.3 1 N-CA-C 99.482 -4.266 . . . . 0.0 99.482 -176.127 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.47 105.2 11.85 Favored 'General case' 0 CA--C 1.491 -1.322 0 N-CA-C 101.533 -3.506 . . . . 0.0 101.533 174.137 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.406 HG23 ' H ' ' A' ' 41' ' ' VAL . 3.5 t -41.64 -71.59 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.496 -1.109 0 C-N-CA 127.114 2.165 . . . . 0.0 115.136 -163.277 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -77.25 53.03 3.45 Favored Glycine 0 CA--C 1.501 -0.785 0 C-N-CA 126.413 1.958 . . . . 0.0 111.485 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 41.9 m-70 -167.59 -60.52 0.03 OUTLIER 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 105.093 -2.188 . . . . 0.0 105.093 171.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 150.46 -154.05 25.41 Favored Glycine 0 C--N 1.352 1.463 0 N-CA-C 108.397 -1.881 . . . . 0.0 108.397 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 63.2 tp -71.91 125.85 28.25 Favored 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 178.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -131.5 172.46 12.19 Favored 'General case' 0 CA--C 1.476 -1.867 0 N-CA-C 103.684 -2.71 . . . . 0.0 103.684 -163.038 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 38.6 t -125.68 167.91 14.48 Favored 'General case' 0 CA--C 1.486 -1.515 0 N-CA-C 101.508 -3.516 . . . . 0.0 101.508 176.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.4 ' HA ' ' HA ' ' A' ' 5' ' ' TYR . 11.0 t-105 -124.56 147.03 48.69 Favored 'General case' 0 CA--C 1.484 -1.572 0 N-CA-C 101.542 -3.503 . . . . 0.0 101.542 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 22.0 m -139.5 148.72 43.04 Favored 'General case' 0 CA--C 1.486 -1.506 0 N-CA-C 100.516 -3.883 . . . . 0.0 100.516 176.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -122.59 136.56 54.91 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 102.703 -3.073 . . . . 0.0 102.703 -174.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 71.16 49.76 0.32 Allowed 'General case' 0 CA--C 1.499 -1.006 0 C-N-CA 127.313 2.245 . . . . 0.0 110.928 176.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 20.0 mt -88.43 135.1 33.12 Favored Pre-proline 0 CA--C 1.498 -1.047 0 N-CA-C 105.344 -2.095 . . . . 0.0 105.344 177.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -73.15 170.59 19.48 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 122.241 1.961 . . . . 0.0 110.315 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -77.36 -3.94 42.64 Favored 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 -164.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -92.96 1.8 57.12 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 123.944 0.898 . . . . 0.0 109.885 -178.36 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.5 t -102.61 137.2 31.54 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.146 0 N-CA-C 103.386 -2.82 . . . . 0.0 103.386 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -108.14 144.52 16.2 Favored Glycine 0 CA--C 1.481 -2.091 0 N-CA-C 103.376 -3.889 . . . . 0.0 103.376 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 27.3 pt -139.18 -147.46 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.379 0 N-CA-C 103.529 -2.767 . . . . 0.0 103.529 -166.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.701 HD13 ' HB2' ' A' ' 7' ' ' ALA . 15.8 mm -69.73 121.11 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 175.092 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.496 -1.101 0 C-N-CA 124.554 1.141 . . . . 0.0 109.171 -164.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 27.5 m . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 121.11 0.481 . . . . 0.0 110.038 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.31 173.02 9.11 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 106.163 -1.792 . . . . 0.0 106.163 175.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -134.53 140.97 46.54 Favored 'General case' 0 N--CA 1.431 -1.398 1 N-CA-C 95.4 -5.778 . . . . 0.0 95.4 164.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.65 -175.77 33.03 Favored Glycine 0 CA--C 1.475 -2.42 1 N-CA-C 101.56 -4.616 . . . . 0.0 101.56 176.05 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 48' ' ' TRP . 24.4 m-85 -82.95 136.8 34.43 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 101.16 -3.644 . . . . 0.0 101.16 158.376 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.414 ' HA ' HG22 ' A' ' 58' ' ' ILE . 13.5 tt -87.29 132.98 31.29 Favored 'Isoleucine or valine' 0 C--O 1.252 1.19 0 N-CA-C 105.612 -1.995 . . . . 0.0 105.612 -174.343 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.496 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -107.56 -179.68 3.98 Favored 'General case' 0 C--N 1.366 1.314 0 O-C-N 127.691 3.119 . . . . 0.0 108.702 175.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -95.37 135.98 22.87 Favored Pre-proline 0 N--CA 1.433 -1.307 0 N-CA-C 100.508 -3.886 . . . . 0.0 100.508 167.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -78.15 60.42 7.39 Favored 'Trans proline' 0 CA--C 1.514 -0.519 0 C-N-CA 123.836 3.024 . . . . 0.0 112.49 -163.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -118.13 -83.28 0.64 Allowed 'General case' 0 N--CA 1.422 -1.827 1 N-CA-C 96.686 -5.302 . . . . 0.0 96.686 159.542 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 19.8 t30 -166.17 143.48 5.3 Favored 'General case' 0 N--CA 1.419 -1.976 1 N-CA-C 92.616 -6.809 . . . . 0.0 92.616 159.261 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.1 m 176.3 -157.11 0.02 OUTLIER 'General case' 0 CA--C 1.49 -1.333 1 N-CA-C 99.737 -4.172 . . . . 0.0 99.737 178.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.505 HG12 HD12 ' A' ' 59' ' ' ILE . 0.8 OUTLIER -120.83 155.95 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.913 1 N-CA-C 97.46 -5.015 . . . . 0.0 97.46 160.592 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -93.64 136.88 33.47 Favored 'General case' 0 CA--C 1.48 -1.724 1 N-CA-C 96.895 -5.224 . . . . 0.0 96.895 162.595 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 79.0 m80 -85.85 176.27 8.19 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 -169.068 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 12.2 t -140.67 158.23 44.29 Favored 'General case' 0 N--CA 1.413 -2.31 1 N-CA-C 94.056 -6.276 . . . . 0.0 94.056 178.771 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -124.93 138.69 31.94 Favored Pre-proline 0 N--CA 1.419 -1.986 1 N-CA-C 95.654 -5.684 . . . . 0.0 95.654 177.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_exo -63.53 94.94 0.18 Allowed 'Trans proline' 0 CA--C 1.512 -0.598 0 CA-C-N 124.71 2.718 . . . . 0.0 114.182 -171.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 164.64 -173.51 40.57 Favored Glycine 0 N--CA 1.421 -2.308 1 N-CA-C 97.927 -6.069 . . . . 0.0 97.927 -176.708 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.1 m -84.49 -32.59 23.88 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 117.333 0.566 . . . . 0.0 110.421 -177.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.5 m -46.7 -59.68 2.88 Favored 'General case' 0 N--CA 1.439 -0.984 0 C-N-CA 127.594 2.358 . . . . 0.0 116.582 -156.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -72.82 -54.69 7.04 Favored Glycine 0 C--N 1.349 1.286 0 N-CA-C 110.179 -1.169 . . . . 0.0 110.179 -174.197 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 49.1 t -61.29 -48.39 81.62 Favored 'General case' 0 CA--C 1.499 -1.016 0 C-N-CA 125.418 1.487 . . . . 0.0 111.473 -171.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -62.34 -42.78 99.67 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 118.729 0.695 . . . . 0.0 109.543 -175.306 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.0 m -66.5 -50.86 61.85 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 123.567 0.747 . . . . 0.0 110.639 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 55.7 mt -64.09 -41.83 97.15 Favored 'General case' 0 C--N 1.362 1.124 0 C-N-CA 124.697 1.199 . . . . 0.0 110.35 -175.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 15.9 t -62.35 -46.44 88.65 Favored 'General case' 0 CA--C 1.5 -0.967 0 C-N-CA 123.649 0.779 . . . . 0.0 108.98 177.358 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -66.82 -45.0 79.68 Favored 'General case' 0 CA--C 1.504 -0.802 0 O-C-N 121.76 -0.587 . . . . 0.0 110.899 -173.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -72.33 -23.58 61.18 Favored 'General case' 0 C--N 1.354 0.774 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -174.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 42.6 mmtm -88.22 -18.82 27.82 Favored 'General case' 0 C--N 1.354 0.772 0 CA-C-N 118.673 0.669 . . . . 0.0 109.393 175.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.35 41.66 1.35 Allowed Glycine 0 CA--C 1.483 -1.952 0 N-CA-C 109.331 -1.507 . . . . 0.0 109.331 161.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -103.79 128.5 9.52 Favored Glycine 0 CA--C 1.486 -1.76 0 N-CA-C 103.56 -3.816 . . . . 0.0 103.56 171.1 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.7 p -99.87 4.49 45.17 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 122.339 1.066 . . . . 0.0 108.725 -166.381 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 46.4 m -160.3 165.12 31.92 Favored 'General case' 0 N--CA 1.421 -1.893 1 N-CA-C 98.66 -4.571 . . . . 0.0 98.66 166.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 179.69 -173.72 45.44 Favored Glycine 0 N--CA 1.414 -2.801 1 N-CA-C 99.563 -5.415 . . . . 0.0 99.563 -176.476 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 18.6 p80 -171.42 173.65 4.73 Favored 'General case' 0 N--CA 1.43 -1.428 1 N-CA-C 99.463 -4.273 . . . . 0.0 99.463 172.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 49.0 t -94.32 153.92 17.76 Favored 'General case' 0 CA--C 1.502 -0.878 0 N-CA-C 105.361 -2.088 . . . . 0.0 105.361 -176.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.63 -165.3 28.65 Favored Glycine 0 N--CA 1.431 -1.659 0 N-CA-C 104.927 -3.269 . . . . 0.0 104.927 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -148.42 147.58 29.34 Favored 'General case' 0 N--CA 1.429 -1.495 1 N-CA-C 98.012 -4.811 . . . . 0.0 98.012 -170.197 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -130.17 100.7 5.5 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 102.106 -3.294 . . . . 0.0 102.106 167.216 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.9 t -70.22 120.08 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 -173.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 141.07 -48.4 0.82 Allowed Glycine 0 CA--C 1.484 -1.865 1 N-CA-C 102.019 -4.433 . . . . 0.0 102.019 -164.411 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 18.3 m-70 -106.69 -74.93 0.64 Allowed 'General case' 0 CA--C 1.501 -0.934 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 173.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 169.16 -156.53 27.82 Favored Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 105.427 -3.069 . . . . 0.0 105.427 -173.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.78 130.11 42.13 Favored 'General case' 0 C--N 1.358 0.939 0 C-N-CA 127.809 2.443 . . . . 0.0 104.819 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -130.5 174.81 9.53 Favored 'General case' 0 CA--C 1.478 -1.792 0 N-CA-C 104.734 -2.321 . . . . 0.0 104.734 -168.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 19.3 t -121.38 158.16 28.9 Favored 'General case' 0 CA--C 1.492 -1.263 1 N-CA-C 99.575 -4.231 . . . . 0.0 99.575 172.199 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.423 ' HA ' ' HA ' ' A' ' 5' ' ' TYR . 12.3 t-105 -117.81 150.5 39.04 Favored 'General case' 0 CA--C 1.495 -1.173 0 N-CA-C 102.233 -3.247 . . . . 0.0 102.233 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 59.1 m -147.47 152.01 37.35 Favored 'General case' 0 CA--C 1.492 -1.272 0 N-CA-C 105.057 -2.201 . . . . 0.0 105.057 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -119.79 145.14 46.87 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 104.636 -2.357 . . . . 0.0 104.636 171.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 65.2 53.02 1.38 Allowed 'General case' 0 CA--C 1.49 -1.331 0 C-N-CA 127.283 2.233 . . . . 0.0 110.461 170.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 31.2 mt -91.31 139.95 25.53 Favored Pre-proline 0 CA--C 1.498 -1.028 0 N-CA-C 103.602 -2.74 . . . . 0.0 103.602 175.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -72.17 169.96 20.23 Favored 'Trans proline' 0 N--CA 1.447 -1.233 0 C-N-CA 122.544 2.163 . . . . 0.0 109.456 176.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -83.0 13.65 3.85 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -165.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -103.7 4.28 35.19 Favored 'General case' 0 CA--C 1.501 -0.922 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 177.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.0 t -104.85 154.53 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 N-CA-C 103.181 -2.896 . . . . 0.0 103.181 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -122.94 158.62 17.59 Favored Glycine 0 CA--C 1.483 -1.954 1 N-CA-C 102.731 -4.147 . . . . 0.0 102.731 -175.318 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.414 HG22 ' HA ' ' A' ' 6' ' ' ILE . 28.4 pt -151.18 -178.81 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.594 0 N-CA-C 102.469 -3.16 . . . . 0.0 102.469 -163.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.505 HD12 HG12 ' A' ' 13' ' ' VAL . 1.5 mm -69.61 131.9 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.045 0 O-C-N 123.974 0.796 . . . . 0.0 109.813 -166.086 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.6 t . . . . . 0 N--CA 1.429 -1.516 1 N-CA-C 98.98 -4.452 . . . . 0.0 98.98 173.358 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 5.7 m . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 121.811 0.815 . . . . 0.0 111.343 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.411 HH21 HG12 ' A' ' 58' ' ' ILE . 20.5 mtp85 -106.27 147.93 28.56 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 104.834 -2.284 . . . . 0.0 104.834 177.054 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -129.51 120.1 24.83 Favored 'General case' 0 CA--C 1.489 -1.378 1 N-CA-C 98.044 -4.798 . . . . 0.0 98.044 166.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.78 -170.62 26.76 Favored Glycine 0 CA--C 1.481 -2.058 0 N-CA-C 104.89 -3.284 . . . . 0.0 104.89 -169.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -96.6 140.25 31.5 Favored 'General case' 0 CA--C 1.491 -1.321 0 N-CA-C 101.73 -3.433 . . . . 0.0 101.73 168.036 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.7 tt -91.07 149.21 4.14 Favored 'Isoleucine or valine' 0 C--O 1.246 0.894 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 178.432 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.697 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -141.32 173.0 11.9 Favored 'General case' 0 N--CA 1.413 -2.304 1 N-CA-C 99.457 -4.275 . . . . 0.0 99.457 175.42 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -79.97 149.95 71.09 Favored Pre-proline 0 N--CA 1.434 -1.226 0 N-CA-C 103.14 -2.911 . . . . 0.0 103.14 165.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -79.95 -1.87 11.71 Favored 'Trans proline' 0 CA--C 1.499 -1.246 0 CA-C-N 121.113 1.433 . . . . 0.0 112.484 -142.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -96.33 13.79 26.49 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 -177.028 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 53.5 t30 77.28 44.89 0.09 Allowed 'General case' 0 CA--C 1.5 -0.951 0 C-N-CA 127.693 2.397 . . . . 0.0 108.354 178.03 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.3 m -122.82 110.73 15.82 Favored 'General case' 0 CA--C 1.482 -1.664 1 N-CA-C 99.42 -4.289 . . . . 0.0 99.42 -176.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 18.0 m -67.22 160.33 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.234 0 CA-C-N 119.652 1.115 . . . . 0.0 112.925 -163.277 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -101.71 117.49 34.98 Favored 'General case' 0 CA--C 1.479 -1.772 1 N-CA-C 97.341 -5.059 . . . . 0.0 97.341 179.645 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -83.15 125.85 31.97 Favored 'General case' 0 CA--C 1.486 -1.496 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 -158.28 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 40.4 t -92.24 149.59 21.37 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 104.026 -2.583 . . . . 0.0 104.026 175.218 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -134.45 140.0 34.41 Favored Pre-proline 0 N--CA 1.416 -2.141 1 N-CA-C 96.977 -5.194 . . . . 0.0 96.977 172.455 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -68.65 67.67 1.16 Allowed 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 124.124 3.216 . . . . 0.0 113.431 174.241 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -178.13 50.86 0.1 OUTLIER Glycine 0 CA--C 1.487 -1.656 1 N-CA-C 99.41 -5.476 . . . . 0.0 99.41 177.321 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.0 m -86.25 45.02 1.18 Allowed 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 114.104 -1.048 . . . . 0.0 112.909 -147.086 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.5 p -72.93 -42.63 63.27 Favored 'General case' 0 N--CA 1.444 -0.756 0 O-C-N 121.372 -0.83 . . . . 0.0 109.379 -175.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -68.97 -43.71 71.67 Favored Glycine 0 C--N 1.349 1.289 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 177.105 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.7 t -59.73 -44.4 93.79 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 125.455 1.502 . . . . 0.0 111.754 178.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -67.5 -35.32 78.9 Favored 'General case' 0 C--N 1.353 0.737 0 O-C-N 120.974 -1.079 . . . . 0.0 110.596 177.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 40.7 m -70.05 -33.69 72.27 Favored 'General case' 0 N--CA 1.45 -0.448 0 O-C-N 121.052 -1.03 . . . . 0.0 109.955 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 20.3 mt -66.89 -38.38 86.15 Favored 'General case' 0 CA--C 1.496 -1.129 0 O-C-N 121.518 -0.739 . . . . 0.0 109.705 177.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 36.8 t -54.82 -47.89 73.51 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 122.149 -0.344 . . . . 0.0 111.699 170.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.5 mmtm -63.06 -50.32 71.05 Favored 'General case' 0 C--N 1.354 0.784 0 O-C-N 121.394 -0.816 . . . . 0.0 111.276 -178.1 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -70.71 -8.91 55.53 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 112.897 0.702 . . . . 0.0 112.897 -173.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.9 mmmp? -102.69 2.9 36.44 Favored 'General case' 0 C--N 1.354 0.785 0 O-C-N 121.469 -0.769 . . . . 0.0 111.239 173.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 93.96 29.0 10.17 Favored Glycine 0 C--N 1.35 1.341 0 N-CA-C 111.436 -0.666 . . . . 0.0 111.436 169.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -91.93 140.97 15.42 Favored Glycine 0 C--N 1.354 1.578 0 N-CA-C 106.851 -2.5 . . . . 0.0 106.851 171.223 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.4 m -99.11 -26.38 14.23 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 -165.231 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.6 m -147.93 175.64 10.8 Favored 'General case' 0 CA--C 1.482 -1.661 1 N-CA-C 99.92 -4.104 . . . . 0.0 99.92 171.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -171.68 -176.44 40.66 Favored Glycine 0 N--CA 1.42 -2.382 1 N-CA-C 100.579 -5.008 . . . . 0.0 100.579 -173.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 9.7 p80 -177.91 -152.5 0.03 OUTLIER 'General case' 0 N--CA 1.434 -1.254 1 N-CA-C 97.687 -4.931 . . . . 0.0 97.687 173.101 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 24.8 t -149.5 154.77 39.29 Favored 'General case' 0 N--CA 1.425 -1.723 1 N-CA-C 97.904 -4.85 . . . . 0.0 97.904 -173.493 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 178.76 -179.29 48.82 Favored Glycine 0 N--CA 1.425 -2.092 1 N-CA-C 96.8 -6.52 . . . . 0.0 96.8 -178.438 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.419 ' CD1' ' HA ' ' A' ' 45' ' ' LEU . 61.3 t80 -158.25 134.34 9.26 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 101.295 -3.595 . . . . 0.0 101.295 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.599 ' H ' HG23 ' A' ' 41' ' ' VAL . 28.7 mmmt -168.72 57.35 0.05 Allowed 'General case' 0 CA--C 1.499 -1.005 1 N-CA-C 97.747 -4.909 . . . . 0.0 97.747 172.545 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.599 HG23 ' H ' ' A' ' 40' ' ' LYS . 13.7 t -134.89 163.94 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.369 1 N-CA-C 99.579 -4.23 . . . . 0.0 99.579 -169.125 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -116.45 89.46 0.49 Allowed Glycine 0 CA--C 1.487 -1.69 1 N-CA-C 101.822 -4.511 . . . . 0.0 101.822 170.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 60.9 m-70 -175.01 -154.63 0.05 Allowed 'General case' 0 N--CA 1.429 -1.507 1 N-CA-C 96.779 -5.267 . . . . 0.0 96.779 -175.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -83.72 -69.86 1.37 Allowed Glycine 0 C--N 1.351 1.395 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -176.254 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.419 ' HA ' ' CD1' ' A' ' 39' ' ' PHE . 0.1 OUTLIER -167.54 152.7 7.12 Favored 'General case' 0 CA--C 1.489 -1.383 1 N-CA-C 96.363 -5.421 . . . . 0.0 96.363 178.61 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.19 166.06 25.54 Favored 'General case' 0 CA--C 1.486 -1.49 0 N-CA-C 102.521 -3.141 . . . . 0.0 102.521 -167.223 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 99.6 m -101.84 150.96 22.64 Favored 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 104.318 -2.475 . . . . 0.0 104.318 -178.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 44.0 t-105 -93.75 146.33 23.93 Favored 'General case' 0 CA--C 1.496 -1.125 0 N-CA-C 104.327 -2.471 . . . . 0.0 104.327 177.006 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 60.6 m -133.95 141.14 47.18 Favored 'General case' 0 CA--C 1.48 -1.744 0 N-CA-C 104.651 -2.351 . . . . 0.0 104.651 169.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -113.46 128.63 56.51 Favored 'General case' 0 N--CA 1.427 -1.596 0 N-CA-C 101.843 -3.392 . . . . 0.0 101.843 176.631 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 63.33 74.1 0.43 Allowed 'General case' 0 N--CA 1.434 -1.245 0 C-N-CA 126.571 1.948 . . . . 0.0 110.823 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 17.8 mt -97.99 141.9 23.71 Favored Pre-proline 0 CA--C 1.496 -1.122 0 N-CA-C 103.006 -2.961 . . . . 0.0 103.006 164.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -72.85 166.43 30.02 Favored 'Trans proline' 0 N--CA 1.443 -1.476 0 C-N-CA 122.382 2.054 . . . . 0.0 109.186 178.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -77.28 1.25 19.22 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -164.307 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -101.86 5.83 41.2 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 123.855 0.862 . . . . 0.0 109.594 -177.231 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.9 t -97.6 163.93 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 103.428 -2.804 . . . . 0.0 103.428 178.162 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -142.98 150.79 22.62 Favored Glycine 0 CA--C 1.475 -2.426 1 N-CA-C 97.247 -6.341 . . . . 0.0 97.247 -178.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.411 HG12 HH21 ' A' ' 2' ' ' ARG . 18.8 pt -153.77 -147.65 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.49 -1.358 0 N-CA-C 101.553 -3.499 . . . . 0.0 101.553 -154.087 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.697 HD13 ' HB2' ' A' ' 7' ' ' ALA . 7.3 mm -59.51 119.37 3.81 Favored 'Isoleucine or valine' 0 C--N 1.36 1.045 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 174.116 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.496 -1.126 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.491 -162.039 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 24.1 m . . . . . 0 N--CA 1.484 1.263 0 CA-C-O 120.999 0.428 . . . . 0.0 110.455 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.67 173.34 6.92 Favored 'General case' 0 CA--C 1.5 -0.957 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 173.258 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -130.0 140.08 50.94 Favored 'General case' 0 CA--C 1.488 -1.43 1 N-CA-C 94.563 -6.088 . . . . 0.0 94.563 163.421 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.72 176.07 38.22 Favored Glycine 0 CA--C 1.476 -2.346 0 N-CA-C 104.901 -3.279 . . . . 0.0 104.901 -178.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -83.62 126.93 33.35 Favored 'General case' 0 CA--C 1.497 -1.067 0 N-CA-C 101.184 -3.636 . . . . 0.0 101.184 157.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.4 tt -90.3 137.39 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 -172.009 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.68 -150.92 0.34 Allowed 'General case' 0 N--CA 1.427 -1.589 0 C-N-CA 127.605 2.362 . . . . 0.0 107.606 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -119.52 139.54 27.98 Favored Pre-proline 0 N--CA 1.424 -1.769 1 N-CA-C 93.847 -6.353 . . . . 0.0 93.847 165.182 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -83.0 30.81 0.53 Allowed 'Trans proline' 0 CA--C 1.505 -0.966 0 C-N-CA 122.306 2.004 . . . . 0.0 113.916 -135.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -106.25 -89.45 0.43 Allowed 'General case' 0 N--CA 1.424 -1.727 0 N-CA-C 101.43 -3.544 . . . . 0.0 101.43 177.041 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -157.16 138.07 13.39 Favored 'General case' 0 N--CA 1.417 -2.091 1 N-CA-C 92.377 -6.898 . . . . 0.0 92.377 164.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 5.5 m 176.59 -163.54 0.03 OUTLIER 'General case' 0 CA--C 1.489 -1.4 1 N-CA-C 97.414 -5.032 . . . . 0.0 97.414 178.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.499 HG12 HD12 ' A' ' 59' ' ' ILE . 15.4 m -119.73 163.08 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.626 1 N-CA-C 99.19 -4.374 . . . . 0.0 99.19 159.975 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -83.44 164.75 19.71 Favored 'General case' 0 CA--C 1.501 -0.925 0 N-CA-C 102.722 -3.066 . . . . 0.0 102.722 162.529 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 22.8 m80 -90.29 158.12 17.33 Favored 'General case' 0 CA--C 1.484 -1.595 0 N-CA-C 101.538 -3.504 . . . . 0.0 101.538 178.239 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -160.19 177.48 10.63 Favored 'General case' 0 N--CA 1.41 -2.432 1 N-CA-C 95.92 -5.585 . . . . 0.0 95.92 -174.48 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -147.06 167.29 13.94 Favored Pre-proline 0 N--CA 1.412 -2.331 1 N-CA-C 96.019 -5.548 . . . . 0.0 96.019 -161.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.05 49.67 2.33 Favored 'Trans proline' 0 C--N 1.316 -1.169 0 CA-C-N 124.752 2.733 . . . . 0.0 110.61 169.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -172.68 139.34 5.17 Favored Glycine 0 CA--C 1.478 -2.234 1 N-CA-C 99.702 -5.359 . . . . 0.0 99.702 -177.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.0 m -92.15 11.04 26.88 Favored 'General case' 0 CA--C 1.499 -0.994 0 C-N-CA 123.673 0.789 . . . . 0.0 112.27 -165.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.4 m -51.14 -53.74 31.73 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 126.29 1.836 . . . . 0.0 113.871 -168.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.93 -35.52 27.61 Favored Glycine 0 C--N 1.352 1.427 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -177.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 44.1 t -59.95 -44.61 94.3 Favored 'General case' 0 CA--C 1.499 -0.989 0 C-N-CA 125.379 1.471 . . . . 0.0 110.769 -174.433 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -59.13 -44.3 92.02 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 124.478 1.111 . . . . 0.0 110.329 178.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -68.87 -38.17 79.54 Favored 'General case' 0 N--CA 1.443 -0.787 0 O-C-N 121.018 -1.051 . . . . 0.0 112.848 175.337 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 85.8 mt -65.03 -40.33 94.69 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-O 122.29 1.043 . . . . 0.0 109.742 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.6 t -60.14 -46.99 87.78 Favored 'General case' 0 N--CA 1.433 -1.286 0 C-N-CA 123.895 0.878 . . . . 0.0 110.404 -178.455 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -74.26 -29.34 61.63 Favored 'General case' 0 N--CA 1.444 -0.762 0 O-C-N 121.725 -0.609 . . . . 0.0 112.433 -176.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -79.04 -25.33 43.2 Favored 'General case' 0 C--N 1.357 0.918 0 O-C-N 121.023 -1.048 . . . . 0.0 111.094 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.1 mmmp? -82.53 -29.3 30.51 Favored 'General case' 0 C--N 1.358 0.935 0 O-C-N 121.451 -0.781 . . . . 0.0 109.381 172.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 110.25 43.68 1.06 Allowed Glycine 0 CA--C 1.485 -1.793 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 164.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -104.06 161.3 15.69 Favored Glycine 0 CA--C 1.488 -1.608 0 N-CA-C 103.394 -3.883 . . . . 0.0 103.394 166.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.1 p -71.94 -52.34 17.68 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-O 122.281 1.039 . . . . 0.0 109.924 -168.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 39.3 m -160.85 -176.55 5.59 Favored 'General case' 0 N--CA 1.421 -1.924 1 N-CA-C 98.002 -4.814 . . . . 0.0 98.002 170.312 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -172.67 -176.17 41.14 Favored Glycine 0 N--CA 1.416 -2.673 1 N-CA-C 98.766 -5.734 . . . . 0.0 98.766 -169.013 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 39.6 m80 -157.96 169.42 24.62 Favored 'General case' 0 N--CA 1.432 -1.366 1 N-CA-C 99.504 -4.258 . . . . 0.0 99.504 -176.651 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 64.1 m -84.22 159.92 20.9 Favored 'General case' 0 CA--C 1.499 -0.992 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 172.079 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -170.02 -178.51 41.05 Favored Glycine 0 N--CA 1.423 -2.19 1 N-CA-C 99.186 -5.566 . . . . 0.0 99.186 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -151.82 -169.33 3.33 Favored 'General case' 0 N--CA 1.422 -1.849 1 N-CA-C 99.224 -4.362 . . . . 0.0 99.224 174.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -154.21 -141.86 0.11 Allowed 'General case' 0 N--CA 1.424 -1.747 1 N-CA-C 93.637 -6.431 . . . . 0.0 93.637 -168.657 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.2 t -124.95 151.62 30.7 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.293 1 N-CA-C 96.995 -5.187 . . . . 0.0 96.995 149.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 160.49 -137.14 4.84 Favored Glycine 0 N--CA 1.42 -2.398 1 N-CA-C 98.683 -5.767 . . . . 0.0 98.683 -163.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 33.2 m170 -87.49 -35.08 18.41 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -160.205 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -169.92 -65.14 0.04 OUTLIER Glycine 0 C--N 1.357 1.73 0 C-N-CA 118.031 -2.033 . . . . 0.0 110.692 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.26 -178.08 6.43 Favored 'General case' 0 N--CA 1.434 -1.242 1 N-CA-C 94.784 -6.006 . . . . 0.0 94.784 167.786 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -150.36 171.72 16.54 Favored 'General case' 0 CA--C 1.482 -1.667 0 N-CA-C 102.206 -3.257 . . . . 0.0 102.206 174.131 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 8.5 t -110.13 155.61 21.69 Favored 'General case' 0 CA--C 1.489 -1.396 1 N-CA-C 99.378 -4.304 . . . . 0.0 99.378 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 6.5 t-105 -118.57 154.45 32.58 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 102.454 -3.165 . . . . 0.0 102.454 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 9.8 m -151.06 154.86 37.81 Favored 'General case' 0 CA--C 1.49 -1.365 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 176.065 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -117.81 143.42 46.28 Favored 'General case' 0 CA--C 1.495 -1.145 0 N-CA-C 104.689 -2.338 . . . . 0.0 104.689 169.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 65.02 58.27 0.92 Allowed 'General case' 0 CA--C 1.498 -1.023 0 C-N-CA 127.681 2.392 . . . . 0.0 112.507 171.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 31.3 mt -97.03 146.57 31.53 Favored Pre-proline 0 CA--C 1.502 -0.872 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 177.386 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -64.25 162.51 29.76 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 123.167 2.578 . . . . 0.0 111.244 174.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -68.88 -22.79 64.17 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -169.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 18.5 p-10 -94.66 19.82 9.42 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 124.345 1.058 . . . . 0.0 110.376 -176.132 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.3 t -106.91 126.2 62.91 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.274 0 N-CA-C 101.596 -3.483 . . . . 0.0 101.596 169.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -90.95 154.55 23.11 Favored Glycine 0 CA--C 1.492 -1.385 0 N-CA-C 107.923 -2.071 . . . . 0.0 107.923 -174.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 45.8 pt -136.68 -171.84 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 -170.464 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.499 HD12 HG12 ' A' ' 13' ' ' VAL . 2.3 mm -69.77 127.55 31.83 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.275 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 -174.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 42.6 t . . . . . 0 N--CA 1.426 -1.632 0 N-CA-C 101.81 -3.404 . . . . 0.0 101.81 177.908 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 15.2 m . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 121.565 0.698 . . . . 0.0 110.515 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 6.1 mmm180 -101.66 141.89 33.84 Favored 'General case' 0 CA--C 1.495 -1.169 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 -178.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -130.19 116.51 18.53 Favored 'General case' 0 CA--C 1.489 -1.403 1 N-CA-C 95.815 -5.624 . . . . 0.0 95.815 158.699 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.86 -172.2 28.94 Favored Glycine 0 CA--C 1.476 -2.405 1 N-CA-C 100.981 -4.848 . . . . 0.0 100.981 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.446 ' HB2' HD13 ' A' ' 59' ' ' ILE . 40.2 m-85 -76.86 144.87 38.72 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 104.359 -2.46 . . . . 0.0 104.359 161.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.5 tt -91.23 140.99 15.1 Favored 'Isoleucine or valine' 0 C--O 1.249 1.046 0 N-CA-C 104.617 -2.364 . . . . 0.0 104.617 171.465 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.472 ' HB2' ' CD1' ' A' ' 59' ' ' ILE . . . -141.29 176.99 8.4 Favored 'General case' 0 N--CA 1.41 -2.457 1 N-CA-C 98.875 -4.491 . . . . 0.0 98.875 177.215 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -85.44 153.38 58.8 Favored Pre-proline 0 N--CA 1.431 -1.386 0 N-CA-C 103.705 -2.702 . . . . 0.0 103.705 172.238 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -68.1 -16.93 45.53 Favored 'Trans proline' 0 CA--C 1.502 -1.121 0 N-CA-C 117.625 2.125 . . . . 0.0 117.625 -149.599 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.4 mp0 -95.37 18.47 12.48 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-N 119.317 0.962 . . . . 0.0 108.52 -175.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 58.3 t-20 82.06 48.19 0.02 OUTLIER 'General case' 0 C--N 1.356 0.853 0 C-N-CA 125.85 1.66 . . . . 0.0 107.841 168.154 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.3 m -125.49 122.19 35.9 Favored 'General case' 0 CA--C 1.487 -1.477 0 N-CA-C 101.001 -3.703 . . . . 0.0 101.001 178.596 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.1 m -56.88 155.16 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.057 0 CA-C-N 120.858 1.663 . . . . 0.0 113.437 -170.209 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.64 131.84 54.71 Favored 'General case' 0 CA--C 1.468 -2.205 1 N-CA-C 93.344 -6.539 . . . . 0.0 93.344 177.464 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 66.7 m80 -92.83 -156.65 0.49 Allowed 'General case' 0 CA--C 1.49 -1.362 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 -164.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 5.6 t -155.11 168.39 27.17 Favored 'General case' 0 N--CA 1.417 -2.111 1 N-CA-C 94.399 -6.149 . . . . 0.0 94.399 -173.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -122.81 121.45 27.38 Favored Pre-proline 0 N--CA 1.42 -1.935 1 N-CA-C 94.694 -6.039 . . . . 0.0 94.694 175.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -62.45 99.33 0.2 Allowed 'Trans proline' 0 CA--C 1.51 -0.686 0 CA-C-N 123.106 2.145 . . . . 0.0 116.709 -158.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 169.91 -175.6 43.95 Favored Glycine 0 N--CA 1.422 -2.245 1 N-CA-C 96.168 -6.773 . . . . 0.0 96.168 176.651 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -69.95 -39.03 76.27 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 119.433 1.617 . . . . 0.0 109.124 178.532 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -45.63 -49.02 14.69 Favored 'General case' 0 N--CA 1.437 -1.122 0 C-N-CA 130.746 3.619 . . . . 0.0 115.566 -171.401 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.5 -40.88 59.05 Favored Glycine 0 CA--C 1.49 -1.499 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -172.162 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 43.3 t -70.33 -48.1 58.04 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.265 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -52.99 -44.21 67.05 Favored 'General case' 0 C--N 1.354 0.797 0 C-N-CA 124.512 1.125 . . . . 0.0 111.487 -178.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 34.2 m -60.6 -53.84 52.63 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 123.524 0.73 . . . . 0.0 111.142 177.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 83.8 mt -71.86 -40.16 69.17 Favored 'General case' 0 CA--C 1.5 -0.971 0 CA-C-O 122.104 0.955 . . . . 0.0 110.19 -172.101 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 33.7 t -61.07 -44.28 97.62 Favored 'General case' 0 CA--C 1.5 -0.98 0 C-N-CA 124.932 1.293 . . . . 0.0 109.372 178.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm -68.01 -43.89 77.78 Favored 'General case' 0 CA--C 1.502 -0.892 0 O-C-N 121.986 -0.446 . . . . 0.0 110.1 -173.325 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -71.67 -13.0 61.61 Favored 'General case' 0 C--N 1.351 0.663 0 O-C-N 121.691 -0.63 . . . . 0.0 112.512 -175.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.4 mmtm -98.43 -2.81 38.18 Favored 'General case' 0 CA--C 1.504 -0.79 0 C-N-CA 123.23 0.612 . . . . 0.0 110.056 176.03 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.0 32.72 8.73 Favored Glycine 0 CA--C 1.491 -1.416 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 172.041 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -91.44 142.1 15.95 Favored Glycine 0 C--N 1.354 1.556 0 N-CA-C 106.642 -2.583 . . . . 0.0 106.642 171.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.1 m -98.35 -17.24 18.97 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 -163.303 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 59.5 m -159.93 167.5 27.87 Favored 'General case' 0 CA--C 1.482 -1.639 1 N-CA-C 99.226 -4.361 . . . . 0.0 99.226 171.263 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -171.34 174.77 44.99 Favored Glycine 0 CA--C 1.476 -2.365 1 N-CA-C 100.328 -5.109 . . . . 0.0 100.328 -179.219 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 11.3 p80 -158.5 159.49 35.68 Favored 'General case' 0 N--CA 1.426 -1.637 1 N-CA-C 98.452 -4.648 . . . . 0.0 98.452 176.048 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 42.3 t -87.03 159.04 19.1 Favored 'General case' 0 CA--C 1.501 -0.942 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 -173.514 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -174.68 -172.05 39.39 Favored Glycine 0 N--CA 1.423 -2.221 0 N-CA-C 103.861 -3.696 . . . . 0.0 103.861 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -130.08 148.97 51.98 Favored 'General case' 0 N--CA 1.426 -1.636 1 N-CA-C 97.202 -5.11 . . . . 0.0 97.202 -175.168 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.0 tptm -115.24 112.68 22.83 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 100.61 -3.848 . . . . 0.0 100.61 175.091 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.7 t -82.06 117.24 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 -173.275 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 119.79 -13.0 10.78 Favored Glycine 0 C--N 1.347 1.163 0 N-CA-C 107.856 -2.097 . . . . 0.0 107.856 -169.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 35.1 m80 -128.77 -78.83 0.56 Allowed 'General case' 0 CA--C 1.501 -0.929 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 175.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 168.11 -162.18 35.96 Favored Glycine 0 N--CA 1.427 -1.915 0 N-CA-C 103.808 -3.717 . . . . 0.0 103.808 -168.371 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 41.1 tp -63.17 131.08 47.28 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 127.448 2.299 . . . . 0.0 107.123 176.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -136.48 -171.72 2.97 Favored 'General case' 0 CA--C 1.492 -1.286 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 -165.193 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 4.2 t -139.19 156.73 46.9 Favored 'General case' 0 CA--C 1.488 -1.409 0 N-CA-C 100.594 -3.854 . . . . 0.0 100.594 173.035 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.423 ' HA ' ' HA ' ' A' ' 5' ' ' TYR . 15.6 t-105 -115.06 147.59 39.98 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 103.423 -2.806 . . . . 0.0 103.423 178.018 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 63.4 m -136.44 143.93 44.17 Favored 'General case' 0 CA--C 1.489 -1.384 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 172.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -113.64 131.05 56.28 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 102.309 -3.219 . . . . 0.0 102.309 177.218 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 57.86 71.26 0.59 Allowed 'General case' 0 CA--C 1.498 -1.046 0 C-N-CA 126.877 2.071 . . . . 0.0 110.946 178.154 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 15.9 mt -96.03 145.94 30.43 Favored Pre-proline 0 CA--C 1.499 -1.005 0 N-CA-C 102.78 -3.045 . . . . 0.0 102.78 164.329 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.06 166.7 28.33 Favored 'Trans proline' 0 N--CA 1.447 -1.236 0 C-N-CA 122.295 1.997 . . . . 0.0 109.527 172.569 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -77.86 -9.65 59.16 Favored 'General case' 0 CA--C 1.5 -0.973 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -163.471 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -85.65 7.33 23.77 Favored 'General case' 0 CA--C 1.506 -0.737 0 C-N-CA 123.996 0.918 . . . . 0.0 109.95 -179.152 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.0 t -104.35 113.46 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.636 0 N-CA-C 103.877 -2.638 . . . . 0.0 103.877 172.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -84.38 155.5 31.11 Favored Glycine 0 CA--C 1.493 -1.334 0 N-CA-C 104.604 -3.399 . . . . 0.0 104.604 169.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 15.1 pt -144.1 -134.59 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 N-CA-C 102.674 -3.084 . . . . 0.0 102.674 -166.721 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.472 ' CD1' ' HB2' ' A' ' 7' ' ' ALA . 3.2 mp -74.41 112.35 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 N-CA-C 102.39 -3.189 . . . . 0.0 102.39 168.138 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.425 -1.694 0 N-CA-C 100.8 -3.778 . . . . 0.0 100.8 -158.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 28.1 m . . . . . 0 N--CA 1.483 1.176 0 CA-C-O 120.977 0.418 . . . . 0.0 110.528 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -102.16 162.79 12.64 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 172.498 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -125.19 132.12 53.07 Favored 'General case' 0 CA--C 1.493 -1.217 1 N-CA-C 96.192 -5.484 . . . . 0.0 96.192 158.649 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.1 -170.13 26.43 Favored Glycine 0 CA--C 1.481 -2.055 0 N-CA-C 103.979 -3.648 . . . . 0.0 103.979 176.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -83.29 135.82 34.6 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 103.765 -2.679 . . . . 0.0 103.765 162.208 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.8 tt -91.47 147.52 5.21 Favored 'Isoleucine or valine' 0 C--O 1.244 0.814 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 175.416 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.454 ' HB2' HD12 ' A' ' 59' ' ' ILE . . . -149.3 -169.24 3.32 Favored 'General case' 0 N--CA 1.42 -1.952 0 N-CA-C 104.632 -2.358 . . . . 0.0 104.632 178.589 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -88.57 150.45 46.32 Favored Pre-proline 0 N--CA 1.432 -1.365 0 N-CA-C 104.624 -2.362 . . . . 0.0 104.624 169.479 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -70.57 32.47 0.22 Allowed 'Trans proline' 0 CA--C 1.517 -0.347 0 C-N-CA 123.911 3.074 . . . . 0.0 116.029 -174.245 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -109.54 11.05 25.02 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 106.957 -1.498 . . . . 0.0 106.957 -176.396 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 50.1 t30 67.66 53.65 0.7 Allowed 'General case' 0 CA--C 1.5 -0.949 0 C-N-CA 127.798 2.439 . . . . 0.0 108.285 -172.594 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -110.93 -154.72 0.55 Allowed 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -167.026 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.8 m -135.51 161.35 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.592 1 N-CA-C 98.021 -4.807 . . . . 0.0 98.021 163.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -113.64 130.79 56.34 Favored 'General case' 0 CA--C 1.479 -1.76 1 N-CA-C 96.683 -5.302 . . . . 0.0 96.683 173.918 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 27.7 m80 -82.98 141.88 31.78 Favored 'General case' 0 CA--C 1.493 -1.236 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 -173.397 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.402 ' H ' ' HG ' ' A' ' 45' ' ' LEU . 1.8 t -91.39 -179.18 5.32 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 -178.182 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -131.49 126.04 20.97 Favored Pre-proline 0 N--CA 1.412 -2.332 1 N-CA-C 97.073 -5.158 . . . . 0.0 97.073 -174.549 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_exo -62.96 67.97 0.14 Allowed 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.402 2.735 . . . . 0.0 112.029 164.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 171.96 77.21 0.05 OUTLIER Glycine 0 N--CA 1.423 -2.204 1 N-CA-C 95.346 -7.102 . . . . 0.0 95.346 -172.656 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.2 m -49.24 -38.1 25.51 Favored 'General case' 0 N--CA 1.438 -1.045 0 C-N-CA 128.532 2.733 . . . . 0.0 113.404 -159.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.5 m -61.05 -17.4 52.19 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 -177.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.8 -52.11 50.81 Favored Glycine 0 C--N 1.35 1.333 0 CA-C-N 119.982 1.265 . . . . 0.0 110.384 173.131 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -88.23 -20.99 24.77 Favored 'General case' 0 CA--C 1.496 -1.114 0 O-C-N 121.465 -1.021 . . . . 0.0 109.488 -175.58 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -64.28 -34.66 78.63 Favored 'General case' 0 C--N 1.355 0.818 0 O-C-N 121.232 -0.917 . . . . 0.0 109.515 170.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 33.4 m -64.88 -44.79 88.52 Favored 'General case' 0 C--N 1.354 0.771 0 O-C-N 120.8 -1.188 . . . . 0.0 109.862 172.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 84.1 mt -62.4 -43.33 99.08 Favored 'General case' 0 C--N 1.361 1.109 0 CA-C-O 121.732 0.777 . . . . 0.0 110.897 178.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 41.7 t -54.37 -48.86 71.03 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 125.132 1.373 . . . . 0.0 109.875 173.394 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.6 tptp -66.13 -40.55 90.74 Favored 'General case' 0 N--CA 1.441 -0.911 0 O-C-N 121.837 -0.539 . . . . 0.0 111.783 -174.684 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -76.94 -24.57 52.37 Favored 'General case' 0 C--N 1.354 0.773 0 O-C-N 121.772 -0.58 . . . . 0.0 112.455 -177.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -75.43 -39.16 59.24 Favored 'General case' 0 C--N 1.361 1.081 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 171.43 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 120.7 44.05 0.43 Allowed Glycine 0 CA--C 1.483 -1.963 0 N-CA-C 108.066 -2.014 . . . . 0.0 108.066 166.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -95.84 136.97 13.14 Favored Glycine 0 CA--C 1.486 -1.767 0 N-CA-C 103.159 -3.976 . . . . 0.0 103.159 167.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.0 m -102.38 2.87 37.24 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 -158.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.3 m -160.64 165.42 30.64 Favored 'General case' 0 CA--C 1.488 -1.441 1 N-CA-C 99.517 -4.253 . . . . 0.0 99.517 159.433 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -175.67 168.85 41.4 Favored Glycine 0 CA--C 1.48 -2.117 0 N-CA-C 103.513 -3.835 . . . . 0.0 103.513 -177.5 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -174.1 -178.86 1.55 Allowed 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 100.619 -3.845 . . . . 0.0 100.619 -176.22 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 74.4 m -87.47 163.44 16.7 Favored 'General case' 0 CA--C 1.495 -1.157 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -164.07 -177.71 37.03 Favored Glycine 0 N--CA 1.423 -2.209 1 N-CA-C 99.641 -5.384 . . . . 0.0 99.641 176.657 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -136.35 140.24 43.14 Favored 'General case' 0 N--CA 1.431 -1.403 1 N-CA-C 96.929 -5.211 . . . . 0.0 96.929 177.625 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.4 tmtt? -108.99 100.68 9.84 Favored 'General case' 0 CA--C 1.492 -1.265 0 N-CA-C 101.625 -3.472 . . . . 0.0 101.625 178.036 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.1 t -71.42 117.4 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 -178.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 135.46 -38.18 1.83 Allowed Glycine 0 CA--C 1.489 -1.571 0 N-CA-C 105.648 -2.981 . . . . 0.0 105.648 -167.479 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -121.07 -74.41 0.61 Allowed 'General case' 0 CA--C 1.498 -1.033 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 177.065 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 171.71 -158.82 30.0 Favored Glycine 0 N--CA 1.427 -1.918 0 N-CA-C 104.812 -3.315 . . . . 0.0 104.812 -169.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.402 ' HG ' ' H ' ' A' ' 16' ' ' CYS . 43.8 tp -67.19 129.84 41.19 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 126.67 1.988 . . . . 0.0 106.249 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -137.23 175.27 9.76 Favored 'General case' 0 CA--C 1.484 -1.581 0 N-CA-C 102.006 -3.331 . . . . 0.0 102.006 -167.24 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 64.0 m -117.95 160.65 21.1 Favored 'General case' 0 CA--C 1.476 -1.884 0 N-CA-C 102.582 -3.118 . . . . 0.0 102.582 174.257 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 30.7 t-105 -117.52 148.52 41.78 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 103.531 -2.766 . . . . 0.0 103.531 -176.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 67.9 m -142.09 148.2 38.0 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 104.602 -2.369 . . . . 0.0 104.602 172.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -112.77 140.28 47.69 Favored 'General case' 0 CA--C 1.492 -1.272 0 N-CA-C 101.499 -3.519 . . . . 0.0 101.499 168.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 66.66 66.12 0.45 Allowed 'General case' 0 CA--C 1.498 -1.035 0 C-N-CA 126.222 1.809 . . . . 0.0 110.691 169.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 14.4 mt -103.74 138.99 19.69 Favored Pre-proline 0 CA--C 1.498 -1.047 0 N-CA-C 104.609 -2.367 . . . . 0.0 104.609 172.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.9 170.05 20.64 Favored 'Trans proline' 0 N--CA 1.447 -1.241 0 C-N-CA 122.542 2.161 . . . . 0.0 110.751 177.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -76.96 -0.45 24.38 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -172.609 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -87.3 3.35 47.12 Favored 'General case' 0 CA--C 1.505 -0.781 0 O-C-N 121.455 -0.778 . . . . 0.0 110.253 177.217 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.0 t -103.83 148.08 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.278 0 N-CA-C 102.582 -3.118 . . . . 0.0 102.582 178.749 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -129.19 144.38 15.37 Favored Glycine 0 CA--C 1.476 -2.372 1 N-CA-C 97.034 -6.426 . . . . 0.0 97.034 174.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 27.4 pt -142.31 -141.7 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.32 0 N-CA-C 104.305 -2.479 . . . . 0.0 104.305 -154.66 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.454 HD12 ' HB2' ' A' ' 7' ' ' ALA . 1.7 mp -70.25 113.6 6.53 Favored 'Isoleucine or valine' 0 C--N 1.352 0.691 0 N-CA-C 104.548 -2.39 . . . . 0.0 104.548 168.087 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.496 -1.109 0 CA-C-O 122.655 1.217 . . . . 0.0 108.272 -160.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 29.8 m . . . . . 0 N--CA 1.484 1.252 0 CA-C-O 121.129 0.49 . . . . 0.0 110.079 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.5 171.97 7.97 Favored 'General case' 0 CA--C 1.493 -1.219 0 N-CA-C 101.116 -3.661 . . . . 0.0 101.116 161.282 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -129.35 135.25 48.49 Favored 'General case' 0 CA--C 1.485 -1.526 1 N-CA-C 94.007 -6.294 . . . . 0.0 94.007 169.747 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.81 -177.27 34.73 Favored Glycine 0 CA--C 1.473 -2.556 1 N-CA-C 102.957 -4.057 . . . . 0.0 102.957 -177.014 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -87.97 136.53 32.92 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 101.954 -3.35 . . . . 0.0 101.954 164.664 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 16.1 tt -90.62 144.26 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.366 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 -177.547 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -126.26 -148.42 0.39 Allowed 'General case' 0 N--CA 1.423 -1.779 0 C-N-CA 128.674 2.79 . . . . 0.0 106.68 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -133.22 148.78 70.48 Favored Pre-proline 0 N--CA 1.422 -1.857 1 N-CA-C 95.572 -5.714 . . . . 0.0 95.572 166.77 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -82.01 39.9 0.91 Allowed 'Trans proline' 0 CA--C 1.513 -0.543 0 C-N-CA 123.601 2.867 . . . . 0.0 112.151 -154.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -111.64 17.03 20.32 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 106.557 -1.646 . . . . 0.0 106.557 -178.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 49.9 t30 64.56 60.23 0.91 Allowed 'General case' 0 CA--C 1.497 -1.063 0 C-N-CA 128.265 2.626 . . . . 0.0 108.583 -172.506 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -117.9 -158.37 0.71 Allowed 'General case' 0 CA--C 1.493 -1.224 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -166.639 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.1 m -137.26 156.79 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.687 1 N-CA-C 96.103 -5.517 . . . . 0.0 96.103 167.058 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -93.73 121.04 34.76 Favored 'General case' 0 CA--C 1.486 -1.51 0 N-CA-C 100.529 -3.878 . . . . 0.0 100.529 170.121 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -74.88 107.74 7.16 Favored 'General case' 0 CA--C 1.492 -1.26 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 -168.247 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.3 t -83.65 150.14 26.08 Favored 'General case' 0 CA--C 1.485 -1.54 0 CA-C-N 114.399 -1.273 . . . . 0.0 107.68 -164.054 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -112.04 112.99 52.38 Favored Pre-proline 0 N--CA 1.428 -1.572 0 N-CA-C 102.046 -3.316 . . . . 0.0 102.046 178.223 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_exo -59.41 137.59 79.06 Favored 'Trans proline' 0 CA--C 1.503 -1.047 0 C-N-CA 122.625 2.216 . . . . 0.0 110.677 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 119.83 -54.95 0.63 Allowed Glycine 0 CA--C 1.488 -1.607 1 N-CA-C 101.617 -4.593 . . . . 0.0 101.617 -157.86 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.0 m 91.24 12.04 0.04 OUTLIER 'General case' 0 CA--C 1.496 -1.105 0 C-N-CA 127.518 2.327 . . . . 0.0 111.224 174.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.7 m -56.65 -53.88 52.6 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 124.473 1.109 . . . . 0.0 113.047 -172.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -74.8 -31.81 57.81 Favored Glycine 0 C--N 1.35 1.342 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.024 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.7 t -67.03 -51.68 51.79 Favored 'General case' 0 CA--C 1.488 -1.419 0 C-N-CA 124.174 0.99 . . . . 0.0 109.602 -174.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -65.44 -36.74 84.82 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -176.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.8 m -60.33 -50.5 73.38 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 121.52 -0.738 . . . . 0.0 111.137 173.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 32.3 mt -64.5 -42.0 96.09 Favored 'General case' 0 CA--C 1.498 -1.046 0 C-N-CA 123.9 0.88 . . . . 0.0 109.99 -179.119 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 19.5 t -55.91 -46.0 78.53 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 124.123 0.969 . . . . 0.0 110.82 176.288 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 37.5 mtmm -63.55 -46.67 84.89 Favored 'General case' 0 C--N 1.356 0.864 0 CA-C-N 118.213 0.461 . . . . 0.0 111.259 -177.533 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -73.13 -21.95 60.63 Favored 'General case' 0 C--N 1.351 0.636 0 O-C-N 121.666 -0.646 . . . . 0.0 112.267 -175.152 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 48.9 mmtm -86.14 -10.39 54.91 Favored 'General case' 0 C--N 1.355 0.844 0 O-C-N 121.855 -0.528 . . . . 0.0 110.907 174.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.57 28.85 7.72 Favored Glycine 0 CA--C 1.489 -1.535 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 168.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -94.83 146.46 18.18 Favored Glycine 0 CA--C 1.487 -1.68 0 N-CA-C 105.037 -3.225 . . . . 0.0 105.037 165.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.5 p -72.58 -43.33 63.52 Favored 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 124.483 1.113 . . . . 0.0 110.354 -166.085 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 34.9 m -160.63 -178.59 6.98 Favored 'General case' 0 N--CA 1.422 -1.863 1 N-CA-C 97.8 -4.889 . . . . 0.0 97.8 165.425 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -174.7 177.35 46.84 Favored Glycine 0 N--CA 1.417 -2.605 1 N-CA-C 98.947 -5.661 . . . . 0.0 98.947 -167.294 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 81.8 m-70 -164.52 171.28 14.77 Favored 'General case' 0 CA--C 1.492 -1.257 1 N-CA-C 98.621 -4.585 . . . . 0.0 98.621 -171.475 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 72.5 m -81.16 160.52 24.35 Favored 'General case' 0 CA--C 1.502 -0.881 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 165.291 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -167.34 171.77 42.1 Favored Glycine 0 CA--C 1.481 -2.084 1 N-CA-C 98.58 -5.808 . . . . 0.0 98.58 173.239 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -156.26 140.38 16.45 Favored 'General case' 0 N--CA 1.426 -1.628 1 N-CA-C 97.82 -4.882 . . . . 0.0 97.82 -176.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -155.42 47.96 0.52 Allowed 'General case' 0 CA--C 1.491 -1.298 1 N-CA-C 99.514 -4.254 . . . . 0.0 99.514 174.847 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.404 HG12 ' H ' ' A' ' 42' ' ' GLY 0.276 2.1 t 61.68 -147.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 N-CA-C 105.482 -2.044 . . . . 0.0 105.482 -152.271 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.404 ' H ' HG12 ' A' ' 41' ' ' VAL . . . 142.93 -88.11 0.18 Allowed Glycine 0 CA--C 1.48 -2.109 1 N-CA-C 100.853 -4.899 . . . . 0.0 100.853 -178.455 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 10.4 m-70 -150.26 -69.57 0.19 Allowed 'General case' 0 CA--C 1.493 -1.223 1 N-CA-C 98.215 -4.735 . . . . 0.0 98.215 168.179 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -115.01 -159.37 12.29 Favored Glycine 0 N--CA 1.437 -1.267 0 N-CA-C 103.304 -3.918 . . . . 0.0 103.304 168.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -83.18 110.98 18.51 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 -174.291 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -98.77 175.39 5.98 Favored 'General case' 0 CA--C 1.492 -1.28 0 C-N-CA 124.649 1.18 . . . . 0.0 108.182 -167.123 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 10.8 t -111.12 148.65 32.24 Favored 'General case' 0 CA--C 1.499 -1.018 0 N-CA-C 102.387 -3.19 . . . . 0.0 102.387 -174.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 70.0 t-105 -100.19 150.64 22.31 Favored 'General case' 0 CA--C 1.492 -1.286 0 N-CA-C 104.355 -2.461 . . . . 0.0 104.355 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 26.1 m -141.01 143.72 34.59 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 101.422 -3.547 . . . . 0.0 101.422 166.57 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -110.11 23.34 14.45 Favored 'General case' 0 CA--C 1.503 -0.862 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -167.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -177.29 156.44 1.23 Allowed 'General case' 0 N--CA 1.418 -2.037 1 N-CA-C 94.321 -6.177 . . . . 0.0 94.321 170.729 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 14.8 mt -159.41 154.22 21.15 Favored Pre-proline 0 CA--C 1.488 -1.437 1 N-CA-C 96.128 -5.508 . . . . 0.0 96.128 157.53 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.18 161.39 46.18 Favored 'Trans proline' 0 N--CA 1.446 -1.287 0 C-N-CA 122.006 1.804 . . . . 0.0 108.328 165.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -77.92 -6.52 54.6 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -165.041 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -86.91 -1.79 58.1 Favored 'General case' 0 CA--C 1.506 -0.73 0 O-C-N 121.439 -0.788 . . . . 0.0 109.629 -178.291 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.1 t -94.16 111.01 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.16 0 N-CA-C 104.287 -2.486 . . . . 0.0 104.287 177.279 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -84.98 143.65 20.59 Favored Glycine 0 CA--C 1.492 -1.382 0 N-CA-C 106.627 -2.589 . . . . 0.0 106.627 176.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 13.6 pt -125.34 -134.65 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.276 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 -162.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.1 mp -76.18 119.45 24.29 Favored 'Isoleucine or valine' 0 C--N 1.354 0.784 0 N-CA-C 102.884 -3.006 . . . . 0.0 102.884 165.447 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.9 t . . . . . 0 CA--C 1.497 -1.065 0 C-N-CA 124.954 1.302 . . . . 0.0 109.175 -163.496 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 34.1 m . . . . . 0 N--CA 1.485 1.284 0 CA-C-O 121.17 0.509 . . . . 0.0 109.903 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -106.11 157.95 17.18 Favored 'General case' 0 CA--C 1.499 -0.987 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 171.477 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -126.44 125.73 42.63 Favored 'General case' 0 CA--C 1.484 -1.589 1 N-CA-C 94.386 -6.153 . . . . 0.0 94.386 156.792 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.72 178.34 37.64 Favored Glycine 0 CA--C 1.475 -2.41 0 N-CA-C 107.601 -2.2 . . . . 0.0 107.601 -171.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -82.65 129.79 35.01 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 166.708 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.444 HG13 HG22 ' A' ' 58' ' ' ILE . 14.0 tt -91.05 144.18 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 -179.704 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.448 ' HB2' HD12 ' A' ' 59' ' ' ILE . . . -144.85 179.34 7.39 Favored 'General case' 0 N--CA 1.417 -2.078 1 N-CA-C 98.731 -4.544 . . . . 0.0 98.731 -177.405 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -79.64 156.2 75.55 Favored Pre-proline 0 N--CA 1.437 -1.12 0 CA-C-O 116.735 -1.603 . . . . 0.0 106.836 178.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -67.9 -18.82 46.85 Favored 'Trans proline' 0 CA--C 1.504 -0.999 0 CA-C-N 122.989 2.103 . . . . 0.0 116.709 -152.066 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -101.21 7.12 43.19 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -177.345 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 86.73 126.62 0.03 OUTLIER 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 128.822 2.849 . . . . 0.0 107.112 176.591 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 156.9 126.47 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.345 1 N-CA-C 99.16 -4.385 . . . . 0.0 99.16 172.294 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.0 m -63.36 156.46 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.23 0 CA-C-O 123.011 1.386 . . . . 0.0 112.705 -162.266 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -100.52 121.16 41.12 Favored 'General case' 0 N--CA 1.42 -1.947 1 N-CA-C 97.317 -5.068 . . . . 0.0 97.317 176.609 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 45.6 m80 -80.83 126.04 30.84 Favored 'General case' 0 CA--C 1.487 -1.472 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 -166.13 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 9.2 t -94.11 174.05 7.35 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 -176.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -146.31 156.71 49.88 Favored Pre-proline 0 N--CA 1.417 -2.093 1 N-CA-C 97.311 -5.07 . . . . 0.0 97.311 -177.756 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_exo -69.65 -14.94 37.18 Favored 'Trans proline' 0 CA--C 1.511 -0.653 0 CA-C-N 122.977 2.099 . . . . 0.0 111.715 175.704 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -113.18 81.84 0.3 Allowed Glycine 0 CA--C 1.486 -1.778 1 N-CA-C 101.162 -4.775 . . . . 0.0 101.162 169.771 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 m -82.09 29.07 0.42 Allowed 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 125.647 1.579 . . . . 0.0 113.1 -160.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.5 m -56.65 -50.98 70.47 Favored 'General case' 0 N--CA 1.435 -1.193 0 C-N-CA 126.879 2.072 . . . . 0.0 113.737 -161.437 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.03 -31.87 72.69 Favored Glycine 0 C--N 1.352 1.439 0 N-CA-C 111.374 -0.69 . . . . 0.0 111.374 -176.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.3 t -78.49 -31.8 47.91 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -174.279 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -62.08 -41.83 98.59 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 123.708 0.803 . . . . 0.0 110.436 174.259 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.02 -35.31 80.3 Favored 'General case' 0 C--N 1.352 0.707 0 O-C-N 121.048 -1.032 . . . . 0.0 112.196 174.568 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 92.0 mt -67.45 -41.76 84.21 Favored 'General case' 0 C--N 1.357 0.893 0 CA-C-O 121.938 0.875 . . . . 0.0 109.663 176.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 27.2 t -55.41 -47.57 75.71 Favored 'General case' 0 CA--C 1.507 -0.691 0 C-N-CA 125.027 1.331 . . . . 0.0 110.135 177.476 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -59.04 -50.79 72.73 Favored 'General case' 0 C--N 1.354 0.797 0 C-N-CA 122.827 0.451 . . . . 0.0 111.697 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -71.16 -23.11 62.0 Favored 'General case' 0 C--N 1.356 0.871 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -174.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.0 mmtp -81.92 -14.8 55.63 Favored 'General case' 0 C--N 1.355 0.805 0 C-N-CA 123.147 0.579 . . . . 0.0 110.713 175.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 110.26 24.39 5.7 Favored Glycine 0 CA--C 1.49 -1.472 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 167.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -97.11 122.31 7.38 Favored Glycine 0 C--N 1.353 1.484 0 N-CA-C 105.899 -2.88 . . . . 0.0 105.899 177.465 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.7 p -99.57 9.2 43.62 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 122.225 1.012 . . . . 0.0 109.162 -168.052 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 57.9 m -160.11 164.85 32.69 Favored 'General case' 0 CA--C 1.479 -1.786 1 N-CA-C 97.598 -4.964 . . . . 0.0 97.598 164.319 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.457 ' HA2' ' HA ' ' A' ' 49' ' ' CYS . . . -158.15 164.95 33.59 Favored Glycine 0 CA--C 1.465 -3.07 1 N-CA-C 99.605 -5.398 . . . . 0.0 99.605 -173.427 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -156.76 -159.18 0.84 Allowed 'General case' 0 N--CA 1.421 -1.88 1 N-CA-C 98.185 -4.746 . . . . 0.0 98.185 -177.8 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 34.0 t -148.13 166.43 27.88 Favored 'General case' 0 N--CA 1.424 -1.733 1 N-CA-C 97.798 -4.89 . . . . 0.0 97.798 -170.264 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -179.7 -161.83 27.67 Favored Glycine 0 N--CA 1.421 -2.306 1 N-CA-C 100.571 -5.012 . . . . 0.0 100.571 176.149 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -140.55 148.27 40.75 Favored 'General case' 0 N--CA 1.432 -1.358 1 N-CA-C 100.072 -4.047 . . . . 0.0 100.072 -178.035 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.9 mmpt? -123.74 103.06 8.16 Favored 'General case' 0 CA--C 1.491 -1.295 0 N-CA-C 104.027 -2.583 . . . . 0.0 104.027 173.092 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.7 t -74.06 118.71 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 136.65 -36.72 1.95 Allowed Glycine 0 CA--C 1.487 -1.712 0 N-CA-C 104.131 -3.587 . . . . 0.0 104.131 -165.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 39.1 m170 -125.56 -68.89 0.81 Allowed 'General case' 0 CA--C 1.499 -0.99 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 178.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 162.02 -150.58 20.07 Favored Glycine 0 N--CA 1.429 -1.774 0 N-CA-C 105.297 -3.121 . . . . 0.0 105.297 -175.62 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -70.78 127.72 33.61 Favored 'General case' 0 C--N 1.353 0.745 0 N-CA-C 103.66 -2.718 . . . . 0.0 103.66 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.67 155.77 49.89 Favored 'General case' 0 CA--C 1.479 -1.759 0 N-CA-C 101.235 -3.617 . . . . 0.0 101.235 -168.296 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 58.0 m -100.44 177.67 4.96 Favored 'General case' 0 CA--C 1.49 -1.334 0 N-CA-C 103.663 -2.717 . . . . 0.0 103.663 -176.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 3.8 t-105 -140.92 150.08 42.7 Favored 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 101.507 -3.516 . . . . 0.0 101.507 -177.085 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.457 ' HA ' ' HA2' ' A' ' 35' ' ' GLY . 56.1 m -142.85 154.4 44.12 Favored 'General case' 0 CA--C 1.493 -1.224 0 N-CA-C 104.667 -2.346 . . . . 0.0 104.667 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -123.34 135.47 54.19 Favored 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 175.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 77.7 41.89 0.13 Allowed 'General case' 0 CA--C 1.493 -1.215 0 C-N-CA 127.428 2.291 . . . . 0.0 110.612 169.375 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 49.2 mt -80.69 135.57 52.47 Favored Pre-proline 0 CA--C 1.502 -0.876 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 177.04 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -72.02 169.61 20.94 Favored 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 122.416 2.077 . . . . 0.0 109.513 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -76.44 -5.79 48.93 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -163.359 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -86.17 -7.7 58.37 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 123.432 0.693 . . . . 0.0 110.208 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.0 t -93.17 126.93 45.54 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.045 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 -176.207 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -97.29 150.89 19.65 Favored Glycine 0 CA--C 1.485 -1.842 0 N-CA-C 104.075 -3.61 . . . . 0.0 104.075 178.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.444 HG22 HG13 ' A' ' 6' ' ' ILE . 20.2 pt -148.25 -143.74 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 N-CA-C 102.032 -3.321 . . . . 0.0 102.032 -166.79 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.448 HD12 ' HB2' ' A' ' 7' ' ' ALA . 2.9 mp -71.8 119.78 18.89 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 104.881 -2.266 . . . . 0.0 104.881 168.559 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.426 -1.658 0 N-CA-C 102.198 -3.26 . . . . 0.0 102.198 -156.088 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 25.3 m . . . . . 0 N--CA 1.488 1.459 0 CA-C-O 121.107 0.479 . . . . 0.0 110.962 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.53 166.22 16.43 Favored 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 170.085 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -130.1 131.81 45.88 Favored 'General case' 0 CA--C 1.492 -1.276 1 N-CA-C 95.173 -5.862 . . . . 0.0 95.173 165.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.86 -173.34 30.4 Favored Glycine 0 CA--C 1.476 -2.372 0 N-CA-C 104.24 -3.544 . . . . 0.0 104.24 178.358 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -80.04 131.83 35.86 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 102.156 -3.275 . . . . 0.0 102.156 157.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.2 tt -90.72 145.79 6.99 Favored 'Isoleucine or valine' 0 C--O 1.243 0.756 0 N-CA-C 105.52 -2.03 . . . . 0.0 105.52 -177.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.678 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -126.28 -176.17 3.58 Favored 'General case' 0 N--CA 1.424 -1.742 0 C-N-CA 126.165 1.786 . . . . 0.0 106.748 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -82.95 145.31 49.43 Favored Pre-proline 0 N--CA 1.437 -1.119 0 N-CA-C 104.548 -2.389 . . . . 0.0 104.548 157.289 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_exo -67.28 -22.06 46.87 Favored 'Trans proline' 0 CA--C 1.502 -1.107 0 CA-C-N 122.827 2.045 . . . . 0.0 116.295 -149.548 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -84.67 38.7 0.71 Allowed 'General case' 0 N--CA 1.438 -1.035 0 C-N-CA 124.825 1.25 . . . . 0.0 110.784 -167.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 50.7 t30 63.85 48.46 3.17 Favored 'General case' 0 C--N 1.354 0.782 0 C-N-CA 127.812 2.445 . . . . 0.0 110.143 -178.449 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -104.15 -146.68 0.38 Allowed 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 -177.645 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.557 HG12 HD12 ' A' ' 59' ' ' ILE . 3.1 m -133.11 -166.01 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.338 1 N-CA-C 97.653 -4.943 . . . . 0.0 97.653 164.373 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -120.41 155.41 33.52 Favored 'General case' 0 CA--C 1.491 -1.315 1 N-CA-C 95.704 -5.665 . . . . 0.0 95.704 170.845 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 33.4 m80 -91.1 99.2 12.26 Favored 'General case' 0 CA--C 1.486 -1.481 0 N-CA-C 102.846 -3.02 . . . . 0.0 102.846 175.084 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 7.2 t -104.94 -176.02 2.96 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 104.273 -2.492 . . . . 0.0 104.273 174.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -137.85 164.55 40.23 Favored Pre-proline 0 N--CA 1.417 -2.084 1 N-CA-C 99.15 -4.389 . . . . 0.0 99.15 -158.266 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.25 55.87 3.65 Favored 'Trans proline' 0 C--N 1.322 -0.863 0 C-N-CA 123.263 2.642 . . . . 0.0 111.063 171.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -173.47 146.31 8.81 Favored Glycine 0 N--CA 1.421 -2.362 1 N-CA-C 99.577 -5.409 . . . . 0.0 99.577 175.526 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.4 m -93.35 8.77 39.13 Favored 'General case' 0 N--CA 1.438 -1.068 0 C-N-CA 123.92 0.888 . . . . 0.0 110.397 -174.145 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -50.38 -51.64 44.24 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 128.492 2.717 . . . . 0.0 114.131 -164.426 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -89.97 -22.01 37.29 Favored Glycine 0 C--N 1.351 1.365 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.9 t -81.28 -12.49 59.06 Favored 'General case' 0 C--N 1.355 0.835 0 O-C-N 121.046 -1.267 . . . . 0.0 109.592 -172.488 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -51.79 -55.21 21.16 Favored 'General case' 0 C--N 1.352 0.694 0 C-N-CA 124.584 1.154 . . . . 0.0 109.793 166.177 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.74 -44.98 96.01 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 123.965 0.906 . . . . 0.0 112.131 175.09 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.52 -39.02 93.01 Favored 'General case' 0 C--N 1.361 1.073 0 CA-C-N 118.977 0.808 . . . . 0.0 111.232 -177.315 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.6 t -68.05 -42.74 80.06 Favored 'General case' 0 N--CA 1.439 -0.987 0 O-C-N 121.301 -0.874 . . . . 0.0 109.51 -178.647 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -77.89 -26.41 49.13 Favored 'General case' 0 CA--C 1.505 -0.77 0 O-C-N 121.007 -1.058 . . . . 0.0 111.963 -174.103 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -76.66 -21.55 55.28 Favored 'General case' 0 C--N 1.355 0.815 0 O-C-N 121.243 -0.911 . . . . 0.0 110.988 179.088 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -79.93 -48.82 12.8 Favored 'General case' 0 CA--C 1.494 -1.174 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 168.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 120.83 48.36 0.3 Allowed Glycine 0 CA--C 1.489 -1.576 0 N-CA-C 108.214 -1.954 . . . . 0.0 108.214 177.016 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.07 139.29 14.73 Favored Glycine 0 N--CA 1.433 -1.531 0 N-CA-C 103.689 -3.764 . . . . 0.0 103.689 164.193 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -98.6 2.87 47.77 Favored 'General case' 0 N--CA 1.438 -1.05 0 C-N-CA 124.258 1.023 . . . . 0.0 109.607 -169.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 24.1 m -160.42 159.25 30.76 Favored 'General case' 0 CA--C 1.474 -1.954 0 N-CA-C 100.529 -3.878 . . . . 0.0 100.529 165.471 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.4 ' HA2' ' HA ' ' A' ' 49' ' ' CYS . . . -165.82 169.79 40.31 Favored Glycine 0 N--CA 1.418 -2.555 1 N-CA-C 101.407 -4.677 . . . . 0.0 101.407 -179.146 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 35.1 m80 -161.4 -170.16 2.54 Favored 'General case' 0 CA--C 1.491 -1.295 1 N-CA-C 98.558 -4.608 . . . . 0.0 98.558 -174.098 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 73.1 m -145.87 162.57 37.42 Favored 'General case' 0 CA--C 1.485 -1.553 1 N-CA-C 98.852 -4.499 . . . . 0.0 98.852 172.17 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 173.29 179.97 44.31 Favored Glycine 0 N--CA 1.425 -2.049 1 N-CA-C 100.072 -5.211 . . . . 0.0 100.072 -177.099 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -151.1 141.91 22.84 Favored 'General case' 0 N--CA 1.426 -1.674 1 N-CA-C 96.407 -5.405 . . . . 0.0 96.407 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.9 mttp -157.74 58.22 0.49 Allowed 'General case' 0 CA--C 1.488 -1.434 1 N-CA-C 98.303 -4.703 . . . . 0.0 98.303 173.559 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.732 HG12 ' H ' ' A' ' 42' ' ' GLY 0.272 2.9 t 69.77 -172.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 C-N-CA 127.054 2.142 . . . . 0.0 105.543 -158.264 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.732 ' H ' HG12 ' A' ' 41' ' ' VAL . . . 145.04 -127.96 3.03 Favored Glycine 0 N--CA 1.421 -2.338 1 N-CA-C 97.716 -6.153 . . . . 0.0 97.716 -173.031 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -130.37 -39.16 1.33 Allowed 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 104.515 -2.402 . . . . 0.0 104.515 175.671 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -158.09 -177.0 30.78 Favored Glycine 0 N--CA 1.425 -2.051 1 N-CA-C 95.798 -6.921 . . . . 0.0 95.798 176.727 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.2 tt -72.25 114.94 10.91 Favored 'General case' 0 C--N 1.351 0.666 0 CA-C-N 118.693 1.247 . . . . 0.0 108.177 -171.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -105.85 -177.81 3.47 Favored 'General case' 0 CA--C 1.485 -1.529 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 -164.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 34.6 t -115.0 161.56 18.17 Favored 'General case' 0 CA--C 1.493 -1.236 0 N-CA-C 102.432 -3.173 . . . . 0.0 102.432 -175.445 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 33.0 t-105 -117.57 151.75 36.52 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 102.878 -3.008 . . . . 0.0 102.878 178.529 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.4 ' HA ' ' HA2' ' A' ' 35' ' ' GLY . 15.0 m -148.21 149.79 32.58 Favored 'General case' 0 CA--C 1.495 -1.157 0 N-CA-C 103.428 -2.805 . . . . 0.0 103.428 171.564 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -111.3 141.99 44.11 Favored 'General case' 0 CA--C 1.495 -1.15 0 N-CA-C 104.212 -2.514 . . . . 0.0 104.212 171.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 66.01 53.28 1.11 Allowed 'General case' 0 CA--C 1.491 -1.298 0 C-N-CA 127.488 2.315 . . . . 0.0 111.164 167.466 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 40.0 mt -94.81 142.93 25.35 Favored Pre-proline 0 CA--C 1.495 -1.147 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 177.376 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -72.01 166.74 28.7 Favored 'Trans proline' 0 N--CA 1.447 -1.258 0 C-N-CA 122.61 2.206 . . . . 0.0 110.134 175.148 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -68.99 -17.07 63.88 Favored 'General case' 0 CA--C 1.506 -0.728 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -167.321 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -76.48 -6.82 53.45 Favored 'General case' 0 CA--C 1.504 -0.81 0 O-C-N 121.439 -0.788 . . . . 0.0 110.942 -178.258 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.3 t -94.09 107.96 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 N-CA-C 104.474 -2.417 . . . . 0.0 104.474 178.107 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -81.63 148.39 27.6 Favored Glycine 0 CA--C 1.489 -1.549 0 N-CA-C 106.393 -2.683 . . . . 0.0 106.393 178.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 41.0 pt -133.66 -160.05 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.303 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 -165.008 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.678 HD13 ' HB2' ' A' ' 7' ' ' ALA . 0.3 OUTLIER -73.7 121.15 24.07 Favored 'Isoleucine or valine' 0 C--N 1.362 1.146 0 N-CA-C 104.829 -2.286 . . . . 0.0 104.829 176.042 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.4 t . . . . . 0 N--CA 1.44 -0.943 0 N-CA-C 101.899 -3.371 . . . . 0.0 101.899 -162.567 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 33.5 m . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 121.354 0.597 . . . . 0.0 109.629 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -94.24 148.46 22.17 Favored 'General case' 0 CA--C 1.502 -0.879 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 173.679 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -122.37 118.19 27.84 Favored 'General case' 0 CA--C 1.489 -1.399 1 N-CA-C 94.394 -6.15 . . . . 0.0 94.394 154.23 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.61 -174.13 31.1 Favored Glycine 0 CA--C 1.479 -2.214 0 N-CA-C 106.196 -2.762 . . . . 0.0 106.196 -171.092 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 48' ' ' TRP . 92.3 m-85 -86.22 134.96 33.74 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 104.872 -2.27 . . . . 0.0 104.872 167.121 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 16.9 tt -90.63 151.23 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 176.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.513 ' HB2' ' CD1' ' A' ' 59' ' ' ILE . . . -156.3 -177.81 6.86 Favored 'General case' 0 N--CA 1.416 -2.144 1 N-CA-C 98.949 -4.463 . . . . 0.0 98.949 -177.142 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -93.53 156.91 39.31 Favored Pre-proline 0 N--CA 1.435 -1.186 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 178.776 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -77.36 -1.96 12.14 Favored 'Trans proline' 0 CA--C 1.509 -0.745 0 CA-C-N 121.283 1.494 . . . . 0.0 115.254 -155.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -95.13 13.41 25.39 Favored 'General case' 0 C--N 1.358 0.96 0 CA-C-N 121.214 1.825 . . . . 0.0 107.498 176.557 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 43.4 t30 83.23 43.44 0.02 OUTLIER 'General case' 0 C--N 1.361 1.102 0 C-N-CA 126.081 1.752 . . . . 0.0 107.494 168.26 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.44 ' O ' ' HB1' ' A' ' 7' ' ' ALA . 0.7 OUTLIER -131.36 132.18 44.25 Favored 'General case' 0 CA--C 1.487 -1.462 0 N-CA-C 102.374 -3.195 . . . . 0.0 102.374 -173.148 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.481 HG12 HD11 ' A' ' 59' ' ' ILE 0.253 1.7 m -60.57 159.25 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 CA-C-O 123.435 1.588 . . . . 0.0 115.228 -173.411 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -114.73 139.97 49.26 Favored 'General case' 0 N--CA 1.416 -2.157 1 N-CA-C 92.687 -6.783 . . . . 0.0 92.687 169.554 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -90.42 -162.28 0.88 Allowed 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 178.523 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 25.4 t -150.06 171.62 16.57 Favored 'General case' 0 N--CA 1.417 -2.121 1 N-CA-C 97.52 -4.993 . . . . 0.0 97.52 -172.244 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -127.28 123.68 23.42 Favored Pre-proline 0 N--CA 1.419 -2.018 1 N-CA-C 95.925 -5.583 . . . . 0.0 95.925 -178.125 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -55.88 96.6 0.06 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.604 0 CA-C-N 124.224 2.544 . . . . 0.0 116.691 -168.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 159.92 -159.36 30.61 Favored Glycine 0 N--CA 1.422 -2.267 1 N-CA-C 98.07 -6.012 . . . . 0.0 98.07 -178.166 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.8 p -94.25 -43.67 8.33 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 170.717 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -39.74 -61.95 0.77 Allowed 'General case' 0 N--CA 1.442 -0.875 0 C-N-CA 128.812 2.845 . . . . 0.0 118.243 -150.287 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -72.09 -39.5 58.28 Favored Glycine 0 C--N 1.348 1.227 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -173.301 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 9.6 t -83.65 -28.45 28.39 Favored 'General case' 0 CA--C 1.5 -0.962 0 O-C-N 121.277 -1.131 . . . . 0.0 109.329 -177.016 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -60.81 -46.52 90.2 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-N 119.353 0.979 . . . . 0.0 109.679 175.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.9 p -67.06 -39.15 86.83 Favored 'General case' 0 N--CA 1.44 -0.941 0 O-C-N 121.894 -0.504 . . . . 0.0 111.721 179.411 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 40.7 mt -63.22 -47.61 81.77 Favored 'General case' 0 C--N 1.357 0.899 0 O-C-N 121.032 -1.043 . . . . 0.0 111.127 172.125 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 3.0 t -66.01 -32.33 73.75 Favored 'General case' 0 CA--C 1.501 -0.911 0 O-C-N 120.155 -1.59 . . . . 0.0 110.827 -175.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -65.41 -35.26 80.41 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 122.943 0.497 . . . . 0.0 111.488 176.039 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -75.93 -34.18 59.87 Favored 'General case' 0 C--N 1.359 0.999 0 O-C-N 121.559 -0.713 . . . . 0.0 111.108 177.148 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.2 mmmp? -72.15 -40.23 68.17 Favored 'General case' 0 C--N 1.36 1.026 0 C-N-CA 123.535 0.734 . . . . 0.0 110.519 178.127 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 128.41 43.57 0.23 Allowed Glycine 0 CA--C 1.492 -1.368 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 162.286 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -111.12 145.32 17.55 Favored Glycine 0 CA--C 1.491 -1.415 0 N-CA-C 105.512 -3.035 . . . . 0.0 105.512 169.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.4 p -92.23 4.61 52.89 Favored 'General case' 0 C--N 1.352 0.676 0 CA-C-N 118.053 0.926 . . . . 0.0 110.154 -171.656 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 57.4 m -157.13 156.66 33.09 Favored 'General case' 0 CA--C 1.483 -1.603 0 N-CA-C 100.981 -3.711 . . . . 0.0 100.981 168.063 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -152.98 141.17 8.16 Favored Glycine 0 N--CA 1.422 -2.278 1 N-CA-C 97.782 -6.127 . . . . 0.0 97.782 -178.581 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 15.1 t-80 -159.94 175.6 12.84 Favored 'General case' 0 N--CA 1.429 -1.495 1 N-CA-C 99.692 -4.188 . . . . 0.0 99.692 -169.263 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 63.2 m -95.22 -174.93 3.36 Favored 'General case' 0 CA--C 1.491 -1.296 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 176.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 177.13 -166.56 37.25 Favored Glycine 0 N--CA 1.417 -2.604 1 N-CA-C 96.196 -6.762 . . . . 0.0 96.196 179.282 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -144.51 138.82 27.84 Favored 'General case' 0 N--CA 1.43 -1.437 1 N-CA-C 96.098 -5.519 . . . . 0.0 96.098 173.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 26.2 tptp -120.69 100.14 6.94 Favored 'General case' 0 CA--C 1.487 -1.471 0 N-CA-C 102.358 -3.201 . . . . 0.0 102.358 -179.188 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.5 t -68.45 134.1 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 -175.466 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 115.67 -36.83 3.69 Favored Glycine 0 CA--C 1.492 -1.387 0 N-CA-C 105.951 -2.86 . . . . 0.0 105.951 -171.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 57.9 m-70 -106.19 -66.85 0.97 Allowed 'General case' 0 CA--C 1.494 -1.177 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 174.567 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 150.1 -143.26 10.51 Favored Glycine 0 CA--C 1.481 -2.054 0 N-CA-C 103.826 -3.71 . . . . 0.0 103.826 -174.683 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.9 tp -65.58 135.98 55.78 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 105.124 -2.176 . . . . 0.0 105.124 172.515 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -155.04 172.6 17.85 Favored 'General case' 0 CA--C 1.475 -1.917 1 N-CA-C 97.98 -4.822 . . . . 0.0 97.98 -168.635 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 9.1 t -118.34 159.78 22.8 Favored 'General case' 0 CA--C 1.487 -1.444 0 N-CA-C 103.089 -2.93 . . . . 0.0 103.089 -173.452 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.407 ' HA ' ' HA ' ' A' ' 5' ' ' TYR . 19.0 t-105 -118.83 146.18 45.06 Favored 'General case' 0 CA--C 1.496 -1.116 0 N-CA-C 103.288 -2.856 . . . . 0.0 103.288 -176.544 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 79.5 m -146.26 157.78 43.83 Favored 'General case' 0 CA--C 1.487 -1.457 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 173.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -118.06 138.88 51.93 Favored 'General case' 0 CA--C 1.495 -1.15 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 176.255 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 64.62 61.89 0.81 Allowed 'General case' 0 CA--C 1.494 -1.191 0 C-N-CA 128.102 2.561 . . . . 0.0 111.646 173.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 28.6 mt -96.04 133.45 25.2 Favored Pre-proline 0 CA--C 1.502 -0.882 0 N-CA-C 104.015 -2.587 . . . . 0.0 104.015 172.007 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -75.32 173.97 13.6 Favored 'Trans proline' 0 N--CA 1.447 -1.247 0 CA-C-N 122.057 1.771 . . . . 0.0 109.768 -178.447 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -74.3 -5.53 42.69 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -169.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -90.61 -0.93 57.86 Favored 'General case' 0 CA--C 1.502 -0.872 0 O-C-N 121.239 -0.913 . . . . 0.0 110.015 -178.315 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.5 t -97.88 152.01 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 N-CA-C 102.677 -3.083 . . . . 0.0 102.677 178.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -123.01 153.28 16.96 Favored Glycine 0 CA--C 1.481 -2.045 1 N-CA-C 98.767 -5.733 . . . . 0.0 98.767 177.153 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 19.5 pt -152.82 -154.63 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 N-CA-C 101.258 -3.608 . . . . 0.0 101.258 -163.083 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.513 ' CD1' ' HB2' ' A' ' 7' ' ' ALA . 4.5 mp -73.76 119.28 20.61 Favored 'Isoleucine or valine' 0 C--N 1.362 1.11 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 169.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.428 -1.537 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 -157.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 27.3 m . . . . . 0 N--CA 1.485 1.29 0 CA-C-O 121.413 0.625 . . . . 0.0 110.646 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -99.25 155.62 17.4 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 105.318 -2.105 . . . . 0.0 105.318 166.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -122.16 126.32 48.06 Favored 'General case' 0 CA--C 1.486 -1.488 1 N-CA-C 94.331 -6.174 . . . . 0.0 94.331 153.19 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.55 179.91 36.65 Favored Glycine 0 CA--C 1.475 -2.466 0 N-CA-C 104.345 -3.502 . . . . 0.0 104.345 -174.619 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -79.89 134.05 36.28 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 104.461 -2.422 . . . . 0.0 104.461 168.674 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 16.4 tt -90.36 149.4 4.06 Favored 'Isoleucine or valine' 0 C--N 1.355 0.808 0 N-CA-C 105.62 -1.992 . . . . 0.0 105.62 -178.647 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.764 ' HB2' HD12 ' A' ' 59' ' ' ILE . . . -139.96 -173.07 3.54 Favored 'General case' 0 N--CA 1.417 -2.113 0 C-N-CA 126.255 1.822 . . . . 0.0 106.898 -170.577 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -95.18 148.33 34.48 Favored Pre-proline 0 N--CA 1.432 -1.36 0 N-CA-C 102.085 -3.302 . . . . 0.0 102.085 163.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_exo -69.62 -26.86 27.8 Favored 'Trans proline' 0 CA--C 1.501 -1.144 0 CA-C-N 123.034 2.119 . . . . 0.0 115.52 -153.069 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -88.76 53.78 2.81 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-N 119.224 0.92 . . . . 0.0 110.483 -167.363 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 75.32 41.34 0.29 Allowed 'General case' 0 C--N 1.354 0.786 0 C-N-CA 125.793 1.637 . . . . 0.0 110.121 167.095 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 55.6 m -117.05 -154.86 0.57 Allowed 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -168.22 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.807 HG12 HD11 ' A' ' 59' ' ' ILE . 1.6 m -133.01 175.57 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.4 1 N-CA-C 98.433 -4.655 . . . . 0.0 98.433 166.66 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . 0.31 0.2 OUTLIER -119.62 141.14 49.57 Favored 'General case' 0 CA--C 1.477 -1.861 1 N-CA-C 92.684 -6.784 . . . . 0.0 92.684 170.045 . . . . . . . . 4 3 . 1 . 017 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 -90.46 145.66 24.74 Favored 'General case' 0 CA--C 1.491 -1.306 0 N-CA-C 103.558 -2.756 . . . . 0.0 103.558 174.135 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.7 t -90.48 167.71 12.39 Favored 'General case' 0 CA--C 1.483 -1.606 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 -176.638 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -114.38 113.44 45.75 Favored Pre-proline 0 N--CA 1.42 -1.952 1 N-CA-C 98.424 -4.658 . . . . 0.0 98.424 168.427 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -57.59 129.59 34.53 Favored 'Trans proline' 0 CA--C 1.507 -0.87 0 CA-C-N 123.154 2.162 . . . . 0.0 111.351 178.448 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 126.61 -56.98 0.71 Allowed Glycine 0 CA--C 1.49 -1.5 1 N-CA-C 101.853 -4.499 . . . . 0.0 101.853 -157.62 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.5 m 107.3 -6.1 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.321 0 C-N-CA 129.25 3.02 . . . . 0.0 110.932 174.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.1 m -42.42 -55.36 3.45 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 127.625 2.37 . . . . 0.0 115.275 -166.726 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -72.26 -45.86 37.2 Favored Glycine 0 C--N 1.351 1.378 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 -176.566 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.9 m -72.89 -32.59 65.48 Favored 'General case' 0 CA--C 1.492 -1.269 0 O-C-N 121.474 -1.015 . . . . 0.0 112.003 -174.203 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -65.78 -38.32 88.7 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 174.113 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 32.2 m -65.29 -43.35 91.42 Favored 'General case' 0 C--N 1.35 0.603 0 O-C-N 120.733 -1.23 . . . . 0.0 110.144 176.101 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 33.9 mt -63.69 -40.39 96.69 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-O 122.17 0.986 . . . . 0.0 110.474 178.447 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.4 t -57.14 -43.8 82.77 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 124.6 1.16 . . . . 0.0 110.79 175.275 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -64.03 -43.61 95.05 Favored 'General case' 0 C--N 1.355 0.84 0 CA-C-N 118.494 0.588 . . . . 0.0 111.633 -178.318 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -79.04 -30.63 44.23 Favored 'General case' 0 CA--C 1.507 -0.674 0 O-C-N 122.039 -0.413 . . . . 0.0 111.27 -172.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -83.77 -22.11 31.99 Favored 'General case' 0 C--N 1.355 0.843 0 O-C-N 121.774 -0.579 . . . . 0.0 109.847 177.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 108.65 48.27 0.86 Allowed Glycine 0 CA--C 1.491 -1.439 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 159.319 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.23 154.27 16.9 Favored Glycine 0 C--N 1.35 1.326 0 N-CA-C 106.582 -2.607 . . . . 0.0 106.582 170.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 39.3 p -90.81 -20.53 22.23 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-O 122.341 1.067 . . . . 0.0 109.927 -165.69 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.9 m -160.22 159.75 31.9 Favored 'General case' 0 N--CA 1.423 -1.818 1 N-CA-C 98.122 -4.77 . . . . 0.0 98.122 179.237 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -178.6 172.52 44.87 Favored Glycine 0 CA--C 1.467 -2.944 1 N-CA-C 100.039 -5.224 . . . . 0.0 100.039 -179.347 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 177.95 -160.07 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 100.262 -3.977 . . . . 0.0 100.262 -174.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 61.6 m -76.77 177.49 7.56 Favored 'General case' 0 CA--C 1.504 -0.821 0 CA-C-O 121.898 0.856 . . . . 0.0 110.704 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -164.05 -179.11 38.1 Favored Glycine 0 N--CA 1.42 -2.426 1 N-CA-C 98.663 -5.775 . . . . 0.0 98.663 178.463 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -143.7 159.99 41.5 Favored 'General case' 0 N--CA 1.422 -1.833 1 N-CA-C 97.623 -4.955 . . . . 0.0 97.623 -177.59 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.1 mmmm -148.95 167.08 26.72 Favored 'General case' 0 N--CA 1.421 -1.886 1 N-CA-C 95.995 -5.557 . . . . 0.0 95.995 169.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -133.43 156.77 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.685 1 N-CA-C 94.391 -6.151 . . . . 0.0 94.391 173.228 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.89 -60.53 0.73 Allowed Glycine 0 CA--C 1.492 -1.394 0 N-CA-C 104.771 -3.331 . . . . 0.0 104.771 -170.172 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 23.4 m170 -90.24 -90.61 0.15 Allowed 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 166.51 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 163.86 -156.61 28.54 Favored Glycine 0 CA--C 1.479 -2.194 1 N-CA-C 99.399 -5.48 . . . . 0.0 99.399 179.033 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 54.0 tp -43.52 126.73 4.53 Favored 'General case' 0 C--N 1.352 0.712 0 C-N-CA 128.001 2.521 . . . . 0.0 111.646 -179.49 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -127.67 -171.19 2.38 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 105.416 -2.068 . . . . 0.0 105.416 -168.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 63.7 m -131.23 176.21 8.47 Favored 'General case' 0 CA--C 1.482 -1.641 0 N-CA-C 102.746 -3.057 . . . . 0.0 102.746 171.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 12.5 t-105 -137.58 154.03 49.85 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 -177.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 22.6 m -145.59 152.84 40.34 Favored 'General case' 0 CA--C 1.493 -1.25 0 N-CA-C 104.269 -2.493 . . . . 0.0 104.269 171.198 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -109.53 143.54 39.05 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 104.31 -2.478 . . . . 0.0 104.31 168.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 55.9 62.48 2.37 Favored 'General case' 0 CA--C 1.499 -1.017 0 C-N-CA 127.871 2.469 . . . . 0.0 113.128 173.062 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 33.5 mt -95.61 134.74 23.77 Favored Pre-proline 0 CA--C 1.498 -1.021 0 N-CA-C 103.614 -2.735 . . . . 0.0 103.614 171.654 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -71.53 176.54 7.93 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 CA-C-N 122.375 1.884 . . . . 0.0 111.72 178.439 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -75.02 -8.76 57.45 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 113.65 0.982 . . . . 0.0 113.65 -167.375 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.8 p-10 -85.99 -8.24 58.1 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 121.605 -0.684 . . . . 0.0 110.069 -179.272 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.0 t -92.9 127.78 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 -175.02 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -97.32 140.69 15.19 Favored Glycine 0 CA--C 1.484 -1.898 0 N-CA-C 104.424 -3.47 . . . . 0.0 104.424 177.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 24.4 pt -139.09 -151.8 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 N-CA-C 104.157 -2.535 . . . . 0.0 104.157 -165.677 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.807 HD11 HG12 ' A' ' 13' ' ' VAL . 1.8 mp -66.41 118.77 10.27 Favored 'Isoleucine or valine' 0 C--N 1.364 1.209 0 N-CA-C 103.501 -2.778 . . . . 0.0 103.501 168.107 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.4 t . . . . . 0 N--CA 1.422 -1.843 1 N-CA-C 96.95 -5.204 . . . . 0.0 96.95 -168.285 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 27.4 m . . . . . 0 N--CA 1.484 1.265 0 CA-C-O 121.174 0.512 . . . . 0.0 110.26 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -105.03 160.34 15.12 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 106.109 -1.811 . . . . 0.0 106.109 168.688 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -127.69 126.62 42.24 Favored 'General case' 0 CA--C 1.49 -1.357 1 N-CA-C 96.636 -5.32 . . . . 0.0 96.636 158.834 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.04 -170.83 27.35 Favored Glycine 0 CA--C 1.477 -2.328 1 N-CA-C 102.084 -4.407 . . . . 0.0 102.084 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -81.08 141.68 34.07 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 103.611 -2.737 . . . . 0.0 103.611 164.015 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 11.5 tt -90.4 142.14 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 N-CA-C 104.903 -2.258 . . . . 0.0 104.903 175.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.944 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -130.52 175.65 8.81 Favored 'General case' 0 N--CA 1.414 -2.233 0 N-CA-C 103.919 -2.622 . . . . 0.0 103.919 -175.012 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -79.6 154.21 76.11 Favored Pre-proline 0 N--CA 1.432 -1.34 0 N-CA-C 105.032 -2.21 . . . . 0.0 105.032 166.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -68.96 0.34 5.18 Favored 'Trans proline' 0 CA--C 1.511 -0.627 0 C-N-CA 121.94 1.76 . . . . 0.0 116.609 -168.05 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -102.28 9.56 39.85 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 119.773 1.169 . . . . 0.0 108.525 -175.277 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 66.3 t30 73.34 57.54 0.11 Allowed 'General case' 0 CA--C 1.497 -1.096 0 C-N-CA 126.278 1.831 . . . . 0.0 107.951 -177.025 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 30.5 m -142.01 135.71 29.55 Favored 'General case' 0 CA--C 1.485 -1.541 1 N-CA-C 99.01 -4.441 . . . . 0.0 99.01 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.462 HG12 HD11 ' A' ' 59' ' ' ILE . 2.7 m -60.95 148.47 9.07 Favored 'Isoleucine or valine' 0 C--N 1.354 0.764 0 CA-C-N 120.463 1.483 . . . . 0.0 112.35 -172.811 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -98.02 132.09 43.88 Favored 'General case' 0 CA--C 1.483 -1.623 1 N-CA-C 97.97 -4.826 . . . . 0.0 97.97 177.211 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 66.9 m80 -90.38 -175.58 4.52 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 -166.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 5.7 t -147.03 157.55 43.65 Favored 'General case' 0 N--CA 1.413 -2.305 1 N-CA-C 96.392 -5.41 . . . . 0.0 96.392 -175.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -117.34 110.92 40.51 Favored Pre-proline 0 N--CA 1.419 -2.008 1 N-CA-C 96.906 -5.22 . . . . 0.0 96.906 172.405 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_exo -60.1 114.57 2.15 Favored 'Trans proline' 0 CA--C 1.506 -0.899 0 CA-C-N 123.324 2.223 . . . . 0.0 113.811 -162.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 154.45 -42.98 0.59 Allowed Glycine 0 N--CA 1.432 -1.568 1 N-CA-C 100.584 -5.006 . . . . 0.0 100.584 -163.7 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.6 m 95.84 21.84 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.31 0 C-N-CA 127.329 2.251 . . . . 0.0 111.071 167.504 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 p -68.13 -52.29 36.47 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 125.493 1.517 . . . . 0.0 110.302 -174.725 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.62 -38.39 90.17 Favored Glycine 0 C--N 1.347 1.192 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 178.169 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 41.9 t -66.15 -48.33 71.13 Favored 'General case' 0 CA--C 1.502 -0.872 0 C-N-CA 124.283 1.033 . . . . 0.0 110.013 -177.05 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -53.34 -49.91 66.11 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 125.539 1.536 . . . . 0.0 109.925 175.323 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.4 m -60.51 -53.09 61.75 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 124.105 0.962 . . . . 0.0 111.299 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 37.4 mt -65.47 -44.45 87.13 Favored 'General case' 0 CA--C 1.492 -1.257 0 C-N-CA 125.068 1.347 . . . . 0.0 110.234 -175.542 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.8 t -62.56 -44.97 95.0 Favored 'General case' 0 N--CA 1.435 -1.189 0 C-N-CA 123.021 0.528 . . . . 0.0 109.788 179.114 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -69.25 -41.94 76.27 Favored 'General case' 0 CA--C 1.503 -0.856 0 O-C-N 122.247 -0.283 . . . . 0.0 110.402 -174.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -74.73 -27.36 60.33 Favored 'General case' 0 CA--C 1.505 -0.777 0 O-C-N 121.715 -0.616 . . . . 0.0 111.621 -176.335 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.36 -23.53 27.97 Favored 'General case' 0 C--N 1.358 0.966 0 CA-C-O 121.571 0.7 . . . . 0.0 109.331 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.08 43.05 1.23 Allowed Glycine 0 CA--C 1.484 -1.859 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 162.421 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -98.91 152.09 19.61 Favored Glycine 0 CA--C 1.491 -1.461 0 N-CA-C 104.278 -3.529 . . . . 0.0 104.278 165.517 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 23.5 p -87.77 -44.53 11.06 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -168.638 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 18.3 m -129.06 157.23 42.32 Favored 'General case' 0 CA--C 1.485 -1.547 0 N-CA-C 102.14 -3.282 . . . . 0.0 102.14 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -161.26 160.19 31.9 Favored Glycine 0 N--CA 1.416 -2.683 1 N-CA-C 98.473 -5.851 . . . . 0.0 98.473 178.834 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 20.0 p80 -164.21 176.53 9.12 Favored 'General case' 0 N--CA 1.427 -1.594 1 N-CA-C 96.719 -5.289 . . . . 0.0 96.719 -178.441 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 70.3 m -110.58 165.76 11.55 Favored 'General case' 0 CA--C 1.481 -1.69 0 CA-C-N 119.566 1.075 . . . . 0.0 108.256 -173.612 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -175.6 -169.05 36.83 Favored Glycine 0 N--CA 1.424 -2.154 1 N-CA-C 100.649 -4.981 . . . . 0.0 100.649 -179.475 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -130.32 138.88 50.67 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 101.605 -3.48 . . . . 0.0 101.605 -172.418 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -108.1 111.89 24.16 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 102.855 -3.017 . . . . 0.0 102.855 174.618 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.8 t -80.81 120.66 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 -175.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 119.93 -7.12 12.03 Favored Glycine 0 CA--C 1.494 -1.267 0 N-CA-C 106.838 -2.505 . . . . 0.0 106.838 -166.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 44.8 m-70 -139.69 -79.56 0.31 Allowed 'General case' 0 CA--C 1.497 -1.067 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 167.537 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 170.4 -161.52 34.55 Favored Glycine 0 N--CA 1.426 -2.023 0 N-CA-C 104.188 -3.565 . . . . 0.0 104.188 -166.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 30.8 tp -65.57 133.44 51.19 Favored 'General case' 0 CA--C 1.505 -0.77 0 C-N-CA 127.197 2.199 . . . . 0.0 107.275 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.25 -176.41 4.25 Favored 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 -166.346 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.2 t -125.13 151.16 46.13 Favored 'General case' 0 CA--C 1.491 -1.323 1 N-CA-C 98.631 -4.581 . . . . 0.0 98.631 175.226 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 38.0 t-105 -107.15 152.8 23.58 Favored 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 103.941 -2.614 . . . . 0.0 103.941 179.053 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 22.9 m -143.77 150.57 38.78 Favored 'General case' 0 CA--C 1.483 -1.621 0 N-CA-C 104.307 -2.479 . . . . 0.0 104.307 170.449 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -116.09 140.44 49.28 Favored 'General case' 0 CA--C 1.492 -1.277 0 N-CA-C 102.464 -3.161 . . . . 0.0 102.464 171.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 67.21 56.67 0.62 Allowed 'General case' 0 CA--C 1.496 -1.112 0 C-N-CA 127.103 2.161 . . . . 0.0 111.601 172.211 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 25.1 mt -93.96 134.04 26.7 Favored Pre-proline 0 CA--C 1.496 -1.12 0 N-CA-C 104.411 -2.44 . . . . 0.0 104.411 174.475 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -75.06 173.61 14.22 Favored 'Trans proline' 0 N--CA 1.445 -1.327 0 C-N-CA 122.236 1.958 . . . . 0.0 110.236 178.265 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -64.75 -13.21 54.22 Favored 'General case' 0 CA--C 1.506 -0.744 0 C-N-CA 125.795 1.638 . . . . 0.0 114.477 -173.509 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -89.88 8.76 30.48 Favored 'General case' 0 CA--C 1.504 -0.807 0 O-C-N 121.503 -0.748 . . . . 0.0 110.247 -176.511 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.7 t -110.54 141.93 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.339 0 N-CA-C 102.552 -3.129 . . . . 0.0 102.552 177.388 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -115.79 148.14 18.91 Favored Glycine 0 CA--C 1.479 -2.21 1 N-CA-C 100.3 -5.12 . . . . 0.0 100.3 175.176 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 24.2 pt -147.28 -151.22 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.426 -1.635 0 N-CA-C 102.34 -3.207 . . . . 0.0 102.34 -163.104 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.944 HD13 ' HB2' ' A' ' 7' ' ' ALA . 7.5 mm -71.65 122.55 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 178.561 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.431 -1.404 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 -163.24 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.2 m . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 121.164 0.507 . . . . 0.0 110.411 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -109.94 159.26 17.41 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 175.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -126.99 127.13 44.33 Favored 'General case' 0 CA--C 1.488 -1.41 1 N-CA-C 95.21 -5.848 . . . . 0.0 95.21 158.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.82 -169.14 24.73 Favored Glycine 0 CA--C 1.474 -2.53 1 N-CA-C 102.372 -4.291 . . . . 0.0 102.372 -179.62 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 48' ' ' TRP . 16.4 m-85 -83.71 143.85 29.76 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 103.859 -2.645 . . . . 0.0 103.859 161.27 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.0 tt -90.79 141.49 14.33 Favored 'Isoleucine or valine' 0 C--O 1.25 1.102 0 N-CA-C 105.939 -1.875 . . . . 0.0 105.939 174.006 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.802 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -140.18 174.41 10.54 Favored 'General case' 0 N--CA 1.42 -1.966 1 N-CA-C 99.915 -4.106 . . . . 0.0 99.915 175.628 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -85.2 160.25 55.02 Favored Pre-proline 0 N--CA 1.432 -1.36 0 C-N-CA 126.983 2.113 . . . . 0.0 106.014 178.449 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -70.23 -11.98 31.19 Favored 'Trans proline' 0 CA--C 1.505 -0.95 0 CA-C-N 121.4 1.536 . . . . 0.0 116.024 -160.577 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -99.58 15.02 27.98 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -178.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 63.7 t30 74.43 54.64 0.09 Allowed 'General case' 0 CA--C 1.501 -0.929 0 C-N-CA 125.706 1.603 . . . . 0.0 110.052 172.487 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.455 ' O ' ' HB1' ' A' ' 7' ' ' ALA . 1.2 m -133.86 136.59 44.47 Favored 'General case' 0 CA--C 1.478 -1.823 1 N-CA-C 98.909 -4.478 . . . . 0.0 98.909 176.692 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -64.35 155.18 6.35 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.932 0 CA-C-N 120.186 1.357 . . . . 0.0 112.224 -172.16 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -104.8 128.2 52.87 Favored 'General case' 0 CA--C 1.473 -1.997 1 N-CA-C 91.416 -7.253 . . . . 0.0 91.416 177.154 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 34.8 m-70 -88.5 -150.57 0.19 Allowed 'General case' 0 CA--C 1.491 -1.291 0 N-CA-C 105.41 -2.07 . . . . 0.0 105.41 -167.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 8.0 t -153.19 161.99 41.81 Favored 'General case' 0 N--CA 1.413 -2.303 1 N-CA-C 94.094 -6.262 . . . . 0.0 94.094 -176.006 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -111.73 112.82 53.34 Favored Pre-proline 0 N--CA 1.422 -1.847 1 N-CA-C 95.907 -5.59 . . . . 0.0 95.907 171.688 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo -60.39 101.06 0.16 Allowed 'Trans proline' 0 CA--C 1.508 -0.811 0 C-N-CA 122.457 2.105 . . . . 0.0 116.449 -157.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 169.16 -178.33 42.42 Favored Glycine 0 N--CA 1.422 -2.247 1 N-CA-C 95.893 -6.883 . . . . 0.0 95.893 178.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.3 m -69.78 -39.24 76.77 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 119.45 1.625 . . . . 0.0 109.234 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -43.87 -53.03 6.39 Favored 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 130.653 3.581 . . . . 0.0 115.607 -173.278 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.71 -39.7 66.29 Favored Glycine 0 C--N 1.353 1.473 0 O-C-N 120.998 -1.064 . . . . 0.0 111.441 -171.444 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 38.9 t -70.92 -47.24 60.19 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -54.91 -44.14 73.92 Favored 'General case' 0 C--N 1.354 0.769 0 C-N-CA 123.267 0.627 . . . . 0.0 110.845 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 26.6 m -59.92 -50.13 74.97 Favored 'General case' 0 C--N 1.35 0.601 0 C-N-CA 123.193 0.597 . . . . 0.0 111.509 177.172 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 50.3 mt -67.77 -40.43 84.03 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-O 122.437 1.113 . . . . 0.0 110.43 -176.343 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.0 t -62.44 -42.75 99.69 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 124.64 1.176 . . . . 0.0 109.419 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 24.0 mtpp -68.44 -42.57 78.65 Favored 'General case' 0 C--N 1.355 0.831 0 C-N-CA 123.072 0.549 . . . . 0.0 111.674 -179.072 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -75.07 -22.16 58.51 Favored 'General case' 0 C--N 1.354 0.782 0 O-C-N 121.455 -0.778 . . . . 0.0 111.24 -174.469 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.3 mmtm -79.86 -60.33 2.38 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 170.222 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 135.39 50.12 0.07 OUTLIER Glycine 0 CA--C 1.489 -1.577 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 171.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.5 141.95 15.57 Favored Glycine 0 CA--C 1.491 -1.442 0 N-CA-C 103.839 -3.704 . . . . 0.0 103.839 164.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.1 p -100.11 3.32 43.85 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 123.813 0.845 . . . . 0.0 110.334 -165.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.4 m -160.1 158.53 30.49 Favored 'General case' 0 CA--C 1.476 -1.894 1 N-CA-C 97.773 -4.899 . . . . 0.0 97.773 168.069 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -170.76 164.76 37.97 Favored Glycine 0 CA--C 1.469 -2.817 1 N-CA-C 99.56 -5.416 . . . . 0.0 99.56 -176.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 59.9 m80 -155.05 152.98 30.25 Favored 'General case' 0 N--CA 1.43 -1.45 1 N-CA-C 100.049 -4.056 . . . . 0.0 100.049 -175.784 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 44.9 t -85.1 153.76 22.49 Favored 'General case' 0 CA--C 1.505 -0.778 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 -175.311 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -174.55 -177.1 43.42 Favored Glycine 0 CA--C 1.482 -2.017 0 N-CA-C 105.061 -3.216 . . . . 0.0 105.061 179.348 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -119.98 142.61 48.62 Favored 'General case' 0 N--CA 1.431 -1.42 1 N-CA-C 99.547 -4.242 . . . . 0.0 99.547 -179.003 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 24.8 tptp -119.31 103.91 9.91 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 101.457 -3.534 . . . . 0.0 101.457 175.213 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.9 t -73.07 136.9 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 N-CA-C 105.868 -1.901 . . . . 0.0 105.868 -178.374 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 113.34 -24.75 12.01 Favored Glycine 0 CA--C 1.491 -1.435 0 N-CA-C 106.23 -2.748 . . . . 0.0 106.23 -168.529 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 39.6 m80 -127.98 -81.11 0.59 Allowed 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 174.546 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 168.17 -151.76 19.14 Favored Glycine 0 N--CA 1.429 -1.798 0 N-CA-C 105.169 -3.172 . . . . 0.0 105.169 -171.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 49.1 tp -65.41 126.14 27.33 Favored 'General case' 0 CA--C 1.506 -0.721 0 C-N-CA 126.634 1.974 . . . . 0.0 106.856 178.497 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -134.27 -167.99 2.06 Favored 'General case' 0 CA--C 1.489 -1.372 0 N-CA-C 105.369 -2.085 . . . . 0.0 105.369 -166.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.7 t -136.86 148.23 46.97 Favored 'General case' 0 CA--C 1.489 -1.369 0 N-CA-C 100.349 -3.945 . . . . 0.0 100.349 172.47 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.414 ' HA ' ' HA ' ' A' ' 5' ' ' TYR . 20.3 t-105 -102.89 148.69 25.33 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 104.111 -2.552 . . . . 0.0 104.111 177.713 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 50.2 m -144.77 149.2 35.1 Favored 'General case' 0 CA--C 1.498 -1.052 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 176.041 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -113.62 142.84 45.51 Favored 'General case' 0 CA--C 1.495 -1.164 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 172.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 62.69 57.03 1.85 Allowed 'General case' 0 CA--C 1.494 -1.191 0 C-N-CA 127.985 2.514 . . . . 0.0 111.103 172.038 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 17.8 mt -90.07 137.28 28.09 Favored Pre-proline 0 N--CA 1.44 -0.959 0 N-CA-C 104.899 -2.26 . . . . 0.0 104.899 174.159 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_exo -69.02 171.88 12.88 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 122.036 1.824 . . . . 0.0 113.047 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -76.25 -13.16 60.17 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 123.39 0.676 . . . . 0.0 112.203 -171.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -91.64 13.3 18.37 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 124.122 0.969 . . . . 0.0 110.426 178.308 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.3 t -104.22 160.9 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 N-CA-C 101.535 -3.506 . . . . 0.0 101.535 171.813 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -138.05 150.52 20.97 Favored Glycine 0 CA--C 1.481 -2.09 1 N-CA-C 96.986 -6.446 . . . . 0.0 96.986 178.748 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 29.4 pt -156.68 -155.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 N-CA-C 101.586 -3.487 . . . . 0.0 101.586 -158.233 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.802 HD13 ' HB2' ' A' ' 7' ' ' ALA . 3.2 mm -63.08 137.51 24.48 Favored 'Isoleucine or valine' 0 C--N 1.363 1.163 0 C-N-CA 123.943 0.897 . . . . 0.0 109.556 -177.524 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.419 -1.986 1 N-CA-C 96.295 -5.446 . . . . 0.0 96.295 -178.68 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 17.3 m . . . . . 0 N--CA 1.481 1.121 0 CA-C-O 121.621 0.724 . . . . 0.0 110.56 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -100.6 174.06 6.25 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 102.654 -3.091 . . . . 0.0 102.654 159.049 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -119.16 150.17 40.49 Favored 'General case' 0 CA--C 1.487 -1.464 1 N-CA-C 94.262 -6.199 . . . . 0.0 94.262 155.411 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -160.7 165.12 34.97 Favored Glycine 0 CA--C 1.471 -2.691 0 C-N-CA 116.618 -2.706 . . . . 0.0 108.822 -172.701 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -87.87 116.24 25.88 Favored 'General case' 0 N--CA 1.429 -1.504 1 N-CA-C 99.51 -4.255 . . . . 0.0 99.51 160.677 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 13.8 tt -75.72 135.0 27.98 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.419 0 N-CA-C 104.524 -2.399 . . . . 0.0 104.524 -172.539 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.599 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -125.89 -172.99 2.73 Favored 'General case' 0 N--CA 1.419 -2.01 0 O-C-N 126.309 2.256 . . . . 0.0 107.793 -178.86 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -101.54 139.52 20.47 Favored Pre-proline 0 N--CA 1.424 -1.753 1 N-CA-C 98.126 -4.768 . . . . 0.0 98.126 164.297 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -76.78 -0.31 10.38 Favored 'Trans proline' 0 CA--C 1.504 -1.008 0 C-N-CA 122.457 2.104 . . . . 0.0 112.501 -152.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 84.5 mt-10 -95.28 45.35 1.1 Allowed 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 124.756 1.222 . . . . 0.0 108.322 -165.188 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 66.49 49.31 1.39 Allowed 'General case' 0 C--N 1.355 0.806 0 C-N-CA 126.555 1.942 . . . . 0.0 108.174 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -128.29 -160.59 1.03 Allowed 'General case' 0 CA--C 1.492 -1.269 0 O-C-N 120.651 -1.281 . . . . 0.0 110.91 -171.727 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.551 HG12 HD12 ' A' ' 59' ' ' ILE . 9.7 m -125.37 -171.23 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.435 1 N-CA-C 99.618 -4.216 . . . . 0.0 99.618 167.997 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -126.89 150.44 49.28 Favored 'General case' 0 CA--C 1.477 -1.827 1 N-CA-C 95.338 -5.801 . . . . 0.0 95.338 173.755 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 61.0 m170 -99.08 122.91 42.93 Favored 'General case' 0 CA--C 1.485 -1.535 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 -178.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 41.9 t -83.54 151.08 25.56 Favored 'General case' 0 N--CA 1.427 -1.597 0 N-CA-C 105.95 -1.871 . . . . 0.0 105.95 176.708 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -98.44 118.41 63.38 Favored Pre-proline 0 N--CA 1.428 -1.528 1 N-CA-C 100.148 -4.019 . . . . 0.0 100.148 175.253 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -62.7 103.15 0.32 Allowed 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.687 2.258 . . . . 0.0 112.849 -165.091 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 168.59 -52.59 0.22 Allowed Glycine 0 N--CA 1.427 -1.902 1 N-CA-C 100.238 -5.145 . . . . 0.0 100.238 -175.755 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.8 m 134.11 -42.92 0.01 OUTLIER 'General case' 0 CA--C 1.489 -1.403 0 C-N-CA 128.953 2.901 . . . . 0.0 105.81 174.093 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.6 m -39.66 -55.53 1.87 Allowed 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 128.311 2.645 . . . . 0.0 117.165 -150.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.89 -34.64 71.64 Favored Glycine 0 C--N 1.346 1.103 0 O-C-N 121.478 -0.764 . . . . 0.0 111.723 -175.413 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.7 t -86.51 -18.31 31.91 Favored 'General case' 0 CA--C 1.5 -0.953 0 O-C-N 121.46 -1.023 . . . . 0.0 108.4 -176.234 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -66.1 -44.06 85.45 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 170.665 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -62.94 -33.3 75.06 Favored 'General case' 0 C--N 1.353 0.758 0 O-C-N 121.123 -0.986 . . . . 0.0 113.019 172.761 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 86.3 mt -66.76 -41.42 87.79 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-N 119.1 0.864 . . . . 0.0 110.212 175.084 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 11.4 t -56.41 -50.42 71.66 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 123.763 0.825 . . . . 0.0 110.337 174.159 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -56.89 -51.48 68.94 Favored 'General case' 0 C--N 1.359 0.979 0 C-N-CA 123.621 0.769 . . . . 0.0 111.888 -179.5 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -69.57 -19.28 63.68 Favored 'General case' 0 C--N 1.354 0.78 0 O-C-N 121.519 -0.738 . . . . 0.0 112.976 -173.577 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 48.6 mmtm -96.46 0.44 50.36 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 177.603 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.11 21.34 23.16 Favored Glycine 0 C--N 1.352 1.428 0 O-C-N 121.416 -0.803 . . . . 0.0 111.582 168.49 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -88.48 124.02 7.03 Favored Glycine 0 CA--C 1.485 -1.82 0 N-CA-C 106.466 -2.653 . . . . 0.0 106.466 169.34 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -77.17 -56.39 4.61 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 124.947 1.299 . . . . 0.0 108.435 -173.015 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.2 m -114.17 156.94 23.34 Favored 'General case' 0 CA--C 1.484 -1.584 0 N-CA-C 103.883 -2.636 . . . . 0.0 103.883 178.297 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -168.13 177.72 42.16 Favored Glycine 0 N--CA 1.416 -2.696 1 N-CA-C 99.926 -5.27 . . . . 0.0 99.926 -177.217 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -171.97 -172.99 1.06 Allowed 'General case' 0 N--CA 1.425 -1.69 1 N-CA-C 95.955 -5.572 . . . . 0.0 95.955 173.821 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 88.1 m -122.58 158.88 28.96 Favored 'General case' 0 CA--C 1.48 -1.734 0 N-CA-C 102.509 -3.145 . . . . 0.0 102.509 174.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.42 174.42 46.67 Favored Glycine 0 CA--C 1.481 -2.058 1 N-CA-C 100.741 -4.944 . . . . 0.0 100.741 -174.826 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -146.16 127.7 15.09 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 102.638 -3.097 . . . . 0.0 102.638 -178.224 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 35.5 mmtm -156.83 82.37 0.95 Allowed 'General case' 0 CA--C 1.493 -1.241 1 N-CA-C 96.417 -5.401 . . . . 0.0 96.417 153.525 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.8 t -143.57 -178.1 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.071 1 N-CA-C 99.702 -4.184 . . . . 0.0 99.702 -169.795 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -135.04 26.95 3.21 Favored Glycine 0 C--N 1.349 1.27 0 N-CA-C 108.022 -2.031 . . . . 0.0 108.022 177.24 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 39.4 m170 -116.22 -75.34 0.58 Allowed 'General case' 0 CA--C 1.5 -0.969 0 N-CA-C 104.346 -2.465 . . . . 0.0 104.346 173.497 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -171.75 -169.31 34.44 Favored Glycine 0 CA--C 1.478 -2.247 1 N-CA-C 98.312 -5.915 . . . . 0.0 98.312 -175.627 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . 0.256 0.2 OUTLIER -65.39 147.49 53.34 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 123.817 0.847 . . . . 0.0 111.066 -178.072 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -141.22 175.63 9.49 Favored 'General case' 0 CA--C 1.485 -1.551 0 N-CA-C 101.984 -3.339 . . . . 0.0 101.984 -166.07 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.5 m -120.05 155.38 33.04 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 104.407 -2.442 . . . . 0.0 104.407 178.77 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 73.5 t-105 -102.08 148.89 24.84 Favored 'General case' 0 CA--C 1.489 -1.391 0 N-CA-C 104.35 -2.463 . . . . 0.0 104.35 -177.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 69.2 m -140.09 140.91 36.18 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 102.174 -3.269 . . . . 0.0 102.174 168.414 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -106.73 19.11 20.95 Favored 'General case' 0 C--N 1.352 0.714 0 CA-C-O 121.413 0.625 . . . . 0.0 110.127 -169.544 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -166.77 144.27 4.95 Favored 'General case' 0 N--CA 1.422 -1.825 1 N-CA-C 93.573 -6.454 . . . . 0.0 93.573 169.671 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 21.5 mt -150.58 142.11 15.27 Favored Pre-proline 0 CA--C 1.486 -1.518 1 N-CA-C 99.13 -4.396 . . . . 0.0 99.13 153.449 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -74.06 172.13 16.58 Favored 'Trans proline' 0 N--CA 1.444 -1.402 0 C-N-CA 122.19 1.927 . . . . 0.0 110.14 174.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -75.48 -1.99 26.74 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 -166.686 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -92.0 -7.73 48.05 Favored 'General case' 0 CA--C 1.505 -0.765 0 O-C-N 121.57 -0.707 . . . . 0.0 109.573 179.178 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.8 t -101.47 129.71 52.18 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.308 0 N-CA-C 103.748 -2.686 . . . . 0.0 103.748 -174.68 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -98.45 160.19 20.49 Favored Glycine 0 CA--C 1.485 -1.804 0 N-CA-C 106.133 -2.787 . . . . 0.0 106.133 -178.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 23.2 pt -146.56 -162.67 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.549 0 N-CA-C 103.543 -2.762 . . . . 0.0 103.543 -165.534 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.599 HD13 ' HB2' ' A' ' 7' ' ' ALA . 2.8 mm -63.51 137.4 24.75 Favored 'Isoleucine or valine' 0 C--N 1.361 1.084 0 C-N-CA 124.074 0.95 . . . . 0.0 109.167 -176.598 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 55.3 t . . . . . 0 N--CA 1.442 -0.843 0 N-CA-C 103.643 -2.725 . . . . 0.0 103.643 178.813 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 34.8 m . . . . . 0 N--CA 1.485 1.303 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.52 165.48 27.46 Favored 'General case' 0 N--CA 1.426 -1.63 1 N-CA-C 100.071 -4.048 . . . . 0.0 100.071 165.753 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -133.41 128.21 35.05 Favored 'General case' 0 N--CA 1.429 -1.522 1 N-CA-C 93.867 -6.345 . . . . 0.0 93.867 166.649 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.03 -175.31 32.93 Favored Glycine 0 CA--C 1.47 -2.748 1 N-CA-C 102.064 -4.414 . . . . 0.0 102.064 176.477 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -75.34 133.1 41.32 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 104.555 -2.387 . . . . 0.0 104.555 163.533 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.9 tt -89.87 137.99 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.315 0 N-CA-C 104.611 -2.366 . . . . 0.0 104.611 -175.436 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.456 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -100.97 -144.81 0.34 Allowed 'General case' 0 N--CA 1.426 -1.674 0 C-N-CA 127.185 2.194 . . . . 0.0 106.717 -178.283 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -128.91 143.03 47.12 Favored Pre-proline 0 N--CA 1.421 -1.895 1 N-CA-C 93.47 -6.493 . . . . 0.0 93.47 163.577 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -82.57 27.27 0.61 Allowed 'Trans proline' 0 CA--C 1.506 -0.917 0 C-N-CA 122.651 2.234 . . . . 0.0 113.731 -141.248 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 41.4 mp0 -104.38 -78.52 0.56 Allowed 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 102.589 -3.115 . . . . 0.0 102.589 -178.156 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -161.33 142.97 11.71 Favored 'General case' 0 N--CA 1.425 -1.699 1 N-CA-C 92.464 -6.865 . . . . 0.0 92.464 156.188 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER 176.29 -166.68 0.04 OUTLIER 'General case' 0 CA--C 1.486 -1.513 0 N-CA-C 101.485 -3.524 . . . . 0.0 101.485 179.816 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.554 HG12 HD12 ' A' ' 59' ' ' ILE . 1.0 OUTLIER -121.29 160.56 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.725 1 N-CA-C 99.006 -4.442 . . . . 0.0 99.006 156.929 . . . . . . . . 4 4 . 1 . 021 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -82.71 -168.87 2.21 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 104.798 -2.297 . . . . 0.0 104.798 161.074 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 9.2 m-70 -134.61 177.76 7.53 Favored 'General case' 0 N--CA 1.422 -1.858 1 N-CA-C 95.271 -5.826 . . . . 0.0 95.271 168.291 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 40.9 t -154.89 169.31 24.32 Favored 'General case' 0 N--CA 1.416 -2.148 1 N-CA-C 96.088 -5.523 . . . . 0.0 96.088 -168.275 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -126.3 120.41 23.58 Favored Pre-proline 0 N--CA 1.42 -1.931 1 N-CA-C 98.795 -4.52 . . . . 0.0 98.795 178.768 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 0.8 OUTLIER -55.56 135.2 68.2 Favored 'Trans proline' 0 CA--C 1.505 -0.951 0 C-N-CA 122.568 2.179 . . . . 0.0 112.384 -178.452 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 116.27 -43.55 1.64 Allowed Glycine 0 N--CA 1.438 -1.231 0 N-CA-C 103.989 -3.644 . . . . 0.0 103.989 -158.322 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.0 m 82.56 23.85 0.18 Allowed 'General case' 0 CA--C 1.496 -1.111 0 C-N-CA 128.105 2.562 . . . . 0.0 110.647 175.836 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.7 -61.2 2.68 Favored 'General case' 0 N--CA 1.44 -0.933 0 C-N-CA 126.808 2.043 . . . . 0.0 110.998 -168.995 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.14 -32.23 72.6 Favored Glycine 0 C--N 1.347 1.187 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 -175.468 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 11.5 t -78.45 -21.38 49.22 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-O 119.302 -0.38 . . . . 0.0 110.054 -173.482 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -60.43 -46.96 88.16 Favored 'General case' 0 C--N 1.352 0.692 0 CA-C-N 119.585 1.084 . . . . 0.0 109.409 173.394 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.13 -49.26 75.06 Favored 'General case' 0 N--CA 1.44 -0.934 0 O-C-N 121.537 -0.727 . . . . 0.0 112.521 171.09 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 73.8 mt -63.91 -44.28 93.39 Favored 'General case' 0 C--N 1.358 0.96 0 CA-C-O 121.722 0.772 . . . . 0.0 111.59 -173.882 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 13.7 t -60.0 -42.54 94.47 Favored 'General case' 0 CA--C 1.503 -0.855 0 C-N-CA 123.589 0.756 . . . . 0.0 109.558 179.175 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.6 mtmm -74.47 -35.05 63.28 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-N 119.211 0.914 . . . . 0.0 112.801 -177.966 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -70.75 -24.71 62.66 Favored 'General case' 0 C--N 1.358 0.941 0 CA-C-N 120.13 1.332 . . . . 0.0 111.536 178.628 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 48.4 mmtm -85.12 -13.58 49.8 Favored 'General case' 0 C--N 1.355 0.822 0 O-C-N 121.882 -0.512 . . . . 0.0 110.067 173.933 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.89 32.0 5.79 Favored Glycine 0 CA--C 1.492 -1.385 0 CA-C-O 119.375 -0.68 . . . . 0.0 111.636 166.718 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.3 138.29 14.29 Favored Glycine 0 CA--C 1.488 -1.653 0 N-CA-C 105.379 -3.089 . . . . 0.0 105.379 174.247 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 18.0 p -100.67 2.76 41.83 Favored 'General case' 0 N--CA 1.44 -0.97 0 O-C-N 122.063 -0.669 . . . . 0.0 110.042 -163.723 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.5 m -160.17 153.41 21.94 Favored 'General case' 0 CA--C 1.483 -1.6 1 N-CA-C 99.225 -4.361 . . . . 0.0 99.225 168.621 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -171.31 161.97 34.56 Favored Glycine 0 CA--C 1.474 -2.526 1 N-CA-C 100.022 -5.231 . . . . 0.0 100.022 178.296 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 14.8 p80 -165.81 170.71 13.61 Favored 'General case' 0 CA--C 1.488 -1.417 0 N-CA-C 100.215 -3.994 . . . . 0.0 100.215 -177.05 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 62.9 m -77.53 147.63 35.68 Favored 'General case' 0 CA--C 1.491 -1.29 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 177.843 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -163.88 173.43 39.93 Favored Glycine 0 CA--C 1.476 -2.404 1 N-CA-C 98.493 -5.843 . . . . 0.0 98.493 179.9 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -168.89 -169.33 0.98 Allowed 'General case' 0 N--CA 1.422 -1.867 1 N-CA-C 97.01 -5.182 . . . . 0.0 97.01 178.142 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.6 mptt 97.65 61.29 0.0 OUTLIER 'General case' 0 CA--C 1.492 -1.251 0 C-N-CA 131.186 3.794 . . . . 0.0 101.753 -164.692 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 19.3 t -143.21 172.92 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.738 1 N-CA-C 96.501 -5.37 . . . . 0.0 96.501 -177.743 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -113.21 89.57 0.52 Allowed Glycine 0 CA--C 1.486 -1.77 0 N-CA-C 104.329 -3.509 . . . . 0.0 104.329 176.643 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 17.4 m170 -172.09 -132.21 0.01 OUTLIER 'General case' 0 N--CA 1.438 -1.041 1 N-CA-C 99.422 -4.288 . . . . 0.0 99.422 172.741 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -110.87 -41.03 1.23 Allowed Glycine 0 C--N 1.358 1.758 0 CA-C-N 120.843 1.656 . . . . 0.0 113.317 -170.32 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 13.6 tp -165.63 177.4 7.35 Favored 'General case' 0 N--CA 1.434 -1.236 1 N-CA-C 95.769 -5.641 . . . . 0.0 95.769 -173.385 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -159.02 -174.86 4.95 Favored 'General case' 0 CA--C 1.478 -1.822 1 N-CA-C 98.288 -4.708 . . . . 0.0 98.288 175.409 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 46.8 t -130.25 164.51 24.4 Favored 'General case' 0 CA--C 1.492 -1.286 1 N-CA-C 99.943 -4.095 . . . . 0.0 99.943 167.872 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 24.9 t-105 -111.99 152.23 28.35 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 104.231 -2.507 . . . . 0.0 104.231 176.997 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 15.3 m -145.55 150.69 36.88 Favored 'General case' 0 C--N 1.36 1.032 0 N-CA-C 104.797 -2.297 . . . . 0.0 104.797 173.73 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -113.15 138.5 49.85 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 104.878 -2.268 . . . . 0.0 104.878 171.178 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 64.79 58.4 0.97 Allowed 'General case' 0 CA--C 1.491 -1.297 0 C-N-CA 127.199 2.2 . . . . 0.0 111.697 166.505 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 20.4 mt -89.11 143.91 31.85 Favored Pre-proline 0 N--CA 1.441 -0.912 0 N-CA-C 104.21 -2.515 . . . . 0.0 104.21 170.788 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -73.11 170.37 19.98 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.574 2.183 . . . . 0.0 109.773 177.573 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -70.47 -12.16 61.39 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -167.293 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -84.61 -9.06 58.63 Favored 'General case' 0 CA--C 1.506 -0.744 0 O-C-N 121.381 -0.825 . . . . 0.0 110.27 -176.469 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.5 t -92.35 133.92 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 -176.39 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -98.2 150.03 19.31 Favored Glycine 0 CA--C 1.487 -1.698 0 N-CA-C 105.193 -3.163 . . . . 0.0 105.193 179.273 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 28.4 pt -135.29 -166.43 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 103.459 -2.793 . . . . 0.0 103.459 -172.707 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.554 HD12 HG12 ' A' ' 13' ' ' VAL . 1.3 mm -66.45 130.06 31.45 Favored 'Isoleucine or valine' 0 C--N 1.362 1.11 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 -173.256 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 77.4 t . . . . . 0 N--CA 1.427 -1.612 0 N-CA-C 102.101 -3.296 . . . . 0.0 102.101 171.477 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 27.0 m . . . . . 0 N--CA 1.485 1.285 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -105.41 157.25 17.47 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 171.667 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -131.04 123.8 29.48 Favored 'General case' 0 N--CA 1.431 -1.386 1 N-CA-C 93.459 -6.497 . . . . 0.0 93.459 155.518 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.81 -173.61 30.68 Favored Glycine 0 CA--C 1.478 -2.28 1 N-CA-C 101.705 -4.558 . . . . 0.0 101.705 -177.426 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -79.93 137.69 36.94 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 103.673 -2.714 . . . . 0.0 103.673 166.683 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.2 tt -90.72 150.84 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.976 0 N-CA-C 105.171 -2.159 . . . . 0.0 105.171 179.489 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.858 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -143.88 179.68 7.02 Favored 'General case' 0 N--CA 1.411 -2.386 0 N-CA-C 101.309 -3.589 . . . . 0.0 101.309 -173.093 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -86.08 145.8 41.49 Favored Pre-proline 0 N--CA 1.427 -1.597 0 N-CA-C 102.559 -3.126 . . . . 0.0 102.559 171.33 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.11 5.42 5.76 Favored 'Trans proline' 0 CA--C 1.501 -1.157 0 C-N-CA 122.249 1.966 . . . . 0.0 112.491 -151.27 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -107.99 21.53 17.26 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 -179.919 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 62.4 t30 76.18 52.65 0.05 Allowed 'General case' 0 CA--C 1.496 -1.125 0 C-N-CA 126.903 2.081 . . . . 0.0 109.627 167.512 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.492 ' O ' ' HB1' ' A' ' 7' ' ' ALA . 26.0 m -140.47 138.72 34.86 Favored 'General case' 0 CA--C 1.478 -1.806 0 N-CA-C 100.636 -3.839 . . . . 0.0 100.636 -175.937 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.0 m -66.95 152.19 9.83 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.94 0 CA-C-N 120.544 1.52 . . . . 0.0 111.058 -173.188 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -89.43 122.52 32.71 Favored 'General case' 0 CA--C 1.484 -1.565 1 N-CA-C 100.01 -4.07 . . . . 0.0 100.01 176.018 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 58.6 m80 -86.02 138.34 32.04 Favored 'General case' 0 CA--C 1.478 -1.794 0 N-CA-C 102.427 -3.175 . . . . 0.0 102.427 -174.561 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.0 t -148.53 -179.02 6.65 Favored 'General case' 0 N--CA 1.411 -2.413 1 N-CA-C 93.666 -6.42 . . . . 0.0 93.666 -170.122 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -147.36 171.67 6.07 Favored Pre-proline 0 N--CA 1.412 -2.344 1 N-CA-C 97.515 -4.995 . . . . 0.0 97.515 -157.79 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -66.7 44.58 0.21 Allowed 'Trans proline' 0 C--N 1.324 -0.738 0 C-N-CA 123.307 2.672 . . . . 0.0 116.79 -178.912 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -174.93 148.5 9.69 Favored Glycine 0 N--CA 1.42 -2.427 1 N-CA-C 98.202 -5.959 . . . . 0.0 98.202 172.973 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -78.25 38.12 0.28 Allowed 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 124.813 1.245 . . . . 0.0 112.389 -174.881 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.6 m -54.47 -62.46 1.64 Allowed 'General case' 0 N--CA 1.44 -0.947 0 C-N-CA 127.577 2.351 . . . . 0.0 112.447 -162.816 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -90.16 -19.7 45.31 Favored Glycine 0 C--N 1.35 1.338 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 179.901 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.4 t -80.58 -15.22 57.17 Favored 'General case' 0 N--CA 1.442 -0.837 0 O-C-N 121.679 -0.895 . . . . 0.0 110.462 -167.455 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -54.68 -54.51 40.8 Favored 'General case' 0 C--N 1.353 0.743 0 C-N-CA 125.334 1.454 . . . . 0.0 109.594 172.152 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -61.24 -48.43 81.48 Favored 'General case' 0 N--CA 1.435 -1.184 0 C-N-CA 125.233 1.413 . . . . 0.0 112.111 172.518 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 96.3 mt -65.53 -42.19 92.26 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-O 122.192 0.996 . . . . 0.0 111.368 -171.31 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 14.2 t -61.71 -44.39 97.02 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 124.19 0.996 . . . . 0.0 108.491 179.059 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -68.07 -40.2 82.79 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -179.267 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -72.53 -20.37 61.36 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 120.122 1.328 . . . . 0.0 112.371 -179.114 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.8 mmtm -85.82 -16.34 39.04 Favored 'General case' 0 C--N 1.354 0.783 0 C-N-CA 123.349 0.659 . . . . 0.0 109.947 173.07 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.23 29.63 6.66 Favored Glycine 0 CA--C 1.487 -1.682 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 168.743 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -93.85 142.95 16.25 Favored Glycine 0 N--CA 1.435 -1.386 0 N-CA-C 105.792 -2.923 . . . . 0.0 105.792 172.987 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.1 m -109.84 -3.86 16.39 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 122.866 1.317 . . . . 0.0 108.211 -160.84 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 43.1 m -160.49 165.83 30.25 Favored 'General case' 0 CA--C 1.483 -1.633 1 N-CA-C 98.027 -4.805 . . . . 0.0 98.027 166.232 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -166.33 174.99 41.87 Favored Glycine 0 CA--C 1.473 -2.536 1 N-CA-C 101.561 -4.616 . . . . 0.0 101.561 -176.457 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -166.42 -175.15 3.11 Favored 'General case' 0 N--CA 1.431 -1.415 1 N-CA-C 97.604 -4.961 . . . . 0.0 97.604 -172.505 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 86.4 m -146.06 161.35 40.32 Favored 'General case' 0 CA--C 1.487 -1.468 1 N-CA-C 99.531 -4.248 . . . . 0.0 99.531 172.178 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 179.65 -176.89 47.92 Favored Glycine 0 N--CA 1.426 -1.991 1 N-CA-C 101.837 -4.505 . . . . 0.0 101.837 -177.197 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -99.36 161.14 13.79 Favored 'General case' 0 N--CA 1.436 -1.175 0 N-CA-C 104.829 -2.286 . . . . 0.0 104.829 -178.256 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.26 158.81 40.79 Favored 'General case' 0 N--CA 1.425 -1.707 1 N-CA-C 96.047 -5.538 . . . . 0.0 96.047 163.869 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.4 t -111.7 141.07 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.16 0 N-CA-C 103.505 -2.776 . . . . 0.0 103.505 -170.364 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 145.22 -66.41 0.43 Allowed Glycine 0 CA--C 1.482 -2.024 1 N-CA-C 103.054 -4.018 . . . . 0.0 103.054 179.857 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -97.31 -75.86 0.53 Allowed 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 172.49 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 171.46 -158.84 30.23 Favored Glycine 0 CA--C 1.477 -2.287 1 N-CA-C 102.562 -4.215 . . . . 0.0 102.562 -173.901 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.3 tt -69.01 137.16 53.45 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 -173.436 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -137.98 -179.01 5.52 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 104.346 -2.465 . . . . 0.0 104.346 -162.432 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 30.6 t -117.32 169.81 9.19 Favored 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 101.142 -3.651 . . . . 0.0 101.142 179.204 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 7.8 t-105 -131.44 150.42 52.16 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 102.452 -3.166 . . . . 0.0 102.452 -177.842 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 22.2 m -146.64 153.97 40.93 Favored 'General case' 0 CA--C 1.493 -1.25 0 N-CA-C 103.743 -2.688 . . . . 0.0 103.743 176.441 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -121.09 134.6 55.26 Favored 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 104.756 -2.313 . . . . 0.0 104.756 175.331 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 73.08 57.84 0.11 Allowed 'General case' 0 CA--C 1.492 -1.279 0 C-N-CA 126.941 2.096 . . . . 0.0 109.799 170.382 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 31.4 mt -96.32 144.25 27.51 Favored Pre-proline 0 CA--C 1.499 -0.987 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 176.967 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -66.6 164.37 29.19 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.562 2.174 . . . . 0.0 112.552 173.815 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -63.95 -27.58 69.24 Favored 'General case' 0 N--CA 1.442 -0.875 0 C-N-CA 125.224 1.409 . . . . 0.0 113.859 -173.455 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -94.97 17.25 14.23 Favored 'General case' 0 CA--C 1.503 -0.85 0 O-C-N 121.237 -0.915 . . . . 0.0 110.288 -174.796 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 20.4 t -97.21 122.84 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 N-CA-C 102.125 -3.287 . . . . 0.0 102.125 168.758 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -91.87 148.19 19.11 Favored Glycine 0 CA--C 1.488 -1.637 0 N-CA-C 104.817 -3.313 . . . . 0.0 104.817 179.272 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 25.5 pt -140.83 -149.68 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 N-CA-C 103.762 -2.681 . . . . 0.0 103.762 -169.284 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.858 HD13 ' HB2' ' A' ' 7' ' ' ALA . 5.7 mm -71.24 115.42 11.16 Favored 'Isoleucine or valine' 0 C--N 1.357 0.9 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 177.272 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.257 1.2 t . . . . . 0 N--CA 1.438 -1.07 0 N-CA-C 102.519 -3.141 . . . . 0.0 102.519 -166.394 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 17.0 m . . . . . 0 N--CA 1.485 1.312 0 CA-C-O 121.709 0.766 . . . . 0.0 110.864 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.5 HH21 HG12 ' A' ' 58' ' ' ILE . 21.1 mtp85 -115.67 159.8 20.87 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 -173.298 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -135.89 134.31 38.63 Favored 'General case' 0 CA--C 1.489 -1.402 1 N-CA-C 96.674 -5.306 . . . . 0.0 96.674 164.071 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.01 -178.22 35.72 Favored Glycine 0 CA--C 1.48 -2.108 0 N-CA-C 106.687 -2.565 . . . . 0.0 106.687 175.558 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -75.36 128.7 35.98 Favored 'General case' 0 CA--C 1.497 -1.076 0 N-CA-C 104.386 -2.45 . . . . 0.0 104.386 158.745 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.469 HG22 ' HB2' ' A' ' 47' ' ' CYS . 5.7 tt -89.85 136.92 22.54 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.975 0 N-CA-C 105.444 -2.058 . . . . 0.0 105.444 -173.733 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.427 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -97.39 -147.11 0.31 Allowed 'General case' 0 N--CA 1.423 -1.806 0 CA-C-N 112.067 -2.333 . . . . 0.0 106.938 174.622 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.404 ' H ' ' HB1' ' A' ' 7' ' ' ALA . 54.2 mt-30 -125.07 141.21 37.85 Favored Pre-proline 0 N--CA 1.42 -1.968 1 N-CA-C 93.575 -6.454 . . . . 0.0 93.575 168.831 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -80.54 23.38 0.71 Allowed 'Trans proline' 0 C--N 1.323 -0.769 0 C-N-CA 122.707 2.271 . . . . 0.0 114.276 -145.443 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -95.48 -82.0 0.39 Allowed 'General case' 0 CA--C 1.489 -1.368 0 N-CA-C 103.043 -2.947 . . . . 0.0 103.043 -179.965 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -165.38 123.78 1.64 Allowed 'General case' 0 N--CA 1.425 -1.698 1 N-CA-C 91.584 -7.191 . . . . 0.0 91.584 169.05 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.3 m -174.59 -166.14 0.24 Allowed 'General case' 0 CA--C 1.496 -1.127 0 N-CA-C 101.825 -3.398 . . . . 0.0 101.825 -179.163 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.419 HG12 HD12 ' A' ' 59' ' ' ILE . 0.9 OUTLIER -125.24 167.32 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.387 1 N-CA-C 96.829 -5.248 . . . . 0.0 96.829 160.039 . . . . . . . . 4 4 . 1 . 023 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -88.83 -159.01 0.53 Allowed 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 104.718 -2.327 . . . . 0.0 104.718 163.236 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 51.5 m80 -140.46 160.65 39.53 Favored 'General case' 0 N--CA 1.417 -2.112 1 N-CA-C 94.982 -5.932 . . . . 0.0 94.982 168.796 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.4 t -161.23 -153.63 0.31 Allowed 'General case' 0 N--CA 1.415 -2.191 1 N-CA-C 94.188 -6.227 . . . . 0.0 94.188 -178.896 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -147.33 174.2 3.58 Favored Pre-proline 0 N--CA 1.414 -2.238 1 N-CA-C 99.201 -4.37 . . . . 0.0 99.201 -166.069 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_exo -67.82 44.06 0.26 Allowed 'Trans proline' 0 C--N 1.321 -0.883 0 C-N-CA 123.635 2.89 . . . . 0.0 114.245 168.047 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -176.07 147.66 8.78 Favored Glycine 0 N--CA 1.425 -2.094 1 N-CA-C 98.884 -5.686 . . . . 0.0 98.884 179.232 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.3 m -79.36 -16.11 56.8 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -164.182 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.6 m -39.86 -56.75 1.72 Allowed 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 117.264 2.32 . . . . 0.0 117.264 -151.561 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -77.61 -34.59 39.07 Favored Glycine 0 C--N 1.349 1.301 0 O-C-N 121.291 -0.881 . . . . 0.0 111.131 -174.432 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.3 t -84.24 -12.32 54.95 Favored 'General case' 0 CA--C 1.499 -0.999 0 O-C-N 121.695 -0.885 . . . . 0.0 109.065 -172.792 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -62.88 -48.29 79.64 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 172.787 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -58.54 -48.28 81.38 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 123.235 0.614 . . . . 0.0 112.318 171.334 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 90.8 mt -63.97 -42.41 97.26 Favored 'General case' 0 C--N 1.357 0.934 0 CA-C-O 121.895 0.855 . . . . 0.0 111.445 -175.603 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 24.9 t -59.67 -46.97 87.45 Favored 'General case' 0 CA--C 1.5 -0.954 0 C-N-CA 125.304 1.442 . . . . 0.0 108.998 177.253 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 45.3 mttp -70.79 -40.57 72.5 Favored 'General case' 0 N--CA 1.438 -1.064 0 O-C-N 121.683 -0.635 . . . . 0.0 111.405 -173.568 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -71.05 -18.11 62.58 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 118.914 0.779 . . . . 0.0 112.601 -179.111 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -97.57 -1.84 43.03 Favored 'General case' 0 C--N 1.355 0.822 0 O-C-N 121.731 -0.606 . . . . 0.0 110.478 175.152 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.97 33.72 6.51 Favored Glycine 0 C--N 1.352 1.422 0 CA-C-O 119.762 -0.465 . . . . 0.0 112.122 167.209 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -104.79 125.58 8.39 Favored Glycine 0 CA--C 1.49 -1.506 0 N-CA-C 104.826 -3.309 . . . . 0.0 104.826 168.582 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.9 p -100.54 6.08 44.17 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-O 122.139 0.971 . . . . 0.0 109.694 -164.557 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 26.9 m -160.17 159.11 31.25 Favored 'General case' 0 CA--C 1.476 -1.87 1 N-CA-C 98.503 -4.629 . . . . 0.0 98.503 167.289 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -170.89 177.32 43.97 Favored Glycine 0 N--CA 1.418 -2.539 1 N-CA-C 99.421 -5.472 . . . . 0.0 99.421 -176.012 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 52.6 m80 -165.33 -172.96 2.65 Favored 'General case' 0 N--CA 1.431 -1.404 1 N-CA-C 97.18 -5.119 . . . . 0.0 97.18 -177.724 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 100.0 m -140.61 156.51 46.25 Favored 'General case' 0 CA--C 1.477 -1.84 0 N-CA-C 100.503 -3.888 . . . . 0.0 100.503 174.684 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 170.22 -168.74 41.69 Favored Glycine 0 N--CA 1.424 -2.108 1 N-CA-C 98.373 -5.891 . . . . 0.0 98.373 -169.128 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -152.85 -177.95 6.59 Favored 'General case' 0 N--CA 1.427 -1.611 1 N-CA-C 98.921 -4.474 . . . . 0.0 98.921 -177.591 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 25.2 tptp 128.11 63.66 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.149 2 C-N-CA 133.38 4.672 . . . . 0.0 99.372 -179.602 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.5 HG12 ' H ' ' A' ' 42' ' ' GLY . 2.7 t -146.17 -167.08 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.518 1 N-CA-C 97.277 -5.083 . . . . 0.0 97.277 -172.867 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.5 ' H ' HG12 ' A' ' 41' ' ' VAL . . . -139.81 68.77 0.48 Allowed Glycine 0 CA--C 1.487 -1.7 0 N-CA-C 105.616 -2.994 . . . . 0.0 105.616 -176.383 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 21.7 m170 -158.33 -107.43 0.02 OUTLIER 'General case' 0 N--CA 1.434 -1.272 0 N-CA-C 100.894 -3.743 . . . . 0.0 100.894 173.172 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -121.21 -70.39 0.28 Allowed Glycine 0 C--N 1.355 1.587 0 CA-C-N 120.111 1.323 . . . . 0.0 111.932 -170.559 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -149.53 179.78 7.7 Favored 'General case' 0 N--CA 1.434 -1.245 1 N-CA-C 95.328 -5.805 . . . . 0.0 95.328 176.499 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -157.03 -174.48 4.94 Favored 'General case' 0 CA--C 1.486 -1.498 1 N-CA-C 99.936 -4.098 . . . . 0.0 99.936 -179.81 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.469 ' HB2' HG22 ' A' ' 6' ' ' ILE . 1.6 m -116.31 -179.13 3.58 Favored 'General case' 0 CA--C 1.486 -1.484 0 N-CA-C 102.308 -3.219 . . . . 0.0 102.308 165.814 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 32.2 t-105 -122.07 153.53 38.52 Favored 'General case' 0 CA--C 1.496 -1.121 0 N-CA-C 102.885 -3.006 . . . . 0.0 102.885 174.275 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 37.3 m -145.64 147.46 32.04 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 170.457 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -114.08 144.24 43.45 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 105.024 -2.213 . . . . 0.0 105.024 173.572 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 69.7 42.9 1.03 Allowed 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 127.289 2.236 . . . . 0.0 111.602 167.215 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 38.7 mt -84.04 137.95 40.09 Favored Pre-proline 0 CA--C 1.504 -0.825 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 178.391 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -73.6 168.91 23.58 Favored 'Trans proline' 0 N--CA 1.447 -1.208 0 C-N-CA 122.187 1.925 . . . . 0.0 110.333 177.514 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -67.78 -9.22 42.3 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 124.652 1.181 . . . . 0.0 114.054 -171.317 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 -91.15 -0.12 57.64 Favored 'General case' 0 CA--C 1.507 -0.709 0 O-C-N 121.557 -0.715 . . . . 0.0 110.923 -176.946 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.46 HG12 ' H ' ' A' ' 57' ' ' GLY . 2.0 t -99.93 178.12 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 N-CA-C 103.755 -2.683 . . . . 0.0 103.755 179.463 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.46 ' H ' HG12 ' A' ' 56' ' ' VAL . . . -143.61 161.58 27.72 Favored Glycine 0 CA--C 1.479 -2.205 1 N-CA-C 100.086 -5.206 . . . . 0.0 100.086 -176.035 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.5 HG12 HH21 ' A' ' 2' ' ' ARG . 17.8 pt -152.99 -166.94 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.627 1 N-CA-C 99.32 -4.326 . . . . 0.0 99.32 -167.655 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.427 HD13 ' HB2' ' A' ' 7' ' ' ALA . 2.9 mm -63.7 134.28 28.79 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 179.146 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.8 t . . . . . 0 N--CA 1.423 -1.822 1 N-CA-C 93.404 -6.517 . . . . 0.0 93.404 -179.183 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 19.1 m . . . . . 0 N--CA 1.485 1.295 0 CA-C-O 121.403 0.621 . . . . 0.0 110.424 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -103.97 167.71 9.59 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 104.637 -2.357 . . . . 0.0 104.637 163.551 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -125.86 140.45 52.64 Favored 'General case' 0 CA--C 1.485 -1.556 1 N-CA-C 93.75 -6.389 . . . . 0.0 93.75 156.714 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.79 178.94 37.46 Favored Glycine 0 CA--C 1.474 -2.523 0 C-N-CA 116.904 -2.569 . . . . 0.0 107.513 -178.479 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -73.87 130.16 39.35 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 104.075 -2.565 . . . . 0.0 104.075 155.409 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.8 tt -90.63 137.81 20.86 Favored 'Isoleucine or valine' 0 C--O 1.253 1.275 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 179.247 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.594 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -100.24 -158.38 0.67 Allowed 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 112.755 -2.021 . . . . 0.0 107.484 176.062 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -98.87 142.39 24.52 Favored Pre-proline 0 CA--C 1.49 -1.344 1 N-CA-C 97.422 -5.029 . . . . 0.0 97.422 163.815 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -78.49 26.47 0.52 Allowed 'Trans proline' 0 CA--C 1.509 -0.759 0 C-N-CA 123.07 2.514 . . . . 0.0 114.654 -136.292 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -115.5 -78.95 0.58 Allowed 'General case' 0 N--CA 1.425 -1.704 0 N-CA-C 102.415 -3.18 . . . . 0.0 102.415 177.65 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -165.89 147.83 7.14 Favored 'General case' 0 N--CA 1.429 -1.513 1 N-CA-C 96.544 -5.354 . . . . 0.0 96.544 164.958 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 20.3 m 164.91 -152.73 0.0 OUTLIER 'General case' 0 CA--C 1.499 -1.017 1 N-CA-C 97.308 -5.071 . . . . 0.0 97.308 179.238 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.543 HG12 HD12 ' A' ' 59' ' ' ILE . 0.8 OUTLIER -126.77 163.69 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 1 N-CA-C 98.844 -4.502 . . . . 0.0 98.844 160.111 . . . . . . . . 4 4 . 1 . 024 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -87.8 -158.87 0.49 Allowed 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 104.79 -2.3 . . . . 0.0 104.79 164.447 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -142.82 -178.46 5.82 Favored 'General case' 0 N--CA 1.424 -1.735 1 N-CA-C 97.032 -5.173 . . . . 0.0 97.032 166.739 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.3 t -155.05 166.13 34.56 Favored 'General case' 0 N--CA 1.415 -2.19 1 N-CA-C 96.643 -5.318 . . . . 0.0 96.643 -171.513 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -121.84 125.24 26.78 Favored Pre-proline 0 N--CA 1.42 -1.951 1 N-CA-C 99.841 -4.133 . . . . 0.0 99.841 179.251 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -58.4 111.72 0.96 Allowed 'Trans proline' 0 CA--C 1.503 -1.046 0 C-N-CA 123.327 2.684 . . . . 0.0 112.653 -174.0 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 140.06 -36.79 1.78 Allowed Glycine 0 CA--C 1.49 -1.522 1 N-CA-C 102.739 -4.144 . . . . 0.0 102.739 -166.937 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.3 m 85.23 11.85 0.26 Allowed 'General case' 0 CA--C 1.496 -1.096 0 C-N-CA 128.187 2.595 . . . . 0.0 111.04 172.384 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -48.87 -55.17 12.5 Favored 'General case' 0 N--CA 1.436 -1.148 0 C-N-CA 129.4 3.08 . . . . 0.0 113.526 -169.822 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -85.95 -26.28 35.04 Favored Glycine 0 C--N 1.35 1.359 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 -172.75 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 15.7 t -79.53 -17.09 54.8 Favored 'General case' 0 C--N 1.354 0.78 0 O-C-N 122.238 -0.566 . . . . 0.0 110.187 -172.412 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -62.45 -43.09 99.64 Favored 'General case' 0 C--N 1.354 0.801 0 O-C-N 120.973 -1.079 . . . . 0.0 109.364 174.118 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -56.14 -54.24 47.42 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 124.262 1.025 . . . . 0.0 111.132 169.794 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 91.1 mt -61.75 -45.43 93.93 Favored 'General case' 0 CA--C 1.496 -1.122 0 C-N-CA 123.49 0.716 . . . . 0.0 111.036 -172.739 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.8 t -60.28 -46.5 89.63 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 123.711 0.805 . . . . 0.0 109.407 179.381 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 78.7 mttt -67.31 -43.0 82.74 Favored 'General case' 0 CA--C 1.502 -0.884 0 O-C-N 121.956 -0.465 . . . . 0.0 111.629 -177.329 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -75.26 -21.08 58.8 Favored 'General case' 0 CA--C 1.508 -0.641 0 O-C-N 121.606 -0.684 . . . . 0.0 112.432 -176.5 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -87.94 -15.94 35.19 Favored 'General case' 0 C--N 1.356 0.865 0 CA-C-N 118.971 0.805 . . . . 0.0 109.875 172.822 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.2 34.33 3.98 Favored Glycine 0 CA--C 1.492 -1.366 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 166.655 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -96.83 157.26 21.15 Favored Glycine 0 CA--C 1.491 -1.42 0 N-CA-C 105.535 -3.026 . . . . 0.0 105.535 164.786 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 30.4 m -85.09 -42.38 14.86 Favored 'General case' 0 CA--C 1.497 -1.063 0 CA-C-O 123.119 1.438 . . . . 0.0 107.988 -168.628 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.5 m -158.99 166.59 31.43 Favored 'General case' 0 N--CA 1.417 -2.104 1 N-CA-C 97.083 -5.155 . . . . 0.0 97.083 -178.9 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -175.11 175.6 47.13 Favored Glycine 0 N--CA 1.421 -2.312 1 N-CA-C 98.545 -5.822 . . . . 0.0 98.545 -169.459 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 34.2 p-80 -167.11 -179.35 4.56 Favored 'General case' 0 N--CA 1.428 -1.54 1 N-CA-C 98.575 -4.602 . . . . 0.0 98.575 -173.695 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 80.2 m -74.08 171.29 13.8 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-N 119.476 1.035 . . . . 0.0 111.13 -178.842 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.86 170.34 43.31 Favored Glycine 0 N--CA 1.422 -2.237 1 N-CA-C 99.466 -5.454 . . . . 0.0 99.466 178.525 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -138.39 136.23 36.09 Favored 'General case' 0 N--CA 1.429 -1.489 1 N-CA-C 97.258 -5.09 . . . . 0.0 97.258 177.796 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.5 tmtm? -118.61 102.27 8.75 Favored 'General case' 0 CA--C 1.494 -1.189 0 N-CA-C 102.341 -3.207 . . . . 0.0 102.341 -177.477 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.6 t -73.87 122.28 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 -172.407 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 139.86 -43.26 1.15 Allowed Glycine 0 CA--C 1.484 -1.897 0 N-CA-C 103.115 -3.994 . . . . 0.0 103.115 -171.687 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -113.42 -63.96 1.37 Allowed 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 178.488 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 164.1 -162.65 35.4 Favored Glycine 0 CA--C 1.489 -1.547 0 N-CA-C 108.112 -1.995 . . . . 0.0 108.112 -170.452 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 28.8 tp -63.5 133.96 54.78 Favored 'General case' 0 CA--C 1.501 -0.936 0 C-N-CA 127.768 2.427 . . . . 0.0 105.657 173.515 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -136.59 -158.28 0.85 Allowed 'General case' 0 CA--C 1.483 -1.597 0 N-CA-C 103.289 -2.856 . . . . 0.0 103.289 -167.253 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 52.9 t -138.52 168.72 19.16 Favored 'General case' 0 CA--C 1.49 -1.336 0 N-CA-C 101.683 -3.451 . . . . 0.0 101.683 163.322 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 42.0 t-105 -121.16 145.89 47.34 Favored 'General case' 0 CA--C 1.499 -1.0 0 N-CA-C 103.418 -2.808 . . . . 0.0 103.418 -177.444 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 6.9 m -141.06 146.29 36.96 Favored 'General case' 0 CA--C 1.49 -1.33 0 N-CA-C 105.623 -1.991 . . . . 0.0 105.623 177.159 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -113.51 130.99 56.23 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 179.066 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 65.64 78.65 0.27 Allowed 'General case' 0 CA--C 1.491 -1.318 0 C-N-CA 129.378 3.071 . . . . 0.0 110.422 178.462 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -104.98 125.71 32.98 Favored Pre-proline 0 CA--C 1.496 -1.111 0 N-CA-C 102.216 -3.253 . . . . 0.0 102.216 177.9 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -72.06 170.74 18.25 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 CA-C-N 123.514 2.291 . . . . 0.0 110.126 174.169 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -85.67 18.15 2.99 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -165.64 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -100.92 1.28 39.68 Favored 'General case' 0 CA--C 1.502 -0.885 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 174.045 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.2 t -110.69 133.7 55.32 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.082 0 N-CA-C 103.68 -2.711 . . . . 0.0 103.68 -174.669 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -100.58 148.77 18.41 Favored Glycine 0 CA--C 1.489 -1.579 0 N-CA-C 106.097 -2.801 . . . . 0.0 106.097 178.611 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 25.3 pt -129.83 -146.57 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.492 -1.265 0 N-CA-C 104.222 -2.51 . . . . 0.0 104.222 -169.213 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.594 HD13 ' HB2' ' A' ' 7' ' ' ALA . 3.1 mm -73.03 1.42 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.747 0 CA-C-N 118.904 0.774 . . . . 0.0 112.194 -172.484 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.491 -1.298 0 O-C-N 119.109 -2.244 . . . . 0.0 105.853 161.353 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 22.8 m . . . . . 0 N--CA 1.484 1.252 0 CA-C-O 121.202 0.525 . . . . 0.0 110.512 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.46 174.97 5.65 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 103.439 -2.8 . . . . 0.0 103.439 160.798 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -126.22 142.02 51.69 Favored 'General case' 0 CA--C 1.489 -1.399 1 N-CA-C 93.354 -6.535 . . . . 0.0 93.354 162.716 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.28 170.74 37.14 Favored Glycine 0 CA--C 1.47 -2.732 0 N-CA-C 106.446 -2.662 . . . . 0.0 106.446 -174.292 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -88.77 125.22 34.78 Favored 'General case' 0 CA--C 1.488 -1.411 0 N-CA-C 100.708 -3.812 . . . . 0.0 100.708 162.611 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.9 tt -87.84 140.72 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.088 0 N-CA-C 105.58 -2.007 . . . . 0.0 105.58 -174.271 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.625 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -116.41 -158.55 0.69 Allowed 'General case' 0 N--CA 1.424 -1.727 0 C-N-CA 128.12 2.568 . . . . 0.0 107.55 -175.118 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -88.3 144.5 34.16 Favored Pre-proline 0 N--CA 1.44 -0.928 0 N-CA-C 100.493 -3.891 . . . . 0.0 100.493 162.239 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -78.36 27.16 0.5 Allowed 'Trans proline' 0 CA--C 1.511 -0.637 0 C-N-CA 123.322 2.681 . . . . 0.0 113.811 -152.897 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 53.6 mp0 -111.37 -82.07 0.58 Allowed 'General case' 0 N--CA 1.425 -1.699 0 N-CA-C 101.912 -3.366 . . . . 0.0 101.912 178.955 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -163.47 143.95 8.92 Favored 'General case' 0 N--CA 1.424 -1.754 1 N-CA-C 93.521 -6.474 . . . . 0.0 93.521 167.496 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 9.1 m 170.66 -156.21 0.01 OUTLIER 'General case' 0 CA--C 1.494 -1.178 1 N-CA-C 98.166 -4.753 . . . . 0.0 98.166 175.203 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.599 HG12 HD12 ' A' ' 59' ' ' ILE . 7.8 m -130.98 168.4 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.531 1 N-CA-C 96.815 -5.254 . . . . 0.0 96.815 160.284 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -89.89 163.55 14.95 Favored 'General case' 0 CA--C 1.499 -1.018 0 N-CA-C 100.957 -3.72 . . . . 0.0 100.957 161.915 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 71.3 m80 -108.13 101.2 10.45 Favored 'General case' 0 CA--C 1.48 -1.727 0 N-CA-C 102.74 -3.059 . . . . 0.0 102.74 -174.654 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.8 t -107.44 -171.51 1.89 Allowed 'General case' 0 N--CA 1.425 -1.7 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 -177.896 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -142.43 167.9 15.02 Favored Pre-proline 0 N--CA 1.416 -2.148 1 N-CA-C 98.552 -4.61 . . . . 0.0 98.552 -160.289 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.94 54.23 2.09 Favored 'Trans proline' 0 C--N 1.327 -0.588 0 C-N-CA 123.259 2.639 . . . . 0.0 110.749 166.497 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -178.51 134.16 2.3 Favored Glycine 0 N--CA 1.425 -2.068 1 N-CA-C 99.403 -5.479 . . . . 0.0 99.403 -178.519 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.98 26.06 9.17 Favored 'General case' 0 N--CA 1.434 -1.249 0 C-N-CA 124.305 1.042 . . . . 0.0 109.722 -168.938 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.5 m -49.68 -48.26 49.67 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 126.73 2.012 . . . . 0.0 115.37 -169.759 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -90.1 -26.35 24.18 Favored Glycine 0 C--N 1.351 1.364 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 -179.374 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -85.88 -14.69 44.12 Favored 'General case' 0 CA--C 1.5 -0.976 0 O-C-N 121.53 -0.982 . . . . 0.0 109.989 -167.946 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -58.9 -49.54 77.4 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 125.724 1.61 . . . . 0.0 108.113 171.979 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.4 -45.25 93.98 Favored 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 124.599 1.16 . . . . 0.0 112.162 174.173 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 95.9 mt -64.34 -41.29 96.84 Favored 'General case' 0 C--N 1.357 0.933 0 CA-C-O 121.69 0.757 . . . . 0.0 111.9 -178.064 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 13.2 t -59.79 -44.72 93.81 Favored 'General case' 0 N--CA 1.443 -0.799 0 O-C-N 121.59 -0.694 . . . . 0.0 109.815 176.776 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 46.1 mttp -63.66 -50.9 67.44 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 123.129 0.571 . . . . 0.0 111.163 -177.581 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -67.71 -23.57 65.29 Favored 'General case' 0 C--N 1.351 0.674 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -175.549 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -91.71 -5.72 53.22 Favored 'General case' 0 C--N 1.357 0.902 0 O-C-N 121.728 -0.607 . . . . 0.0 110.701 177.718 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.25 32.37 5.82 Favored Glycine 0 CA--C 1.492 -1.386 0 N-CA-C 111.579 -0.608 . . . . 0.0 111.579 165.713 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -108.75 140.26 15.51 Favored Glycine 0 CA--C 1.486 -1.735 0 N-CA-C 106.173 -2.771 . . . . 0.0 106.173 170.857 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.78 -76.29 0.34 Allowed 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 -171.814 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.8 m -85.85 151.83 23.48 Favored 'General case' 0 CA--C 1.491 -1.293 0 N-CA-C 105.496 -2.038 . . . . 0.0 105.496 176.706 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -158.41 171.61 35.26 Favored Glycine 0 N--CA 1.414 -2.787 1 N-CA-C 99.246 -5.542 . . . . 0.0 99.246 -175.936 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 52.9 m80 -168.0 -170.38 1.33 Allowed 'General case' 0 N--CA 1.426 -1.662 1 N-CA-C 95.982 -5.562 . . . . 0.0 95.982 -176.156 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 46.8 m -138.09 161.47 36.69 Favored 'General case' 0 N--CA 1.427 -1.579 1 N-CA-C 97.465 -5.013 . . . . 0.0 97.465 167.602 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 178.29 179.49 48.25 Favored Glycine 0 CA--C 1.481 -2.06 1 N-CA-C 100.779 -4.928 . . . . 0.0 100.779 -174.018 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -144.46 138.83 27.93 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 100.228 -3.989 . . . . 0.0 100.228 -170.294 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -148.11 50.39 1.03 Allowed 'General case' 0 CA--C 1.491 -1.302 1 N-CA-C 99.599 -4.223 . . . . 0.0 99.599 170.549 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . 0.275 2.2 t 60.61 -142.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.142 0 C-N-CA 125.84 1.656 . . . . 0.0 106.84 -160.288 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 121.55 -86.09 0.39 Allowed Glycine 0 CA--C 1.484 -1.899 1 N-CA-C 102.894 -4.082 . . . . 0.0 102.894 -176.714 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 26.1 m170 -159.93 -47.9 0.05 Allowed 'General case' 0 CA--C 1.498 -1.033 0 N-CA-C 104.726 -2.324 . . . . 0.0 104.726 -175.486 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -160.07 -176.89 32.65 Favored Glycine 0 N--CA 1.428 -1.878 1 N-CA-C 97.119 -6.393 . . . . 0.0 97.119 -178.508 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.7 tt -73.33 120.63 19.21 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 118.61 1.205 . . . . 0.0 108.689 -169.567 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -105.22 179.01 4.4 Favored 'General case' 0 CA--C 1.491 -1.308 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -162.82 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 58.9 m -109.46 157.13 19.26 Favored 'General case' 0 CA--C 1.486 -1.486 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 179.79 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 65.7 t-105 -109.88 148.93 30.65 Favored 'General case' 0 CA--C 1.487 -1.479 0 N-CA-C 103.717 -2.697 . . . . 0.0 103.717 179.591 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 45.1 m -140.94 141.81 34.45 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 101.72 -3.437 . . . . 0.0 101.72 167.382 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -108.61 17.12 22.33 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-O 121.396 0.617 . . . . 0.0 109.653 -166.679 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -171.0 144.52 2.15 Favored 'General case' 0 N--CA 1.418 -2.042 1 N-CA-C 93.624 -6.436 . . . . 0.0 93.624 172.364 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 17.0 mt -153.48 146.22 17.54 Favored Pre-proline 0 CA--C 1.487 -1.445 1 N-CA-C 97.325 -5.065 . . . . 0.0 97.325 155.61 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.38 170.21 19.8 Favored 'Trans proline' 0 N--CA 1.447 -1.207 0 C-N-CA 122.6 2.2 . . . . 0.0 109.221 173.33 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -65.89 -19.79 66.0 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -167.259 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -83.61 -2.37 55.94 Favored 'General case' 0 CA--C 1.501 -0.923 0 C-N-CA 124.18 0.992 . . . . 0.0 111.289 -172.923 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.8 t -100.09 126.31 53.62 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.303 0 N-CA-C 103.753 -2.684 . . . . 0.0 103.753 -177.67 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -92.68 158.71 24.4 Favored Glycine 0 CA--C 1.485 -1.8 0 N-CA-C 105.324 -3.11 . . . . 0.0 105.324 178.559 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 25.8 pt -144.89 -156.99 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.517 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 -166.491 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.625 HD13 ' HB2' ' A' ' 7' ' ' ALA . 0.7 OUTLIER -71.93 128.03 34.51 Favored 'Isoleucine or valine' 0 C--N 1.365 1.247 0 N-CA-C 104.967 -2.234 . . . . 0.0 104.967 176.085 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.6 t . . . . . 0 N--CA 1.427 -1.596 0 N-CA-C 101.292 -3.596 . . . . 0.0 101.292 176.886 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 4.8 m . . . . . 0 N--CA 1.483 1.185 0 CA-C-O 122.443 1.116 . . . . 0.0 111.065 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 34.6 mtp85 -97.26 151.38 19.93 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 -171.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -130.63 125.3 33.71 Favored 'General case' 0 CA--C 1.485 -1.519 1 N-CA-C 96.597 -5.335 . . . . 0.0 96.597 165.037 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.76 -178.12 35.41 Favored Glycine 0 CA--C 1.477 -2.32 0 N-CA-C 103.162 -3.975 . . . . 0.0 103.162 176.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 48' ' ' TRP . 85.3 m-85 -76.88 133.33 39.32 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 168.246 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 17.4 tt -91.34 147.49 5.22 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 CA-C-N 120.163 1.347 . . . . 0.0 108.406 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.664 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -134.87 -150.98 0.41 Allowed 'General case' 0 N--CA 1.426 -1.654 0 C-N-CA 127.657 2.383 . . . . 0.0 106.869 -177.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -125.67 144.96 49.85 Favored Pre-proline 0 N--CA 1.426 -1.668 1 N-CA-C 94.661 -6.052 . . . . 0.0 94.661 162.377 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -80.6 -1.77 11.49 Favored 'Trans proline' 0 CA--C 1.501 -1.143 0 CA-C-N 123.165 2.166 . . . . 0.0 112.714 -143.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 48.8 mm-40 -86.37 46.85 1.39 Allowed 'General case' 0 N--CA 1.438 -1.043 0 C-N-CA 124.574 1.15 . . . . 0.0 109.874 -167.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 65.59 45.87 2.6 Favored 'General case' 0 C--N 1.356 0.889 0 C-N-CA 126.343 1.857 . . . . 0.0 107.598 177.355 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 94.9 m -122.38 -162.64 1.02 Allowed 'General case' 0 CA--C 1.486 -1.502 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 -169.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.671 HG12 HD12 ' A' ' 59' ' ' ILE . 0.6 OUTLIER -141.59 170.26 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.838 1 N-CA-C 96.897 -5.223 . . . . 0.0 96.897 173.137 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -98.2 -163.95 1.09 Allowed 'General case' 0 CA--C 1.5 -0.966 0 N-CA-C 101.254 -3.61 . . . . 0.0 101.254 163.462 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 69.8 m80 -139.56 162.67 34.5 Favored 'General case' 0 CA--C 1.482 -1.672 1 N-CA-C 96.085 -5.524 . . . . 0.0 96.085 166.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 8.4 t -123.03 164.36 18.72 Favored 'General case' 0 CA--C 1.477 -1.837 0 N-CA-C 101.965 -3.346 . . . . 0.0 101.965 -167.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -112.53 122.06 37.32 Favored Pre-proline 0 N--CA 1.425 -1.693 1 N-CA-C 97.341 -5.059 . . . . 0.0 97.341 166.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_exo -56.34 96.47 0.06 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.578 0 CA-C-N 123.823 2.401 . . . . 0.0 117.081 -169.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 162.28 -161.06 33.23 Favored Glycine 0 N--CA 1.417 -2.568 1 N-CA-C 97.597 -6.201 . . . . 0.0 97.597 -179.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -84.86 -45.35 12.37 Favored 'General case' 0 N--CA 1.426 -1.652 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 176.207 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.9 m -39.29 -56.22 1.57 Allowed 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 117.356 2.354 . . . . 0.0 117.356 -145.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -68.34 -74.74 0.57 Allowed Glycine 0 C--N 1.351 1.363 0 O-C-N 121.606 -0.683 . . . . 0.0 111.815 -176.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.6 p -87.0 -6.02 58.89 Favored 'General case' 0 CA--C 1.497 -1.073 0 O-C-N 121.219 -1.165 . . . . 0.0 113.048 -166.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -69.88 -33.72 72.6 Favored 'General case' 0 C--N 1.359 0.983 0 CA-C-N 119.774 1.17 . . . . 0.0 108.276 166.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 26.6 m -70.27 -42.02 72.68 Favored 'General case' 0 N--CA 1.447 -0.624 0 O-C-N 120.936 -1.102 . . . . 0.0 108.679 177.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 96.3 mt -61.31 -40.41 94.06 Favored 'General case' 0 C--N 1.355 0.824 0 CA-C-O 121.73 0.776 . . . . 0.0 110.734 175.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.0 t -55.13 -43.34 74.03 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 123.841 0.856 . . . . 0.0 111.256 174.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -60.51 -46.55 89.73 Favored 'General case' 0 C--N 1.356 0.884 0 CA-C-N 118.361 0.528 . . . . 0.0 111.877 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -76.83 -23.57 52.75 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -174.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -80.79 -30.93 35.88 Favored 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 173.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 117.56 35.59 1.07 Allowed Glycine 0 CA--C 1.487 -1.67 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 162.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.58 142.89 15.72 Favored Glycine 0 CA--C 1.488 -1.638 0 N-CA-C 105.097 -3.201 . . . . 0.0 105.097 173.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.3 p -105.17 15.4 27.54 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-O 121.657 0.741 . . . . 0.0 109.798 -167.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 65.8 m -158.39 154.92 27.75 Favored 'General case' 0 CA--C 1.475 -1.92 1 N-CA-C 98.405 -4.665 . . . . 0.0 98.405 159.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -153.87 147.85 17.72 Favored Glycine 0 CA--C 1.468 -2.853 1 N-CA-C 97.491 -6.243 . . . . 0.0 97.491 -170.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -156.61 -171.37 3.66 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 101.566 -3.494 . . . . 0.0 101.566 -171.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 79.3 m -103.36 -179.38 3.93 Favored 'General case' 0 CA--C 1.491 -1.307 0 N-CA-C 104.278 -2.49 . . . . 0.0 104.278 174.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.17 178.29 45.2 Favored Glycine 0 N--CA 1.421 -2.347 0 N-CA-C 103.505 -3.838 . . . . 0.0 103.505 170.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -131.45 133.4 45.13 Favored 'General case' 0 CA--C 1.488 -1.418 1 N-CA-C 98.912 -4.477 . . . . 0.0 98.912 172.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -118.93 99.25 6.63 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 102.2 -3.259 . . . . 0.0 102.2 178.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.0 t -69.34 129.91 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 -175.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 124.75 -41.55 1.69 Allowed Glycine 0 CA--C 1.488 -1.649 0 N-CA-C 104.516 -3.434 . . . . 0.0 104.516 -168.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 30.5 m80 -108.94 -69.85 0.84 Allowed 'General case' 0 CA--C 1.496 -1.102 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 176.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 158.39 -155.49 26.51 Favored Glycine 0 N--CA 1.429 -1.823 0 N-CA-C 103.915 -3.674 . . . . 0.0 103.915 -170.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.1 tt -73.43 141.66 46.91 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 105.953 -1.869 . . . . 0.0 105.953 -178.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.78 -172.75 3.46 Favored 'General case' 0 CA--C 1.489 -1.394 0 N-CA-C 104.116 -2.55 . . . . 0.0 104.116 -168.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 45.5 m -117.5 176.61 5.09 Favored 'General case' 0 CA--C 1.477 -1.838 0 N-CA-C 103.001 -2.963 . . . . 0.0 103.001 170.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.428 ' HA ' ' HA ' ' A' ' 5' ' ' TYR . 8.1 t-105 -138.79 151.89 47.43 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 102.89 -3.004 . . . . 0.0 102.89 -178.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 4.4 m -143.78 156.18 44.41 Favored 'General case' 0 CA--C 1.486 -1.517 0 N-CA-C 104.927 -2.249 . . . . 0.0 104.927 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -127.77 136.87 52.09 Favored 'General case' 0 CA--C 1.49 -1.36 0 N-CA-C 104.219 -2.511 . . . . 0.0 104.219 175.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 73.9 49.73 0.12 Allowed 'General case' 0 CA--C 1.493 -1.233 0 C-N-CA 126.671 1.988 . . . . 0.0 110.549 170.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 50.2 mt -89.33 141.83 29.31 Favored Pre-proline 0 CA--C 1.504 -0.803 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 177.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -66.1 162.51 35.3 Favored 'Trans proline' 0 N--CA 1.448 -1.175 0 C-N-CA 122.222 1.948 . . . . 0.0 111.906 177.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -60.2 -17.11 38.94 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -86.2 -1.02 57.07 Favored 'General case' 0 CA--C 1.504 -0.825 0 O-C-N 121.55 -0.719 . . . . 0.0 111.208 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.1 t -94.14 156.72 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 N-CA-C 103.472 -2.788 . . . . 0.0 103.472 177.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -141.28 152.81 23.56 Favored Glycine 0 CA--C 1.48 -2.122 1 N-CA-C 98.103 -5.999 . . . . 0.0 98.103 -177.321 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 21.4 pt -146.21 -144.25 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 N-CA-C 104.66 -2.348 . . . . 0.0 104.66 -156.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.671 HD12 HG12 ' A' ' 13' ' ' VAL . 1.9 mm -68.74 147.06 12.42 Favored 'Isoleucine or valine' 0 C--N 1.359 0.98 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 178.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 15.5 t -144.09 163.92 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.596 1 N-CA-C 94.511 -6.107 . . . . 0.0 94.511 177.562 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -158.38 155.5 28.8 Favored 'General case' 0 CA--C 1.478 -1.791 1 N-CA-C 98.31 -4.7 . . . . 0.0 98.31 164.429 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 137.24 -47.42 0.95 Allowed Glycine 0 CA--C 1.485 -1.793 1 N-CA-C 99.385 -5.486 . . . . 0.0 99.385 -157.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -102.32 -144.8 0.36 Allowed 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 104.854 -2.276 . . . . 0.0 104.854 165.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -155.96 177.42 11.43 Favored 'General case' 0 N--CA 1.423 -1.808 1 N-CA-C 95.505 -5.739 . . . . 0.0 95.505 -173.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 45.8 t -76.79 142.67 40.26 Favored 'General case' 0 CA--C 1.497 -1.069 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -172.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 36.0 p-80 -146.92 161.31 41.01 Favored 'General case' 0 N--CA 1.424 -1.743 1 N-CA-C 97.683 -4.932 . . . . 0.0 97.683 173.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.7 m -179.13 175.48 0.96 Allowed 'General case' 0 N--CA 1.425 -1.704 1 N-CA-C 95.45 -5.759 . . . . 0.0 95.45 176.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.357 0.907 0 O-C-N 123.838 0.711 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 30.3 m . . . . . 0 N--CA 1.481 1.093 0 CA-C-O 121.228 0.537 . . . . 0.0 110.089 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -83.52 157.34 22.4 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 173.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -124.71 125.8 44.67 Favored 'General case' 0 CA--C 1.49 -1.337 1 N-CA-C 92.769 -6.752 . . . . 0.0 92.769 151.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.54 178.54 37.4 Favored Glycine 0 CA--C 1.473 -2.568 0 N-CA-C 106.022 -2.831 . . . . 0.0 106.022 -170.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 48' ' ' TRP . 65.0 m-85 -87.12 125.03 33.88 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 171.072 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.467 HG13 HG22 ' A' ' 58' ' ' ILE . 18.6 tt -90.51 152.07 3.4 Favored 'Isoleucine or valine' 0 C--N 1.357 0.93 0 CA-C-N 120.272 1.396 . . . . 0.0 108.143 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.808 ' HB2' HD12 ' A' ' 59' ' ' ILE . . . -144.09 -159.19 0.96 Allowed 'General case' 0 N--CA 1.418 -2.053 0 C-N-CA 126.426 1.89 . . . . 0.0 107.83 -167.61 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 -105.48 144.29 28.52 Favored Pre-proline 0 N--CA 1.432 -1.356 1 N-CA-C 99.345 -4.317 . . . . 0.0 99.345 158.332 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -79.04 -12.34 14.56 Favored 'Trans proline' 0 CA--C 1.503 -1.052 0 CA-C-N 122.236 1.834 . . . . 0.0 112.544 -153.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -87.59 55.49 3.52 Favored 'General case' 0 C--N 1.36 1.022 0 CA-C-N 120.591 1.541 . . . . 0.0 108.666 -173.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.5 t30 73.24 37.4 0.75 Allowed 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 128.075 2.55 . . . . 0.0 110.993 168.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -108.94 -162.33 0.81 Allowed 'General case' 0 CA--C 1.504 -0.816 0 O-C-N 121.053 -1.029 . . . . 0.0 111.693 -167.009 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.754 HG12 HD11 ' A' ' 59' ' ' ILE . 3.7 m -133.96 170.46 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.225 1 N-CA-C 98.662 -4.569 . . . . 0.0 98.662 162.241 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . 0.313 1.3 m-85 -111.15 151.17 28.48 Favored 'General case' 0 CA--C 1.487 -1.456 1 N-CA-C 95.1 -5.889 . . . . 0.0 95.1 166.041 . . . . . . . . 3 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 34.8 m80 -92.21 144.65 25.2 Favored 'General case' 0 CA--C 1.496 -1.109 0 N-CA-C 102.772 -3.047 . . . . 0.0 102.772 171.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 39.0 t -92.41 164.77 13.36 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 -177.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -108.29 101.78 43.69 Favored Pre-proline 0 N--CA 1.425 -1.712 1 N-CA-C 98.959 -4.46 . . . . 0.0 98.959 169.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -68.18 107.78 1.62 Allowed 'Trans proline' 0 CA--C 1.501 -1.147 0 C-N-CA 122.367 2.045 . . . . 0.0 110.58 -161.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 160.79 -45.2 0.41 Allowed Glycine 0 CA--C 1.48 -2.104 1 N-CA-C 97.972 -6.051 . . . . 0.0 97.972 -169.135 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.2 m 122.8 -34.91 0.01 OUTLIER 'General case' 0 CA--C 1.487 -1.47 0 C-N-CA 128.8 2.84 . . . . 0.0 107.898 161.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 m -38.9 -51.92 1.76 Allowed 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 127.644 2.377 . . . . 0.0 116.377 -160.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.14 -41.99 68.53 Favored Glycine 0 C--N 1.355 1.594 0 O-C-N 121.287 -0.883 . . . . 0.0 111.513 -176.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.8 t -88.09 -24.88 23.29 Favored 'General case' 0 CA--C 1.496 -1.105 0 O-C-N 121.562 -0.964 . . . . 0.0 109.037 -171.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -65.83 -36.51 83.68 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 170.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 44.0 m -64.42 -37.85 88.95 Favored 'General case' 0 C--N 1.348 0.517 0 O-C-N 121.055 -1.028 . . . . 0.0 110.635 174.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 78.8 mt -63.96 -40.04 95.51 Favored 'General case' 0 C--N 1.357 0.931 0 CA-C-O 122.192 0.996 . . . . 0.0 110.559 175.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 38.3 t -58.17 -46.04 86.43 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.109 1.363 . . . . 0.0 110.347 174.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.17 -49.22 76.69 Favored 'General case' 0 C--N 1.359 0.984 0 O-C-N 121.752 -0.592 . . . . 0.0 110.613 -178.067 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -70.1 -21.18 63.15 Favored 'General case' 0 C--N 1.354 0.802 0 O-C-N 121.688 -0.632 . . . . 0.0 112.626 -173.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -96.5 5.79 50.09 Favored 'General case' 0 C--N 1.355 0.846 0 O-C-N 121.671 -0.643 . . . . 0.0 110.52 177.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.37 36.94 19.18 Favored Glycine 0 CA--C 1.493 -1.311 0 O-C-N 121.847 -0.533 . . . . 0.0 111.937 169.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -97.27 138.91 14.18 Favored Glycine 0 CA--C 1.487 -1.672 1 N-CA-C 102.862 -4.095 . . . . 0.0 102.862 164.196 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.4 m -105.96 -5.12 19.86 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -156.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 71.5 m -160.72 177.74 10.16 Favored 'General case' 0 CA--C 1.496 -1.121 1 N-CA-C 97.948 -4.834 . . . . 0.0 97.948 163.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -176.3 -170.88 39.49 Favored Glycine 0 CA--C 1.476 -2.369 1 N-CA-C 102.112 -4.395 . . . . 0.0 102.112 178.297 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -177.76 -154.51 0.03 OUTLIER 'General case' 0 N--CA 1.426 -1.634 1 N-CA-C 95.504 -5.739 . . . . 0.0 95.504 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 98.2 m -146.37 -176.6 5.24 Favored 'General case' 0 CA--C 1.48 -1.717 0 N-CA-C 101.24 -3.615 . . . . 0.0 101.24 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -175.66 -164.13 29.58 Favored Glycine 0 N--CA 1.422 -2.258 1 N-CA-C 99.971 -5.251 . . . . 0.0 99.971 -177.26 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -126.44 148.83 49.58 Favored 'General case' 0 N--CA 1.431 -1.385 1 N-CA-C 100.124 -4.028 . . . . 0.0 100.124 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -129.33 106.84 9.08 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 103.451 -2.796 . . . . 0.0 103.451 174.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.3 t -73.21 124.83 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 -174.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 134.95 -43.86 1.22 Allowed Glycine 0 CA--C 1.483 -1.944 0 N-CA-C 104.863 -3.295 . . . . 0.0 104.863 -171.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 38.9 m170 -114.97 -71.67 0.73 Allowed 'General case' 0 CA--C 1.498 -1.047 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 175.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 166.83 -145.25 9.74 Favored Glycine 0 N--CA 1.429 -1.78 0 N-CA-C 106.678 -2.569 . . . . 0.0 106.678 -177.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 45.9 tp -66.42 133.39 50.35 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 126.448 1.899 . . . . 0.0 106.458 177.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -138.49 171.86 13.75 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 102.84 -3.022 . . . . 0.0 102.84 -167.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 63.3 m -114.93 -179.94 3.77 Favored 'General case' 0 CA--C 1.484 -1.591 0 N-CA-C 102.991 -2.966 . . . . 0.0 102.991 176.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.461 ' HA ' ' HA ' ' A' ' 5' ' ' TYR . 9.8 t-105 -144.94 151.38 38.57 Favored 'General case' 0 CA--C 1.493 -1.239 0 N-CA-C 102.932 -2.988 . . . . 0.0 102.932 -174.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 45.8 m -137.26 151.73 49.02 Favored 'General case' 0 CA--C 1.487 -1.466 0 N-CA-C 104.697 -2.335 . . . . 0.0 104.697 172.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -115.57 130.7 56.96 Favored 'General case' 0 CA--C 1.495 -1.144 0 N-CA-C 103.794 -2.669 . . . . 0.0 103.794 170.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 65.01 72.58 0.43 Allowed 'General case' 0 CA--C 1.498 -1.041 0 C-N-CA 126.449 1.9 . . . . 0.0 110.685 175.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 20.9 mt -104.46 139.35 20.02 Favored Pre-proline 0 CA--C 1.492 -1.26 0 N-CA-C 102.197 -3.26 . . . . 0.0 102.197 166.064 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -70.67 168.48 22.62 Favored 'Trans proline' 0 N--CA 1.447 -1.24 0 C-N-CA 122.605 2.204 . . . . 0.0 110.114 175.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -84.07 5.42 26.03 Favored 'General case' 0 N--CA 1.443 -0.822 0 O-C-N 121.634 -0.666 . . . . 0.0 112.787 -164.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 -92.3 0.31 57.44 Favored 'General case' 0 CA--C 1.502 -0.876 0 O-C-N 121.638 -0.664 . . . . 0.0 109.584 176.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.1 t -91.65 163.12 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 N-CA-C 104.764 -2.31 . . . . 0.0 104.764 178.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -141.41 150.45 21.89 Favored Glycine 0 CA--C 1.483 -1.935 1 N-CA-C 97.552 -6.219 . . . . 0.0 97.552 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.467 HG22 HG13 ' A' ' 6' ' ' ILE . 16.6 pt -152.32 -140.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 N-CA-C 104.216 -2.513 . . . . 0.0 104.216 -155.338 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.808 HD12 ' HB2' ' A' ' 7' ' ' ALA . 1.7 mp -65.06 126.52 24.22 Favored 'Isoleucine or valine' 0 C--N 1.362 1.128 0 N-CA-C 104.792 -2.299 . . . . 0.0 104.792 163.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.7 t -133.76 142.33 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.839 1 N-CA-C 95.568 -5.716 . . . . 0.0 95.568 -178.248 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 62.41 -54.8 0.15 Allowed 'General case' 0 C--N 1.359 1.019 0 C-N-CA 128.244 2.618 . . . . 0.0 117.448 164.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.08 15.0 59.74 Favored Glycine 0 N--CA 1.438 -1.202 0 C-N-CA 125.476 1.512 . . . . 0.0 112.98 176.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -81.71 -52.7 6.89 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-N 118.534 1.167 . . . . 0.0 112.248 -171.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -161.7 -178.53 6.6 Favored 'General case' 0 N--CA 1.434 -1.234 1 N-CA-C 97.766 -4.901 . . . . 0.0 97.766 -171.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 16.0 t -130.4 154.65 47.48 Favored 'General case' 0 CA--C 1.482 -1.636 1 N-CA-C 97.874 -4.861 . . . . 0.0 97.874 173.365 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -137.22 127.1 25.7 Favored 'General case' 0 CA--C 1.487 -1.454 0 N-CA-C 101.295 -3.595 . . . . 0.0 101.295 175.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.9 m -171.71 172.51 4.9 Favored 'General case' 0 N--CA 1.425 -1.712 1 N-CA-C 96.054 -5.535 . . . . 0.0 96.054 -177.369 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.359 1.007 0 CA-C-N 119.258 0.936 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 27.2 m . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 121.272 0.558 . . . . 0.0 109.728 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.02 169.07 17.35 Favored 'General case' 0 N--CA 1.434 -1.23 1 N-CA-C 98.578 -4.601 . . . . 0.0 98.578 167.618 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 -130.63 133.06 45.82 Favored 'General case' 0 CA--C 1.48 -1.737 1 N-CA-C 94.366 -6.161 . . . . 0.0 94.366 169.327 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.66 -178.23 35.4 Favored Glycine 0 CA--C 1.474 -2.528 0 C-N-CA 117.397 -2.335 . . . . 0.0 107.411 -173.044 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 48' ' ' TRP . 42.2 m-85 -78.45 130.46 36.09 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 102.713 -3.069 . . . . 0.0 102.713 158.343 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.7 tt -90.47 137.29 21.9 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 N-CA-C 105.331 -2.1 . . . . 0.0 105.331 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.547 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -94.3 -144.76 0.25 Allowed 'General case' 0 N--CA 1.424 -1.734 0 CA-C-N 112.319 -2.219 . . . . 0.0 107.79 177.417 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 62.7 mt-30 -109.57 147.02 35.23 Favored Pre-proline 0 N--CA 1.43 -1.464 1 N-CA-C 96.068 -5.53 . . . . 0.0 96.068 165.372 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -76.34 7.59 3.31 Favored 'Trans proline' 0 CA--C 1.506 -0.888 0 C-N-CA 122.671 2.247 . . . . 0.0 113.883 -145.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 18.1 mp0 -88.4 -76.35 0.4 Allowed 'General case' 0 N--CA 1.426 -1.643 0 N-CA-C 103.234 -2.876 . . . . 0.0 103.234 176.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -176.84 144.02 0.45 Allowed 'General case' 0 N--CA 1.419 -2.003 1 N-CA-C 93.64 -6.429 . . . . 0.0 93.64 -178.155 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 160.69 -153.48 0.0 OUTLIER 'General case' 0 CA--C 1.493 -1.237 0 N-CA-C 101.705 -3.443 . . . . 0.0 101.705 173.494 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.612 HG12 HD12 ' A' ' 59' ' ' ILE . 0.3 OUTLIER -126.1 165.15 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.33 1 N-CA-C 99.477 -4.268 . . . . 0.0 99.477 159.649 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -86.01 -148.89 0.13 Allowed 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 164.436 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 46.4 m80 -142.33 176.29 9.1 Favored 'General case' 0 CA--C 1.483 -1.632 1 N-CA-C 97.209 -5.108 . . . . 0.0 97.209 164.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 8.2 t -136.18 159.97 40.09 Favored 'General case' 0 N--CA 1.426 -1.644 1 N-CA-C 96.482 -5.377 . . . . 0.0 96.482 -177.118 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -111.19 107.75 57.32 Favored Pre-proline 0 N--CA 1.428 -1.557 1 N-CA-C 97.529 -4.989 . . . . 0.0 97.529 170.104 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_exo -53.03 103.82 0.09 OUTLIER 'Trans proline' 0 CA--C 1.513 -0.557 0 CA-C-N 124.439 2.621 . . . . 0.0 116.871 -155.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 161.69 -170.33 37.38 Favored Glycine 0 N--CA 1.426 -2.011 1 N-CA-C 97.228 -6.349 . . . . 0.0 97.228 -172.064 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.2 m -86.98 -42.47 13.1 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 118.82 1.31 . . . . 0.0 109.566 179.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -40.1 -55.18 2.15 Favored 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 129.08 2.952 . . . . 0.0 117.231 -156.51 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.27 -48.79 43.57 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 111.074 -0.811 . . . . 0.0 111.074 -174.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 68.4 m -71.85 -34.04 68.92 Favored 'General case' 0 CA--C 1.49 -1.363 0 O-C-N 121.71 -0.876 . . . . 0.0 111.13 -176.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -59.16 -46.56 88.07 Favored 'General case' 0 C--N 1.35 0.597 0 CA-C-O 121.351 0.596 . . . . 0.0 109.422 173.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.0 m -64.45 -48.1 76.55 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 123.044 0.538 . . . . 0.0 111.031 177.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 75.5 mt -60.76 -43.6 97.8 Favored 'General case' 0 C--N 1.362 1.149 0 CA-C-O 121.846 0.831 . . . . 0.0 109.964 -177.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.8 t -56.9 -44.16 82.07 Favored 'General case' 0 N--CA 1.437 -1.092 0 C-N-CA 123.322 0.649 . . . . 0.0 111.46 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -77.35 -31.41 54.41 Favored 'General case' 0 C--N 1.353 0.735 0 C-N-CA 121.149 -0.22 . . . . 0.0 111.533 -173.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -76.75 -30.77 56.7 Favored 'General case' 0 CA--C 1.506 -0.727 0 O-C-N 121.58 -0.7 . . . . 0.0 110.71 177.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -78.24 -49.62 13.39 Favored 'General case' 0 C--N 1.359 1.013 0 CA-C-N 118.974 0.806 . . . . 0.0 109.816 177.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 131.67 47.99 0.11 Allowed Glycine 0 CA--C 1.488 -1.647 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 173.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -117.48 160.85 13.45 Favored Glycine 0 CA--C 1.484 -1.881 0 N-CA-C 104.077 -3.609 . . . . 0.0 104.077 161.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -64.68 -54.9 24.34 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 124.88 1.272 . . . . 0.0 110.621 -164.606 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.9 m -160.79 177.63 10.24 Favored 'General case' 0 N--CA 1.423 -1.813 1 N-CA-C 97.199 -5.111 . . . . 0.0 97.199 170.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -161.48 174.76 38.06 Favored Glycine 0 CA--C 1.474 -2.501 1 N-CA-C 101.346 -4.701 . . . . 0.0 101.346 -163.106 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 53.8 m80 -156.66 -153.04 0.4 Allowed 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 100.348 -3.945 . . . . 0.0 100.348 -168.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 81.6 m -147.53 177.64 9.09 Favored 'General case' 0 CA--C 1.483 -1.627 0 N-CA-C 103.762 -2.681 . . . . 0.0 103.762 -174.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 171.53 -157.14 27.37 Favored Glycine 0 N--CA 1.423 -2.215 1 N-CA-C 95.9 -6.88 . . . . 0.0 95.9 178.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -140.44 146.51 38.37 Favored 'General case' 0 CA--C 1.489 -1.385 1 N-CA-C 98.091 -4.781 . . . . 0.0 98.091 -174.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 9.7 tmtt? -115.75 97.29 6.04 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 103.144 -2.91 . . . . 0.0 103.144 174.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.4 t -70.86 120.37 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 -176.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 136.86 -37.38 1.87 Allowed Glycine 0 CA--C 1.486 -1.78 0 N-CA-C 103.949 -3.66 . . . . 0.0 103.949 -167.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 15.6 m170 -125.1 -64.71 1.07 Allowed 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 165.89 -161.22 34.8 Favored Glycine 0 N--CA 1.432 -1.626 0 N-CA-C 107.219 -2.353 . . . . 0.0 107.219 -171.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.7 tp -69.43 143.49 53.58 Favored 'General case' 0 CA--C 1.502 -0.904 0 C-N-CA 127.969 2.508 . . . . 0.0 105.725 177.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -153.05 178.3 9.86 Favored 'General case' 0 CA--C 1.488 -1.428 0 N-CA-C 103.759 -2.682 . . . . 0.0 103.759 -168.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 50.8 m -112.16 161.72 16.23 Favored 'General case' 0 CA--C 1.493 -1.25 0 N-CA-C 103.135 -2.913 . . . . 0.0 103.135 177.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.414 ' HA ' ' HA ' ' A' ' 5' ' ' TYR . 61.1 t-105 -101.83 152.18 21.2 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 104.598 -2.371 . . . . 0.0 104.598 166.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.8 m -141.4 141.17 33.77 Favored 'General case' 0 CA--C 1.491 -1.31 0 N-CA-C 104.568 -2.382 . . . . 0.0 104.568 164.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -105.67 107.9 19.13 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 102.606 -3.109 . . . . 0.0 102.606 174.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 90.06 135.4 0.03 OUTLIER 'General case' 0 N--CA 1.432 -1.365 0 C-N-CA 128.243 2.617 . . . . 0.0 106.068 -173.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -145.13 155.89 54.73 Favored Pre-proline 0 N--CA 1.426 -1.668 1 N-CA-C 96.335 -5.431 . . . . 0.0 96.335 149.166 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -70.16 165.06 32.68 Favored 'Trans proline' 0 N--CA 1.445 -1.346 0 C-N-CA 122.404 2.069 . . . . 0.0 109.139 164.232 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -74.7 -9.04 58.18 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 114.12 1.155 . . . . 0.0 114.12 -163.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 -84.35 -12.35 54.68 Favored 'General case' 0 CA--C 1.507 -0.696 0 O-C-N 121.397 -0.814 . . . . 0.0 110.176 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.2 t -87.29 118.39 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -87.45 147.01 20.45 Favored Glycine 0 CA--C 1.487 -1.702 0 N-CA-C 106.934 -2.467 . . . . 0.0 106.934 -178.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 46.1 pt -117.97 -153.81 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 -173.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.612 HD12 HG12 ' A' ' 13' ' ' VAL . 9.2 mm -66.77 -30.27 49.13 Favored 'Isoleucine or valine' 0 C--N 1.357 0.894 0 O-C-N 121.412 -0.805 . . . . 0.0 111.949 -165.331 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -127.79 153.12 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.658 1 N-CA-C 99.058 -4.423 . . . . 0.0 99.058 175.074 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -166.5 176.76 7.11 Favored 'General case' 0 N--CA 1.423 -1.791 1 N-CA-C 95.499 -5.741 . . . . 0.0 95.499 -172.248 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -90.73 72.6 1.89 Allowed Glycine 0 CA--C 1.491 -1.45 0 N-CA-C 104.615 -3.394 . . . . 0.0 104.615 171.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -168.89 -169.4 0.99 Allowed 'General case' 0 N--CA 1.423 -1.779 1 N-CA-C 99.632 -4.21 . . . . 0.0 99.632 -166.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 28.9 ttpp -156.35 162.73 40.05 Favored 'General case' 0 N--CA 1.426 -1.629 1 N-CA-C 96.128 -5.508 . . . . 0.0 96.128 171.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 41.6 t -68.95 139.19 55.05 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-O 121.751 0.786 . . . . 0.0 111.962 -166.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 4.3 p80 -142.6 151.55 41.61 Favored 'General case' 0 N--CA 1.424 -1.768 1 N-CA-C 95.648 -5.686 . . . . 0.0 95.648 164.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 40.5 t 176.23 -173.38 0.09 Allowed 'General case' 0 N--CA 1.431 -1.402 1 N-CA-C 95.166 -5.865 . . . . 0.0 95.166 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.357 0.898 0 O-C-N 124.469 1.106 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 9.9 m . . . . . 0 N--CA 1.483 1.221 0 CA-C-O 122.441 1.115 . . . . 0.0 110.913 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 16.2 mtp85 -100.64 158.03 16.24 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 -174.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -130.47 128.71 41.79 Favored 'General case' 0 CA--C 1.486 -1.481 1 N-CA-C 97.124 -5.139 . . . . 0.0 97.124 168.269 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.82 178.31 37.73 Favored Glycine 0 CA--C 1.481 -2.037 0 N-CA-C 107.272 -2.331 . . . . 0.0 107.272 -177.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -79.64 127.95 32.8 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 104.034 -2.58 . . . . 0.0 104.034 164.103 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.26 11.6 tt -91.51 147.6 5.16 Favored 'Isoleucine or valine' 0 C--O 1.243 0.737 0 CA-C-N 120.487 1.494 . . . . 0.0 108.879 178.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -135.77 -128.61 0.15 Allowed 'General case' 0 N--CA 1.426 -1.663 0 C-N-CA 128.035 2.534 . . . . 0.0 104.548 172.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -139.71 152.02 67.39 Favored Pre-proline 0 N--CA 1.424 -1.743 1 N-CA-C 96.513 -5.365 . . . . 0.0 96.513 176.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -74.89 35.14 0.4 Allowed 'Trans proline' 0 CA--C 1.514 -0.504 0 CA-C-N 124.241 2.55 . . . . 0.0 117.096 -159.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 53.0 mm-40 -124.53 32.79 5.39 Favored 'General case' 0 CA--C 1.497 -1.083 0 CA-C-N 120.202 1.364 . . . . 0.0 107.635 -169.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 48.99 58.1 5.73 Favored 'General case' 0 CA--C 1.489 -1.382 0 C-N-CA 128.686 2.794 . . . . 0.0 112.196 -174.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 91.3 m -116.89 -160.26 0.76 Allowed 'General case' 0 CA--C 1.482 -1.649 0 N-CA-C 103.285 -2.857 . . . . 0.0 103.285 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -134.85 169.39 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.827 1 N-CA-C 96.059 -5.534 . . . . 0.0 96.059 170.697 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -96.62 -154.27 0.44 Allowed 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 101.711 -3.44 . . . . 0.0 101.711 163.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 33.4 m80 -137.43 172.62 12.71 Favored 'General case' 0 CA--C 1.478 -1.792 1 N-CA-C 97.457 -5.016 . . . . 0.0 97.457 166.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 29.3 t -132.11 158.39 41.77 Favored 'General case' 0 N--CA 1.422 -1.868 1 N-CA-C 97.497 -5.001 . . . . 0.0 97.497 -175.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -112.45 104.78 56.13 Favored Pre-proline 0 N--CA 1.428 -1.546 1 N-CA-C 98.232 -4.729 . . . . 0.0 98.232 168.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -51.43 98.69 0.04 OUTLIER 'Trans proline' 0 CA--C 1.51 -0.708 0 C-N-CA 123.473 2.782 . . . . 0.0 117.07 -154.615 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 163.21 -171.48 38.95 Favored Glycine 0 N--CA 1.423 -2.227 1 N-CA-C 96.704 -6.558 . . . . 0.0 96.704 -172.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 38.1 m -82.46 -31.12 29.56 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 118.682 1.241 . . . . 0.0 111.154 -177.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.2 m -39.59 -71.48 0.08 Allowed 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 117.006 2.224 . . . . 0.0 117.006 -151.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.44 -43.82 52.67 Favored Glycine 0 C--N 1.347 1.153 0 O-C-N 121.198 -0.939 . . . . 0.0 111.113 -173.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 35.2 m -67.24 -43.98 80.59 Favored 'General case' 0 CA--C 1.486 -1.504 0 O-C-N 122.039 -0.683 . . . . 0.0 112.1 -173.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -66.35 -35.3 80.0 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -178.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.3 m -63.18 -50.41 70.45 Favored 'General case' 0 N--CA 1.445 -0.695 0 O-C-N 121.78 -0.575 . . . . 0.0 110.023 174.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.9 mt -63.56 -40.15 96.23 Favored 'General case' 0 C--N 1.359 0.998 0 CA-C-O 122.052 0.93 . . . . 0.0 110.923 -177.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 19.5 t -57.11 -47.6 80.68 Favored 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 125.775 1.63 . . . . 0.0 110.115 177.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 50.3 mttp -74.36 -34.63 63.42 Favored 'General case' 0 C--N 1.353 0.718 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.519 -173.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -77.43 -20.78 54.02 Favored 'General case' 0 C--N 1.354 0.771 0 O-C-N 121.712 -0.617 . . . . 0.0 111.407 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.6 mmtm -76.6 -59.09 2.92 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 168.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 134.64 48.77 0.08 OUTLIER Glycine 0 CA--C 1.489 -1.548 0 N-CA-C 108.896 -1.682 . . . . 0.0 108.896 170.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -107.18 139.97 15.14 Favored Glycine 0 CA--C 1.482 -1.976 1 N-CA-C 101.549 -4.62 . . . . 0.0 101.549 164.196 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.6 p -80.02 -49.5 11.72 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-N 118.587 1.193 . . . . 0.0 108.528 -170.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.3 m -103.41 139.84 38.26 Favored 'General case' 0 CA--C 1.487 -1.478 0 N-CA-C 102.101 -3.296 . . . . 0.0 102.101 -172.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -146.48 142.65 10.65 Favored Glycine 0 CA--C 1.473 -2.58 1 N-CA-C 101.215 -4.754 . . . . 0.0 101.215 -168.313 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 66.4 m80 -155.86 -157.43 0.72 Allowed 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 100.286 -3.968 . . . . 0.0 100.286 -173.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 85.5 m -143.73 177.36 8.56 Favored 'General case' 0 CA--C 1.476 -1.893 1 N-CA-C 99.099 -4.408 . . . . 0.0 99.099 177.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -179.27 -175.99 46.63 Favored Glycine 0 N--CA 1.419 -2.476 1 N-CA-C 98.092 -6.003 . . . . 0.0 98.092 177.12 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -116.68 139.44 50.54 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 102.048 -3.316 . . . . 0.0 102.048 177.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.9 94.27 4.96 Favored 'General case' 0 CA--C 1.498 -1.038 0 N-CA-C 103.506 -2.776 . . . . 0.0 103.506 178.26 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.7 t -70.76 116.82 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 -174.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 136.83 -39.59 1.62 Allowed Glycine 0 CA--C 1.488 -1.642 0 N-CA-C 105.929 -2.868 . . . . 0.0 105.929 -169.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 27.0 m170 -119.25 -66.85 1.03 Allowed 'General case' 0 CA--C 1.499 -0.992 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 178.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 167.04 -159.89 33.41 Favored Glycine 0 N--CA 1.432 -1.631 0 N-CA-C 106.262 -2.735 . . . . 0.0 106.262 -173.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 57.8 tp -68.21 142.28 55.71 Favored 'General case' 0 C--N 1.351 0.665 0 C-N-CA 126.779 2.032 . . . . 0.0 106.175 175.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -150.19 -178.04 6.28 Favored 'General case' 0 CA--C 1.485 -1.528 0 N-CA-C 104.046 -2.575 . . . . 0.0 104.046 -167.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 67.3 m -107.02 163.63 12.82 Favored 'General case' 0 CA--C 1.492 -1.287 0 N-CA-C 102.689 -3.078 . . . . 0.0 102.689 176.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 14.6 t-105 -128.14 146.67 50.64 Favored 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 104.435 -2.432 . . . . 0.0 104.435 177.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 61.2 m -140.43 151.49 44.93 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 174.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -118.95 143.44 47.03 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 103.806 -2.665 . . . . 0.0 103.806 166.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 77.02 54.94 0.04 OUTLIER 'General case' 0 CA--C 1.497 -1.075 0 C-N-CA 127.018 2.127 . . . . 0.0 110.883 171.128 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 33.5 mt -97.77 135.67 21.47 Favored Pre-proline 0 CA--C 1.5 -0.948 0 N-CA-C 105.12 -2.178 . . . . 0.0 105.12 173.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -74.46 167.92 26.01 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 CA-C-N 122.628 1.974 . . . . 0.0 111.103 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -61.28 -19.86 62.21 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 126.561 1.944 . . . . 0.0 114.686 -170.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.4 p-10 -86.54 -2.2 58.28 Favored 'General case' 0 CA--C 1.505 -0.767 0 C-N-CA 123.722 0.809 . . . . 0.0 110.628 -176.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.5 t -91.09 163.32 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 N-CA-C 104.078 -2.564 . . . . 0.0 104.078 177.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -145.84 154.53 26.0 Favored Glycine 0 CA--C 1.48 -2.132 1 N-CA-C 96.668 -6.573 . . . . 0.0 96.668 179.255 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 16.1 pt -139.66 -126.65 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 N-CA-C 104.885 -2.265 . . . . 0.0 104.885 -158.006 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.0 mm -74.5 62.28 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.582 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 169.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -155.13 142.4 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.682 0 N-CA-C 103.008 -2.96 . . . . 0.0 103.008 -167.433 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.482 ' HG3' ' H ' ' A' ' 62' ' ' GLY . 11.0 tp10 150.31 -166.22 0.0 OUTLIER 'General case' 0 CA--C 1.5 -0.95 2 N-CA-C 95.629 -5.693 . . . . 0.0 95.629 175.666 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.482 ' H ' ' HG3' ' A' ' 61' ' ' GLU . . . -80.11 70.31 2.96 Favored Glycine 0 C--N 1.347 1.171 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 -177.199 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 69.54 -47.44 0.6 Allowed 'General case' 0 C--N 1.352 0.703 0 C-N-CA 128.638 2.775 . . . . 0.0 115.014 167.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 15.4 tptm -98.25 151.64 20.26 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -164.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 38.9 t -87.79 145.11 26.26 Favored 'General case' 0 CA--C 1.492 -1.28 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 179.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -169.26 -172.08 1.42 Allowed 'General case' 0 N--CA 1.421 -1.888 1 N-CA-C 97.862 -4.866 . . . . 0.0 97.862 179.105 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 36.0 m -172.84 171.99 4.19 Favored 'General case' 0 N--CA 1.425 -1.712 1 N-CA-C 95.937 -5.579 . . . . 0.0 95.937 173.531 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.359 0.981 0 O-C-N 124.294 0.996 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 18.6 m . . . . . 0 N--CA 1.486 1.325 0 CA-C-O 121.898 0.856 . . . . 0.0 110.649 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 22.6 mtp85 -121.71 154.81 36.38 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 104.669 -2.345 . . . . 0.0 104.669 -172.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -137.48 132.71 33.7 Favored 'General case' 0 CA--C 1.486 -1.481 1 N-CA-C 97.273 -5.084 . . . . 0.0 97.273 166.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.29 -166.29 20.79 Favored Glycine 0 CA--C 1.477 -2.34 1 N-CA-C 101.948 -4.461 . . . . 0.0 101.948 172.145 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -74.81 142.14 44.25 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 103.872 -2.64 . . . . 0.0 103.872 161.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.1 tt -90.24 136.26 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.125 0 N-CA-C 105.018 -2.215 . . . . 0.0 105.018 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.657 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -109.59 -149.94 0.45 Allowed 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 127.385 2.274 . . . . 0.0 106.255 179.447 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.415 ' H ' ' HB1' ' A' ' 7' ' ' ALA . 58.6 mt-30 -115.13 142.87 29.22 Favored Pre-proline 0 N--CA 1.426 -1.669 1 N-CA-C 97.454 -5.017 . . . . 0.0 97.454 171.108 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -75.58 29.81 0.38 Allowed 'Trans proline' 0 CA--C 1.503 -1.042 0 N-CA-C 117.764 2.179 . . . . 0.0 117.764 -141.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -120.35 -78.74 0.59 Allowed 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 101.733 -3.432 . . . . 0.0 101.733 -178.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 53.6 t-20 -160.92 142.72 12.17 Favored 'General case' 0 N--CA 1.423 -1.803 1 N-CA-C 93.932 -6.322 . . . . 0.0 93.932 166.24 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 65' ' ' CYS . 19.0 m 173.42 -157.09 0.01 OUTLIER 'General case' 0 CA--C 1.496 -1.122 1 N-CA-C 98.743 -4.54 . . . . 0.0 98.743 172.613 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.609 HG12 HD12 ' A' ' 59' ' ' ILE . 0.4 OUTLIER -126.8 167.68 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.575 1 N-CA-C 98.372 -4.677 . . . . 0.0 98.372 158.956 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -87.04 -162.7 0.82 Allowed 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 103.126 -2.916 . . . . 0.0 103.126 163.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 47.4 m80 -143.16 168.62 19.32 Favored 'General case' 0 N--CA 1.417 -2.114 1 N-CA-C 94.198 -6.223 . . . . 0.0 94.198 165.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.4 t -160.45 -151.01 0.23 Allowed 'General case' 0 N--CA 1.418 -2.037 1 N-CA-C 95.894 -5.595 . . . . 0.0 95.894 -176.485 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -148.44 147.77 26.5 Favored Pre-proline 0 N--CA 1.409 -2.493 1 N-CA-C 95.198 -5.853 . . . . 0.0 95.198 -167.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -71.23 73.8 2.04 Favored 'Trans proline' 0 C--N 1.32 -0.939 0 CA-C-N 125.383 2.958 . . . . 0.0 114.134 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -172.82 162.74 34.4 Favored Glycine 0 N--CA 1.425 -2.071 1 N-CA-C 98.704 -5.759 . . . . 0.0 98.704 175.062 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.2 m -81.65 -7.88 59.64 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 118.752 1.276 . . . . 0.0 111.775 -172.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -53.55 -28.38 31.41 Favored 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 128.448 2.699 . . . . 0.0 115.417 -169.401 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -87.06 -73.48 1.28 Allowed Glycine 0 C--N 1.348 1.211 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 176.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 75.6 m -79.99 -12.57 59.7 Favored 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 -162.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -63.17 -44.97 93.96 Favored 'General case' 0 C--N 1.358 0.972 0 CA-C-N 121.65 2.023 . . . . 0.0 108.38 173.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -57.67 -51.22 70.4 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 127.1 2.16 . . . . 0.0 110.794 174.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 84.6 mt -64.85 -40.1 94.61 Favored 'General case' 0 CA--C 1.497 -1.077 0 C-N-CA 124.088 0.955 . . . . 0.0 111.133 -177.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.7 t -56.77 -44.24 81.64 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 124.556 1.143 . . . . 0.0 109.847 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 52.0 mttp -71.15 -34.93 71.45 Favored 'General case' 0 N--CA 1.443 -0.801 0 O-C-N 122.151 -0.343 . . . . 0.0 111.54 -174.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -78.58 -26.67 45.55 Favored 'General case' 0 C--N 1.355 0.821 0 O-C-N 121.543 -0.723 . . . . 0.0 112.359 177.068 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.4 mmtm -80.54 -26.07 38.26 Favored 'General case' 0 C--N 1.357 0.92 0 CA-C-N 118.911 0.778 . . . . 0.0 109.843 176.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.53 37.64 1.88 Allowed Glycine 0 CA--C 1.486 -1.765 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 163.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -108.27 143.86 16.16 Favored Glycine 0 CA--C 1.485 -1.84 0 N-CA-C 103.226 -3.95 . . . . 0.0 103.226 168.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.4 m -73.5 -29.82 62.73 Favored 'General case' 0 N--CA 1.437 -1.084 0 O-C-N 122.074 -0.662 . . . . 0.0 110.473 -167.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.1 m -159.74 161.6 34.77 Favored 'General case' 0 CA--C 1.481 -1.704 0 N-CA-C 102.734 -3.062 . . . . 0.0 102.734 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -171.38 175.25 44.97 Favored Glycine 0 N--CA 1.419 -2.441 1 N-CA-C 99.944 -5.262 . . . . 0.0 99.944 -172.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 12.6 p80 -169.67 -171.71 1.27 Allowed 'General case' 0 N--CA 1.431 -1.418 1 N-CA-C 98.224 -4.732 . . . . 0.0 98.224 -174.461 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 73.8 m -127.41 153.07 46.71 Favored 'General case' 0 CA--C 1.486 -1.498 0 N-CA-C 104.433 -2.432 . . . . 0.0 104.433 -173.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -172.18 167.17 40.1 Favored Glycine 0 CA--C 1.477 -2.316 1 N-CA-C 100.004 -5.238 . . . . 0.0 100.004 -173.352 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -98.67 161.18 13.8 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 104.741 -2.318 . . . . 0.0 104.741 -172.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.99 173.36 13.44 Favored 'General case' 0 N--CA 1.428 -1.55 1 N-CA-C 96.009 -5.552 . . . . 0.0 96.009 163.5 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -132.34 155.81 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.548 1 N-CA-C 97.607 -4.96 . . . . 0.0 97.607 177.928 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 130.34 -52.18 0.84 Allowed Glycine 0 CA--C 1.485 -1.789 1 N-CA-C 101.535 -4.626 . . . . 0.0 101.535 -170.186 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 66.9 m170 -117.48 -73.88 0.63 Allowed 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 104.318 -2.475 . . . . 0.0 104.318 168.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 164.45 -145.67 10.58 Favored Glycine 0 CA--C 1.472 -2.63 1 N-CA-C 100.876 -4.89 . . . . 0.0 100.876 178.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 33.2 tp -62.97 137.77 58.37 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 125.304 1.442 . . . . 0.0 107.388 -173.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -152.04 -171.12 3.84 Favored 'General case' 0 CA--C 1.479 -1.764 1 N-CA-C 97.556 -4.979 . . . . 0.0 97.556 -160.515 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 3.0 p -147.11 -174.15 4.43 Favored 'General case' 0 CA--C 1.478 -1.824 0 C-N-CA 115.734 -2.386 . . . . 0.0 104.616 169.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 43.7 t-105 -127.73 157.1 41.26 Favored 'General case' 0 CA--C 1.505 -0.785 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 -167.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 6.0 m -150.15 152.31 34.5 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 168.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -118.94 140.1 50.56 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 104.478 -2.416 . . . . 0.0 104.478 168.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 77.36 47.67 0.06 Allowed 'General case' 0 CA--C 1.496 -1.108 0 C-N-CA 127.451 2.301 . . . . 0.0 111.378 166.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 38.4 mt -91.48 137.14 26.07 Favored Pre-proline 0 CA--C 1.503 -0.862 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 178.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -77.94 174.71 12.13 Favored 'Trans proline' 0 N--CA 1.447 -1.217 0 C-N-CA 122.274 1.983 . . . . 0.0 111.494 -179.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -69.49 -9.05 52.15 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 125.254 1.421 . . . . 0.0 114.203 -171.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -92.73 -0.15 57.32 Favored 'General case' 0 CA--C 1.501 -0.934 0 O-C-N 121.667 -0.646 . . . . 0.0 110.008 -179.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.408 HG12 ' H ' ' A' ' 57' ' ' GLY . 1.5 t -99.05 179.13 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 N-CA-C 102.49 -3.152 . . . . 0.0 102.49 174.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.408 ' H ' HG12 ' A' ' 56' ' ' VAL . . . -152.12 159.4 28.33 Favored Glycine 0 CA--C 1.479 -2.216 1 N-CA-C 97.258 -6.337 . . . . 0.0 97.258 -178.528 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 18.2 pt -146.81 -156.46 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.271 0 N-CA-C 103.296 -2.853 . . . . 0.0 103.296 -165.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.657 HD13 ' HB2' ' A' ' 7' ' ' ALA . 1.1 mm -73.02 129.86 35.9 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.094 0 N-CA-C 104.839 -2.282 . . . . 0.0 104.839 176.395 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.9 t -106.62 108.86 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.653 0 N-CA-C 100.687 -3.82 . . . . 0.0 100.687 172.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 64.08 -110.51 0.27 Allowed 'General case' 0 C--N 1.359 0.992 0 C-N-CA 125.374 1.47 . . . . 0.0 107.906 -171.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -169.53 38.9 0.2 Allowed Glycine 0 CA--C 1.48 -2.139 1 N-CA-C 100.453 -5.059 . . . . 0.0 100.453 173.17 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -101.18 -71.4 0.71 Allowed 'General case' 0 CA--C 1.495 -1.164 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -163.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 6.7 tppt? -105.3 169.67 8.32 Favored 'General case' 0 CA--C 1.502 -0.871 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 -162.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 35.7 t -144.85 137.58 26.42 Favored 'General case' 0 N--CA 1.422 -1.866 1 N-CA-C 95.013 -5.921 . . . . 0.0 95.013 170.897 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -165.68 173.02 11.2 Favored 'General case' 0 CA--C 1.485 -1.54 0 N-CA-C 100.413 -3.921 . . . . 0.0 100.413 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 38.7 m -167.66 173.93 8.11 Favored 'General case' 0 N--CA 1.421 -1.906 1 N-CA-C 96.271 -5.455 . . . . 0.0 96.271 178.083 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.358 0.939 0 O-C-N 124.111 0.882 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 26.7 m . . . . . 0 N--CA 1.483 1.184 0 CA-C-O 121.578 0.704 . . . . 0.0 109.798 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -100.31 156.2 17.37 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 104.136 -2.542 . . . . 0.0 104.136 166.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -123.99 122.04 36.87 Favored 'General case' 0 CA--C 1.487 -1.468 1 N-CA-C 95.705 -5.665 . . . . 0.0 95.705 164.499 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.55 -175.7 32.85 Favored Glycine 0 CA--C 1.477 -2.324 0 N-CA-C 105.01 -3.236 . . . . 0.0 105.01 -171.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -88.3 135.71 33.32 Favored 'General case' 0 CA--C 1.491 -1.319 0 N-CA-C 103.524 -2.769 . . . . 0.0 103.524 170.056 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 17.0 tt -90.25 139.34 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 N-CA-C 106.854 -1.535 . . . . 0.0 106.854 -177.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.506 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -111.16 -161.44 0.75 Allowed 'General case' 0 N--CA 1.426 -1.632 0 C-N-CA 127.536 2.334 . . . . 0.0 106.412 178.126 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -107.02 146.36 33.0 Favored Pre-proline 0 N--CA 1.427 -1.583 1 N-CA-C 97.985 -4.82 . . . . 0.0 97.985 164.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -80.22 -3.47 12.64 Favored 'Trans proline' 0 CA--C 1.5 -1.225 0 C-N-CA 121.183 1.256 . . . . 0.0 114.125 -135.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -91.28 -46.59 7.97 Favored 'General case' 0 CA--C 1.5 -0.98 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 49.8 t-20 171.1 142.53 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.465 1 N-CA-C 97.962 -4.829 . . . . 0.0 97.962 167.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 171.31 -157.2 0.01 OUTLIER 'General case' 0 CA--C 1.488 -1.419 0 C-N-CA 126.986 2.114 . . . . 0.0 105.587 178.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.461 HG12 HD12 ' A' ' 59' ' ' ILE . 1.5 m -125.83 155.81 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.775 1 N-CA-C 96.772 -5.27 . . . . 0.0 96.772 155.293 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -98.91 141.78 31.24 Favored 'General case' 0 CA--C 1.482 -1.636 1 N-CA-C 97.506 -4.998 . . . . 0.0 97.506 165.098 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -84.31 178.79 7.63 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 105.33 -2.1 . . . . 0.0 105.33 179.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 36.4 t -146.79 163.28 36.52 Favored 'General case' 0 N--CA 1.419 -1.979 1 N-CA-C 96.76 -5.274 . . . . 0.0 96.76 -173.161 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -126.27 132.57 24.36 Favored Pre-proline 0 N--CA 1.417 -2.11 1 N-CA-C 98.383 -4.673 . . . . 0.0 98.383 -173.126 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -65.53 -6.64 14.1 Favored 'Trans proline' 0 CA--C 1.514 -0.479 0 CA-C-N 123.576 2.313 . . . . 0.0 113.518 177.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -95.55 89.35 1.15 Allowed Glycine 0 C--N 1.352 1.426 1 N-CA-C 101.216 -4.754 . . . . 0.0 101.216 158.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.9 m -60.04 -15.56 23.78 Favored 'General case' 0 CA--C 1.498 -1.057 0 C-N-CA 127.404 2.281 . . . . 0.0 115.868 -159.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -44.41 -45.0 8.76 Favored 'General case' 0 N--CA 1.436 -1.155 0 C-N-CA 128.618 2.767 . . . . 0.0 114.087 -175.621 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.73 -50.28 65.51 Favored Glycine 0 C--N 1.355 1.587 0 N-CA-C 111.972 -0.451 . . . . 0.0 111.972 -175.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 19.5 t -76.14 -24.23 54.86 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -177.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -61.37 -48.24 82.19 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 175.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -60.57 -40.06 90.26 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 172.197 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 96.1 mt -64.96 -44.12 90.44 Favored 'General case' 0 C--N 1.357 0.928 0 CA-C-N 119.321 0.964 . . . . 0.0 110.551 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 9.1 t -58.23 -46.85 85.17 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 125.257 1.423 . . . . 0.0 109.632 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -67.75 -37.18 81.79 Favored 'General case' 0 C--N 1.354 0.766 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -177.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -77.11 -22.76 52.22 Favored 'General case' 0 C--N 1.354 0.794 0 O-C-N 121.192 -0.942 . . . . 0.0 111.397 -176.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -85.99 -34.29 20.86 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 175.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 114.89 44.03 0.71 Allowed Glycine 0 CA--C 1.482 -1.978 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 164.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.13 149.08 16.59 Favored Glycine 0 CA--C 1.487 -1.715 1 N-CA-C 102.322 -4.311 . . . . 0.0 102.322 163.32 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.1 m -70.61 -47.45 60.03 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 122.265 1.031 . . . . 0.0 110.203 -165.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 33.8 m -160.82 -174.0 4.2 Favored 'General case' 0 N--CA 1.422 -1.849 1 N-CA-C 97.802 -4.888 . . . . 0.0 97.802 167.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -175.92 -177.96 45.35 Favored Glycine 0 N--CA 1.418 -2.543 1 N-CA-C 99.329 -5.508 . . . . 0.0 99.329 -169.123 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 68.4 m80 -155.96 176.98 11.94 Favored 'General case' 0 N--CA 1.425 -1.71 1 N-CA-C 99.421 -4.288 . . . . 0.0 99.421 -172.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 68.0 m -88.38 164.31 15.59 Favored 'General case' 0 CA--C 1.49 -1.361 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -179.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -167.68 -169.84 31.71 Favored Glycine 0 N--CA 1.414 -2.815 1 N-CA-C 100.45 -5.06 . . . . 0.0 100.45 176.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -152.61 156.65 39.69 Favored 'General case' 0 N--CA 1.417 -2.09 1 N-CA-C 94.132 -6.247 . . . . 0.0 94.132 -176.816 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 16.8 ptmt -136.86 17.43 3.05 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 104.248 -2.501 . . . . 0.0 104.248 163.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . 0.276 1.8 t 50.01 -138.24 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.358 0.974 0 C-N-CA 126.764 2.026 . . . . 0.0 107.534 -160.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.43 -72.35 2.17 Favored Glycine 0 CA--C 1.495 -1.217 0 C-N-CA 123.787 0.708 . . . . 0.0 111.652 163.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 9.5 m170 -98.79 -64.41 1.04 Allowed 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 105.127 -2.175 . . . . 0.0 105.127 176.136 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 174.64 -169.23 42.16 Favored Glycine 0 CA--C 1.473 -2.531 1 N-CA-C 100.478 -5.049 . . . . 0.0 100.478 -169.513 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.2 tt -70.2 132.27 45.51 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 105.504 -2.035 . . . . 0.0 105.504 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.404 ' HA ' ' HB ' ' A' ' 13' ' ' VAL . . . -133.63 165.85 23.96 Favored 'General case' 0 CA--C 1.474 -1.954 0 N-CA-C 101.273 -3.603 . . . . 0.0 101.273 -159.067 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 49.7 t -120.2 151.61 38.88 Favored 'General case' 0 CA--C 1.488 -1.422 0 N-CA-C 102.482 -3.155 . . . . 0.0 102.482 -174.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 62.1 t-105 -97.95 149.72 22.11 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 104.108 -2.553 . . . . 0.0 104.108 175.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.8 m -141.35 143.95 34.28 Favored 'General case' 0 CA--C 1.481 -1.688 0 N-CA-C 100.949 -3.723 . . . . 0.0 100.949 170.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -108.55 124.6 50.73 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 104.14 -2.541 . . . . 0.0 104.14 179.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 76.37 73.59 0.08 Allowed 'General case' 0 CA--C 1.498 -1.025 0 C-N-CA 127.093 2.157 . . . . 0.0 110.939 171.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 35.9 mt -103.53 131.47 22.01 Favored Pre-proline 0 CA--C 1.498 -1.041 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 174.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -72.05 174.09 11.85 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 CA-C-N 122.515 1.934 . . . . 0.0 110.28 176.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -69.15 -8.35 44.71 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 -172.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 17.7 p-10 -81.91 -10.69 59.21 Favored 'General case' 0 CA--C 1.505 -0.786 0 O-C-N 121.093 -1.004 . . . . 0.0 109.438 -177.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.8 t -100.24 132.52 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.374 0 N-CA-C 104.538 -2.393 . . . . 0.0 104.538 -176.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -103.77 151.05 17.65 Favored Glycine 0 CA--C 1.485 -1.829 0 N-CA-C 103.099 -4.0 . . . . 0.0 103.099 176.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 24.7 pt -136.14 -152.96 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 N-CA-C 104.823 -2.288 . . . . 0.0 104.823 -164.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.506 HD13 ' HB2' ' A' ' 7' ' ' ALA . 3.8 mm -67.98 133.46 31.63 Favored 'Isoleucine or valine' 0 C--N 1.358 0.956 0 N-CA-C 107.497 -1.298 . . . . 0.0 107.497 -178.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.2 t -129.72 150.99 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.663 1 N-CA-C 96.444 -5.391 . . . . 0.0 96.444 169.095 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -155.19 152.94 29.98 Favored 'General case' 0 CA--C 1.482 -1.67 1 N-CA-C 97.172 -5.122 . . . . 0.0 97.172 178.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 129.9 -44.95 1.17 Allowed Glycine 0 CA--C 1.489 -1.571 1 N-CA-C 100.26 -5.136 . . . . 0.0 100.26 -159.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -106.31 -138.36 0.37 Allowed 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 101.477 -3.527 . . . . 0.0 101.477 159.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 18.0 ttmm -166.14 -163.04 0.58 Allowed 'General case' 0 N--CA 1.423 -1.795 1 N-CA-C 96.366 -5.42 . . . . 0.0 96.366 -179.15 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 52.4 t -57.09 140.91 47.84 Favored 'General case' 0 CA--C 1.501 -0.913 0 C-N-CA 126.478 1.911 . . . . 0.0 112.161 -170.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 9.1 p-80 -145.48 25.03 1.37 Allowed 'General case' 0 CA--C 1.499 -1.008 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 169.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.5 m -82.68 75.73 9.57 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 172.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.363 1.161 0 CA-C-N 116.209 -0.45 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 33.2 m . . . . . 0 N--CA 1.485 1.303 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -107.52 159.2 16.61 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 170.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -130.37 120.72 24.73 Favored 'General case' 0 CA--C 1.49 -1.333 1 N-CA-C 96.218 -5.475 . . . . 0.0 96.218 161.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.02 -175.06 32.64 Favored Glycine 0 CA--C 1.477 -2.325 0 N-CA-C 105.456 -3.058 . . . . 0.0 105.456 -176.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 48' ' ' TRP . 46.6 m-85 -79.53 136.17 36.82 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 104.121 -2.548 . . . . 0.0 104.121 165.076 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 14.4 tt -90.82 146.73 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 N-CA-C 105.663 -1.977 . . . . 0.0 105.663 178.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.701 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -131.38 -178.06 4.68 Favored 'General case' 0 N--CA 1.414 -2.273 0 N-CA-C 105.165 -2.161 . . . . 0.0 105.165 -178.072 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -86.6 149.05 47.89 Favored Pre-proline 0 N--CA 1.435 -1.208 0 N-CA-C 103.225 -2.88 . . . . 0.0 103.225 159.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_exo -71.48 0.56 6.69 Favored 'Trans proline' 0 CA--C 1.504 -0.994 0 CA-C-N 123.222 2.186 . . . . 0.0 115.691 -154.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.7 mp0 -94.44 19.19 9.97 Favored 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 126.039 1.736 . . . . 0.0 109.227 -170.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 67.2 t30 66.25 61.54 0.6 Allowed 'General case' 0 CA--C 1.497 -1.083 0 C-N-CA 127.543 2.337 . . . . 0.0 108.803 -178.005 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 85.4 m -122.13 -137.58 0.31 Allowed 'General case' 0 CA--C 1.481 -1.699 0 N-CA-C 103.307 -2.849 . . . . 0.0 103.307 -178.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -136.56 173.24 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.923 1 N-CA-C 99.855 -4.128 . . . . 0.0 99.855 164.279 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -124.59 138.82 54.29 Favored 'General case' 0 N--CA 1.414 -2.268 1 N-CA-C 93.555 -6.461 . . . . 0.0 93.555 174.26 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 54.6 m80 -87.26 -178.32 6.18 Favored 'General case' 0 CA--C 1.492 -1.268 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 -173.023 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.2 t -153.43 173.37 15.76 Favored 'General case' 0 N--CA 1.412 -2.341 1 N-CA-C 95.361 -5.792 . . . . 0.0 95.361 -168.014 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -140.52 142.15 28.04 Favored Pre-proline 0 N--CA 1.409 -2.501 1 N-CA-C 95.352 -5.796 . . . . 0.0 95.352 -177.073 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -75.06 64.81 6.12 Favored 'Trans proline' 0 C--N 1.326 -0.613 0 C-N-CA 123.698 2.932 . . . . 0.0 109.369 172.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 156.99 60.82 0.01 OUTLIER Glycine 0 CA--C 1.482 -1.988 1 N-CA-C 97.82 -6.112 . . . . 0.0 97.82 -170.411 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 m -84.09 46.34 1.19 Allowed 'General case' 0 N--CA 1.436 -1.16 0 C-N-CA 124.994 1.318 . . . . 0.0 113.403 -154.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.9 p -70.5 -38.88 74.39 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 124.63 1.172 . . . . 0.0 108.951 -178.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.94 -37.1 92.92 Favored Glycine 0 C--N 1.351 1.379 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 177.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 38.7 t -72.75 -31.04 64.64 Favored 'General case' 0 C--N 1.358 0.952 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -57.23 -44.89 84.21 Favored 'General case' 0 C--N 1.354 0.764 0 CA-C-N 119.827 1.194 . . . . 0.0 110.267 178.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -58.2 -48.1 81.39 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 171.091 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 95.9 mt -65.64 -41.09 93.0 Favored 'General case' 0 C--N 1.359 0.991 0 CA-C-O 122.651 1.215 . . . . 0.0 110.813 -176.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 9.0 t -62.99 -46.07 89.4 Favored 'General case' 0 CA--C 1.495 -1.148 0 C-N-CA 125.301 1.44 . . . . 0.0 108.871 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.7 mmtm -65.29 -43.71 90.31 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-O 119.327 -0.368 . . . . 0.0 111.423 -178.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 25.8 pt-20 -72.3 -19.05 61.73 Favored 'General case' 0 C--N 1.354 0.8 0 CA-C-N 118.76 0.709 . . . . 0.0 112.351 -174.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -88.45 -17.69 29.87 Favored 'General case' 0 CA--C 1.506 -0.731 0 C-N-CA 123.244 0.618 . . . . 0.0 110.199 175.042 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.88 27.06 5.56 Favored Glycine 0 CA--C 1.489 -1.553 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 169.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -95.69 123.08 7.53 Favored Glycine 0 CA--C 1.49 -1.499 0 N-CA-C 105.467 -3.053 . . . . 0.0 105.467 174.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.8 p -97.28 -4.64 38.38 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -167.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.8 p -159.11 169.94 23.11 Favored 'General case' 0 N--CA 1.427 -1.576 1 N-CA-C 97.859 -4.867 . . . . 0.0 97.859 172.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -176.09 179.65 47.07 Favored Glycine 0 CA--C 1.474 -2.498 1 N-CA-C 102.007 -4.437 . . . . 0.0 102.007 -172.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 38.8 m80 -154.12 -161.22 1.2 Allowed 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 100.821 -3.77 . . . . 0.0 100.821 -174.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 12.5 t -147.87 161.88 40.39 Favored 'General case' 0 N--CA 1.431 -1.396 1 N-CA-C 98.994 -4.447 . . . . 0.0 98.994 -172.149 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 170.03 -160.23 33.07 Favored Glycine 0 N--CA 1.428 -1.858 1 N-CA-C 102.285 -4.326 . . . . 0.0 102.285 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -134.53 143.13 47.25 Favored 'General case' 0 N--CA 1.433 -1.3 1 N-CA-C 99.482 -4.266 . . . . 0.0 99.482 -176.127 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.47 105.2 11.85 Favored 'General case' 0 CA--C 1.491 -1.322 0 N-CA-C 101.533 -3.506 . . . . 0.0 101.533 174.137 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.406 HG23 ' H ' ' A' ' 41' ' ' VAL . 3.5 t -41.64 -71.59 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.496 -1.109 0 C-N-CA 127.114 2.165 . . . . 0.0 115.136 -163.277 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -77.25 53.03 3.45 Favored Glycine 0 CA--C 1.501 -0.785 0 C-N-CA 126.413 1.958 . . . . 0.0 111.485 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 41.9 m-70 -167.59 -60.52 0.03 OUTLIER 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 105.093 -2.188 . . . . 0.0 105.093 171.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 150.46 -154.05 25.41 Favored Glycine 0 C--N 1.352 1.463 0 N-CA-C 108.397 -1.881 . . . . 0.0 108.397 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 63.2 tp -71.91 125.85 28.25 Favored 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 178.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -131.5 172.46 12.19 Favored 'General case' 0 CA--C 1.476 -1.867 0 N-CA-C 103.684 -2.71 . . . . 0.0 103.684 -163.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 38.6 t -125.68 167.91 14.48 Favored 'General case' 0 CA--C 1.486 -1.515 0 N-CA-C 101.508 -3.516 . . . . 0.0 101.508 176.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.4 ' HA ' ' HA ' ' A' ' 5' ' ' TYR . 11.0 t-105 -124.56 147.03 48.69 Favored 'General case' 0 CA--C 1.484 -1.572 0 N-CA-C 101.542 -3.503 . . . . 0.0 101.542 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 22.0 m -139.5 148.72 43.04 Favored 'General case' 0 CA--C 1.486 -1.506 0 N-CA-C 100.516 -3.883 . . . . 0.0 100.516 176.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -122.59 136.56 54.91 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 102.703 -3.073 . . . . 0.0 102.703 -174.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 71.16 49.76 0.32 Allowed 'General case' 0 CA--C 1.499 -1.006 0 C-N-CA 127.313 2.245 . . . . 0.0 110.928 176.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 20.0 mt -88.43 135.1 33.12 Favored Pre-proline 0 CA--C 1.498 -1.047 0 N-CA-C 105.344 -2.095 . . . . 0.0 105.344 177.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -73.15 170.59 19.48 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 122.241 1.961 . . . . 0.0 110.315 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -77.36 -3.94 42.64 Favored 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 -164.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -92.96 1.8 57.12 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 123.944 0.898 . . . . 0.0 109.885 -178.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.5 t -102.61 137.2 31.54 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.146 0 N-CA-C 103.386 -2.82 . . . . 0.0 103.386 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -108.14 144.52 16.2 Favored Glycine 0 CA--C 1.481 -2.091 0 N-CA-C 103.376 -3.889 . . . . 0.0 103.376 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 27.3 pt -139.18 -147.46 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.379 0 N-CA-C 103.529 -2.767 . . . . 0.0 103.529 -166.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.701 HD13 ' HB2' ' A' ' 7' ' ' ALA . 15.8 mm -69.73 121.11 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 175.092 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -108.65 -21.88 5.32 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.101 0 C-N-CA 124.554 1.141 . . . . 0.0 109.171 -164.564 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.401 ' HG3' ' H ' ' A' ' 62' ' ' GLY . 36.3 tp10 173.71 -167.05 0.03 OUTLIER 'General case' 0 N--CA 1.433 -1.32 1 N-CA-C 95.393 -5.78 . . . . 0.0 95.393 178.127 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.401 ' H ' ' HG3' ' A' ' 61' ' ' GLU . . . -125.06 121.15 4.2 Favored Glycine 0 CA--C 1.479 -2.194 1 N-CA-C 94.824 -7.311 . . . . 0.0 94.824 162.826 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -163.72 -61.53 0.04 OUTLIER 'General case' 0 CA--C 1.487 -1.477 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 -164.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -153.4 158.66 41.8 Favored 'General case' 0 N--CA 1.427 -1.621 1 N-CA-C 98.916 -4.475 . . . . 0.0 98.916 -173.056 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 1.2 t -145.62 154.92 42.66 Favored 'General case' 0 N--CA 1.43 -1.427 1 N-CA-C 94.718 -6.03 . . . . 0.0 94.718 177.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 38.0 p-80 -157.84 177.91 10.82 Favored 'General case' 0 N--CA 1.429 -1.509 1 N-CA-C 99.87 -4.122 . . . . 0.0 99.87 175.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 30.3 m -172.94 175.78 3.21 Favored 'General case' 0 N--CA 1.426 -1.637 1 N-CA-C 96.166 -5.494 . . . . 0.0 96.166 177.192 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.358 0.948 0 O-C-N 124.405 1.066 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 27.5 m . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 121.11 0.481 . . . . 0.0 110.038 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.31 173.02 9.11 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 106.163 -1.792 . . . . 0.0 106.163 175.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -134.53 140.97 46.54 Favored 'General case' 0 N--CA 1.431 -1.398 1 N-CA-C 95.4 -5.778 . . . . 0.0 95.4 164.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.65 -175.77 33.03 Favored Glycine 0 CA--C 1.475 -2.42 1 N-CA-C 101.56 -4.616 . . . . 0.0 101.56 176.05 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 48' ' ' TRP . 24.4 m-85 -82.95 136.8 34.43 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 101.16 -3.644 . . . . 0.0 101.16 158.376 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.414 ' HA ' HG22 ' A' ' 58' ' ' ILE . 13.5 tt -87.29 132.98 31.29 Favored 'Isoleucine or valine' 0 C--O 1.252 1.19 0 N-CA-C 105.612 -1.995 . . . . 0.0 105.612 -174.343 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.496 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -107.56 -179.68 3.98 Favored 'General case' 0 C--N 1.366 1.314 0 O-C-N 127.691 3.119 . . . . 0.0 108.702 175.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -95.37 135.98 22.87 Favored Pre-proline 0 N--CA 1.433 -1.307 0 N-CA-C 100.508 -3.886 . . . . 0.0 100.508 167.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -78.15 60.42 7.39 Favored 'Trans proline' 0 CA--C 1.514 -0.519 0 C-N-CA 123.836 3.024 . . . . 0.0 112.49 -163.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -118.13 -83.28 0.64 Allowed 'General case' 0 N--CA 1.422 -1.827 1 N-CA-C 96.686 -5.302 . . . . 0.0 96.686 159.542 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 19.8 t30 -166.17 143.48 5.3 Favored 'General case' 0 N--CA 1.419 -1.976 1 N-CA-C 92.616 -6.809 . . . . 0.0 92.616 159.261 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 65' ' ' CYS . 7.1 m 176.3 -157.11 0.02 OUTLIER 'General case' 0 CA--C 1.49 -1.333 1 N-CA-C 99.737 -4.172 . . . . 0.0 99.737 178.92 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.505 HG12 HD12 ' A' ' 59' ' ' ILE . 0.8 OUTLIER -120.83 155.95 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.913 1 N-CA-C 97.46 -5.015 . . . . 0.0 97.46 160.592 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -93.64 136.88 33.47 Favored 'General case' 0 CA--C 1.48 -1.724 1 N-CA-C 96.895 -5.224 . . . . 0.0 96.895 162.595 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 79.0 m80 -85.85 176.27 8.19 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 -169.068 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 12.2 t -140.67 158.23 44.29 Favored 'General case' 0 N--CA 1.413 -2.31 1 N-CA-C 94.056 -6.276 . . . . 0.0 94.056 178.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -124.93 138.69 31.94 Favored Pre-proline 0 N--CA 1.419 -1.986 1 N-CA-C 95.654 -5.684 . . . . 0.0 95.654 177.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_exo -63.53 94.94 0.18 Allowed 'Trans proline' 0 CA--C 1.512 -0.598 0 CA-C-N 124.71 2.718 . . . . 0.0 114.182 -171.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 164.64 -173.51 40.57 Favored Glycine 0 N--CA 1.421 -2.308 1 N-CA-C 97.927 -6.069 . . . . 0.0 97.927 -176.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.1 m -84.49 -32.59 23.88 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 117.333 0.566 . . . . 0.0 110.421 -177.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.5 m -46.7 -59.68 2.88 Favored 'General case' 0 N--CA 1.439 -0.984 0 C-N-CA 127.594 2.358 . . . . 0.0 116.582 -156.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -72.82 -54.69 7.04 Favored Glycine 0 C--N 1.349 1.286 0 N-CA-C 110.179 -1.169 . . . . 0.0 110.179 -174.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 49.1 t -61.29 -48.39 81.62 Favored 'General case' 0 CA--C 1.499 -1.016 0 C-N-CA 125.418 1.487 . . . . 0.0 111.473 -171.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -62.34 -42.78 99.67 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 118.729 0.695 . . . . 0.0 109.543 -175.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.0 m -66.5 -50.86 61.85 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 123.567 0.747 . . . . 0.0 110.639 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 55.7 mt -64.09 -41.83 97.15 Favored 'General case' 0 C--N 1.362 1.124 0 C-N-CA 124.697 1.199 . . . . 0.0 110.35 -175.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 15.9 t -62.35 -46.44 88.65 Favored 'General case' 0 CA--C 1.5 -0.967 0 C-N-CA 123.649 0.779 . . . . 0.0 108.98 177.358 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -66.82 -45.0 79.68 Favored 'General case' 0 CA--C 1.504 -0.802 0 O-C-N 121.76 -0.587 . . . . 0.0 110.899 -173.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -72.33 -23.58 61.18 Favored 'General case' 0 C--N 1.354 0.774 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -174.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 42.6 mmtm -88.22 -18.82 27.82 Favored 'General case' 0 C--N 1.354 0.772 0 CA-C-N 118.673 0.669 . . . . 0.0 109.393 175.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.35 41.66 1.35 Allowed Glycine 0 CA--C 1.483 -1.952 0 N-CA-C 109.331 -1.507 . . . . 0.0 109.331 161.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -103.79 128.5 9.52 Favored Glycine 0 CA--C 1.486 -1.76 0 N-CA-C 103.56 -3.816 . . . . 0.0 103.56 171.1 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.7 p -99.87 4.49 45.17 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 122.339 1.066 . . . . 0.0 108.725 -166.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 46.4 m -160.3 165.12 31.92 Favored 'General case' 0 N--CA 1.421 -1.893 1 N-CA-C 98.66 -4.571 . . . . 0.0 98.66 166.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 179.69 -173.72 45.44 Favored Glycine 0 N--CA 1.414 -2.801 1 N-CA-C 99.563 -5.415 . . . . 0.0 99.563 -176.476 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 18.6 p80 -171.42 173.65 4.73 Favored 'General case' 0 N--CA 1.43 -1.428 1 N-CA-C 99.463 -4.273 . . . . 0.0 99.463 172.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 49.0 t -94.32 153.92 17.76 Favored 'General case' 0 CA--C 1.502 -0.878 0 N-CA-C 105.361 -2.088 . . . . 0.0 105.361 -176.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.63 -165.3 28.65 Favored Glycine 0 N--CA 1.431 -1.659 0 N-CA-C 104.927 -3.269 . . . . 0.0 104.927 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -148.42 147.58 29.34 Favored 'General case' 0 N--CA 1.429 -1.495 1 N-CA-C 98.012 -4.811 . . . . 0.0 98.012 -170.197 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -130.17 100.7 5.5 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 102.106 -3.294 . . . . 0.0 102.106 167.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.9 t -70.22 120.08 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 -173.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 141.07 -48.4 0.82 Allowed Glycine 0 CA--C 1.484 -1.865 1 N-CA-C 102.019 -4.433 . . . . 0.0 102.019 -164.411 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 18.3 m-70 -106.69 -74.93 0.64 Allowed 'General case' 0 CA--C 1.501 -0.934 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 173.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 169.16 -156.53 27.82 Favored Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 105.427 -3.069 . . . . 0.0 105.427 -173.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.78 130.11 42.13 Favored 'General case' 0 C--N 1.358 0.939 0 C-N-CA 127.809 2.443 . . . . 0.0 104.819 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -130.5 174.81 9.53 Favored 'General case' 0 CA--C 1.478 -1.792 0 N-CA-C 104.734 -2.321 . . . . 0.0 104.734 -168.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 19.3 t -121.38 158.16 28.9 Favored 'General case' 0 CA--C 1.492 -1.263 1 N-CA-C 99.575 -4.231 . . . . 0.0 99.575 172.199 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.423 ' HA ' ' HA ' ' A' ' 5' ' ' TYR . 12.3 t-105 -117.81 150.5 39.04 Favored 'General case' 0 CA--C 1.495 -1.173 0 N-CA-C 102.233 -3.247 . . . . 0.0 102.233 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 59.1 m -147.47 152.01 37.35 Favored 'General case' 0 CA--C 1.492 -1.272 0 N-CA-C 105.057 -2.201 . . . . 0.0 105.057 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -119.79 145.14 46.87 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 104.636 -2.357 . . . . 0.0 104.636 171.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 65.2 53.02 1.38 Allowed 'General case' 0 CA--C 1.49 -1.331 0 C-N-CA 127.283 2.233 . . . . 0.0 110.461 170.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 31.2 mt -91.31 139.95 25.53 Favored Pre-proline 0 CA--C 1.498 -1.028 0 N-CA-C 103.602 -2.74 . . . . 0.0 103.602 175.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -72.17 169.96 20.23 Favored 'Trans proline' 0 N--CA 1.447 -1.233 0 C-N-CA 122.544 2.163 . . . . 0.0 109.456 176.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -83.0 13.65 3.85 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -165.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -103.7 4.28 35.19 Favored 'General case' 0 CA--C 1.501 -0.922 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 177.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.0 t -104.85 154.53 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 N-CA-C 103.181 -2.896 . . . . 0.0 103.181 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -122.94 158.62 17.59 Favored Glycine 0 CA--C 1.483 -1.954 1 N-CA-C 102.731 -4.147 . . . . 0.0 102.731 -175.318 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.414 HG22 ' HA ' ' A' ' 6' ' ' ILE . 28.4 pt -151.18 -178.81 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.594 0 N-CA-C 102.469 -3.16 . . . . 0.0 102.469 -163.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.505 HD12 HG12 ' A' ' 13' ' ' VAL . 1.5 mm -69.61 131.9 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.045 0 O-C-N 123.974 0.796 . . . . 0.0 109.813 -166.086 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.6 t -123.93 160.98 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.516 1 N-CA-C 98.98 -4.452 . . . . 0.0 98.98 173.358 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -157.72 160.61 38.09 Favored 'General case' 0 N--CA 1.426 -1.654 1 N-CA-C 97.429 -5.026 . . . . 0.0 97.429 173.547 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 114.67 -30.14 7.09 Favored Glycine 0 C--N 1.347 1.171 0 N-CA-C 103.459 -3.857 . . . . 0.0 103.459 -157.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -123.44 -149.82 0.43 Allowed 'General case' 0 N--CA 1.43 -1.435 1 N-CA-C 97.965 -4.828 . . . . 0.0 97.965 164.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.402 ' HG2' ' H ' ' A' ' 65' ' ' CYS . 21.8 ttmt -167.09 -161.94 0.45 Allowed 'General case' 0 N--CA 1.43 -1.448 1 N-CA-C 97.763 -4.903 . . . . 0.0 97.763 -179.32 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.402 ' H ' ' HG2' ' A' ' 64' ' ' LYS . 42.3 t -60.71 126.73 28.51 Favored 'General case' 0 CA--C 1.49 -1.349 0 C-N-CA 126.888 2.075 . . . . 0.0 108.201 -178.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 20.4 p-80 -146.81 171.72 14.75 Favored 'General case' 0 CA--C 1.481 -1.685 0 N-CA-C 101.141 -3.652 . . . . 0.0 101.141 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 58.2 m -171.5 173.08 4.86 Favored 'General case' 0 N--CA 1.422 -1.834 1 N-CA-C 95.712 -5.662 . . . . 0.0 95.712 175.576 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.358 0.958 0 O-C-N 124.229 0.956 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 5.7 m . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 121.811 0.815 . . . . 0.0 111.343 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.411 HH21 HG12 ' A' ' 58' ' ' ILE . 20.5 mtp85 -106.27 147.93 28.56 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 104.834 -2.284 . . . . 0.0 104.834 177.054 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -129.51 120.1 24.83 Favored 'General case' 0 CA--C 1.489 -1.378 1 N-CA-C 98.044 -4.798 . . . . 0.0 98.044 166.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.78 -170.62 26.76 Favored Glycine 0 CA--C 1.481 -2.058 0 N-CA-C 104.89 -3.284 . . . . 0.0 104.89 -169.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -96.6 140.25 31.5 Favored 'General case' 0 CA--C 1.491 -1.321 0 N-CA-C 101.73 -3.433 . . . . 0.0 101.73 168.036 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.7 tt -91.07 149.21 4.14 Favored 'Isoleucine or valine' 0 C--O 1.246 0.894 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 178.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.697 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -141.32 173.0 11.9 Favored 'General case' 0 N--CA 1.413 -2.304 1 N-CA-C 99.457 -4.275 . . . . 0.0 99.457 175.42 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -79.97 149.95 71.09 Favored Pre-proline 0 N--CA 1.434 -1.226 0 N-CA-C 103.14 -2.911 . . . . 0.0 103.14 165.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -79.95 -1.87 11.71 Favored 'Trans proline' 0 CA--C 1.499 -1.246 0 CA-C-N 121.113 1.433 . . . . 0.0 112.484 -142.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -96.33 13.79 26.49 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 -177.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 53.5 t30 77.28 44.89 0.09 Allowed 'General case' 0 CA--C 1.5 -0.951 0 C-N-CA 127.693 2.397 . . . . 0.0 108.354 178.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.3 m -122.82 110.73 15.82 Favored 'General case' 0 CA--C 1.482 -1.664 1 N-CA-C 99.42 -4.289 . . . . 0.0 99.42 -176.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 18.0 m -67.22 160.33 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.234 0 CA-C-N 119.652 1.115 . . . . 0.0 112.925 -163.277 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -101.71 117.49 34.98 Favored 'General case' 0 CA--C 1.479 -1.772 1 N-CA-C 97.341 -5.059 . . . . 0.0 97.341 179.645 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -83.15 125.85 31.97 Favored 'General case' 0 CA--C 1.486 -1.496 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 -158.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 40.4 t -92.24 149.59 21.37 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 104.026 -2.583 . . . . 0.0 104.026 175.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -134.45 140.0 34.41 Favored Pre-proline 0 N--CA 1.416 -2.141 1 N-CA-C 96.977 -5.194 . . . . 0.0 96.977 172.455 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -68.65 67.67 1.16 Allowed 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 124.124 3.216 . . . . 0.0 113.431 174.241 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -178.13 50.86 0.1 OUTLIER Glycine 0 CA--C 1.487 -1.656 1 N-CA-C 99.41 -5.476 . . . . 0.0 99.41 177.321 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.0 m -86.25 45.02 1.18 Allowed 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 114.104 -1.048 . . . . 0.0 112.909 -147.086 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.5 p -72.93 -42.63 63.27 Favored 'General case' 0 N--CA 1.444 -0.756 0 O-C-N 121.372 -0.83 . . . . 0.0 109.379 -175.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -68.97 -43.71 71.67 Favored Glycine 0 C--N 1.349 1.289 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 177.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.7 t -59.73 -44.4 93.79 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 125.455 1.502 . . . . 0.0 111.754 178.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -67.5 -35.32 78.9 Favored 'General case' 0 C--N 1.353 0.737 0 O-C-N 120.974 -1.079 . . . . 0.0 110.596 177.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 40.7 m -70.05 -33.69 72.27 Favored 'General case' 0 N--CA 1.45 -0.448 0 O-C-N 121.052 -1.03 . . . . 0.0 109.955 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 20.3 mt -66.89 -38.38 86.15 Favored 'General case' 0 CA--C 1.496 -1.129 0 O-C-N 121.518 -0.739 . . . . 0.0 109.705 177.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 36.8 t -54.82 -47.89 73.51 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 122.149 -0.344 . . . . 0.0 111.699 170.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.5 mmtm -63.06 -50.32 71.05 Favored 'General case' 0 C--N 1.354 0.784 0 O-C-N 121.394 -0.816 . . . . 0.0 111.276 -178.1 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -70.71 -8.91 55.53 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 112.897 0.702 . . . . 0.0 112.897 -173.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.9 mmmp? -102.69 2.9 36.44 Favored 'General case' 0 C--N 1.354 0.785 0 O-C-N 121.469 -0.769 . . . . 0.0 111.239 173.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 93.96 29.0 10.17 Favored Glycine 0 C--N 1.35 1.341 0 N-CA-C 111.436 -0.666 . . . . 0.0 111.436 169.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -91.93 140.97 15.42 Favored Glycine 0 C--N 1.354 1.578 0 N-CA-C 106.851 -2.5 . . . . 0.0 106.851 171.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.4 m -99.11 -26.38 14.23 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 -165.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.6 m -147.93 175.64 10.8 Favored 'General case' 0 CA--C 1.482 -1.661 1 N-CA-C 99.92 -4.104 . . . . 0.0 99.92 171.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -171.68 -176.44 40.66 Favored Glycine 0 N--CA 1.42 -2.382 1 N-CA-C 100.579 -5.008 . . . . 0.0 100.579 -173.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 9.7 p80 -177.91 -152.5 0.03 OUTLIER 'General case' 0 N--CA 1.434 -1.254 1 N-CA-C 97.687 -4.931 . . . . 0.0 97.687 173.101 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 24.8 t -149.5 154.77 39.29 Favored 'General case' 0 N--CA 1.425 -1.723 1 N-CA-C 97.904 -4.85 . . . . 0.0 97.904 -173.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 178.76 -179.29 48.82 Favored Glycine 0 N--CA 1.425 -2.092 1 N-CA-C 96.8 -6.52 . . . . 0.0 96.8 -178.438 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.419 ' CD1' ' HA ' ' A' ' 45' ' ' LEU . 61.3 t80 -158.25 134.34 9.26 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 101.295 -3.595 . . . . 0.0 101.295 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.599 ' H ' HG23 ' A' ' 41' ' ' VAL . 28.7 mmmt -168.72 57.35 0.05 Allowed 'General case' 0 CA--C 1.499 -1.005 1 N-CA-C 97.747 -4.909 . . . . 0.0 97.747 172.545 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.599 HG23 ' H ' ' A' ' 40' ' ' LYS . 13.7 t -134.89 163.94 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.369 1 N-CA-C 99.579 -4.23 . . . . 0.0 99.579 -169.125 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -116.45 89.46 0.49 Allowed Glycine 0 CA--C 1.487 -1.69 1 N-CA-C 101.822 -4.511 . . . . 0.0 101.822 170.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 60.9 m-70 -175.01 -154.63 0.05 Allowed 'General case' 0 N--CA 1.429 -1.507 1 N-CA-C 96.779 -5.267 . . . . 0.0 96.779 -175.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -83.72 -69.86 1.37 Allowed Glycine 0 C--N 1.351 1.395 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -176.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.419 ' HA ' ' CD1' ' A' ' 39' ' ' PHE . 0.1 OUTLIER -167.54 152.7 7.12 Favored 'General case' 0 CA--C 1.489 -1.383 1 N-CA-C 96.363 -5.421 . . . . 0.0 96.363 178.61 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.19 166.06 25.54 Favored 'General case' 0 CA--C 1.486 -1.49 0 N-CA-C 102.521 -3.141 . . . . 0.0 102.521 -167.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 99.6 m -101.84 150.96 22.64 Favored 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 104.318 -2.475 . . . . 0.0 104.318 -178.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 44.0 t-105 -93.75 146.33 23.93 Favored 'General case' 0 CA--C 1.496 -1.125 0 N-CA-C 104.327 -2.471 . . . . 0.0 104.327 177.006 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 60.6 m -133.95 141.14 47.18 Favored 'General case' 0 CA--C 1.48 -1.744 0 N-CA-C 104.651 -2.351 . . . . 0.0 104.651 169.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -113.46 128.63 56.51 Favored 'General case' 0 N--CA 1.427 -1.596 0 N-CA-C 101.843 -3.392 . . . . 0.0 101.843 176.631 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 63.33 74.1 0.43 Allowed 'General case' 0 N--CA 1.434 -1.245 0 C-N-CA 126.571 1.948 . . . . 0.0 110.823 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 17.8 mt -97.99 141.9 23.71 Favored Pre-proline 0 CA--C 1.496 -1.122 0 N-CA-C 103.006 -2.961 . . . . 0.0 103.006 164.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -72.85 166.43 30.02 Favored 'Trans proline' 0 N--CA 1.443 -1.476 0 C-N-CA 122.382 2.054 . . . . 0.0 109.186 178.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -77.28 1.25 19.22 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -164.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -101.86 5.83 41.2 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 123.855 0.862 . . . . 0.0 109.594 -177.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.9 t -97.6 163.93 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 103.428 -2.804 . . . . 0.0 103.428 178.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -142.98 150.79 22.62 Favored Glycine 0 CA--C 1.475 -2.426 1 N-CA-C 97.247 -6.341 . . . . 0.0 97.247 -178.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.411 HG12 HH21 ' A' ' 2' ' ' ARG . 18.8 pt -153.77 -147.65 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.49 -1.358 0 N-CA-C 101.553 -3.499 . . . . 0.0 101.553 -154.087 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.697 HD13 ' HB2' ' A' ' 7' ' ' ALA . 7.3 mm -59.51 119.37 3.81 Favored 'Isoleucine or valine' 0 C--N 1.36 1.045 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 174.116 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -114.52 -15.62 9.92 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.126 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.491 -162.039 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -173.97 167.68 4.26 Favored 'General case' 0 N--CA 1.434 -1.252 1 N-CA-C 97.49 -5.004 . . . . 0.0 97.49 177.871 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -108.41 83.22 0.32 Allowed Glycine 0 CA--C 1.487 -1.718 1 N-CA-C 102.992 -4.043 . . . . 0.0 102.992 172.186 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -149.24 -87.07 0.08 Allowed 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 -171.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.486 ' HG2' ' H ' ' A' ' 65' ' ' CYS . 2.4 ttpm? -162.61 -167.13 1.48 Allowed 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 102.647 -3.094 . . . . 0.0 102.647 -173.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.486 ' H ' ' HG2' ' A' ' 64' ' ' LYS . 52.8 t -117.4 152.86 34.1 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 -165.446 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 45.0 p-80 -116.25 -152.22 0.5 Allowed 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 175.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 31.5 m -171.33 174.57 4.47 Favored 'General case' 0 N--CA 1.424 -1.737 1 N-CA-C 95.7 -5.667 . . . . 0.0 95.7 176.341 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.354 0.798 0 O-C-N 124.456 1.098 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 24.1 m . . . . . 0 N--CA 1.484 1.263 0 CA-C-O 120.999 0.428 . . . . 0.0 110.455 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.67 173.34 6.92 Favored 'General case' 0 CA--C 1.5 -0.957 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 173.258 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -130.0 140.08 50.94 Favored 'General case' 0 CA--C 1.488 -1.43 1 N-CA-C 94.563 -6.088 . . . . 0.0 94.563 163.421 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.72 176.07 38.22 Favored Glycine 0 CA--C 1.476 -2.346 0 N-CA-C 104.901 -3.279 . . . . 0.0 104.901 -178.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -83.62 126.93 33.35 Favored 'General case' 0 CA--C 1.497 -1.067 0 N-CA-C 101.184 -3.636 . . . . 0.0 101.184 157.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.4 tt -90.3 137.39 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 -172.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.68 -150.92 0.34 Allowed 'General case' 0 N--CA 1.427 -1.589 0 C-N-CA 127.605 2.362 . . . . 0.0 107.606 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -119.52 139.54 27.98 Favored Pre-proline 0 N--CA 1.424 -1.769 1 N-CA-C 93.847 -6.353 . . . . 0.0 93.847 165.182 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -83.0 30.81 0.53 Allowed 'Trans proline' 0 CA--C 1.505 -0.966 0 C-N-CA 122.306 2.004 . . . . 0.0 113.916 -135.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -106.25 -89.45 0.43 Allowed 'General case' 0 N--CA 1.424 -1.727 0 N-CA-C 101.43 -3.544 . . . . 0.0 101.43 177.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -157.16 138.07 13.39 Favored 'General case' 0 N--CA 1.417 -2.091 1 N-CA-C 92.377 -6.898 . . . . 0.0 92.377 164.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 5.5 m 176.59 -163.54 0.03 OUTLIER 'General case' 0 CA--C 1.489 -1.4 1 N-CA-C 97.414 -5.032 . . . . 0.0 97.414 178.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.499 HG12 HD12 ' A' ' 59' ' ' ILE . 15.4 m -119.73 163.08 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.626 1 N-CA-C 99.19 -4.374 . . . . 0.0 99.19 159.975 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -83.44 164.75 19.71 Favored 'General case' 0 CA--C 1.501 -0.925 0 N-CA-C 102.722 -3.066 . . . . 0.0 102.722 162.529 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 22.8 m80 -90.29 158.12 17.33 Favored 'General case' 0 CA--C 1.484 -1.595 0 N-CA-C 101.538 -3.504 . . . . 0.0 101.538 178.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -160.19 177.48 10.63 Favored 'General case' 0 N--CA 1.41 -2.432 1 N-CA-C 95.92 -5.585 . . . . 0.0 95.92 -174.48 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -147.06 167.29 13.94 Favored Pre-proline 0 N--CA 1.412 -2.331 1 N-CA-C 96.019 -5.548 . . . . 0.0 96.019 -161.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.05 49.67 2.33 Favored 'Trans proline' 0 C--N 1.316 -1.169 0 CA-C-N 124.752 2.733 . . . . 0.0 110.61 169.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -172.68 139.34 5.17 Favored Glycine 0 CA--C 1.478 -2.234 1 N-CA-C 99.702 -5.359 . . . . 0.0 99.702 -177.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.0 m -92.15 11.04 26.88 Favored 'General case' 0 CA--C 1.499 -0.994 0 C-N-CA 123.673 0.789 . . . . 0.0 112.27 -165.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.4 m -51.14 -53.74 31.73 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 126.29 1.836 . . . . 0.0 113.871 -168.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.93 -35.52 27.61 Favored Glycine 0 C--N 1.352 1.427 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -177.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 44.1 t -59.95 -44.61 94.3 Favored 'General case' 0 CA--C 1.499 -0.989 0 C-N-CA 125.379 1.471 . . . . 0.0 110.769 -174.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -59.13 -44.3 92.02 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 124.478 1.111 . . . . 0.0 110.329 178.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -68.87 -38.17 79.54 Favored 'General case' 0 N--CA 1.443 -0.787 0 O-C-N 121.018 -1.051 . . . . 0.0 112.848 175.337 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 85.8 mt -65.03 -40.33 94.69 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-O 122.29 1.043 . . . . 0.0 109.742 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.6 t -60.14 -46.99 87.78 Favored 'General case' 0 N--CA 1.433 -1.286 0 C-N-CA 123.895 0.878 . . . . 0.0 110.404 -178.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -74.26 -29.34 61.63 Favored 'General case' 0 N--CA 1.444 -0.762 0 O-C-N 121.725 -0.609 . . . . 0.0 112.433 -176.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -79.04 -25.33 43.2 Favored 'General case' 0 C--N 1.357 0.918 0 O-C-N 121.023 -1.048 . . . . 0.0 111.094 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.1 mmmp? -82.53 -29.3 30.51 Favored 'General case' 0 C--N 1.358 0.935 0 O-C-N 121.451 -0.781 . . . . 0.0 109.381 172.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 110.25 43.68 1.06 Allowed Glycine 0 CA--C 1.485 -1.793 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 164.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -104.06 161.3 15.69 Favored Glycine 0 CA--C 1.488 -1.608 0 N-CA-C 103.394 -3.883 . . . . 0.0 103.394 166.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.1 p -71.94 -52.34 17.68 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-O 122.281 1.039 . . . . 0.0 109.924 -168.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 39.3 m -160.85 -176.55 5.59 Favored 'General case' 0 N--CA 1.421 -1.924 1 N-CA-C 98.002 -4.814 . . . . 0.0 98.002 170.312 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -172.67 -176.17 41.14 Favored Glycine 0 N--CA 1.416 -2.673 1 N-CA-C 98.766 -5.734 . . . . 0.0 98.766 -169.013 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 39.6 m80 -157.96 169.42 24.62 Favored 'General case' 0 N--CA 1.432 -1.366 1 N-CA-C 99.504 -4.258 . . . . 0.0 99.504 -176.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 64.1 m -84.22 159.92 20.9 Favored 'General case' 0 CA--C 1.499 -0.992 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 172.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -170.02 -178.51 41.05 Favored Glycine 0 N--CA 1.423 -2.19 1 N-CA-C 99.186 -5.566 . . . . 0.0 99.186 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -151.82 -169.33 3.33 Favored 'General case' 0 N--CA 1.422 -1.849 1 N-CA-C 99.224 -4.362 . . . . 0.0 99.224 174.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -154.21 -141.86 0.11 Allowed 'General case' 0 N--CA 1.424 -1.747 1 N-CA-C 93.637 -6.431 . . . . 0.0 93.637 -168.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.2 t -124.95 151.62 30.7 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.293 1 N-CA-C 96.995 -5.187 . . . . 0.0 96.995 149.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 160.49 -137.14 4.84 Favored Glycine 0 N--CA 1.42 -2.398 1 N-CA-C 98.683 -5.767 . . . . 0.0 98.683 -163.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 33.2 m170 -87.49 -35.08 18.41 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -160.205 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -169.92 -65.14 0.04 OUTLIER Glycine 0 C--N 1.357 1.73 0 C-N-CA 118.031 -2.033 . . . . 0.0 110.692 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.26 -178.08 6.43 Favored 'General case' 0 N--CA 1.434 -1.242 1 N-CA-C 94.784 -6.006 . . . . 0.0 94.784 167.786 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -150.36 171.72 16.54 Favored 'General case' 0 CA--C 1.482 -1.667 0 N-CA-C 102.206 -3.257 . . . . 0.0 102.206 174.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 8.5 t -110.13 155.61 21.69 Favored 'General case' 0 CA--C 1.489 -1.396 1 N-CA-C 99.378 -4.304 . . . . 0.0 99.378 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 6.5 t-105 -118.57 154.45 32.58 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 102.454 -3.165 . . . . 0.0 102.454 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 9.8 m -151.06 154.86 37.81 Favored 'General case' 0 CA--C 1.49 -1.365 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 176.065 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -117.81 143.42 46.28 Favored 'General case' 0 CA--C 1.495 -1.145 0 N-CA-C 104.689 -2.338 . . . . 0.0 104.689 169.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 65.02 58.27 0.92 Allowed 'General case' 0 CA--C 1.498 -1.023 0 C-N-CA 127.681 2.392 . . . . 0.0 112.507 171.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 31.3 mt -97.03 146.57 31.53 Favored Pre-proline 0 CA--C 1.502 -0.872 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 177.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -64.25 162.51 29.76 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 123.167 2.578 . . . . 0.0 111.244 174.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -68.88 -22.79 64.17 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -169.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 18.5 p-10 -94.66 19.82 9.42 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 124.345 1.058 . . . . 0.0 110.376 -176.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.3 t -106.91 126.2 62.91 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.274 0 N-CA-C 101.596 -3.483 . . . . 0.0 101.596 169.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -90.95 154.55 23.11 Favored Glycine 0 CA--C 1.492 -1.385 0 N-CA-C 107.923 -2.071 . . . . 0.0 107.923 -174.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 45.8 pt -136.68 -171.84 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 -170.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.499 HD12 HG12 ' A' ' 13' ' ' VAL . 2.3 mm -69.77 127.55 31.83 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.275 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 -174.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 42.6 t -113.41 103.57 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.632 0 N-CA-C 101.81 -3.404 . . . . 0.0 101.81 177.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 64.8 -117.25 0.4 Allowed 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 124.686 1.195 . . . . 0.0 108.469 -177.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -168.1 45.46 0.24 Allowed Glycine 0 N--CA 1.431 -1.68 1 N-CA-C 99.542 -5.423 . . . . 0.0 99.542 168.412 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -84.09 -51.78 6.81 Favored 'General case' 0 CA--C 1.493 -1.235 0 CA-C-O 121.523 0.678 . . . . 0.0 109.416 -164.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 24.8 tptt -149.37 166.37 29.25 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 103.976 -2.601 . . . . 0.0 103.976 -171.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 18.0 t -129.25 136.4 50.05 Favored 'General case' 0 N--CA 1.423 -1.797 1 N-CA-C 93.599 -6.445 . . . . 0.0 93.599 166.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -157.09 159.36 37.81 Favored 'General case' 0 CA--C 1.484 -1.579 1 N-CA-C 99.889 -4.115 . . . . 0.0 99.889 -175.324 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 59.2 m -131.78 135.51 46.84 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 100.594 -3.854 . . . . 0.0 100.594 -173.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.36 1.052 0 O-C-N 124.046 0.842 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 15.2 m . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 121.565 0.698 . . . . 0.0 110.515 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 6.1 mmm180 -101.66 141.89 33.84 Favored 'General case' 0 CA--C 1.495 -1.169 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 -178.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -130.19 116.51 18.53 Favored 'General case' 0 CA--C 1.489 -1.403 1 N-CA-C 95.815 -5.624 . . . . 0.0 95.815 158.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.86 -172.2 28.94 Favored Glycine 0 CA--C 1.476 -2.405 1 N-CA-C 100.981 -4.848 . . . . 0.0 100.981 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.446 ' HB2' HD13 ' A' ' 59' ' ' ILE . 40.2 m-85 -76.86 144.87 38.72 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 104.359 -2.46 . . . . 0.0 104.359 161.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.5 tt -91.23 140.99 15.1 Favored 'Isoleucine or valine' 0 C--O 1.249 1.046 0 N-CA-C 104.617 -2.364 . . . . 0.0 104.617 171.465 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.472 ' HB2' ' CD1' ' A' ' 59' ' ' ILE . . . -141.29 176.99 8.4 Favored 'General case' 0 N--CA 1.41 -2.457 1 N-CA-C 98.875 -4.491 . . . . 0.0 98.875 177.215 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -85.44 153.38 58.8 Favored Pre-proline 0 N--CA 1.431 -1.386 0 N-CA-C 103.705 -2.702 . . . . 0.0 103.705 172.238 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -68.1 -16.93 45.53 Favored 'Trans proline' 0 CA--C 1.502 -1.121 0 N-CA-C 117.625 2.125 . . . . 0.0 117.625 -149.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.4 mp0 -95.37 18.47 12.48 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-N 119.317 0.962 . . . . 0.0 108.52 -175.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 58.3 t-20 82.06 48.19 0.02 OUTLIER 'General case' 0 C--N 1.356 0.853 0 C-N-CA 125.85 1.66 . . . . 0.0 107.841 168.154 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.3 m -125.49 122.19 35.9 Favored 'General case' 0 CA--C 1.487 -1.477 0 N-CA-C 101.001 -3.703 . . . . 0.0 101.001 178.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.1 m -56.88 155.16 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.057 0 CA-C-N 120.858 1.663 . . . . 0.0 113.437 -170.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.64 131.84 54.71 Favored 'General case' 0 CA--C 1.468 -2.205 1 N-CA-C 93.344 -6.539 . . . . 0.0 93.344 177.464 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 66.7 m80 -92.83 -156.65 0.49 Allowed 'General case' 0 CA--C 1.49 -1.362 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 -164.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 5.6 t -155.11 168.39 27.17 Favored 'General case' 0 N--CA 1.417 -2.111 1 N-CA-C 94.399 -6.149 . . . . 0.0 94.399 -173.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -122.81 121.45 27.38 Favored Pre-proline 0 N--CA 1.42 -1.935 1 N-CA-C 94.694 -6.039 . . . . 0.0 94.694 175.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -62.45 99.33 0.2 Allowed 'Trans proline' 0 CA--C 1.51 -0.686 0 CA-C-N 123.106 2.145 . . . . 0.0 116.709 -158.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 169.91 -175.6 43.95 Favored Glycine 0 N--CA 1.422 -2.245 1 N-CA-C 96.168 -6.773 . . . . 0.0 96.168 176.651 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -69.95 -39.03 76.27 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 119.433 1.617 . . . . 0.0 109.124 178.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -45.63 -49.02 14.69 Favored 'General case' 0 N--CA 1.437 -1.122 0 C-N-CA 130.746 3.619 . . . . 0.0 115.566 -171.401 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.5 -40.88 59.05 Favored Glycine 0 CA--C 1.49 -1.499 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -172.162 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 43.3 t -70.33 -48.1 58.04 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.265 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -52.99 -44.21 67.05 Favored 'General case' 0 C--N 1.354 0.797 0 C-N-CA 124.512 1.125 . . . . 0.0 111.487 -178.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 34.2 m -60.6 -53.84 52.63 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 123.524 0.73 . . . . 0.0 111.142 177.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 83.8 mt -71.86 -40.16 69.17 Favored 'General case' 0 CA--C 1.5 -0.971 0 CA-C-O 122.104 0.955 . . . . 0.0 110.19 -172.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 33.7 t -61.07 -44.28 97.62 Favored 'General case' 0 CA--C 1.5 -0.98 0 C-N-CA 124.932 1.293 . . . . 0.0 109.372 178.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm -68.01 -43.89 77.78 Favored 'General case' 0 CA--C 1.502 -0.892 0 O-C-N 121.986 -0.446 . . . . 0.0 110.1 -173.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -71.67 -13.0 61.61 Favored 'General case' 0 C--N 1.351 0.663 0 O-C-N 121.691 -0.63 . . . . 0.0 112.512 -175.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.4 mmtm -98.43 -2.81 38.18 Favored 'General case' 0 CA--C 1.504 -0.79 0 C-N-CA 123.23 0.612 . . . . 0.0 110.056 176.03 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.0 32.72 8.73 Favored Glycine 0 CA--C 1.491 -1.416 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 172.041 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -91.44 142.1 15.95 Favored Glycine 0 C--N 1.354 1.556 0 N-CA-C 106.642 -2.583 . . . . 0.0 106.642 171.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.1 m -98.35 -17.24 18.97 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 -163.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 59.5 m -159.93 167.5 27.87 Favored 'General case' 0 CA--C 1.482 -1.639 1 N-CA-C 99.226 -4.361 . . . . 0.0 99.226 171.263 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -171.34 174.77 44.99 Favored Glycine 0 CA--C 1.476 -2.365 1 N-CA-C 100.328 -5.109 . . . . 0.0 100.328 -179.219 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 11.3 p80 -158.5 159.49 35.68 Favored 'General case' 0 N--CA 1.426 -1.637 1 N-CA-C 98.452 -4.648 . . . . 0.0 98.452 176.048 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 42.3 t -87.03 159.04 19.1 Favored 'General case' 0 CA--C 1.501 -0.942 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 -173.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -174.68 -172.05 39.39 Favored Glycine 0 N--CA 1.423 -2.221 0 N-CA-C 103.861 -3.696 . . . . 0.0 103.861 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -130.08 148.97 51.98 Favored 'General case' 0 N--CA 1.426 -1.636 1 N-CA-C 97.202 -5.11 . . . . 0.0 97.202 -175.168 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.0 tptm -115.24 112.68 22.83 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 100.61 -3.848 . . . . 0.0 100.61 175.091 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.7 t -82.06 117.24 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 -173.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 119.79 -13.0 10.78 Favored Glycine 0 C--N 1.347 1.163 0 N-CA-C 107.856 -2.097 . . . . 0.0 107.856 -169.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 35.1 m80 -128.77 -78.83 0.56 Allowed 'General case' 0 CA--C 1.501 -0.929 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 175.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 168.11 -162.18 35.96 Favored Glycine 0 N--CA 1.427 -1.915 0 N-CA-C 103.808 -3.717 . . . . 0.0 103.808 -168.371 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 41.1 tp -63.17 131.08 47.28 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 127.448 2.299 . . . . 0.0 107.123 176.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -136.48 -171.72 2.97 Favored 'General case' 0 CA--C 1.492 -1.286 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 -165.193 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 4.2 t -139.19 156.73 46.9 Favored 'General case' 0 CA--C 1.488 -1.409 0 N-CA-C 100.594 -3.854 . . . . 0.0 100.594 173.035 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.423 ' HA ' ' HA ' ' A' ' 5' ' ' TYR . 15.6 t-105 -115.06 147.59 39.98 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 103.423 -2.806 . . . . 0.0 103.423 178.018 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 63.4 m -136.44 143.93 44.17 Favored 'General case' 0 CA--C 1.489 -1.384 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 172.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -113.64 131.05 56.28 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 102.309 -3.219 . . . . 0.0 102.309 177.218 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 57.86 71.26 0.59 Allowed 'General case' 0 CA--C 1.498 -1.046 0 C-N-CA 126.877 2.071 . . . . 0.0 110.946 178.154 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 15.9 mt -96.03 145.94 30.43 Favored Pre-proline 0 CA--C 1.499 -1.005 0 N-CA-C 102.78 -3.045 . . . . 0.0 102.78 164.329 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.06 166.7 28.33 Favored 'Trans proline' 0 N--CA 1.447 -1.236 0 C-N-CA 122.295 1.997 . . . . 0.0 109.527 172.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -77.86 -9.65 59.16 Favored 'General case' 0 CA--C 1.5 -0.973 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -163.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -85.65 7.33 23.77 Favored 'General case' 0 CA--C 1.506 -0.737 0 C-N-CA 123.996 0.918 . . . . 0.0 109.95 -179.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.0 t -104.35 113.46 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.636 0 N-CA-C 103.877 -2.638 . . . . 0.0 103.877 172.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -84.38 155.5 31.11 Favored Glycine 0 CA--C 1.493 -1.334 0 N-CA-C 104.604 -3.399 . . . . 0.0 104.604 169.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 15.1 pt -144.1 -134.59 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 N-CA-C 102.674 -3.084 . . . . 0.0 102.674 -166.721 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.472 ' CD1' ' HB2' ' A' ' 7' ' ' ALA . 3.2 mp -74.41 112.35 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 N-CA-C 102.39 -3.189 . . . . 0.0 102.39 168.138 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -130.44 138.71 53.13 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.694 0 N-CA-C 100.8 -3.778 . . . . 0.0 100.8 -158.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 67.85 -70.3 0.13 Allowed 'General case' 0 C--N 1.356 0.883 0 C-N-CA 126.679 1.992 . . . . 0.0 109.015 -165.163 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 152.52 -53.46 0.47 Allowed Glycine 0 CA--C 1.483 -1.913 0 N-CA-C 104.424 -3.471 . . . . 0.0 104.424 175.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 78.1 tt0 -31.2 -83.24 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.854 0 C-N-CA 129.604 3.161 . . . . 0.0 116.821 -164.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 42.6 tttm -169.26 -167.65 0.74 Allowed 'General case' 0 N--CA 1.426 -1.651 1 N-CA-C 98.056 -4.794 . . . . 0.0 98.056 -175.663 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 19.6 t -86.96 148.93 25.12 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 -171.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -135.38 -162.34 1.25 Allowed 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 -178.184 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 18.9 m -174.95 176.98 2.06 Favored 'General case' 0 N--CA 1.427 -1.62 1 N-CA-C 95.771 -5.64 . . . . 0.0 95.771 178.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.359 1.004 0 O-C-N 124.255 0.972 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 28.1 m . . . . . 0 N--CA 1.483 1.176 0 CA-C-O 120.977 0.418 . . . . 0.0 110.528 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -102.16 162.79 12.64 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 172.498 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -125.19 132.12 53.07 Favored 'General case' 0 CA--C 1.493 -1.217 1 N-CA-C 96.192 -5.484 . . . . 0.0 96.192 158.649 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.1 -170.13 26.43 Favored Glycine 0 CA--C 1.481 -2.055 0 N-CA-C 103.979 -3.648 . . . . 0.0 103.979 176.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -83.29 135.82 34.6 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 103.765 -2.679 . . . . 0.0 103.765 162.208 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.8 tt -91.47 147.52 5.21 Favored 'Isoleucine or valine' 0 C--O 1.244 0.814 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 175.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.454 ' HB2' HD12 ' A' ' 59' ' ' ILE . . . -149.3 -169.24 3.32 Favored 'General case' 0 N--CA 1.42 -1.952 0 N-CA-C 104.632 -2.358 . . . . 0.0 104.632 178.589 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -88.57 150.45 46.32 Favored Pre-proline 0 N--CA 1.432 -1.365 0 N-CA-C 104.624 -2.362 . . . . 0.0 104.624 169.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -70.57 32.47 0.22 Allowed 'Trans proline' 0 CA--C 1.517 -0.347 0 C-N-CA 123.911 3.074 . . . . 0.0 116.029 -174.245 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -109.54 11.05 25.02 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 106.957 -1.498 . . . . 0.0 106.957 -176.396 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 50.1 t30 67.66 53.65 0.7 Allowed 'General case' 0 CA--C 1.5 -0.949 0 C-N-CA 127.798 2.439 . . . . 0.0 108.285 -172.594 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -110.93 -154.72 0.55 Allowed 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -167.026 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.8 m -135.51 161.35 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.592 1 N-CA-C 98.021 -4.807 . . . . 0.0 98.021 163.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -113.64 130.79 56.34 Favored 'General case' 0 CA--C 1.479 -1.76 1 N-CA-C 96.683 -5.302 . . . . 0.0 96.683 173.918 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 27.7 m80 -82.98 141.88 31.78 Favored 'General case' 0 CA--C 1.493 -1.236 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 -173.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.402 ' H ' ' HG ' ' A' ' 45' ' ' LEU . 1.8 t -91.39 -179.18 5.32 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 -178.182 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -131.49 126.04 20.97 Favored Pre-proline 0 N--CA 1.412 -2.332 1 N-CA-C 97.073 -5.158 . . . . 0.0 97.073 -174.549 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_exo -62.96 67.97 0.14 Allowed 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.402 2.735 . . . . 0.0 112.029 164.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 171.96 77.21 0.05 OUTLIER Glycine 0 N--CA 1.423 -2.204 1 N-CA-C 95.346 -7.102 . . . . 0.0 95.346 -172.656 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.2 m -49.24 -38.1 25.51 Favored 'General case' 0 N--CA 1.438 -1.045 0 C-N-CA 128.532 2.733 . . . . 0.0 113.404 -159.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.5 m -61.05 -17.4 52.19 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 -177.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.8 -52.11 50.81 Favored Glycine 0 C--N 1.35 1.333 0 CA-C-N 119.982 1.265 . . . . 0.0 110.384 173.131 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -88.23 -20.99 24.77 Favored 'General case' 0 CA--C 1.496 -1.114 0 O-C-N 121.465 -1.021 . . . . 0.0 109.488 -175.58 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -64.28 -34.66 78.63 Favored 'General case' 0 C--N 1.355 0.818 0 O-C-N 121.232 -0.917 . . . . 0.0 109.515 170.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 33.4 m -64.88 -44.79 88.52 Favored 'General case' 0 C--N 1.354 0.771 0 O-C-N 120.8 -1.188 . . . . 0.0 109.862 172.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 84.1 mt -62.4 -43.33 99.08 Favored 'General case' 0 C--N 1.361 1.109 0 CA-C-O 121.732 0.777 . . . . 0.0 110.897 178.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 41.7 t -54.37 -48.86 71.03 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 125.132 1.373 . . . . 0.0 109.875 173.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.6 tptp -66.13 -40.55 90.74 Favored 'General case' 0 N--CA 1.441 -0.911 0 O-C-N 121.837 -0.539 . . . . 0.0 111.783 -174.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -76.94 -24.57 52.37 Favored 'General case' 0 C--N 1.354 0.773 0 O-C-N 121.772 -0.58 . . . . 0.0 112.455 -177.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -75.43 -39.16 59.24 Favored 'General case' 0 C--N 1.361 1.081 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 171.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 120.7 44.05 0.43 Allowed Glycine 0 CA--C 1.483 -1.963 0 N-CA-C 108.066 -2.014 . . . . 0.0 108.066 166.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -95.84 136.97 13.14 Favored Glycine 0 CA--C 1.486 -1.767 0 N-CA-C 103.159 -3.976 . . . . 0.0 103.159 167.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.0 m -102.38 2.87 37.24 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 -158.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.3 m -160.64 165.42 30.64 Favored 'General case' 0 CA--C 1.488 -1.441 1 N-CA-C 99.517 -4.253 . . . . 0.0 99.517 159.433 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -175.67 168.85 41.4 Favored Glycine 0 CA--C 1.48 -2.117 0 N-CA-C 103.513 -3.835 . . . . 0.0 103.513 -177.5 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -174.1 -178.86 1.55 Allowed 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 100.619 -3.845 . . . . 0.0 100.619 -176.22 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 74.4 m -87.47 163.44 16.7 Favored 'General case' 0 CA--C 1.495 -1.157 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -164.07 -177.71 37.03 Favored Glycine 0 N--CA 1.423 -2.209 1 N-CA-C 99.641 -5.384 . . . . 0.0 99.641 176.657 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -136.35 140.24 43.14 Favored 'General case' 0 N--CA 1.431 -1.403 1 N-CA-C 96.929 -5.211 . . . . 0.0 96.929 177.625 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.4 tmtt? -108.99 100.68 9.84 Favored 'General case' 0 CA--C 1.492 -1.265 0 N-CA-C 101.625 -3.472 . . . . 0.0 101.625 178.036 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.1 t -71.42 117.4 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 -178.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 135.46 -38.18 1.83 Allowed Glycine 0 CA--C 1.489 -1.571 0 N-CA-C 105.648 -2.981 . . . . 0.0 105.648 -167.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -121.07 -74.41 0.61 Allowed 'General case' 0 CA--C 1.498 -1.033 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 177.065 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 171.71 -158.82 30.0 Favored Glycine 0 N--CA 1.427 -1.918 0 N-CA-C 104.812 -3.315 . . . . 0.0 104.812 -169.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.402 ' HG ' ' H ' ' A' ' 16' ' ' CYS . 43.8 tp -67.19 129.84 41.19 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 126.67 1.988 . . . . 0.0 106.249 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -137.23 175.27 9.76 Favored 'General case' 0 CA--C 1.484 -1.581 0 N-CA-C 102.006 -3.331 . . . . 0.0 102.006 -167.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 64.0 m -117.95 160.65 21.1 Favored 'General case' 0 CA--C 1.476 -1.884 0 N-CA-C 102.582 -3.118 . . . . 0.0 102.582 174.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 30.7 t-105 -117.52 148.52 41.78 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 103.531 -2.766 . . . . 0.0 103.531 -176.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 67.9 m -142.09 148.2 38.0 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 104.602 -2.369 . . . . 0.0 104.602 172.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -112.77 140.28 47.69 Favored 'General case' 0 CA--C 1.492 -1.272 0 N-CA-C 101.499 -3.519 . . . . 0.0 101.499 168.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 66.66 66.12 0.45 Allowed 'General case' 0 CA--C 1.498 -1.035 0 C-N-CA 126.222 1.809 . . . . 0.0 110.691 169.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 14.4 mt -103.74 138.99 19.69 Favored Pre-proline 0 CA--C 1.498 -1.047 0 N-CA-C 104.609 -2.367 . . . . 0.0 104.609 172.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.9 170.05 20.64 Favored 'Trans proline' 0 N--CA 1.447 -1.241 0 C-N-CA 122.542 2.161 . . . . 0.0 110.751 177.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -76.96 -0.45 24.38 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -172.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -87.3 3.35 47.12 Favored 'General case' 0 CA--C 1.505 -0.781 0 O-C-N 121.455 -0.778 . . . . 0.0 110.253 177.217 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.0 t -103.83 148.08 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.278 0 N-CA-C 102.582 -3.118 . . . . 0.0 102.582 178.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -129.19 144.38 15.37 Favored Glycine 0 CA--C 1.476 -2.372 1 N-CA-C 97.034 -6.426 . . . . 0.0 97.034 174.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 27.4 pt -142.31 -141.7 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.32 0 N-CA-C 104.305 -2.479 . . . . 0.0 104.305 -154.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.454 HD12 ' HB2' ' A' ' 7' ' ' ALA . 1.7 mp -70.25 113.6 6.53 Favored 'Isoleucine or valine' 0 C--N 1.352 0.691 0 N-CA-C 104.548 -2.39 . . . . 0.0 104.548 168.087 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -111.76 -17.71 8.18 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.109 0 CA-C-O 122.655 1.217 . . . . 0.0 108.272 -160.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -170.68 -173.4 1.38 Allowed 'General case' 0 N--CA 1.424 -1.755 1 N-CA-C 96.192 -5.485 . . . . 0.0 96.192 171.433 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -129.14 73.01 0.47 Allowed Glycine 0 CA--C 1.482 -2.014 1 N-CA-C 101.568 -4.613 . . . . 0.0 101.568 170.621 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -105.49 -71.48 0.74 Allowed 'General case' 0 CA--C 1.492 -1.288 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 -174.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -165.1 177.67 7.56 Favored 'General case' 0 N--CA 1.426 -1.666 1 N-CA-C 96.575 -5.343 . . . . 0.0 96.575 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 35.9 t -112.49 149.7 32.27 Favored 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 102.433 -3.173 . . . . 0.0 102.433 176.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 14.7 p80 -113.42 62.45 0.65 Allowed 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 176.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.45 67.01 1.94 Allowed 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 126.219 1.808 . . . . 0.0 110.326 -178.569 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.365 1.262 0 CA-C-N 115.317 -0.856 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 29.8 m . . . . . 0 N--CA 1.484 1.252 0 CA-C-O 121.129 0.49 . . . . 0.0 110.079 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.5 171.97 7.97 Favored 'General case' 0 CA--C 1.493 -1.219 0 N-CA-C 101.116 -3.661 . . . . 0.0 101.116 161.282 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -129.35 135.25 48.49 Favored 'General case' 0 CA--C 1.485 -1.526 1 N-CA-C 94.007 -6.294 . . . . 0.0 94.007 169.747 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.81 -177.27 34.73 Favored Glycine 0 CA--C 1.473 -2.556 1 N-CA-C 102.957 -4.057 . . . . 0.0 102.957 -177.014 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -87.97 136.53 32.92 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 101.954 -3.35 . . . . 0.0 101.954 164.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 16.1 tt -90.62 144.26 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.366 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 -177.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -126.26 -148.42 0.39 Allowed 'General case' 0 N--CA 1.423 -1.779 0 C-N-CA 128.674 2.79 . . . . 0.0 106.68 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -133.22 148.78 70.48 Favored Pre-proline 0 N--CA 1.422 -1.857 1 N-CA-C 95.572 -5.714 . . . . 0.0 95.572 166.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -82.01 39.9 0.91 Allowed 'Trans proline' 0 CA--C 1.513 -0.543 0 C-N-CA 123.601 2.867 . . . . 0.0 112.151 -154.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -111.64 17.03 20.32 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 106.557 -1.646 . . . . 0.0 106.557 -178.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 49.9 t30 64.56 60.23 0.91 Allowed 'General case' 0 CA--C 1.497 -1.063 0 C-N-CA 128.265 2.626 . . . . 0.0 108.583 -172.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -117.9 -158.37 0.71 Allowed 'General case' 0 CA--C 1.493 -1.224 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -166.639 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.1 m -137.26 156.79 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.687 1 N-CA-C 96.103 -5.517 . . . . 0.0 96.103 167.058 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -93.73 121.04 34.76 Favored 'General case' 0 CA--C 1.486 -1.51 0 N-CA-C 100.529 -3.878 . . . . 0.0 100.529 170.121 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -74.88 107.74 7.16 Favored 'General case' 0 CA--C 1.492 -1.26 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 -168.247 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.3 t -83.65 150.14 26.08 Favored 'General case' 0 CA--C 1.485 -1.54 0 CA-C-N 114.399 -1.273 . . . . 0.0 107.68 -164.054 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -112.04 112.99 52.38 Favored Pre-proline 0 N--CA 1.428 -1.572 0 N-CA-C 102.046 -3.316 . . . . 0.0 102.046 178.223 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_exo -59.41 137.59 79.06 Favored 'Trans proline' 0 CA--C 1.503 -1.047 0 C-N-CA 122.625 2.216 . . . . 0.0 110.677 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 119.83 -54.95 0.63 Allowed Glycine 0 CA--C 1.488 -1.607 1 N-CA-C 101.617 -4.593 . . . . 0.0 101.617 -157.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.0 m 91.24 12.04 0.04 OUTLIER 'General case' 0 CA--C 1.496 -1.105 0 C-N-CA 127.518 2.327 . . . . 0.0 111.224 174.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.7 m -56.65 -53.88 52.6 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 124.473 1.109 . . . . 0.0 113.047 -172.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -74.8 -31.81 57.81 Favored Glycine 0 C--N 1.35 1.342 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.024 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.7 t -67.03 -51.68 51.79 Favored 'General case' 0 CA--C 1.488 -1.419 0 C-N-CA 124.174 0.99 . . . . 0.0 109.602 -174.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -65.44 -36.74 84.82 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -176.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.8 m -60.33 -50.5 73.38 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 121.52 -0.738 . . . . 0.0 111.137 173.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 32.3 mt -64.5 -42.0 96.09 Favored 'General case' 0 CA--C 1.498 -1.046 0 C-N-CA 123.9 0.88 . . . . 0.0 109.99 -179.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 19.5 t -55.91 -46.0 78.53 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 124.123 0.969 . . . . 0.0 110.82 176.288 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 37.5 mtmm -63.55 -46.67 84.89 Favored 'General case' 0 C--N 1.356 0.864 0 CA-C-N 118.213 0.461 . . . . 0.0 111.259 -177.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -73.13 -21.95 60.63 Favored 'General case' 0 C--N 1.351 0.636 0 O-C-N 121.666 -0.646 . . . . 0.0 112.267 -175.152 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 48.9 mmtm -86.14 -10.39 54.91 Favored 'General case' 0 C--N 1.355 0.844 0 O-C-N 121.855 -0.528 . . . . 0.0 110.907 174.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.57 28.85 7.72 Favored Glycine 0 CA--C 1.489 -1.535 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 168.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -94.83 146.46 18.18 Favored Glycine 0 CA--C 1.487 -1.68 0 N-CA-C 105.037 -3.225 . . . . 0.0 105.037 165.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.5 p -72.58 -43.33 63.52 Favored 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 124.483 1.113 . . . . 0.0 110.354 -166.085 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 34.9 m -160.63 -178.59 6.98 Favored 'General case' 0 N--CA 1.422 -1.863 1 N-CA-C 97.8 -4.889 . . . . 0.0 97.8 165.425 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -174.7 177.35 46.84 Favored Glycine 0 N--CA 1.417 -2.605 1 N-CA-C 98.947 -5.661 . . . . 0.0 98.947 -167.294 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 81.8 m-70 -164.52 171.28 14.77 Favored 'General case' 0 CA--C 1.492 -1.257 1 N-CA-C 98.621 -4.585 . . . . 0.0 98.621 -171.475 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 72.5 m -81.16 160.52 24.35 Favored 'General case' 0 CA--C 1.502 -0.881 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 165.291 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -167.34 171.77 42.1 Favored Glycine 0 CA--C 1.481 -2.084 1 N-CA-C 98.58 -5.808 . . . . 0.0 98.58 173.239 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -156.26 140.38 16.45 Favored 'General case' 0 N--CA 1.426 -1.628 1 N-CA-C 97.82 -4.882 . . . . 0.0 97.82 -176.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -155.42 47.96 0.52 Allowed 'General case' 0 CA--C 1.491 -1.298 1 N-CA-C 99.514 -4.254 . . . . 0.0 99.514 174.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.404 HG12 ' H ' ' A' ' 42' ' ' GLY 0.276 2.1 t 61.68 -147.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 N-CA-C 105.482 -2.044 . . . . 0.0 105.482 -152.271 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.404 ' H ' HG12 ' A' ' 41' ' ' VAL . . . 142.93 -88.11 0.18 Allowed Glycine 0 CA--C 1.48 -2.109 1 N-CA-C 100.853 -4.899 . . . . 0.0 100.853 -178.455 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 10.4 m-70 -150.26 -69.57 0.19 Allowed 'General case' 0 CA--C 1.493 -1.223 1 N-CA-C 98.215 -4.735 . . . . 0.0 98.215 168.179 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -115.01 -159.37 12.29 Favored Glycine 0 N--CA 1.437 -1.267 0 N-CA-C 103.304 -3.918 . . . . 0.0 103.304 168.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -83.18 110.98 18.51 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 -174.291 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -98.77 175.39 5.98 Favored 'General case' 0 CA--C 1.492 -1.28 0 C-N-CA 124.649 1.18 . . . . 0.0 108.182 -167.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 10.8 t -111.12 148.65 32.24 Favored 'General case' 0 CA--C 1.499 -1.018 0 N-CA-C 102.387 -3.19 . . . . 0.0 102.387 -174.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 70.0 t-105 -100.19 150.64 22.31 Favored 'General case' 0 CA--C 1.492 -1.286 0 N-CA-C 104.355 -2.461 . . . . 0.0 104.355 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 26.1 m -141.01 143.72 34.59 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 101.422 -3.547 . . . . 0.0 101.422 166.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -110.11 23.34 14.45 Favored 'General case' 0 CA--C 1.503 -0.862 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -167.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -177.29 156.44 1.23 Allowed 'General case' 0 N--CA 1.418 -2.037 1 N-CA-C 94.321 -6.177 . . . . 0.0 94.321 170.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 14.8 mt -159.41 154.22 21.15 Favored Pre-proline 0 CA--C 1.488 -1.437 1 N-CA-C 96.128 -5.508 . . . . 0.0 96.128 157.53 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.18 161.39 46.18 Favored 'Trans proline' 0 N--CA 1.446 -1.287 0 C-N-CA 122.006 1.804 . . . . 0.0 108.328 165.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -77.92 -6.52 54.6 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -165.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -86.91 -1.79 58.1 Favored 'General case' 0 CA--C 1.506 -0.73 0 O-C-N 121.439 -0.788 . . . . 0.0 109.629 -178.291 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.1 t -94.16 111.01 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.16 0 N-CA-C 104.287 -2.486 . . . . 0.0 104.287 177.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -84.98 143.65 20.59 Favored Glycine 0 CA--C 1.492 -1.382 0 N-CA-C 106.627 -2.589 . . . . 0.0 106.627 176.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 13.6 pt -125.34 -134.65 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.276 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 -162.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.1 mp -76.18 119.45 24.29 Favored 'Isoleucine or valine' 0 C--N 1.354 0.784 0 N-CA-C 102.884 -3.006 . . . . 0.0 102.884 165.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.9 t -104.76 -22.78 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.065 0 C-N-CA 124.954 1.302 . . . . 0.0 109.175 -163.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -171.39 163.58 6.93 Favored 'General case' 0 N--CA 1.431 -1.409 1 N-CA-C 99.188 -4.375 . . . . 0.0 99.188 173.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -92.94 65.17 2.0 Allowed Glycine 0 CA--C 1.496 -1.127 0 N-CA-C 105.52 -3.032 . . . . 0.0 105.52 171.134 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -104.91 -84.91 0.48 Allowed 'General case' 0 CA--C 1.496 -1.097 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 -172.062 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -166.98 164.19 16.05 Favored 'General case' 0 N--CA 1.424 -1.735 1 N-CA-C 98.2 -4.741 . . . . 0.0 98.2 -176.253 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 51.4 t -106.33 144.62 32.77 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 176.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 25.1 p-80 -102.53 74.33 1.37 Allowed 'General case' 0 CA--C 1.498 -1.036 0 N-CA-C 105.207 -2.146 . . . . 0.0 105.207 172.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.2 m -69.05 57.63 0.1 Allowed 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 127.077 2.151 . . . . 0.0 114.219 -173.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.358 0.962 0 CA-C-N 116.857 -0.156 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 34.1 m . . . . . 0 N--CA 1.485 1.284 0 CA-C-O 121.17 0.509 . . . . 0.0 109.903 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -106.11 157.95 17.18 Favored 'General case' 0 CA--C 1.499 -0.987 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 171.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -126.44 125.73 42.63 Favored 'General case' 0 CA--C 1.484 -1.589 1 N-CA-C 94.386 -6.153 . . . . 0.0 94.386 156.792 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.72 178.34 37.64 Favored Glycine 0 CA--C 1.475 -2.41 0 N-CA-C 107.601 -2.2 . . . . 0.0 107.601 -171.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -82.65 129.79 35.01 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 166.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.444 HG13 HG22 ' A' ' 58' ' ' ILE . 14.0 tt -91.05 144.18 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 -179.704 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.448 ' HB2' HD12 ' A' ' 59' ' ' ILE . . . -144.85 179.34 7.39 Favored 'General case' 0 N--CA 1.417 -2.078 1 N-CA-C 98.731 -4.544 . . . . 0.0 98.731 -177.405 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -79.64 156.2 75.55 Favored Pre-proline 0 N--CA 1.437 -1.12 0 CA-C-O 116.735 -1.603 . . . . 0.0 106.836 178.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -67.9 -18.82 46.85 Favored 'Trans proline' 0 CA--C 1.504 -0.999 0 CA-C-N 122.989 2.103 . . . . 0.0 116.709 -152.066 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -101.21 7.12 43.19 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -177.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 86.73 126.62 0.03 OUTLIER 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 128.822 2.849 . . . . 0.0 107.112 176.591 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 156.9 126.47 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.345 1 N-CA-C 99.16 -4.385 . . . . 0.0 99.16 172.294 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.0 m -63.36 156.46 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.23 0 CA-C-O 123.011 1.386 . . . . 0.0 112.705 -162.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -100.52 121.16 41.12 Favored 'General case' 0 N--CA 1.42 -1.947 1 N-CA-C 97.317 -5.068 . . . . 0.0 97.317 176.609 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 45.6 m80 -80.83 126.04 30.84 Favored 'General case' 0 CA--C 1.487 -1.472 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 -166.13 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 9.2 t -94.11 174.05 7.35 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 -176.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -146.31 156.71 49.88 Favored Pre-proline 0 N--CA 1.417 -2.093 1 N-CA-C 97.311 -5.07 . . . . 0.0 97.311 -177.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_exo -69.65 -14.94 37.18 Favored 'Trans proline' 0 CA--C 1.511 -0.653 0 CA-C-N 122.977 2.099 . . . . 0.0 111.715 175.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -113.18 81.84 0.3 Allowed Glycine 0 CA--C 1.486 -1.778 1 N-CA-C 101.162 -4.775 . . . . 0.0 101.162 169.771 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 m -82.09 29.07 0.42 Allowed 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 125.647 1.579 . . . . 0.0 113.1 -160.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.5 m -56.65 -50.98 70.47 Favored 'General case' 0 N--CA 1.435 -1.193 0 C-N-CA 126.879 2.072 . . . . 0.0 113.737 -161.437 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.03 -31.87 72.69 Favored Glycine 0 C--N 1.352 1.439 0 N-CA-C 111.374 -0.69 . . . . 0.0 111.374 -176.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.3 t -78.49 -31.8 47.91 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -174.279 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -62.08 -41.83 98.59 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 123.708 0.803 . . . . 0.0 110.436 174.259 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.02 -35.31 80.3 Favored 'General case' 0 C--N 1.352 0.707 0 O-C-N 121.048 -1.032 . . . . 0.0 112.196 174.568 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 92.0 mt -67.45 -41.76 84.21 Favored 'General case' 0 C--N 1.357 0.893 0 CA-C-O 121.938 0.875 . . . . 0.0 109.663 176.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 27.2 t -55.41 -47.57 75.71 Favored 'General case' 0 CA--C 1.507 -0.691 0 C-N-CA 125.027 1.331 . . . . 0.0 110.135 177.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -59.04 -50.79 72.73 Favored 'General case' 0 C--N 1.354 0.797 0 C-N-CA 122.827 0.451 . . . . 0.0 111.697 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -71.16 -23.11 62.0 Favored 'General case' 0 C--N 1.356 0.871 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -174.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.0 mmtp -81.92 -14.8 55.63 Favored 'General case' 0 C--N 1.355 0.805 0 C-N-CA 123.147 0.579 . . . . 0.0 110.713 175.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 110.26 24.39 5.7 Favored Glycine 0 CA--C 1.49 -1.472 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 167.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -97.11 122.31 7.38 Favored Glycine 0 C--N 1.353 1.484 0 N-CA-C 105.899 -2.88 . . . . 0.0 105.899 177.465 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.7 p -99.57 9.2 43.62 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 122.225 1.012 . . . . 0.0 109.162 -168.052 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 57.9 m -160.11 164.85 32.69 Favored 'General case' 0 CA--C 1.479 -1.786 1 N-CA-C 97.598 -4.964 . . . . 0.0 97.598 164.319 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.457 ' HA2' ' HA ' ' A' ' 49' ' ' CYS . . . -158.15 164.95 33.59 Favored Glycine 0 CA--C 1.465 -3.07 1 N-CA-C 99.605 -5.398 . . . . 0.0 99.605 -173.427 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -156.76 -159.18 0.84 Allowed 'General case' 0 N--CA 1.421 -1.88 1 N-CA-C 98.185 -4.746 . . . . 0.0 98.185 -177.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 34.0 t -148.13 166.43 27.88 Favored 'General case' 0 N--CA 1.424 -1.733 1 N-CA-C 97.798 -4.89 . . . . 0.0 97.798 -170.264 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -179.7 -161.83 27.67 Favored Glycine 0 N--CA 1.421 -2.306 1 N-CA-C 100.571 -5.012 . . . . 0.0 100.571 176.149 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -140.55 148.27 40.75 Favored 'General case' 0 N--CA 1.432 -1.358 1 N-CA-C 100.072 -4.047 . . . . 0.0 100.072 -178.035 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.9 mmpt? -123.74 103.06 8.16 Favored 'General case' 0 CA--C 1.491 -1.295 0 N-CA-C 104.027 -2.583 . . . . 0.0 104.027 173.092 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.7 t -74.06 118.71 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 136.65 -36.72 1.95 Allowed Glycine 0 CA--C 1.487 -1.712 0 N-CA-C 104.131 -3.587 . . . . 0.0 104.131 -165.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 39.1 m170 -125.56 -68.89 0.81 Allowed 'General case' 0 CA--C 1.499 -0.99 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 178.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 162.02 -150.58 20.07 Favored Glycine 0 N--CA 1.429 -1.774 0 N-CA-C 105.297 -3.121 . . . . 0.0 105.297 -175.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -70.78 127.72 33.61 Favored 'General case' 0 C--N 1.353 0.745 0 N-CA-C 103.66 -2.718 . . . . 0.0 103.66 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.67 155.77 49.89 Favored 'General case' 0 CA--C 1.479 -1.759 0 N-CA-C 101.235 -3.617 . . . . 0.0 101.235 -168.296 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 58.0 m -100.44 177.67 4.96 Favored 'General case' 0 CA--C 1.49 -1.334 0 N-CA-C 103.663 -2.717 . . . . 0.0 103.663 -176.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 3.8 t-105 -140.92 150.08 42.7 Favored 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 101.507 -3.516 . . . . 0.0 101.507 -177.085 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.457 ' HA ' ' HA2' ' A' ' 35' ' ' GLY . 56.1 m -142.85 154.4 44.12 Favored 'General case' 0 CA--C 1.493 -1.224 0 N-CA-C 104.667 -2.346 . . . . 0.0 104.667 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -123.34 135.47 54.19 Favored 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 175.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 77.7 41.89 0.13 Allowed 'General case' 0 CA--C 1.493 -1.215 0 C-N-CA 127.428 2.291 . . . . 0.0 110.612 169.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 49.2 mt -80.69 135.57 52.47 Favored Pre-proline 0 CA--C 1.502 -0.876 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 177.04 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -72.02 169.61 20.94 Favored 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 122.416 2.077 . . . . 0.0 109.513 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -76.44 -5.79 48.93 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -163.359 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -86.17 -7.7 58.37 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 123.432 0.693 . . . . 0.0 110.208 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.0 t -93.17 126.93 45.54 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.045 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 -176.207 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -97.29 150.89 19.65 Favored Glycine 0 CA--C 1.485 -1.842 0 N-CA-C 104.075 -3.61 . . . . 0.0 104.075 178.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.444 HG22 HG13 ' A' ' 6' ' ' ILE . 20.2 pt -148.25 -143.74 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 N-CA-C 102.032 -3.321 . . . . 0.0 102.032 -166.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.448 HD12 ' HB2' ' A' ' 7' ' ' ALA . 2.9 mp -71.8 119.78 18.89 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 104.881 -2.266 . . . . 0.0 104.881 168.559 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -152.46 159.78 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.658 0 N-CA-C 102.198 -3.26 . . . . 0.0 102.198 -156.088 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 80.39 -115.82 0.02 OUTLIER 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 103.093 -2.929 . . . . 0.0 103.093 -170.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -107.19 -60.16 0.57 Allowed Glycine 0 CA--C 1.486 -1.766 1 N-CA-C 101.271 -4.732 . . . . 0.0 101.271 161.323 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -156.67 159.3 38.27 Favored 'General case' 0 N--CA 1.419 -1.99 1 N-CA-C 95.278 -5.823 . . . . 0.0 95.278 161.007 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.1 tppt? -173.56 -177.2 1.4 Allowed 'General case' 0 N--CA 1.429 -1.524 1 N-CA-C 96.057 -5.534 . . . . 0.0 96.057 -177.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 2.3 t -147.49 145.97 29.34 Favored 'General case' 0 N--CA 1.424 -1.735 1 N-CA-C 95.586 -5.709 . . . . 0.0 95.586 163.25 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -163.43 173.62 12.94 Favored 'General case' 0 N--CA 1.426 -1.632 1 N-CA-C 98.405 -4.665 . . . . 0.0 98.405 165.033 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.6 m -174.87 172.61 2.89 Favored 'General case' 0 N--CA 1.425 -1.724 1 N-CA-C 96.052 -5.536 . . . . 0.0 96.052 -178.729 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.358 0.969 0 O-C-N 124.101 0.876 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 25.3 m . . . . . 0 N--CA 1.488 1.459 0 CA-C-O 121.107 0.479 . . . . 0.0 110.962 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.53 166.22 16.43 Favored 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 170.085 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -130.1 131.81 45.88 Favored 'General case' 0 CA--C 1.492 -1.276 1 N-CA-C 95.173 -5.862 . . . . 0.0 95.173 165.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.86 -173.34 30.4 Favored Glycine 0 CA--C 1.476 -2.372 0 N-CA-C 104.24 -3.544 . . . . 0.0 104.24 178.358 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -80.04 131.83 35.86 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 102.156 -3.275 . . . . 0.0 102.156 157.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.2 tt -90.72 145.79 6.99 Favored 'Isoleucine or valine' 0 C--O 1.243 0.756 0 N-CA-C 105.52 -2.03 . . . . 0.0 105.52 -177.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.678 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -126.28 -176.17 3.58 Favored 'General case' 0 N--CA 1.424 -1.742 0 C-N-CA 126.165 1.786 . . . . 0.0 106.748 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -82.95 145.31 49.43 Favored Pre-proline 0 N--CA 1.437 -1.119 0 N-CA-C 104.548 -2.389 . . . . 0.0 104.548 157.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_exo -67.28 -22.06 46.87 Favored 'Trans proline' 0 CA--C 1.502 -1.107 0 CA-C-N 122.827 2.045 . . . . 0.0 116.295 -149.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -84.67 38.7 0.71 Allowed 'General case' 0 N--CA 1.438 -1.035 0 C-N-CA 124.825 1.25 . . . . 0.0 110.784 -167.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 50.7 t30 63.85 48.46 3.17 Favored 'General case' 0 C--N 1.354 0.782 0 C-N-CA 127.812 2.445 . . . . 0.0 110.143 -178.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -104.15 -146.68 0.38 Allowed 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 -177.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.557 HG12 HD12 ' A' ' 59' ' ' ILE . 3.1 m -133.11 -166.01 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.338 1 N-CA-C 97.653 -4.943 . . . . 0.0 97.653 164.373 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -120.41 155.41 33.52 Favored 'General case' 0 CA--C 1.491 -1.315 1 N-CA-C 95.704 -5.665 . . . . 0.0 95.704 170.845 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 33.4 m80 -91.1 99.2 12.26 Favored 'General case' 0 CA--C 1.486 -1.481 0 N-CA-C 102.846 -3.02 . . . . 0.0 102.846 175.084 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 7.2 t -104.94 -176.02 2.96 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 104.273 -2.492 . . . . 0.0 104.273 174.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -137.85 164.55 40.23 Favored Pre-proline 0 N--CA 1.417 -2.084 1 N-CA-C 99.15 -4.389 . . . . 0.0 99.15 -158.266 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.25 55.87 3.65 Favored 'Trans proline' 0 C--N 1.322 -0.863 0 C-N-CA 123.263 2.642 . . . . 0.0 111.063 171.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -173.47 146.31 8.81 Favored Glycine 0 N--CA 1.421 -2.362 1 N-CA-C 99.577 -5.409 . . . . 0.0 99.577 175.526 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.4 m -93.35 8.77 39.13 Favored 'General case' 0 N--CA 1.438 -1.068 0 C-N-CA 123.92 0.888 . . . . 0.0 110.397 -174.145 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -50.38 -51.64 44.24 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 128.492 2.717 . . . . 0.0 114.131 -164.426 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -89.97 -22.01 37.29 Favored Glycine 0 C--N 1.351 1.365 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.9 t -81.28 -12.49 59.06 Favored 'General case' 0 C--N 1.355 0.835 0 O-C-N 121.046 -1.267 . . . . 0.0 109.592 -172.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -51.79 -55.21 21.16 Favored 'General case' 0 C--N 1.352 0.694 0 C-N-CA 124.584 1.154 . . . . 0.0 109.793 166.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.74 -44.98 96.01 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 123.965 0.906 . . . . 0.0 112.131 175.09 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.52 -39.02 93.01 Favored 'General case' 0 C--N 1.361 1.073 0 CA-C-N 118.977 0.808 . . . . 0.0 111.232 -177.315 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.6 t -68.05 -42.74 80.06 Favored 'General case' 0 N--CA 1.439 -0.987 0 O-C-N 121.301 -0.874 . . . . 0.0 109.51 -178.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -77.89 -26.41 49.13 Favored 'General case' 0 CA--C 1.505 -0.77 0 O-C-N 121.007 -1.058 . . . . 0.0 111.963 -174.103 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -76.66 -21.55 55.28 Favored 'General case' 0 C--N 1.355 0.815 0 O-C-N 121.243 -0.911 . . . . 0.0 110.988 179.088 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -79.93 -48.82 12.8 Favored 'General case' 0 CA--C 1.494 -1.174 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 168.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 120.83 48.36 0.3 Allowed Glycine 0 CA--C 1.489 -1.576 0 N-CA-C 108.214 -1.954 . . . . 0.0 108.214 177.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.07 139.29 14.73 Favored Glycine 0 N--CA 1.433 -1.531 0 N-CA-C 103.689 -3.764 . . . . 0.0 103.689 164.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -98.6 2.87 47.77 Favored 'General case' 0 N--CA 1.438 -1.05 0 C-N-CA 124.258 1.023 . . . . 0.0 109.607 -169.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 24.1 m -160.42 159.25 30.76 Favored 'General case' 0 CA--C 1.474 -1.954 0 N-CA-C 100.529 -3.878 . . . . 0.0 100.529 165.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.4 ' HA2' ' HA ' ' A' ' 49' ' ' CYS . . . -165.82 169.79 40.31 Favored Glycine 0 N--CA 1.418 -2.555 1 N-CA-C 101.407 -4.677 . . . . 0.0 101.407 -179.146 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 35.1 m80 -161.4 -170.16 2.54 Favored 'General case' 0 CA--C 1.491 -1.295 1 N-CA-C 98.558 -4.608 . . . . 0.0 98.558 -174.098 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 73.1 m -145.87 162.57 37.42 Favored 'General case' 0 CA--C 1.485 -1.553 1 N-CA-C 98.852 -4.499 . . . . 0.0 98.852 172.17 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 173.29 179.97 44.31 Favored Glycine 0 N--CA 1.425 -2.049 1 N-CA-C 100.072 -5.211 . . . . 0.0 100.072 -177.099 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -151.1 141.91 22.84 Favored 'General case' 0 N--CA 1.426 -1.674 1 N-CA-C 96.407 -5.405 . . . . 0.0 96.407 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.9 mttp -157.74 58.22 0.49 Allowed 'General case' 0 CA--C 1.488 -1.434 1 N-CA-C 98.303 -4.703 . . . . 0.0 98.303 173.559 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.732 HG12 ' H ' ' A' ' 42' ' ' GLY 0.272 2.9 t 69.77 -172.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 C-N-CA 127.054 2.142 . . . . 0.0 105.543 -158.264 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.732 ' H ' HG12 ' A' ' 41' ' ' VAL . . . 145.04 -127.96 3.03 Favored Glycine 0 N--CA 1.421 -2.338 1 N-CA-C 97.716 -6.153 . . . . 0.0 97.716 -173.031 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 59.3 m170 -130.37 -39.16 1.33 Allowed 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 104.515 -2.402 . . . . 0.0 104.515 175.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -158.09 -177.0 30.78 Favored Glycine 0 N--CA 1.425 -2.051 1 N-CA-C 95.798 -6.921 . . . . 0.0 95.798 176.727 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.2 tt -72.25 114.94 10.91 Favored 'General case' 0 C--N 1.351 0.666 0 CA-C-N 118.693 1.247 . . . . 0.0 108.177 -171.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -105.85 -177.81 3.47 Favored 'General case' 0 CA--C 1.485 -1.529 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 -164.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 34.6 t -115.0 161.56 18.17 Favored 'General case' 0 CA--C 1.493 -1.236 0 N-CA-C 102.432 -3.173 . . . . 0.0 102.432 -175.445 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 33.0 t-105 -117.57 151.75 36.52 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 102.878 -3.008 . . . . 0.0 102.878 178.529 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.4 ' HA ' ' HA2' ' A' ' 35' ' ' GLY . 15.0 m -148.21 149.79 32.58 Favored 'General case' 0 CA--C 1.495 -1.157 0 N-CA-C 103.428 -2.805 . . . . 0.0 103.428 171.564 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -111.3 141.99 44.11 Favored 'General case' 0 CA--C 1.495 -1.15 0 N-CA-C 104.212 -2.514 . . . . 0.0 104.212 171.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 66.01 53.28 1.11 Allowed 'General case' 0 CA--C 1.491 -1.298 0 C-N-CA 127.488 2.315 . . . . 0.0 111.164 167.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 40.0 mt -94.81 142.93 25.35 Favored Pre-proline 0 CA--C 1.495 -1.147 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 177.376 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -72.01 166.74 28.7 Favored 'Trans proline' 0 N--CA 1.447 -1.258 0 C-N-CA 122.61 2.206 . . . . 0.0 110.134 175.148 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -68.99 -17.07 63.88 Favored 'General case' 0 CA--C 1.506 -0.728 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -167.321 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -76.48 -6.82 53.45 Favored 'General case' 0 CA--C 1.504 -0.81 0 O-C-N 121.439 -0.788 . . . . 0.0 110.942 -178.258 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.3 t -94.09 107.96 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 N-CA-C 104.474 -2.417 . . . . 0.0 104.474 178.107 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -81.63 148.39 27.6 Favored Glycine 0 CA--C 1.489 -1.549 0 N-CA-C 106.393 -2.683 . . . . 0.0 106.393 178.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 41.0 pt -133.66 -160.05 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.303 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 -165.008 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.678 HD13 ' HB2' ' A' ' 7' ' ' ALA . 0.3 OUTLIER -73.7 121.15 24.07 Favored 'Isoleucine or valine' 0 C--N 1.362 1.146 0 N-CA-C 104.829 -2.286 . . . . 0.0 104.829 176.042 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.4 t -133.06 34.35 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 N-CA-C 101.899 -3.371 . . . . 0.0 101.899 -162.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -72.16 94.28 1.52 Allowed 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 112.782 -2.008 . . . . 0.0 112.875 -169.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -143.42 31.68 1.91 Allowed Glycine 0 N--CA 1.437 -1.234 1 N-CA-C 101.8 -4.52 . . . . 0.0 101.8 155.116 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 178.48 -178.86 0.29 Allowed 'General case' 0 N--CA 1.432 -1.33 1 N-CA-C 95.093 -5.891 . . . . 0.0 95.093 -170.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 54.5 tttt -127.09 -154.64 0.64 Allowed 'General case' 0 CA--C 1.502 -0.881 0 N-CA-C 105.013 -2.217 . . . . 0.0 105.013 177.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 16.1 t -81.69 152.52 27.03 Favored 'General case' 0 CA--C 1.496 -1.129 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 -169.063 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 28.0 p-80 -131.05 169.14 16.27 Favored 'General case' 0 CA--C 1.487 -1.451 0 N-CA-C 100.822 -3.77 . . . . 0.0 100.822 174.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.6 m -171.29 174.06 4.68 Favored 'General case' 0 N--CA 1.424 -1.767 1 N-CA-C 96.096 -5.52 . . . . 0.0 96.096 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.357 0.921 0 O-C-N 124.301 1.0 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 33.5 m . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 121.354 0.597 . . . . 0.0 109.629 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -94.24 148.46 22.17 Favored 'General case' 0 CA--C 1.502 -0.879 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 173.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -122.37 118.19 27.84 Favored 'General case' 0 CA--C 1.489 -1.399 1 N-CA-C 94.394 -6.15 . . . . 0.0 94.394 154.23 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.61 -174.13 31.1 Favored Glycine 0 CA--C 1.479 -2.214 0 N-CA-C 106.196 -2.762 . . . . 0.0 106.196 -171.092 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 48' ' ' TRP . 92.3 m-85 -86.22 134.96 33.74 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 104.872 -2.27 . . . . 0.0 104.872 167.121 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 16.9 tt -90.63 151.23 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 176.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.513 ' HB2' ' CD1' ' A' ' 59' ' ' ILE . . . -156.3 -177.81 6.86 Favored 'General case' 0 N--CA 1.416 -2.144 1 N-CA-C 98.949 -4.463 . . . . 0.0 98.949 -177.142 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -93.53 156.91 39.31 Favored Pre-proline 0 N--CA 1.435 -1.186 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 178.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -77.36 -1.96 12.14 Favored 'Trans proline' 0 CA--C 1.509 -0.745 0 CA-C-N 121.283 1.494 . . . . 0.0 115.254 -155.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -95.13 13.41 25.39 Favored 'General case' 0 C--N 1.358 0.96 0 CA-C-N 121.214 1.825 . . . . 0.0 107.498 176.557 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 43.4 t30 83.23 43.44 0.02 OUTLIER 'General case' 0 C--N 1.361 1.102 0 C-N-CA 126.081 1.752 . . . . 0.0 107.494 168.26 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.44 ' O ' ' HB1' ' A' ' 7' ' ' ALA . 0.7 OUTLIER -131.36 132.18 44.25 Favored 'General case' 0 CA--C 1.487 -1.462 0 N-CA-C 102.374 -3.195 . . . . 0.0 102.374 -173.148 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.481 HG12 HD11 ' A' ' 59' ' ' ILE 0.253 1.7 m -60.57 159.25 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 CA-C-O 123.435 1.588 . . . . 0.0 115.228 -173.411 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -114.73 139.97 49.26 Favored 'General case' 0 N--CA 1.416 -2.157 1 N-CA-C 92.687 -6.783 . . . . 0.0 92.687 169.554 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -90.42 -162.28 0.88 Allowed 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 178.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 25.4 t -150.06 171.62 16.57 Favored 'General case' 0 N--CA 1.417 -2.121 1 N-CA-C 97.52 -4.993 . . . . 0.0 97.52 -172.244 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -127.28 123.68 23.42 Favored Pre-proline 0 N--CA 1.419 -2.018 1 N-CA-C 95.925 -5.583 . . . . 0.0 95.925 -178.125 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -55.88 96.6 0.06 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.604 0 CA-C-N 124.224 2.544 . . . . 0.0 116.691 -168.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 159.92 -159.36 30.61 Favored Glycine 0 N--CA 1.422 -2.267 1 N-CA-C 98.07 -6.012 . . . . 0.0 98.07 -178.166 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.8 p -94.25 -43.67 8.33 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 170.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -39.74 -61.95 0.77 Allowed 'General case' 0 N--CA 1.442 -0.875 0 C-N-CA 128.812 2.845 . . . . 0.0 118.243 -150.287 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -72.09 -39.5 58.28 Favored Glycine 0 C--N 1.348 1.227 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -173.301 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 9.6 t -83.65 -28.45 28.39 Favored 'General case' 0 CA--C 1.5 -0.962 0 O-C-N 121.277 -1.131 . . . . 0.0 109.329 -177.016 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -60.81 -46.52 90.2 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-N 119.353 0.979 . . . . 0.0 109.679 175.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.9 p -67.06 -39.15 86.83 Favored 'General case' 0 N--CA 1.44 -0.941 0 O-C-N 121.894 -0.504 . . . . 0.0 111.721 179.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 40.7 mt -63.22 -47.61 81.77 Favored 'General case' 0 C--N 1.357 0.899 0 O-C-N 121.032 -1.043 . . . . 0.0 111.127 172.125 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 3.0 t -66.01 -32.33 73.75 Favored 'General case' 0 CA--C 1.501 -0.911 0 O-C-N 120.155 -1.59 . . . . 0.0 110.827 -175.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -65.41 -35.26 80.41 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 122.943 0.497 . . . . 0.0 111.488 176.039 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -75.93 -34.18 59.87 Favored 'General case' 0 C--N 1.359 0.999 0 O-C-N 121.559 -0.713 . . . . 0.0 111.108 177.148 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.2 mmmp? -72.15 -40.23 68.17 Favored 'General case' 0 C--N 1.36 1.026 0 C-N-CA 123.535 0.734 . . . . 0.0 110.519 178.127 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 128.41 43.57 0.23 Allowed Glycine 0 CA--C 1.492 -1.368 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 162.286 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -111.12 145.32 17.55 Favored Glycine 0 CA--C 1.491 -1.415 0 N-CA-C 105.512 -3.035 . . . . 0.0 105.512 169.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.4 p -92.23 4.61 52.89 Favored 'General case' 0 C--N 1.352 0.676 0 CA-C-N 118.053 0.926 . . . . 0.0 110.154 -171.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 57.4 m -157.13 156.66 33.09 Favored 'General case' 0 CA--C 1.483 -1.603 0 N-CA-C 100.981 -3.711 . . . . 0.0 100.981 168.063 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -152.98 141.17 8.16 Favored Glycine 0 N--CA 1.422 -2.278 1 N-CA-C 97.782 -6.127 . . . . 0.0 97.782 -178.581 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 15.1 t-80 -159.94 175.6 12.84 Favored 'General case' 0 N--CA 1.429 -1.495 1 N-CA-C 99.692 -4.188 . . . . 0.0 99.692 -169.263 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 63.2 m -95.22 -174.93 3.36 Favored 'General case' 0 CA--C 1.491 -1.296 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 176.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 177.13 -166.56 37.25 Favored Glycine 0 N--CA 1.417 -2.604 1 N-CA-C 96.196 -6.762 . . . . 0.0 96.196 179.282 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -144.51 138.82 27.84 Favored 'General case' 0 N--CA 1.43 -1.437 1 N-CA-C 96.098 -5.519 . . . . 0.0 96.098 173.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 26.2 tptp -120.69 100.14 6.94 Favored 'General case' 0 CA--C 1.487 -1.471 0 N-CA-C 102.358 -3.201 . . . . 0.0 102.358 -179.188 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.5 t -68.45 134.1 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 -175.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 115.67 -36.83 3.69 Favored Glycine 0 CA--C 1.492 -1.387 0 N-CA-C 105.951 -2.86 . . . . 0.0 105.951 -171.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 57.9 m-70 -106.19 -66.85 0.97 Allowed 'General case' 0 CA--C 1.494 -1.177 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 174.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 150.1 -143.26 10.51 Favored Glycine 0 CA--C 1.481 -2.054 0 N-CA-C 103.826 -3.71 . . . . 0.0 103.826 -174.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.9 tp -65.58 135.98 55.78 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 105.124 -2.176 . . . . 0.0 105.124 172.515 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -155.04 172.6 17.85 Favored 'General case' 0 CA--C 1.475 -1.917 1 N-CA-C 97.98 -4.822 . . . . 0.0 97.98 -168.635 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 9.1 t -118.34 159.78 22.8 Favored 'General case' 0 CA--C 1.487 -1.444 0 N-CA-C 103.089 -2.93 . . . . 0.0 103.089 -173.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.407 ' HA ' ' HA ' ' A' ' 5' ' ' TYR . 19.0 t-105 -118.83 146.18 45.06 Favored 'General case' 0 CA--C 1.496 -1.116 0 N-CA-C 103.288 -2.856 . . . . 0.0 103.288 -176.544 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 79.5 m -146.26 157.78 43.83 Favored 'General case' 0 CA--C 1.487 -1.457 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 173.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -118.06 138.88 51.93 Favored 'General case' 0 CA--C 1.495 -1.15 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 176.255 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 64.62 61.89 0.81 Allowed 'General case' 0 CA--C 1.494 -1.191 0 C-N-CA 128.102 2.561 . . . . 0.0 111.646 173.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 28.6 mt -96.04 133.45 25.2 Favored Pre-proline 0 CA--C 1.502 -0.882 0 N-CA-C 104.015 -2.587 . . . . 0.0 104.015 172.007 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -75.32 173.97 13.6 Favored 'Trans proline' 0 N--CA 1.447 -1.247 0 CA-C-N 122.057 1.771 . . . . 0.0 109.768 -178.447 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -74.3 -5.53 42.69 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -169.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -90.61 -0.93 57.86 Favored 'General case' 0 CA--C 1.502 -0.872 0 O-C-N 121.239 -0.913 . . . . 0.0 110.015 -178.315 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.5 t -97.88 152.01 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 N-CA-C 102.677 -3.083 . . . . 0.0 102.677 178.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -123.01 153.28 16.96 Favored Glycine 0 CA--C 1.481 -2.045 1 N-CA-C 98.767 -5.733 . . . . 0.0 98.767 177.153 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 19.5 pt -152.82 -154.63 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 N-CA-C 101.258 -3.608 . . . . 0.0 101.258 -163.083 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.513 ' CD1' ' HB2' ' A' ' 7' ' ' ALA . 4.5 mp -73.76 119.28 20.61 Favored 'Isoleucine or valine' 0 C--N 1.362 1.11 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 169.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -149.77 -175.42 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.537 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 -157.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 75.92 -56.54 0.59 Allowed 'General case' 0 CA--C 1.503 -0.852 0 C-N-CA 127.437 2.295 . . . . 0.0 112.702 167.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 108.87 -10.56 34.66 Favored Glycine 0 CA--C 1.492 -1.35 0 N-CA-C 107.309 -2.316 . . . . 0.0 107.309 -175.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -105.36 -165.32 1.11 Allowed 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 103.634 -2.728 . . . . 0.0 103.634 168.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 31.2 tttp -109.97 -149.9 0.45 Allowed 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 -170.441 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 29.5 t -81.26 153.73 26.97 Favored 'General case' 0 CA--C 1.496 -1.13 0 C-N-CA 124.951 1.301 . . . . 0.0 108.795 -168.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -138.41 179.81 6.24 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 101.961 -3.348 . . . . 0.0 101.961 176.26 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.4 m -171.99 172.71 4.63 Favored 'General case' 0 N--CA 1.425 -1.72 1 N-CA-C 95.8 -5.63 . . . . 0.0 95.8 179.034 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.358 0.969 0 O-C-N 124.202 0.939 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 27.3 m . . . . . 0 N--CA 1.485 1.29 0 CA-C-O 121.413 0.625 . . . . 0.0 110.646 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -99.25 155.62 17.4 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 105.318 -2.105 . . . . 0.0 105.318 166.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -122.16 126.32 48.06 Favored 'General case' 0 CA--C 1.486 -1.488 1 N-CA-C 94.331 -6.174 . . . . 0.0 94.331 153.19 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.55 179.91 36.65 Favored Glycine 0 CA--C 1.475 -2.466 0 N-CA-C 104.345 -3.502 . . . . 0.0 104.345 -174.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -79.89 134.05 36.28 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 104.461 -2.422 . . . . 0.0 104.461 168.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 16.4 tt -90.36 149.4 4.06 Favored 'Isoleucine or valine' 0 C--N 1.355 0.808 0 N-CA-C 105.62 -1.992 . . . . 0.0 105.62 -178.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.764 ' HB2' HD12 ' A' ' 59' ' ' ILE . . . -139.96 -173.07 3.54 Favored 'General case' 0 N--CA 1.417 -2.113 0 C-N-CA 126.255 1.822 . . . . 0.0 106.898 -170.577 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -95.18 148.33 34.48 Favored Pre-proline 0 N--CA 1.432 -1.36 0 N-CA-C 102.085 -3.302 . . . . 0.0 102.085 163.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_exo -69.62 -26.86 27.8 Favored 'Trans proline' 0 CA--C 1.501 -1.144 0 CA-C-N 123.034 2.119 . . . . 0.0 115.52 -153.069 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -88.76 53.78 2.81 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-N 119.224 0.92 . . . . 0.0 110.483 -167.363 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.463 HD21 ' HB3' ' A' ' 61' ' ' GLU . 4.2 t-20 75.32 41.34 0.29 Allowed 'General case' 0 C--N 1.354 0.786 0 C-N-CA 125.793 1.637 . . . . 0.0 110.121 167.095 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 55.6 m -117.05 -154.86 0.57 Allowed 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -168.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.807 HG12 HD11 ' A' ' 59' ' ' ILE . 1.6 m -133.01 175.57 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.4 1 N-CA-C 98.433 -4.655 . . . . 0.0 98.433 166.66 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . 0.31 0.2 OUTLIER -119.62 141.14 49.57 Favored 'General case' 0 CA--C 1.477 -1.861 1 N-CA-C 92.684 -6.784 . . . . 0.0 92.684 170.045 . . . . . . . . 4 3 . 1 . 017 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 -90.46 145.66 24.74 Favored 'General case' 0 CA--C 1.491 -1.306 0 N-CA-C 103.558 -2.756 . . . . 0.0 103.558 174.135 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.7 t -90.48 167.71 12.39 Favored 'General case' 0 CA--C 1.483 -1.606 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 -176.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -114.38 113.44 45.75 Favored Pre-proline 0 N--CA 1.42 -1.952 1 N-CA-C 98.424 -4.658 . . . . 0.0 98.424 168.427 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -57.59 129.59 34.53 Favored 'Trans proline' 0 CA--C 1.507 -0.87 0 CA-C-N 123.154 2.162 . . . . 0.0 111.351 178.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 126.61 -56.98 0.71 Allowed Glycine 0 CA--C 1.49 -1.5 1 N-CA-C 101.853 -4.499 . . . . 0.0 101.853 -157.62 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.5 m 107.3 -6.1 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.321 0 C-N-CA 129.25 3.02 . . . . 0.0 110.932 174.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.1 m -42.42 -55.36 3.45 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 127.625 2.37 . . . . 0.0 115.275 -166.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -72.26 -45.86 37.2 Favored Glycine 0 C--N 1.351 1.378 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 -176.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.9 m -72.89 -32.59 65.48 Favored 'General case' 0 CA--C 1.492 -1.269 0 O-C-N 121.474 -1.015 . . . . 0.0 112.003 -174.203 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -65.78 -38.32 88.7 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 174.113 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 32.2 m -65.29 -43.35 91.42 Favored 'General case' 0 C--N 1.35 0.603 0 O-C-N 120.733 -1.23 . . . . 0.0 110.144 176.101 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 33.9 mt -63.69 -40.39 96.69 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-O 122.17 0.986 . . . . 0.0 110.474 178.447 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.4 t -57.14 -43.8 82.77 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 124.6 1.16 . . . . 0.0 110.79 175.275 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -64.03 -43.61 95.05 Favored 'General case' 0 C--N 1.355 0.84 0 CA-C-N 118.494 0.588 . . . . 0.0 111.633 -178.318 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -79.04 -30.63 44.23 Favored 'General case' 0 CA--C 1.507 -0.674 0 O-C-N 122.039 -0.413 . . . . 0.0 111.27 -172.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -83.77 -22.11 31.99 Favored 'General case' 0 C--N 1.355 0.843 0 O-C-N 121.774 -0.579 . . . . 0.0 109.847 177.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 108.65 48.27 0.86 Allowed Glycine 0 CA--C 1.491 -1.439 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 159.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.23 154.27 16.9 Favored Glycine 0 C--N 1.35 1.326 0 N-CA-C 106.582 -2.607 . . . . 0.0 106.582 170.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 39.3 p -90.81 -20.53 22.23 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-O 122.341 1.067 . . . . 0.0 109.927 -165.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.9 m -160.22 159.75 31.9 Favored 'General case' 0 N--CA 1.423 -1.818 1 N-CA-C 98.122 -4.77 . . . . 0.0 98.122 179.237 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -178.6 172.52 44.87 Favored Glycine 0 CA--C 1.467 -2.944 1 N-CA-C 100.039 -5.224 . . . . 0.0 100.039 -179.347 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 177.95 -160.07 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 100.262 -3.977 . . . . 0.0 100.262 -174.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 61.6 m -76.77 177.49 7.56 Favored 'General case' 0 CA--C 1.504 -0.821 0 CA-C-O 121.898 0.856 . . . . 0.0 110.704 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -164.05 -179.11 38.1 Favored Glycine 0 N--CA 1.42 -2.426 1 N-CA-C 98.663 -5.775 . . . . 0.0 98.663 178.463 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -143.7 159.99 41.5 Favored 'General case' 0 N--CA 1.422 -1.833 1 N-CA-C 97.623 -4.955 . . . . 0.0 97.623 -177.59 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.1 mmmm -148.95 167.08 26.72 Favored 'General case' 0 N--CA 1.421 -1.886 1 N-CA-C 95.995 -5.557 . . . . 0.0 95.995 169.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -133.43 156.77 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.685 1 N-CA-C 94.391 -6.151 . . . . 0.0 94.391 173.228 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.89 -60.53 0.73 Allowed Glycine 0 CA--C 1.492 -1.394 0 N-CA-C 104.771 -3.331 . . . . 0.0 104.771 -170.172 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 23.4 m170 -90.24 -90.61 0.15 Allowed 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 166.51 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 163.86 -156.61 28.54 Favored Glycine 0 CA--C 1.479 -2.194 1 N-CA-C 99.399 -5.48 . . . . 0.0 99.399 179.033 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 54.0 tp -43.52 126.73 4.53 Favored 'General case' 0 C--N 1.352 0.712 0 C-N-CA 128.001 2.521 . . . . 0.0 111.646 -179.49 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -127.67 -171.19 2.38 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 105.416 -2.068 . . . . 0.0 105.416 -168.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 63.7 m -131.23 176.21 8.47 Favored 'General case' 0 CA--C 1.482 -1.641 0 N-CA-C 102.746 -3.057 . . . . 0.0 102.746 171.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 12.5 t-105 -137.58 154.03 49.85 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 -177.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 22.6 m -145.59 152.84 40.34 Favored 'General case' 0 CA--C 1.493 -1.25 0 N-CA-C 104.269 -2.493 . . . . 0.0 104.269 171.198 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -109.53 143.54 39.05 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 104.31 -2.478 . . . . 0.0 104.31 168.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 55.9 62.48 2.37 Favored 'General case' 0 CA--C 1.499 -1.017 0 C-N-CA 127.871 2.469 . . . . 0.0 113.128 173.062 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 33.5 mt -95.61 134.74 23.77 Favored Pre-proline 0 CA--C 1.498 -1.021 0 N-CA-C 103.614 -2.735 . . . . 0.0 103.614 171.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -71.53 176.54 7.93 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 CA-C-N 122.375 1.884 . . . . 0.0 111.72 178.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -75.02 -8.76 57.45 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 113.65 0.982 . . . . 0.0 113.65 -167.375 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.8 p-10 -85.99 -8.24 58.1 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 121.605 -0.684 . . . . 0.0 110.069 -179.272 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.0 t -92.9 127.78 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 -175.02 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -97.32 140.69 15.19 Favored Glycine 0 CA--C 1.484 -1.898 0 N-CA-C 104.424 -3.47 . . . . 0.0 104.424 177.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 24.4 pt -139.09 -151.8 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 N-CA-C 104.157 -2.535 . . . . 0.0 104.157 -165.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.807 HD11 HG12 ' A' ' 13' ' ' VAL . 1.8 mp -66.41 118.77 10.27 Favored 'Isoleucine or valine' 0 C--N 1.364 1.209 0 N-CA-C 103.501 -2.778 . . . . 0.0 103.501 168.107 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.4 t -137.86 148.63 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.843 1 N-CA-C 96.95 -5.204 . . . . 0.0 96.95 -168.285 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.463 ' HB3' HD21 ' A' ' 11' ' ' ASN . 13.7 tp10 60.37 -64.42 0.06 Allowed 'General case' 0 CA--C 1.504 -0.791 0 C-N-CA 130.169 3.388 . . . . 0.0 115.321 173.771 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.77 58.88 1.56 Allowed Glycine 0 N--CA 1.437 -1.239 0 N-CA-C 104.924 -3.27 . . . . 0.0 104.924 -160.027 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -102.82 -90.09 0.37 Allowed 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 103.575 -2.75 . . . . 0.0 103.575 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 53.2 tptt -173.76 160.97 3.77 Favored 'General case' 0 N--CA 1.423 -1.801 1 N-CA-C 96.996 -5.187 . . . . 0.0 96.996 176.398 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 41.4 t -83.21 135.61 34.72 Favored 'General case' 0 CA--C 1.5 -0.955 0 N-CA-C 103.501 -2.777 . . . . 0.0 103.501 178.44 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 46.6 p-80 -149.59 159.82 44.0 Favored 'General case' 0 CA--C 1.484 -1.59 0 N-CA-C 102.812 -3.033 . . . . 0.0 102.812 -170.015 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.0 m -80.4 56.72 2.62 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 118.665 0.666 . . . . 0.0 111.258 -177.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.361 1.079 0 CA-C-N 116.223 -0.444 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 27.4 m . . . . . 0 N--CA 1.484 1.265 0 CA-C-O 121.174 0.512 . . . . 0.0 110.26 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -105.03 160.34 15.12 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 106.109 -1.811 . . . . 0.0 106.109 168.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -127.69 126.62 42.24 Favored 'General case' 0 CA--C 1.49 -1.357 1 N-CA-C 96.636 -5.32 . . . . 0.0 96.636 158.834 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.04 -170.83 27.35 Favored Glycine 0 CA--C 1.477 -2.328 1 N-CA-C 102.084 -4.407 . . . . 0.0 102.084 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -81.08 141.68 34.07 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 103.611 -2.737 . . . . 0.0 103.611 164.015 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 11.5 tt -90.4 142.14 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 N-CA-C 104.903 -2.258 . . . . 0.0 104.903 175.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.944 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -130.52 175.65 8.81 Favored 'General case' 0 N--CA 1.414 -2.233 0 N-CA-C 103.919 -2.622 . . . . 0.0 103.919 -175.012 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -79.6 154.21 76.11 Favored Pre-proline 0 N--CA 1.432 -1.34 0 N-CA-C 105.032 -2.21 . . . . 0.0 105.032 166.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -68.96 0.34 5.18 Favored 'Trans proline' 0 CA--C 1.511 -0.627 0 C-N-CA 121.94 1.76 . . . . 0.0 116.609 -168.05 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -102.28 9.56 39.85 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 119.773 1.169 . . . . 0.0 108.525 -175.277 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 66.3 t30 73.34 57.54 0.11 Allowed 'General case' 0 CA--C 1.497 -1.096 0 C-N-CA 126.278 1.831 . . . . 0.0 107.951 -177.025 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 30.5 m -142.01 135.71 29.55 Favored 'General case' 0 CA--C 1.485 -1.541 1 N-CA-C 99.01 -4.441 . . . . 0.0 99.01 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.462 HG12 HD11 ' A' ' 59' ' ' ILE . 2.7 m -60.95 148.47 9.07 Favored 'Isoleucine or valine' 0 C--N 1.354 0.764 0 CA-C-N 120.463 1.483 . . . . 0.0 112.35 -172.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -98.02 132.09 43.88 Favored 'General case' 0 CA--C 1.483 -1.623 1 N-CA-C 97.97 -4.826 . . . . 0.0 97.97 177.211 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 66.9 m80 -90.38 -175.58 4.52 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 -166.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 5.7 t -147.03 157.55 43.65 Favored 'General case' 0 N--CA 1.413 -2.305 1 N-CA-C 96.392 -5.41 . . . . 0.0 96.392 -175.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -117.34 110.92 40.51 Favored Pre-proline 0 N--CA 1.419 -2.008 1 N-CA-C 96.906 -5.22 . . . . 0.0 96.906 172.405 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_exo -60.1 114.57 2.15 Favored 'Trans proline' 0 CA--C 1.506 -0.899 0 CA-C-N 123.324 2.223 . . . . 0.0 113.811 -162.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 154.45 -42.98 0.59 Allowed Glycine 0 N--CA 1.432 -1.568 1 N-CA-C 100.584 -5.006 . . . . 0.0 100.584 -163.7 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.6 m 95.84 21.84 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.31 0 C-N-CA 127.329 2.251 . . . . 0.0 111.071 167.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 p -68.13 -52.29 36.47 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 125.493 1.517 . . . . 0.0 110.302 -174.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.62 -38.39 90.17 Favored Glycine 0 C--N 1.347 1.192 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 178.169 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 41.9 t -66.15 -48.33 71.13 Favored 'General case' 0 CA--C 1.502 -0.872 0 C-N-CA 124.283 1.033 . . . . 0.0 110.013 -177.05 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -53.34 -49.91 66.11 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 125.539 1.536 . . . . 0.0 109.925 175.323 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.4 m -60.51 -53.09 61.75 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 124.105 0.962 . . . . 0.0 111.299 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 37.4 mt -65.47 -44.45 87.13 Favored 'General case' 0 CA--C 1.492 -1.257 0 C-N-CA 125.068 1.347 . . . . 0.0 110.234 -175.542 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.8 t -62.56 -44.97 95.0 Favored 'General case' 0 N--CA 1.435 -1.189 0 C-N-CA 123.021 0.528 . . . . 0.0 109.788 179.114 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -69.25 -41.94 76.27 Favored 'General case' 0 CA--C 1.503 -0.856 0 O-C-N 122.247 -0.283 . . . . 0.0 110.402 -174.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -74.73 -27.36 60.33 Favored 'General case' 0 CA--C 1.505 -0.777 0 O-C-N 121.715 -0.616 . . . . 0.0 111.621 -176.335 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.36 -23.53 27.97 Favored 'General case' 0 C--N 1.358 0.966 0 CA-C-O 121.571 0.7 . . . . 0.0 109.331 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.08 43.05 1.23 Allowed Glycine 0 CA--C 1.484 -1.859 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 162.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -98.91 152.09 19.61 Favored Glycine 0 CA--C 1.491 -1.461 0 N-CA-C 104.278 -3.529 . . . . 0.0 104.278 165.517 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 23.5 p -87.77 -44.53 11.06 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -168.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 18.3 m -129.06 157.23 42.32 Favored 'General case' 0 CA--C 1.485 -1.547 0 N-CA-C 102.14 -3.282 . . . . 0.0 102.14 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -161.26 160.19 31.9 Favored Glycine 0 N--CA 1.416 -2.683 1 N-CA-C 98.473 -5.851 . . . . 0.0 98.473 178.834 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 20.0 p80 -164.21 176.53 9.12 Favored 'General case' 0 N--CA 1.427 -1.594 1 N-CA-C 96.719 -5.289 . . . . 0.0 96.719 -178.441 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 70.3 m -110.58 165.76 11.55 Favored 'General case' 0 CA--C 1.481 -1.69 0 CA-C-N 119.566 1.075 . . . . 0.0 108.256 -173.612 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -175.6 -169.05 36.83 Favored Glycine 0 N--CA 1.424 -2.154 1 N-CA-C 100.649 -4.981 . . . . 0.0 100.649 -179.475 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -130.32 138.88 50.67 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 101.605 -3.48 . . . . 0.0 101.605 -172.418 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -108.1 111.89 24.16 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 102.855 -3.017 . . . . 0.0 102.855 174.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.8 t -80.81 120.66 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 -175.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 119.93 -7.12 12.03 Favored Glycine 0 CA--C 1.494 -1.267 0 N-CA-C 106.838 -2.505 . . . . 0.0 106.838 -166.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 12.4 m80 -139.69 -79.56 0.31 Allowed 'General case' 0 CA--C 1.497 -1.067 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 167.537 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 170.4 -161.52 34.55 Favored Glycine 0 N--CA 1.426 -2.023 0 N-CA-C 104.188 -3.565 . . . . 0.0 104.188 -166.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 30.8 tp -65.57 133.44 51.19 Favored 'General case' 0 CA--C 1.505 -0.77 0 C-N-CA 127.197 2.199 . . . . 0.0 107.275 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.25 -176.41 4.25 Favored 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 -166.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.2 t -125.13 151.16 46.13 Favored 'General case' 0 CA--C 1.491 -1.323 1 N-CA-C 98.631 -4.581 . . . . 0.0 98.631 175.226 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 38.0 t-105 -107.15 152.8 23.58 Favored 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 103.941 -2.614 . . . . 0.0 103.941 179.053 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 22.9 m -143.77 150.57 38.78 Favored 'General case' 0 CA--C 1.483 -1.621 0 N-CA-C 104.307 -2.479 . . . . 0.0 104.307 170.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -116.09 140.44 49.28 Favored 'General case' 0 CA--C 1.492 -1.277 0 N-CA-C 102.464 -3.161 . . . . 0.0 102.464 171.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 67.21 56.67 0.62 Allowed 'General case' 0 CA--C 1.496 -1.112 0 C-N-CA 127.103 2.161 . . . . 0.0 111.601 172.211 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 25.1 mt -93.96 134.04 26.7 Favored Pre-proline 0 CA--C 1.496 -1.12 0 N-CA-C 104.411 -2.44 . . . . 0.0 104.411 174.475 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -75.06 173.61 14.22 Favored 'Trans proline' 0 N--CA 1.445 -1.327 0 C-N-CA 122.236 1.958 . . . . 0.0 110.236 178.265 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -64.75 -13.21 54.22 Favored 'General case' 0 CA--C 1.506 -0.744 0 C-N-CA 125.795 1.638 . . . . 0.0 114.477 -173.509 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -89.88 8.76 30.48 Favored 'General case' 0 CA--C 1.504 -0.807 0 O-C-N 121.503 -0.748 . . . . 0.0 110.247 -176.511 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.7 t -110.54 141.93 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.339 0 N-CA-C 102.552 -3.129 . . . . 0.0 102.552 177.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -115.79 148.14 18.91 Favored Glycine 0 CA--C 1.479 -2.21 1 N-CA-C 100.3 -5.12 . . . . 0.0 100.3 175.176 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 24.2 pt -147.28 -151.22 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.426 -1.635 0 N-CA-C 102.34 -3.207 . . . . 0.0 102.34 -163.104 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.944 HD13 ' HB2' ' A' ' 7' ' ' ALA . 7.5 mm -71.65 122.55 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 178.561 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -142.77 171.41 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.404 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 -163.24 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 71.67 -57.86 0.6 Allowed 'General case' 0 C--N 1.362 1.115 0 C-N-CA 126.925 2.09 . . . . 0.0 113.161 169.094 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 155.18 -69.03 0.29 Allowed Glycine 0 N--CA 1.424 -2.142 1 N-CA-C 100.416 -5.074 . . . . 0.0 100.416 -170.425 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 73.6 tt0 -166.79 153.35 8.64 Favored 'General case' 0 N--CA 1.423 -1.814 1 N-CA-C 97.286 -5.079 . . . . 0.0 97.286 179.559 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 18.6 ttmm -179.71 -173.06 0.23 Allowed 'General case' 0 N--CA 1.429 -1.514 1 N-CA-C 95.031 -5.915 . . . . 0.0 95.031 167.07 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 34.9 t -166.0 156.78 13.14 Favored 'General case' 0 N--CA 1.429 -1.484 1 N-CA-C 95.298 -5.816 . . . . 0.0 95.298 160.273 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 29.7 p-80 -162.13 -173.51 3.68 Favored 'General case' 0 CA--C 1.486 -1.509 0 N-CA-C 100.418 -3.919 . . . . 0.0 100.418 173.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 39.0 m -172.72 173.77 3.82 Favored 'General case' 0 N--CA 1.424 -1.727 1 N-CA-C 95.921 -5.585 . . . . 0.0 95.921 179.372 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.358 0.96 0 O-C-N 124.018 0.824 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.2 m . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 121.164 0.507 . . . . 0.0 110.411 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -109.94 159.26 17.41 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 175.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -126.99 127.13 44.33 Favored 'General case' 0 CA--C 1.488 -1.41 1 N-CA-C 95.21 -5.848 . . . . 0.0 95.21 158.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.82 -169.14 24.73 Favored Glycine 0 CA--C 1.474 -2.53 1 N-CA-C 102.372 -4.291 . . . . 0.0 102.372 -179.62 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 48' ' ' TRP . 16.4 m-85 -83.71 143.85 29.76 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 103.859 -2.645 . . . . 0.0 103.859 161.27 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.0 tt -90.79 141.49 14.33 Favored 'Isoleucine or valine' 0 C--O 1.25 1.102 0 N-CA-C 105.939 -1.875 . . . . 0.0 105.939 174.006 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.802 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -140.18 174.41 10.54 Favored 'General case' 0 N--CA 1.42 -1.966 1 N-CA-C 99.915 -4.106 . . . . 0.0 99.915 175.628 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -85.2 160.25 55.02 Favored Pre-proline 0 N--CA 1.432 -1.36 0 C-N-CA 126.983 2.113 . . . . 0.0 106.014 178.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -70.23 -11.98 31.19 Favored 'Trans proline' 0 CA--C 1.505 -0.95 0 CA-C-N 121.4 1.536 . . . . 0.0 116.024 -160.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -99.58 15.02 27.98 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -178.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 63.7 t30 74.43 54.64 0.09 Allowed 'General case' 0 CA--C 1.501 -0.929 0 C-N-CA 125.706 1.603 . . . . 0.0 110.052 172.487 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.455 ' O ' ' HB1' ' A' ' 7' ' ' ALA . 1.2 m -133.86 136.59 44.47 Favored 'General case' 0 CA--C 1.478 -1.823 1 N-CA-C 98.909 -4.478 . . . . 0.0 98.909 176.692 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -64.35 155.18 6.35 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.932 0 CA-C-N 120.186 1.357 . . . . 0.0 112.224 -172.16 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -104.8 128.2 52.87 Favored 'General case' 0 CA--C 1.473 -1.997 1 N-CA-C 91.416 -7.253 . . . . 0.0 91.416 177.154 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 34.8 m-70 -88.5 -150.57 0.19 Allowed 'General case' 0 CA--C 1.491 -1.291 0 N-CA-C 105.41 -2.07 . . . . 0.0 105.41 -167.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 8.0 t -153.19 161.99 41.81 Favored 'General case' 0 N--CA 1.413 -2.303 1 N-CA-C 94.094 -6.262 . . . . 0.0 94.094 -176.006 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -111.73 112.82 53.34 Favored Pre-proline 0 N--CA 1.422 -1.847 1 N-CA-C 95.907 -5.59 . . . . 0.0 95.907 171.688 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo -60.39 101.06 0.16 Allowed 'Trans proline' 0 CA--C 1.508 -0.811 0 C-N-CA 122.457 2.105 . . . . 0.0 116.449 -157.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 169.16 -178.33 42.42 Favored Glycine 0 N--CA 1.422 -2.247 1 N-CA-C 95.893 -6.883 . . . . 0.0 95.893 178.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.3 m -69.78 -39.24 76.77 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 119.45 1.625 . . . . 0.0 109.234 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -43.87 -53.03 6.39 Favored 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 130.653 3.581 . . . . 0.0 115.607 -173.278 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.71 -39.7 66.29 Favored Glycine 0 C--N 1.353 1.473 0 O-C-N 120.998 -1.064 . . . . 0.0 111.441 -171.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 38.9 t -70.92 -47.24 60.19 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -54.91 -44.14 73.92 Favored 'General case' 0 C--N 1.354 0.769 0 C-N-CA 123.267 0.627 . . . . 0.0 110.845 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 26.6 m -59.92 -50.13 74.97 Favored 'General case' 0 C--N 1.35 0.601 0 C-N-CA 123.193 0.597 . . . . 0.0 111.509 177.172 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 50.3 mt -67.77 -40.43 84.03 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-O 122.437 1.113 . . . . 0.0 110.43 -176.343 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.0 t -62.44 -42.75 99.69 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 124.64 1.176 . . . . 0.0 109.419 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 24.0 mtpp -68.44 -42.57 78.65 Favored 'General case' 0 C--N 1.355 0.831 0 C-N-CA 123.072 0.549 . . . . 0.0 111.674 -179.072 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -75.07 -22.16 58.51 Favored 'General case' 0 C--N 1.354 0.782 0 O-C-N 121.455 -0.778 . . . . 0.0 111.24 -174.469 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.3 mmtm -79.86 -60.33 2.38 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 170.222 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 135.39 50.12 0.07 OUTLIER Glycine 0 CA--C 1.489 -1.577 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 171.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.5 141.95 15.57 Favored Glycine 0 CA--C 1.491 -1.442 0 N-CA-C 103.839 -3.704 . . . . 0.0 103.839 164.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.1 p -100.11 3.32 43.85 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 123.813 0.845 . . . . 0.0 110.334 -165.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.4 m -160.1 158.53 30.49 Favored 'General case' 0 CA--C 1.476 -1.894 1 N-CA-C 97.773 -4.899 . . . . 0.0 97.773 168.069 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -170.76 164.76 37.97 Favored Glycine 0 CA--C 1.469 -2.817 1 N-CA-C 99.56 -5.416 . . . . 0.0 99.56 -176.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 59.9 m80 -155.05 152.98 30.25 Favored 'General case' 0 N--CA 1.43 -1.45 1 N-CA-C 100.049 -4.056 . . . . 0.0 100.049 -175.784 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 44.9 t -85.1 153.76 22.49 Favored 'General case' 0 CA--C 1.505 -0.778 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 -175.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -174.55 -177.1 43.42 Favored Glycine 0 CA--C 1.482 -2.017 0 N-CA-C 105.061 -3.216 . . . . 0.0 105.061 179.348 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -119.98 142.61 48.62 Favored 'General case' 0 N--CA 1.431 -1.42 1 N-CA-C 99.547 -4.242 . . . . 0.0 99.547 -179.003 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 24.8 tptp -119.31 103.91 9.91 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 101.457 -3.534 . . . . 0.0 101.457 175.213 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.9 t -73.07 136.9 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 N-CA-C 105.868 -1.901 . . . . 0.0 105.868 -178.374 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 113.34 -24.75 12.01 Favored Glycine 0 CA--C 1.491 -1.435 0 N-CA-C 106.23 -2.748 . . . . 0.0 106.23 -168.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 39.6 m80 -127.98 -81.11 0.59 Allowed 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 174.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 168.17 -151.76 19.14 Favored Glycine 0 N--CA 1.429 -1.798 0 N-CA-C 105.169 -3.172 . . . . 0.0 105.169 -171.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 49.1 tp -65.41 126.14 27.33 Favored 'General case' 0 CA--C 1.506 -0.721 0 C-N-CA 126.634 1.974 . . . . 0.0 106.856 178.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -134.27 -167.99 2.06 Favored 'General case' 0 CA--C 1.489 -1.372 0 N-CA-C 105.369 -2.085 . . . . 0.0 105.369 -166.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.7 t -136.86 148.23 46.97 Favored 'General case' 0 CA--C 1.489 -1.369 0 N-CA-C 100.349 -3.945 . . . . 0.0 100.349 172.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.414 ' HA ' ' HA ' ' A' ' 5' ' ' TYR . 20.3 t-105 -102.89 148.69 25.33 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 104.111 -2.552 . . . . 0.0 104.111 177.713 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 50.2 m -144.77 149.2 35.1 Favored 'General case' 0 CA--C 1.498 -1.052 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 176.041 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -113.62 142.84 45.51 Favored 'General case' 0 CA--C 1.495 -1.164 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 172.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 62.69 57.03 1.85 Allowed 'General case' 0 CA--C 1.494 -1.191 0 C-N-CA 127.985 2.514 . . . . 0.0 111.103 172.038 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 17.8 mt -90.07 137.28 28.09 Favored Pre-proline 0 N--CA 1.44 -0.959 0 N-CA-C 104.899 -2.26 . . . . 0.0 104.899 174.159 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_exo -69.02 171.88 12.88 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 122.036 1.824 . . . . 0.0 113.047 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -76.25 -13.16 60.17 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 123.39 0.676 . . . . 0.0 112.203 -171.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -91.64 13.3 18.37 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 124.122 0.969 . . . . 0.0 110.426 178.308 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.3 t -104.22 160.9 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 N-CA-C 101.535 -3.506 . . . . 0.0 101.535 171.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -138.05 150.52 20.97 Favored Glycine 0 CA--C 1.481 -2.09 1 N-CA-C 96.986 -6.446 . . . . 0.0 96.986 178.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 29.4 pt -156.68 -155.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 N-CA-C 101.586 -3.487 . . . . 0.0 101.586 -158.233 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.802 HD13 ' HB2' ' A' ' 7' ' ' ALA . 3.2 mm -63.08 137.51 24.48 Favored 'Isoleucine or valine' 0 C--N 1.363 1.163 0 C-N-CA 123.943 0.897 . . . . 0.0 109.556 -177.524 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -149.46 166.71 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.986 1 N-CA-C 96.295 -5.446 . . . . 0.0 96.295 -178.68 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.404 ' HG2' ' H ' ' A' ' 62' ' ' GLY . 28.2 tt0 -170.0 174.55 5.47 Favored 'General case' 0 N--CA 1.428 -1.545 1 N-CA-C 97.686 -4.931 . . . . 0.0 97.686 177.64 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.404 ' H ' ' HG2' ' A' ' 61' ' ' GLU . . . 79.52 35.94 27.78 Favored Glycine 0 C--N 1.349 1.268 0 N-CA-C 104.971 -3.252 . . . . 0.0 104.971 -159.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 178.59 -154.03 0.02 OUTLIER 'General case' 0 N--CA 1.42 -1.948 1 N-CA-C 95.712 -5.662 . . . . 0.0 95.712 -159.475 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -168.76 -156.69 0.17 Allowed 'General case' 0 N--CA 1.427 -1.61 1 N-CA-C 95.877 -5.601 . . . . 0.0 95.877 -168.8 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 42.3 t -101.81 157.81 16.57 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 102.948 -2.982 . . . . 0.0 102.948 170.226 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 9.1 p80 -142.82 -168.46 2.78 Favored 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 102.598 -3.112 . . . . 0.0 102.598 175.358 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 42.1 m -169.74 171.82 7.14 Favored 'General case' 0 N--CA 1.425 -1.692 1 N-CA-C 96.237 -5.468 . . . . 0.0 96.237 176.361 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.357 0.9 0 O-C-N 124.457 1.098 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 17.3 m . . . . . 0 N--CA 1.481 1.121 0 CA-C-O 121.621 0.724 . . . . 0.0 110.56 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -100.6 174.06 6.25 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 102.654 -3.091 . . . . 0.0 102.654 159.049 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -119.16 150.17 40.49 Favored 'General case' 0 CA--C 1.487 -1.464 1 N-CA-C 94.262 -6.199 . . . . 0.0 94.262 155.411 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -160.7 165.12 34.97 Favored Glycine 0 CA--C 1.471 -2.691 0 C-N-CA 116.618 -2.706 . . . . 0.0 108.822 -172.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -87.87 116.24 25.88 Favored 'General case' 0 N--CA 1.429 -1.504 1 N-CA-C 99.51 -4.255 . . . . 0.0 99.51 160.677 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 13.8 tt -75.72 135.0 27.98 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.419 0 N-CA-C 104.524 -2.399 . . . . 0.0 104.524 -172.539 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.599 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -125.89 -172.99 2.73 Favored 'General case' 0 N--CA 1.419 -2.01 0 O-C-N 126.309 2.256 . . . . 0.0 107.793 -178.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -101.54 139.52 20.47 Favored Pre-proline 0 N--CA 1.424 -1.753 1 N-CA-C 98.126 -4.768 . . . . 0.0 98.126 164.297 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -76.78 -0.31 10.38 Favored 'Trans proline' 0 CA--C 1.504 -1.008 0 C-N-CA 122.457 2.104 . . . . 0.0 112.501 -152.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 84.5 mt-10 -95.28 45.35 1.1 Allowed 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 124.756 1.222 . . . . 0.0 108.322 -165.188 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.418 HD21 ' HA ' ' A' ' 61' ' ' GLU . 0.7 OUTLIER 66.49 49.31 1.39 Allowed 'General case' 0 C--N 1.355 0.806 0 C-N-CA 126.555 1.942 . . . . 0.0 108.174 179.788 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -128.29 -160.59 1.03 Allowed 'General case' 0 CA--C 1.492 -1.269 0 O-C-N 120.651 -1.281 . . . . 0.0 110.91 -171.727 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.551 HG12 HD12 ' A' ' 59' ' ' ILE . 9.7 m -125.37 -171.23 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.435 1 N-CA-C 99.618 -4.216 . . . . 0.0 99.618 167.997 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -126.89 150.44 49.28 Favored 'General case' 0 CA--C 1.477 -1.827 1 N-CA-C 95.338 -5.801 . . . . 0.0 95.338 173.755 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 61.0 m170 -99.08 122.91 42.93 Favored 'General case' 0 CA--C 1.485 -1.535 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 -178.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 41.9 t -83.54 151.08 25.56 Favored 'General case' 0 N--CA 1.427 -1.597 0 N-CA-C 105.95 -1.871 . . . . 0.0 105.95 176.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -98.44 118.41 63.38 Favored Pre-proline 0 N--CA 1.428 -1.528 1 N-CA-C 100.148 -4.019 . . . . 0.0 100.148 175.253 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -62.7 103.15 0.32 Allowed 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.687 2.258 . . . . 0.0 112.849 -165.091 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 168.59 -52.59 0.22 Allowed Glycine 0 N--CA 1.427 -1.902 1 N-CA-C 100.238 -5.145 . . . . 0.0 100.238 -175.755 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.8 m 134.11 -42.92 0.01 OUTLIER 'General case' 0 CA--C 1.489 -1.403 0 C-N-CA 128.953 2.901 . . . . 0.0 105.81 174.093 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.6 m -39.66 -55.53 1.87 Allowed 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 128.311 2.645 . . . . 0.0 117.165 -150.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.89 -34.64 71.64 Favored Glycine 0 C--N 1.346 1.103 0 O-C-N 121.478 -0.764 . . . . 0.0 111.723 -175.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.7 t -86.51 -18.31 31.91 Favored 'General case' 0 CA--C 1.5 -0.953 0 O-C-N 121.46 -1.023 . . . . 0.0 108.4 -176.234 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -66.1 -44.06 85.45 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 170.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -62.94 -33.3 75.06 Favored 'General case' 0 C--N 1.353 0.758 0 O-C-N 121.123 -0.986 . . . . 0.0 113.019 172.761 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 86.3 mt -66.76 -41.42 87.79 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-N 119.1 0.864 . . . . 0.0 110.212 175.084 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 11.4 t -56.41 -50.42 71.66 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 123.763 0.825 . . . . 0.0 110.337 174.159 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -56.89 -51.48 68.94 Favored 'General case' 0 C--N 1.359 0.979 0 C-N-CA 123.621 0.769 . . . . 0.0 111.888 -179.5 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -69.57 -19.28 63.68 Favored 'General case' 0 C--N 1.354 0.78 0 O-C-N 121.519 -0.738 . . . . 0.0 112.976 -173.577 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 48.6 mmtm -96.46 0.44 50.36 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 177.603 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.11 21.34 23.16 Favored Glycine 0 C--N 1.352 1.428 0 O-C-N 121.416 -0.803 . . . . 0.0 111.582 168.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -88.48 124.02 7.03 Favored Glycine 0 CA--C 1.485 -1.82 0 N-CA-C 106.466 -2.653 . . . . 0.0 106.466 169.34 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -77.17 -56.39 4.61 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 124.947 1.299 . . . . 0.0 108.435 -173.015 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.2 m -114.17 156.94 23.34 Favored 'General case' 0 CA--C 1.484 -1.584 0 N-CA-C 103.883 -2.636 . . . . 0.0 103.883 178.297 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -168.13 177.72 42.16 Favored Glycine 0 N--CA 1.416 -2.696 1 N-CA-C 99.926 -5.27 . . . . 0.0 99.926 -177.217 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -171.97 -172.99 1.06 Allowed 'General case' 0 N--CA 1.425 -1.69 1 N-CA-C 95.955 -5.572 . . . . 0.0 95.955 173.821 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 88.1 m -122.58 158.88 28.96 Favored 'General case' 0 CA--C 1.48 -1.734 0 N-CA-C 102.509 -3.145 . . . . 0.0 102.509 174.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.42 174.42 46.67 Favored Glycine 0 CA--C 1.481 -2.058 1 N-CA-C 100.741 -4.944 . . . . 0.0 100.741 -174.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -146.16 127.7 15.09 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 102.638 -3.097 . . . . 0.0 102.638 -178.224 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 35.5 mmtm -156.83 82.37 0.95 Allowed 'General case' 0 CA--C 1.493 -1.241 1 N-CA-C 96.417 -5.401 . . . . 0.0 96.417 153.525 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.8 t -143.57 -178.1 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.071 1 N-CA-C 99.702 -4.184 . . . . 0.0 99.702 -169.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -135.04 26.95 3.21 Favored Glycine 0 C--N 1.349 1.27 0 N-CA-C 108.022 -2.031 . . . . 0.0 108.022 177.24 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 39.4 m170 -116.22 -75.34 0.58 Allowed 'General case' 0 CA--C 1.5 -0.969 0 N-CA-C 104.346 -2.465 . . . . 0.0 104.346 173.497 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -171.75 -169.31 34.44 Favored Glycine 0 CA--C 1.478 -2.247 1 N-CA-C 98.312 -5.915 . . . . 0.0 98.312 -175.627 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . 0.256 0.2 OUTLIER -65.39 147.49 53.34 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 123.817 0.847 . . . . 0.0 111.066 -178.072 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -141.22 175.63 9.49 Favored 'General case' 0 CA--C 1.485 -1.551 0 N-CA-C 101.984 -3.339 . . . . 0.0 101.984 -166.07 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.5 m -120.05 155.38 33.04 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 104.407 -2.442 . . . . 0.0 104.407 178.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 73.5 t-105 -102.08 148.89 24.84 Favored 'General case' 0 CA--C 1.489 -1.391 0 N-CA-C 104.35 -2.463 . . . . 0.0 104.35 -177.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 69.2 m -140.09 140.91 36.18 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 102.174 -3.269 . . . . 0.0 102.174 168.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -106.73 19.11 20.95 Favored 'General case' 0 C--N 1.352 0.714 0 CA-C-O 121.413 0.625 . . . . 0.0 110.127 -169.544 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -166.77 144.27 4.95 Favored 'General case' 0 N--CA 1.422 -1.825 1 N-CA-C 93.573 -6.454 . . . . 0.0 93.573 169.671 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 21.5 mt -150.58 142.11 15.27 Favored Pre-proline 0 CA--C 1.486 -1.518 1 N-CA-C 99.13 -4.396 . . . . 0.0 99.13 153.449 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -74.06 172.13 16.58 Favored 'Trans proline' 0 N--CA 1.444 -1.402 0 C-N-CA 122.19 1.927 . . . . 0.0 110.14 174.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -75.48 -1.99 26.74 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 -166.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -92.0 -7.73 48.05 Favored 'General case' 0 CA--C 1.505 -0.765 0 O-C-N 121.57 -0.707 . . . . 0.0 109.573 179.178 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.8 t -101.47 129.71 52.18 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.308 0 N-CA-C 103.748 -2.686 . . . . 0.0 103.748 -174.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -98.45 160.19 20.49 Favored Glycine 0 CA--C 1.485 -1.804 0 N-CA-C 106.133 -2.787 . . . . 0.0 106.133 -178.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 23.2 pt -146.56 -162.67 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.549 0 N-CA-C 103.543 -2.762 . . . . 0.0 103.543 -165.534 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.599 HD13 ' HB2' ' A' ' 7' ' ' ALA . 2.8 mm -63.51 137.4 24.75 Favored 'Isoleucine or valine' 0 C--N 1.361 1.084 0 C-N-CA 124.074 0.95 . . . . 0.0 109.167 -176.598 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 55.3 t -118.36 -92.82 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 N-CA-C 103.643 -2.725 . . . . 0.0 103.643 178.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.418 ' HA ' HD21 ' A' ' 11' ' ' ASN 0.343 34.0 tt0 77.8 59.27 0.03 OUTLIER 'General case' 0 CA--C 1.499 -1.01 0 CA-C-O 124.214 1.959 . . . . 0.0 111.009 172.145 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -126.63 43.09 1.38 Allowed Glycine 0 CA--C 1.491 -1.433 1 N-CA-C 100.911 -4.876 . . . . 0.0 100.911 157.388 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 179.92 -158.08 0.03 OUTLIER 'General case' 0 N--CA 1.426 -1.673 1 N-CA-C 96.05 -5.537 . . . . 0.0 96.05 -174.828 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 35.6 tptt -142.04 178.09 7.77 Favored 'General case' 0 N--CA 1.425 -1.716 1 N-CA-C 96.864 -5.236 . . . . 0.0 96.864 175.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 41.6 t -77.22 150.41 35.42 Favored 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 123.319 0.648 . . . . 0.0 109.347 -168.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -134.89 149.37 50.29 Favored 'General case' 0 N--CA 1.428 -1.545 1 N-CA-C 96.978 -5.193 . . . . 0.0 96.978 165.077 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.7 m 176.42 175.14 0.33 Allowed 'General case' 0 N--CA 1.43 -1.454 1 N-CA-C 96.012 -5.551 . . . . 0.0 96.012 -173.808 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.359 1.008 0 O-C-N 124.095 0.872 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 34.8 m . . . . . 0 N--CA 1.485 1.303 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.52 165.48 27.46 Favored 'General case' 0 N--CA 1.426 -1.63 1 N-CA-C 100.071 -4.048 . . . . 0.0 100.071 165.753 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -133.41 128.21 35.05 Favored 'General case' 0 N--CA 1.429 -1.522 1 N-CA-C 93.867 -6.345 . . . . 0.0 93.867 166.649 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.03 -175.31 32.93 Favored Glycine 0 CA--C 1.47 -2.748 1 N-CA-C 102.064 -4.414 . . . . 0.0 102.064 176.477 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -75.34 133.1 41.32 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 104.555 -2.387 . . . . 0.0 104.555 163.533 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.9 tt -89.87 137.99 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.315 0 N-CA-C 104.611 -2.366 . . . . 0.0 104.611 -175.436 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.456 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -100.97 -144.81 0.34 Allowed 'General case' 0 N--CA 1.426 -1.674 0 C-N-CA 127.185 2.194 . . . . 0.0 106.717 -178.283 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -128.91 143.03 47.12 Favored Pre-proline 0 N--CA 1.421 -1.895 1 N-CA-C 93.47 -6.493 . . . . 0.0 93.47 163.577 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -82.57 27.27 0.61 Allowed 'Trans proline' 0 CA--C 1.506 -0.917 0 C-N-CA 122.651 2.234 . . . . 0.0 113.731 -141.248 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 41.4 mp0 -104.38 -78.52 0.56 Allowed 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 102.589 -3.115 . . . . 0.0 102.589 -178.156 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -161.33 142.97 11.71 Favored 'General case' 0 N--CA 1.425 -1.699 1 N-CA-C 92.464 -6.865 . . . . 0.0 92.464 156.188 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 65' ' ' CYS . 1.0 OUTLIER 176.29 -166.68 0.04 OUTLIER 'General case' 0 CA--C 1.486 -1.513 0 N-CA-C 101.485 -3.524 . . . . 0.0 101.485 179.816 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.554 HG12 HD12 ' A' ' 59' ' ' ILE . 1.0 OUTLIER -121.29 160.56 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.725 1 N-CA-C 99.006 -4.442 . . . . 0.0 99.006 156.929 . . . . . . . . 4 4 . 1 . 021 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -82.71 -168.87 2.21 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 104.798 -2.297 . . . . 0.0 104.798 161.074 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 9.2 m-70 -134.61 177.76 7.53 Favored 'General case' 0 N--CA 1.422 -1.858 1 N-CA-C 95.271 -5.826 . . . . 0.0 95.271 168.291 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 40.9 t -154.89 169.31 24.32 Favored 'General case' 0 N--CA 1.416 -2.148 1 N-CA-C 96.088 -5.523 . . . . 0.0 96.088 -168.275 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -126.3 120.41 23.58 Favored Pre-proline 0 N--CA 1.42 -1.931 1 N-CA-C 98.795 -4.52 . . . . 0.0 98.795 178.768 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 0.8 OUTLIER -55.56 135.2 68.2 Favored 'Trans proline' 0 CA--C 1.505 -0.951 0 C-N-CA 122.568 2.179 . . . . 0.0 112.384 -178.452 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 116.27 -43.55 1.64 Allowed Glycine 0 N--CA 1.438 -1.231 0 N-CA-C 103.989 -3.644 . . . . 0.0 103.989 -158.322 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.0 m 82.56 23.85 0.18 Allowed 'General case' 0 CA--C 1.496 -1.111 0 C-N-CA 128.105 2.562 . . . . 0.0 110.647 175.836 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.7 -61.2 2.68 Favored 'General case' 0 N--CA 1.44 -0.933 0 C-N-CA 126.808 2.043 . . . . 0.0 110.998 -168.995 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.14 -32.23 72.6 Favored Glycine 0 C--N 1.347 1.187 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 -175.468 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 11.5 t -78.45 -21.38 49.22 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-O 119.302 -0.38 . . . . 0.0 110.054 -173.482 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -60.43 -46.96 88.16 Favored 'General case' 0 C--N 1.352 0.692 0 CA-C-N 119.585 1.084 . . . . 0.0 109.409 173.394 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.13 -49.26 75.06 Favored 'General case' 0 N--CA 1.44 -0.934 0 O-C-N 121.537 -0.727 . . . . 0.0 112.521 171.09 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 73.8 mt -63.91 -44.28 93.39 Favored 'General case' 0 C--N 1.358 0.96 0 CA-C-O 121.722 0.772 . . . . 0.0 111.59 -173.882 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 13.7 t -60.0 -42.54 94.47 Favored 'General case' 0 CA--C 1.503 -0.855 0 C-N-CA 123.589 0.756 . . . . 0.0 109.558 179.175 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.6 mtmm -74.47 -35.05 63.28 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-N 119.211 0.914 . . . . 0.0 112.801 -177.966 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -70.75 -24.71 62.66 Favored 'General case' 0 C--N 1.358 0.941 0 CA-C-N 120.13 1.332 . . . . 0.0 111.536 178.628 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 48.4 mmtm -85.12 -13.58 49.8 Favored 'General case' 0 C--N 1.355 0.822 0 O-C-N 121.882 -0.512 . . . . 0.0 110.067 173.933 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.89 32.0 5.79 Favored Glycine 0 CA--C 1.492 -1.385 0 CA-C-O 119.375 -0.68 . . . . 0.0 111.636 166.718 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.3 138.29 14.29 Favored Glycine 0 CA--C 1.488 -1.653 0 N-CA-C 105.379 -3.089 . . . . 0.0 105.379 174.247 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 18.0 p -100.67 2.76 41.83 Favored 'General case' 0 N--CA 1.44 -0.97 0 O-C-N 122.063 -0.669 . . . . 0.0 110.042 -163.723 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.5 m -160.17 153.41 21.94 Favored 'General case' 0 CA--C 1.483 -1.6 1 N-CA-C 99.225 -4.361 . . . . 0.0 99.225 168.621 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -171.31 161.97 34.56 Favored Glycine 0 CA--C 1.474 -2.526 1 N-CA-C 100.022 -5.231 . . . . 0.0 100.022 178.296 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 14.8 p80 -165.81 170.71 13.61 Favored 'General case' 0 CA--C 1.488 -1.417 0 N-CA-C 100.215 -3.994 . . . . 0.0 100.215 -177.05 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 62.9 m -77.53 147.63 35.68 Favored 'General case' 0 CA--C 1.491 -1.29 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 177.843 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -163.88 173.43 39.93 Favored Glycine 0 CA--C 1.476 -2.404 1 N-CA-C 98.493 -5.843 . . . . 0.0 98.493 179.9 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -168.89 -169.33 0.98 Allowed 'General case' 0 N--CA 1.422 -1.867 1 N-CA-C 97.01 -5.182 . . . . 0.0 97.01 178.142 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.6 mptt 97.65 61.29 0.0 OUTLIER 'General case' 0 CA--C 1.492 -1.251 0 C-N-CA 131.186 3.794 . . . . 0.0 101.753 -164.692 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 19.3 t -143.21 172.92 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.738 1 N-CA-C 96.501 -5.37 . . . . 0.0 96.501 -177.743 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -113.21 89.57 0.52 Allowed Glycine 0 CA--C 1.486 -1.77 0 N-CA-C 104.329 -3.509 . . . . 0.0 104.329 176.643 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 17.4 m170 -172.09 -132.21 0.01 OUTLIER 'General case' 0 N--CA 1.438 -1.041 1 N-CA-C 99.422 -4.288 . . . . 0.0 99.422 172.741 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -110.87 -41.03 1.23 Allowed Glycine 0 C--N 1.358 1.758 0 CA-C-N 120.843 1.656 . . . . 0.0 113.317 -170.32 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 13.6 tp -165.63 177.4 7.35 Favored 'General case' 0 N--CA 1.434 -1.236 1 N-CA-C 95.769 -5.641 . . . . 0.0 95.769 -173.385 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -159.02 -174.86 4.95 Favored 'General case' 0 CA--C 1.478 -1.822 1 N-CA-C 98.288 -4.708 . . . . 0.0 98.288 175.409 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 46.8 t -130.25 164.51 24.4 Favored 'General case' 0 CA--C 1.492 -1.286 1 N-CA-C 99.943 -4.095 . . . . 0.0 99.943 167.872 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 24.9 t-105 -111.99 152.23 28.35 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 104.231 -2.507 . . . . 0.0 104.231 176.997 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 15.3 m -145.55 150.69 36.88 Favored 'General case' 0 C--N 1.36 1.032 0 N-CA-C 104.797 -2.297 . . . . 0.0 104.797 173.73 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -113.15 138.5 49.85 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 104.878 -2.268 . . . . 0.0 104.878 171.178 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 64.79 58.4 0.97 Allowed 'General case' 0 CA--C 1.491 -1.297 0 C-N-CA 127.199 2.2 . . . . 0.0 111.697 166.505 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 20.4 mt -89.11 143.91 31.85 Favored Pre-proline 0 N--CA 1.441 -0.912 0 N-CA-C 104.21 -2.515 . . . . 0.0 104.21 170.788 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -73.11 170.37 19.98 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.574 2.183 . . . . 0.0 109.773 177.573 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -70.47 -12.16 61.39 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -167.293 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -84.61 -9.06 58.63 Favored 'General case' 0 CA--C 1.506 -0.744 0 O-C-N 121.381 -0.825 . . . . 0.0 110.27 -176.469 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.5 t -92.35 133.92 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 -176.39 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -98.2 150.03 19.31 Favored Glycine 0 CA--C 1.487 -1.698 0 N-CA-C 105.193 -3.163 . . . . 0.0 105.193 179.273 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 28.4 pt -135.29 -166.43 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 103.459 -2.793 . . . . 0.0 103.459 -172.707 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.554 HD12 HG12 ' A' ' 13' ' ' VAL . 1.3 mm -66.45 130.06 31.45 Favored 'Isoleucine or valine' 0 C--N 1.362 1.11 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 -173.256 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 77.4 t -110.63 101.4 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.612 0 N-CA-C 102.101 -3.296 . . . . 0.0 102.101 171.477 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 65.59 -114.58 0.29 Allowed 'General case' 0 C--N 1.355 0.832 0 C-N-CA 125.401 1.48 . . . . 0.0 109.626 -179.281 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -173.88 44.49 0.15 Allowed Glycine 0 CA--C 1.491 -1.464 1 N-CA-C 100.15 -5.18 . . . . 0.0 100.15 171.387 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -95.93 -36.68 10.99 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -162.418 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -149.35 160.36 43.49 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 102.993 -2.965 . . . . 0.0 102.993 -174.605 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 29.0 t -139.86 133.52 30.4 Favored 'General case' 0 N--CA 1.423 -1.809 1 N-CA-C 92.895 -6.706 . . . . 0.0 92.895 167.718 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 26.7 p-80 -160.08 169.05 24.17 Favored 'General case' 0 CA--C 1.48 -1.744 0 N-CA-C 100.972 -3.714 . . . . 0.0 100.972 -173.807 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.3 m -171.43 174.5 4.44 Favored 'General case' 0 N--CA 1.421 -1.893 1 N-CA-C 95.41 -5.774 . . . . 0.0 95.41 177.884 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.356 0.857 0 O-C-N 124.239 0.962 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 27.0 m . . . . . 0 N--CA 1.485 1.285 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -105.41 157.25 17.47 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 171.667 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -131.04 123.8 29.48 Favored 'General case' 0 N--CA 1.431 -1.386 1 N-CA-C 93.459 -6.497 . . . . 0.0 93.459 155.518 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.81 -173.61 30.68 Favored Glycine 0 CA--C 1.478 -2.28 1 N-CA-C 101.705 -4.558 . . . . 0.0 101.705 -177.426 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -79.93 137.69 36.94 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 103.673 -2.714 . . . . 0.0 103.673 166.683 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.2 tt -90.72 150.84 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.976 0 N-CA-C 105.171 -2.159 . . . . 0.0 105.171 179.489 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.858 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -143.88 179.68 7.02 Favored 'General case' 0 N--CA 1.411 -2.386 0 N-CA-C 101.309 -3.589 . . . . 0.0 101.309 -173.093 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -86.08 145.8 41.49 Favored Pre-proline 0 N--CA 1.427 -1.597 0 N-CA-C 102.559 -3.126 . . . . 0.0 102.559 171.33 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.11 5.42 5.76 Favored 'Trans proline' 0 CA--C 1.501 -1.157 0 C-N-CA 122.249 1.966 . . . . 0.0 112.491 -151.27 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -107.99 21.53 17.26 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 -179.919 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.487 HD21 ' HA ' ' A' ' 61' ' ' GLU . 62.4 t30 76.18 52.65 0.05 Allowed 'General case' 0 CA--C 1.496 -1.125 0 C-N-CA 126.903 2.081 . . . . 0.0 109.627 167.512 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.492 ' O ' ' HB1' ' A' ' 7' ' ' ALA . 26.0 m -140.47 138.72 34.86 Favored 'General case' 0 CA--C 1.478 -1.806 0 N-CA-C 100.636 -3.839 . . . . 0.0 100.636 -175.937 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.0 m -66.95 152.19 9.83 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.94 0 CA-C-N 120.544 1.52 . . . . 0.0 111.058 -173.188 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -89.43 122.52 32.71 Favored 'General case' 0 CA--C 1.484 -1.565 1 N-CA-C 100.01 -4.07 . . . . 0.0 100.01 176.018 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 58.6 m80 -86.02 138.34 32.04 Favored 'General case' 0 CA--C 1.478 -1.794 0 N-CA-C 102.427 -3.175 . . . . 0.0 102.427 -174.561 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.0 t -148.53 -179.02 6.65 Favored 'General case' 0 N--CA 1.411 -2.413 1 N-CA-C 93.666 -6.42 . . . . 0.0 93.666 -170.122 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -147.36 171.67 6.07 Favored Pre-proline 0 N--CA 1.412 -2.344 1 N-CA-C 97.515 -4.995 . . . . 0.0 97.515 -157.79 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -66.7 44.58 0.21 Allowed 'Trans proline' 0 C--N 1.324 -0.738 0 C-N-CA 123.307 2.672 . . . . 0.0 116.79 -178.912 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -174.93 148.5 9.69 Favored Glycine 0 N--CA 1.42 -2.427 1 N-CA-C 98.202 -5.959 . . . . 0.0 98.202 172.973 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -78.25 38.12 0.28 Allowed 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 124.813 1.245 . . . . 0.0 112.389 -174.881 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.6 m -54.47 -62.46 1.64 Allowed 'General case' 0 N--CA 1.44 -0.947 0 C-N-CA 127.577 2.351 . . . . 0.0 112.447 -162.816 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -90.16 -19.7 45.31 Favored Glycine 0 C--N 1.35 1.338 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 179.901 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.4 t -80.58 -15.22 57.17 Favored 'General case' 0 N--CA 1.442 -0.837 0 O-C-N 121.679 -0.895 . . . . 0.0 110.462 -167.455 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -54.68 -54.51 40.8 Favored 'General case' 0 C--N 1.353 0.743 0 C-N-CA 125.334 1.454 . . . . 0.0 109.594 172.152 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -61.24 -48.43 81.48 Favored 'General case' 0 N--CA 1.435 -1.184 0 C-N-CA 125.233 1.413 . . . . 0.0 112.111 172.518 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 96.3 mt -65.53 -42.19 92.26 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-O 122.192 0.996 . . . . 0.0 111.368 -171.31 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 14.2 t -61.71 -44.39 97.02 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 124.19 0.996 . . . . 0.0 108.491 179.059 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -68.07 -40.2 82.79 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -179.267 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -72.53 -20.37 61.36 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 120.122 1.328 . . . . 0.0 112.371 -179.114 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.8 mmtm -85.82 -16.34 39.04 Favored 'General case' 0 C--N 1.354 0.783 0 C-N-CA 123.349 0.659 . . . . 0.0 109.947 173.07 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.23 29.63 6.66 Favored Glycine 0 CA--C 1.487 -1.682 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 168.743 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -93.85 142.95 16.25 Favored Glycine 0 N--CA 1.435 -1.386 0 N-CA-C 105.792 -2.923 . . . . 0.0 105.792 172.987 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.1 m -109.84 -3.86 16.39 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 122.866 1.317 . . . . 0.0 108.211 -160.84 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 43.1 m -160.49 165.83 30.25 Favored 'General case' 0 CA--C 1.483 -1.633 1 N-CA-C 98.027 -4.805 . . . . 0.0 98.027 166.232 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -166.33 174.99 41.87 Favored Glycine 0 CA--C 1.473 -2.536 1 N-CA-C 101.561 -4.616 . . . . 0.0 101.561 -176.457 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -166.42 -175.15 3.11 Favored 'General case' 0 N--CA 1.431 -1.415 1 N-CA-C 97.604 -4.961 . . . . 0.0 97.604 -172.505 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 86.4 m -146.06 161.35 40.32 Favored 'General case' 0 CA--C 1.487 -1.468 1 N-CA-C 99.531 -4.248 . . . . 0.0 99.531 172.178 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 179.65 -176.89 47.92 Favored Glycine 0 N--CA 1.426 -1.991 1 N-CA-C 101.837 -4.505 . . . . 0.0 101.837 -177.197 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -99.36 161.14 13.79 Favored 'General case' 0 N--CA 1.436 -1.175 0 N-CA-C 104.829 -2.286 . . . . 0.0 104.829 -178.256 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.26 158.81 40.79 Favored 'General case' 0 N--CA 1.425 -1.707 1 N-CA-C 96.047 -5.538 . . . . 0.0 96.047 163.869 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.4 t -111.7 141.07 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.16 0 N-CA-C 103.505 -2.776 . . . . 0.0 103.505 -170.364 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 145.22 -66.41 0.43 Allowed Glycine 0 CA--C 1.482 -2.024 1 N-CA-C 103.054 -4.018 . . . . 0.0 103.054 179.857 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -97.31 -75.86 0.53 Allowed 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 172.49 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 171.46 -158.84 30.23 Favored Glycine 0 CA--C 1.477 -2.287 1 N-CA-C 102.562 -4.215 . . . . 0.0 102.562 -173.901 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.3 tt -69.01 137.16 53.45 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 -173.436 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -137.98 -179.01 5.52 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 104.346 -2.465 . . . . 0.0 104.346 -162.432 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 30.6 t -117.32 169.81 9.19 Favored 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 101.142 -3.651 . . . . 0.0 101.142 179.204 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 7.8 t-105 -131.44 150.42 52.16 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 102.452 -3.166 . . . . 0.0 102.452 -177.842 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 22.2 m -146.64 153.97 40.93 Favored 'General case' 0 CA--C 1.493 -1.25 0 N-CA-C 103.743 -2.688 . . . . 0.0 103.743 176.441 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -121.09 134.6 55.26 Favored 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 104.756 -2.313 . . . . 0.0 104.756 175.331 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 73.08 57.84 0.11 Allowed 'General case' 0 CA--C 1.492 -1.279 0 C-N-CA 126.941 2.096 . . . . 0.0 109.799 170.382 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 31.4 mt -96.32 144.25 27.51 Favored Pre-proline 0 CA--C 1.499 -0.987 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 176.967 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -66.6 164.37 29.19 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.562 2.174 . . . . 0.0 112.552 173.815 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -63.95 -27.58 69.24 Favored 'General case' 0 N--CA 1.442 -0.875 0 C-N-CA 125.224 1.409 . . . . 0.0 113.859 -173.455 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -94.97 17.25 14.23 Favored 'General case' 0 CA--C 1.503 -0.85 0 O-C-N 121.237 -0.915 . . . . 0.0 110.288 -174.796 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 20.4 t -97.21 122.84 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 N-CA-C 102.125 -3.287 . . . . 0.0 102.125 168.758 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -91.87 148.19 19.11 Favored Glycine 0 CA--C 1.488 -1.637 0 N-CA-C 104.817 -3.313 . . . . 0.0 104.817 179.272 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 25.5 pt -140.83 -149.68 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 N-CA-C 103.762 -2.681 . . . . 0.0 103.762 -169.284 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.858 HD13 ' HB2' ' A' ' 7' ' ' ALA . 5.7 mm -71.24 115.42 11.16 Favored 'Isoleucine or valine' 0 C--N 1.357 0.9 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 177.272 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.257 1.2 t -132.14 21.78 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.07 0 N-CA-C 102.519 -3.141 . . . . 0.0 102.519 -166.394 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.487 ' HA ' HD21 ' A' ' 11' ' ' ASN . 43.0 tt0 -65.28 134.85 54.5 Favored 'General case' 0 CA--C 1.498 -1.045 0 C-N-CA 127.034 2.134 . . . . 0.0 109.912 -175.071 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.89 -45.56 0.74 Allowed Glycine 0 N--CA 1.433 -1.566 1 N-CA-C 98.634 -5.787 . . . . 0.0 98.634 -158.426 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.465 ' HG3' ' H ' ' A' ' 64' ' ' LYS . 12.0 tp10 -98.99 -159.18 0.72 Allowed 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 102.73 -3.063 . . . . 0.0 102.73 156.594 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.465 ' H ' ' HG3' ' A' ' 63' ' ' GLU . 9.7 tptm -137.58 -165.55 1.79 Allowed 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 104.532 -2.396 . . . . 0.0 104.532 -170.846 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 37.7 t -82.13 147.85 28.83 Favored 'General case' 0 CA--C 1.496 -1.102 0 C-N-CA 126.465 1.906 . . . . 0.0 107.249 -177.174 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 10.3 p80 -141.96 156.21 45.46 Favored 'General case' 0 N--CA 1.427 -1.607 1 N-CA-C 97.413 -5.032 . . . . 0.0 97.413 165.491 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.4 m 179.53 177.7 0.57 Allowed 'General case' 0 N--CA 1.429 -1.511 1 N-CA-C 96.136 -5.505 . . . . 0.0 96.136 -179.815 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.357 0.901 0 O-C-N 124.429 1.081 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 17.0 m . . . . . 0 N--CA 1.485 1.312 0 CA-C-O 121.709 0.766 . . . . 0.0 110.864 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.5 HH21 HG12 ' A' ' 58' ' ' ILE . 21.1 mtp85 -115.67 159.8 20.87 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 -173.298 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -135.89 134.31 38.63 Favored 'General case' 0 CA--C 1.489 -1.402 1 N-CA-C 96.674 -5.306 . . . . 0.0 96.674 164.071 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.01 -178.22 35.72 Favored Glycine 0 CA--C 1.48 -2.108 0 N-CA-C 106.687 -2.565 . . . . 0.0 106.687 175.558 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -75.36 128.7 35.98 Favored 'General case' 0 CA--C 1.497 -1.076 0 N-CA-C 104.386 -2.45 . . . . 0.0 104.386 158.745 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.469 HG22 ' HB2' ' A' ' 47' ' ' CYS . 5.7 tt -89.85 136.92 22.54 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.975 0 N-CA-C 105.444 -2.058 . . . . 0.0 105.444 -173.733 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.427 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -97.39 -147.11 0.31 Allowed 'General case' 0 N--CA 1.423 -1.806 0 CA-C-N 112.067 -2.333 . . . . 0.0 106.938 174.622 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.404 ' H ' ' HB1' ' A' ' 7' ' ' ALA . 54.2 mt-30 -125.07 141.21 37.85 Favored Pre-proline 0 N--CA 1.42 -1.968 1 N-CA-C 93.575 -6.454 . . . . 0.0 93.575 168.831 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -80.54 23.38 0.71 Allowed 'Trans proline' 0 C--N 1.323 -0.769 0 C-N-CA 122.707 2.271 . . . . 0.0 114.276 -145.443 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -95.48 -82.0 0.39 Allowed 'General case' 0 CA--C 1.489 -1.368 0 N-CA-C 103.043 -2.947 . . . . 0.0 103.043 -179.965 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -165.38 123.78 1.64 Allowed 'General case' 0 N--CA 1.425 -1.698 1 N-CA-C 91.584 -7.191 . . . . 0.0 91.584 169.05 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.3 m -174.59 -166.14 0.24 Allowed 'General case' 0 CA--C 1.496 -1.127 0 N-CA-C 101.825 -3.398 . . . . 0.0 101.825 -179.163 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.419 HG12 HD12 ' A' ' 59' ' ' ILE . 0.9 OUTLIER -125.24 167.32 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.387 1 N-CA-C 96.829 -5.248 . . . . 0.0 96.829 160.039 . . . . . . . . 4 4 . 1 . 023 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -88.83 -159.01 0.53 Allowed 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 104.718 -2.327 . . . . 0.0 104.718 163.236 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 51.5 m80 -140.46 160.65 39.53 Favored 'General case' 0 N--CA 1.417 -2.112 1 N-CA-C 94.982 -5.932 . . . . 0.0 94.982 168.796 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.4 t -161.23 -153.63 0.31 Allowed 'General case' 0 N--CA 1.415 -2.191 1 N-CA-C 94.188 -6.227 . . . . 0.0 94.188 -178.896 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -147.33 174.2 3.58 Favored Pre-proline 0 N--CA 1.414 -2.238 1 N-CA-C 99.201 -4.37 . . . . 0.0 99.201 -166.069 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_exo -67.82 44.06 0.26 Allowed 'Trans proline' 0 C--N 1.321 -0.883 0 C-N-CA 123.635 2.89 . . . . 0.0 114.245 168.047 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -176.07 147.66 8.78 Favored Glycine 0 N--CA 1.425 -2.094 1 N-CA-C 98.884 -5.686 . . . . 0.0 98.884 179.232 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.3 m -79.36 -16.11 56.8 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -164.182 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.6 m -39.86 -56.75 1.72 Allowed 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 117.264 2.32 . . . . 0.0 117.264 -151.561 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -77.61 -34.59 39.07 Favored Glycine 0 C--N 1.349 1.301 0 O-C-N 121.291 -0.881 . . . . 0.0 111.131 -174.432 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.3 t -84.24 -12.32 54.95 Favored 'General case' 0 CA--C 1.499 -0.999 0 O-C-N 121.695 -0.885 . . . . 0.0 109.065 -172.792 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -62.88 -48.29 79.64 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 172.787 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -58.54 -48.28 81.38 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 123.235 0.614 . . . . 0.0 112.318 171.334 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 90.8 mt -63.97 -42.41 97.26 Favored 'General case' 0 C--N 1.357 0.934 0 CA-C-O 121.895 0.855 . . . . 0.0 111.445 -175.603 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 24.9 t -59.67 -46.97 87.45 Favored 'General case' 0 CA--C 1.5 -0.954 0 C-N-CA 125.304 1.442 . . . . 0.0 108.998 177.253 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 45.3 mttp -70.79 -40.57 72.5 Favored 'General case' 0 N--CA 1.438 -1.064 0 O-C-N 121.683 -0.635 . . . . 0.0 111.405 -173.568 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -71.05 -18.11 62.58 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 118.914 0.779 . . . . 0.0 112.601 -179.111 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -97.57 -1.84 43.03 Favored 'General case' 0 C--N 1.355 0.822 0 O-C-N 121.731 -0.606 . . . . 0.0 110.478 175.152 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.97 33.72 6.51 Favored Glycine 0 C--N 1.352 1.422 0 CA-C-O 119.762 -0.465 . . . . 0.0 112.122 167.209 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -104.79 125.58 8.39 Favored Glycine 0 CA--C 1.49 -1.506 0 N-CA-C 104.826 -3.309 . . . . 0.0 104.826 168.582 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.9 p -100.54 6.08 44.17 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-O 122.139 0.971 . . . . 0.0 109.694 -164.557 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 26.9 m -160.17 159.11 31.25 Favored 'General case' 0 CA--C 1.476 -1.87 1 N-CA-C 98.503 -4.629 . . . . 0.0 98.503 167.289 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -170.89 177.32 43.97 Favored Glycine 0 N--CA 1.418 -2.539 1 N-CA-C 99.421 -5.472 . . . . 0.0 99.421 -176.012 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 52.6 m80 -165.33 -172.96 2.65 Favored 'General case' 0 N--CA 1.431 -1.404 1 N-CA-C 97.18 -5.119 . . . . 0.0 97.18 -177.724 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 100.0 m -140.61 156.51 46.25 Favored 'General case' 0 CA--C 1.477 -1.84 0 N-CA-C 100.503 -3.888 . . . . 0.0 100.503 174.684 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 170.22 -168.74 41.69 Favored Glycine 0 N--CA 1.424 -2.108 1 N-CA-C 98.373 -5.891 . . . . 0.0 98.373 -169.128 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -152.85 -177.95 6.59 Favored 'General case' 0 N--CA 1.427 -1.611 1 N-CA-C 98.921 -4.474 . . . . 0.0 98.921 -177.591 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 25.2 tptp 128.11 63.66 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.149 2 C-N-CA 133.38 4.672 . . . . 0.0 99.372 -179.602 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.5 HG12 ' H ' ' A' ' 42' ' ' GLY . 2.7 t -146.17 -167.08 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.518 1 N-CA-C 97.277 -5.083 . . . . 0.0 97.277 -172.867 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.5 ' H ' HG12 ' A' ' 41' ' ' VAL . . . -139.81 68.77 0.48 Allowed Glycine 0 CA--C 1.487 -1.7 0 N-CA-C 105.616 -2.994 . . . . 0.0 105.616 -176.383 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 21.7 m170 -158.33 -107.43 0.02 OUTLIER 'General case' 0 N--CA 1.434 -1.272 0 N-CA-C 100.894 -3.743 . . . . 0.0 100.894 173.172 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -121.21 -70.39 0.28 Allowed Glycine 0 C--N 1.355 1.587 0 CA-C-N 120.111 1.323 . . . . 0.0 111.932 -170.559 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -149.53 179.78 7.7 Favored 'General case' 0 N--CA 1.434 -1.245 1 N-CA-C 95.328 -5.805 . . . . 0.0 95.328 176.499 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -157.03 -174.48 4.94 Favored 'General case' 0 CA--C 1.486 -1.498 1 N-CA-C 99.936 -4.098 . . . . 0.0 99.936 -179.81 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.469 ' HB2' HG22 ' A' ' 6' ' ' ILE . 1.6 m -116.31 -179.13 3.58 Favored 'General case' 0 CA--C 1.486 -1.484 0 N-CA-C 102.308 -3.219 . . . . 0.0 102.308 165.814 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 32.2 t-105 -122.07 153.53 38.52 Favored 'General case' 0 CA--C 1.496 -1.121 0 N-CA-C 102.885 -3.006 . . . . 0.0 102.885 174.275 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 37.3 m -145.64 147.46 32.04 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 170.457 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -114.08 144.24 43.45 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 105.024 -2.213 . . . . 0.0 105.024 173.572 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 69.7 42.9 1.03 Allowed 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 127.289 2.236 . . . . 0.0 111.602 167.215 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 38.7 mt -84.04 137.95 40.09 Favored Pre-proline 0 CA--C 1.504 -0.825 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 178.391 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -73.6 168.91 23.58 Favored 'Trans proline' 0 N--CA 1.447 -1.208 0 C-N-CA 122.187 1.925 . . . . 0.0 110.333 177.514 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -67.78 -9.22 42.3 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 124.652 1.181 . . . . 0.0 114.054 -171.317 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 -91.15 -0.12 57.64 Favored 'General case' 0 CA--C 1.507 -0.709 0 O-C-N 121.557 -0.715 . . . . 0.0 110.923 -176.946 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.46 HG12 ' H ' ' A' ' 57' ' ' GLY . 2.0 t -99.93 178.12 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 N-CA-C 103.755 -2.683 . . . . 0.0 103.755 179.463 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.46 ' H ' HG12 ' A' ' 56' ' ' VAL . . . -143.61 161.58 27.72 Favored Glycine 0 CA--C 1.479 -2.205 1 N-CA-C 100.086 -5.206 . . . . 0.0 100.086 -176.035 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.5 HG12 HH21 ' A' ' 2' ' ' ARG . 17.8 pt -152.99 -166.94 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.627 1 N-CA-C 99.32 -4.326 . . . . 0.0 99.32 -167.655 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.427 HD13 ' HB2' ' A' ' 7' ' ' ALA . 2.9 mm -63.7 134.28 28.79 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 179.146 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.8 t -144.0 169.21 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.822 1 N-CA-C 93.404 -6.517 . . . . 0.0 93.404 -179.183 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 24.6 tp10 -150.43 159.25 44.61 Favored 'General case' 0 N--CA 1.428 -1.556 1 N-CA-C 98.363 -4.681 . . . . 0.0 98.363 171.4 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 136.95 -41.6 1.39 Allowed Glycine 0 CA--C 1.489 -1.582 1 N-CA-C 102.42 -4.272 . . . . 0.0 102.42 -164.527 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -97.04 -106.42 0.17 Allowed 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 174.402 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 19.7 tptm 174.07 -140.63 0.0 OUTLIER 'General case' 0 CA--C 1.491 -1.31 1 N-CA-C 98.629 -4.582 . . . . 0.0 98.629 -167.508 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 43.3 t -110.52 129.17 55.85 Favored 'General case' 0 CA--C 1.485 -1.536 0 N-CA-C 100.515 -3.884 . . . . 0.0 100.515 165.155 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 3.0 p80 -154.28 166.13 34.12 Favored 'General case' 0 CA--C 1.481 -1.704 0 N-CA-C 100.652 -3.833 . . . . 0.0 100.652 -176.677 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 28.7 m -174.38 176.5 2.4 Favored 'General case' 0 N--CA 1.425 -1.705 1 N-CA-C 96.198 -5.482 . . . . 0.0 96.198 175.326 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.356 0.855 0 O-C-N 124.591 1.182 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 19.1 m . . . . . 0 N--CA 1.485 1.295 0 CA-C-O 121.403 0.621 . . . . 0.0 110.424 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -103.97 167.71 9.59 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 104.637 -2.357 . . . . 0.0 104.637 163.551 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -125.86 140.45 52.64 Favored 'General case' 0 CA--C 1.485 -1.556 1 N-CA-C 93.75 -6.389 . . . . 0.0 93.75 156.714 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.79 178.94 37.46 Favored Glycine 0 CA--C 1.474 -2.523 0 C-N-CA 116.904 -2.569 . . . . 0.0 107.513 -178.479 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -73.87 130.16 39.35 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 104.075 -2.565 . . . . 0.0 104.075 155.409 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.8 tt -90.63 137.81 20.86 Favored 'Isoleucine or valine' 0 C--O 1.253 1.275 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 179.247 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.594 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -100.24 -158.38 0.67 Allowed 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 112.755 -2.021 . . . . 0.0 107.484 176.062 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -98.87 142.39 24.52 Favored Pre-proline 0 CA--C 1.49 -1.344 1 N-CA-C 97.422 -5.029 . . . . 0.0 97.422 163.815 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -78.49 26.47 0.52 Allowed 'Trans proline' 0 CA--C 1.509 -0.759 0 C-N-CA 123.07 2.514 . . . . 0.0 114.654 -136.292 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -115.5 -78.95 0.58 Allowed 'General case' 0 N--CA 1.425 -1.704 0 N-CA-C 102.415 -3.18 . . . . 0.0 102.415 177.65 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -165.89 147.83 7.14 Favored 'General case' 0 N--CA 1.429 -1.513 1 N-CA-C 96.544 -5.354 . . . . 0.0 96.544 164.958 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 20.3 m 164.91 -152.73 0.0 OUTLIER 'General case' 0 CA--C 1.499 -1.017 1 N-CA-C 97.308 -5.071 . . . . 0.0 97.308 179.238 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.543 HG12 HD12 ' A' ' 59' ' ' ILE . 0.8 OUTLIER -126.77 163.69 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 1 N-CA-C 98.844 -4.502 . . . . 0.0 98.844 160.111 . . . . . . . . 4 4 . 1 . 024 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -87.8 -158.87 0.49 Allowed 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 104.79 -2.3 . . . . 0.0 104.79 164.447 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -142.82 -178.46 5.82 Favored 'General case' 0 N--CA 1.424 -1.735 1 N-CA-C 97.032 -5.173 . . . . 0.0 97.032 166.739 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.3 t -155.05 166.13 34.56 Favored 'General case' 0 N--CA 1.415 -2.19 1 N-CA-C 96.643 -5.318 . . . . 0.0 96.643 -171.513 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -121.84 125.24 26.78 Favored Pre-proline 0 N--CA 1.42 -1.951 1 N-CA-C 99.841 -4.133 . . . . 0.0 99.841 179.251 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -58.4 111.72 0.96 Allowed 'Trans proline' 0 CA--C 1.503 -1.046 0 C-N-CA 123.327 2.684 . . . . 0.0 112.653 -174.0 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 140.06 -36.79 1.78 Allowed Glycine 0 CA--C 1.49 -1.522 1 N-CA-C 102.739 -4.144 . . . . 0.0 102.739 -166.937 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.3 m 85.23 11.85 0.26 Allowed 'General case' 0 CA--C 1.496 -1.096 0 C-N-CA 128.187 2.595 . . . . 0.0 111.04 172.384 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -48.87 -55.17 12.5 Favored 'General case' 0 N--CA 1.436 -1.148 0 C-N-CA 129.4 3.08 . . . . 0.0 113.526 -169.822 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -85.95 -26.28 35.04 Favored Glycine 0 C--N 1.35 1.359 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 -172.75 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 15.7 t -79.53 -17.09 54.8 Favored 'General case' 0 C--N 1.354 0.78 0 O-C-N 122.238 -0.566 . . . . 0.0 110.187 -172.412 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -62.45 -43.09 99.64 Favored 'General case' 0 C--N 1.354 0.801 0 O-C-N 120.973 -1.079 . . . . 0.0 109.364 174.118 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -56.14 -54.24 47.42 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 124.262 1.025 . . . . 0.0 111.132 169.794 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 91.1 mt -61.75 -45.43 93.93 Favored 'General case' 0 CA--C 1.496 -1.122 0 C-N-CA 123.49 0.716 . . . . 0.0 111.036 -172.739 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.8 t -60.28 -46.5 89.63 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 123.711 0.805 . . . . 0.0 109.407 179.381 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 78.7 mttt -67.31 -43.0 82.74 Favored 'General case' 0 CA--C 1.502 -0.884 0 O-C-N 121.956 -0.465 . . . . 0.0 111.629 -177.329 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -75.26 -21.08 58.8 Favored 'General case' 0 CA--C 1.508 -0.641 0 O-C-N 121.606 -0.684 . . . . 0.0 112.432 -176.5 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -87.94 -15.94 35.19 Favored 'General case' 0 C--N 1.356 0.865 0 CA-C-N 118.971 0.805 . . . . 0.0 109.875 172.822 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.2 34.33 3.98 Favored Glycine 0 CA--C 1.492 -1.366 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 166.655 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -96.83 157.26 21.15 Favored Glycine 0 CA--C 1.491 -1.42 0 N-CA-C 105.535 -3.026 . . . . 0.0 105.535 164.786 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 30.4 m -85.09 -42.38 14.86 Favored 'General case' 0 CA--C 1.497 -1.063 0 CA-C-O 123.119 1.438 . . . . 0.0 107.988 -168.628 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.5 m -158.99 166.59 31.43 Favored 'General case' 0 N--CA 1.417 -2.104 1 N-CA-C 97.083 -5.155 . . . . 0.0 97.083 -178.9 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -175.11 175.6 47.13 Favored Glycine 0 N--CA 1.421 -2.312 1 N-CA-C 98.545 -5.822 . . . . 0.0 98.545 -169.459 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 34.2 p-80 -167.11 -179.35 4.56 Favored 'General case' 0 N--CA 1.428 -1.54 1 N-CA-C 98.575 -4.602 . . . . 0.0 98.575 -173.695 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 80.2 m -74.08 171.29 13.8 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-N 119.476 1.035 . . . . 0.0 111.13 -178.842 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.86 170.34 43.31 Favored Glycine 0 N--CA 1.422 -2.237 1 N-CA-C 99.466 -5.454 . . . . 0.0 99.466 178.525 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -138.39 136.23 36.09 Favored 'General case' 0 N--CA 1.429 -1.489 1 N-CA-C 97.258 -5.09 . . . . 0.0 97.258 177.796 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.5 tmtm? -118.61 102.27 8.75 Favored 'General case' 0 CA--C 1.494 -1.189 0 N-CA-C 102.341 -3.207 . . . . 0.0 102.341 -177.477 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.6 t -73.87 122.28 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 -172.407 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 139.86 -43.26 1.15 Allowed Glycine 0 CA--C 1.484 -1.897 0 N-CA-C 103.115 -3.994 . . . . 0.0 103.115 -171.687 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -113.42 -63.96 1.37 Allowed 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 178.488 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 164.1 -162.65 35.4 Favored Glycine 0 CA--C 1.489 -1.547 0 N-CA-C 108.112 -1.995 . . . . 0.0 108.112 -170.452 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 28.8 tp -63.5 133.96 54.78 Favored 'General case' 0 CA--C 1.501 -0.936 0 C-N-CA 127.768 2.427 . . . . 0.0 105.657 173.515 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -136.59 -158.28 0.85 Allowed 'General case' 0 CA--C 1.483 -1.597 0 N-CA-C 103.289 -2.856 . . . . 0.0 103.289 -167.253 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 52.9 t -138.52 168.72 19.16 Favored 'General case' 0 CA--C 1.49 -1.336 0 N-CA-C 101.683 -3.451 . . . . 0.0 101.683 163.322 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 42.0 t-105 -121.16 145.89 47.34 Favored 'General case' 0 CA--C 1.499 -1.0 0 N-CA-C 103.418 -2.808 . . . . 0.0 103.418 -177.444 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 6.9 m -141.06 146.29 36.96 Favored 'General case' 0 CA--C 1.49 -1.33 0 N-CA-C 105.623 -1.991 . . . . 0.0 105.623 177.159 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -113.51 130.99 56.23 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 179.066 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 65.64 78.65 0.27 Allowed 'General case' 0 CA--C 1.491 -1.318 0 C-N-CA 129.378 3.071 . . . . 0.0 110.422 178.462 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -104.98 125.71 32.98 Favored Pre-proline 0 CA--C 1.496 -1.111 0 N-CA-C 102.216 -3.253 . . . . 0.0 102.216 177.9 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -72.06 170.74 18.25 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 CA-C-N 123.514 2.291 . . . . 0.0 110.126 174.169 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -85.67 18.15 2.99 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -165.64 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -100.92 1.28 39.68 Favored 'General case' 0 CA--C 1.502 -0.885 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 174.045 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.2 t -110.69 133.7 55.32 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.082 0 N-CA-C 103.68 -2.711 . . . . 0.0 103.68 -174.669 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -100.58 148.77 18.41 Favored Glycine 0 CA--C 1.489 -1.579 0 N-CA-C 106.097 -2.801 . . . . 0.0 106.097 178.611 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 25.3 pt -129.83 -146.57 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.492 -1.265 0 N-CA-C 104.222 -2.51 . . . . 0.0 104.222 -169.213 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.594 HD13 ' HB2' ' A' ' 7' ' ' ALA . 3.1 mm -73.03 1.42 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.747 0 CA-C-N 118.904 0.774 . . . . 0.0 112.194 -172.484 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.37 164.69 15.52 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.298 0 O-C-N 119.109 -2.244 . . . . 0.0 105.853 161.353 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -179.22 -62.75 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.274 1 N-CA-C 97.571 -4.974 . . . . 0.0 97.571 -161.544 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -156.36 157.34 27.82 Favored Glycine 0 N--CA 1.424 -2.147 1 N-CA-C 93.655 -7.778 . . . . 0.0 93.655 165.566 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -88.59 95.07 10.1 Favored 'General case' 0 CA--C 1.499 -0.988 0 CA-C-N 119.714 1.757 . . . . 0.0 108.096 -170.37 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -165.66 176.77 7.79 Favored 'General case' 0 N--CA 1.429 -1.49 1 N-CA-C 98.795 -4.52 . . . . 0.0 98.795 174.152 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 1.8 t -128.36 135.23 49.29 Favored 'General case' 0 CA--C 1.487 -1.48 1 N-CA-C 98.754 -4.536 . . . . 0.0 98.754 -179.243 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 3.4 p80 -168.61 146.56 4.04 Favored 'General case' 0 N--CA 1.427 -1.606 1 N-CA-C 98.097 -4.779 . . . . 0.0 98.097 -175.736 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 60.2 m -153.3 158.37 41.5 Favored 'General case' 0 N--CA 1.427 -1.615 1 N-CA-C 95.053 -5.906 . . . . 0.0 95.053 -178.832 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.36 1.028 0 O-C-N 124.258 0.974 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 22.8 m . . . . . 0 N--CA 1.484 1.252 0 CA-C-O 121.202 0.525 . . . . 0.0 110.512 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.46 174.97 5.65 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 103.439 -2.8 . . . . 0.0 103.439 160.798 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -126.22 142.02 51.69 Favored 'General case' 0 CA--C 1.489 -1.399 1 N-CA-C 93.354 -6.535 . . . . 0.0 93.354 162.716 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.28 170.74 37.14 Favored Glycine 0 CA--C 1.47 -2.732 0 N-CA-C 106.446 -2.662 . . . . 0.0 106.446 -174.292 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -88.77 125.22 34.78 Favored 'General case' 0 CA--C 1.488 -1.411 0 N-CA-C 100.708 -3.812 . . . . 0.0 100.708 162.611 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.9 tt -87.84 140.72 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.088 0 N-CA-C 105.58 -2.007 . . . . 0.0 105.58 -174.271 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.625 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -116.41 -158.55 0.69 Allowed 'General case' 0 N--CA 1.424 -1.727 0 C-N-CA 128.12 2.568 . . . . 0.0 107.55 -175.118 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -88.3 144.5 34.16 Favored Pre-proline 0 N--CA 1.44 -0.928 0 N-CA-C 100.493 -3.891 . . . . 0.0 100.493 162.239 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -78.36 27.16 0.5 Allowed 'Trans proline' 0 CA--C 1.511 -0.637 0 C-N-CA 123.322 2.681 . . . . 0.0 113.811 -152.897 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.43 ' HB3' ' NE2' ' A' ' 66' ' ' HIS . 53.6 mp0 -111.37 -82.07 0.58 Allowed 'General case' 0 N--CA 1.425 -1.699 0 N-CA-C 101.912 -3.366 . . . . 0.0 101.912 178.955 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -163.47 143.95 8.92 Favored 'General case' 0 N--CA 1.424 -1.754 1 N-CA-C 93.521 -6.474 . . . . 0.0 93.521 167.496 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 9.1 m 170.66 -156.21 0.01 OUTLIER 'General case' 0 CA--C 1.494 -1.178 1 N-CA-C 98.166 -4.753 . . . . 0.0 98.166 175.203 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.599 HG12 HD12 ' A' ' 59' ' ' ILE . 7.8 m -130.98 168.4 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.531 1 N-CA-C 96.815 -5.254 . . . . 0.0 96.815 160.284 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -89.89 163.55 14.95 Favored 'General case' 0 CA--C 1.499 -1.018 0 N-CA-C 100.957 -3.72 . . . . 0.0 100.957 161.915 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 71.3 m80 -108.13 101.2 10.45 Favored 'General case' 0 CA--C 1.48 -1.727 0 N-CA-C 102.74 -3.059 . . . . 0.0 102.74 -174.654 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.8 t -107.44 -171.51 1.89 Allowed 'General case' 0 N--CA 1.425 -1.7 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 -177.896 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -142.43 167.9 15.02 Favored Pre-proline 0 N--CA 1.416 -2.148 1 N-CA-C 98.552 -4.61 . . . . 0.0 98.552 -160.289 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.94 54.23 2.09 Favored 'Trans proline' 0 C--N 1.327 -0.588 0 C-N-CA 123.259 2.639 . . . . 0.0 110.749 166.497 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -178.51 134.16 2.3 Favored Glycine 0 N--CA 1.425 -2.068 1 N-CA-C 99.403 -5.479 . . . . 0.0 99.403 -178.519 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.98 26.06 9.17 Favored 'General case' 0 N--CA 1.434 -1.249 0 C-N-CA 124.305 1.042 . . . . 0.0 109.722 -168.938 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.5 m -49.68 -48.26 49.67 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 126.73 2.012 . . . . 0.0 115.37 -169.759 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -90.1 -26.35 24.18 Favored Glycine 0 C--N 1.351 1.364 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 -179.374 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -85.88 -14.69 44.12 Favored 'General case' 0 CA--C 1.5 -0.976 0 O-C-N 121.53 -0.982 . . . . 0.0 109.989 -167.946 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -58.9 -49.54 77.4 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 125.724 1.61 . . . . 0.0 108.113 171.979 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.4 -45.25 93.98 Favored 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 124.599 1.16 . . . . 0.0 112.162 174.173 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 95.9 mt -64.34 -41.29 96.84 Favored 'General case' 0 C--N 1.357 0.933 0 CA-C-O 121.69 0.757 . . . . 0.0 111.9 -178.064 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 13.2 t -59.79 -44.72 93.81 Favored 'General case' 0 N--CA 1.443 -0.799 0 O-C-N 121.59 -0.694 . . . . 0.0 109.815 176.776 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 46.1 mttp -63.66 -50.9 67.44 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 123.129 0.571 . . . . 0.0 111.163 -177.581 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -67.71 -23.57 65.29 Favored 'General case' 0 C--N 1.351 0.674 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -175.549 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -91.71 -5.72 53.22 Favored 'General case' 0 C--N 1.357 0.902 0 O-C-N 121.728 -0.607 . . . . 0.0 110.701 177.718 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.25 32.37 5.82 Favored Glycine 0 CA--C 1.492 -1.386 0 N-CA-C 111.579 -0.608 . . . . 0.0 111.579 165.713 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -108.75 140.26 15.51 Favored Glycine 0 CA--C 1.486 -1.735 0 N-CA-C 106.173 -2.771 . . . . 0.0 106.173 170.857 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.78 -76.29 0.34 Allowed 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 -171.814 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.8 m -85.85 151.83 23.48 Favored 'General case' 0 CA--C 1.491 -1.293 0 N-CA-C 105.496 -2.038 . . . . 0.0 105.496 176.706 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -158.41 171.61 35.26 Favored Glycine 0 N--CA 1.414 -2.787 1 N-CA-C 99.246 -5.542 . . . . 0.0 99.246 -175.936 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 52.9 m80 -168.0 -170.38 1.33 Allowed 'General case' 0 N--CA 1.426 -1.662 1 N-CA-C 95.982 -5.562 . . . . 0.0 95.982 -176.156 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 46.8 m -138.09 161.47 36.69 Favored 'General case' 0 N--CA 1.427 -1.579 1 N-CA-C 97.465 -5.013 . . . . 0.0 97.465 167.602 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 178.29 179.49 48.25 Favored Glycine 0 CA--C 1.481 -2.06 1 N-CA-C 100.779 -4.928 . . . . 0.0 100.779 -174.018 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -144.46 138.83 27.93 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 100.228 -3.989 . . . . 0.0 100.228 -170.294 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -148.11 50.39 1.03 Allowed 'General case' 0 CA--C 1.491 -1.302 1 N-CA-C 99.599 -4.223 . . . . 0.0 99.599 170.549 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . 0.275 2.2 t 60.61 -142.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.142 0 C-N-CA 125.84 1.656 . . . . 0.0 106.84 -160.288 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 121.55 -86.09 0.39 Allowed Glycine 0 CA--C 1.484 -1.899 1 N-CA-C 102.894 -4.082 . . . . 0.0 102.894 -176.714 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 26.1 m170 -159.93 -47.9 0.05 Allowed 'General case' 0 CA--C 1.498 -1.033 0 N-CA-C 104.726 -2.324 . . . . 0.0 104.726 -175.486 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -160.07 -176.89 32.65 Favored Glycine 0 N--CA 1.428 -1.878 1 N-CA-C 97.119 -6.393 . . . . 0.0 97.119 -178.508 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.7 tt -73.33 120.63 19.21 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 118.61 1.205 . . . . 0.0 108.689 -169.567 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -105.22 179.01 4.4 Favored 'General case' 0 CA--C 1.491 -1.308 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -162.82 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 58.9 m -109.46 157.13 19.26 Favored 'General case' 0 CA--C 1.486 -1.486 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 179.79 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 65.7 t-105 -109.88 148.93 30.65 Favored 'General case' 0 CA--C 1.487 -1.479 0 N-CA-C 103.717 -2.697 . . . . 0.0 103.717 179.591 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 45.1 m -140.94 141.81 34.45 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 101.72 -3.437 . . . . 0.0 101.72 167.382 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -108.61 17.12 22.33 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-O 121.396 0.617 . . . . 0.0 109.653 -166.679 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -171.0 144.52 2.15 Favored 'General case' 0 N--CA 1.418 -2.042 1 N-CA-C 93.624 -6.436 . . . . 0.0 93.624 172.364 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 17.0 mt -153.48 146.22 17.54 Favored Pre-proline 0 CA--C 1.487 -1.445 1 N-CA-C 97.325 -5.065 . . . . 0.0 97.325 155.61 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.38 170.21 19.8 Favored 'Trans proline' 0 N--CA 1.447 -1.207 0 C-N-CA 122.6 2.2 . . . . 0.0 109.221 173.33 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -65.89 -19.79 66.0 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -167.259 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -83.61 -2.37 55.94 Favored 'General case' 0 CA--C 1.501 -0.923 0 C-N-CA 124.18 0.992 . . . . 0.0 111.289 -172.923 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.8 t -100.09 126.31 53.62 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.303 0 N-CA-C 103.753 -2.684 . . . . 0.0 103.753 -177.67 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -92.68 158.71 24.4 Favored Glycine 0 CA--C 1.485 -1.8 0 N-CA-C 105.324 -3.11 . . . . 0.0 105.324 178.559 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 25.8 pt -144.89 -156.99 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.517 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 -166.491 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.625 HD13 ' HB2' ' A' ' 7' ' ' ALA . 0.7 OUTLIER -71.93 128.03 34.51 Favored 'Isoleucine or valine' 0 C--N 1.365 1.247 0 N-CA-C 104.967 -2.234 . . . . 0.0 104.967 176.085 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.6 t -110.91 109.49 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.596 0 N-CA-C 101.292 -3.596 . . . . 0.0 101.292 176.886 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.517 ' HG3' ' H ' ' A' ' 62' ' ' GLY . 17.4 tp10 60.47 -120.21 0.88 Allowed 'General case' 0 C--N 1.361 1.076 0 C-N-CA 125.712 1.605 . . . . 0.0 106.961 -173.911 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.517 ' H ' ' HG3' ' A' ' 61' ' ' GLU . . . -145.72 50.78 0.61 Allowed Glycine 0 N--CA 1.431 -1.668 1 N-CA-C 98.567 -5.813 . . . . 0.0 98.567 156.655 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -79.82 -58.5 3.14 Favored 'General case' 0 CA--C 1.493 -1.234 0 O-C-N 122.278 -0.542 . . . . 0.0 110.192 -164.854 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 19.9 tttm -147.64 177.91 8.89 Favored 'General case' 0 CA--C 1.489 -1.378 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 -171.781 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 24.8 t -142.72 138.82 30.82 Favored 'General case' 0 N--CA 1.416 -2.13 1 N-CA-C 94.451 -6.129 . . . . 0.0 94.451 175.834 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.43 ' NE2' ' HB3' ' A' ' 10' ' ' GLU . 0.4 OUTLIER -163.48 157.06 19.28 Favored 'General case' 0 N--CA 1.43 -1.465 1 N-CA-C 97.637 -4.949 . . . . 0.0 97.637 176.907 . . . . . . . . 4 4 . 1 . 025 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.1 m -142.55 143.18 32.37 Favored 'General case' 0 N--CA 1.428 -1.534 1 N-CA-C 98.017 -4.809 . . . . 0.0 98.017 -168.353 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.359 1.01 0 O-C-N 124.448 1.092 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 4.8 m . . . . . 0 N--CA 1.483 1.185 0 CA-C-O 122.443 1.116 . . . . 0.0 111.065 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 34.6 mtp85 -97.26 151.38 19.93 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 -171.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -130.63 125.3 33.71 Favored 'General case' 0 CA--C 1.485 -1.519 1 N-CA-C 96.597 -5.335 . . . . 0.0 96.597 165.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.76 -178.12 35.41 Favored Glycine 0 CA--C 1.477 -2.32 0 N-CA-C 103.162 -3.975 . . . . 0.0 103.162 176.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 48' ' ' TRP . 85.3 m-85 -76.88 133.33 39.32 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 168.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 17.4 tt -91.34 147.49 5.22 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 CA-C-N 120.163 1.347 . . . . 0.0 108.406 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.664 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -134.87 -150.98 0.41 Allowed 'General case' 0 N--CA 1.426 -1.654 0 C-N-CA 127.657 2.383 . . . . 0.0 106.869 -177.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -125.67 144.96 49.85 Favored Pre-proline 0 N--CA 1.426 -1.668 1 N-CA-C 94.661 -6.052 . . . . 0.0 94.661 162.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -80.6 -1.77 11.49 Favored 'Trans proline' 0 CA--C 1.501 -1.143 0 CA-C-N 123.165 2.166 . . . . 0.0 112.714 -143.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 48.8 mm-40 -86.37 46.85 1.39 Allowed 'General case' 0 N--CA 1.438 -1.043 0 C-N-CA 124.574 1.15 . . . . 0.0 109.874 -167.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.43 ' O ' ' HE1' ' A' ' 43' ' ' HIS . 0.2 OUTLIER 65.59 45.87 2.6 Favored 'General case' 0 C--N 1.356 0.889 0 C-N-CA 126.343 1.857 . . . . 0.0 107.598 177.355 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 94.9 m -122.38 -162.64 1.02 Allowed 'General case' 0 CA--C 1.486 -1.502 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 -169.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.671 HG12 HD12 ' A' ' 59' ' ' ILE . 0.6 OUTLIER -141.59 170.26 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.838 1 N-CA-C 96.897 -5.223 . . . . 0.0 96.897 173.137 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -98.2 -163.95 1.09 Allowed 'General case' 0 CA--C 1.5 -0.966 0 N-CA-C 101.254 -3.61 . . . . 0.0 101.254 163.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 69.8 m80 -139.56 162.67 34.5 Favored 'General case' 0 CA--C 1.482 -1.672 1 N-CA-C 96.085 -5.524 . . . . 0.0 96.085 166.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 8.4 t -123.03 164.36 18.72 Favored 'General case' 0 CA--C 1.477 -1.837 0 N-CA-C 101.965 -3.346 . . . . 0.0 101.965 -167.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -112.53 122.06 37.32 Favored Pre-proline 0 N--CA 1.425 -1.693 1 N-CA-C 97.341 -5.059 . . . . 0.0 97.341 166.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_exo -56.34 96.47 0.06 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.578 0 CA-C-N 123.823 2.401 . . . . 0.0 117.081 -169.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 162.28 -161.06 33.23 Favored Glycine 0 N--CA 1.417 -2.568 1 N-CA-C 97.597 -6.201 . . . . 0.0 97.597 -179.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -84.86 -45.35 12.37 Favored 'General case' 0 N--CA 1.426 -1.652 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 176.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.9 m -39.29 -56.22 1.57 Allowed 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 117.356 2.354 . . . . 0.0 117.356 -145.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -68.34 -74.74 0.57 Allowed Glycine 0 C--N 1.351 1.363 0 O-C-N 121.606 -0.683 . . . . 0.0 111.815 -176.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.6 p -87.0 -6.02 58.89 Favored 'General case' 0 CA--C 1.497 -1.073 0 O-C-N 121.219 -1.165 . . . . 0.0 113.048 -166.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -69.88 -33.72 72.6 Favored 'General case' 0 C--N 1.359 0.983 0 CA-C-N 119.774 1.17 . . . . 0.0 108.276 166.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 26.6 m -70.27 -42.02 72.68 Favored 'General case' 0 N--CA 1.447 -0.624 0 O-C-N 120.936 -1.102 . . . . 0.0 108.679 177.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 96.3 mt -61.31 -40.41 94.06 Favored 'General case' 0 C--N 1.355 0.824 0 CA-C-O 121.73 0.776 . . . . 0.0 110.734 175.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.0 t -55.13 -43.34 74.03 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 123.841 0.856 . . . . 0.0 111.256 174.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -60.51 -46.55 89.73 Favored 'General case' 0 C--N 1.356 0.884 0 CA-C-N 118.361 0.528 . . . . 0.0 111.877 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -76.83 -23.57 52.75 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -174.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -80.79 -30.93 35.88 Favored 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 173.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 117.56 35.59 1.07 Allowed Glycine 0 CA--C 1.487 -1.67 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 162.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.58 142.89 15.72 Favored Glycine 0 CA--C 1.488 -1.638 0 N-CA-C 105.097 -3.201 . . . . 0.0 105.097 173.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.3 p -105.17 15.4 27.54 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-O 121.657 0.741 . . . . 0.0 109.798 -167.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 65.8 m -158.39 154.92 27.75 Favored 'General case' 0 CA--C 1.475 -1.92 1 N-CA-C 98.405 -4.665 . . . . 0.0 98.405 159.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -153.87 147.85 17.72 Favored Glycine 0 CA--C 1.468 -2.853 1 N-CA-C 97.491 -6.243 . . . . 0.0 97.491 -170.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -156.61 -171.37 3.66 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 101.566 -3.494 . . . . 0.0 101.566 -171.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 79.3 m -103.36 -179.38 3.93 Favored 'General case' 0 CA--C 1.491 -1.307 0 N-CA-C 104.278 -2.49 . . . . 0.0 104.278 174.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.17 178.29 45.2 Favored Glycine 0 N--CA 1.421 -2.347 0 N-CA-C 103.505 -3.838 . . . . 0.0 103.505 170.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -131.45 133.4 45.13 Favored 'General case' 0 CA--C 1.488 -1.418 1 N-CA-C 98.912 -4.477 . . . . 0.0 98.912 172.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -118.93 99.25 6.63 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 102.2 -3.259 . . . . 0.0 102.2 178.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.0 t -69.34 129.91 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 -175.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 124.75 -41.55 1.69 Allowed Glycine 0 CA--C 1.488 -1.649 0 N-CA-C 104.516 -3.434 . . . . 0.0 104.516 -168.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.43 ' HE1' ' O ' ' A' ' 11' ' ' ASN . 14.2 m-70 -108.94 -69.85 0.84 Allowed 'General case' 0 CA--C 1.496 -1.102 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 176.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 158.39 -155.49 26.51 Favored Glycine 0 N--CA 1.429 -1.823 0 N-CA-C 103.915 -3.674 . . . . 0.0 103.915 -170.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.1 tt -73.43 141.66 46.91 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 105.953 -1.869 . . . . 0.0 105.953 -178.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.78 -172.75 3.46 Favored 'General case' 0 CA--C 1.489 -1.394 0 N-CA-C 104.116 -2.55 . . . . 0.0 104.116 -168.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 45.5 m -117.5 176.61 5.09 Favored 'General case' 0 CA--C 1.477 -1.838 0 N-CA-C 103.001 -2.963 . . . . 0.0 103.001 170.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.428 ' HA ' ' HA ' ' A' ' 5' ' ' TYR . 8.1 t-105 -138.79 151.89 47.43 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 102.89 -3.004 . . . . 0.0 102.89 -178.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 4.4 m -143.78 156.18 44.41 Favored 'General case' 0 CA--C 1.486 -1.517 0 N-CA-C 104.927 -2.249 . . . . 0.0 104.927 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -127.77 136.87 52.09 Favored 'General case' 0 CA--C 1.49 -1.36 0 N-CA-C 104.219 -2.511 . . . . 0.0 104.219 175.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 73.9 49.73 0.12 Allowed 'General case' 0 CA--C 1.493 -1.233 0 C-N-CA 126.671 1.988 . . . . 0.0 110.549 170.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 50.2 mt -89.33 141.83 29.31 Favored Pre-proline 0 CA--C 1.504 -0.803 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 177.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -66.1 162.51 35.3 Favored 'Trans proline' 0 N--CA 1.448 -1.175 0 C-N-CA 122.222 1.948 . . . . 0.0 111.906 177.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -60.2 -17.11 38.94 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -86.2 -1.02 57.07 Favored 'General case' 0 CA--C 1.504 -0.825 0 O-C-N 121.55 -0.719 . . . . 0.0 111.208 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.1 t -94.14 156.72 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 N-CA-C 103.472 -2.788 . . . . 0.0 103.472 177.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -141.28 152.81 23.56 Favored Glycine 0 CA--C 1.48 -2.122 1 N-CA-C 98.103 -5.999 . . . . 0.0 98.103 -177.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 21.4 pt -146.21 -144.25 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 N-CA-C 104.66 -2.348 . . . . 0.0 104.66 -156.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.671 HD12 HG12 ' A' ' 13' ' ' VAL . 1.9 mm -68.74 147.06 12.42 Favored 'Isoleucine or valine' 0 C--N 1.359 0.98 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 178.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 15.5 t . . . . . 0 N--CA 1.427 -1.596 1 N-CA-C 94.511 -6.107 . . . . 0.0 94.511 177.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 30.3 m . . . . . 0 N--CA 1.481 1.093 0 CA-C-O 121.228 0.537 . . . . 0.0 110.089 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -83.52 157.34 22.4 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 173.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -124.71 125.8 44.67 Favored 'General case' 0 CA--C 1.49 -1.337 1 N-CA-C 92.769 -6.752 . . . . 0.0 92.769 151.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.54 178.54 37.4 Favored Glycine 0 CA--C 1.473 -2.568 0 N-CA-C 106.022 -2.831 . . . . 0.0 106.022 -170.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 48' ' ' TRP . 65.0 m-85 -87.12 125.03 33.88 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 171.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.467 HG13 HG22 ' A' ' 58' ' ' ILE . 18.6 tt -90.51 152.07 3.4 Favored 'Isoleucine or valine' 0 C--N 1.357 0.93 0 CA-C-N 120.272 1.396 . . . . 0.0 108.143 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.808 ' HB2' HD12 ' A' ' 59' ' ' ILE . . . -144.09 -159.19 0.96 Allowed 'General case' 0 N--CA 1.418 -2.053 0 C-N-CA 126.426 1.89 . . . . 0.0 107.83 -167.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 -105.48 144.29 28.52 Favored Pre-proline 0 N--CA 1.432 -1.356 1 N-CA-C 99.345 -4.317 . . . . 0.0 99.345 158.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -79.04 -12.34 14.56 Favored 'Trans proline' 0 CA--C 1.503 -1.052 0 CA-C-N 122.236 1.834 . . . . 0.0 112.544 -153.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -87.59 55.49 3.52 Favored 'General case' 0 C--N 1.36 1.022 0 CA-C-N 120.591 1.541 . . . . 0.0 108.666 -173.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.5 t30 73.24 37.4 0.75 Allowed 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 128.075 2.55 . . . . 0.0 110.993 168.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -108.94 -162.33 0.81 Allowed 'General case' 0 CA--C 1.504 -0.816 0 O-C-N 121.053 -1.029 . . . . 0.0 111.693 -167.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.754 HG12 HD11 ' A' ' 59' ' ' ILE . 3.7 m -133.96 170.46 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.225 1 N-CA-C 98.662 -4.569 . . . . 0.0 98.662 162.241 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . 0.313 1.3 m-85 -111.15 151.17 28.48 Favored 'General case' 0 CA--C 1.487 -1.456 1 N-CA-C 95.1 -5.889 . . . . 0.0 95.1 166.041 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 34.8 m80 -92.21 144.65 25.2 Favored 'General case' 0 CA--C 1.496 -1.109 0 N-CA-C 102.772 -3.047 . . . . 0.0 102.772 171.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 39.0 t -92.41 164.77 13.36 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 -177.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -108.29 101.78 43.69 Favored Pre-proline 0 N--CA 1.425 -1.712 1 N-CA-C 98.959 -4.46 . . . . 0.0 98.959 169.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -68.18 107.78 1.62 Allowed 'Trans proline' 0 CA--C 1.501 -1.147 0 C-N-CA 122.367 2.045 . . . . 0.0 110.58 -161.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 160.79 -45.2 0.41 Allowed Glycine 0 CA--C 1.48 -2.104 1 N-CA-C 97.972 -6.051 . . . . 0.0 97.972 -169.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.2 m 122.8 -34.91 0.01 OUTLIER 'General case' 0 CA--C 1.487 -1.47 0 C-N-CA 128.8 2.84 . . . . 0.0 107.898 161.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 m -38.9 -51.92 1.76 Allowed 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 127.644 2.377 . . . . 0.0 116.377 -160.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.14 -41.99 68.53 Favored Glycine 0 C--N 1.355 1.594 0 O-C-N 121.287 -0.883 . . . . 0.0 111.513 -176.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.8 t -88.09 -24.88 23.29 Favored 'General case' 0 CA--C 1.496 -1.105 0 O-C-N 121.562 -0.964 . . . . 0.0 109.037 -171.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -65.83 -36.51 83.68 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 170.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 44.0 m -64.42 -37.85 88.95 Favored 'General case' 0 C--N 1.348 0.517 0 O-C-N 121.055 -1.028 . . . . 0.0 110.635 174.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 78.8 mt -63.96 -40.04 95.51 Favored 'General case' 0 C--N 1.357 0.931 0 CA-C-O 122.192 0.996 . . . . 0.0 110.559 175.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 38.3 t -58.17 -46.04 86.43 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.109 1.363 . . . . 0.0 110.347 174.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.17 -49.22 76.69 Favored 'General case' 0 C--N 1.359 0.984 0 O-C-N 121.752 -0.592 . . . . 0.0 110.613 -178.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -70.1 -21.18 63.15 Favored 'General case' 0 C--N 1.354 0.802 0 O-C-N 121.688 -0.632 . . . . 0.0 112.626 -173.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -96.5 5.79 50.09 Favored 'General case' 0 C--N 1.355 0.846 0 O-C-N 121.671 -0.643 . . . . 0.0 110.52 177.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.37 36.94 19.18 Favored Glycine 0 CA--C 1.493 -1.311 0 O-C-N 121.847 -0.533 . . . . 0.0 111.937 169.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -97.27 138.91 14.18 Favored Glycine 0 CA--C 1.487 -1.672 1 N-CA-C 102.862 -4.095 . . . . 0.0 102.862 164.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.4 m -105.96 -5.12 19.86 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -156.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 71.5 m -160.72 177.74 10.16 Favored 'General case' 0 CA--C 1.496 -1.121 1 N-CA-C 97.948 -4.834 . . . . 0.0 97.948 163.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -176.3 -170.88 39.49 Favored Glycine 0 CA--C 1.476 -2.369 1 N-CA-C 102.112 -4.395 . . . . 0.0 102.112 178.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -177.76 -154.51 0.03 OUTLIER 'General case' 0 N--CA 1.426 -1.634 1 N-CA-C 95.504 -5.739 . . . . 0.0 95.504 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 98.2 m -146.37 -176.6 5.24 Favored 'General case' 0 CA--C 1.48 -1.717 0 N-CA-C 101.24 -3.615 . . . . 0.0 101.24 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -175.66 -164.13 29.58 Favored Glycine 0 N--CA 1.422 -2.258 1 N-CA-C 99.971 -5.251 . . . . 0.0 99.971 -177.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -126.44 148.83 49.58 Favored 'General case' 0 N--CA 1.431 -1.385 1 N-CA-C 100.124 -4.028 . . . . 0.0 100.124 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -129.33 106.84 9.08 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 103.451 -2.796 . . . . 0.0 103.451 174.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.3 t -73.21 124.83 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 -174.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 134.95 -43.86 1.22 Allowed Glycine 0 CA--C 1.483 -1.944 0 N-CA-C 104.863 -3.295 . . . . 0.0 104.863 -171.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 38.9 m170 -114.97 -71.67 0.73 Allowed 'General case' 0 CA--C 1.498 -1.047 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 175.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 166.83 -145.25 9.74 Favored Glycine 0 N--CA 1.429 -1.78 0 N-CA-C 106.678 -2.569 . . . . 0.0 106.678 -177.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 45.9 tp -66.42 133.39 50.35 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 126.448 1.899 . . . . 0.0 106.458 177.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -138.49 171.86 13.75 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 102.84 -3.022 . . . . 0.0 102.84 -167.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 63.3 m -114.93 -179.94 3.77 Favored 'General case' 0 CA--C 1.484 -1.591 0 N-CA-C 102.991 -2.966 . . . . 0.0 102.991 176.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.461 ' HA ' ' HA ' ' A' ' 5' ' ' TYR . 9.8 t-105 -144.94 151.38 38.57 Favored 'General case' 0 CA--C 1.493 -1.239 0 N-CA-C 102.932 -2.988 . . . . 0.0 102.932 -174.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 45.8 m -137.26 151.73 49.02 Favored 'General case' 0 CA--C 1.487 -1.466 0 N-CA-C 104.697 -2.335 . . . . 0.0 104.697 172.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -115.57 130.7 56.96 Favored 'General case' 0 CA--C 1.495 -1.144 0 N-CA-C 103.794 -2.669 . . . . 0.0 103.794 170.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 65.01 72.58 0.43 Allowed 'General case' 0 CA--C 1.498 -1.041 0 C-N-CA 126.449 1.9 . . . . 0.0 110.685 175.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 20.9 mt -104.46 139.35 20.02 Favored Pre-proline 0 CA--C 1.492 -1.26 0 N-CA-C 102.197 -3.26 . . . . 0.0 102.197 166.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -70.67 168.48 22.62 Favored 'Trans proline' 0 N--CA 1.447 -1.24 0 C-N-CA 122.605 2.204 . . . . 0.0 110.114 175.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -84.07 5.42 26.03 Favored 'General case' 0 N--CA 1.443 -0.822 0 O-C-N 121.634 -0.666 . . . . 0.0 112.787 -164.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 -92.3 0.31 57.44 Favored 'General case' 0 CA--C 1.502 -0.876 0 O-C-N 121.638 -0.664 . . . . 0.0 109.584 176.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.1 t -91.65 163.12 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 N-CA-C 104.764 -2.31 . . . . 0.0 104.764 178.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -141.41 150.45 21.89 Favored Glycine 0 CA--C 1.483 -1.935 1 N-CA-C 97.552 -6.219 . . . . 0.0 97.552 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.467 HG22 HG13 ' A' ' 6' ' ' ILE . 16.6 pt -152.32 -140.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 N-CA-C 104.216 -2.513 . . . . 0.0 104.216 -155.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.808 HD12 ' HB2' ' A' ' 7' ' ' ALA . 1.7 mp -65.06 126.52 24.22 Favored 'Isoleucine or valine' 0 C--N 1.362 1.128 0 N-CA-C 104.792 -2.299 . . . . 0.0 104.792 163.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.7 t . . . . . 0 N--CA 1.422 -1.839 1 N-CA-C 95.568 -5.716 . . . . 0.0 95.568 -178.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 27.2 m . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 121.272 0.558 . . . . 0.0 109.728 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.02 169.07 17.35 Favored 'General case' 0 N--CA 1.434 -1.23 1 N-CA-C 98.578 -4.601 . . . . 0.0 98.578 167.618 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 -130.63 133.06 45.82 Favored 'General case' 0 CA--C 1.48 -1.737 1 N-CA-C 94.366 -6.161 . . . . 0.0 94.366 169.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.66 -178.23 35.4 Favored Glycine 0 CA--C 1.474 -2.528 0 C-N-CA 117.397 -2.335 . . . . 0.0 107.411 -173.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 48' ' ' TRP . 42.2 m-85 -78.45 130.46 36.09 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 102.713 -3.069 . . . . 0.0 102.713 158.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.7 tt -90.47 137.29 21.9 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 N-CA-C 105.331 -2.1 . . . . 0.0 105.331 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.547 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -94.3 -144.76 0.25 Allowed 'General case' 0 N--CA 1.424 -1.734 0 CA-C-N 112.319 -2.219 . . . . 0.0 107.79 177.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 62.7 mt-30 -109.57 147.02 35.23 Favored Pre-proline 0 N--CA 1.43 -1.464 1 N-CA-C 96.068 -5.53 . . . . 0.0 96.068 165.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -76.34 7.59 3.31 Favored 'Trans proline' 0 CA--C 1.506 -0.888 0 C-N-CA 122.671 2.247 . . . . 0.0 113.883 -145.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 18.1 mp0 -88.4 -76.35 0.4 Allowed 'General case' 0 N--CA 1.426 -1.643 0 N-CA-C 103.234 -2.876 . . . . 0.0 103.234 176.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -176.84 144.02 0.45 Allowed 'General case' 0 N--CA 1.419 -2.003 1 N-CA-C 93.64 -6.429 . . . . 0.0 93.64 -178.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 160.69 -153.48 0.0 OUTLIER 'General case' 0 CA--C 1.493 -1.237 0 N-CA-C 101.705 -3.443 . . . . 0.0 101.705 173.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.612 HG12 HD12 ' A' ' 59' ' ' ILE . 0.3 OUTLIER -126.1 165.15 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.33 1 N-CA-C 99.477 -4.268 . . . . 0.0 99.477 159.649 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -86.01 -148.89 0.13 Allowed 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 164.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 46.4 m80 -142.33 176.29 9.1 Favored 'General case' 0 CA--C 1.483 -1.632 1 N-CA-C 97.209 -5.108 . . . . 0.0 97.209 164.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 8.2 t -136.18 159.97 40.09 Favored 'General case' 0 N--CA 1.426 -1.644 1 N-CA-C 96.482 -5.377 . . . . 0.0 96.482 -177.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -111.19 107.75 57.32 Favored Pre-proline 0 N--CA 1.428 -1.557 1 N-CA-C 97.529 -4.989 . . . . 0.0 97.529 170.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_exo -53.03 103.82 0.09 OUTLIER 'Trans proline' 0 CA--C 1.513 -0.557 0 CA-C-N 124.439 2.621 . . . . 0.0 116.871 -155.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 161.69 -170.33 37.38 Favored Glycine 0 N--CA 1.426 -2.011 1 N-CA-C 97.228 -6.349 . . . . 0.0 97.228 -172.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.2 m -86.98 -42.47 13.1 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 118.82 1.31 . . . . 0.0 109.566 179.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -40.1 -55.18 2.15 Favored 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 129.08 2.952 . . . . 0.0 117.231 -156.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.27 -48.79 43.57 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 111.074 -0.811 . . . . 0.0 111.074 -174.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 68.4 m -71.85 -34.04 68.92 Favored 'General case' 0 CA--C 1.49 -1.363 0 O-C-N 121.71 -0.876 . . . . 0.0 111.13 -176.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -59.16 -46.56 88.07 Favored 'General case' 0 C--N 1.35 0.597 0 CA-C-O 121.351 0.596 . . . . 0.0 109.422 173.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.0 m -64.45 -48.1 76.55 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 123.044 0.538 . . . . 0.0 111.031 177.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 75.5 mt -60.76 -43.6 97.8 Favored 'General case' 0 C--N 1.362 1.149 0 CA-C-O 121.846 0.831 . . . . 0.0 109.964 -177.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.8 t -56.9 -44.16 82.07 Favored 'General case' 0 N--CA 1.437 -1.092 0 C-N-CA 123.322 0.649 . . . . 0.0 111.46 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -77.35 -31.41 54.41 Favored 'General case' 0 C--N 1.353 0.735 0 C-N-CA 121.149 -0.22 . . . . 0.0 111.533 -173.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -76.75 -30.77 56.7 Favored 'General case' 0 CA--C 1.506 -0.727 0 O-C-N 121.58 -0.7 . . . . 0.0 110.71 177.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -78.24 -49.62 13.39 Favored 'General case' 0 C--N 1.359 1.013 0 CA-C-N 118.974 0.806 . . . . 0.0 109.816 177.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 131.67 47.99 0.11 Allowed Glycine 0 CA--C 1.488 -1.647 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 173.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -117.48 160.85 13.45 Favored Glycine 0 CA--C 1.484 -1.881 0 N-CA-C 104.077 -3.609 . . . . 0.0 104.077 161.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -64.68 -54.9 24.34 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 124.88 1.272 . . . . 0.0 110.621 -164.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.9 m -160.79 177.63 10.24 Favored 'General case' 0 N--CA 1.423 -1.813 1 N-CA-C 97.199 -5.111 . . . . 0.0 97.199 170.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -161.48 174.76 38.06 Favored Glycine 0 CA--C 1.474 -2.501 1 N-CA-C 101.346 -4.701 . . . . 0.0 101.346 -163.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 53.8 m80 -156.66 -153.04 0.4 Allowed 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 100.348 -3.945 . . . . 0.0 100.348 -168.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 81.6 m -147.53 177.64 9.09 Favored 'General case' 0 CA--C 1.483 -1.627 0 N-CA-C 103.762 -2.681 . . . . 0.0 103.762 -174.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 171.53 -157.14 27.37 Favored Glycine 0 N--CA 1.423 -2.215 1 N-CA-C 95.9 -6.88 . . . . 0.0 95.9 178.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -140.44 146.51 38.37 Favored 'General case' 0 CA--C 1.489 -1.385 1 N-CA-C 98.091 -4.781 . . . . 0.0 98.091 -174.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 9.7 tmtt? -115.75 97.29 6.04 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 103.144 -2.91 . . . . 0.0 103.144 174.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.4 t -70.86 120.37 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 -176.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 136.86 -37.38 1.87 Allowed Glycine 0 CA--C 1.486 -1.78 0 N-CA-C 103.949 -3.66 . . . . 0.0 103.949 -167.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 15.6 m170 -125.1 -64.71 1.07 Allowed 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 165.89 -161.22 34.8 Favored Glycine 0 N--CA 1.432 -1.626 0 N-CA-C 107.219 -2.353 . . . . 0.0 107.219 -171.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.7 tp -69.43 143.49 53.58 Favored 'General case' 0 CA--C 1.502 -0.904 0 C-N-CA 127.969 2.508 . . . . 0.0 105.725 177.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -153.05 178.3 9.86 Favored 'General case' 0 CA--C 1.488 -1.428 0 N-CA-C 103.759 -2.682 . . . . 0.0 103.759 -168.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 50.8 m -112.16 161.72 16.23 Favored 'General case' 0 CA--C 1.493 -1.25 0 N-CA-C 103.135 -2.913 . . . . 0.0 103.135 177.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.414 ' HA ' ' HA ' ' A' ' 5' ' ' TYR . 61.1 t-105 -101.83 152.18 21.2 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 104.598 -2.371 . . . . 0.0 104.598 166.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.8 m -141.4 141.17 33.77 Favored 'General case' 0 CA--C 1.491 -1.31 0 N-CA-C 104.568 -2.382 . . . . 0.0 104.568 164.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -105.67 107.9 19.13 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 102.606 -3.109 . . . . 0.0 102.606 174.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 90.06 135.4 0.03 OUTLIER 'General case' 0 N--CA 1.432 -1.365 0 C-N-CA 128.243 2.617 . . . . 0.0 106.068 -173.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -145.13 155.89 54.73 Favored Pre-proline 0 N--CA 1.426 -1.668 1 N-CA-C 96.335 -5.431 . . . . 0.0 96.335 149.166 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -70.16 165.06 32.68 Favored 'Trans proline' 0 N--CA 1.445 -1.346 0 C-N-CA 122.404 2.069 . . . . 0.0 109.139 164.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -74.7 -9.04 58.18 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 114.12 1.155 . . . . 0.0 114.12 -163.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 -84.35 -12.35 54.68 Favored 'General case' 0 CA--C 1.507 -0.696 0 O-C-N 121.397 -0.814 . . . . 0.0 110.176 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.2 t -87.29 118.39 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -87.45 147.01 20.45 Favored Glycine 0 CA--C 1.487 -1.702 0 N-CA-C 106.934 -2.467 . . . . 0.0 106.934 -178.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 46.1 pt -117.97 -153.81 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 -173.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.612 HD12 HG12 ' A' ' 13' ' ' VAL . 9.2 mm -66.77 -30.27 49.13 Favored 'Isoleucine or valine' 0 C--N 1.357 0.894 0 O-C-N 121.412 -0.805 . . . . 0.0 111.949 -165.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.426 -1.658 1 N-CA-C 99.058 -4.423 . . . . 0.0 99.058 175.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 9.9 m . . . . . 0 N--CA 1.483 1.221 0 CA-C-O 122.441 1.115 . . . . 0.0 110.913 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 16.2 mtp85 -100.64 158.03 16.24 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 -174.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -130.47 128.71 41.79 Favored 'General case' 0 CA--C 1.486 -1.481 1 N-CA-C 97.124 -5.139 . . . . 0.0 97.124 168.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.82 178.31 37.73 Favored Glycine 0 CA--C 1.481 -2.037 0 N-CA-C 107.272 -2.331 . . . . 0.0 107.272 -177.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -79.64 127.95 32.8 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 104.034 -2.58 . . . . 0.0 104.034 164.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.26 11.6 tt -91.51 147.6 5.16 Favored 'Isoleucine or valine' 0 C--O 1.243 0.737 0 CA-C-N 120.487 1.494 . . . . 0.0 108.879 178.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -135.77 -128.61 0.15 Allowed 'General case' 0 N--CA 1.426 -1.663 0 C-N-CA 128.035 2.534 . . . . 0.0 104.548 172.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -139.71 152.02 67.39 Favored Pre-proline 0 N--CA 1.424 -1.743 1 N-CA-C 96.513 -5.365 . . . . 0.0 96.513 176.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -74.89 35.14 0.4 Allowed 'Trans proline' 0 CA--C 1.514 -0.504 0 CA-C-N 124.241 2.55 . . . . 0.0 117.096 -159.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 53.0 mm-40 -124.53 32.79 5.39 Favored 'General case' 0 CA--C 1.497 -1.083 0 CA-C-N 120.202 1.364 . . . . 0.0 107.635 -169.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 48.99 58.1 5.73 Favored 'General case' 0 CA--C 1.489 -1.382 0 C-N-CA 128.686 2.794 . . . . 0.0 112.196 -174.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 91.3 m -116.89 -160.26 0.76 Allowed 'General case' 0 CA--C 1.482 -1.649 0 N-CA-C 103.285 -2.857 . . . . 0.0 103.285 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -134.85 169.39 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.827 1 N-CA-C 96.059 -5.534 . . . . 0.0 96.059 170.697 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -96.62 -154.27 0.44 Allowed 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 101.711 -3.44 . . . . 0.0 101.711 163.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 33.4 m80 -137.43 172.62 12.71 Favored 'General case' 0 CA--C 1.478 -1.792 1 N-CA-C 97.457 -5.016 . . . . 0.0 97.457 166.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 29.3 t -132.11 158.39 41.77 Favored 'General case' 0 N--CA 1.422 -1.868 1 N-CA-C 97.497 -5.001 . . . . 0.0 97.497 -175.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -112.45 104.78 56.13 Favored Pre-proline 0 N--CA 1.428 -1.546 1 N-CA-C 98.232 -4.729 . . . . 0.0 98.232 168.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -51.43 98.69 0.04 OUTLIER 'Trans proline' 0 CA--C 1.51 -0.708 0 C-N-CA 123.473 2.782 . . . . 0.0 117.07 -154.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 163.21 -171.48 38.95 Favored Glycine 0 N--CA 1.423 -2.227 1 N-CA-C 96.704 -6.558 . . . . 0.0 96.704 -172.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 38.1 m -82.46 -31.12 29.56 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 118.682 1.241 . . . . 0.0 111.154 -177.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.2 m -39.59 -71.48 0.08 Allowed 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 117.006 2.224 . . . . 0.0 117.006 -151.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.44 -43.82 52.67 Favored Glycine 0 C--N 1.347 1.153 0 O-C-N 121.198 -0.939 . . . . 0.0 111.113 -173.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 35.2 m -67.24 -43.98 80.59 Favored 'General case' 0 CA--C 1.486 -1.504 0 O-C-N 122.039 -0.683 . . . . 0.0 112.1 -173.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -66.35 -35.3 80.0 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -178.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.3 m -63.18 -50.41 70.45 Favored 'General case' 0 N--CA 1.445 -0.695 0 O-C-N 121.78 -0.575 . . . . 0.0 110.023 174.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.9 mt -63.56 -40.15 96.23 Favored 'General case' 0 C--N 1.359 0.998 0 CA-C-O 122.052 0.93 . . . . 0.0 110.923 -177.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 19.5 t -57.11 -47.6 80.68 Favored 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 125.775 1.63 . . . . 0.0 110.115 177.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 50.3 mttp -74.36 -34.63 63.42 Favored 'General case' 0 C--N 1.353 0.718 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.519 -173.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -77.43 -20.78 54.02 Favored 'General case' 0 C--N 1.354 0.771 0 O-C-N 121.712 -0.617 . . . . 0.0 111.407 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.6 mmtm -76.6 -59.09 2.92 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 168.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 134.64 48.77 0.08 OUTLIER Glycine 0 CA--C 1.489 -1.548 0 N-CA-C 108.896 -1.682 . . . . 0.0 108.896 170.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -107.18 139.97 15.14 Favored Glycine 0 CA--C 1.482 -1.976 1 N-CA-C 101.549 -4.62 . . . . 0.0 101.549 164.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.6 p -80.02 -49.5 11.72 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-N 118.587 1.193 . . . . 0.0 108.528 -170.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.3 m -103.41 139.84 38.26 Favored 'General case' 0 CA--C 1.487 -1.478 0 N-CA-C 102.101 -3.296 . . . . 0.0 102.101 -172.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -146.48 142.65 10.65 Favored Glycine 0 CA--C 1.473 -2.58 1 N-CA-C 101.215 -4.754 . . . . 0.0 101.215 -168.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 66.4 m80 -155.86 -157.43 0.72 Allowed 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 100.286 -3.968 . . . . 0.0 100.286 -173.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 85.5 m -143.73 177.36 8.56 Favored 'General case' 0 CA--C 1.476 -1.893 1 N-CA-C 99.099 -4.408 . . . . 0.0 99.099 177.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -179.27 -175.99 46.63 Favored Glycine 0 N--CA 1.419 -2.476 1 N-CA-C 98.092 -6.003 . . . . 0.0 98.092 177.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -116.68 139.44 50.54 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 102.048 -3.316 . . . . 0.0 102.048 177.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.9 94.27 4.96 Favored 'General case' 0 CA--C 1.498 -1.038 0 N-CA-C 103.506 -2.776 . . . . 0.0 103.506 178.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.7 t -70.76 116.82 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 -174.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 136.83 -39.59 1.62 Allowed Glycine 0 CA--C 1.488 -1.642 0 N-CA-C 105.929 -2.868 . . . . 0.0 105.929 -169.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 27.0 m170 -119.25 -66.85 1.03 Allowed 'General case' 0 CA--C 1.499 -0.992 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 178.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 167.04 -159.89 33.41 Favored Glycine 0 N--CA 1.432 -1.631 0 N-CA-C 106.262 -2.735 . . . . 0.0 106.262 -173.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 57.8 tp -68.21 142.28 55.71 Favored 'General case' 0 C--N 1.351 0.665 0 C-N-CA 126.779 2.032 . . . . 0.0 106.175 175.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -150.19 -178.04 6.28 Favored 'General case' 0 CA--C 1.485 -1.528 0 N-CA-C 104.046 -2.575 . . . . 0.0 104.046 -167.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 67.3 m -107.02 163.63 12.82 Favored 'General case' 0 CA--C 1.492 -1.287 0 N-CA-C 102.689 -3.078 . . . . 0.0 102.689 176.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 14.6 t-105 -128.14 146.67 50.64 Favored 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 104.435 -2.432 . . . . 0.0 104.435 177.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 61.2 m -140.43 151.49 44.93 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 174.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -118.95 143.44 47.03 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 103.806 -2.665 . . . . 0.0 103.806 166.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 77.02 54.94 0.04 OUTLIER 'General case' 0 CA--C 1.497 -1.075 0 C-N-CA 127.018 2.127 . . . . 0.0 110.883 171.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 33.5 mt -97.77 135.67 21.47 Favored Pre-proline 0 CA--C 1.5 -0.948 0 N-CA-C 105.12 -2.178 . . . . 0.0 105.12 173.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -74.46 167.92 26.01 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 CA-C-N 122.628 1.974 . . . . 0.0 111.103 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -61.28 -19.86 62.21 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 126.561 1.944 . . . . 0.0 114.686 -170.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.4 p-10 -86.54 -2.2 58.28 Favored 'General case' 0 CA--C 1.505 -0.767 0 C-N-CA 123.722 0.809 . . . . 0.0 110.628 -176.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.5 t -91.09 163.32 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 N-CA-C 104.078 -2.564 . . . . 0.0 104.078 177.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -145.84 154.53 26.0 Favored Glycine 0 CA--C 1.48 -2.132 1 N-CA-C 96.668 -6.573 . . . . 0.0 96.668 179.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 16.1 pt -139.66 -126.65 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 N-CA-C 104.885 -2.265 . . . . 0.0 104.885 -158.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.0 mm -74.5 62.28 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.582 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 169.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.425 -1.682 0 N-CA-C 103.008 -2.96 . . . . 0.0 103.008 -167.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 18.6 m . . . . . 0 N--CA 1.486 1.325 0 CA-C-O 121.898 0.856 . . . . 0.0 110.649 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 22.6 mtp85 -121.71 154.81 36.38 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 104.669 -2.345 . . . . 0.0 104.669 -172.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -137.48 132.71 33.7 Favored 'General case' 0 CA--C 1.486 -1.481 1 N-CA-C 97.273 -5.084 . . . . 0.0 97.273 166.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.29 -166.29 20.79 Favored Glycine 0 CA--C 1.477 -2.34 1 N-CA-C 101.948 -4.461 . . . . 0.0 101.948 172.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -74.81 142.14 44.25 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 103.872 -2.64 . . . . 0.0 103.872 161.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.1 tt -90.24 136.26 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.125 0 N-CA-C 105.018 -2.215 . . . . 0.0 105.018 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.657 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -109.59 -149.94 0.45 Allowed 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 127.385 2.274 . . . . 0.0 106.255 179.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.415 ' H ' ' HB1' ' A' ' 7' ' ' ALA . 58.6 mt-30 -115.13 142.87 29.22 Favored Pre-proline 0 N--CA 1.426 -1.669 1 N-CA-C 97.454 -5.017 . . . . 0.0 97.454 171.108 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -75.58 29.81 0.38 Allowed 'Trans proline' 0 CA--C 1.503 -1.042 0 N-CA-C 117.764 2.179 . . . . 0.0 117.764 -141.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -120.35 -78.74 0.59 Allowed 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 101.733 -3.432 . . . . 0.0 101.733 -178.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 53.6 t-20 -160.92 142.72 12.17 Favored 'General case' 0 N--CA 1.423 -1.803 1 N-CA-C 93.932 -6.322 . . . . 0.0 93.932 166.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 19.0 m 173.42 -157.09 0.01 OUTLIER 'General case' 0 CA--C 1.496 -1.122 1 N-CA-C 98.743 -4.54 . . . . 0.0 98.743 172.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.609 HG12 HD12 ' A' ' 59' ' ' ILE . 0.4 OUTLIER -126.8 167.68 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.575 1 N-CA-C 98.372 -4.677 . . . . 0.0 98.372 158.956 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -87.04 -162.7 0.82 Allowed 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 103.126 -2.916 . . . . 0.0 103.126 163.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 47.4 m80 -143.16 168.62 19.32 Favored 'General case' 0 N--CA 1.417 -2.114 1 N-CA-C 94.198 -6.223 . . . . 0.0 94.198 165.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.4 t -160.45 -151.01 0.23 Allowed 'General case' 0 N--CA 1.418 -2.037 1 N-CA-C 95.894 -5.595 . . . . 0.0 95.894 -176.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -148.44 147.77 26.5 Favored Pre-proline 0 N--CA 1.409 -2.493 1 N-CA-C 95.198 -5.853 . . . . 0.0 95.198 -167.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -71.23 73.8 2.04 Favored 'Trans proline' 0 C--N 1.32 -0.939 0 CA-C-N 125.383 2.958 . . . . 0.0 114.134 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -172.82 162.74 34.4 Favored Glycine 0 N--CA 1.425 -2.071 1 N-CA-C 98.704 -5.759 . . . . 0.0 98.704 175.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.2 m -81.65 -7.88 59.64 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 118.752 1.276 . . . . 0.0 111.775 -172.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -53.55 -28.38 31.41 Favored 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 128.448 2.699 . . . . 0.0 115.417 -169.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -87.06 -73.48 1.28 Allowed Glycine 0 C--N 1.348 1.211 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 176.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 75.6 m -79.99 -12.57 59.7 Favored 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 -162.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -63.17 -44.97 93.96 Favored 'General case' 0 C--N 1.358 0.972 0 CA-C-N 121.65 2.023 . . . . 0.0 108.38 173.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -57.67 -51.22 70.4 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 127.1 2.16 . . . . 0.0 110.794 174.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 84.6 mt -64.85 -40.1 94.61 Favored 'General case' 0 CA--C 1.497 -1.077 0 C-N-CA 124.088 0.955 . . . . 0.0 111.133 -177.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.7 t -56.77 -44.24 81.64 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 124.556 1.143 . . . . 0.0 109.847 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 52.0 mttp -71.15 -34.93 71.45 Favored 'General case' 0 N--CA 1.443 -0.801 0 O-C-N 122.151 -0.343 . . . . 0.0 111.54 -174.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -78.58 -26.67 45.55 Favored 'General case' 0 C--N 1.355 0.821 0 O-C-N 121.543 -0.723 . . . . 0.0 112.359 177.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.4 mmtm -80.54 -26.07 38.26 Favored 'General case' 0 C--N 1.357 0.92 0 CA-C-N 118.911 0.778 . . . . 0.0 109.843 176.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.53 37.64 1.88 Allowed Glycine 0 CA--C 1.486 -1.765 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 163.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -108.27 143.86 16.16 Favored Glycine 0 CA--C 1.485 -1.84 0 N-CA-C 103.226 -3.95 . . . . 0.0 103.226 168.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.4 m -73.5 -29.82 62.73 Favored 'General case' 0 N--CA 1.437 -1.084 0 O-C-N 122.074 -0.662 . . . . 0.0 110.473 -167.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.1 m -159.74 161.6 34.77 Favored 'General case' 0 CA--C 1.481 -1.704 0 N-CA-C 102.734 -3.062 . . . . 0.0 102.734 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -171.38 175.25 44.97 Favored Glycine 0 N--CA 1.419 -2.441 1 N-CA-C 99.944 -5.262 . . . . 0.0 99.944 -172.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 44.2 p-80 -169.67 -171.71 1.27 Allowed 'General case' 0 N--CA 1.431 -1.418 1 N-CA-C 98.224 -4.732 . . . . 0.0 98.224 -174.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 73.8 m -127.41 153.07 46.71 Favored 'General case' 0 CA--C 1.486 -1.498 0 N-CA-C 104.433 -2.432 . . . . 0.0 104.433 -173.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -172.18 167.17 40.1 Favored Glycine 0 CA--C 1.477 -2.316 1 N-CA-C 100.004 -5.238 . . . . 0.0 100.004 -173.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -98.67 161.18 13.8 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 104.741 -2.318 . . . . 0.0 104.741 -172.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.99 173.36 13.44 Favored 'General case' 0 N--CA 1.428 -1.55 1 N-CA-C 96.009 -5.552 . . . . 0.0 96.009 163.5 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -132.34 155.81 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.548 1 N-CA-C 97.607 -4.96 . . . . 0.0 97.607 177.928 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 130.34 -52.18 0.84 Allowed Glycine 0 CA--C 1.485 -1.789 1 N-CA-C 101.535 -4.626 . . . . 0.0 101.535 -170.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 66.9 m170 -117.48 -73.88 0.63 Allowed 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 104.318 -2.475 . . . . 0.0 104.318 168.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 164.45 -145.67 10.58 Favored Glycine 0 CA--C 1.472 -2.63 1 N-CA-C 100.876 -4.89 . . . . 0.0 100.876 178.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 33.2 tp -62.97 137.77 58.37 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 125.304 1.442 . . . . 0.0 107.388 -173.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -152.04 -171.12 3.84 Favored 'General case' 0 CA--C 1.479 -1.764 1 N-CA-C 97.556 -4.979 . . . . 0.0 97.556 -160.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 3.0 p -147.11 -174.15 4.43 Favored 'General case' 0 CA--C 1.478 -1.824 0 C-N-CA 115.734 -2.386 . . . . 0.0 104.616 169.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 43.7 t-105 -127.73 157.1 41.26 Favored 'General case' 0 CA--C 1.505 -0.785 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 -167.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 6.0 m -150.15 152.31 34.5 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 168.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -118.94 140.1 50.56 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 104.478 -2.416 . . . . 0.0 104.478 168.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 77.36 47.67 0.06 Allowed 'General case' 0 CA--C 1.496 -1.108 0 C-N-CA 127.451 2.301 . . . . 0.0 111.378 166.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 38.4 mt -91.48 137.14 26.07 Favored Pre-proline 0 CA--C 1.503 -0.862 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 178.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -77.94 174.71 12.13 Favored 'Trans proline' 0 N--CA 1.447 -1.217 0 C-N-CA 122.274 1.983 . . . . 0.0 111.494 -179.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -69.49 -9.05 52.15 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 125.254 1.421 . . . . 0.0 114.203 -171.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -92.73 -0.15 57.32 Favored 'General case' 0 CA--C 1.501 -0.934 0 O-C-N 121.667 -0.646 . . . . 0.0 110.008 -179.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.408 HG12 ' H ' ' A' ' 57' ' ' GLY . 1.5 t -99.05 179.13 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 N-CA-C 102.49 -3.152 . . . . 0.0 102.49 174.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.408 ' H ' HG12 ' A' ' 56' ' ' VAL . . . -152.12 159.4 28.33 Favored Glycine 0 CA--C 1.479 -2.216 1 N-CA-C 97.258 -6.337 . . . . 0.0 97.258 -178.528 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 18.2 pt -146.81 -156.46 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.271 0 N-CA-C 103.296 -2.853 . . . . 0.0 103.296 -165.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.657 HD13 ' HB2' ' A' ' 7' ' ' ALA . 1.1 mm -73.02 129.86 35.9 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.094 0 N-CA-C 104.839 -2.282 . . . . 0.0 104.839 176.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.9 t . . . . . 0 N--CA 1.426 -1.653 0 N-CA-C 100.687 -3.82 . . . . 0.0 100.687 172.974 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 26.7 m . . . . . 0 N--CA 1.483 1.184 0 CA-C-O 121.578 0.704 . . . . 0.0 109.798 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -100.31 156.2 17.37 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 104.136 -2.542 . . . . 0.0 104.136 166.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -123.99 122.04 36.87 Favored 'General case' 0 CA--C 1.487 -1.468 1 N-CA-C 95.705 -5.665 . . . . 0.0 95.705 164.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.55 -175.7 32.85 Favored Glycine 0 CA--C 1.477 -2.324 0 N-CA-C 105.01 -3.236 . . . . 0.0 105.01 -171.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -88.3 135.71 33.32 Favored 'General case' 0 CA--C 1.491 -1.319 0 N-CA-C 103.524 -2.769 . . . . 0.0 103.524 170.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 17.0 tt -90.25 139.34 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 N-CA-C 106.854 -1.535 . . . . 0.0 106.854 -177.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.506 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -111.16 -161.44 0.75 Allowed 'General case' 0 N--CA 1.426 -1.632 0 C-N-CA 127.536 2.334 . . . . 0.0 106.412 178.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -107.02 146.36 33.0 Favored Pre-proline 0 N--CA 1.427 -1.583 1 N-CA-C 97.985 -4.82 . . . . 0.0 97.985 164.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -80.22 -3.47 12.64 Favored 'Trans proline' 0 CA--C 1.5 -1.225 0 C-N-CA 121.183 1.256 . . . . 0.0 114.125 -135.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -91.28 -46.59 7.97 Favored 'General case' 0 CA--C 1.5 -0.98 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 49.8 t-20 171.1 142.53 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.465 1 N-CA-C 97.962 -4.829 . . . . 0.0 97.962 167.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 171.31 -157.2 0.01 OUTLIER 'General case' 0 CA--C 1.488 -1.419 0 C-N-CA 126.986 2.114 . . . . 0.0 105.587 178.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.461 HG12 HD12 ' A' ' 59' ' ' ILE . 1.5 m -125.83 155.81 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.775 1 N-CA-C 96.772 -5.27 . . . . 0.0 96.772 155.293 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -98.91 141.78 31.24 Favored 'General case' 0 CA--C 1.482 -1.636 1 N-CA-C 97.506 -4.998 . . . . 0.0 97.506 165.098 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -84.31 178.79 7.63 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 105.33 -2.1 . . . . 0.0 105.33 179.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 36.4 t -146.79 163.28 36.52 Favored 'General case' 0 N--CA 1.419 -1.979 1 N-CA-C 96.76 -5.274 . . . . 0.0 96.76 -173.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -126.27 132.57 24.36 Favored Pre-proline 0 N--CA 1.417 -2.11 1 N-CA-C 98.383 -4.673 . . . . 0.0 98.383 -173.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -65.53 -6.64 14.1 Favored 'Trans proline' 0 CA--C 1.514 -0.479 0 CA-C-N 123.576 2.313 . . . . 0.0 113.518 177.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -95.55 89.35 1.15 Allowed Glycine 0 C--N 1.352 1.426 1 N-CA-C 101.216 -4.754 . . . . 0.0 101.216 158.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.9 m -60.04 -15.56 23.78 Favored 'General case' 0 CA--C 1.498 -1.057 0 C-N-CA 127.404 2.281 . . . . 0.0 115.868 -159.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -44.41 -45.0 8.76 Favored 'General case' 0 N--CA 1.436 -1.155 0 C-N-CA 128.618 2.767 . . . . 0.0 114.087 -175.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.73 -50.28 65.51 Favored Glycine 0 C--N 1.355 1.587 0 N-CA-C 111.972 -0.451 . . . . 0.0 111.972 -175.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 19.5 t -76.14 -24.23 54.86 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -177.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -61.37 -48.24 82.19 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 175.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -60.57 -40.06 90.26 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 172.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 96.1 mt -64.96 -44.12 90.44 Favored 'General case' 0 C--N 1.357 0.928 0 CA-C-N 119.321 0.964 . . . . 0.0 110.551 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 9.1 t -58.23 -46.85 85.17 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 125.257 1.423 . . . . 0.0 109.632 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -67.75 -37.18 81.79 Favored 'General case' 0 C--N 1.354 0.766 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -177.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -77.11 -22.76 52.22 Favored 'General case' 0 C--N 1.354 0.794 0 O-C-N 121.192 -0.942 . . . . 0.0 111.397 -176.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -85.99 -34.29 20.86 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 175.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 114.89 44.03 0.71 Allowed Glycine 0 CA--C 1.482 -1.978 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 164.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.13 149.08 16.59 Favored Glycine 0 CA--C 1.487 -1.715 1 N-CA-C 102.322 -4.311 . . . . 0.0 102.322 163.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.1 m -70.61 -47.45 60.03 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 122.265 1.031 . . . . 0.0 110.203 -165.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 33.8 m -160.82 -174.0 4.2 Favored 'General case' 0 N--CA 1.422 -1.849 1 N-CA-C 97.802 -4.888 . . . . 0.0 97.802 167.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -175.92 -177.96 45.35 Favored Glycine 0 N--CA 1.418 -2.543 1 N-CA-C 99.329 -5.508 . . . . 0.0 99.329 -169.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 68.4 m80 -155.96 176.98 11.94 Favored 'General case' 0 N--CA 1.425 -1.71 1 N-CA-C 99.421 -4.288 . . . . 0.0 99.421 -172.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 68.0 m -88.38 164.31 15.59 Favored 'General case' 0 CA--C 1.49 -1.361 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -179.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -167.68 -169.84 31.71 Favored Glycine 0 N--CA 1.414 -2.815 1 N-CA-C 100.45 -5.06 . . . . 0.0 100.45 176.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -152.61 156.65 39.69 Favored 'General case' 0 N--CA 1.417 -2.09 1 N-CA-C 94.132 -6.247 . . . . 0.0 94.132 -176.816 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 16.8 ptmt -136.86 17.43 3.05 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 104.248 -2.501 . . . . 0.0 104.248 163.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . 0.276 1.8 t 50.01 -138.24 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.358 0.974 0 C-N-CA 126.764 2.026 . . . . 0.0 107.534 -160.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.43 -72.35 2.17 Favored Glycine 0 CA--C 1.495 -1.217 0 C-N-CA 123.787 0.708 . . . . 0.0 111.652 163.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 9.5 m170 -98.79 -64.41 1.04 Allowed 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 105.127 -2.175 . . . . 0.0 105.127 176.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 174.64 -169.23 42.16 Favored Glycine 0 CA--C 1.473 -2.531 1 N-CA-C 100.478 -5.049 . . . . 0.0 100.478 -169.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.2 tt -70.2 132.27 45.51 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 105.504 -2.035 . . . . 0.0 105.504 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.404 ' HA ' ' HB ' ' A' ' 13' ' ' VAL . . . -133.63 165.85 23.96 Favored 'General case' 0 CA--C 1.474 -1.954 0 N-CA-C 101.273 -3.603 . . . . 0.0 101.273 -159.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 49.7 t -120.2 151.61 38.88 Favored 'General case' 0 CA--C 1.488 -1.422 0 N-CA-C 102.482 -3.155 . . . . 0.0 102.482 -174.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 62.1 t-105 -97.95 149.72 22.11 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 104.108 -2.553 . . . . 0.0 104.108 175.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.8 m -141.35 143.95 34.28 Favored 'General case' 0 CA--C 1.481 -1.688 0 N-CA-C 100.949 -3.723 . . . . 0.0 100.949 170.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -108.55 124.6 50.73 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 104.14 -2.541 . . . . 0.0 104.14 179.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 76.37 73.59 0.08 Allowed 'General case' 0 CA--C 1.498 -1.025 0 C-N-CA 127.093 2.157 . . . . 0.0 110.939 171.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 35.9 mt -103.53 131.47 22.01 Favored Pre-proline 0 CA--C 1.498 -1.041 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 174.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -72.05 174.09 11.85 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 CA-C-N 122.515 1.934 . . . . 0.0 110.28 176.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -69.15 -8.35 44.71 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 -172.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 17.7 p-10 -81.91 -10.69 59.21 Favored 'General case' 0 CA--C 1.505 -0.786 0 O-C-N 121.093 -1.004 . . . . 0.0 109.438 -177.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.8 t -100.24 132.52 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.374 0 N-CA-C 104.538 -2.393 . . . . 0.0 104.538 -176.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -103.77 151.05 17.65 Favored Glycine 0 CA--C 1.485 -1.829 0 N-CA-C 103.099 -4.0 . . . . 0.0 103.099 176.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 24.7 pt -136.14 -152.96 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 N-CA-C 104.823 -2.288 . . . . 0.0 104.823 -164.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.506 HD13 ' HB2' ' A' ' 7' ' ' ALA . 3.8 mm -67.98 133.46 31.63 Favored 'Isoleucine or valine' 0 C--N 1.358 0.956 0 N-CA-C 107.497 -1.298 . . . . 0.0 107.497 -178.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.2 t . . . . . 0 N--CA 1.426 -1.663 1 N-CA-C 96.444 -5.391 . . . . 0.0 96.444 169.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 33.2 m . . . . . 0 N--CA 1.485 1.303 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -107.52 159.2 16.61 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 170.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -130.37 120.72 24.73 Favored 'General case' 0 CA--C 1.49 -1.333 1 N-CA-C 96.218 -5.475 . . . . 0.0 96.218 161.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.02 -175.06 32.64 Favored Glycine 0 CA--C 1.477 -2.325 0 N-CA-C 105.456 -3.058 . . . . 0.0 105.456 -176.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 48' ' ' TRP . 46.6 m-85 -79.53 136.17 36.82 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 104.121 -2.548 . . . . 0.0 104.121 165.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 14.4 tt -90.82 146.73 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 N-CA-C 105.663 -1.977 . . . . 0.0 105.663 178.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.701 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -131.38 -178.06 4.68 Favored 'General case' 0 N--CA 1.414 -2.273 0 N-CA-C 105.165 -2.161 . . . . 0.0 105.165 -178.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -86.6 149.05 47.89 Favored Pre-proline 0 N--CA 1.435 -1.208 0 N-CA-C 103.225 -2.88 . . . . 0.0 103.225 159.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_exo -71.48 0.56 6.69 Favored 'Trans proline' 0 CA--C 1.504 -0.994 0 CA-C-N 123.222 2.186 . . . . 0.0 115.691 -154.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.7 mp0 -94.44 19.19 9.97 Favored 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 126.039 1.736 . . . . 0.0 109.227 -170.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 67.2 t30 66.25 61.54 0.6 Allowed 'General case' 0 CA--C 1.497 -1.083 0 C-N-CA 127.543 2.337 . . . . 0.0 108.803 -178.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 85.4 m -122.13 -137.58 0.31 Allowed 'General case' 0 CA--C 1.481 -1.699 0 N-CA-C 103.307 -2.849 . . . . 0.0 103.307 -178.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -136.56 173.24 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.923 1 N-CA-C 99.855 -4.128 . . . . 0.0 99.855 164.279 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -124.59 138.82 54.29 Favored 'General case' 0 N--CA 1.414 -2.268 1 N-CA-C 93.555 -6.461 . . . . 0.0 93.555 174.26 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 54.6 m80 -87.26 -178.32 6.18 Favored 'General case' 0 CA--C 1.492 -1.268 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 -173.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.2 t -153.43 173.37 15.76 Favored 'General case' 0 N--CA 1.412 -2.341 1 N-CA-C 95.361 -5.792 . . . . 0.0 95.361 -168.014 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -140.52 142.15 28.04 Favored Pre-proline 0 N--CA 1.409 -2.501 1 N-CA-C 95.352 -5.796 . . . . 0.0 95.352 -177.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -75.06 64.81 6.12 Favored 'Trans proline' 0 C--N 1.326 -0.613 0 C-N-CA 123.698 2.932 . . . . 0.0 109.369 172.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 156.99 60.82 0.01 OUTLIER Glycine 0 CA--C 1.482 -1.988 1 N-CA-C 97.82 -6.112 . . . . 0.0 97.82 -170.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 m -84.09 46.34 1.19 Allowed 'General case' 0 N--CA 1.436 -1.16 0 C-N-CA 124.994 1.318 . . . . 0.0 113.403 -154.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.9 p -70.5 -38.88 74.39 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 124.63 1.172 . . . . 0.0 108.951 -178.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.94 -37.1 92.92 Favored Glycine 0 C--N 1.351 1.379 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 177.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 38.7 t -72.75 -31.04 64.64 Favored 'General case' 0 C--N 1.358 0.952 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -57.23 -44.89 84.21 Favored 'General case' 0 C--N 1.354 0.764 0 CA-C-N 119.827 1.194 . . . . 0.0 110.267 178.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -58.2 -48.1 81.39 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 171.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 95.9 mt -65.64 -41.09 93.0 Favored 'General case' 0 C--N 1.359 0.991 0 CA-C-O 122.651 1.215 . . . . 0.0 110.813 -176.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 9.0 t -62.99 -46.07 89.4 Favored 'General case' 0 CA--C 1.495 -1.148 0 C-N-CA 125.301 1.44 . . . . 0.0 108.871 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.7 mmtm -65.29 -43.71 90.31 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-O 119.327 -0.368 . . . . 0.0 111.423 -178.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 25.8 pt-20 -72.3 -19.05 61.73 Favored 'General case' 0 C--N 1.354 0.8 0 CA-C-N 118.76 0.709 . . . . 0.0 112.351 -174.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -88.45 -17.69 29.87 Favored 'General case' 0 CA--C 1.506 -0.731 0 C-N-CA 123.244 0.618 . . . . 0.0 110.199 175.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.88 27.06 5.56 Favored Glycine 0 CA--C 1.489 -1.553 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 169.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -95.69 123.08 7.53 Favored Glycine 0 CA--C 1.49 -1.499 0 N-CA-C 105.467 -3.053 . . . . 0.0 105.467 174.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.8 p -97.28 -4.64 38.38 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -167.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.8 p -159.11 169.94 23.11 Favored 'General case' 0 N--CA 1.427 -1.576 1 N-CA-C 97.859 -4.867 . . . . 0.0 97.859 172.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -176.09 179.65 47.07 Favored Glycine 0 CA--C 1.474 -2.498 1 N-CA-C 102.007 -4.437 . . . . 0.0 102.007 -172.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -154.12 -161.22 1.2 Allowed 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 100.821 -3.77 . . . . 0.0 100.821 -174.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 12.5 t -147.87 161.88 40.39 Favored 'General case' 0 N--CA 1.431 -1.396 1 N-CA-C 98.994 -4.447 . . . . 0.0 98.994 -172.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 170.03 -160.23 33.07 Favored Glycine 0 N--CA 1.428 -1.858 1 N-CA-C 102.285 -4.326 . . . . 0.0 102.285 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -134.53 143.13 47.25 Favored 'General case' 0 N--CA 1.433 -1.3 1 N-CA-C 99.482 -4.266 . . . . 0.0 99.482 -176.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.47 105.2 11.85 Favored 'General case' 0 CA--C 1.491 -1.322 0 N-CA-C 101.533 -3.506 . . . . 0.0 101.533 174.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.406 HG23 ' H ' ' A' ' 41' ' ' VAL . 3.5 t -41.64 -71.59 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.496 -1.109 0 C-N-CA 127.114 2.165 . . . . 0.0 115.136 -163.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -77.25 53.03 3.45 Favored Glycine 0 CA--C 1.501 -0.785 0 C-N-CA 126.413 1.958 . . . . 0.0 111.485 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 41.9 m-70 -167.59 -60.52 0.03 OUTLIER 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 105.093 -2.188 . . . . 0.0 105.093 171.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 150.46 -154.05 25.41 Favored Glycine 0 C--N 1.352 1.463 0 N-CA-C 108.397 -1.881 . . . . 0.0 108.397 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 63.2 tp -71.91 125.85 28.25 Favored 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 178.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -131.5 172.46 12.19 Favored 'General case' 0 CA--C 1.476 -1.867 0 N-CA-C 103.684 -2.71 . . . . 0.0 103.684 -163.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 38.6 t -125.68 167.91 14.48 Favored 'General case' 0 CA--C 1.486 -1.515 0 N-CA-C 101.508 -3.516 . . . . 0.0 101.508 176.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.4 ' HA ' ' HA ' ' A' ' 5' ' ' TYR . 11.0 t-105 -124.56 147.03 48.69 Favored 'General case' 0 CA--C 1.484 -1.572 0 N-CA-C 101.542 -3.503 . . . . 0.0 101.542 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 22.0 m -139.5 148.72 43.04 Favored 'General case' 0 CA--C 1.486 -1.506 0 N-CA-C 100.516 -3.883 . . . . 0.0 100.516 176.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -122.59 136.56 54.91 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 102.703 -3.073 . . . . 0.0 102.703 -174.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 71.16 49.76 0.32 Allowed 'General case' 0 CA--C 1.499 -1.006 0 C-N-CA 127.313 2.245 . . . . 0.0 110.928 176.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 20.0 mt -88.43 135.1 33.12 Favored Pre-proline 0 CA--C 1.498 -1.047 0 N-CA-C 105.344 -2.095 . . . . 0.0 105.344 177.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -73.15 170.59 19.48 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 122.241 1.961 . . . . 0.0 110.315 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -77.36 -3.94 42.64 Favored 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 -164.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -92.96 1.8 57.12 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 123.944 0.898 . . . . 0.0 109.885 -178.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.5 t -102.61 137.2 31.54 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.146 0 N-CA-C 103.386 -2.82 . . . . 0.0 103.386 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -108.14 144.52 16.2 Favored Glycine 0 CA--C 1.481 -2.091 0 N-CA-C 103.376 -3.889 . . . . 0.0 103.376 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 27.3 pt -139.18 -147.46 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.379 0 N-CA-C 103.529 -2.767 . . . . 0.0 103.529 -166.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.701 HD13 ' HB2' ' A' ' 7' ' ' ALA . 15.8 mm -69.73 121.11 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 175.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.496 -1.101 0 C-N-CA 124.554 1.141 . . . . 0.0 109.171 -164.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 27.5 m . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 121.11 0.481 . . . . 0.0 110.038 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.31 173.02 9.11 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 106.163 -1.792 . . . . 0.0 106.163 175.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -134.53 140.97 46.54 Favored 'General case' 0 N--CA 1.431 -1.398 1 N-CA-C 95.4 -5.778 . . . . 0.0 95.4 164.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.65 -175.77 33.03 Favored Glycine 0 CA--C 1.475 -2.42 1 N-CA-C 101.56 -4.616 . . . . 0.0 101.56 176.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 48' ' ' TRP . 24.4 m-85 -82.95 136.8 34.43 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 101.16 -3.644 . . . . 0.0 101.16 158.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.414 ' HA ' HG22 ' A' ' 58' ' ' ILE . 13.5 tt -87.29 132.98 31.29 Favored 'Isoleucine or valine' 0 C--O 1.252 1.19 0 N-CA-C 105.612 -1.995 . . . . 0.0 105.612 -174.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.496 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -107.56 -179.68 3.98 Favored 'General case' 0 C--N 1.366 1.314 0 O-C-N 127.691 3.119 . . . . 0.0 108.702 175.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -95.37 135.98 22.87 Favored Pre-proline 0 N--CA 1.433 -1.307 0 N-CA-C 100.508 -3.886 . . . . 0.0 100.508 167.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -78.15 60.42 7.39 Favored 'Trans proline' 0 CA--C 1.514 -0.519 0 C-N-CA 123.836 3.024 . . . . 0.0 112.49 -163.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -118.13 -83.28 0.64 Allowed 'General case' 0 N--CA 1.422 -1.827 1 N-CA-C 96.686 -5.302 . . . . 0.0 96.686 159.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 19.8 t30 -166.17 143.48 5.3 Favored 'General case' 0 N--CA 1.419 -1.976 1 N-CA-C 92.616 -6.809 . . . . 0.0 92.616 159.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.1 m 176.3 -157.11 0.02 OUTLIER 'General case' 0 CA--C 1.49 -1.333 1 N-CA-C 99.737 -4.172 . . . . 0.0 99.737 178.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.505 HG12 HD12 ' A' ' 59' ' ' ILE . 0.8 OUTLIER -120.83 155.95 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.913 1 N-CA-C 97.46 -5.015 . . . . 0.0 97.46 160.592 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -93.64 136.88 33.47 Favored 'General case' 0 CA--C 1.48 -1.724 1 N-CA-C 96.895 -5.224 . . . . 0.0 96.895 162.595 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 79.0 m80 -85.85 176.27 8.19 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 -169.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 12.2 t -140.67 158.23 44.29 Favored 'General case' 0 N--CA 1.413 -2.31 1 N-CA-C 94.056 -6.276 . . . . 0.0 94.056 178.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -124.93 138.69 31.94 Favored Pre-proline 0 N--CA 1.419 -1.986 1 N-CA-C 95.654 -5.684 . . . . 0.0 95.654 177.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_exo -63.53 94.94 0.18 Allowed 'Trans proline' 0 CA--C 1.512 -0.598 0 CA-C-N 124.71 2.718 . . . . 0.0 114.182 -171.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 164.64 -173.51 40.57 Favored Glycine 0 N--CA 1.421 -2.308 1 N-CA-C 97.927 -6.069 . . . . 0.0 97.927 -176.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.1 m -84.49 -32.59 23.88 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 117.333 0.566 . . . . 0.0 110.421 -177.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.5 m -46.7 -59.68 2.88 Favored 'General case' 0 N--CA 1.439 -0.984 0 C-N-CA 127.594 2.358 . . . . 0.0 116.582 -156.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -72.82 -54.69 7.04 Favored Glycine 0 C--N 1.349 1.286 0 N-CA-C 110.179 -1.169 . . . . 0.0 110.179 -174.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 49.1 t -61.29 -48.39 81.62 Favored 'General case' 0 CA--C 1.499 -1.016 0 C-N-CA 125.418 1.487 . . . . 0.0 111.473 -171.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -62.34 -42.78 99.67 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 118.729 0.695 . . . . 0.0 109.543 -175.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.0 m -66.5 -50.86 61.85 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 123.567 0.747 . . . . 0.0 110.639 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 55.7 mt -64.09 -41.83 97.15 Favored 'General case' 0 C--N 1.362 1.124 0 C-N-CA 124.697 1.199 . . . . 0.0 110.35 -175.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 15.9 t -62.35 -46.44 88.65 Favored 'General case' 0 CA--C 1.5 -0.967 0 C-N-CA 123.649 0.779 . . . . 0.0 108.98 177.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -66.82 -45.0 79.68 Favored 'General case' 0 CA--C 1.504 -0.802 0 O-C-N 121.76 -0.587 . . . . 0.0 110.899 -173.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -72.33 -23.58 61.18 Favored 'General case' 0 C--N 1.354 0.774 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -174.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 42.6 mmtm -88.22 -18.82 27.82 Favored 'General case' 0 C--N 1.354 0.772 0 CA-C-N 118.673 0.669 . . . . 0.0 109.393 175.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.35 41.66 1.35 Allowed Glycine 0 CA--C 1.483 -1.952 0 N-CA-C 109.331 -1.507 . . . . 0.0 109.331 161.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -103.79 128.5 9.52 Favored Glycine 0 CA--C 1.486 -1.76 0 N-CA-C 103.56 -3.816 . . . . 0.0 103.56 171.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.7 p -99.87 4.49 45.17 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 122.339 1.066 . . . . 0.0 108.725 -166.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 46.4 m -160.3 165.12 31.92 Favored 'General case' 0 N--CA 1.421 -1.893 1 N-CA-C 98.66 -4.571 . . . . 0.0 98.66 166.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 179.69 -173.72 45.44 Favored Glycine 0 N--CA 1.414 -2.801 1 N-CA-C 99.563 -5.415 . . . . 0.0 99.563 -176.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 10.1 p-80 -171.42 173.65 4.73 Favored 'General case' 0 N--CA 1.43 -1.428 1 N-CA-C 99.463 -4.273 . . . . 0.0 99.463 172.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 49.0 t -94.32 153.92 17.76 Favored 'General case' 0 CA--C 1.502 -0.878 0 N-CA-C 105.361 -2.088 . . . . 0.0 105.361 -176.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.63 -165.3 28.65 Favored Glycine 0 N--CA 1.431 -1.659 0 N-CA-C 104.927 -3.269 . . . . 0.0 104.927 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -148.42 147.58 29.34 Favored 'General case' 0 N--CA 1.429 -1.495 1 N-CA-C 98.012 -4.811 . . . . 0.0 98.012 -170.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -130.17 100.7 5.5 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 102.106 -3.294 . . . . 0.0 102.106 167.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.9 t -70.22 120.08 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 -173.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 141.07 -48.4 0.82 Allowed Glycine 0 CA--C 1.484 -1.865 1 N-CA-C 102.019 -4.433 . . . . 0.0 102.019 -164.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 18.3 m-70 -106.69 -74.93 0.64 Allowed 'General case' 0 CA--C 1.501 -0.934 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 173.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 169.16 -156.53 27.82 Favored Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 105.427 -3.069 . . . . 0.0 105.427 -173.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.78 130.11 42.13 Favored 'General case' 0 C--N 1.358 0.939 0 C-N-CA 127.809 2.443 . . . . 0.0 104.819 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -130.5 174.81 9.53 Favored 'General case' 0 CA--C 1.478 -1.792 0 N-CA-C 104.734 -2.321 . . . . 0.0 104.734 -168.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 19.3 t -121.38 158.16 28.9 Favored 'General case' 0 CA--C 1.492 -1.263 1 N-CA-C 99.575 -4.231 . . . . 0.0 99.575 172.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.423 ' HA ' ' HA ' ' A' ' 5' ' ' TYR . 12.3 t-105 -117.81 150.5 39.04 Favored 'General case' 0 CA--C 1.495 -1.173 0 N-CA-C 102.233 -3.247 . . . . 0.0 102.233 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 59.1 m -147.47 152.01 37.35 Favored 'General case' 0 CA--C 1.492 -1.272 0 N-CA-C 105.057 -2.201 . . . . 0.0 105.057 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -119.79 145.14 46.87 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 104.636 -2.357 . . . . 0.0 104.636 171.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 65.2 53.02 1.38 Allowed 'General case' 0 CA--C 1.49 -1.331 0 C-N-CA 127.283 2.233 . . . . 0.0 110.461 170.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 31.2 mt -91.31 139.95 25.53 Favored Pre-proline 0 CA--C 1.498 -1.028 0 N-CA-C 103.602 -2.74 . . . . 0.0 103.602 175.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -72.17 169.96 20.23 Favored 'Trans proline' 0 N--CA 1.447 -1.233 0 C-N-CA 122.544 2.163 . . . . 0.0 109.456 176.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -83.0 13.65 3.85 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -165.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -103.7 4.28 35.19 Favored 'General case' 0 CA--C 1.501 -0.922 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 177.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.0 t -104.85 154.53 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 N-CA-C 103.181 -2.896 . . . . 0.0 103.181 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -122.94 158.62 17.59 Favored Glycine 0 CA--C 1.483 -1.954 1 N-CA-C 102.731 -4.147 . . . . 0.0 102.731 -175.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.414 HG22 ' HA ' ' A' ' 6' ' ' ILE . 28.4 pt -151.18 -178.81 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.594 0 N-CA-C 102.469 -3.16 . . . . 0.0 102.469 -163.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.505 HD12 HG12 ' A' ' 13' ' ' VAL . 1.5 mm -69.61 131.9 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.045 0 O-C-N 123.974 0.796 . . . . 0.0 109.813 -166.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.6 t . . . . . 0 N--CA 1.429 -1.516 1 N-CA-C 98.98 -4.452 . . . . 0.0 98.98 173.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 5.7 m . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 121.811 0.815 . . . . 0.0 111.343 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.411 HH21 HG12 ' A' ' 58' ' ' ILE . 20.5 mtp85 -106.27 147.93 28.56 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 104.834 -2.284 . . . . 0.0 104.834 177.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -129.51 120.1 24.83 Favored 'General case' 0 CA--C 1.489 -1.378 1 N-CA-C 98.044 -4.798 . . . . 0.0 98.044 166.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.78 -170.62 26.76 Favored Glycine 0 CA--C 1.481 -2.058 0 N-CA-C 104.89 -3.284 . . . . 0.0 104.89 -169.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -96.6 140.25 31.5 Favored 'General case' 0 CA--C 1.491 -1.321 0 N-CA-C 101.73 -3.433 . . . . 0.0 101.73 168.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.7 tt -91.07 149.21 4.14 Favored 'Isoleucine or valine' 0 C--O 1.246 0.894 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 178.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.697 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -141.32 173.0 11.9 Favored 'General case' 0 N--CA 1.413 -2.304 1 N-CA-C 99.457 -4.275 . . . . 0.0 99.457 175.42 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -79.97 149.95 71.09 Favored Pre-proline 0 N--CA 1.434 -1.226 0 N-CA-C 103.14 -2.911 . . . . 0.0 103.14 165.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -79.95 -1.87 11.71 Favored 'Trans proline' 0 CA--C 1.499 -1.246 0 CA-C-N 121.113 1.433 . . . . 0.0 112.484 -142.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -96.33 13.79 26.49 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 -177.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 53.5 t30 77.28 44.89 0.09 Allowed 'General case' 0 CA--C 1.5 -0.951 0 C-N-CA 127.693 2.397 . . . . 0.0 108.354 178.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.3 m -122.82 110.73 15.82 Favored 'General case' 0 CA--C 1.482 -1.664 1 N-CA-C 99.42 -4.289 . . . . 0.0 99.42 -176.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 18.0 m -67.22 160.33 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.234 0 CA-C-N 119.652 1.115 . . . . 0.0 112.925 -163.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -101.71 117.49 34.98 Favored 'General case' 0 CA--C 1.479 -1.772 1 N-CA-C 97.341 -5.059 . . . . 0.0 97.341 179.645 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -83.15 125.85 31.97 Favored 'General case' 0 CA--C 1.486 -1.496 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 -158.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 40.4 t -92.24 149.59 21.37 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 104.026 -2.583 . . . . 0.0 104.026 175.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -134.45 140.0 34.41 Favored Pre-proline 0 N--CA 1.416 -2.141 1 N-CA-C 96.977 -5.194 . . . . 0.0 96.977 172.455 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -68.65 67.67 1.16 Allowed 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 124.124 3.216 . . . . 0.0 113.431 174.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -178.13 50.86 0.1 OUTLIER Glycine 0 CA--C 1.487 -1.656 1 N-CA-C 99.41 -5.476 . . . . 0.0 99.41 177.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.0 m -86.25 45.02 1.18 Allowed 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 114.104 -1.048 . . . . 0.0 112.909 -147.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.5 p -72.93 -42.63 63.27 Favored 'General case' 0 N--CA 1.444 -0.756 0 O-C-N 121.372 -0.83 . . . . 0.0 109.379 -175.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -68.97 -43.71 71.67 Favored Glycine 0 C--N 1.349 1.289 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 177.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.7 t -59.73 -44.4 93.79 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 125.455 1.502 . . . . 0.0 111.754 178.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -67.5 -35.32 78.9 Favored 'General case' 0 C--N 1.353 0.737 0 O-C-N 120.974 -1.079 . . . . 0.0 110.596 177.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 40.7 m -70.05 -33.69 72.27 Favored 'General case' 0 N--CA 1.45 -0.448 0 O-C-N 121.052 -1.03 . . . . 0.0 109.955 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 20.3 mt -66.89 -38.38 86.15 Favored 'General case' 0 CA--C 1.496 -1.129 0 O-C-N 121.518 -0.739 . . . . 0.0 109.705 177.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 36.8 t -54.82 -47.89 73.51 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 122.149 -0.344 . . . . 0.0 111.699 170.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.5 mmtm -63.06 -50.32 71.05 Favored 'General case' 0 C--N 1.354 0.784 0 O-C-N 121.394 -0.816 . . . . 0.0 111.276 -178.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -70.71 -8.91 55.53 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 112.897 0.702 . . . . 0.0 112.897 -173.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.9 mmmp? -102.69 2.9 36.44 Favored 'General case' 0 C--N 1.354 0.785 0 O-C-N 121.469 -0.769 . . . . 0.0 111.239 173.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 93.96 29.0 10.17 Favored Glycine 0 C--N 1.35 1.341 0 N-CA-C 111.436 -0.666 . . . . 0.0 111.436 169.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -91.93 140.97 15.42 Favored Glycine 0 C--N 1.354 1.578 0 N-CA-C 106.851 -2.5 . . . . 0.0 106.851 171.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.4 m -99.11 -26.38 14.23 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 -165.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.6 m -147.93 175.64 10.8 Favored 'General case' 0 CA--C 1.482 -1.661 1 N-CA-C 99.92 -4.104 . . . . 0.0 99.92 171.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -171.68 -176.44 40.66 Favored Glycine 0 N--CA 1.42 -2.382 1 N-CA-C 100.579 -5.008 . . . . 0.0 100.579 -173.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.444 ' CE1' ' CD1' ' A' ' 48' ' ' TRP . 16.2 p-80 -177.91 -152.5 0.03 OUTLIER 'General case' 0 N--CA 1.434 -1.254 1 N-CA-C 97.687 -4.931 . . . . 0.0 97.687 173.101 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 24.8 t -149.5 154.77 39.29 Favored 'General case' 0 N--CA 1.425 -1.723 1 N-CA-C 97.904 -4.85 . . . . 0.0 97.904 -173.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 178.76 -179.29 48.82 Favored Glycine 0 N--CA 1.425 -2.092 1 N-CA-C 96.8 -6.52 . . . . 0.0 96.8 -178.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.419 ' CD1' ' HA ' ' A' ' 45' ' ' LEU . 61.3 t80 -158.25 134.34 9.26 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 101.295 -3.595 . . . . 0.0 101.295 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.599 ' H ' HG23 ' A' ' 41' ' ' VAL . 28.7 mmmt -168.72 57.35 0.05 Allowed 'General case' 0 CA--C 1.499 -1.005 1 N-CA-C 97.747 -4.909 . . . . 0.0 97.747 172.545 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.599 HG23 ' H ' ' A' ' 40' ' ' LYS . 13.7 t -134.89 163.94 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.369 1 N-CA-C 99.579 -4.23 . . . . 0.0 99.579 -169.125 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -116.45 89.46 0.49 Allowed Glycine 0 CA--C 1.487 -1.69 1 N-CA-C 101.822 -4.511 . . . . 0.0 101.822 170.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 60.9 m-70 -175.01 -154.63 0.05 Allowed 'General case' 0 N--CA 1.429 -1.507 1 N-CA-C 96.779 -5.267 . . . . 0.0 96.779 -175.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -83.72 -69.86 1.37 Allowed Glycine 0 C--N 1.351 1.395 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -176.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.419 ' HA ' ' CD1' ' A' ' 39' ' ' PHE . 0.1 OUTLIER -167.54 152.7 7.12 Favored 'General case' 0 CA--C 1.489 -1.383 1 N-CA-C 96.363 -5.421 . . . . 0.0 96.363 178.61 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.19 166.06 25.54 Favored 'General case' 0 CA--C 1.486 -1.49 0 N-CA-C 102.521 -3.141 . . . . 0.0 102.521 -167.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 99.6 m -101.84 150.96 22.64 Favored 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 104.318 -2.475 . . . . 0.0 104.318 -178.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.444 ' CD1' ' CE1' ' A' ' 36' ' ' HIS . 44.0 t-105 -93.75 146.33 23.93 Favored 'General case' 0 CA--C 1.496 -1.125 0 N-CA-C 104.327 -2.471 . . . . 0.0 104.327 177.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 60.6 m -133.95 141.14 47.18 Favored 'General case' 0 CA--C 1.48 -1.744 0 N-CA-C 104.651 -2.351 . . . . 0.0 104.651 169.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -113.46 128.63 56.51 Favored 'General case' 0 N--CA 1.427 -1.596 0 N-CA-C 101.843 -3.392 . . . . 0.0 101.843 176.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 63.33 74.1 0.43 Allowed 'General case' 0 N--CA 1.434 -1.245 0 C-N-CA 126.571 1.948 . . . . 0.0 110.823 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 17.8 mt -97.99 141.9 23.71 Favored Pre-proline 0 CA--C 1.496 -1.122 0 N-CA-C 103.006 -2.961 . . . . 0.0 103.006 164.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -72.85 166.43 30.02 Favored 'Trans proline' 0 N--CA 1.443 -1.476 0 C-N-CA 122.382 2.054 . . . . 0.0 109.186 178.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -77.28 1.25 19.22 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -164.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -101.86 5.83 41.2 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 123.855 0.862 . . . . 0.0 109.594 -177.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.9 t -97.6 163.93 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 103.428 -2.804 . . . . 0.0 103.428 178.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -142.98 150.79 22.62 Favored Glycine 0 CA--C 1.475 -2.426 1 N-CA-C 97.247 -6.341 . . . . 0.0 97.247 -178.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.411 HG12 HH21 ' A' ' 2' ' ' ARG . 18.8 pt -153.77 -147.65 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.49 -1.358 0 N-CA-C 101.553 -3.499 . . . . 0.0 101.553 -154.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.697 HD13 ' HB2' ' A' ' 7' ' ' ALA . 7.3 mm -59.51 119.37 3.81 Favored 'Isoleucine or valine' 0 C--N 1.36 1.045 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 174.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.496 -1.126 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.491 -162.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 24.1 m . . . . . 0 N--CA 1.484 1.263 0 CA-C-O 120.999 0.428 . . . . 0.0 110.455 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.67 173.34 6.92 Favored 'General case' 0 CA--C 1.5 -0.957 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 173.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -130.0 140.08 50.94 Favored 'General case' 0 CA--C 1.488 -1.43 1 N-CA-C 94.563 -6.088 . . . . 0.0 94.563 163.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.72 176.07 38.22 Favored Glycine 0 CA--C 1.476 -2.346 0 N-CA-C 104.901 -3.279 . . . . 0.0 104.901 -178.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -83.62 126.93 33.35 Favored 'General case' 0 CA--C 1.497 -1.067 0 N-CA-C 101.184 -3.636 . . . . 0.0 101.184 157.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.4 tt -90.3 137.39 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 -172.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.68 -150.92 0.34 Allowed 'General case' 0 N--CA 1.427 -1.589 0 C-N-CA 127.605 2.362 . . . . 0.0 107.606 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -119.52 139.54 27.98 Favored Pre-proline 0 N--CA 1.424 -1.769 1 N-CA-C 93.847 -6.353 . . . . 0.0 93.847 165.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -83.0 30.81 0.53 Allowed 'Trans proline' 0 CA--C 1.505 -0.966 0 C-N-CA 122.306 2.004 . . . . 0.0 113.916 -135.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -106.25 -89.45 0.43 Allowed 'General case' 0 N--CA 1.424 -1.727 0 N-CA-C 101.43 -3.544 . . . . 0.0 101.43 177.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -157.16 138.07 13.39 Favored 'General case' 0 N--CA 1.417 -2.091 1 N-CA-C 92.377 -6.898 . . . . 0.0 92.377 164.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 5.5 m 176.59 -163.54 0.03 OUTLIER 'General case' 0 CA--C 1.489 -1.4 1 N-CA-C 97.414 -5.032 . . . . 0.0 97.414 178.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.499 HG12 HD12 ' A' ' 59' ' ' ILE . 15.4 m -119.73 163.08 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.626 1 N-CA-C 99.19 -4.374 . . . . 0.0 99.19 159.975 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -83.44 164.75 19.71 Favored 'General case' 0 CA--C 1.501 -0.925 0 N-CA-C 102.722 -3.066 . . . . 0.0 102.722 162.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 22.8 m80 -90.29 158.12 17.33 Favored 'General case' 0 CA--C 1.484 -1.595 0 N-CA-C 101.538 -3.504 . . . . 0.0 101.538 178.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -160.19 177.48 10.63 Favored 'General case' 0 N--CA 1.41 -2.432 1 N-CA-C 95.92 -5.585 . . . . 0.0 95.92 -174.48 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -147.06 167.29 13.94 Favored Pre-proline 0 N--CA 1.412 -2.331 1 N-CA-C 96.019 -5.548 . . . . 0.0 96.019 -161.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.05 49.67 2.33 Favored 'Trans proline' 0 C--N 1.316 -1.169 0 CA-C-N 124.752 2.733 . . . . 0.0 110.61 169.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -172.68 139.34 5.17 Favored Glycine 0 CA--C 1.478 -2.234 1 N-CA-C 99.702 -5.359 . . . . 0.0 99.702 -177.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.0 m -92.15 11.04 26.88 Favored 'General case' 0 CA--C 1.499 -0.994 0 C-N-CA 123.673 0.789 . . . . 0.0 112.27 -165.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.4 m -51.14 -53.74 31.73 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 126.29 1.836 . . . . 0.0 113.871 -168.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.93 -35.52 27.61 Favored Glycine 0 C--N 1.352 1.427 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -177.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 44.1 t -59.95 -44.61 94.3 Favored 'General case' 0 CA--C 1.499 -0.989 0 C-N-CA 125.379 1.471 . . . . 0.0 110.769 -174.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -59.13 -44.3 92.02 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 124.478 1.111 . . . . 0.0 110.329 178.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -68.87 -38.17 79.54 Favored 'General case' 0 N--CA 1.443 -0.787 0 O-C-N 121.018 -1.051 . . . . 0.0 112.848 175.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 85.8 mt -65.03 -40.33 94.69 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-O 122.29 1.043 . . . . 0.0 109.742 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.6 t -60.14 -46.99 87.78 Favored 'General case' 0 N--CA 1.433 -1.286 0 C-N-CA 123.895 0.878 . . . . 0.0 110.404 -178.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -74.26 -29.34 61.63 Favored 'General case' 0 N--CA 1.444 -0.762 0 O-C-N 121.725 -0.609 . . . . 0.0 112.433 -176.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -79.04 -25.33 43.2 Favored 'General case' 0 C--N 1.357 0.918 0 O-C-N 121.023 -1.048 . . . . 0.0 111.094 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.1 mmmp? -82.53 -29.3 30.51 Favored 'General case' 0 C--N 1.358 0.935 0 O-C-N 121.451 -0.781 . . . . 0.0 109.381 172.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 110.25 43.68 1.06 Allowed Glycine 0 CA--C 1.485 -1.793 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 164.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -104.06 161.3 15.69 Favored Glycine 0 CA--C 1.488 -1.608 0 N-CA-C 103.394 -3.883 . . . . 0.0 103.394 166.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.1 p -71.94 -52.34 17.68 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-O 122.281 1.039 . . . . 0.0 109.924 -168.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 39.3 m -160.85 -176.55 5.59 Favored 'General case' 0 N--CA 1.421 -1.924 1 N-CA-C 98.002 -4.814 . . . . 0.0 98.002 170.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -172.67 -176.17 41.14 Favored Glycine 0 N--CA 1.416 -2.673 1 N-CA-C 98.766 -5.734 . . . . 0.0 98.766 -169.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 39.6 m80 -157.96 169.42 24.62 Favored 'General case' 0 N--CA 1.432 -1.366 1 N-CA-C 99.504 -4.258 . . . . 0.0 99.504 -176.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 64.1 m -84.22 159.92 20.9 Favored 'General case' 0 CA--C 1.499 -0.992 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 172.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -170.02 -178.51 41.05 Favored Glycine 0 N--CA 1.423 -2.19 1 N-CA-C 99.186 -5.566 . . . . 0.0 99.186 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -151.82 -169.33 3.33 Favored 'General case' 0 N--CA 1.422 -1.849 1 N-CA-C 99.224 -4.362 . . . . 0.0 99.224 174.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -154.21 -141.86 0.11 Allowed 'General case' 0 N--CA 1.424 -1.747 1 N-CA-C 93.637 -6.431 . . . . 0.0 93.637 -168.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.2 t -124.95 151.62 30.7 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.293 1 N-CA-C 96.995 -5.187 . . . . 0.0 96.995 149.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 160.49 -137.14 4.84 Favored Glycine 0 N--CA 1.42 -2.398 1 N-CA-C 98.683 -5.767 . . . . 0.0 98.683 -163.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 33.2 m170 -87.49 -35.08 18.41 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -160.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -169.92 -65.14 0.04 OUTLIER Glycine 0 C--N 1.357 1.73 0 C-N-CA 118.031 -2.033 . . . . 0.0 110.692 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.26 -178.08 6.43 Favored 'General case' 0 N--CA 1.434 -1.242 1 N-CA-C 94.784 -6.006 . . . . 0.0 94.784 167.786 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -150.36 171.72 16.54 Favored 'General case' 0 CA--C 1.482 -1.667 0 N-CA-C 102.206 -3.257 . . . . 0.0 102.206 174.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 8.5 t -110.13 155.61 21.69 Favored 'General case' 0 CA--C 1.489 -1.396 1 N-CA-C 99.378 -4.304 . . . . 0.0 99.378 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 6.5 t-105 -118.57 154.45 32.58 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 102.454 -3.165 . . . . 0.0 102.454 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 9.8 m -151.06 154.86 37.81 Favored 'General case' 0 CA--C 1.49 -1.365 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 176.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -117.81 143.42 46.28 Favored 'General case' 0 CA--C 1.495 -1.145 0 N-CA-C 104.689 -2.338 . . . . 0.0 104.689 169.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 65.02 58.27 0.92 Allowed 'General case' 0 CA--C 1.498 -1.023 0 C-N-CA 127.681 2.392 . . . . 0.0 112.507 171.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 31.3 mt -97.03 146.57 31.53 Favored Pre-proline 0 CA--C 1.502 -0.872 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 177.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -64.25 162.51 29.76 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 123.167 2.578 . . . . 0.0 111.244 174.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -68.88 -22.79 64.17 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -169.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 18.5 p-10 -94.66 19.82 9.42 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 124.345 1.058 . . . . 0.0 110.376 -176.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.3 t -106.91 126.2 62.91 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.274 0 N-CA-C 101.596 -3.483 . . . . 0.0 101.596 169.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -90.95 154.55 23.11 Favored Glycine 0 CA--C 1.492 -1.385 0 N-CA-C 107.923 -2.071 . . . . 0.0 107.923 -174.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 45.8 pt -136.68 -171.84 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 -170.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.499 HD12 HG12 ' A' ' 13' ' ' VAL . 2.3 mm -69.77 127.55 31.83 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.275 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 -174.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 42.6 t . . . . . 0 N--CA 1.426 -1.632 0 N-CA-C 101.81 -3.404 . . . . 0.0 101.81 177.908 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 15.2 m . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 121.565 0.698 . . . . 0.0 110.515 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 6.1 mmm180 -101.66 141.89 33.84 Favored 'General case' 0 CA--C 1.495 -1.169 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 -178.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -130.19 116.51 18.53 Favored 'General case' 0 CA--C 1.489 -1.403 1 N-CA-C 95.815 -5.624 . . . . 0.0 95.815 158.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.86 -172.2 28.94 Favored Glycine 0 CA--C 1.476 -2.405 1 N-CA-C 100.981 -4.848 . . . . 0.0 100.981 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.446 ' HB2' HD13 ' A' ' 59' ' ' ILE . 40.2 m-85 -76.86 144.87 38.72 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 104.359 -2.46 . . . . 0.0 104.359 161.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.5 tt -91.23 140.99 15.1 Favored 'Isoleucine or valine' 0 C--O 1.249 1.046 0 N-CA-C 104.617 -2.364 . . . . 0.0 104.617 171.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.472 ' HB2' ' CD1' ' A' ' 59' ' ' ILE . . . -141.29 176.99 8.4 Favored 'General case' 0 N--CA 1.41 -2.457 1 N-CA-C 98.875 -4.491 . . . . 0.0 98.875 177.215 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -85.44 153.38 58.8 Favored Pre-proline 0 N--CA 1.431 -1.386 0 N-CA-C 103.705 -2.702 . . . . 0.0 103.705 172.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -68.1 -16.93 45.53 Favored 'Trans proline' 0 CA--C 1.502 -1.121 0 N-CA-C 117.625 2.125 . . . . 0.0 117.625 -149.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.4 mp0 -95.37 18.47 12.48 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-N 119.317 0.962 . . . . 0.0 108.52 -175.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 58.3 t-20 82.06 48.19 0.02 OUTLIER 'General case' 0 C--N 1.356 0.853 0 C-N-CA 125.85 1.66 . . . . 0.0 107.841 168.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.3 m -125.49 122.19 35.9 Favored 'General case' 0 CA--C 1.487 -1.477 0 N-CA-C 101.001 -3.703 . . . . 0.0 101.001 178.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.1 m -56.88 155.16 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.057 0 CA-C-N 120.858 1.663 . . . . 0.0 113.437 -170.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.64 131.84 54.71 Favored 'General case' 0 CA--C 1.468 -2.205 1 N-CA-C 93.344 -6.539 . . . . 0.0 93.344 177.464 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 66.7 m80 -92.83 -156.65 0.49 Allowed 'General case' 0 CA--C 1.49 -1.362 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 -164.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 5.6 t -155.11 168.39 27.17 Favored 'General case' 0 N--CA 1.417 -2.111 1 N-CA-C 94.399 -6.149 . . . . 0.0 94.399 -173.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -122.81 121.45 27.38 Favored Pre-proline 0 N--CA 1.42 -1.935 1 N-CA-C 94.694 -6.039 . . . . 0.0 94.694 175.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -62.45 99.33 0.2 Allowed 'Trans proline' 0 CA--C 1.51 -0.686 0 CA-C-N 123.106 2.145 . . . . 0.0 116.709 -158.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 169.91 -175.6 43.95 Favored Glycine 0 N--CA 1.422 -2.245 1 N-CA-C 96.168 -6.773 . . . . 0.0 96.168 176.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -69.95 -39.03 76.27 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 119.433 1.617 . . . . 0.0 109.124 178.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -45.63 -49.02 14.69 Favored 'General case' 0 N--CA 1.437 -1.122 0 C-N-CA 130.746 3.619 . . . . 0.0 115.566 -171.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.5 -40.88 59.05 Favored Glycine 0 CA--C 1.49 -1.499 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -172.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 43.3 t -70.33 -48.1 58.04 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -52.99 -44.21 67.05 Favored 'General case' 0 C--N 1.354 0.797 0 C-N-CA 124.512 1.125 . . . . 0.0 111.487 -178.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 34.2 m -60.6 -53.84 52.63 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 123.524 0.73 . . . . 0.0 111.142 177.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 83.8 mt -71.86 -40.16 69.17 Favored 'General case' 0 CA--C 1.5 -0.971 0 CA-C-O 122.104 0.955 . . . . 0.0 110.19 -172.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 33.7 t -61.07 -44.28 97.62 Favored 'General case' 0 CA--C 1.5 -0.98 0 C-N-CA 124.932 1.293 . . . . 0.0 109.372 178.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm -68.01 -43.89 77.78 Favored 'General case' 0 CA--C 1.502 -0.892 0 O-C-N 121.986 -0.446 . . . . 0.0 110.1 -173.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -71.67 -13.0 61.61 Favored 'General case' 0 C--N 1.351 0.663 0 O-C-N 121.691 -0.63 . . . . 0.0 112.512 -175.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.4 mmtm -98.43 -2.81 38.18 Favored 'General case' 0 CA--C 1.504 -0.79 0 C-N-CA 123.23 0.612 . . . . 0.0 110.056 176.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.0 32.72 8.73 Favored Glycine 0 CA--C 1.491 -1.416 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 172.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -91.44 142.1 15.95 Favored Glycine 0 C--N 1.354 1.556 0 N-CA-C 106.642 -2.583 . . . . 0.0 106.642 171.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.1 m -98.35 -17.24 18.97 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 -163.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 59.5 m -159.93 167.5 27.87 Favored 'General case' 0 CA--C 1.482 -1.639 1 N-CA-C 99.226 -4.361 . . . . 0.0 99.226 171.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -171.34 174.77 44.99 Favored Glycine 0 CA--C 1.476 -2.365 1 N-CA-C 100.328 -5.109 . . . . 0.0 100.328 -179.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 32.1 p-80 -158.5 159.49 35.68 Favored 'General case' 0 N--CA 1.426 -1.637 1 N-CA-C 98.452 -4.648 . . . . 0.0 98.452 176.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 42.3 t -87.03 159.04 19.1 Favored 'General case' 0 CA--C 1.501 -0.942 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 -173.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -174.68 -172.05 39.39 Favored Glycine 0 N--CA 1.423 -2.221 0 N-CA-C 103.861 -3.696 . . . . 0.0 103.861 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -130.08 148.97 51.98 Favored 'General case' 0 N--CA 1.426 -1.636 1 N-CA-C 97.202 -5.11 . . . . 0.0 97.202 -175.168 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.0 tptm -115.24 112.68 22.83 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 100.61 -3.848 . . . . 0.0 100.61 175.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.7 t -82.06 117.24 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 -173.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 119.79 -13.0 10.78 Favored Glycine 0 C--N 1.347 1.163 0 N-CA-C 107.856 -2.097 . . . . 0.0 107.856 -169.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -128.77 -78.83 0.56 Allowed 'General case' 0 CA--C 1.501 -0.929 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 175.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 168.11 -162.18 35.96 Favored Glycine 0 N--CA 1.427 -1.915 0 N-CA-C 103.808 -3.717 . . . . 0.0 103.808 -168.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 41.1 tp -63.17 131.08 47.28 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 127.448 2.299 . . . . 0.0 107.123 176.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -136.48 -171.72 2.97 Favored 'General case' 0 CA--C 1.492 -1.286 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 -165.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 4.2 t -139.19 156.73 46.9 Favored 'General case' 0 CA--C 1.488 -1.409 0 N-CA-C 100.594 -3.854 . . . . 0.0 100.594 173.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.423 ' HA ' ' HA ' ' A' ' 5' ' ' TYR . 15.6 t-105 -115.06 147.59 39.98 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 103.423 -2.806 . . . . 0.0 103.423 178.018 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 63.4 m -136.44 143.93 44.17 Favored 'General case' 0 CA--C 1.489 -1.384 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 172.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -113.64 131.05 56.28 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 102.309 -3.219 . . . . 0.0 102.309 177.218 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 57.86 71.26 0.59 Allowed 'General case' 0 CA--C 1.498 -1.046 0 C-N-CA 126.877 2.071 . . . . 0.0 110.946 178.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 15.9 mt -96.03 145.94 30.43 Favored Pre-proline 0 CA--C 1.499 -1.005 0 N-CA-C 102.78 -3.045 . . . . 0.0 102.78 164.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.06 166.7 28.33 Favored 'Trans proline' 0 N--CA 1.447 -1.236 0 C-N-CA 122.295 1.997 . . . . 0.0 109.527 172.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -77.86 -9.65 59.16 Favored 'General case' 0 CA--C 1.5 -0.973 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -163.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -85.65 7.33 23.77 Favored 'General case' 0 CA--C 1.506 -0.737 0 C-N-CA 123.996 0.918 . . . . 0.0 109.95 -179.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.0 t -104.35 113.46 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.636 0 N-CA-C 103.877 -2.638 . . . . 0.0 103.877 172.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -84.38 155.5 31.11 Favored Glycine 0 CA--C 1.493 -1.334 0 N-CA-C 104.604 -3.399 . . . . 0.0 104.604 169.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 15.1 pt -144.1 -134.59 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 N-CA-C 102.674 -3.084 . . . . 0.0 102.674 -166.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.472 ' CD1' ' HB2' ' A' ' 7' ' ' ALA . 3.2 mp -74.41 112.35 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 N-CA-C 102.39 -3.189 . . . . 0.0 102.39 168.138 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.425 -1.694 0 N-CA-C 100.8 -3.778 . . . . 0.0 100.8 -158.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 28.1 m . . . . . 0 N--CA 1.483 1.176 0 CA-C-O 120.977 0.418 . . . . 0.0 110.528 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -102.16 162.79 12.64 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 172.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -125.19 132.12 53.07 Favored 'General case' 0 CA--C 1.493 -1.217 1 N-CA-C 96.192 -5.484 . . . . 0.0 96.192 158.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.1 -170.13 26.43 Favored Glycine 0 CA--C 1.481 -2.055 0 N-CA-C 103.979 -3.648 . . . . 0.0 103.979 176.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -83.29 135.82 34.6 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 103.765 -2.679 . . . . 0.0 103.765 162.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.8 tt -91.47 147.52 5.21 Favored 'Isoleucine or valine' 0 C--O 1.244 0.814 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 175.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.454 ' HB2' HD12 ' A' ' 59' ' ' ILE . . . -149.3 -169.24 3.32 Favored 'General case' 0 N--CA 1.42 -1.952 0 N-CA-C 104.632 -2.358 . . . . 0.0 104.632 178.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -88.57 150.45 46.32 Favored Pre-proline 0 N--CA 1.432 -1.365 0 N-CA-C 104.624 -2.362 . . . . 0.0 104.624 169.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -70.57 32.47 0.22 Allowed 'Trans proline' 0 CA--C 1.517 -0.347 0 C-N-CA 123.911 3.074 . . . . 0.0 116.029 -174.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -109.54 11.05 25.02 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 106.957 -1.498 . . . . 0.0 106.957 -176.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 50.1 t30 67.66 53.65 0.7 Allowed 'General case' 0 CA--C 1.5 -0.949 0 C-N-CA 127.798 2.439 . . . . 0.0 108.285 -172.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -110.93 -154.72 0.55 Allowed 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -167.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.8 m -135.51 161.35 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.592 1 N-CA-C 98.021 -4.807 . . . . 0.0 98.021 163.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -113.64 130.79 56.34 Favored 'General case' 0 CA--C 1.479 -1.76 1 N-CA-C 96.683 -5.302 . . . . 0.0 96.683 173.918 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 27.7 m80 -82.98 141.88 31.78 Favored 'General case' 0 CA--C 1.493 -1.236 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 -173.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.402 ' H ' ' HG ' ' A' ' 45' ' ' LEU . 1.8 t -91.39 -179.18 5.32 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 -178.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -131.49 126.04 20.97 Favored Pre-proline 0 N--CA 1.412 -2.332 1 N-CA-C 97.073 -5.158 . . . . 0.0 97.073 -174.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_exo -62.96 67.97 0.14 Allowed 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.402 2.735 . . . . 0.0 112.029 164.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 171.96 77.21 0.05 OUTLIER Glycine 0 N--CA 1.423 -2.204 1 N-CA-C 95.346 -7.102 . . . . 0.0 95.346 -172.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.2 m -49.24 -38.1 25.51 Favored 'General case' 0 N--CA 1.438 -1.045 0 C-N-CA 128.532 2.733 . . . . 0.0 113.404 -159.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.5 m -61.05 -17.4 52.19 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 -177.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.8 -52.11 50.81 Favored Glycine 0 C--N 1.35 1.333 0 CA-C-N 119.982 1.265 . . . . 0.0 110.384 173.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -88.23 -20.99 24.77 Favored 'General case' 0 CA--C 1.496 -1.114 0 O-C-N 121.465 -1.021 . . . . 0.0 109.488 -175.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -64.28 -34.66 78.63 Favored 'General case' 0 C--N 1.355 0.818 0 O-C-N 121.232 -0.917 . . . . 0.0 109.515 170.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 33.4 m -64.88 -44.79 88.52 Favored 'General case' 0 C--N 1.354 0.771 0 O-C-N 120.8 -1.188 . . . . 0.0 109.862 172.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 84.1 mt -62.4 -43.33 99.08 Favored 'General case' 0 C--N 1.361 1.109 0 CA-C-O 121.732 0.777 . . . . 0.0 110.897 178.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 41.7 t -54.37 -48.86 71.03 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 125.132 1.373 . . . . 0.0 109.875 173.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.6 tptp -66.13 -40.55 90.74 Favored 'General case' 0 N--CA 1.441 -0.911 0 O-C-N 121.837 -0.539 . . . . 0.0 111.783 -174.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -76.94 -24.57 52.37 Favored 'General case' 0 C--N 1.354 0.773 0 O-C-N 121.772 -0.58 . . . . 0.0 112.455 -177.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -75.43 -39.16 59.24 Favored 'General case' 0 C--N 1.361 1.081 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 171.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 120.7 44.05 0.43 Allowed Glycine 0 CA--C 1.483 -1.963 0 N-CA-C 108.066 -2.014 . . . . 0.0 108.066 166.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -95.84 136.97 13.14 Favored Glycine 0 CA--C 1.486 -1.767 0 N-CA-C 103.159 -3.976 . . . . 0.0 103.159 167.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.0 m -102.38 2.87 37.24 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 -158.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.3 m -160.64 165.42 30.64 Favored 'General case' 0 CA--C 1.488 -1.441 1 N-CA-C 99.517 -4.253 . . . . 0.0 99.517 159.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -175.67 168.85 41.4 Favored Glycine 0 CA--C 1.48 -2.117 0 N-CA-C 103.513 -3.835 . . . . 0.0 103.513 -177.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.472 ' CE1' ' CD1' ' A' ' 48' ' ' TRP . 35.1 p-80 -174.1 -178.86 1.55 Allowed 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 100.619 -3.845 . . . . 0.0 100.619 -176.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 74.4 m -87.47 163.44 16.7 Favored 'General case' 0 CA--C 1.495 -1.157 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -164.07 -177.71 37.03 Favored Glycine 0 N--CA 1.423 -2.209 1 N-CA-C 99.641 -5.384 . . . . 0.0 99.641 176.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -136.35 140.24 43.14 Favored 'General case' 0 N--CA 1.431 -1.403 1 N-CA-C 96.929 -5.211 . . . . 0.0 96.929 177.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.4 tmtt? -108.99 100.68 9.84 Favored 'General case' 0 CA--C 1.492 -1.265 0 N-CA-C 101.625 -3.472 . . . . 0.0 101.625 178.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.1 t -71.42 117.4 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 -178.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 135.46 -38.18 1.83 Allowed Glycine 0 CA--C 1.489 -1.571 0 N-CA-C 105.648 -2.981 . . . . 0.0 105.648 -167.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 30.7 m170 -121.07 -74.41 0.61 Allowed 'General case' 0 CA--C 1.498 -1.033 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 177.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 171.71 -158.82 30.0 Favored Glycine 0 N--CA 1.427 -1.918 0 N-CA-C 104.812 -3.315 . . . . 0.0 104.812 -169.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.402 ' HG ' ' H ' ' A' ' 16' ' ' CYS . 43.8 tp -67.19 129.84 41.19 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 126.67 1.988 . . . . 0.0 106.249 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -137.23 175.27 9.76 Favored 'General case' 0 CA--C 1.484 -1.581 0 N-CA-C 102.006 -3.331 . . . . 0.0 102.006 -167.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 64.0 m -117.95 160.65 21.1 Favored 'General case' 0 CA--C 1.476 -1.884 0 N-CA-C 102.582 -3.118 . . . . 0.0 102.582 174.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.472 ' CD1' ' CE1' ' A' ' 36' ' ' HIS . 30.7 t-105 -117.52 148.52 41.78 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 103.531 -2.766 . . . . 0.0 103.531 -176.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 67.9 m -142.09 148.2 38.0 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 104.602 -2.369 . . . . 0.0 104.602 172.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -112.77 140.28 47.69 Favored 'General case' 0 CA--C 1.492 -1.272 0 N-CA-C 101.499 -3.519 . . . . 0.0 101.499 168.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 66.66 66.12 0.45 Allowed 'General case' 0 CA--C 1.498 -1.035 0 C-N-CA 126.222 1.809 . . . . 0.0 110.691 169.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 14.4 mt -103.74 138.99 19.69 Favored Pre-proline 0 CA--C 1.498 -1.047 0 N-CA-C 104.609 -2.367 . . . . 0.0 104.609 172.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.9 170.05 20.64 Favored 'Trans proline' 0 N--CA 1.447 -1.241 0 C-N-CA 122.542 2.161 . . . . 0.0 110.751 177.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -76.96 -0.45 24.38 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -172.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -87.3 3.35 47.12 Favored 'General case' 0 CA--C 1.505 -0.781 0 O-C-N 121.455 -0.778 . . . . 0.0 110.253 177.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.0 t -103.83 148.08 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.278 0 N-CA-C 102.582 -3.118 . . . . 0.0 102.582 178.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -129.19 144.38 15.37 Favored Glycine 0 CA--C 1.476 -2.372 1 N-CA-C 97.034 -6.426 . . . . 0.0 97.034 174.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 27.4 pt -142.31 -141.7 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.32 0 N-CA-C 104.305 -2.479 . . . . 0.0 104.305 -154.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.454 HD12 ' HB2' ' A' ' 7' ' ' ALA . 1.7 mp -70.25 113.6 6.53 Favored 'Isoleucine or valine' 0 C--N 1.352 0.691 0 N-CA-C 104.548 -2.39 . . . . 0.0 104.548 168.087 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.496 -1.109 0 CA-C-O 122.655 1.217 . . . . 0.0 108.272 -160.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 29.8 m . . . . . 0 N--CA 1.484 1.252 0 CA-C-O 121.129 0.49 . . . . 0.0 110.079 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.5 171.97 7.97 Favored 'General case' 0 CA--C 1.493 -1.219 0 N-CA-C 101.116 -3.661 . . . . 0.0 101.116 161.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -129.35 135.25 48.49 Favored 'General case' 0 CA--C 1.485 -1.526 1 N-CA-C 94.007 -6.294 . . . . 0.0 94.007 169.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.81 -177.27 34.73 Favored Glycine 0 CA--C 1.473 -2.556 1 N-CA-C 102.957 -4.057 . . . . 0.0 102.957 -177.014 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -87.97 136.53 32.92 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 101.954 -3.35 . . . . 0.0 101.954 164.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 16.1 tt -90.62 144.26 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.366 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 -177.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -126.26 -148.42 0.39 Allowed 'General case' 0 N--CA 1.423 -1.779 0 C-N-CA 128.674 2.79 . . . . 0.0 106.68 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -133.22 148.78 70.48 Favored Pre-proline 0 N--CA 1.422 -1.857 1 N-CA-C 95.572 -5.714 . . . . 0.0 95.572 166.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -82.01 39.9 0.91 Allowed 'Trans proline' 0 CA--C 1.513 -0.543 0 C-N-CA 123.601 2.867 . . . . 0.0 112.151 -154.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -111.64 17.03 20.32 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 106.557 -1.646 . . . . 0.0 106.557 -178.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.436 ' O ' ' HE1' ' A' ' 43' ' ' HIS . 49.9 t30 64.56 60.23 0.91 Allowed 'General case' 0 CA--C 1.497 -1.063 0 C-N-CA 128.265 2.626 . . . . 0.0 108.583 -172.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -117.9 -158.37 0.71 Allowed 'General case' 0 CA--C 1.493 -1.224 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -166.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.1 m -137.26 156.79 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.687 1 N-CA-C 96.103 -5.517 . . . . 0.0 96.103 167.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -93.73 121.04 34.76 Favored 'General case' 0 CA--C 1.486 -1.51 0 N-CA-C 100.529 -3.878 . . . . 0.0 100.529 170.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -74.88 107.74 7.16 Favored 'General case' 0 CA--C 1.492 -1.26 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 -168.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.3 t -83.65 150.14 26.08 Favored 'General case' 0 CA--C 1.485 -1.54 0 CA-C-N 114.399 -1.273 . . . . 0.0 107.68 -164.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -112.04 112.99 52.38 Favored Pre-proline 0 N--CA 1.428 -1.572 0 N-CA-C 102.046 -3.316 . . . . 0.0 102.046 178.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_exo -59.41 137.59 79.06 Favored 'Trans proline' 0 CA--C 1.503 -1.047 0 C-N-CA 122.625 2.216 . . . . 0.0 110.677 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 119.83 -54.95 0.63 Allowed Glycine 0 CA--C 1.488 -1.607 1 N-CA-C 101.617 -4.593 . . . . 0.0 101.617 -157.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.0 m 91.24 12.04 0.04 OUTLIER 'General case' 0 CA--C 1.496 -1.105 0 C-N-CA 127.518 2.327 . . . . 0.0 111.224 174.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.7 m -56.65 -53.88 52.6 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 124.473 1.109 . . . . 0.0 113.047 -172.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -74.8 -31.81 57.81 Favored Glycine 0 C--N 1.35 1.342 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.7 t -67.03 -51.68 51.79 Favored 'General case' 0 CA--C 1.488 -1.419 0 C-N-CA 124.174 0.99 . . . . 0.0 109.602 -174.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -65.44 -36.74 84.82 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -176.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.8 m -60.33 -50.5 73.38 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 121.52 -0.738 . . . . 0.0 111.137 173.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 32.3 mt -64.5 -42.0 96.09 Favored 'General case' 0 CA--C 1.498 -1.046 0 C-N-CA 123.9 0.88 . . . . 0.0 109.99 -179.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 19.5 t -55.91 -46.0 78.53 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 124.123 0.969 . . . . 0.0 110.82 176.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 37.5 mtmm -63.55 -46.67 84.89 Favored 'General case' 0 C--N 1.356 0.864 0 CA-C-N 118.213 0.461 . . . . 0.0 111.259 -177.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -73.13 -21.95 60.63 Favored 'General case' 0 C--N 1.351 0.636 0 O-C-N 121.666 -0.646 . . . . 0.0 112.267 -175.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 48.9 mmtm -86.14 -10.39 54.91 Favored 'General case' 0 C--N 1.355 0.844 0 O-C-N 121.855 -0.528 . . . . 0.0 110.907 174.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.57 28.85 7.72 Favored Glycine 0 CA--C 1.489 -1.535 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 168.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -94.83 146.46 18.18 Favored Glycine 0 CA--C 1.487 -1.68 0 N-CA-C 105.037 -3.225 . . . . 0.0 105.037 165.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.5 p -72.58 -43.33 63.52 Favored 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 124.483 1.113 . . . . 0.0 110.354 -166.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 34.9 m -160.63 -178.59 6.98 Favored 'General case' 0 N--CA 1.422 -1.863 1 N-CA-C 97.8 -4.889 . . . . 0.0 97.8 165.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -174.7 177.35 46.84 Favored Glycine 0 N--CA 1.417 -2.605 1 N-CA-C 98.947 -5.661 . . . . 0.0 98.947 -167.294 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 81.8 m-70 -164.52 171.28 14.77 Favored 'General case' 0 CA--C 1.492 -1.257 1 N-CA-C 98.621 -4.585 . . . . 0.0 98.621 -171.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 72.5 m -81.16 160.52 24.35 Favored 'General case' 0 CA--C 1.502 -0.881 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 165.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -167.34 171.77 42.1 Favored Glycine 0 CA--C 1.481 -2.084 1 N-CA-C 98.58 -5.808 . . . . 0.0 98.58 173.239 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -156.26 140.38 16.45 Favored 'General case' 0 N--CA 1.426 -1.628 1 N-CA-C 97.82 -4.882 . . . . 0.0 97.82 -176.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -155.42 47.96 0.52 Allowed 'General case' 0 CA--C 1.491 -1.298 1 N-CA-C 99.514 -4.254 . . . . 0.0 99.514 174.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.404 HG12 ' H ' ' A' ' 42' ' ' GLY 0.276 2.1 t 61.68 -147.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 N-CA-C 105.482 -2.044 . . . . 0.0 105.482 -152.271 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.404 ' H ' HG12 ' A' ' 41' ' ' VAL . . . 142.93 -88.11 0.18 Allowed Glycine 0 CA--C 1.48 -2.109 1 N-CA-C 100.853 -4.899 . . . . 0.0 100.853 -178.455 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.436 ' HE1' ' O ' ' A' ' 11' ' ' ASN . 47.0 m170 -150.26 -69.57 0.19 Allowed 'General case' 0 CA--C 1.493 -1.223 1 N-CA-C 98.215 -4.735 . . . . 0.0 98.215 168.179 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -115.01 -159.37 12.29 Favored Glycine 0 N--CA 1.437 -1.267 0 N-CA-C 103.304 -3.918 . . . . 0.0 103.304 168.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -83.18 110.98 18.51 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 -174.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -98.77 175.39 5.98 Favored 'General case' 0 CA--C 1.492 -1.28 0 C-N-CA 124.649 1.18 . . . . 0.0 108.182 -167.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 10.8 t -111.12 148.65 32.24 Favored 'General case' 0 CA--C 1.499 -1.018 0 N-CA-C 102.387 -3.19 . . . . 0.0 102.387 -174.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 70.0 t-105 -100.19 150.64 22.31 Favored 'General case' 0 CA--C 1.492 -1.286 0 N-CA-C 104.355 -2.461 . . . . 0.0 104.355 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 26.1 m -141.01 143.72 34.59 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 101.422 -3.547 . . . . 0.0 101.422 166.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -110.11 23.34 14.45 Favored 'General case' 0 CA--C 1.503 -0.862 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -167.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -177.29 156.44 1.23 Allowed 'General case' 0 N--CA 1.418 -2.037 1 N-CA-C 94.321 -6.177 . . . . 0.0 94.321 170.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 14.8 mt -159.41 154.22 21.15 Favored Pre-proline 0 CA--C 1.488 -1.437 1 N-CA-C 96.128 -5.508 . . . . 0.0 96.128 157.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.18 161.39 46.18 Favored 'Trans proline' 0 N--CA 1.446 -1.287 0 C-N-CA 122.006 1.804 . . . . 0.0 108.328 165.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -77.92 -6.52 54.6 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -165.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -86.91 -1.79 58.1 Favored 'General case' 0 CA--C 1.506 -0.73 0 O-C-N 121.439 -0.788 . . . . 0.0 109.629 -178.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.1 t -94.16 111.01 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.16 0 N-CA-C 104.287 -2.486 . . . . 0.0 104.287 177.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -84.98 143.65 20.59 Favored Glycine 0 CA--C 1.492 -1.382 0 N-CA-C 106.627 -2.589 . . . . 0.0 106.627 176.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 13.6 pt -125.34 -134.65 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.276 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 -162.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.1 mp -76.18 119.45 24.29 Favored 'Isoleucine or valine' 0 C--N 1.354 0.784 0 N-CA-C 102.884 -3.006 . . . . 0.0 102.884 165.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.9 t . . . . . 0 CA--C 1.497 -1.065 0 C-N-CA 124.954 1.302 . . . . 0.0 109.175 -163.496 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 34.1 m . . . . . 0 N--CA 1.485 1.284 0 CA-C-O 121.17 0.509 . . . . 0.0 109.903 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -106.11 157.95 17.18 Favored 'General case' 0 CA--C 1.499 -0.987 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 171.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -126.44 125.73 42.63 Favored 'General case' 0 CA--C 1.484 -1.589 1 N-CA-C 94.386 -6.153 . . . . 0.0 94.386 156.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.72 178.34 37.64 Favored Glycine 0 CA--C 1.475 -2.41 0 N-CA-C 107.601 -2.2 . . . . 0.0 107.601 -171.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -82.65 129.79 35.01 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 166.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.444 HG13 HG22 ' A' ' 58' ' ' ILE . 14.0 tt -91.05 144.18 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 -179.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.448 ' HB2' HD12 ' A' ' 59' ' ' ILE . . . -144.85 179.34 7.39 Favored 'General case' 0 N--CA 1.417 -2.078 1 N-CA-C 98.731 -4.544 . . . . 0.0 98.731 -177.405 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -79.64 156.2 75.55 Favored Pre-proline 0 N--CA 1.437 -1.12 0 CA-C-O 116.735 -1.603 . . . . 0.0 106.836 178.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -67.9 -18.82 46.85 Favored 'Trans proline' 0 CA--C 1.504 -0.999 0 CA-C-N 122.989 2.103 . . . . 0.0 116.709 -152.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -101.21 7.12 43.19 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -177.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 86.73 126.62 0.03 OUTLIER 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 128.822 2.849 . . . . 0.0 107.112 176.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 156.9 126.47 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.345 1 N-CA-C 99.16 -4.385 . . . . 0.0 99.16 172.294 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.0 m -63.36 156.46 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.23 0 CA-C-O 123.011 1.386 . . . . 0.0 112.705 -162.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -100.52 121.16 41.12 Favored 'General case' 0 N--CA 1.42 -1.947 1 N-CA-C 97.317 -5.068 . . . . 0.0 97.317 176.609 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 45.6 m80 -80.83 126.04 30.84 Favored 'General case' 0 CA--C 1.487 -1.472 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 -166.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 9.2 t -94.11 174.05 7.35 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 -176.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -146.31 156.71 49.88 Favored Pre-proline 0 N--CA 1.417 -2.093 1 N-CA-C 97.311 -5.07 . . . . 0.0 97.311 -177.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_exo -69.65 -14.94 37.18 Favored 'Trans proline' 0 CA--C 1.511 -0.653 0 CA-C-N 122.977 2.099 . . . . 0.0 111.715 175.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -113.18 81.84 0.3 Allowed Glycine 0 CA--C 1.486 -1.778 1 N-CA-C 101.162 -4.775 . . . . 0.0 101.162 169.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 m -82.09 29.07 0.42 Allowed 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 125.647 1.579 . . . . 0.0 113.1 -160.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.5 m -56.65 -50.98 70.47 Favored 'General case' 0 N--CA 1.435 -1.193 0 C-N-CA 126.879 2.072 . . . . 0.0 113.737 -161.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.03 -31.87 72.69 Favored Glycine 0 C--N 1.352 1.439 0 N-CA-C 111.374 -0.69 . . . . 0.0 111.374 -176.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.3 t -78.49 -31.8 47.91 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -174.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -62.08 -41.83 98.59 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 123.708 0.803 . . . . 0.0 110.436 174.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.02 -35.31 80.3 Favored 'General case' 0 C--N 1.352 0.707 0 O-C-N 121.048 -1.032 . . . . 0.0 112.196 174.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 92.0 mt -67.45 -41.76 84.21 Favored 'General case' 0 C--N 1.357 0.893 0 CA-C-O 121.938 0.875 . . . . 0.0 109.663 176.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 27.2 t -55.41 -47.57 75.71 Favored 'General case' 0 CA--C 1.507 -0.691 0 C-N-CA 125.027 1.331 . . . . 0.0 110.135 177.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -59.04 -50.79 72.73 Favored 'General case' 0 C--N 1.354 0.797 0 C-N-CA 122.827 0.451 . . . . 0.0 111.697 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -71.16 -23.11 62.0 Favored 'General case' 0 C--N 1.356 0.871 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -174.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.0 mmtp -81.92 -14.8 55.63 Favored 'General case' 0 C--N 1.355 0.805 0 C-N-CA 123.147 0.579 . . . . 0.0 110.713 175.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 110.26 24.39 5.7 Favored Glycine 0 CA--C 1.49 -1.472 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 167.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -97.11 122.31 7.38 Favored Glycine 0 C--N 1.353 1.484 0 N-CA-C 105.899 -2.88 . . . . 0.0 105.899 177.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.7 p -99.57 9.2 43.62 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 122.225 1.012 . . . . 0.0 109.162 -168.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 57.9 m -160.11 164.85 32.69 Favored 'General case' 0 CA--C 1.479 -1.786 1 N-CA-C 97.598 -4.964 . . . . 0.0 97.598 164.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.457 ' HA2' ' HA ' ' A' ' 49' ' ' CYS . . . -158.15 164.95 33.59 Favored Glycine 0 CA--C 1.465 -3.07 1 N-CA-C 99.605 -5.398 . . . . 0.0 99.605 -173.427 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -156.76 -159.18 0.84 Allowed 'General case' 0 N--CA 1.421 -1.88 1 N-CA-C 98.185 -4.746 . . . . 0.0 98.185 -177.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 34.0 t -148.13 166.43 27.88 Favored 'General case' 0 N--CA 1.424 -1.733 1 N-CA-C 97.798 -4.89 . . . . 0.0 97.798 -170.264 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -179.7 -161.83 27.67 Favored Glycine 0 N--CA 1.421 -2.306 1 N-CA-C 100.571 -5.012 . . . . 0.0 100.571 176.149 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -140.55 148.27 40.75 Favored 'General case' 0 N--CA 1.432 -1.358 1 N-CA-C 100.072 -4.047 . . . . 0.0 100.072 -178.035 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.9 mmpt? -123.74 103.06 8.16 Favored 'General case' 0 CA--C 1.491 -1.295 0 N-CA-C 104.027 -2.583 . . . . 0.0 104.027 173.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.7 t -74.06 118.71 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 136.65 -36.72 1.95 Allowed Glycine 0 CA--C 1.487 -1.712 0 N-CA-C 104.131 -3.587 . . . . 0.0 104.131 -165.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 39.1 m170 -125.56 -68.89 0.81 Allowed 'General case' 0 CA--C 1.499 -0.99 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 178.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 162.02 -150.58 20.07 Favored Glycine 0 N--CA 1.429 -1.774 0 N-CA-C 105.297 -3.121 . . . . 0.0 105.297 -175.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -70.78 127.72 33.61 Favored 'General case' 0 C--N 1.353 0.745 0 N-CA-C 103.66 -2.718 . . . . 0.0 103.66 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.67 155.77 49.89 Favored 'General case' 0 CA--C 1.479 -1.759 0 N-CA-C 101.235 -3.617 . . . . 0.0 101.235 -168.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 58.0 m -100.44 177.67 4.96 Favored 'General case' 0 CA--C 1.49 -1.334 0 N-CA-C 103.663 -2.717 . . . . 0.0 103.663 -176.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 3.8 t-105 -140.92 150.08 42.7 Favored 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 101.507 -3.516 . . . . 0.0 101.507 -177.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.457 ' HA ' ' HA2' ' A' ' 35' ' ' GLY . 56.1 m -142.85 154.4 44.12 Favored 'General case' 0 CA--C 1.493 -1.224 0 N-CA-C 104.667 -2.346 . . . . 0.0 104.667 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -123.34 135.47 54.19 Favored 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 175.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 77.7 41.89 0.13 Allowed 'General case' 0 CA--C 1.493 -1.215 0 C-N-CA 127.428 2.291 . . . . 0.0 110.612 169.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 49.2 mt -80.69 135.57 52.47 Favored Pre-proline 0 CA--C 1.502 -0.876 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 177.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -72.02 169.61 20.94 Favored 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 122.416 2.077 . . . . 0.0 109.513 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -76.44 -5.79 48.93 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -163.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -86.17 -7.7 58.37 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 123.432 0.693 . . . . 0.0 110.208 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.0 t -93.17 126.93 45.54 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.045 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 -176.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -97.29 150.89 19.65 Favored Glycine 0 CA--C 1.485 -1.842 0 N-CA-C 104.075 -3.61 . . . . 0.0 104.075 178.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.444 HG22 HG13 ' A' ' 6' ' ' ILE . 20.2 pt -148.25 -143.74 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 N-CA-C 102.032 -3.321 . . . . 0.0 102.032 -166.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.448 HD12 ' HB2' ' A' ' 7' ' ' ALA . 2.9 mp -71.8 119.78 18.89 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 104.881 -2.266 . . . . 0.0 104.881 168.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.426 -1.658 0 N-CA-C 102.198 -3.26 . . . . 0.0 102.198 -156.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 25.3 m . . . . . 0 N--CA 1.488 1.459 0 CA-C-O 121.107 0.479 . . . . 0.0 110.962 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.53 166.22 16.43 Favored 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 170.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -130.1 131.81 45.88 Favored 'General case' 0 CA--C 1.492 -1.276 1 N-CA-C 95.173 -5.862 . . . . 0.0 95.173 165.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.86 -173.34 30.4 Favored Glycine 0 CA--C 1.476 -2.372 0 N-CA-C 104.24 -3.544 . . . . 0.0 104.24 178.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -80.04 131.83 35.86 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 102.156 -3.275 . . . . 0.0 102.156 157.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.2 tt -90.72 145.79 6.99 Favored 'Isoleucine or valine' 0 C--O 1.243 0.756 0 N-CA-C 105.52 -2.03 . . . . 0.0 105.52 -177.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.678 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -126.28 -176.17 3.58 Favored 'General case' 0 N--CA 1.424 -1.742 0 C-N-CA 126.165 1.786 . . . . 0.0 106.748 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -82.95 145.31 49.43 Favored Pre-proline 0 N--CA 1.437 -1.119 0 N-CA-C 104.548 -2.389 . . . . 0.0 104.548 157.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_exo -67.28 -22.06 46.87 Favored 'Trans proline' 0 CA--C 1.502 -1.107 0 CA-C-N 122.827 2.045 . . . . 0.0 116.295 -149.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -84.67 38.7 0.71 Allowed 'General case' 0 N--CA 1.438 -1.035 0 C-N-CA 124.825 1.25 . . . . 0.0 110.784 -167.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 50.7 t30 63.85 48.46 3.17 Favored 'General case' 0 C--N 1.354 0.782 0 C-N-CA 127.812 2.445 . . . . 0.0 110.143 -178.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -104.15 -146.68 0.38 Allowed 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 -177.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.557 HG12 HD12 ' A' ' 59' ' ' ILE . 3.1 m -133.11 -166.01 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.338 1 N-CA-C 97.653 -4.943 . . . . 0.0 97.653 164.373 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -120.41 155.41 33.52 Favored 'General case' 0 CA--C 1.491 -1.315 1 N-CA-C 95.704 -5.665 . . . . 0.0 95.704 170.845 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 33.4 m80 -91.1 99.2 12.26 Favored 'General case' 0 CA--C 1.486 -1.481 0 N-CA-C 102.846 -3.02 . . . . 0.0 102.846 175.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 7.2 t -104.94 -176.02 2.96 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 104.273 -2.492 . . . . 0.0 104.273 174.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -137.85 164.55 40.23 Favored Pre-proline 0 N--CA 1.417 -2.084 1 N-CA-C 99.15 -4.389 . . . . 0.0 99.15 -158.266 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.25 55.87 3.65 Favored 'Trans proline' 0 C--N 1.322 -0.863 0 C-N-CA 123.263 2.642 . . . . 0.0 111.063 171.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -173.47 146.31 8.81 Favored Glycine 0 N--CA 1.421 -2.362 1 N-CA-C 99.577 -5.409 . . . . 0.0 99.577 175.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.4 m -93.35 8.77 39.13 Favored 'General case' 0 N--CA 1.438 -1.068 0 C-N-CA 123.92 0.888 . . . . 0.0 110.397 -174.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -50.38 -51.64 44.24 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 128.492 2.717 . . . . 0.0 114.131 -164.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -89.97 -22.01 37.29 Favored Glycine 0 C--N 1.351 1.365 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.9 t -81.28 -12.49 59.06 Favored 'General case' 0 C--N 1.355 0.835 0 O-C-N 121.046 -1.267 . . . . 0.0 109.592 -172.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -51.79 -55.21 21.16 Favored 'General case' 0 C--N 1.352 0.694 0 C-N-CA 124.584 1.154 . . . . 0.0 109.793 166.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.74 -44.98 96.01 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 123.965 0.906 . . . . 0.0 112.131 175.09 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.52 -39.02 93.01 Favored 'General case' 0 C--N 1.361 1.073 0 CA-C-N 118.977 0.808 . . . . 0.0 111.232 -177.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.6 t -68.05 -42.74 80.06 Favored 'General case' 0 N--CA 1.439 -0.987 0 O-C-N 121.301 -0.874 . . . . 0.0 109.51 -178.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -77.89 -26.41 49.13 Favored 'General case' 0 CA--C 1.505 -0.77 0 O-C-N 121.007 -1.058 . . . . 0.0 111.963 -174.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -76.66 -21.55 55.28 Favored 'General case' 0 C--N 1.355 0.815 0 O-C-N 121.243 -0.911 . . . . 0.0 110.988 179.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -79.93 -48.82 12.8 Favored 'General case' 0 CA--C 1.494 -1.174 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 168.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 120.83 48.36 0.3 Allowed Glycine 0 CA--C 1.489 -1.576 0 N-CA-C 108.214 -1.954 . . . . 0.0 108.214 177.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.07 139.29 14.73 Favored Glycine 0 N--CA 1.433 -1.531 0 N-CA-C 103.689 -3.764 . . . . 0.0 103.689 164.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -98.6 2.87 47.77 Favored 'General case' 0 N--CA 1.438 -1.05 0 C-N-CA 124.258 1.023 . . . . 0.0 109.607 -169.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 24.1 m -160.42 159.25 30.76 Favored 'General case' 0 CA--C 1.474 -1.954 0 N-CA-C 100.529 -3.878 . . . . 0.0 100.529 165.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.4 ' HA2' ' HA ' ' A' ' 49' ' ' CYS . . . -165.82 169.79 40.31 Favored Glycine 0 N--CA 1.418 -2.555 1 N-CA-C 101.407 -4.677 . . . . 0.0 101.407 -179.146 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 78.7 m-70 -161.4 -170.16 2.54 Favored 'General case' 0 CA--C 1.491 -1.295 1 N-CA-C 98.558 -4.608 . . . . 0.0 98.558 -174.098 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 73.1 m -145.87 162.57 37.42 Favored 'General case' 0 CA--C 1.485 -1.553 1 N-CA-C 98.852 -4.499 . . . . 0.0 98.852 172.17 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 173.29 179.97 44.31 Favored Glycine 0 N--CA 1.425 -2.049 1 N-CA-C 100.072 -5.211 . . . . 0.0 100.072 -177.099 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -151.1 141.91 22.84 Favored 'General case' 0 N--CA 1.426 -1.674 1 N-CA-C 96.407 -5.405 . . . . 0.0 96.407 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.9 mttp -157.74 58.22 0.49 Allowed 'General case' 0 CA--C 1.488 -1.434 1 N-CA-C 98.303 -4.703 . . . . 0.0 98.303 173.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.732 HG12 ' H ' ' A' ' 42' ' ' GLY 0.272 2.9 t 69.77 -172.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 C-N-CA 127.054 2.142 . . . . 0.0 105.543 -158.264 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.732 ' H ' HG12 ' A' ' 41' ' ' VAL . . . 145.04 -127.96 3.03 Favored Glycine 0 N--CA 1.421 -2.338 1 N-CA-C 97.716 -6.153 . . . . 0.0 97.716 -173.031 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 59.3 m170 -130.37 -39.16 1.33 Allowed 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 104.515 -2.402 . . . . 0.0 104.515 175.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -158.09 -177.0 30.78 Favored Glycine 0 N--CA 1.425 -2.051 1 N-CA-C 95.798 -6.921 . . . . 0.0 95.798 176.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.2 tt -72.25 114.94 10.91 Favored 'General case' 0 C--N 1.351 0.666 0 CA-C-N 118.693 1.247 . . . . 0.0 108.177 -171.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -105.85 -177.81 3.47 Favored 'General case' 0 CA--C 1.485 -1.529 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 -164.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 34.6 t -115.0 161.56 18.17 Favored 'General case' 0 CA--C 1.493 -1.236 0 N-CA-C 102.432 -3.173 . . . . 0.0 102.432 -175.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 33.0 t-105 -117.57 151.75 36.52 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 102.878 -3.008 . . . . 0.0 102.878 178.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.4 ' HA ' ' HA2' ' A' ' 35' ' ' GLY . 15.0 m -148.21 149.79 32.58 Favored 'General case' 0 CA--C 1.495 -1.157 0 N-CA-C 103.428 -2.805 . . . . 0.0 103.428 171.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -111.3 141.99 44.11 Favored 'General case' 0 CA--C 1.495 -1.15 0 N-CA-C 104.212 -2.514 . . . . 0.0 104.212 171.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 66.01 53.28 1.11 Allowed 'General case' 0 CA--C 1.491 -1.298 0 C-N-CA 127.488 2.315 . . . . 0.0 111.164 167.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 40.0 mt -94.81 142.93 25.35 Favored Pre-proline 0 CA--C 1.495 -1.147 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 177.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -72.01 166.74 28.7 Favored 'Trans proline' 0 N--CA 1.447 -1.258 0 C-N-CA 122.61 2.206 . . . . 0.0 110.134 175.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -68.99 -17.07 63.88 Favored 'General case' 0 CA--C 1.506 -0.728 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -167.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -76.48 -6.82 53.45 Favored 'General case' 0 CA--C 1.504 -0.81 0 O-C-N 121.439 -0.788 . . . . 0.0 110.942 -178.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.3 t -94.09 107.96 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 N-CA-C 104.474 -2.417 . . . . 0.0 104.474 178.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -81.63 148.39 27.6 Favored Glycine 0 CA--C 1.489 -1.549 0 N-CA-C 106.393 -2.683 . . . . 0.0 106.393 178.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 41.0 pt -133.66 -160.05 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.303 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 -165.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.678 HD13 ' HB2' ' A' ' 7' ' ' ALA . 0.3 OUTLIER -73.7 121.15 24.07 Favored 'Isoleucine or valine' 0 C--N 1.362 1.146 0 N-CA-C 104.829 -2.286 . . . . 0.0 104.829 176.042 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.4 t . . . . . 0 N--CA 1.44 -0.943 0 N-CA-C 101.899 -3.371 . . . . 0.0 101.899 -162.567 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 33.5 m . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 121.354 0.597 . . . . 0.0 109.629 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -94.24 148.46 22.17 Favored 'General case' 0 CA--C 1.502 -0.879 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 173.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -122.37 118.19 27.84 Favored 'General case' 0 CA--C 1.489 -1.399 1 N-CA-C 94.394 -6.15 . . . . 0.0 94.394 154.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.61 -174.13 31.1 Favored Glycine 0 CA--C 1.479 -2.214 0 N-CA-C 106.196 -2.762 . . . . 0.0 106.196 -171.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 48' ' ' TRP . 92.3 m-85 -86.22 134.96 33.74 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 104.872 -2.27 . . . . 0.0 104.872 167.121 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 16.9 tt -90.63 151.23 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 176.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.513 ' HB2' ' CD1' ' A' ' 59' ' ' ILE . . . -156.3 -177.81 6.86 Favored 'General case' 0 N--CA 1.416 -2.144 1 N-CA-C 98.949 -4.463 . . . . 0.0 98.949 -177.142 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -93.53 156.91 39.31 Favored Pre-proline 0 N--CA 1.435 -1.186 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 178.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -77.36 -1.96 12.14 Favored 'Trans proline' 0 CA--C 1.509 -0.745 0 CA-C-N 121.283 1.494 . . . . 0.0 115.254 -155.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -95.13 13.41 25.39 Favored 'General case' 0 C--N 1.358 0.96 0 CA-C-N 121.214 1.825 . . . . 0.0 107.498 176.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 43.4 t30 83.23 43.44 0.02 OUTLIER 'General case' 0 C--N 1.361 1.102 0 C-N-CA 126.081 1.752 . . . . 0.0 107.494 168.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.44 ' O ' ' HB1' ' A' ' 7' ' ' ALA . 0.7 OUTLIER -131.36 132.18 44.25 Favored 'General case' 0 CA--C 1.487 -1.462 0 N-CA-C 102.374 -3.195 . . . . 0.0 102.374 -173.148 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.481 HG12 HD11 ' A' ' 59' ' ' ILE 0.253 1.7 m -60.57 159.25 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 CA-C-O 123.435 1.588 . . . . 0.0 115.228 -173.411 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -114.73 139.97 49.26 Favored 'General case' 0 N--CA 1.416 -2.157 1 N-CA-C 92.687 -6.783 . . . . 0.0 92.687 169.554 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 66.1 m170 -90.42 -162.28 0.88 Allowed 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 178.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 25.4 t -150.06 171.62 16.57 Favored 'General case' 0 N--CA 1.417 -2.121 1 N-CA-C 97.52 -4.993 . . . . 0.0 97.52 -172.244 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -127.28 123.68 23.42 Favored Pre-proline 0 N--CA 1.419 -2.018 1 N-CA-C 95.925 -5.583 . . . . 0.0 95.925 -178.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -55.88 96.6 0.06 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.604 0 CA-C-N 124.224 2.544 . . . . 0.0 116.691 -168.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 159.92 -159.36 30.61 Favored Glycine 0 N--CA 1.422 -2.267 1 N-CA-C 98.07 -6.012 . . . . 0.0 98.07 -178.166 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.8 p -94.25 -43.67 8.33 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 170.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -39.74 -61.95 0.77 Allowed 'General case' 0 N--CA 1.442 -0.875 0 C-N-CA 128.812 2.845 . . . . 0.0 118.243 -150.287 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -72.09 -39.5 58.28 Favored Glycine 0 C--N 1.348 1.227 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -173.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 9.6 t -83.65 -28.45 28.39 Favored 'General case' 0 CA--C 1.5 -0.962 0 O-C-N 121.277 -1.131 . . . . 0.0 109.329 -177.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -60.81 -46.52 90.2 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-N 119.353 0.979 . . . . 0.0 109.679 175.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.9 p -67.06 -39.15 86.83 Favored 'General case' 0 N--CA 1.44 -0.941 0 O-C-N 121.894 -0.504 . . . . 0.0 111.721 179.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 40.7 mt -63.22 -47.61 81.77 Favored 'General case' 0 C--N 1.357 0.899 0 O-C-N 121.032 -1.043 . . . . 0.0 111.127 172.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 3.0 t -66.01 -32.33 73.75 Favored 'General case' 0 CA--C 1.501 -0.911 0 O-C-N 120.155 -1.59 . . . . 0.0 110.827 -175.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -65.41 -35.26 80.41 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 122.943 0.497 . . . . 0.0 111.488 176.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -75.93 -34.18 59.87 Favored 'General case' 0 C--N 1.359 0.999 0 O-C-N 121.559 -0.713 . . . . 0.0 111.108 177.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.2 mmmp? -72.15 -40.23 68.17 Favored 'General case' 0 C--N 1.36 1.026 0 C-N-CA 123.535 0.734 . . . . 0.0 110.519 178.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 128.41 43.57 0.23 Allowed Glycine 0 CA--C 1.492 -1.368 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 162.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -111.12 145.32 17.55 Favored Glycine 0 CA--C 1.491 -1.415 0 N-CA-C 105.512 -3.035 . . . . 0.0 105.512 169.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.4 p -92.23 4.61 52.89 Favored 'General case' 0 C--N 1.352 0.676 0 CA-C-N 118.053 0.926 . . . . 0.0 110.154 -171.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 57.4 m -157.13 156.66 33.09 Favored 'General case' 0 CA--C 1.483 -1.603 0 N-CA-C 100.981 -3.711 . . . . 0.0 100.981 168.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -152.98 141.17 8.16 Favored Glycine 0 N--CA 1.422 -2.278 1 N-CA-C 97.782 -6.127 . . . . 0.0 97.782 -178.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 15.1 t-80 -159.94 175.6 12.84 Favored 'General case' 0 N--CA 1.429 -1.495 1 N-CA-C 99.692 -4.188 . . . . 0.0 99.692 -169.263 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 63.2 m -95.22 -174.93 3.36 Favored 'General case' 0 CA--C 1.491 -1.296 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 176.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 177.13 -166.56 37.25 Favored Glycine 0 N--CA 1.417 -2.604 1 N-CA-C 96.196 -6.762 . . . . 0.0 96.196 179.282 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -144.51 138.82 27.84 Favored 'General case' 0 N--CA 1.43 -1.437 1 N-CA-C 96.098 -5.519 . . . . 0.0 96.098 173.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 26.2 tptp -120.69 100.14 6.94 Favored 'General case' 0 CA--C 1.487 -1.471 0 N-CA-C 102.358 -3.201 . . . . 0.0 102.358 -179.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.5 t -68.45 134.1 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 -175.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 115.67 -36.83 3.69 Favored Glycine 0 CA--C 1.492 -1.387 0 N-CA-C 105.951 -2.86 . . . . 0.0 105.951 -171.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 57.9 m-70 -106.19 -66.85 0.97 Allowed 'General case' 0 CA--C 1.494 -1.177 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 174.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 150.1 -143.26 10.51 Favored Glycine 0 CA--C 1.481 -2.054 0 N-CA-C 103.826 -3.71 . . . . 0.0 103.826 -174.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.9 tp -65.58 135.98 55.78 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 105.124 -2.176 . . . . 0.0 105.124 172.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -155.04 172.6 17.85 Favored 'General case' 0 CA--C 1.475 -1.917 1 N-CA-C 97.98 -4.822 . . . . 0.0 97.98 -168.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 9.1 t -118.34 159.78 22.8 Favored 'General case' 0 CA--C 1.487 -1.444 0 N-CA-C 103.089 -2.93 . . . . 0.0 103.089 -173.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.407 ' HA ' ' HA ' ' A' ' 5' ' ' TYR . 19.0 t-105 -118.83 146.18 45.06 Favored 'General case' 0 CA--C 1.496 -1.116 0 N-CA-C 103.288 -2.856 . . . . 0.0 103.288 -176.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 79.5 m -146.26 157.78 43.83 Favored 'General case' 0 CA--C 1.487 -1.457 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 173.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -118.06 138.88 51.93 Favored 'General case' 0 CA--C 1.495 -1.15 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 176.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 64.62 61.89 0.81 Allowed 'General case' 0 CA--C 1.494 -1.191 0 C-N-CA 128.102 2.561 . . . . 0.0 111.646 173.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 28.6 mt -96.04 133.45 25.2 Favored Pre-proline 0 CA--C 1.502 -0.882 0 N-CA-C 104.015 -2.587 . . . . 0.0 104.015 172.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -75.32 173.97 13.6 Favored 'Trans proline' 0 N--CA 1.447 -1.247 0 CA-C-N 122.057 1.771 . . . . 0.0 109.768 -178.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -74.3 -5.53 42.69 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -169.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -90.61 -0.93 57.86 Favored 'General case' 0 CA--C 1.502 -0.872 0 O-C-N 121.239 -0.913 . . . . 0.0 110.015 -178.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.5 t -97.88 152.01 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 N-CA-C 102.677 -3.083 . . . . 0.0 102.677 178.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -123.01 153.28 16.96 Favored Glycine 0 CA--C 1.481 -2.045 1 N-CA-C 98.767 -5.733 . . . . 0.0 98.767 177.153 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 19.5 pt -152.82 -154.63 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 N-CA-C 101.258 -3.608 . . . . 0.0 101.258 -163.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.513 ' CD1' ' HB2' ' A' ' 7' ' ' ALA . 4.5 mp -73.76 119.28 20.61 Favored 'Isoleucine or valine' 0 C--N 1.362 1.11 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 169.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.428 -1.537 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 -157.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 27.3 m . . . . . 0 N--CA 1.485 1.29 0 CA-C-O 121.413 0.625 . . . . 0.0 110.646 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -99.25 155.62 17.4 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 105.318 -2.105 . . . . 0.0 105.318 166.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -122.16 126.32 48.06 Favored 'General case' 0 CA--C 1.486 -1.488 1 N-CA-C 94.331 -6.174 . . . . 0.0 94.331 153.19 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.55 179.91 36.65 Favored Glycine 0 CA--C 1.475 -2.466 0 N-CA-C 104.345 -3.502 . . . . 0.0 104.345 -174.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -79.89 134.05 36.28 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 104.461 -2.422 . . . . 0.0 104.461 168.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 16.4 tt -90.36 149.4 4.06 Favored 'Isoleucine or valine' 0 C--N 1.355 0.808 0 N-CA-C 105.62 -1.992 . . . . 0.0 105.62 -178.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.764 ' HB2' HD12 ' A' ' 59' ' ' ILE . . . -139.96 -173.07 3.54 Favored 'General case' 0 N--CA 1.417 -2.113 0 C-N-CA 126.255 1.822 . . . . 0.0 106.898 -170.577 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -95.18 148.33 34.48 Favored Pre-proline 0 N--CA 1.432 -1.36 0 N-CA-C 102.085 -3.302 . . . . 0.0 102.085 163.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_exo -69.62 -26.86 27.8 Favored 'Trans proline' 0 CA--C 1.501 -1.144 0 CA-C-N 123.034 2.119 . . . . 0.0 115.52 -153.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -88.76 53.78 2.81 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-N 119.224 0.92 . . . . 0.0 110.483 -167.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 75.32 41.34 0.29 Allowed 'General case' 0 C--N 1.354 0.786 0 C-N-CA 125.793 1.637 . . . . 0.0 110.121 167.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 55.6 m -117.05 -154.86 0.57 Allowed 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -168.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.807 HG12 HD11 ' A' ' 59' ' ' ILE . 1.6 m -133.01 175.57 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.4 1 N-CA-C 98.433 -4.655 . . . . 0.0 98.433 166.66 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . 0.31 0.2 OUTLIER -119.62 141.14 49.57 Favored 'General case' 0 CA--C 1.477 -1.861 1 N-CA-C 92.684 -6.784 . . . . 0.0 92.684 170.045 . . . . . . . . 4 3 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 21.5 m80 -90.46 145.66 24.74 Favored 'General case' 0 CA--C 1.491 -1.306 0 N-CA-C 103.558 -2.756 . . . . 0.0 103.558 174.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.7 t -90.48 167.71 12.39 Favored 'General case' 0 CA--C 1.483 -1.606 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 -176.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -114.38 113.44 45.75 Favored Pre-proline 0 N--CA 1.42 -1.952 1 N-CA-C 98.424 -4.658 . . . . 0.0 98.424 168.427 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -57.59 129.59 34.53 Favored 'Trans proline' 0 CA--C 1.507 -0.87 0 CA-C-N 123.154 2.162 . . . . 0.0 111.351 178.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 126.61 -56.98 0.71 Allowed Glycine 0 CA--C 1.49 -1.5 1 N-CA-C 101.853 -4.499 . . . . 0.0 101.853 -157.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.5 m 107.3 -6.1 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.321 0 C-N-CA 129.25 3.02 . . . . 0.0 110.932 174.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.1 m -42.42 -55.36 3.45 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 127.625 2.37 . . . . 0.0 115.275 -166.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -72.26 -45.86 37.2 Favored Glycine 0 C--N 1.351 1.378 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 -176.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.9 m -72.89 -32.59 65.48 Favored 'General case' 0 CA--C 1.492 -1.269 0 O-C-N 121.474 -1.015 . . . . 0.0 112.003 -174.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -65.78 -38.32 88.7 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 174.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 32.2 m -65.29 -43.35 91.42 Favored 'General case' 0 C--N 1.35 0.603 0 O-C-N 120.733 -1.23 . . . . 0.0 110.144 176.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 33.9 mt -63.69 -40.39 96.69 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-O 122.17 0.986 . . . . 0.0 110.474 178.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.4 t -57.14 -43.8 82.77 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 124.6 1.16 . . . . 0.0 110.79 175.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -64.03 -43.61 95.05 Favored 'General case' 0 C--N 1.355 0.84 0 CA-C-N 118.494 0.588 . . . . 0.0 111.633 -178.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -79.04 -30.63 44.23 Favored 'General case' 0 CA--C 1.507 -0.674 0 O-C-N 122.039 -0.413 . . . . 0.0 111.27 -172.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -83.77 -22.11 31.99 Favored 'General case' 0 C--N 1.355 0.843 0 O-C-N 121.774 -0.579 . . . . 0.0 109.847 177.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 108.65 48.27 0.86 Allowed Glycine 0 CA--C 1.491 -1.439 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 159.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.23 154.27 16.9 Favored Glycine 0 C--N 1.35 1.326 0 N-CA-C 106.582 -2.607 . . . . 0.0 106.582 170.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 39.3 p -90.81 -20.53 22.23 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-O 122.341 1.067 . . . . 0.0 109.927 -165.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.9 m -160.22 159.75 31.9 Favored 'General case' 0 N--CA 1.423 -1.818 1 N-CA-C 98.122 -4.77 . . . . 0.0 98.122 179.237 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -178.6 172.52 44.87 Favored Glycine 0 CA--C 1.467 -2.944 1 N-CA-C 100.039 -5.224 . . . . 0.0 100.039 -179.347 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 177.95 -160.07 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 100.262 -3.977 . . . . 0.0 100.262 -174.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 61.6 m -76.77 177.49 7.56 Favored 'General case' 0 CA--C 1.504 -0.821 0 CA-C-O 121.898 0.856 . . . . 0.0 110.704 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -164.05 -179.11 38.1 Favored Glycine 0 N--CA 1.42 -2.426 1 N-CA-C 98.663 -5.775 . . . . 0.0 98.663 178.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -143.7 159.99 41.5 Favored 'General case' 0 N--CA 1.422 -1.833 1 N-CA-C 97.623 -4.955 . . . . 0.0 97.623 -177.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.1 mmmm -148.95 167.08 26.72 Favored 'General case' 0 N--CA 1.421 -1.886 1 N-CA-C 95.995 -5.557 . . . . 0.0 95.995 169.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -133.43 156.77 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.685 1 N-CA-C 94.391 -6.151 . . . . 0.0 94.391 173.228 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.89 -60.53 0.73 Allowed Glycine 0 CA--C 1.492 -1.394 0 N-CA-C 104.771 -3.331 . . . . 0.0 104.771 -170.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 23.4 m170 -90.24 -90.61 0.15 Allowed 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 166.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 163.86 -156.61 28.54 Favored Glycine 0 CA--C 1.479 -2.194 1 N-CA-C 99.399 -5.48 . . . . 0.0 99.399 179.033 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 54.0 tp -43.52 126.73 4.53 Favored 'General case' 0 C--N 1.352 0.712 0 C-N-CA 128.001 2.521 . . . . 0.0 111.646 -179.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -127.67 -171.19 2.38 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 105.416 -2.068 . . . . 0.0 105.416 -168.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 63.7 m -131.23 176.21 8.47 Favored 'General case' 0 CA--C 1.482 -1.641 0 N-CA-C 102.746 -3.057 . . . . 0.0 102.746 171.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 12.5 t-105 -137.58 154.03 49.85 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 -177.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 22.6 m -145.59 152.84 40.34 Favored 'General case' 0 CA--C 1.493 -1.25 0 N-CA-C 104.269 -2.493 . . . . 0.0 104.269 171.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -109.53 143.54 39.05 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 104.31 -2.478 . . . . 0.0 104.31 168.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 55.9 62.48 2.37 Favored 'General case' 0 CA--C 1.499 -1.017 0 C-N-CA 127.871 2.469 . . . . 0.0 113.128 173.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 33.5 mt -95.61 134.74 23.77 Favored Pre-proline 0 CA--C 1.498 -1.021 0 N-CA-C 103.614 -2.735 . . . . 0.0 103.614 171.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -71.53 176.54 7.93 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 CA-C-N 122.375 1.884 . . . . 0.0 111.72 178.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -75.02 -8.76 57.45 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 113.65 0.982 . . . . 0.0 113.65 -167.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.8 p-10 -85.99 -8.24 58.1 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 121.605 -0.684 . . . . 0.0 110.069 -179.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.0 t -92.9 127.78 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 -175.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -97.32 140.69 15.19 Favored Glycine 0 CA--C 1.484 -1.898 0 N-CA-C 104.424 -3.47 . . . . 0.0 104.424 177.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 24.4 pt -139.09 -151.8 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 N-CA-C 104.157 -2.535 . . . . 0.0 104.157 -165.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.807 HD11 HG12 ' A' ' 13' ' ' VAL . 1.8 mp -66.41 118.77 10.27 Favored 'Isoleucine or valine' 0 C--N 1.364 1.209 0 N-CA-C 103.501 -2.778 . . . . 0.0 103.501 168.107 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.4 t . . . . . 0 N--CA 1.422 -1.843 1 N-CA-C 96.95 -5.204 . . . . 0.0 96.95 -168.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 27.4 m . . . . . 0 N--CA 1.484 1.265 0 CA-C-O 121.174 0.512 . . . . 0.0 110.26 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -105.03 160.34 15.12 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 106.109 -1.811 . . . . 0.0 106.109 168.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -127.69 126.62 42.24 Favored 'General case' 0 CA--C 1.49 -1.357 1 N-CA-C 96.636 -5.32 . . . . 0.0 96.636 158.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.04 -170.83 27.35 Favored Glycine 0 CA--C 1.477 -2.328 1 N-CA-C 102.084 -4.407 . . . . 0.0 102.084 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -81.08 141.68 34.07 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 103.611 -2.737 . . . . 0.0 103.611 164.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 11.5 tt -90.4 142.14 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 N-CA-C 104.903 -2.258 . . . . 0.0 104.903 175.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.944 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -130.52 175.65 8.81 Favored 'General case' 0 N--CA 1.414 -2.233 0 N-CA-C 103.919 -2.622 . . . . 0.0 103.919 -175.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -79.6 154.21 76.11 Favored Pre-proline 0 N--CA 1.432 -1.34 0 N-CA-C 105.032 -2.21 . . . . 0.0 105.032 166.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -68.96 0.34 5.18 Favored 'Trans proline' 0 CA--C 1.511 -0.627 0 C-N-CA 121.94 1.76 . . . . 0.0 116.609 -168.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -102.28 9.56 39.85 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 119.773 1.169 . . . . 0.0 108.525 -175.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 66.3 t30 73.34 57.54 0.11 Allowed 'General case' 0 CA--C 1.497 -1.096 0 C-N-CA 126.278 1.831 . . . . 0.0 107.951 -177.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 30.5 m -142.01 135.71 29.55 Favored 'General case' 0 CA--C 1.485 -1.541 1 N-CA-C 99.01 -4.441 . . . . 0.0 99.01 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.462 HG12 HD11 ' A' ' 59' ' ' ILE . 2.7 m -60.95 148.47 9.07 Favored 'Isoleucine or valine' 0 C--N 1.354 0.764 0 CA-C-N 120.463 1.483 . . . . 0.0 112.35 -172.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -98.02 132.09 43.88 Favored 'General case' 0 CA--C 1.483 -1.623 1 N-CA-C 97.97 -4.826 . . . . 0.0 97.97 177.211 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 66.9 m80 -90.38 -175.58 4.52 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 -166.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 5.7 t -147.03 157.55 43.65 Favored 'General case' 0 N--CA 1.413 -2.305 1 N-CA-C 96.392 -5.41 . . . . 0.0 96.392 -175.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -117.34 110.92 40.51 Favored Pre-proline 0 N--CA 1.419 -2.008 1 N-CA-C 96.906 -5.22 . . . . 0.0 96.906 172.405 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_exo -60.1 114.57 2.15 Favored 'Trans proline' 0 CA--C 1.506 -0.899 0 CA-C-N 123.324 2.223 . . . . 0.0 113.811 -162.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 154.45 -42.98 0.59 Allowed Glycine 0 N--CA 1.432 -1.568 1 N-CA-C 100.584 -5.006 . . . . 0.0 100.584 -163.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.6 m 95.84 21.84 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.31 0 C-N-CA 127.329 2.251 . . . . 0.0 111.071 167.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 p -68.13 -52.29 36.47 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 125.493 1.517 . . . . 0.0 110.302 -174.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.62 -38.39 90.17 Favored Glycine 0 C--N 1.347 1.192 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 178.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 41.9 t -66.15 -48.33 71.13 Favored 'General case' 0 CA--C 1.502 -0.872 0 C-N-CA 124.283 1.033 . . . . 0.0 110.013 -177.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -53.34 -49.91 66.11 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 125.539 1.536 . . . . 0.0 109.925 175.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.4 m -60.51 -53.09 61.75 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 124.105 0.962 . . . . 0.0 111.299 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 37.4 mt -65.47 -44.45 87.13 Favored 'General case' 0 CA--C 1.492 -1.257 0 C-N-CA 125.068 1.347 . . . . 0.0 110.234 -175.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.8 t -62.56 -44.97 95.0 Favored 'General case' 0 N--CA 1.435 -1.189 0 C-N-CA 123.021 0.528 . . . . 0.0 109.788 179.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -69.25 -41.94 76.27 Favored 'General case' 0 CA--C 1.503 -0.856 0 O-C-N 122.247 -0.283 . . . . 0.0 110.402 -174.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -74.73 -27.36 60.33 Favored 'General case' 0 CA--C 1.505 -0.777 0 O-C-N 121.715 -0.616 . . . . 0.0 111.621 -176.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.36 -23.53 27.97 Favored 'General case' 0 C--N 1.358 0.966 0 CA-C-O 121.571 0.7 . . . . 0.0 109.331 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.08 43.05 1.23 Allowed Glycine 0 CA--C 1.484 -1.859 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 162.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -98.91 152.09 19.61 Favored Glycine 0 CA--C 1.491 -1.461 0 N-CA-C 104.278 -3.529 . . . . 0.0 104.278 165.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 23.5 p -87.77 -44.53 11.06 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -168.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 18.3 m -129.06 157.23 42.32 Favored 'General case' 0 CA--C 1.485 -1.547 0 N-CA-C 102.14 -3.282 . . . . 0.0 102.14 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -161.26 160.19 31.9 Favored Glycine 0 N--CA 1.416 -2.683 1 N-CA-C 98.473 -5.851 . . . . 0.0 98.473 178.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 9.0 p-80 -164.21 176.53 9.12 Favored 'General case' 0 N--CA 1.427 -1.594 1 N-CA-C 96.719 -5.289 . . . . 0.0 96.719 -178.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 70.3 m -110.58 165.76 11.55 Favored 'General case' 0 CA--C 1.481 -1.69 0 CA-C-N 119.566 1.075 . . . . 0.0 108.256 -173.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -175.6 -169.05 36.83 Favored Glycine 0 N--CA 1.424 -2.154 1 N-CA-C 100.649 -4.981 . . . . 0.0 100.649 -179.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -130.32 138.88 50.67 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 101.605 -3.48 . . . . 0.0 101.605 -172.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -108.1 111.89 24.16 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 102.855 -3.017 . . . . 0.0 102.855 174.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.8 t -80.81 120.66 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 -175.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 119.93 -7.12 12.03 Favored Glycine 0 CA--C 1.494 -1.267 0 N-CA-C 106.838 -2.505 . . . . 0.0 106.838 -166.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 44.8 m-70 -139.69 -79.56 0.31 Allowed 'General case' 0 CA--C 1.497 -1.067 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 167.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 170.4 -161.52 34.55 Favored Glycine 0 N--CA 1.426 -2.023 0 N-CA-C 104.188 -3.565 . . . . 0.0 104.188 -166.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 30.8 tp -65.57 133.44 51.19 Favored 'General case' 0 CA--C 1.505 -0.77 0 C-N-CA 127.197 2.199 . . . . 0.0 107.275 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.25 -176.41 4.25 Favored 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 -166.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.2 t -125.13 151.16 46.13 Favored 'General case' 0 CA--C 1.491 -1.323 1 N-CA-C 98.631 -4.581 . . . . 0.0 98.631 175.226 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 38.0 t-105 -107.15 152.8 23.58 Favored 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 103.941 -2.614 . . . . 0.0 103.941 179.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 22.9 m -143.77 150.57 38.78 Favored 'General case' 0 CA--C 1.483 -1.621 0 N-CA-C 104.307 -2.479 . . . . 0.0 104.307 170.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -116.09 140.44 49.28 Favored 'General case' 0 CA--C 1.492 -1.277 0 N-CA-C 102.464 -3.161 . . . . 0.0 102.464 171.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 67.21 56.67 0.62 Allowed 'General case' 0 CA--C 1.496 -1.112 0 C-N-CA 127.103 2.161 . . . . 0.0 111.601 172.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 25.1 mt -93.96 134.04 26.7 Favored Pre-proline 0 CA--C 1.496 -1.12 0 N-CA-C 104.411 -2.44 . . . . 0.0 104.411 174.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -75.06 173.61 14.22 Favored 'Trans proline' 0 N--CA 1.445 -1.327 0 C-N-CA 122.236 1.958 . . . . 0.0 110.236 178.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -64.75 -13.21 54.22 Favored 'General case' 0 CA--C 1.506 -0.744 0 C-N-CA 125.795 1.638 . . . . 0.0 114.477 -173.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -89.88 8.76 30.48 Favored 'General case' 0 CA--C 1.504 -0.807 0 O-C-N 121.503 -0.748 . . . . 0.0 110.247 -176.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.7 t -110.54 141.93 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.339 0 N-CA-C 102.552 -3.129 . . . . 0.0 102.552 177.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -115.79 148.14 18.91 Favored Glycine 0 CA--C 1.479 -2.21 1 N-CA-C 100.3 -5.12 . . . . 0.0 100.3 175.176 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 24.2 pt -147.28 -151.22 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.426 -1.635 0 N-CA-C 102.34 -3.207 . . . . 0.0 102.34 -163.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.944 HD13 ' HB2' ' A' ' 7' ' ' ALA . 7.5 mm -71.65 122.55 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 178.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.431 -1.404 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 -163.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.2 m . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 121.164 0.507 . . . . 0.0 110.411 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -109.94 159.26 17.41 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 175.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -126.99 127.13 44.33 Favored 'General case' 0 CA--C 1.488 -1.41 1 N-CA-C 95.21 -5.848 . . . . 0.0 95.21 158.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.82 -169.14 24.73 Favored Glycine 0 CA--C 1.474 -2.53 1 N-CA-C 102.372 -4.291 . . . . 0.0 102.372 -179.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 48' ' ' TRP . 16.4 m-85 -83.71 143.85 29.76 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 103.859 -2.645 . . . . 0.0 103.859 161.27 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.0 tt -90.79 141.49 14.33 Favored 'Isoleucine or valine' 0 C--O 1.25 1.102 0 N-CA-C 105.939 -1.875 . . . . 0.0 105.939 174.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.802 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -140.18 174.41 10.54 Favored 'General case' 0 N--CA 1.42 -1.966 1 N-CA-C 99.915 -4.106 . . . . 0.0 99.915 175.628 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -85.2 160.25 55.02 Favored Pre-proline 0 N--CA 1.432 -1.36 0 C-N-CA 126.983 2.113 . . . . 0.0 106.014 178.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -70.23 -11.98 31.19 Favored 'Trans proline' 0 CA--C 1.505 -0.95 0 CA-C-N 121.4 1.536 . . . . 0.0 116.024 -160.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -99.58 15.02 27.98 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -178.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 63.7 t30 74.43 54.64 0.09 Allowed 'General case' 0 CA--C 1.501 -0.929 0 C-N-CA 125.706 1.603 . . . . 0.0 110.052 172.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.455 ' O ' ' HB1' ' A' ' 7' ' ' ALA . 1.2 m -133.86 136.59 44.47 Favored 'General case' 0 CA--C 1.478 -1.823 1 N-CA-C 98.909 -4.478 . . . . 0.0 98.909 176.692 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -64.35 155.18 6.35 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.932 0 CA-C-N 120.186 1.357 . . . . 0.0 112.224 -172.16 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -104.8 128.2 52.87 Favored 'General case' 0 CA--C 1.473 -1.997 1 N-CA-C 91.416 -7.253 . . . . 0.0 91.416 177.154 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 41.1 m80 -88.5 -150.57 0.19 Allowed 'General case' 0 CA--C 1.491 -1.291 0 N-CA-C 105.41 -2.07 . . . . 0.0 105.41 -167.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 8.0 t -153.19 161.99 41.81 Favored 'General case' 0 N--CA 1.413 -2.303 1 N-CA-C 94.094 -6.262 . . . . 0.0 94.094 -176.006 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -111.73 112.82 53.34 Favored Pre-proline 0 N--CA 1.422 -1.847 1 N-CA-C 95.907 -5.59 . . . . 0.0 95.907 171.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo -60.39 101.06 0.16 Allowed 'Trans proline' 0 CA--C 1.508 -0.811 0 C-N-CA 122.457 2.105 . . . . 0.0 116.449 -157.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 169.16 -178.33 42.42 Favored Glycine 0 N--CA 1.422 -2.247 1 N-CA-C 95.893 -6.883 . . . . 0.0 95.893 178.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.3 m -69.78 -39.24 76.77 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 119.45 1.625 . . . . 0.0 109.234 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -43.87 -53.03 6.39 Favored 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 130.653 3.581 . . . . 0.0 115.607 -173.278 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.71 -39.7 66.29 Favored Glycine 0 C--N 1.353 1.473 0 O-C-N 120.998 -1.064 . . . . 0.0 111.441 -171.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 38.9 t -70.92 -47.24 60.19 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -54.91 -44.14 73.92 Favored 'General case' 0 C--N 1.354 0.769 0 C-N-CA 123.267 0.627 . . . . 0.0 110.845 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 26.6 m -59.92 -50.13 74.97 Favored 'General case' 0 C--N 1.35 0.601 0 C-N-CA 123.193 0.597 . . . . 0.0 111.509 177.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 50.3 mt -67.77 -40.43 84.03 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-O 122.437 1.113 . . . . 0.0 110.43 -176.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.0 t -62.44 -42.75 99.69 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 124.64 1.176 . . . . 0.0 109.419 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 24.0 mtpp -68.44 -42.57 78.65 Favored 'General case' 0 C--N 1.355 0.831 0 C-N-CA 123.072 0.549 . . . . 0.0 111.674 -179.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -75.07 -22.16 58.51 Favored 'General case' 0 C--N 1.354 0.782 0 O-C-N 121.455 -0.778 . . . . 0.0 111.24 -174.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.3 mmtm -79.86 -60.33 2.38 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 170.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 135.39 50.12 0.07 OUTLIER Glycine 0 CA--C 1.489 -1.577 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 171.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.5 141.95 15.57 Favored Glycine 0 CA--C 1.491 -1.442 0 N-CA-C 103.839 -3.704 . . . . 0.0 103.839 164.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.1 p -100.11 3.32 43.85 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 123.813 0.845 . . . . 0.0 110.334 -165.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.4 m -160.1 158.53 30.49 Favored 'General case' 0 CA--C 1.476 -1.894 1 N-CA-C 97.773 -4.899 . . . . 0.0 97.773 168.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -170.76 164.76 37.97 Favored Glycine 0 CA--C 1.469 -2.817 1 N-CA-C 99.56 -5.416 . . . . 0.0 99.56 -176.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 59.9 m80 -155.05 152.98 30.25 Favored 'General case' 0 N--CA 1.43 -1.45 1 N-CA-C 100.049 -4.056 . . . . 0.0 100.049 -175.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 44.9 t -85.1 153.76 22.49 Favored 'General case' 0 CA--C 1.505 -0.778 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 -175.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -174.55 -177.1 43.42 Favored Glycine 0 CA--C 1.482 -2.017 0 N-CA-C 105.061 -3.216 . . . . 0.0 105.061 179.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -119.98 142.61 48.62 Favored 'General case' 0 N--CA 1.431 -1.42 1 N-CA-C 99.547 -4.242 . . . . 0.0 99.547 -179.003 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 24.8 tptp -119.31 103.91 9.91 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 101.457 -3.534 . . . . 0.0 101.457 175.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.9 t -73.07 136.9 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 N-CA-C 105.868 -1.901 . . . . 0.0 105.868 -178.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 113.34 -24.75 12.01 Favored Glycine 0 CA--C 1.491 -1.435 0 N-CA-C 106.23 -2.748 . . . . 0.0 106.23 -168.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 60.8 m-70 -127.98 -81.11 0.59 Allowed 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 174.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 168.17 -151.76 19.14 Favored Glycine 0 N--CA 1.429 -1.798 0 N-CA-C 105.169 -3.172 . . . . 0.0 105.169 -171.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 49.1 tp -65.41 126.14 27.33 Favored 'General case' 0 CA--C 1.506 -0.721 0 C-N-CA 126.634 1.974 . . . . 0.0 106.856 178.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -134.27 -167.99 2.06 Favored 'General case' 0 CA--C 1.489 -1.372 0 N-CA-C 105.369 -2.085 . . . . 0.0 105.369 -166.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.7 t -136.86 148.23 46.97 Favored 'General case' 0 CA--C 1.489 -1.369 0 N-CA-C 100.349 -3.945 . . . . 0.0 100.349 172.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.414 ' HA ' ' HA ' ' A' ' 5' ' ' TYR . 20.3 t-105 -102.89 148.69 25.33 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 104.111 -2.552 . . . . 0.0 104.111 177.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 50.2 m -144.77 149.2 35.1 Favored 'General case' 0 CA--C 1.498 -1.052 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 176.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -113.62 142.84 45.51 Favored 'General case' 0 CA--C 1.495 -1.164 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 172.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 62.69 57.03 1.85 Allowed 'General case' 0 CA--C 1.494 -1.191 0 C-N-CA 127.985 2.514 . . . . 0.0 111.103 172.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 17.8 mt -90.07 137.28 28.09 Favored Pre-proline 0 N--CA 1.44 -0.959 0 N-CA-C 104.899 -2.26 . . . . 0.0 104.899 174.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_exo -69.02 171.88 12.88 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 122.036 1.824 . . . . 0.0 113.047 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -76.25 -13.16 60.17 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 123.39 0.676 . . . . 0.0 112.203 -171.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -91.64 13.3 18.37 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 124.122 0.969 . . . . 0.0 110.426 178.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.3 t -104.22 160.9 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 N-CA-C 101.535 -3.506 . . . . 0.0 101.535 171.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -138.05 150.52 20.97 Favored Glycine 0 CA--C 1.481 -2.09 1 N-CA-C 96.986 -6.446 . . . . 0.0 96.986 178.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 29.4 pt -156.68 -155.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 N-CA-C 101.586 -3.487 . . . . 0.0 101.586 -158.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.802 HD13 ' HB2' ' A' ' 7' ' ' ALA . 3.2 mm -63.08 137.51 24.48 Favored 'Isoleucine or valine' 0 C--N 1.363 1.163 0 C-N-CA 123.943 0.897 . . . . 0.0 109.556 -177.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.419 -1.986 1 N-CA-C 96.295 -5.446 . . . . 0.0 96.295 -178.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 17.3 m . . . . . 0 N--CA 1.481 1.121 0 CA-C-O 121.621 0.724 . . . . 0.0 110.56 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -100.6 174.06 6.25 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 102.654 -3.091 . . . . 0.0 102.654 159.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -119.16 150.17 40.49 Favored 'General case' 0 CA--C 1.487 -1.464 1 N-CA-C 94.262 -6.199 . . . . 0.0 94.262 155.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -160.7 165.12 34.97 Favored Glycine 0 CA--C 1.471 -2.691 0 C-N-CA 116.618 -2.706 . . . . 0.0 108.822 -172.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -87.87 116.24 25.88 Favored 'General case' 0 N--CA 1.429 -1.504 1 N-CA-C 99.51 -4.255 . . . . 0.0 99.51 160.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 13.8 tt -75.72 135.0 27.98 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.419 0 N-CA-C 104.524 -2.399 . . . . 0.0 104.524 -172.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.599 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -125.89 -172.99 2.73 Favored 'General case' 0 N--CA 1.419 -2.01 0 O-C-N 126.309 2.256 . . . . 0.0 107.793 -178.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -101.54 139.52 20.47 Favored Pre-proline 0 N--CA 1.424 -1.753 1 N-CA-C 98.126 -4.768 . . . . 0.0 98.126 164.297 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -76.78 -0.31 10.38 Favored 'Trans proline' 0 CA--C 1.504 -1.008 0 C-N-CA 122.457 2.104 . . . . 0.0 112.501 -152.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 84.5 mt-10 -95.28 45.35 1.1 Allowed 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 124.756 1.222 . . . . 0.0 108.322 -165.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 66.49 49.31 1.39 Allowed 'General case' 0 C--N 1.355 0.806 0 C-N-CA 126.555 1.942 . . . . 0.0 108.174 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -128.29 -160.59 1.03 Allowed 'General case' 0 CA--C 1.492 -1.269 0 O-C-N 120.651 -1.281 . . . . 0.0 110.91 -171.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.551 HG12 HD12 ' A' ' 59' ' ' ILE . 9.7 m -125.37 -171.23 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.435 1 N-CA-C 99.618 -4.216 . . . . 0.0 99.618 167.997 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -126.89 150.44 49.28 Favored 'General case' 0 CA--C 1.477 -1.827 1 N-CA-C 95.338 -5.801 . . . . 0.0 95.338 173.755 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 61.0 m170 -99.08 122.91 42.93 Favored 'General case' 0 CA--C 1.485 -1.535 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 -178.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 41.9 t -83.54 151.08 25.56 Favored 'General case' 0 N--CA 1.427 -1.597 0 N-CA-C 105.95 -1.871 . . . . 0.0 105.95 176.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -98.44 118.41 63.38 Favored Pre-proline 0 N--CA 1.428 -1.528 1 N-CA-C 100.148 -4.019 . . . . 0.0 100.148 175.253 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -62.7 103.15 0.32 Allowed 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.687 2.258 . . . . 0.0 112.849 -165.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 168.59 -52.59 0.22 Allowed Glycine 0 N--CA 1.427 -1.902 1 N-CA-C 100.238 -5.145 . . . . 0.0 100.238 -175.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.8 m 134.11 -42.92 0.01 OUTLIER 'General case' 0 CA--C 1.489 -1.403 0 C-N-CA 128.953 2.901 . . . . 0.0 105.81 174.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.6 m -39.66 -55.53 1.87 Allowed 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 128.311 2.645 . . . . 0.0 117.165 -150.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.89 -34.64 71.64 Favored Glycine 0 C--N 1.346 1.103 0 O-C-N 121.478 -0.764 . . . . 0.0 111.723 -175.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.7 t -86.51 -18.31 31.91 Favored 'General case' 0 CA--C 1.5 -0.953 0 O-C-N 121.46 -1.023 . . . . 0.0 108.4 -176.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -66.1 -44.06 85.45 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 170.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -62.94 -33.3 75.06 Favored 'General case' 0 C--N 1.353 0.758 0 O-C-N 121.123 -0.986 . . . . 0.0 113.019 172.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 86.3 mt -66.76 -41.42 87.79 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-N 119.1 0.864 . . . . 0.0 110.212 175.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 11.4 t -56.41 -50.42 71.66 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 123.763 0.825 . . . . 0.0 110.337 174.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -56.89 -51.48 68.94 Favored 'General case' 0 C--N 1.359 0.979 0 C-N-CA 123.621 0.769 . . . . 0.0 111.888 -179.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -69.57 -19.28 63.68 Favored 'General case' 0 C--N 1.354 0.78 0 O-C-N 121.519 -0.738 . . . . 0.0 112.976 -173.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 48.6 mmtm -96.46 0.44 50.36 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 177.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.11 21.34 23.16 Favored Glycine 0 C--N 1.352 1.428 0 O-C-N 121.416 -0.803 . . . . 0.0 111.582 168.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -88.48 124.02 7.03 Favored Glycine 0 CA--C 1.485 -1.82 0 N-CA-C 106.466 -2.653 . . . . 0.0 106.466 169.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -77.17 -56.39 4.61 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 124.947 1.299 . . . . 0.0 108.435 -173.015 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.2 m -114.17 156.94 23.34 Favored 'General case' 0 CA--C 1.484 -1.584 0 N-CA-C 103.883 -2.636 . . . . 0.0 103.883 178.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -168.13 177.72 42.16 Favored Glycine 0 N--CA 1.416 -2.696 1 N-CA-C 99.926 -5.27 . . . . 0.0 99.926 -177.217 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 31.6 p-80 -171.97 -172.99 1.06 Allowed 'General case' 0 N--CA 1.425 -1.69 1 N-CA-C 95.955 -5.572 . . . . 0.0 95.955 173.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 88.1 m -122.58 158.88 28.96 Favored 'General case' 0 CA--C 1.48 -1.734 0 N-CA-C 102.509 -3.145 . . . . 0.0 102.509 174.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.42 174.42 46.67 Favored Glycine 0 CA--C 1.481 -2.058 1 N-CA-C 100.741 -4.944 . . . . 0.0 100.741 -174.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -146.16 127.7 15.09 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 102.638 -3.097 . . . . 0.0 102.638 -178.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 35.5 mmtm -156.83 82.37 0.95 Allowed 'General case' 0 CA--C 1.493 -1.241 1 N-CA-C 96.417 -5.401 . . . . 0.0 96.417 153.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.8 t -143.57 -178.1 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.071 1 N-CA-C 99.702 -4.184 . . . . 0.0 99.702 -169.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -135.04 26.95 3.21 Favored Glycine 0 C--N 1.349 1.27 0 N-CA-C 108.022 -2.031 . . . . 0.0 108.022 177.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 39.4 m170 -116.22 -75.34 0.58 Allowed 'General case' 0 CA--C 1.5 -0.969 0 N-CA-C 104.346 -2.465 . . . . 0.0 104.346 173.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -171.75 -169.31 34.44 Favored Glycine 0 CA--C 1.478 -2.247 1 N-CA-C 98.312 -5.915 . . . . 0.0 98.312 -175.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . 0.256 0.2 OUTLIER -65.39 147.49 53.34 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 123.817 0.847 . . . . 0.0 111.066 -178.072 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -141.22 175.63 9.49 Favored 'General case' 0 CA--C 1.485 -1.551 0 N-CA-C 101.984 -3.339 . . . . 0.0 101.984 -166.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.5 m -120.05 155.38 33.04 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 104.407 -2.442 . . . . 0.0 104.407 178.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 73.5 t-105 -102.08 148.89 24.84 Favored 'General case' 0 CA--C 1.489 -1.391 0 N-CA-C 104.35 -2.463 . . . . 0.0 104.35 -177.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 69.2 m -140.09 140.91 36.18 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 102.174 -3.269 . . . . 0.0 102.174 168.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -106.73 19.11 20.95 Favored 'General case' 0 C--N 1.352 0.714 0 CA-C-O 121.413 0.625 . . . . 0.0 110.127 -169.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -166.77 144.27 4.95 Favored 'General case' 0 N--CA 1.422 -1.825 1 N-CA-C 93.573 -6.454 . . . . 0.0 93.573 169.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 21.5 mt -150.58 142.11 15.27 Favored Pre-proline 0 CA--C 1.486 -1.518 1 N-CA-C 99.13 -4.396 . . . . 0.0 99.13 153.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -74.06 172.13 16.58 Favored 'Trans proline' 0 N--CA 1.444 -1.402 0 C-N-CA 122.19 1.927 . . . . 0.0 110.14 174.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -75.48 -1.99 26.74 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 -166.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -92.0 -7.73 48.05 Favored 'General case' 0 CA--C 1.505 -0.765 0 O-C-N 121.57 -0.707 . . . . 0.0 109.573 179.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.8 t -101.47 129.71 52.18 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.308 0 N-CA-C 103.748 -2.686 . . . . 0.0 103.748 -174.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -98.45 160.19 20.49 Favored Glycine 0 CA--C 1.485 -1.804 0 N-CA-C 106.133 -2.787 . . . . 0.0 106.133 -178.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 23.2 pt -146.56 -162.67 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.549 0 N-CA-C 103.543 -2.762 . . . . 0.0 103.543 -165.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.599 HD13 ' HB2' ' A' ' 7' ' ' ALA . 2.8 mm -63.51 137.4 24.75 Favored 'Isoleucine or valine' 0 C--N 1.361 1.084 0 C-N-CA 124.074 0.95 . . . . 0.0 109.167 -176.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 55.3 t . . . . . 0 N--CA 1.442 -0.843 0 N-CA-C 103.643 -2.725 . . . . 0.0 103.643 178.813 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 34.8 m . . . . . 0 N--CA 1.485 1.303 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.52 165.48 27.46 Favored 'General case' 0 N--CA 1.426 -1.63 1 N-CA-C 100.071 -4.048 . . . . 0.0 100.071 165.753 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -133.41 128.21 35.05 Favored 'General case' 0 N--CA 1.429 -1.522 1 N-CA-C 93.867 -6.345 . . . . 0.0 93.867 166.649 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.03 -175.31 32.93 Favored Glycine 0 CA--C 1.47 -2.748 1 N-CA-C 102.064 -4.414 . . . . 0.0 102.064 176.477 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -75.34 133.1 41.32 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 104.555 -2.387 . . . . 0.0 104.555 163.533 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.9 tt -89.87 137.99 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.315 0 N-CA-C 104.611 -2.366 . . . . 0.0 104.611 -175.436 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.456 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -100.97 -144.81 0.34 Allowed 'General case' 0 N--CA 1.426 -1.674 0 C-N-CA 127.185 2.194 . . . . 0.0 106.717 -178.283 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -128.91 143.03 47.12 Favored Pre-proline 0 N--CA 1.421 -1.895 1 N-CA-C 93.47 -6.493 . . . . 0.0 93.47 163.577 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -82.57 27.27 0.61 Allowed 'Trans proline' 0 CA--C 1.506 -0.917 0 C-N-CA 122.651 2.234 . . . . 0.0 113.731 -141.248 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 41.4 mp0 -104.38 -78.52 0.56 Allowed 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 102.589 -3.115 . . . . 0.0 102.589 -178.156 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -161.33 142.97 11.71 Favored 'General case' 0 N--CA 1.425 -1.699 1 N-CA-C 92.464 -6.865 . . . . 0.0 92.464 156.188 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER 176.29 -166.68 0.04 OUTLIER 'General case' 0 CA--C 1.486 -1.513 0 N-CA-C 101.485 -3.524 . . . . 0.0 101.485 179.816 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.554 HG12 HD12 ' A' ' 59' ' ' ILE . 1.0 OUTLIER -121.29 160.56 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.725 1 N-CA-C 99.006 -4.442 . . . . 0.0 99.006 156.929 . . . . . . . . 4 4 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -82.71 -168.87 2.21 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 104.798 -2.297 . . . . 0.0 104.798 161.074 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 42.9 m170 -134.61 177.76 7.53 Favored 'General case' 0 N--CA 1.422 -1.858 1 N-CA-C 95.271 -5.826 . . . . 0.0 95.271 168.291 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 40.9 t -154.89 169.31 24.32 Favored 'General case' 0 N--CA 1.416 -2.148 1 N-CA-C 96.088 -5.523 . . . . 0.0 96.088 -168.275 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -126.3 120.41 23.58 Favored Pre-proline 0 N--CA 1.42 -1.931 1 N-CA-C 98.795 -4.52 . . . . 0.0 98.795 178.768 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 0.8 OUTLIER -55.56 135.2 68.2 Favored 'Trans proline' 0 CA--C 1.505 -0.951 0 C-N-CA 122.568 2.179 . . . . 0.0 112.384 -178.452 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 116.27 -43.55 1.64 Allowed Glycine 0 N--CA 1.438 -1.231 0 N-CA-C 103.989 -3.644 . . . . 0.0 103.989 -158.322 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.0 m 82.56 23.85 0.18 Allowed 'General case' 0 CA--C 1.496 -1.111 0 C-N-CA 128.105 2.562 . . . . 0.0 110.647 175.836 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.7 -61.2 2.68 Favored 'General case' 0 N--CA 1.44 -0.933 0 C-N-CA 126.808 2.043 . . . . 0.0 110.998 -168.995 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.14 -32.23 72.6 Favored Glycine 0 C--N 1.347 1.187 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 -175.468 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 11.5 t -78.45 -21.38 49.22 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-O 119.302 -0.38 . . . . 0.0 110.054 -173.482 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -60.43 -46.96 88.16 Favored 'General case' 0 C--N 1.352 0.692 0 CA-C-N 119.585 1.084 . . . . 0.0 109.409 173.394 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.13 -49.26 75.06 Favored 'General case' 0 N--CA 1.44 -0.934 0 O-C-N 121.537 -0.727 . . . . 0.0 112.521 171.09 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 73.8 mt -63.91 -44.28 93.39 Favored 'General case' 0 C--N 1.358 0.96 0 CA-C-O 121.722 0.772 . . . . 0.0 111.59 -173.882 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 13.7 t -60.0 -42.54 94.47 Favored 'General case' 0 CA--C 1.503 -0.855 0 C-N-CA 123.589 0.756 . . . . 0.0 109.558 179.175 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.6 mtmm -74.47 -35.05 63.28 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-N 119.211 0.914 . . . . 0.0 112.801 -177.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -70.75 -24.71 62.66 Favored 'General case' 0 C--N 1.358 0.941 0 CA-C-N 120.13 1.332 . . . . 0.0 111.536 178.628 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 48.4 mmtm -85.12 -13.58 49.8 Favored 'General case' 0 C--N 1.355 0.822 0 O-C-N 121.882 -0.512 . . . . 0.0 110.067 173.933 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.89 32.0 5.79 Favored Glycine 0 CA--C 1.492 -1.385 0 CA-C-O 119.375 -0.68 . . . . 0.0 111.636 166.718 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.3 138.29 14.29 Favored Glycine 0 CA--C 1.488 -1.653 0 N-CA-C 105.379 -3.089 . . . . 0.0 105.379 174.247 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 18.0 p -100.67 2.76 41.83 Favored 'General case' 0 N--CA 1.44 -0.97 0 O-C-N 122.063 -0.669 . . . . 0.0 110.042 -163.723 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.5 m -160.17 153.41 21.94 Favored 'General case' 0 CA--C 1.483 -1.6 1 N-CA-C 99.225 -4.361 . . . . 0.0 99.225 168.621 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -171.31 161.97 34.56 Favored Glycine 0 CA--C 1.474 -2.526 1 N-CA-C 100.022 -5.231 . . . . 0.0 100.022 178.296 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 14.8 p80 -165.81 170.71 13.61 Favored 'General case' 0 CA--C 1.488 -1.417 0 N-CA-C 100.215 -3.994 . . . . 0.0 100.215 -177.05 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 62.9 m -77.53 147.63 35.68 Favored 'General case' 0 CA--C 1.491 -1.29 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 177.843 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -163.88 173.43 39.93 Favored Glycine 0 CA--C 1.476 -2.404 1 N-CA-C 98.493 -5.843 . . . . 0.0 98.493 179.9 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -168.89 -169.33 0.98 Allowed 'General case' 0 N--CA 1.422 -1.867 1 N-CA-C 97.01 -5.182 . . . . 0.0 97.01 178.142 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.6 mptt 97.65 61.29 0.0 OUTLIER 'General case' 0 CA--C 1.492 -1.251 0 C-N-CA 131.186 3.794 . . . . 0.0 101.753 -164.692 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 19.3 t -143.21 172.92 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.738 1 N-CA-C 96.501 -5.37 . . . . 0.0 96.501 -177.743 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -113.21 89.57 0.52 Allowed Glycine 0 CA--C 1.486 -1.77 0 N-CA-C 104.329 -3.509 . . . . 0.0 104.329 176.643 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 17.4 m170 -172.09 -132.21 0.01 OUTLIER 'General case' 0 N--CA 1.438 -1.041 1 N-CA-C 99.422 -4.288 . . . . 0.0 99.422 172.741 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -110.87 -41.03 1.23 Allowed Glycine 0 C--N 1.358 1.758 0 CA-C-N 120.843 1.656 . . . . 0.0 113.317 -170.32 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 13.6 tp -165.63 177.4 7.35 Favored 'General case' 0 N--CA 1.434 -1.236 1 N-CA-C 95.769 -5.641 . . . . 0.0 95.769 -173.385 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -159.02 -174.86 4.95 Favored 'General case' 0 CA--C 1.478 -1.822 1 N-CA-C 98.288 -4.708 . . . . 0.0 98.288 175.409 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 46.8 t -130.25 164.51 24.4 Favored 'General case' 0 CA--C 1.492 -1.286 1 N-CA-C 99.943 -4.095 . . . . 0.0 99.943 167.872 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 24.9 t-105 -111.99 152.23 28.35 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 104.231 -2.507 . . . . 0.0 104.231 176.997 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 15.3 m -145.55 150.69 36.88 Favored 'General case' 0 C--N 1.36 1.032 0 N-CA-C 104.797 -2.297 . . . . 0.0 104.797 173.73 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -113.15 138.5 49.85 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 104.878 -2.268 . . . . 0.0 104.878 171.178 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 64.79 58.4 0.97 Allowed 'General case' 0 CA--C 1.491 -1.297 0 C-N-CA 127.199 2.2 . . . . 0.0 111.697 166.505 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 20.4 mt -89.11 143.91 31.85 Favored Pre-proline 0 N--CA 1.441 -0.912 0 N-CA-C 104.21 -2.515 . . . . 0.0 104.21 170.788 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -73.11 170.37 19.98 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.574 2.183 . . . . 0.0 109.773 177.573 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -70.47 -12.16 61.39 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -167.293 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -84.61 -9.06 58.63 Favored 'General case' 0 CA--C 1.506 -0.744 0 O-C-N 121.381 -0.825 . . . . 0.0 110.27 -176.469 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.5 t -92.35 133.92 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 -176.39 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -98.2 150.03 19.31 Favored Glycine 0 CA--C 1.487 -1.698 0 N-CA-C 105.193 -3.163 . . . . 0.0 105.193 179.273 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 28.4 pt -135.29 -166.43 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 103.459 -2.793 . . . . 0.0 103.459 -172.707 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.554 HD12 HG12 ' A' ' 13' ' ' VAL . 1.3 mm -66.45 130.06 31.45 Favored 'Isoleucine or valine' 0 C--N 1.362 1.11 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 -173.256 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 77.4 t . . . . . 0 N--CA 1.427 -1.612 0 N-CA-C 102.101 -3.296 . . . . 0.0 102.101 171.477 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 27.0 m . . . . . 0 N--CA 1.485 1.285 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -105.41 157.25 17.47 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 171.667 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -131.04 123.8 29.48 Favored 'General case' 0 N--CA 1.431 -1.386 1 N-CA-C 93.459 -6.497 . . . . 0.0 93.459 155.518 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.81 -173.61 30.68 Favored Glycine 0 CA--C 1.478 -2.28 1 N-CA-C 101.705 -4.558 . . . . 0.0 101.705 -177.426 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -79.93 137.69 36.94 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 103.673 -2.714 . . . . 0.0 103.673 166.683 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.2 tt -90.72 150.84 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.976 0 N-CA-C 105.171 -2.159 . . . . 0.0 105.171 179.489 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.858 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -143.88 179.68 7.02 Favored 'General case' 0 N--CA 1.411 -2.386 0 N-CA-C 101.309 -3.589 . . . . 0.0 101.309 -173.093 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -86.08 145.8 41.49 Favored Pre-proline 0 N--CA 1.427 -1.597 0 N-CA-C 102.559 -3.126 . . . . 0.0 102.559 171.33 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.11 5.42 5.76 Favored 'Trans proline' 0 CA--C 1.501 -1.157 0 C-N-CA 122.249 1.966 . . . . 0.0 112.491 -151.27 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -107.99 21.53 17.26 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 -179.919 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 62.4 t30 76.18 52.65 0.05 Allowed 'General case' 0 CA--C 1.496 -1.125 0 C-N-CA 126.903 2.081 . . . . 0.0 109.627 167.512 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.492 ' O ' ' HB1' ' A' ' 7' ' ' ALA . 26.0 m -140.47 138.72 34.86 Favored 'General case' 0 CA--C 1.478 -1.806 0 N-CA-C 100.636 -3.839 . . . . 0.0 100.636 -175.937 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.0 m -66.95 152.19 9.83 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.94 0 CA-C-N 120.544 1.52 . . . . 0.0 111.058 -173.188 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -89.43 122.52 32.71 Favored 'General case' 0 CA--C 1.484 -1.565 1 N-CA-C 100.01 -4.07 . . . . 0.0 100.01 176.018 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 58.6 m80 -86.02 138.34 32.04 Favored 'General case' 0 CA--C 1.478 -1.794 0 N-CA-C 102.427 -3.175 . . . . 0.0 102.427 -174.561 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.0 t -148.53 -179.02 6.65 Favored 'General case' 0 N--CA 1.411 -2.413 1 N-CA-C 93.666 -6.42 . . . . 0.0 93.666 -170.122 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -147.36 171.67 6.07 Favored Pre-proline 0 N--CA 1.412 -2.344 1 N-CA-C 97.515 -4.995 . . . . 0.0 97.515 -157.79 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -66.7 44.58 0.21 Allowed 'Trans proline' 0 C--N 1.324 -0.738 0 C-N-CA 123.307 2.672 . . . . 0.0 116.79 -178.912 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -174.93 148.5 9.69 Favored Glycine 0 N--CA 1.42 -2.427 1 N-CA-C 98.202 -5.959 . . . . 0.0 98.202 172.973 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -78.25 38.12 0.28 Allowed 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 124.813 1.245 . . . . 0.0 112.389 -174.881 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.6 m -54.47 -62.46 1.64 Allowed 'General case' 0 N--CA 1.44 -0.947 0 C-N-CA 127.577 2.351 . . . . 0.0 112.447 -162.816 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -90.16 -19.7 45.31 Favored Glycine 0 C--N 1.35 1.338 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 179.901 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.4 t -80.58 -15.22 57.17 Favored 'General case' 0 N--CA 1.442 -0.837 0 O-C-N 121.679 -0.895 . . . . 0.0 110.462 -167.455 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -54.68 -54.51 40.8 Favored 'General case' 0 C--N 1.353 0.743 0 C-N-CA 125.334 1.454 . . . . 0.0 109.594 172.152 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -61.24 -48.43 81.48 Favored 'General case' 0 N--CA 1.435 -1.184 0 C-N-CA 125.233 1.413 . . . . 0.0 112.111 172.518 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 96.3 mt -65.53 -42.19 92.26 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-O 122.192 0.996 . . . . 0.0 111.368 -171.31 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 14.2 t -61.71 -44.39 97.02 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 124.19 0.996 . . . . 0.0 108.491 179.059 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -68.07 -40.2 82.79 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -179.267 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -72.53 -20.37 61.36 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 120.122 1.328 . . . . 0.0 112.371 -179.114 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.8 mmtm -85.82 -16.34 39.04 Favored 'General case' 0 C--N 1.354 0.783 0 C-N-CA 123.349 0.659 . . . . 0.0 109.947 173.07 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.23 29.63 6.66 Favored Glycine 0 CA--C 1.487 -1.682 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 168.743 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -93.85 142.95 16.25 Favored Glycine 0 N--CA 1.435 -1.386 0 N-CA-C 105.792 -2.923 . . . . 0.0 105.792 172.987 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.1 m -109.84 -3.86 16.39 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 122.866 1.317 . . . . 0.0 108.211 -160.84 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 43.1 m -160.49 165.83 30.25 Favored 'General case' 0 CA--C 1.483 -1.633 1 N-CA-C 98.027 -4.805 . . . . 0.0 98.027 166.232 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -166.33 174.99 41.87 Favored Glycine 0 CA--C 1.473 -2.536 1 N-CA-C 101.561 -4.616 . . . . 0.0 101.561 -176.457 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -166.42 -175.15 3.11 Favored 'General case' 0 N--CA 1.431 -1.415 1 N-CA-C 97.604 -4.961 . . . . 0.0 97.604 -172.505 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 86.4 m -146.06 161.35 40.32 Favored 'General case' 0 CA--C 1.487 -1.468 1 N-CA-C 99.531 -4.248 . . . . 0.0 99.531 172.178 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 179.65 -176.89 47.92 Favored Glycine 0 N--CA 1.426 -1.991 1 N-CA-C 101.837 -4.505 . . . . 0.0 101.837 -177.197 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -99.36 161.14 13.79 Favored 'General case' 0 N--CA 1.436 -1.175 0 N-CA-C 104.829 -2.286 . . . . 0.0 104.829 -178.256 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.26 158.81 40.79 Favored 'General case' 0 N--CA 1.425 -1.707 1 N-CA-C 96.047 -5.538 . . . . 0.0 96.047 163.869 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.4 t -111.7 141.07 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.16 0 N-CA-C 103.505 -2.776 . . . . 0.0 103.505 -170.364 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 145.22 -66.41 0.43 Allowed Glycine 0 CA--C 1.482 -2.024 1 N-CA-C 103.054 -4.018 . . . . 0.0 103.054 179.857 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 60.6 m170 -97.31 -75.86 0.53 Allowed 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 172.49 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 171.46 -158.84 30.23 Favored Glycine 0 CA--C 1.477 -2.287 1 N-CA-C 102.562 -4.215 . . . . 0.0 102.562 -173.901 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.3 tt -69.01 137.16 53.45 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 -173.436 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -137.98 -179.01 5.52 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 104.346 -2.465 . . . . 0.0 104.346 -162.432 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 30.6 t -117.32 169.81 9.19 Favored 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 101.142 -3.651 . . . . 0.0 101.142 179.204 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 7.8 t-105 -131.44 150.42 52.16 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 102.452 -3.166 . . . . 0.0 102.452 -177.842 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 22.2 m -146.64 153.97 40.93 Favored 'General case' 0 CA--C 1.493 -1.25 0 N-CA-C 103.743 -2.688 . . . . 0.0 103.743 176.441 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -121.09 134.6 55.26 Favored 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 104.756 -2.313 . . . . 0.0 104.756 175.331 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 73.08 57.84 0.11 Allowed 'General case' 0 CA--C 1.492 -1.279 0 C-N-CA 126.941 2.096 . . . . 0.0 109.799 170.382 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 31.4 mt -96.32 144.25 27.51 Favored Pre-proline 0 CA--C 1.499 -0.987 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 176.967 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -66.6 164.37 29.19 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.562 2.174 . . . . 0.0 112.552 173.815 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -63.95 -27.58 69.24 Favored 'General case' 0 N--CA 1.442 -0.875 0 C-N-CA 125.224 1.409 . . . . 0.0 113.859 -173.455 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -94.97 17.25 14.23 Favored 'General case' 0 CA--C 1.503 -0.85 0 O-C-N 121.237 -0.915 . . . . 0.0 110.288 -174.796 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 20.4 t -97.21 122.84 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 N-CA-C 102.125 -3.287 . . . . 0.0 102.125 168.758 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -91.87 148.19 19.11 Favored Glycine 0 CA--C 1.488 -1.637 0 N-CA-C 104.817 -3.313 . . . . 0.0 104.817 179.272 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 25.5 pt -140.83 -149.68 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 N-CA-C 103.762 -2.681 . . . . 0.0 103.762 -169.284 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.858 HD13 ' HB2' ' A' ' 7' ' ' ALA . 5.7 mm -71.24 115.42 11.16 Favored 'Isoleucine or valine' 0 C--N 1.357 0.9 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 177.272 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.257 1.2 t . . . . . 0 N--CA 1.438 -1.07 0 N-CA-C 102.519 -3.141 . . . . 0.0 102.519 -166.394 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 17.0 m . . . . . 0 N--CA 1.485 1.312 0 CA-C-O 121.709 0.766 . . . . 0.0 110.864 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.5 HH21 HG12 ' A' ' 58' ' ' ILE . 21.1 mtp85 -115.67 159.8 20.87 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 -173.298 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -135.89 134.31 38.63 Favored 'General case' 0 CA--C 1.489 -1.402 1 N-CA-C 96.674 -5.306 . . . . 0.0 96.674 164.071 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.01 -178.22 35.72 Favored Glycine 0 CA--C 1.48 -2.108 0 N-CA-C 106.687 -2.565 . . . . 0.0 106.687 175.558 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -75.36 128.7 35.98 Favored 'General case' 0 CA--C 1.497 -1.076 0 N-CA-C 104.386 -2.45 . . . . 0.0 104.386 158.745 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.469 HG22 ' HB2' ' A' ' 47' ' ' CYS . 5.7 tt -89.85 136.92 22.54 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.975 0 N-CA-C 105.444 -2.058 . . . . 0.0 105.444 -173.733 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.427 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -97.39 -147.11 0.31 Allowed 'General case' 0 N--CA 1.423 -1.806 0 CA-C-N 112.067 -2.333 . . . . 0.0 106.938 174.622 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.404 ' H ' ' HB1' ' A' ' 7' ' ' ALA . 54.2 mt-30 -125.07 141.21 37.85 Favored Pre-proline 0 N--CA 1.42 -1.968 1 N-CA-C 93.575 -6.454 . . . . 0.0 93.575 168.831 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -80.54 23.38 0.71 Allowed 'Trans proline' 0 C--N 1.323 -0.769 0 C-N-CA 122.707 2.271 . . . . 0.0 114.276 -145.443 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -95.48 -82.0 0.39 Allowed 'General case' 0 CA--C 1.489 -1.368 0 N-CA-C 103.043 -2.947 . . . . 0.0 103.043 -179.965 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -165.38 123.78 1.64 Allowed 'General case' 0 N--CA 1.425 -1.698 1 N-CA-C 91.584 -7.191 . . . . 0.0 91.584 169.05 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.3 m -174.59 -166.14 0.24 Allowed 'General case' 0 CA--C 1.496 -1.127 0 N-CA-C 101.825 -3.398 . . . . 0.0 101.825 -179.163 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.419 HG12 HD12 ' A' ' 59' ' ' ILE . 0.9 OUTLIER -125.24 167.32 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.387 1 N-CA-C 96.829 -5.248 . . . . 0.0 96.829 160.039 . . . . . . . . 4 4 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -88.83 -159.01 0.53 Allowed 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 104.718 -2.327 . . . . 0.0 104.718 163.236 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 51.5 m80 -140.46 160.65 39.53 Favored 'General case' 0 N--CA 1.417 -2.112 1 N-CA-C 94.982 -5.932 . . . . 0.0 94.982 168.796 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.4 t -161.23 -153.63 0.31 Allowed 'General case' 0 N--CA 1.415 -2.191 1 N-CA-C 94.188 -6.227 . . . . 0.0 94.188 -178.896 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -147.33 174.2 3.58 Favored Pre-proline 0 N--CA 1.414 -2.238 1 N-CA-C 99.201 -4.37 . . . . 0.0 99.201 -166.069 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_exo -67.82 44.06 0.26 Allowed 'Trans proline' 0 C--N 1.321 -0.883 0 C-N-CA 123.635 2.89 . . . . 0.0 114.245 168.047 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -176.07 147.66 8.78 Favored Glycine 0 N--CA 1.425 -2.094 1 N-CA-C 98.884 -5.686 . . . . 0.0 98.884 179.232 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.3 m -79.36 -16.11 56.8 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -164.182 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.6 m -39.86 -56.75 1.72 Allowed 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 117.264 2.32 . . . . 0.0 117.264 -151.561 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -77.61 -34.59 39.07 Favored Glycine 0 C--N 1.349 1.301 0 O-C-N 121.291 -0.881 . . . . 0.0 111.131 -174.432 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.3 t -84.24 -12.32 54.95 Favored 'General case' 0 CA--C 1.499 -0.999 0 O-C-N 121.695 -0.885 . . . . 0.0 109.065 -172.792 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -62.88 -48.29 79.64 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 172.787 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -58.54 -48.28 81.38 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 123.235 0.614 . . . . 0.0 112.318 171.334 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 90.8 mt -63.97 -42.41 97.26 Favored 'General case' 0 C--N 1.357 0.934 0 CA-C-O 121.895 0.855 . . . . 0.0 111.445 -175.603 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 24.9 t -59.67 -46.97 87.45 Favored 'General case' 0 CA--C 1.5 -0.954 0 C-N-CA 125.304 1.442 . . . . 0.0 108.998 177.253 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 45.3 mttp -70.79 -40.57 72.5 Favored 'General case' 0 N--CA 1.438 -1.064 0 O-C-N 121.683 -0.635 . . . . 0.0 111.405 -173.568 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -71.05 -18.11 62.58 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 118.914 0.779 . . . . 0.0 112.601 -179.111 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -97.57 -1.84 43.03 Favored 'General case' 0 C--N 1.355 0.822 0 O-C-N 121.731 -0.606 . . . . 0.0 110.478 175.152 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.97 33.72 6.51 Favored Glycine 0 C--N 1.352 1.422 0 CA-C-O 119.762 -0.465 . . . . 0.0 112.122 167.209 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -104.79 125.58 8.39 Favored Glycine 0 CA--C 1.49 -1.506 0 N-CA-C 104.826 -3.309 . . . . 0.0 104.826 168.582 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.9 p -100.54 6.08 44.17 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-O 122.139 0.971 . . . . 0.0 109.694 -164.557 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 26.9 m -160.17 159.11 31.25 Favored 'General case' 0 CA--C 1.476 -1.87 1 N-CA-C 98.503 -4.629 . . . . 0.0 98.503 167.289 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -170.89 177.32 43.97 Favored Glycine 0 N--CA 1.418 -2.539 1 N-CA-C 99.421 -5.472 . . . . 0.0 99.421 -176.012 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 52.6 m80 -165.33 -172.96 2.65 Favored 'General case' 0 N--CA 1.431 -1.404 1 N-CA-C 97.18 -5.119 . . . . 0.0 97.18 -177.724 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 100.0 m -140.61 156.51 46.25 Favored 'General case' 0 CA--C 1.477 -1.84 0 N-CA-C 100.503 -3.888 . . . . 0.0 100.503 174.684 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 170.22 -168.74 41.69 Favored Glycine 0 N--CA 1.424 -2.108 1 N-CA-C 98.373 -5.891 . . . . 0.0 98.373 -169.128 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -152.85 -177.95 6.59 Favored 'General case' 0 N--CA 1.427 -1.611 1 N-CA-C 98.921 -4.474 . . . . 0.0 98.921 -177.591 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 25.2 tptp 128.11 63.66 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.149 2 C-N-CA 133.38 4.672 . . . . 0.0 99.372 -179.602 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.5 HG12 ' H ' ' A' ' 42' ' ' GLY . 2.7 t -146.17 -167.08 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.518 1 N-CA-C 97.277 -5.083 . . . . 0.0 97.277 -172.867 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.5 ' H ' HG12 ' A' ' 41' ' ' VAL . . . -139.81 68.77 0.48 Allowed Glycine 0 CA--C 1.487 -1.7 0 N-CA-C 105.616 -2.994 . . . . 0.0 105.616 -176.383 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 21.7 m170 -158.33 -107.43 0.02 OUTLIER 'General case' 0 N--CA 1.434 -1.272 0 N-CA-C 100.894 -3.743 . . . . 0.0 100.894 173.172 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -121.21 -70.39 0.28 Allowed Glycine 0 C--N 1.355 1.587 0 CA-C-N 120.111 1.323 . . . . 0.0 111.932 -170.559 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -149.53 179.78 7.7 Favored 'General case' 0 N--CA 1.434 -1.245 1 N-CA-C 95.328 -5.805 . . . . 0.0 95.328 176.499 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -157.03 -174.48 4.94 Favored 'General case' 0 CA--C 1.486 -1.498 1 N-CA-C 99.936 -4.098 . . . . 0.0 99.936 -179.81 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.469 ' HB2' HG22 ' A' ' 6' ' ' ILE . 1.6 m -116.31 -179.13 3.58 Favored 'General case' 0 CA--C 1.486 -1.484 0 N-CA-C 102.308 -3.219 . . . . 0.0 102.308 165.814 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 32.2 t-105 -122.07 153.53 38.52 Favored 'General case' 0 CA--C 1.496 -1.121 0 N-CA-C 102.885 -3.006 . . . . 0.0 102.885 174.275 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 37.3 m -145.64 147.46 32.04 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 170.457 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -114.08 144.24 43.45 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 105.024 -2.213 . . . . 0.0 105.024 173.572 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 69.7 42.9 1.03 Allowed 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 127.289 2.236 . . . . 0.0 111.602 167.215 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 38.7 mt -84.04 137.95 40.09 Favored Pre-proline 0 CA--C 1.504 -0.825 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 178.391 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -73.6 168.91 23.58 Favored 'Trans proline' 0 N--CA 1.447 -1.208 0 C-N-CA 122.187 1.925 . . . . 0.0 110.333 177.514 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -67.78 -9.22 42.3 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 124.652 1.181 . . . . 0.0 114.054 -171.317 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 -91.15 -0.12 57.64 Favored 'General case' 0 CA--C 1.507 -0.709 0 O-C-N 121.557 -0.715 . . . . 0.0 110.923 -176.946 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.46 HG12 ' H ' ' A' ' 57' ' ' GLY . 2.0 t -99.93 178.12 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 N-CA-C 103.755 -2.683 . . . . 0.0 103.755 179.463 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.46 ' H ' HG12 ' A' ' 56' ' ' VAL . . . -143.61 161.58 27.72 Favored Glycine 0 CA--C 1.479 -2.205 1 N-CA-C 100.086 -5.206 . . . . 0.0 100.086 -176.035 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.5 HG12 HH21 ' A' ' 2' ' ' ARG . 17.8 pt -152.99 -166.94 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.627 1 N-CA-C 99.32 -4.326 . . . . 0.0 99.32 -167.655 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.427 HD13 ' HB2' ' A' ' 7' ' ' ALA . 2.9 mm -63.7 134.28 28.79 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 179.146 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.8 t . . . . . 0 N--CA 1.423 -1.822 1 N-CA-C 93.404 -6.517 . . . . 0.0 93.404 -179.183 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 19.1 m . . . . . 0 N--CA 1.485 1.295 0 CA-C-O 121.403 0.621 . . . . 0.0 110.424 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -103.97 167.71 9.59 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 104.637 -2.357 . . . . 0.0 104.637 163.551 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -125.86 140.45 52.64 Favored 'General case' 0 CA--C 1.485 -1.556 1 N-CA-C 93.75 -6.389 . . . . 0.0 93.75 156.714 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.79 178.94 37.46 Favored Glycine 0 CA--C 1.474 -2.523 0 C-N-CA 116.904 -2.569 . . . . 0.0 107.513 -178.479 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -73.87 130.16 39.35 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 104.075 -2.565 . . . . 0.0 104.075 155.409 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.8 tt -90.63 137.81 20.86 Favored 'Isoleucine or valine' 0 C--O 1.253 1.275 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 179.247 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.594 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -100.24 -158.38 0.67 Allowed 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 112.755 -2.021 . . . . 0.0 107.484 176.062 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -98.87 142.39 24.52 Favored Pre-proline 0 CA--C 1.49 -1.344 1 N-CA-C 97.422 -5.029 . . . . 0.0 97.422 163.815 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -78.49 26.47 0.52 Allowed 'Trans proline' 0 CA--C 1.509 -0.759 0 C-N-CA 123.07 2.514 . . . . 0.0 114.654 -136.292 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -115.5 -78.95 0.58 Allowed 'General case' 0 N--CA 1.425 -1.704 0 N-CA-C 102.415 -3.18 . . . . 0.0 102.415 177.65 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -165.89 147.83 7.14 Favored 'General case' 0 N--CA 1.429 -1.513 1 N-CA-C 96.544 -5.354 . . . . 0.0 96.544 164.958 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 20.3 m 164.91 -152.73 0.0 OUTLIER 'General case' 0 CA--C 1.499 -1.017 1 N-CA-C 97.308 -5.071 . . . . 0.0 97.308 179.238 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.543 HG12 HD12 ' A' ' 59' ' ' ILE . 0.8 OUTLIER -126.77 163.69 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 1 N-CA-C 98.844 -4.502 . . . . 0.0 98.844 160.111 . . . . . . . . 4 4 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -87.8 -158.87 0.49 Allowed 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 104.79 -2.3 . . . . 0.0 104.79 164.447 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 71.4 m80 -142.82 -178.46 5.82 Favored 'General case' 0 N--CA 1.424 -1.735 1 N-CA-C 97.032 -5.173 . . . . 0.0 97.032 166.739 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.3 t -155.05 166.13 34.56 Favored 'General case' 0 N--CA 1.415 -2.19 1 N-CA-C 96.643 -5.318 . . . . 0.0 96.643 -171.513 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -121.84 125.24 26.78 Favored Pre-proline 0 N--CA 1.42 -1.951 1 N-CA-C 99.841 -4.133 . . . . 0.0 99.841 179.251 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -58.4 111.72 0.96 Allowed 'Trans proline' 0 CA--C 1.503 -1.046 0 C-N-CA 123.327 2.684 . . . . 0.0 112.653 -174.0 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 140.06 -36.79 1.78 Allowed Glycine 0 CA--C 1.49 -1.522 1 N-CA-C 102.739 -4.144 . . . . 0.0 102.739 -166.937 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.3 m 85.23 11.85 0.26 Allowed 'General case' 0 CA--C 1.496 -1.096 0 C-N-CA 128.187 2.595 . . . . 0.0 111.04 172.384 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -48.87 -55.17 12.5 Favored 'General case' 0 N--CA 1.436 -1.148 0 C-N-CA 129.4 3.08 . . . . 0.0 113.526 -169.822 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -85.95 -26.28 35.04 Favored Glycine 0 C--N 1.35 1.359 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 -172.75 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 15.7 t -79.53 -17.09 54.8 Favored 'General case' 0 C--N 1.354 0.78 0 O-C-N 122.238 -0.566 . . . . 0.0 110.187 -172.412 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -62.45 -43.09 99.64 Favored 'General case' 0 C--N 1.354 0.801 0 O-C-N 120.973 -1.079 . . . . 0.0 109.364 174.118 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -56.14 -54.24 47.42 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 124.262 1.025 . . . . 0.0 111.132 169.794 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 91.1 mt -61.75 -45.43 93.93 Favored 'General case' 0 CA--C 1.496 -1.122 0 C-N-CA 123.49 0.716 . . . . 0.0 111.036 -172.739 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.8 t -60.28 -46.5 89.63 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 123.711 0.805 . . . . 0.0 109.407 179.381 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 78.7 mttt -67.31 -43.0 82.74 Favored 'General case' 0 CA--C 1.502 -0.884 0 O-C-N 121.956 -0.465 . . . . 0.0 111.629 -177.329 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -75.26 -21.08 58.8 Favored 'General case' 0 CA--C 1.508 -0.641 0 O-C-N 121.606 -0.684 . . . . 0.0 112.432 -176.5 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -87.94 -15.94 35.19 Favored 'General case' 0 C--N 1.356 0.865 0 CA-C-N 118.971 0.805 . . . . 0.0 109.875 172.822 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.2 34.33 3.98 Favored Glycine 0 CA--C 1.492 -1.366 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 166.655 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -96.83 157.26 21.15 Favored Glycine 0 CA--C 1.491 -1.42 0 N-CA-C 105.535 -3.026 . . . . 0.0 105.535 164.786 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 30.4 m -85.09 -42.38 14.86 Favored 'General case' 0 CA--C 1.497 -1.063 0 CA-C-O 123.119 1.438 . . . . 0.0 107.988 -168.628 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.5 m -158.99 166.59 31.43 Favored 'General case' 0 N--CA 1.417 -2.104 1 N-CA-C 97.083 -5.155 . . . . 0.0 97.083 -178.9 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -175.11 175.6 47.13 Favored Glycine 0 N--CA 1.421 -2.312 1 N-CA-C 98.545 -5.822 . . . . 0.0 98.545 -169.459 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 34.2 p-80 -167.11 -179.35 4.56 Favored 'General case' 0 N--CA 1.428 -1.54 1 N-CA-C 98.575 -4.602 . . . . 0.0 98.575 -173.695 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 80.2 m -74.08 171.29 13.8 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-N 119.476 1.035 . . . . 0.0 111.13 -178.842 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.86 170.34 43.31 Favored Glycine 0 N--CA 1.422 -2.237 1 N-CA-C 99.466 -5.454 . . . . 0.0 99.466 178.525 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -138.39 136.23 36.09 Favored 'General case' 0 N--CA 1.429 -1.489 1 N-CA-C 97.258 -5.09 . . . . 0.0 97.258 177.796 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.5 tmtm? -118.61 102.27 8.75 Favored 'General case' 0 CA--C 1.494 -1.189 0 N-CA-C 102.341 -3.207 . . . . 0.0 102.341 -177.477 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.6 t -73.87 122.28 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 -172.407 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 139.86 -43.26 1.15 Allowed Glycine 0 CA--C 1.484 -1.897 0 N-CA-C 103.115 -3.994 . . . . 0.0 103.115 -171.687 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -113.42 -63.96 1.37 Allowed 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 178.488 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 164.1 -162.65 35.4 Favored Glycine 0 CA--C 1.489 -1.547 0 N-CA-C 108.112 -1.995 . . . . 0.0 108.112 -170.452 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 28.8 tp -63.5 133.96 54.78 Favored 'General case' 0 CA--C 1.501 -0.936 0 C-N-CA 127.768 2.427 . . . . 0.0 105.657 173.515 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -136.59 -158.28 0.85 Allowed 'General case' 0 CA--C 1.483 -1.597 0 N-CA-C 103.289 -2.856 . . . . 0.0 103.289 -167.253 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 52.9 t -138.52 168.72 19.16 Favored 'General case' 0 CA--C 1.49 -1.336 0 N-CA-C 101.683 -3.451 . . . . 0.0 101.683 163.322 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 42.0 t-105 -121.16 145.89 47.34 Favored 'General case' 0 CA--C 1.499 -1.0 0 N-CA-C 103.418 -2.808 . . . . 0.0 103.418 -177.444 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 6.9 m -141.06 146.29 36.96 Favored 'General case' 0 CA--C 1.49 -1.33 0 N-CA-C 105.623 -1.991 . . . . 0.0 105.623 177.159 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -113.51 130.99 56.23 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 179.066 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 65.64 78.65 0.27 Allowed 'General case' 0 CA--C 1.491 -1.318 0 C-N-CA 129.378 3.071 . . . . 0.0 110.422 178.462 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -104.98 125.71 32.98 Favored Pre-proline 0 CA--C 1.496 -1.111 0 N-CA-C 102.216 -3.253 . . . . 0.0 102.216 177.9 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -72.06 170.74 18.25 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 CA-C-N 123.514 2.291 . . . . 0.0 110.126 174.169 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -85.67 18.15 2.99 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -165.64 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -100.92 1.28 39.68 Favored 'General case' 0 CA--C 1.502 -0.885 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 174.045 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.2 t -110.69 133.7 55.32 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.082 0 N-CA-C 103.68 -2.711 . . . . 0.0 103.68 -174.669 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -100.58 148.77 18.41 Favored Glycine 0 CA--C 1.489 -1.579 0 N-CA-C 106.097 -2.801 . . . . 0.0 106.097 178.611 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 25.3 pt -129.83 -146.57 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.492 -1.265 0 N-CA-C 104.222 -2.51 . . . . 0.0 104.222 -169.213 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.594 HD13 ' HB2' ' A' ' 7' ' ' ALA . 3.1 mm -73.03 1.42 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.747 0 CA-C-N 118.904 0.774 . . . . 0.0 112.194 -172.484 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.491 -1.298 0 O-C-N 119.109 -2.244 . . . . 0.0 105.853 161.353 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 22.8 m . . . . . 0 N--CA 1.484 1.252 0 CA-C-O 121.202 0.525 . . . . 0.0 110.512 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.46 174.97 5.65 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 103.439 -2.8 . . . . 0.0 103.439 160.798 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -126.22 142.02 51.69 Favored 'General case' 0 CA--C 1.489 -1.399 1 N-CA-C 93.354 -6.535 . . . . 0.0 93.354 162.716 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.28 170.74 37.14 Favored Glycine 0 CA--C 1.47 -2.732 0 N-CA-C 106.446 -2.662 . . . . 0.0 106.446 -174.292 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -88.77 125.22 34.78 Favored 'General case' 0 CA--C 1.488 -1.411 0 N-CA-C 100.708 -3.812 . . . . 0.0 100.708 162.611 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.9 tt -87.84 140.72 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.088 0 N-CA-C 105.58 -2.007 . . . . 0.0 105.58 -174.271 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.625 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -116.41 -158.55 0.69 Allowed 'General case' 0 N--CA 1.424 -1.727 0 C-N-CA 128.12 2.568 . . . . 0.0 107.55 -175.118 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -88.3 144.5 34.16 Favored Pre-proline 0 N--CA 1.44 -0.928 0 N-CA-C 100.493 -3.891 . . . . 0.0 100.493 162.239 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -78.36 27.16 0.5 Allowed 'Trans proline' 0 CA--C 1.511 -0.637 0 C-N-CA 123.322 2.681 . . . . 0.0 113.811 -152.897 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 53.6 mp0 -111.37 -82.07 0.58 Allowed 'General case' 0 N--CA 1.425 -1.699 0 N-CA-C 101.912 -3.366 . . . . 0.0 101.912 178.955 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -163.47 143.95 8.92 Favored 'General case' 0 N--CA 1.424 -1.754 1 N-CA-C 93.521 -6.474 . . . . 0.0 93.521 167.496 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 9.1 m 170.66 -156.21 0.01 OUTLIER 'General case' 0 CA--C 1.494 -1.178 1 N-CA-C 98.166 -4.753 . . . . 0.0 98.166 175.203 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.599 HG12 HD12 ' A' ' 59' ' ' ILE . 7.8 m -130.98 168.4 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.531 1 N-CA-C 96.815 -5.254 . . . . 0.0 96.815 160.284 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -89.89 163.55 14.95 Favored 'General case' 0 CA--C 1.499 -1.018 0 N-CA-C 100.957 -3.72 . . . . 0.0 100.957 161.915 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 71.3 m80 -108.13 101.2 10.45 Favored 'General case' 0 CA--C 1.48 -1.727 0 N-CA-C 102.74 -3.059 . . . . 0.0 102.74 -174.654 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.8 t -107.44 -171.51 1.89 Allowed 'General case' 0 N--CA 1.425 -1.7 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 -177.896 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -142.43 167.9 15.02 Favored Pre-proline 0 N--CA 1.416 -2.148 1 N-CA-C 98.552 -4.61 . . . . 0.0 98.552 -160.289 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.94 54.23 2.09 Favored 'Trans proline' 0 C--N 1.327 -0.588 0 C-N-CA 123.259 2.639 . . . . 0.0 110.749 166.497 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -178.51 134.16 2.3 Favored Glycine 0 N--CA 1.425 -2.068 1 N-CA-C 99.403 -5.479 . . . . 0.0 99.403 -178.519 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.98 26.06 9.17 Favored 'General case' 0 N--CA 1.434 -1.249 0 C-N-CA 124.305 1.042 . . . . 0.0 109.722 -168.938 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.5 m -49.68 -48.26 49.67 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 126.73 2.012 . . . . 0.0 115.37 -169.759 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -90.1 -26.35 24.18 Favored Glycine 0 C--N 1.351 1.364 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 -179.374 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -85.88 -14.69 44.12 Favored 'General case' 0 CA--C 1.5 -0.976 0 O-C-N 121.53 -0.982 . . . . 0.0 109.989 -167.946 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -58.9 -49.54 77.4 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 125.724 1.61 . . . . 0.0 108.113 171.979 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.4 -45.25 93.98 Favored 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 124.599 1.16 . . . . 0.0 112.162 174.173 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 95.9 mt -64.34 -41.29 96.84 Favored 'General case' 0 C--N 1.357 0.933 0 CA-C-O 121.69 0.757 . . . . 0.0 111.9 -178.064 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 13.2 t -59.79 -44.72 93.81 Favored 'General case' 0 N--CA 1.443 -0.799 0 O-C-N 121.59 -0.694 . . . . 0.0 109.815 176.776 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 46.1 mttp -63.66 -50.9 67.44 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 123.129 0.571 . . . . 0.0 111.163 -177.581 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -67.71 -23.57 65.29 Favored 'General case' 0 C--N 1.351 0.674 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -175.549 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -91.71 -5.72 53.22 Favored 'General case' 0 C--N 1.357 0.902 0 O-C-N 121.728 -0.607 . . . . 0.0 110.701 177.718 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.25 32.37 5.82 Favored Glycine 0 CA--C 1.492 -1.386 0 N-CA-C 111.579 -0.608 . . . . 0.0 111.579 165.713 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -108.75 140.26 15.51 Favored Glycine 0 CA--C 1.486 -1.735 0 N-CA-C 106.173 -2.771 . . . . 0.0 106.173 170.857 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.78 -76.29 0.34 Allowed 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 -171.814 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.8 m -85.85 151.83 23.48 Favored 'General case' 0 CA--C 1.491 -1.293 0 N-CA-C 105.496 -2.038 . . . . 0.0 105.496 176.706 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -158.41 171.61 35.26 Favored Glycine 0 N--CA 1.414 -2.787 1 N-CA-C 99.246 -5.542 . . . . 0.0 99.246 -175.936 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 52.9 m80 -168.0 -170.38 1.33 Allowed 'General case' 0 N--CA 1.426 -1.662 1 N-CA-C 95.982 -5.562 . . . . 0.0 95.982 -176.156 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 46.8 m -138.09 161.47 36.69 Favored 'General case' 0 N--CA 1.427 -1.579 1 N-CA-C 97.465 -5.013 . . . . 0.0 97.465 167.602 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 178.29 179.49 48.25 Favored Glycine 0 CA--C 1.481 -2.06 1 N-CA-C 100.779 -4.928 . . . . 0.0 100.779 -174.018 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -144.46 138.83 27.93 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 100.228 -3.989 . . . . 0.0 100.228 -170.294 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -148.11 50.39 1.03 Allowed 'General case' 0 CA--C 1.491 -1.302 1 N-CA-C 99.599 -4.223 . . . . 0.0 99.599 170.549 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . 0.275 2.2 t 60.61 -142.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.142 0 C-N-CA 125.84 1.656 . . . . 0.0 106.84 -160.288 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 121.55 -86.09 0.39 Allowed Glycine 0 CA--C 1.484 -1.899 1 N-CA-C 102.894 -4.082 . . . . 0.0 102.894 -176.714 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 26.1 m170 -159.93 -47.9 0.05 Allowed 'General case' 0 CA--C 1.498 -1.033 0 N-CA-C 104.726 -2.324 . . . . 0.0 104.726 -175.486 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -160.07 -176.89 32.65 Favored Glycine 0 N--CA 1.428 -1.878 1 N-CA-C 97.119 -6.393 . . . . 0.0 97.119 -178.508 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.7 tt -73.33 120.63 19.21 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 118.61 1.205 . . . . 0.0 108.689 -169.567 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -105.22 179.01 4.4 Favored 'General case' 0 CA--C 1.491 -1.308 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -162.82 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 58.9 m -109.46 157.13 19.26 Favored 'General case' 0 CA--C 1.486 -1.486 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 179.79 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 65.7 t-105 -109.88 148.93 30.65 Favored 'General case' 0 CA--C 1.487 -1.479 0 N-CA-C 103.717 -2.697 . . . . 0.0 103.717 179.591 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 45.1 m -140.94 141.81 34.45 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 101.72 -3.437 . . . . 0.0 101.72 167.382 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -108.61 17.12 22.33 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-O 121.396 0.617 . . . . 0.0 109.653 -166.679 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -171.0 144.52 2.15 Favored 'General case' 0 N--CA 1.418 -2.042 1 N-CA-C 93.624 -6.436 . . . . 0.0 93.624 172.364 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 17.0 mt -153.48 146.22 17.54 Favored Pre-proline 0 CA--C 1.487 -1.445 1 N-CA-C 97.325 -5.065 . . . . 0.0 97.325 155.61 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.38 170.21 19.8 Favored 'Trans proline' 0 N--CA 1.447 -1.207 0 C-N-CA 122.6 2.2 . . . . 0.0 109.221 173.33 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -65.89 -19.79 66.0 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -167.259 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -83.61 -2.37 55.94 Favored 'General case' 0 CA--C 1.501 -0.923 0 C-N-CA 124.18 0.992 . . . . 0.0 111.289 -172.923 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.8 t -100.09 126.31 53.62 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.303 0 N-CA-C 103.753 -2.684 . . . . 0.0 103.753 -177.67 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -92.68 158.71 24.4 Favored Glycine 0 CA--C 1.485 -1.8 0 N-CA-C 105.324 -3.11 . . . . 0.0 105.324 178.559 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 25.8 pt -144.89 -156.99 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.517 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 -166.491 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.625 HD13 ' HB2' ' A' ' 7' ' ' ALA . 0.7 OUTLIER -71.93 128.03 34.51 Favored 'Isoleucine or valine' 0 C--N 1.365 1.247 0 N-CA-C 104.967 -2.234 . . . . 0.0 104.967 176.085 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.6 t . . . . . 0 N--CA 1.427 -1.596 0 N-CA-C 101.292 -3.596 . . . . 0.0 101.292 176.886 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 4.8 m . . . . . 0 N--CA 1.483 1.185 0 CA-C-O 122.443 1.116 . . . . 0.0 111.065 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 34.6 mtp85 -97.26 151.38 19.93 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 -171.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -130.63 125.3 33.71 Favored 'General case' 0 CA--C 1.485 -1.519 1 N-CA-C 96.597 -5.335 . . . . 0.0 96.597 165.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.76 -178.12 35.41 Favored Glycine 0 CA--C 1.477 -2.32 0 N-CA-C 103.162 -3.975 . . . . 0.0 103.162 176.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 48' ' ' TRP . 85.3 m-85 -76.88 133.33 39.32 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 168.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 17.4 tt -91.34 147.49 5.22 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 CA-C-N 120.163 1.347 . . . . 0.0 108.406 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.664 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -134.87 -150.98 0.41 Allowed 'General case' 0 N--CA 1.426 -1.654 0 C-N-CA 127.657 2.383 . . . . 0.0 106.869 -177.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -125.67 144.96 49.85 Favored Pre-proline 0 N--CA 1.426 -1.668 1 N-CA-C 94.661 -6.052 . . . . 0.0 94.661 162.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -80.6 -1.77 11.49 Favored 'Trans proline' 0 CA--C 1.501 -1.143 0 CA-C-N 123.165 2.166 . . . . 0.0 112.714 -143.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 48.8 mm-40 -86.37 46.85 1.39 Allowed 'General case' 0 N--CA 1.438 -1.043 0 C-N-CA 124.574 1.15 . . . . 0.0 109.874 -167.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.43 ' O ' ' HE1' ' A' ' 43' ' ' HIS . 0.2 OUTLIER 65.59 45.87 2.6 Favored 'General case' 0 C--N 1.356 0.889 0 C-N-CA 126.343 1.857 . . . . 0.0 107.598 177.355 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 94.9 m -122.38 -162.64 1.02 Allowed 'General case' 0 CA--C 1.486 -1.502 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 -169.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.671 HG12 HD12 ' A' ' 59' ' ' ILE . 0.6 OUTLIER -141.59 170.26 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.838 1 N-CA-C 96.897 -5.223 . . . . 0.0 96.897 173.137 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -98.2 -163.95 1.09 Allowed 'General case' 0 CA--C 1.5 -0.966 0 N-CA-C 101.254 -3.61 . . . . 0.0 101.254 163.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 69.8 m80 -139.56 162.67 34.5 Favored 'General case' 0 CA--C 1.482 -1.672 1 N-CA-C 96.085 -5.524 . . . . 0.0 96.085 166.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 8.4 t -123.03 164.36 18.72 Favored 'General case' 0 CA--C 1.477 -1.837 0 N-CA-C 101.965 -3.346 . . . . 0.0 101.965 -167.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -112.53 122.06 37.32 Favored Pre-proline 0 N--CA 1.425 -1.693 1 N-CA-C 97.341 -5.059 . . . . 0.0 97.341 166.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_exo -56.34 96.47 0.06 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.578 0 CA-C-N 123.823 2.401 . . . . 0.0 117.081 -169.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 162.28 -161.06 33.23 Favored Glycine 0 N--CA 1.417 -2.568 1 N-CA-C 97.597 -6.201 . . . . 0.0 97.597 -179.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -84.86 -45.35 12.37 Favored 'General case' 0 N--CA 1.426 -1.652 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 176.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.9 m -39.29 -56.22 1.57 Allowed 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 117.356 2.354 . . . . 0.0 117.356 -145.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -68.34 -74.74 0.57 Allowed Glycine 0 C--N 1.351 1.363 0 O-C-N 121.606 -0.683 . . . . 0.0 111.815 -176.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.6 p -87.0 -6.02 58.89 Favored 'General case' 0 CA--C 1.497 -1.073 0 O-C-N 121.219 -1.165 . . . . 0.0 113.048 -166.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -69.88 -33.72 72.6 Favored 'General case' 0 C--N 1.359 0.983 0 CA-C-N 119.774 1.17 . . . . 0.0 108.276 166.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 26.6 m -70.27 -42.02 72.68 Favored 'General case' 0 N--CA 1.447 -0.624 0 O-C-N 120.936 -1.102 . . . . 0.0 108.679 177.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 96.3 mt -61.31 -40.41 94.06 Favored 'General case' 0 C--N 1.355 0.824 0 CA-C-O 121.73 0.776 . . . . 0.0 110.734 175.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.0 t -55.13 -43.34 74.03 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 123.841 0.856 . . . . 0.0 111.256 174.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -60.51 -46.55 89.73 Favored 'General case' 0 C--N 1.356 0.884 0 CA-C-N 118.361 0.528 . . . . 0.0 111.877 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -76.83 -23.57 52.75 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -174.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -80.79 -30.93 35.88 Favored 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 173.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 117.56 35.59 1.07 Allowed Glycine 0 CA--C 1.487 -1.67 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 162.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.58 142.89 15.72 Favored Glycine 0 CA--C 1.488 -1.638 0 N-CA-C 105.097 -3.201 . . . . 0.0 105.097 173.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.3 p -105.17 15.4 27.54 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-O 121.657 0.741 . . . . 0.0 109.798 -167.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 65.8 m -158.39 154.92 27.75 Favored 'General case' 0 CA--C 1.475 -1.92 1 N-CA-C 98.405 -4.665 . . . . 0.0 98.405 159.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -153.87 147.85 17.72 Favored Glycine 0 CA--C 1.468 -2.853 1 N-CA-C 97.491 -6.243 . . . . 0.0 97.491 -170.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -156.61 -171.37 3.66 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 101.566 -3.494 . . . . 0.0 101.566 -171.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 79.3 m -103.36 -179.38 3.93 Favored 'General case' 0 CA--C 1.491 -1.307 0 N-CA-C 104.278 -2.49 . . . . 0.0 104.278 174.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.17 178.29 45.2 Favored Glycine 0 N--CA 1.421 -2.347 0 N-CA-C 103.505 -3.838 . . . . 0.0 103.505 170.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -131.45 133.4 45.13 Favored 'General case' 0 CA--C 1.488 -1.418 1 N-CA-C 98.912 -4.477 . . . . 0.0 98.912 172.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -118.93 99.25 6.63 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 102.2 -3.259 . . . . 0.0 102.2 178.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.0 t -69.34 129.91 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 -175.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 124.75 -41.55 1.69 Allowed Glycine 0 CA--C 1.488 -1.649 0 N-CA-C 104.516 -3.434 . . . . 0.0 104.516 -168.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.43 ' HE1' ' O ' ' A' ' 11' ' ' ASN . 14.2 m-70 -108.94 -69.85 0.84 Allowed 'General case' 0 CA--C 1.496 -1.102 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 176.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 158.39 -155.49 26.51 Favored Glycine 0 N--CA 1.429 -1.823 0 N-CA-C 103.915 -3.674 . . . . 0.0 103.915 -170.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.1 tt -73.43 141.66 46.91 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 105.953 -1.869 . . . . 0.0 105.953 -178.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.78 -172.75 3.46 Favored 'General case' 0 CA--C 1.489 -1.394 0 N-CA-C 104.116 -2.55 . . . . 0.0 104.116 -168.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 45.5 m -117.5 176.61 5.09 Favored 'General case' 0 CA--C 1.477 -1.838 0 N-CA-C 103.001 -2.963 . . . . 0.0 103.001 170.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.428 ' HA ' ' HA ' ' A' ' 5' ' ' TYR . 8.1 t-105 -138.79 151.89 47.43 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 102.89 -3.004 . . . . 0.0 102.89 -178.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 4.4 m -143.78 156.18 44.41 Favored 'General case' 0 CA--C 1.486 -1.517 0 N-CA-C 104.927 -2.249 . . . . 0.0 104.927 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -127.77 136.87 52.09 Favored 'General case' 0 CA--C 1.49 -1.36 0 N-CA-C 104.219 -2.511 . . . . 0.0 104.219 175.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 73.9 49.73 0.12 Allowed 'General case' 0 CA--C 1.493 -1.233 0 C-N-CA 126.671 1.988 . . . . 0.0 110.549 170.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 50.2 mt -89.33 141.83 29.31 Favored Pre-proline 0 CA--C 1.504 -0.803 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 177.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -66.1 162.51 35.3 Favored 'Trans proline' 0 N--CA 1.448 -1.175 0 C-N-CA 122.222 1.948 . . . . 0.0 111.906 177.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -60.2 -17.11 38.94 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -86.2 -1.02 57.07 Favored 'General case' 0 CA--C 1.504 -0.825 0 O-C-N 121.55 -0.719 . . . . 0.0 111.208 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.1 t -94.14 156.72 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 N-CA-C 103.472 -2.788 . . . . 0.0 103.472 177.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -141.28 152.81 23.56 Favored Glycine 0 CA--C 1.48 -2.122 1 N-CA-C 98.103 -5.999 . . . . 0.0 98.103 -177.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 21.4 pt -146.21 -144.25 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 N-CA-C 104.66 -2.348 . . . . 0.0 104.66 -156.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.671 HD12 HG12 ' A' ' 13' ' ' VAL . 1.9 mm -68.74 147.06 12.42 Favored 'Isoleucine or valine' 0 C--N 1.359 0.98 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 178.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 15.5 t -144.09 163.92 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.596 1 N-CA-C 94.511 -6.107 . . . . 0.0 94.511 177.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -158.38 155.5 28.8 Favored 'General case' 0 CA--C 1.478 -1.791 1 N-CA-C 98.31 -4.7 . . . . 0.0 98.31 164.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 137.24 -47.42 0.95 Allowed Glycine 0 CA--C 1.485 -1.793 1 N-CA-C 99.385 -5.486 . . . . 0.0 99.385 -157.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -102.32 -144.8 0.36 Allowed 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 104.854 -2.276 . . . . 0.0 104.854 165.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -155.96 177.42 11.43 Favored 'General case' 0 N--CA 1.423 -1.808 1 N-CA-C 95.505 -5.739 . . . . 0.0 95.505 -173.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 45.8 t -76.79 142.67 40.26 Favored 'General case' 0 CA--C 1.497 -1.069 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -172.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 36.0 p-80 -146.92 161.31 41.01 Favored 'General case' 0 N--CA 1.424 -1.743 1 N-CA-C 97.683 -4.932 . . . . 0.0 97.683 173.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.7 m -179.13 175.48 0.96 Allowed 'General case' 0 N--CA 1.425 -1.704 1 N-CA-C 95.45 -5.759 . . . . 0.0 95.45 176.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.357 0.907 0 O-C-N 123.838 0.711 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 30.3 m . . . . . 0 N--CA 1.481 1.093 0 CA-C-O 121.228 0.537 . . . . 0.0 110.089 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -83.52 157.34 22.4 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 173.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -124.71 125.8 44.67 Favored 'General case' 0 CA--C 1.49 -1.337 1 N-CA-C 92.769 -6.752 . . . . 0.0 92.769 151.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.54 178.54 37.4 Favored Glycine 0 CA--C 1.473 -2.568 0 N-CA-C 106.022 -2.831 . . . . 0.0 106.022 -170.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 48' ' ' TRP . 65.0 m-85 -87.12 125.03 33.88 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 171.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.467 HG13 HG22 ' A' ' 58' ' ' ILE . 18.6 tt -90.51 152.07 3.4 Favored 'Isoleucine or valine' 0 C--N 1.357 0.93 0 CA-C-N 120.272 1.396 . . . . 0.0 108.143 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.808 ' HB2' HD12 ' A' ' 59' ' ' ILE . . . -144.09 -159.19 0.96 Allowed 'General case' 0 N--CA 1.418 -2.053 0 C-N-CA 126.426 1.89 . . . . 0.0 107.83 -167.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 -105.48 144.29 28.52 Favored Pre-proline 0 N--CA 1.432 -1.356 1 N-CA-C 99.345 -4.317 . . . . 0.0 99.345 158.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -79.04 -12.34 14.56 Favored 'Trans proline' 0 CA--C 1.503 -1.052 0 CA-C-N 122.236 1.834 . . . . 0.0 112.544 -153.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -87.59 55.49 3.52 Favored 'General case' 0 C--N 1.36 1.022 0 CA-C-N 120.591 1.541 . . . . 0.0 108.666 -173.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.5 t30 73.24 37.4 0.75 Allowed 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 128.075 2.55 . . . . 0.0 110.993 168.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -108.94 -162.33 0.81 Allowed 'General case' 0 CA--C 1.504 -0.816 0 O-C-N 121.053 -1.029 . . . . 0.0 111.693 -167.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.754 HG12 HD11 ' A' ' 59' ' ' ILE . 3.7 m -133.96 170.46 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.225 1 N-CA-C 98.662 -4.569 . . . . 0.0 98.662 162.241 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . 0.313 1.3 m-85 -111.15 151.17 28.48 Favored 'General case' 0 CA--C 1.487 -1.456 1 N-CA-C 95.1 -5.889 . . . . 0.0 95.1 166.041 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 34.8 m80 -92.21 144.65 25.2 Favored 'General case' 0 CA--C 1.496 -1.109 0 N-CA-C 102.772 -3.047 . . . . 0.0 102.772 171.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 39.0 t -92.41 164.77 13.36 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 -177.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -108.29 101.78 43.69 Favored Pre-proline 0 N--CA 1.425 -1.712 1 N-CA-C 98.959 -4.46 . . . . 0.0 98.959 169.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -68.18 107.78 1.62 Allowed 'Trans proline' 0 CA--C 1.501 -1.147 0 C-N-CA 122.367 2.045 . . . . 0.0 110.58 -161.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 160.79 -45.2 0.41 Allowed Glycine 0 CA--C 1.48 -2.104 1 N-CA-C 97.972 -6.051 . . . . 0.0 97.972 -169.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.2 m 122.8 -34.91 0.01 OUTLIER 'General case' 0 CA--C 1.487 -1.47 0 C-N-CA 128.8 2.84 . . . . 0.0 107.898 161.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 m -38.9 -51.92 1.76 Allowed 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 127.644 2.377 . . . . 0.0 116.377 -160.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.14 -41.99 68.53 Favored Glycine 0 C--N 1.355 1.594 0 O-C-N 121.287 -0.883 . . . . 0.0 111.513 -176.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.8 t -88.09 -24.88 23.29 Favored 'General case' 0 CA--C 1.496 -1.105 0 O-C-N 121.562 -0.964 . . . . 0.0 109.037 -171.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -65.83 -36.51 83.68 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 170.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 44.0 m -64.42 -37.85 88.95 Favored 'General case' 0 C--N 1.348 0.517 0 O-C-N 121.055 -1.028 . . . . 0.0 110.635 174.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 78.8 mt -63.96 -40.04 95.51 Favored 'General case' 0 C--N 1.357 0.931 0 CA-C-O 122.192 0.996 . . . . 0.0 110.559 175.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 38.3 t -58.17 -46.04 86.43 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.109 1.363 . . . . 0.0 110.347 174.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.17 -49.22 76.69 Favored 'General case' 0 C--N 1.359 0.984 0 O-C-N 121.752 -0.592 . . . . 0.0 110.613 -178.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -70.1 -21.18 63.15 Favored 'General case' 0 C--N 1.354 0.802 0 O-C-N 121.688 -0.632 . . . . 0.0 112.626 -173.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -96.5 5.79 50.09 Favored 'General case' 0 C--N 1.355 0.846 0 O-C-N 121.671 -0.643 . . . . 0.0 110.52 177.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.37 36.94 19.18 Favored Glycine 0 CA--C 1.493 -1.311 0 O-C-N 121.847 -0.533 . . . . 0.0 111.937 169.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -97.27 138.91 14.18 Favored Glycine 0 CA--C 1.487 -1.672 1 N-CA-C 102.862 -4.095 . . . . 0.0 102.862 164.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.4 m -105.96 -5.12 19.86 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -156.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 71.5 m -160.72 177.74 10.16 Favored 'General case' 0 CA--C 1.496 -1.121 1 N-CA-C 97.948 -4.834 . . . . 0.0 97.948 163.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -176.3 -170.88 39.49 Favored Glycine 0 CA--C 1.476 -2.369 1 N-CA-C 102.112 -4.395 . . . . 0.0 102.112 178.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -177.76 -154.51 0.03 OUTLIER 'General case' 0 N--CA 1.426 -1.634 1 N-CA-C 95.504 -5.739 . . . . 0.0 95.504 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 98.2 m -146.37 -176.6 5.24 Favored 'General case' 0 CA--C 1.48 -1.717 0 N-CA-C 101.24 -3.615 . . . . 0.0 101.24 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -175.66 -164.13 29.58 Favored Glycine 0 N--CA 1.422 -2.258 1 N-CA-C 99.971 -5.251 . . . . 0.0 99.971 -177.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -126.44 148.83 49.58 Favored 'General case' 0 N--CA 1.431 -1.385 1 N-CA-C 100.124 -4.028 . . . . 0.0 100.124 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -129.33 106.84 9.08 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 103.451 -2.796 . . . . 0.0 103.451 174.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.3 t -73.21 124.83 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 -174.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 134.95 -43.86 1.22 Allowed Glycine 0 CA--C 1.483 -1.944 0 N-CA-C 104.863 -3.295 . . . . 0.0 104.863 -171.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 38.9 m170 -114.97 -71.67 0.73 Allowed 'General case' 0 CA--C 1.498 -1.047 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 175.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 166.83 -145.25 9.74 Favored Glycine 0 N--CA 1.429 -1.78 0 N-CA-C 106.678 -2.569 . . . . 0.0 106.678 -177.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 45.9 tp -66.42 133.39 50.35 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 126.448 1.899 . . . . 0.0 106.458 177.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -138.49 171.86 13.75 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 102.84 -3.022 . . . . 0.0 102.84 -167.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 63.3 m -114.93 -179.94 3.77 Favored 'General case' 0 CA--C 1.484 -1.591 0 N-CA-C 102.991 -2.966 . . . . 0.0 102.991 176.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.461 ' HA ' ' HA ' ' A' ' 5' ' ' TYR . 9.8 t-105 -144.94 151.38 38.57 Favored 'General case' 0 CA--C 1.493 -1.239 0 N-CA-C 102.932 -2.988 . . . . 0.0 102.932 -174.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 45.8 m -137.26 151.73 49.02 Favored 'General case' 0 CA--C 1.487 -1.466 0 N-CA-C 104.697 -2.335 . . . . 0.0 104.697 172.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -115.57 130.7 56.96 Favored 'General case' 0 CA--C 1.495 -1.144 0 N-CA-C 103.794 -2.669 . . . . 0.0 103.794 170.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 65.01 72.58 0.43 Allowed 'General case' 0 CA--C 1.498 -1.041 0 C-N-CA 126.449 1.9 . . . . 0.0 110.685 175.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 20.9 mt -104.46 139.35 20.02 Favored Pre-proline 0 CA--C 1.492 -1.26 0 N-CA-C 102.197 -3.26 . . . . 0.0 102.197 166.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -70.67 168.48 22.62 Favored 'Trans proline' 0 N--CA 1.447 -1.24 0 C-N-CA 122.605 2.204 . . . . 0.0 110.114 175.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -84.07 5.42 26.03 Favored 'General case' 0 N--CA 1.443 -0.822 0 O-C-N 121.634 -0.666 . . . . 0.0 112.787 -164.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 -92.3 0.31 57.44 Favored 'General case' 0 CA--C 1.502 -0.876 0 O-C-N 121.638 -0.664 . . . . 0.0 109.584 176.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.1 t -91.65 163.12 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 N-CA-C 104.764 -2.31 . . . . 0.0 104.764 178.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -141.41 150.45 21.89 Favored Glycine 0 CA--C 1.483 -1.935 1 N-CA-C 97.552 -6.219 . . . . 0.0 97.552 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.467 HG22 HG13 ' A' ' 6' ' ' ILE . 16.6 pt -152.32 -140.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 N-CA-C 104.216 -2.513 . . . . 0.0 104.216 -155.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.808 HD12 ' HB2' ' A' ' 7' ' ' ALA . 1.7 mp -65.06 126.52 24.22 Favored 'Isoleucine or valine' 0 C--N 1.362 1.128 0 N-CA-C 104.792 -2.299 . . . . 0.0 104.792 163.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.7 t -133.76 142.33 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.839 1 N-CA-C 95.568 -5.716 . . . . 0.0 95.568 -178.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 62.41 -54.8 0.15 Allowed 'General case' 0 C--N 1.359 1.019 0 C-N-CA 128.244 2.618 . . . . 0.0 117.448 164.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.08 15.0 59.74 Favored Glycine 0 N--CA 1.438 -1.202 0 C-N-CA 125.476 1.512 . . . . 0.0 112.98 176.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -81.71 -52.7 6.89 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-N 118.534 1.167 . . . . 0.0 112.248 -171.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -161.7 -178.53 6.6 Favored 'General case' 0 N--CA 1.434 -1.234 1 N-CA-C 97.766 -4.901 . . . . 0.0 97.766 -171.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 16.0 t -130.4 154.65 47.48 Favored 'General case' 0 CA--C 1.482 -1.636 1 N-CA-C 97.874 -4.861 . . . . 0.0 97.874 173.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -137.22 127.1 25.7 Favored 'General case' 0 CA--C 1.487 -1.454 0 N-CA-C 101.295 -3.595 . . . . 0.0 101.295 175.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.9 m -171.71 172.51 4.9 Favored 'General case' 0 N--CA 1.425 -1.712 1 N-CA-C 96.054 -5.535 . . . . 0.0 96.054 -177.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.359 1.007 0 CA-C-N 119.258 0.936 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 27.2 m . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 121.272 0.558 . . . . 0.0 109.728 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.02 169.07 17.35 Favored 'General case' 0 N--CA 1.434 -1.23 1 N-CA-C 98.578 -4.601 . . . . 0.0 98.578 167.618 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 -130.63 133.06 45.82 Favored 'General case' 0 CA--C 1.48 -1.737 1 N-CA-C 94.366 -6.161 . . . . 0.0 94.366 169.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.66 -178.23 35.4 Favored Glycine 0 CA--C 1.474 -2.528 0 C-N-CA 117.397 -2.335 . . . . 0.0 107.411 -173.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 48' ' ' TRP . 42.2 m-85 -78.45 130.46 36.09 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 102.713 -3.069 . . . . 0.0 102.713 158.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.7 tt -90.47 137.29 21.9 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 N-CA-C 105.331 -2.1 . . . . 0.0 105.331 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.547 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -94.3 -144.76 0.25 Allowed 'General case' 0 N--CA 1.424 -1.734 0 CA-C-N 112.319 -2.219 . . . . 0.0 107.79 177.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 62.7 mt-30 -109.57 147.02 35.23 Favored Pre-proline 0 N--CA 1.43 -1.464 1 N-CA-C 96.068 -5.53 . . . . 0.0 96.068 165.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -76.34 7.59 3.31 Favored 'Trans proline' 0 CA--C 1.506 -0.888 0 C-N-CA 122.671 2.247 . . . . 0.0 113.883 -145.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 18.1 mp0 -88.4 -76.35 0.4 Allowed 'General case' 0 N--CA 1.426 -1.643 0 N-CA-C 103.234 -2.876 . . . . 0.0 103.234 176.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -176.84 144.02 0.45 Allowed 'General case' 0 N--CA 1.419 -2.003 1 N-CA-C 93.64 -6.429 . . . . 0.0 93.64 -178.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 160.69 -153.48 0.0 OUTLIER 'General case' 0 CA--C 1.493 -1.237 0 N-CA-C 101.705 -3.443 . . . . 0.0 101.705 173.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.612 HG12 HD12 ' A' ' 59' ' ' ILE . 0.3 OUTLIER -126.1 165.15 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.33 1 N-CA-C 99.477 -4.268 . . . . 0.0 99.477 159.649 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -86.01 -148.89 0.13 Allowed 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 164.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 46.4 m80 -142.33 176.29 9.1 Favored 'General case' 0 CA--C 1.483 -1.632 1 N-CA-C 97.209 -5.108 . . . . 0.0 97.209 164.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 8.2 t -136.18 159.97 40.09 Favored 'General case' 0 N--CA 1.426 -1.644 1 N-CA-C 96.482 -5.377 . . . . 0.0 96.482 -177.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -111.19 107.75 57.32 Favored Pre-proline 0 N--CA 1.428 -1.557 1 N-CA-C 97.529 -4.989 . . . . 0.0 97.529 170.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_exo -53.03 103.82 0.09 OUTLIER 'Trans proline' 0 CA--C 1.513 -0.557 0 CA-C-N 124.439 2.621 . . . . 0.0 116.871 -155.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 161.69 -170.33 37.38 Favored Glycine 0 N--CA 1.426 -2.011 1 N-CA-C 97.228 -6.349 . . . . 0.0 97.228 -172.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.2 m -86.98 -42.47 13.1 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 118.82 1.31 . . . . 0.0 109.566 179.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -40.1 -55.18 2.15 Favored 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 129.08 2.952 . . . . 0.0 117.231 -156.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.27 -48.79 43.57 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 111.074 -0.811 . . . . 0.0 111.074 -174.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 68.4 m -71.85 -34.04 68.92 Favored 'General case' 0 CA--C 1.49 -1.363 0 O-C-N 121.71 -0.876 . . . . 0.0 111.13 -176.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -59.16 -46.56 88.07 Favored 'General case' 0 C--N 1.35 0.597 0 CA-C-O 121.351 0.596 . . . . 0.0 109.422 173.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.0 m -64.45 -48.1 76.55 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 123.044 0.538 . . . . 0.0 111.031 177.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 75.5 mt -60.76 -43.6 97.8 Favored 'General case' 0 C--N 1.362 1.149 0 CA-C-O 121.846 0.831 . . . . 0.0 109.964 -177.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.8 t -56.9 -44.16 82.07 Favored 'General case' 0 N--CA 1.437 -1.092 0 C-N-CA 123.322 0.649 . . . . 0.0 111.46 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -77.35 -31.41 54.41 Favored 'General case' 0 C--N 1.353 0.735 0 C-N-CA 121.149 -0.22 . . . . 0.0 111.533 -173.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -76.75 -30.77 56.7 Favored 'General case' 0 CA--C 1.506 -0.727 0 O-C-N 121.58 -0.7 . . . . 0.0 110.71 177.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -78.24 -49.62 13.39 Favored 'General case' 0 C--N 1.359 1.013 0 CA-C-N 118.974 0.806 . . . . 0.0 109.816 177.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 131.67 47.99 0.11 Allowed Glycine 0 CA--C 1.488 -1.647 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 173.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -117.48 160.85 13.45 Favored Glycine 0 CA--C 1.484 -1.881 0 N-CA-C 104.077 -3.609 . . . . 0.0 104.077 161.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -64.68 -54.9 24.34 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 124.88 1.272 . . . . 0.0 110.621 -164.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.9 m -160.79 177.63 10.24 Favored 'General case' 0 N--CA 1.423 -1.813 1 N-CA-C 97.199 -5.111 . . . . 0.0 97.199 170.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -161.48 174.76 38.06 Favored Glycine 0 CA--C 1.474 -2.501 1 N-CA-C 101.346 -4.701 . . . . 0.0 101.346 -163.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 53.8 m80 -156.66 -153.04 0.4 Allowed 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 100.348 -3.945 . . . . 0.0 100.348 -168.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 81.6 m -147.53 177.64 9.09 Favored 'General case' 0 CA--C 1.483 -1.627 0 N-CA-C 103.762 -2.681 . . . . 0.0 103.762 -174.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 171.53 -157.14 27.37 Favored Glycine 0 N--CA 1.423 -2.215 1 N-CA-C 95.9 -6.88 . . . . 0.0 95.9 178.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -140.44 146.51 38.37 Favored 'General case' 0 CA--C 1.489 -1.385 1 N-CA-C 98.091 -4.781 . . . . 0.0 98.091 -174.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 9.7 tmtt? -115.75 97.29 6.04 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 103.144 -2.91 . . . . 0.0 103.144 174.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.4 t -70.86 120.37 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 -176.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 136.86 -37.38 1.87 Allowed Glycine 0 CA--C 1.486 -1.78 0 N-CA-C 103.949 -3.66 . . . . 0.0 103.949 -167.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 15.6 m170 -125.1 -64.71 1.07 Allowed 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 165.89 -161.22 34.8 Favored Glycine 0 N--CA 1.432 -1.626 0 N-CA-C 107.219 -2.353 . . . . 0.0 107.219 -171.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.7 tp -69.43 143.49 53.58 Favored 'General case' 0 CA--C 1.502 -0.904 0 C-N-CA 127.969 2.508 . . . . 0.0 105.725 177.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -153.05 178.3 9.86 Favored 'General case' 0 CA--C 1.488 -1.428 0 N-CA-C 103.759 -2.682 . . . . 0.0 103.759 -168.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 50.8 m -112.16 161.72 16.23 Favored 'General case' 0 CA--C 1.493 -1.25 0 N-CA-C 103.135 -2.913 . . . . 0.0 103.135 177.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.414 ' HA ' ' HA ' ' A' ' 5' ' ' TYR . 61.1 t-105 -101.83 152.18 21.2 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 104.598 -2.371 . . . . 0.0 104.598 166.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.8 m -141.4 141.17 33.77 Favored 'General case' 0 CA--C 1.491 -1.31 0 N-CA-C 104.568 -2.382 . . . . 0.0 104.568 164.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -105.67 107.9 19.13 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 102.606 -3.109 . . . . 0.0 102.606 174.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 90.06 135.4 0.03 OUTLIER 'General case' 0 N--CA 1.432 -1.365 0 C-N-CA 128.243 2.617 . . . . 0.0 106.068 -173.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -145.13 155.89 54.73 Favored Pre-proline 0 N--CA 1.426 -1.668 1 N-CA-C 96.335 -5.431 . . . . 0.0 96.335 149.166 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -70.16 165.06 32.68 Favored 'Trans proline' 0 N--CA 1.445 -1.346 0 C-N-CA 122.404 2.069 . . . . 0.0 109.139 164.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -74.7 -9.04 58.18 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 114.12 1.155 . . . . 0.0 114.12 -163.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 -84.35 -12.35 54.68 Favored 'General case' 0 CA--C 1.507 -0.696 0 O-C-N 121.397 -0.814 . . . . 0.0 110.176 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.2 t -87.29 118.39 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -87.45 147.01 20.45 Favored Glycine 0 CA--C 1.487 -1.702 0 N-CA-C 106.934 -2.467 . . . . 0.0 106.934 -178.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 46.1 pt -117.97 -153.81 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 -173.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.612 HD12 HG12 ' A' ' 13' ' ' VAL . 9.2 mm -66.77 -30.27 49.13 Favored 'Isoleucine or valine' 0 C--N 1.357 0.894 0 O-C-N 121.412 -0.805 . . . . 0.0 111.949 -165.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -127.79 153.12 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.658 1 N-CA-C 99.058 -4.423 . . . . 0.0 99.058 175.074 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -166.5 176.76 7.11 Favored 'General case' 0 N--CA 1.423 -1.791 1 N-CA-C 95.499 -5.741 . . . . 0.0 95.499 -172.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -90.73 72.6 1.89 Allowed Glycine 0 CA--C 1.491 -1.45 0 N-CA-C 104.615 -3.394 . . . . 0.0 104.615 171.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -168.89 -169.4 0.99 Allowed 'General case' 0 N--CA 1.423 -1.779 1 N-CA-C 99.632 -4.21 . . . . 0.0 99.632 -166.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 28.9 ttpp -156.35 162.73 40.05 Favored 'General case' 0 N--CA 1.426 -1.629 1 N-CA-C 96.128 -5.508 . . . . 0.0 96.128 171.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 41.6 t -68.95 139.19 55.05 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-O 121.751 0.786 . . . . 0.0 111.962 -166.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 16.7 p-80 -142.6 151.55 41.61 Favored 'General case' 0 N--CA 1.424 -1.768 1 N-CA-C 95.648 -5.686 . . . . 0.0 95.648 164.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 40.5 t 176.23 -173.38 0.09 Allowed 'General case' 0 N--CA 1.431 -1.402 1 N-CA-C 95.166 -5.865 . . . . 0.0 95.166 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.357 0.898 0 O-C-N 124.469 1.106 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 9.9 m . . . . . 0 N--CA 1.483 1.221 0 CA-C-O 122.441 1.115 . . . . 0.0 110.913 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 16.2 mtp85 -100.64 158.03 16.24 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 -174.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -130.47 128.71 41.79 Favored 'General case' 0 CA--C 1.486 -1.481 1 N-CA-C 97.124 -5.139 . . . . 0.0 97.124 168.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.82 178.31 37.73 Favored Glycine 0 CA--C 1.481 -2.037 0 N-CA-C 107.272 -2.331 . . . . 0.0 107.272 -177.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -79.64 127.95 32.8 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 104.034 -2.58 . . . . 0.0 104.034 164.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.26 11.6 tt -91.51 147.6 5.16 Favored 'Isoleucine or valine' 0 C--O 1.243 0.737 0 CA-C-N 120.487 1.494 . . . . 0.0 108.879 178.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -135.77 -128.61 0.15 Allowed 'General case' 0 N--CA 1.426 -1.663 0 C-N-CA 128.035 2.534 . . . . 0.0 104.548 172.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -139.71 152.02 67.39 Favored Pre-proline 0 N--CA 1.424 -1.743 1 N-CA-C 96.513 -5.365 . . . . 0.0 96.513 176.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -74.89 35.14 0.4 Allowed 'Trans proline' 0 CA--C 1.514 -0.504 0 CA-C-N 124.241 2.55 . . . . 0.0 117.096 -159.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 53.0 mm-40 -124.53 32.79 5.39 Favored 'General case' 0 CA--C 1.497 -1.083 0 CA-C-N 120.202 1.364 . . . . 0.0 107.635 -169.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 48.99 58.1 5.73 Favored 'General case' 0 CA--C 1.489 -1.382 0 C-N-CA 128.686 2.794 . . . . 0.0 112.196 -174.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 91.3 m -116.89 -160.26 0.76 Allowed 'General case' 0 CA--C 1.482 -1.649 0 N-CA-C 103.285 -2.857 . . . . 0.0 103.285 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -134.85 169.39 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.827 1 N-CA-C 96.059 -5.534 . . . . 0.0 96.059 170.697 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -96.62 -154.27 0.44 Allowed 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 101.711 -3.44 . . . . 0.0 101.711 163.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 33.4 m80 -137.43 172.62 12.71 Favored 'General case' 0 CA--C 1.478 -1.792 1 N-CA-C 97.457 -5.016 . . . . 0.0 97.457 166.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 29.3 t -132.11 158.39 41.77 Favored 'General case' 0 N--CA 1.422 -1.868 1 N-CA-C 97.497 -5.001 . . . . 0.0 97.497 -175.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -112.45 104.78 56.13 Favored Pre-proline 0 N--CA 1.428 -1.546 1 N-CA-C 98.232 -4.729 . . . . 0.0 98.232 168.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -51.43 98.69 0.04 OUTLIER 'Trans proline' 0 CA--C 1.51 -0.708 0 C-N-CA 123.473 2.782 . . . . 0.0 117.07 -154.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 163.21 -171.48 38.95 Favored Glycine 0 N--CA 1.423 -2.227 1 N-CA-C 96.704 -6.558 . . . . 0.0 96.704 -172.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 38.1 m -82.46 -31.12 29.56 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 118.682 1.241 . . . . 0.0 111.154 -177.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.2 m -39.59 -71.48 0.08 Allowed 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 117.006 2.224 . . . . 0.0 117.006 -151.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.44 -43.82 52.67 Favored Glycine 0 C--N 1.347 1.153 0 O-C-N 121.198 -0.939 . . . . 0.0 111.113 -173.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 35.2 m -67.24 -43.98 80.59 Favored 'General case' 0 CA--C 1.486 -1.504 0 O-C-N 122.039 -0.683 . . . . 0.0 112.1 -173.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -66.35 -35.3 80.0 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -178.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.3 m -63.18 -50.41 70.45 Favored 'General case' 0 N--CA 1.445 -0.695 0 O-C-N 121.78 -0.575 . . . . 0.0 110.023 174.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.9 mt -63.56 -40.15 96.23 Favored 'General case' 0 C--N 1.359 0.998 0 CA-C-O 122.052 0.93 . . . . 0.0 110.923 -177.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 19.5 t -57.11 -47.6 80.68 Favored 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 125.775 1.63 . . . . 0.0 110.115 177.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 50.3 mttp -74.36 -34.63 63.42 Favored 'General case' 0 C--N 1.353 0.718 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.519 -173.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -77.43 -20.78 54.02 Favored 'General case' 0 C--N 1.354 0.771 0 O-C-N 121.712 -0.617 . . . . 0.0 111.407 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.6 mmtm -76.6 -59.09 2.92 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 168.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 134.64 48.77 0.08 OUTLIER Glycine 0 CA--C 1.489 -1.548 0 N-CA-C 108.896 -1.682 . . . . 0.0 108.896 170.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -107.18 139.97 15.14 Favored Glycine 0 CA--C 1.482 -1.976 1 N-CA-C 101.549 -4.62 . . . . 0.0 101.549 164.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.6 p -80.02 -49.5 11.72 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-N 118.587 1.193 . . . . 0.0 108.528 -170.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.3 m -103.41 139.84 38.26 Favored 'General case' 0 CA--C 1.487 -1.478 0 N-CA-C 102.101 -3.296 . . . . 0.0 102.101 -172.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -146.48 142.65 10.65 Favored Glycine 0 CA--C 1.473 -2.58 1 N-CA-C 101.215 -4.754 . . . . 0.0 101.215 -168.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 66.4 m80 -155.86 -157.43 0.72 Allowed 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 100.286 -3.968 . . . . 0.0 100.286 -173.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 85.5 m -143.73 177.36 8.56 Favored 'General case' 0 CA--C 1.476 -1.893 1 N-CA-C 99.099 -4.408 . . . . 0.0 99.099 177.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -179.27 -175.99 46.63 Favored Glycine 0 N--CA 1.419 -2.476 1 N-CA-C 98.092 -6.003 . . . . 0.0 98.092 177.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -116.68 139.44 50.54 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 102.048 -3.316 . . . . 0.0 102.048 177.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.9 94.27 4.96 Favored 'General case' 0 CA--C 1.498 -1.038 0 N-CA-C 103.506 -2.776 . . . . 0.0 103.506 178.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.7 t -70.76 116.82 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 -174.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 136.83 -39.59 1.62 Allowed Glycine 0 CA--C 1.488 -1.642 0 N-CA-C 105.929 -2.868 . . . . 0.0 105.929 -169.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 27.0 m170 -119.25 -66.85 1.03 Allowed 'General case' 0 CA--C 1.499 -0.992 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 178.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 167.04 -159.89 33.41 Favored Glycine 0 N--CA 1.432 -1.631 0 N-CA-C 106.262 -2.735 . . . . 0.0 106.262 -173.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 57.8 tp -68.21 142.28 55.71 Favored 'General case' 0 C--N 1.351 0.665 0 C-N-CA 126.779 2.032 . . . . 0.0 106.175 175.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -150.19 -178.04 6.28 Favored 'General case' 0 CA--C 1.485 -1.528 0 N-CA-C 104.046 -2.575 . . . . 0.0 104.046 -167.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 67.3 m -107.02 163.63 12.82 Favored 'General case' 0 CA--C 1.492 -1.287 0 N-CA-C 102.689 -3.078 . . . . 0.0 102.689 176.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 14.6 t-105 -128.14 146.67 50.64 Favored 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 104.435 -2.432 . . . . 0.0 104.435 177.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 61.2 m -140.43 151.49 44.93 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 174.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -118.95 143.44 47.03 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 103.806 -2.665 . . . . 0.0 103.806 166.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 77.02 54.94 0.04 OUTLIER 'General case' 0 CA--C 1.497 -1.075 0 C-N-CA 127.018 2.127 . . . . 0.0 110.883 171.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 33.5 mt -97.77 135.67 21.47 Favored Pre-proline 0 CA--C 1.5 -0.948 0 N-CA-C 105.12 -2.178 . . . . 0.0 105.12 173.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -74.46 167.92 26.01 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 CA-C-N 122.628 1.974 . . . . 0.0 111.103 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -61.28 -19.86 62.21 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 126.561 1.944 . . . . 0.0 114.686 -170.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.4 p-10 -86.54 -2.2 58.28 Favored 'General case' 0 CA--C 1.505 -0.767 0 C-N-CA 123.722 0.809 . . . . 0.0 110.628 -176.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.5 t -91.09 163.32 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 N-CA-C 104.078 -2.564 . . . . 0.0 104.078 177.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -145.84 154.53 26.0 Favored Glycine 0 CA--C 1.48 -2.132 1 N-CA-C 96.668 -6.573 . . . . 0.0 96.668 179.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 16.1 pt -139.66 -126.65 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 N-CA-C 104.885 -2.265 . . . . 0.0 104.885 -158.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.0 mm -74.5 62.28 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.582 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 169.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -155.13 142.4 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.682 0 N-CA-C 103.008 -2.96 . . . . 0.0 103.008 -167.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.482 ' HG3' ' H ' ' A' ' 62' ' ' GLY . 11.0 tp10 150.31 -166.22 0.0 OUTLIER 'General case' 0 CA--C 1.5 -0.95 2 N-CA-C 95.629 -5.693 . . . . 0.0 95.629 175.666 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.482 ' H ' ' HG3' ' A' ' 61' ' ' GLU . . . -80.11 70.31 2.96 Favored Glycine 0 C--N 1.347 1.171 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 -177.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 69.54 -47.44 0.6 Allowed 'General case' 0 C--N 1.352 0.703 0 C-N-CA 128.638 2.775 . . . . 0.0 115.014 167.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 15.4 tptm -98.25 151.64 20.26 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -164.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 38.9 t -87.79 145.11 26.26 Favored 'General case' 0 CA--C 1.492 -1.28 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 179.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -169.26 -172.08 1.42 Allowed 'General case' 0 N--CA 1.421 -1.888 1 N-CA-C 97.862 -4.866 . . . . 0.0 97.862 179.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 36.0 m -172.84 171.99 4.19 Favored 'General case' 0 N--CA 1.425 -1.712 1 N-CA-C 95.937 -5.579 . . . . 0.0 95.937 173.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.359 0.981 0 O-C-N 124.294 0.996 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 18.6 m . . . . . 0 N--CA 1.486 1.325 0 CA-C-O 121.898 0.856 . . . . 0.0 110.649 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 22.6 mtp85 -121.71 154.81 36.38 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 104.669 -2.345 . . . . 0.0 104.669 -172.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -137.48 132.71 33.7 Favored 'General case' 0 CA--C 1.486 -1.481 1 N-CA-C 97.273 -5.084 . . . . 0.0 97.273 166.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.29 -166.29 20.79 Favored Glycine 0 CA--C 1.477 -2.34 1 N-CA-C 101.948 -4.461 . . . . 0.0 101.948 172.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -74.81 142.14 44.25 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 103.872 -2.64 . . . . 0.0 103.872 161.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.1 tt -90.24 136.26 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.125 0 N-CA-C 105.018 -2.215 . . . . 0.0 105.018 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.657 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -109.59 -149.94 0.45 Allowed 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 127.385 2.274 . . . . 0.0 106.255 179.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.415 ' H ' ' HB1' ' A' ' 7' ' ' ALA . 58.6 mt-30 -115.13 142.87 29.22 Favored Pre-proline 0 N--CA 1.426 -1.669 1 N-CA-C 97.454 -5.017 . . . . 0.0 97.454 171.108 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -75.58 29.81 0.38 Allowed 'Trans proline' 0 CA--C 1.503 -1.042 0 N-CA-C 117.764 2.179 . . . . 0.0 117.764 -141.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -120.35 -78.74 0.59 Allowed 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 101.733 -3.432 . . . . 0.0 101.733 -178.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 53.6 t-20 -160.92 142.72 12.17 Favored 'General case' 0 N--CA 1.423 -1.803 1 N-CA-C 93.932 -6.322 . . . . 0.0 93.932 166.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 65' ' ' CYS . 19.0 m 173.42 -157.09 0.01 OUTLIER 'General case' 0 CA--C 1.496 -1.122 1 N-CA-C 98.743 -4.54 . . . . 0.0 98.743 172.613 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.609 HG12 HD12 ' A' ' 59' ' ' ILE . 0.4 OUTLIER -126.8 167.68 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.575 1 N-CA-C 98.372 -4.677 . . . . 0.0 98.372 158.956 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -87.04 -162.7 0.82 Allowed 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 103.126 -2.916 . . . . 0.0 103.126 163.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 47.4 m80 -143.16 168.62 19.32 Favored 'General case' 0 N--CA 1.417 -2.114 1 N-CA-C 94.198 -6.223 . . . . 0.0 94.198 165.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.4 t -160.45 -151.01 0.23 Allowed 'General case' 0 N--CA 1.418 -2.037 1 N-CA-C 95.894 -5.595 . . . . 0.0 95.894 -176.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -148.44 147.77 26.5 Favored Pre-proline 0 N--CA 1.409 -2.493 1 N-CA-C 95.198 -5.853 . . . . 0.0 95.198 -167.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -71.23 73.8 2.04 Favored 'Trans proline' 0 C--N 1.32 -0.939 0 CA-C-N 125.383 2.958 . . . . 0.0 114.134 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -172.82 162.74 34.4 Favored Glycine 0 N--CA 1.425 -2.071 1 N-CA-C 98.704 -5.759 . . . . 0.0 98.704 175.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.2 m -81.65 -7.88 59.64 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 118.752 1.276 . . . . 0.0 111.775 -172.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -53.55 -28.38 31.41 Favored 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 128.448 2.699 . . . . 0.0 115.417 -169.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -87.06 -73.48 1.28 Allowed Glycine 0 C--N 1.348 1.211 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 176.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 75.6 m -79.99 -12.57 59.7 Favored 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 -162.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -63.17 -44.97 93.96 Favored 'General case' 0 C--N 1.358 0.972 0 CA-C-N 121.65 2.023 . . . . 0.0 108.38 173.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -57.67 -51.22 70.4 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 127.1 2.16 . . . . 0.0 110.794 174.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 84.6 mt -64.85 -40.1 94.61 Favored 'General case' 0 CA--C 1.497 -1.077 0 C-N-CA 124.088 0.955 . . . . 0.0 111.133 -177.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.7 t -56.77 -44.24 81.64 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 124.556 1.143 . . . . 0.0 109.847 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 52.0 mttp -71.15 -34.93 71.45 Favored 'General case' 0 N--CA 1.443 -0.801 0 O-C-N 122.151 -0.343 . . . . 0.0 111.54 -174.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -78.58 -26.67 45.55 Favored 'General case' 0 C--N 1.355 0.821 0 O-C-N 121.543 -0.723 . . . . 0.0 112.359 177.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.4 mmtm -80.54 -26.07 38.26 Favored 'General case' 0 C--N 1.357 0.92 0 CA-C-N 118.911 0.778 . . . . 0.0 109.843 176.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.53 37.64 1.88 Allowed Glycine 0 CA--C 1.486 -1.765 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 163.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -108.27 143.86 16.16 Favored Glycine 0 CA--C 1.485 -1.84 0 N-CA-C 103.226 -3.95 . . . . 0.0 103.226 168.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.4 m -73.5 -29.82 62.73 Favored 'General case' 0 N--CA 1.437 -1.084 0 O-C-N 122.074 -0.662 . . . . 0.0 110.473 -167.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.1 m -159.74 161.6 34.77 Favored 'General case' 0 CA--C 1.481 -1.704 0 N-CA-C 102.734 -3.062 . . . . 0.0 102.734 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -171.38 175.25 44.97 Favored Glycine 0 N--CA 1.419 -2.441 1 N-CA-C 99.944 -5.262 . . . . 0.0 99.944 -172.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 44.2 p-80 -169.67 -171.71 1.27 Allowed 'General case' 0 N--CA 1.431 -1.418 1 N-CA-C 98.224 -4.732 . . . . 0.0 98.224 -174.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 73.8 m -127.41 153.07 46.71 Favored 'General case' 0 CA--C 1.486 -1.498 0 N-CA-C 104.433 -2.432 . . . . 0.0 104.433 -173.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -172.18 167.17 40.1 Favored Glycine 0 CA--C 1.477 -2.316 1 N-CA-C 100.004 -5.238 . . . . 0.0 100.004 -173.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -98.67 161.18 13.8 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 104.741 -2.318 . . . . 0.0 104.741 -172.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.99 173.36 13.44 Favored 'General case' 0 N--CA 1.428 -1.55 1 N-CA-C 96.009 -5.552 . . . . 0.0 96.009 163.5 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -132.34 155.81 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.548 1 N-CA-C 97.607 -4.96 . . . . 0.0 97.607 177.928 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 130.34 -52.18 0.84 Allowed Glycine 0 CA--C 1.485 -1.789 1 N-CA-C 101.535 -4.626 . . . . 0.0 101.535 -170.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 66.9 m170 -117.48 -73.88 0.63 Allowed 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 104.318 -2.475 . . . . 0.0 104.318 168.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 164.45 -145.67 10.58 Favored Glycine 0 CA--C 1.472 -2.63 1 N-CA-C 100.876 -4.89 . . . . 0.0 100.876 178.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 33.2 tp -62.97 137.77 58.37 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 125.304 1.442 . . . . 0.0 107.388 -173.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -152.04 -171.12 3.84 Favored 'General case' 0 CA--C 1.479 -1.764 1 N-CA-C 97.556 -4.979 . . . . 0.0 97.556 -160.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 3.0 p -147.11 -174.15 4.43 Favored 'General case' 0 CA--C 1.478 -1.824 0 C-N-CA 115.734 -2.386 . . . . 0.0 104.616 169.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 43.7 t-105 -127.73 157.1 41.26 Favored 'General case' 0 CA--C 1.505 -0.785 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 -167.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 6.0 m -150.15 152.31 34.5 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 168.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -118.94 140.1 50.56 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 104.478 -2.416 . . . . 0.0 104.478 168.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 77.36 47.67 0.06 Allowed 'General case' 0 CA--C 1.496 -1.108 0 C-N-CA 127.451 2.301 . . . . 0.0 111.378 166.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 38.4 mt -91.48 137.14 26.07 Favored Pre-proline 0 CA--C 1.503 -0.862 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 178.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -77.94 174.71 12.13 Favored 'Trans proline' 0 N--CA 1.447 -1.217 0 C-N-CA 122.274 1.983 . . . . 0.0 111.494 -179.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -69.49 -9.05 52.15 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 125.254 1.421 . . . . 0.0 114.203 -171.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -92.73 -0.15 57.32 Favored 'General case' 0 CA--C 1.501 -0.934 0 O-C-N 121.667 -0.646 . . . . 0.0 110.008 -179.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.408 HG12 ' H ' ' A' ' 57' ' ' GLY . 1.5 t -99.05 179.13 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 N-CA-C 102.49 -3.152 . . . . 0.0 102.49 174.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.408 ' H ' HG12 ' A' ' 56' ' ' VAL . . . -152.12 159.4 28.33 Favored Glycine 0 CA--C 1.479 -2.216 1 N-CA-C 97.258 -6.337 . . . . 0.0 97.258 -178.528 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 18.2 pt -146.81 -156.46 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.271 0 N-CA-C 103.296 -2.853 . . . . 0.0 103.296 -165.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.657 HD13 ' HB2' ' A' ' 7' ' ' ALA . 1.1 mm -73.02 129.86 35.9 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.094 0 N-CA-C 104.839 -2.282 . . . . 0.0 104.839 176.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.9 t -106.62 108.86 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.653 0 N-CA-C 100.687 -3.82 . . . . 0.0 100.687 172.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 64.08 -110.51 0.27 Allowed 'General case' 0 C--N 1.359 0.992 0 C-N-CA 125.374 1.47 . . . . 0.0 107.906 -171.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -169.53 38.9 0.2 Allowed Glycine 0 CA--C 1.48 -2.139 1 N-CA-C 100.453 -5.059 . . . . 0.0 100.453 173.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -101.18 -71.4 0.71 Allowed 'General case' 0 CA--C 1.495 -1.164 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -163.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 6.7 tppt? -105.3 169.67 8.32 Favored 'General case' 0 CA--C 1.502 -0.871 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 -162.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 35.7 t -144.85 137.58 26.42 Favored 'General case' 0 N--CA 1.422 -1.866 1 N-CA-C 95.013 -5.921 . . . . 0.0 95.013 170.897 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -165.68 173.02 11.2 Favored 'General case' 0 CA--C 1.485 -1.54 0 N-CA-C 100.413 -3.921 . . . . 0.0 100.413 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 38.7 m -167.66 173.93 8.11 Favored 'General case' 0 N--CA 1.421 -1.906 1 N-CA-C 96.271 -5.455 . . . . 0.0 96.271 178.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.358 0.939 0 O-C-N 124.111 0.882 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 26.7 m . . . . . 0 N--CA 1.483 1.184 0 CA-C-O 121.578 0.704 . . . . 0.0 109.798 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -100.31 156.2 17.37 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 104.136 -2.542 . . . . 0.0 104.136 166.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -123.99 122.04 36.87 Favored 'General case' 0 CA--C 1.487 -1.468 1 N-CA-C 95.705 -5.665 . . . . 0.0 95.705 164.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.55 -175.7 32.85 Favored Glycine 0 CA--C 1.477 -2.324 0 N-CA-C 105.01 -3.236 . . . . 0.0 105.01 -171.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -88.3 135.71 33.32 Favored 'General case' 0 CA--C 1.491 -1.319 0 N-CA-C 103.524 -2.769 . . . . 0.0 103.524 170.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 17.0 tt -90.25 139.34 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 N-CA-C 106.854 -1.535 . . . . 0.0 106.854 -177.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.506 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -111.16 -161.44 0.75 Allowed 'General case' 0 N--CA 1.426 -1.632 0 C-N-CA 127.536 2.334 . . . . 0.0 106.412 178.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -107.02 146.36 33.0 Favored Pre-proline 0 N--CA 1.427 -1.583 1 N-CA-C 97.985 -4.82 . . . . 0.0 97.985 164.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -80.22 -3.47 12.64 Favored 'Trans proline' 0 CA--C 1.5 -1.225 0 C-N-CA 121.183 1.256 . . . . 0.0 114.125 -135.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -91.28 -46.59 7.97 Favored 'General case' 0 CA--C 1.5 -0.98 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 49.8 t-20 171.1 142.53 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.465 1 N-CA-C 97.962 -4.829 . . . . 0.0 97.962 167.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 171.31 -157.2 0.01 OUTLIER 'General case' 0 CA--C 1.488 -1.419 0 C-N-CA 126.986 2.114 . . . . 0.0 105.587 178.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.461 HG12 HD12 ' A' ' 59' ' ' ILE . 1.5 m -125.83 155.81 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.775 1 N-CA-C 96.772 -5.27 . . . . 0.0 96.772 155.293 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -98.91 141.78 31.24 Favored 'General case' 0 CA--C 1.482 -1.636 1 N-CA-C 97.506 -4.998 . . . . 0.0 97.506 165.098 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -84.31 178.79 7.63 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 105.33 -2.1 . . . . 0.0 105.33 179.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 36.4 t -146.79 163.28 36.52 Favored 'General case' 0 N--CA 1.419 -1.979 1 N-CA-C 96.76 -5.274 . . . . 0.0 96.76 -173.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -126.27 132.57 24.36 Favored Pre-proline 0 N--CA 1.417 -2.11 1 N-CA-C 98.383 -4.673 . . . . 0.0 98.383 -173.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -65.53 -6.64 14.1 Favored 'Trans proline' 0 CA--C 1.514 -0.479 0 CA-C-N 123.576 2.313 . . . . 0.0 113.518 177.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -95.55 89.35 1.15 Allowed Glycine 0 C--N 1.352 1.426 1 N-CA-C 101.216 -4.754 . . . . 0.0 101.216 158.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.9 m -60.04 -15.56 23.78 Favored 'General case' 0 CA--C 1.498 -1.057 0 C-N-CA 127.404 2.281 . . . . 0.0 115.868 -159.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -44.41 -45.0 8.76 Favored 'General case' 0 N--CA 1.436 -1.155 0 C-N-CA 128.618 2.767 . . . . 0.0 114.087 -175.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.73 -50.28 65.51 Favored Glycine 0 C--N 1.355 1.587 0 N-CA-C 111.972 -0.451 . . . . 0.0 111.972 -175.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 19.5 t -76.14 -24.23 54.86 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -177.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -61.37 -48.24 82.19 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 175.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -60.57 -40.06 90.26 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 172.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 96.1 mt -64.96 -44.12 90.44 Favored 'General case' 0 C--N 1.357 0.928 0 CA-C-N 119.321 0.964 . . . . 0.0 110.551 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 9.1 t -58.23 -46.85 85.17 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 125.257 1.423 . . . . 0.0 109.632 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -67.75 -37.18 81.79 Favored 'General case' 0 C--N 1.354 0.766 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -177.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -77.11 -22.76 52.22 Favored 'General case' 0 C--N 1.354 0.794 0 O-C-N 121.192 -0.942 . . . . 0.0 111.397 -176.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -85.99 -34.29 20.86 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 175.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 114.89 44.03 0.71 Allowed Glycine 0 CA--C 1.482 -1.978 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 164.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.13 149.08 16.59 Favored Glycine 0 CA--C 1.487 -1.715 1 N-CA-C 102.322 -4.311 . . . . 0.0 102.322 163.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.1 m -70.61 -47.45 60.03 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 122.265 1.031 . . . . 0.0 110.203 -165.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 33.8 m -160.82 -174.0 4.2 Favored 'General case' 0 N--CA 1.422 -1.849 1 N-CA-C 97.802 -4.888 . . . . 0.0 97.802 167.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -175.92 -177.96 45.35 Favored Glycine 0 N--CA 1.418 -2.543 1 N-CA-C 99.329 -5.508 . . . . 0.0 99.329 -169.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 68.4 m80 -155.96 176.98 11.94 Favored 'General case' 0 N--CA 1.425 -1.71 1 N-CA-C 99.421 -4.288 . . . . 0.0 99.421 -172.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 68.0 m -88.38 164.31 15.59 Favored 'General case' 0 CA--C 1.49 -1.361 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -179.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -167.68 -169.84 31.71 Favored Glycine 0 N--CA 1.414 -2.815 1 N-CA-C 100.45 -5.06 . . . . 0.0 100.45 176.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -152.61 156.65 39.69 Favored 'General case' 0 N--CA 1.417 -2.09 1 N-CA-C 94.132 -6.247 . . . . 0.0 94.132 -176.816 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 16.8 ptmt -136.86 17.43 3.05 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 104.248 -2.501 . . . . 0.0 104.248 163.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . 0.276 1.8 t 50.01 -138.24 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.358 0.974 0 C-N-CA 126.764 2.026 . . . . 0.0 107.534 -160.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.43 -72.35 2.17 Favored Glycine 0 CA--C 1.495 -1.217 0 C-N-CA 123.787 0.708 . . . . 0.0 111.652 163.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 9.5 m170 -98.79 -64.41 1.04 Allowed 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 105.127 -2.175 . . . . 0.0 105.127 176.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 174.64 -169.23 42.16 Favored Glycine 0 CA--C 1.473 -2.531 1 N-CA-C 100.478 -5.049 . . . . 0.0 100.478 -169.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.2 tt -70.2 132.27 45.51 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 105.504 -2.035 . . . . 0.0 105.504 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.404 ' HA ' ' HB ' ' A' ' 13' ' ' VAL . . . -133.63 165.85 23.96 Favored 'General case' 0 CA--C 1.474 -1.954 0 N-CA-C 101.273 -3.603 . . . . 0.0 101.273 -159.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 49.7 t -120.2 151.61 38.88 Favored 'General case' 0 CA--C 1.488 -1.422 0 N-CA-C 102.482 -3.155 . . . . 0.0 102.482 -174.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 62.1 t-105 -97.95 149.72 22.11 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 104.108 -2.553 . . . . 0.0 104.108 175.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.8 m -141.35 143.95 34.28 Favored 'General case' 0 CA--C 1.481 -1.688 0 N-CA-C 100.949 -3.723 . . . . 0.0 100.949 170.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -108.55 124.6 50.73 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 104.14 -2.541 . . . . 0.0 104.14 179.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 76.37 73.59 0.08 Allowed 'General case' 0 CA--C 1.498 -1.025 0 C-N-CA 127.093 2.157 . . . . 0.0 110.939 171.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 35.9 mt -103.53 131.47 22.01 Favored Pre-proline 0 CA--C 1.498 -1.041 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 174.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -72.05 174.09 11.85 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 CA-C-N 122.515 1.934 . . . . 0.0 110.28 176.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -69.15 -8.35 44.71 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 -172.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 17.7 p-10 -81.91 -10.69 59.21 Favored 'General case' 0 CA--C 1.505 -0.786 0 O-C-N 121.093 -1.004 . . . . 0.0 109.438 -177.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.8 t -100.24 132.52 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.374 0 N-CA-C 104.538 -2.393 . . . . 0.0 104.538 -176.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -103.77 151.05 17.65 Favored Glycine 0 CA--C 1.485 -1.829 0 N-CA-C 103.099 -4.0 . . . . 0.0 103.099 176.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 24.7 pt -136.14 -152.96 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 N-CA-C 104.823 -2.288 . . . . 0.0 104.823 -164.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.506 HD13 ' HB2' ' A' ' 7' ' ' ALA . 3.8 mm -67.98 133.46 31.63 Favored 'Isoleucine or valine' 0 C--N 1.358 0.956 0 N-CA-C 107.497 -1.298 . . . . 0.0 107.497 -178.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.2 t -129.72 150.99 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.663 1 N-CA-C 96.444 -5.391 . . . . 0.0 96.444 169.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -155.19 152.94 29.98 Favored 'General case' 0 CA--C 1.482 -1.67 1 N-CA-C 97.172 -5.122 . . . . 0.0 97.172 178.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 129.9 -44.95 1.17 Allowed Glycine 0 CA--C 1.489 -1.571 1 N-CA-C 100.26 -5.136 . . . . 0.0 100.26 -159.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -106.31 -138.36 0.37 Allowed 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 101.477 -3.527 . . . . 0.0 101.477 159.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 18.0 ttmm -166.14 -163.04 0.58 Allowed 'General case' 0 N--CA 1.423 -1.795 1 N-CA-C 96.366 -5.42 . . . . 0.0 96.366 -179.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 52.4 t -57.09 140.91 47.84 Favored 'General case' 0 CA--C 1.501 -0.913 0 C-N-CA 126.478 1.911 . . . . 0.0 112.161 -170.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 9.1 p-80 -145.48 25.03 1.37 Allowed 'General case' 0 CA--C 1.499 -1.008 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 169.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.5 m -82.68 75.73 9.57 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 172.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.363 1.161 0 CA-C-N 116.209 -0.45 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 33.2 m . . . . . 0 N--CA 1.485 1.303 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -107.52 159.2 16.61 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 170.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -130.37 120.72 24.73 Favored 'General case' 0 CA--C 1.49 -1.333 1 N-CA-C 96.218 -5.475 . . . . 0.0 96.218 161.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.02 -175.06 32.64 Favored Glycine 0 CA--C 1.477 -2.325 0 N-CA-C 105.456 -3.058 . . . . 0.0 105.456 -176.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 48' ' ' TRP . 46.6 m-85 -79.53 136.17 36.82 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 104.121 -2.548 . . . . 0.0 104.121 165.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 14.4 tt -90.82 146.73 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 N-CA-C 105.663 -1.977 . . . . 0.0 105.663 178.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.701 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -131.38 -178.06 4.68 Favored 'General case' 0 N--CA 1.414 -2.273 0 N-CA-C 105.165 -2.161 . . . . 0.0 105.165 -178.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -86.6 149.05 47.89 Favored Pre-proline 0 N--CA 1.435 -1.208 0 N-CA-C 103.225 -2.88 . . . . 0.0 103.225 159.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_exo -71.48 0.56 6.69 Favored 'Trans proline' 0 CA--C 1.504 -0.994 0 CA-C-N 123.222 2.186 . . . . 0.0 115.691 -154.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.7 mp0 -94.44 19.19 9.97 Favored 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 126.039 1.736 . . . . 0.0 109.227 -170.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 67.2 t30 66.25 61.54 0.6 Allowed 'General case' 0 CA--C 1.497 -1.083 0 C-N-CA 127.543 2.337 . . . . 0.0 108.803 -178.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 85.4 m -122.13 -137.58 0.31 Allowed 'General case' 0 CA--C 1.481 -1.699 0 N-CA-C 103.307 -2.849 . . . . 0.0 103.307 -178.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -136.56 173.24 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.923 1 N-CA-C 99.855 -4.128 . . . . 0.0 99.855 164.279 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -124.59 138.82 54.29 Favored 'General case' 0 N--CA 1.414 -2.268 1 N-CA-C 93.555 -6.461 . . . . 0.0 93.555 174.26 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 54.6 m80 -87.26 -178.32 6.18 Favored 'General case' 0 CA--C 1.492 -1.268 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 -173.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.2 t -153.43 173.37 15.76 Favored 'General case' 0 N--CA 1.412 -2.341 1 N-CA-C 95.361 -5.792 . . . . 0.0 95.361 -168.014 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -140.52 142.15 28.04 Favored Pre-proline 0 N--CA 1.409 -2.501 1 N-CA-C 95.352 -5.796 . . . . 0.0 95.352 -177.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -75.06 64.81 6.12 Favored 'Trans proline' 0 C--N 1.326 -0.613 0 C-N-CA 123.698 2.932 . . . . 0.0 109.369 172.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 156.99 60.82 0.01 OUTLIER Glycine 0 CA--C 1.482 -1.988 1 N-CA-C 97.82 -6.112 . . . . 0.0 97.82 -170.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 m -84.09 46.34 1.19 Allowed 'General case' 0 N--CA 1.436 -1.16 0 C-N-CA 124.994 1.318 . . . . 0.0 113.403 -154.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.9 p -70.5 -38.88 74.39 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 124.63 1.172 . . . . 0.0 108.951 -178.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.94 -37.1 92.92 Favored Glycine 0 C--N 1.351 1.379 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 177.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 38.7 t -72.75 -31.04 64.64 Favored 'General case' 0 C--N 1.358 0.952 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -57.23 -44.89 84.21 Favored 'General case' 0 C--N 1.354 0.764 0 CA-C-N 119.827 1.194 . . . . 0.0 110.267 178.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -58.2 -48.1 81.39 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 171.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 95.9 mt -65.64 -41.09 93.0 Favored 'General case' 0 C--N 1.359 0.991 0 CA-C-O 122.651 1.215 . . . . 0.0 110.813 -176.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 9.0 t -62.99 -46.07 89.4 Favored 'General case' 0 CA--C 1.495 -1.148 0 C-N-CA 125.301 1.44 . . . . 0.0 108.871 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.7 mmtm -65.29 -43.71 90.31 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-O 119.327 -0.368 . . . . 0.0 111.423 -178.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 25.8 pt-20 -72.3 -19.05 61.73 Favored 'General case' 0 C--N 1.354 0.8 0 CA-C-N 118.76 0.709 . . . . 0.0 112.351 -174.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -88.45 -17.69 29.87 Favored 'General case' 0 CA--C 1.506 -0.731 0 C-N-CA 123.244 0.618 . . . . 0.0 110.199 175.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.88 27.06 5.56 Favored Glycine 0 CA--C 1.489 -1.553 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 169.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -95.69 123.08 7.53 Favored Glycine 0 CA--C 1.49 -1.499 0 N-CA-C 105.467 -3.053 . . . . 0.0 105.467 174.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.8 p -97.28 -4.64 38.38 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -167.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.8 p -159.11 169.94 23.11 Favored 'General case' 0 N--CA 1.427 -1.576 1 N-CA-C 97.859 -4.867 . . . . 0.0 97.859 172.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -176.09 179.65 47.07 Favored Glycine 0 CA--C 1.474 -2.498 1 N-CA-C 102.007 -4.437 . . . . 0.0 102.007 -172.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -154.12 -161.22 1.2 Allowed 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 100.821 -3.77 . . . . 0.0 100.821 -174.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 12.5 t -147.87 161.88 40.39 Favored 'General case' 0 N--CA 1.431 -1.396 1 N-CA-C 98.994 -4.447 . . . . 0.0 98.994 -172.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 170.03 -160.23 33.07 Favored Glycine 0 N--CA 1.428 -1.858 1 N-CA-C 102.285 -4.326 . . . . 0.0 102.285 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -134.53 143.13 47.25 Favored 'General case' 0 N--CA 1.433 -1.3 1 N-CA-C 99.482 -4.266 . . . . 0.0 99.482 -176.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.47 105.2 11.85 Favored 'General case' 0 CA--C 1.491 -1.322 0 N-CA-C 101.533 -3.506 . . . . 0.0 101.533 174.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.406 HG23 ' H ' ' A' ' 41' ' ' VAL . 3.5 t -41.64 -71.59 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.496 -1.109 0 C-N-CA 127.114 2.165 . . . . 0.0 115.136 -163.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -77.25 53.03 3.45 Favored Glycine 0 CA--C 1.501 -0.785 0 C-N-CA 126.413 1.958 . . . . 0.0 111.485 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 41.9 m-70 -167.59 -60.52 0.03 OUTLIER 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 105.093 -2.188 . . . . 0.0 105.093 171.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 150.46 -154.05 25.41 Favored Glycine 0 C--N 1.352 1.463 0 N-CA-C 108.397 -1.881 . . . . 0.0 108.397 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 63.2 tp -71.91 125.85 28.25 Favored 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 178.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -131.5 172.46 12.19 Favored 'General case' 0 CA--C 1.476 -1.867 0 N-CA-C 103.684 -2.71 . . . . 0.0 103.684 -163.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 38.6 t -125.68 167.91 14.48 Favored 'General case' 0 CA--C 1.486 -1.515 0 N-CA-C 101.508 -3.516 . . . . 0.0 101.508 176.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.4 ' HA ' ' HA ' ' A' ' 5' ' ' TYR . 11.0 t-105 -124.56 147.03 48.69 Favored 'General case' 0 CA--C 1.484 -1.572 0 N-CA-C 101.542 -3.503 . . . . 0.0 101.542 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 22.0 m -139.5 148.72 43.04 Favored 'General case' 0 CA--C 1.486 -1.506 0 N-CA-C 100.516 -3.883 . . . . 0.0 100.516 176.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -122.59 136.56 54.91 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 102.703 -3.073 . . . . 0.0 102.703 -174.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 71.16 49.76 0.32 Allowed 'General case' 0 CA--C 1.499 -1.006 0 C-N-CA 127.313 2.245 . . . . 0.0 110.928 176.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 20.0 mt -88.43 135.1 33.12 Favored Pre-proline 0 CA--C 1.498 -1.047 0 N-CA-C 105.344 -2.095 . . . . 0.0 105.344 177.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -73.15 170.59 19.48 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 122.241 1.961 . . . . 0.0 110.315 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -77.36 -3.94 42.64 Favored 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 -164.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -92.96 1.8 57.12 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 123.944 0.898 . . . . 0.0 109.885 -178.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.5 t -102.61 137.2 31.54 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.146 0 N-CA-C 103.386 -2.82 . . . . 0.0 103.386 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -108.14 144.52 16.2 Favored Glycine 0 CA--C 1.481 -2.091 0 N-CA-C 103.376 -3.889 . . . . 0.0 103.376 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 27.3 pt -139.18 -147.46 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.379 0 N-CA-C 103.529 -2.767 . . . . 0.0 103.529 -166.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.701 HD13 ' HB2' ' A' ' 7' ' ' ALA . 15.8 mm -69.73 121.11 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 175.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -108.65 -21.88 5.32 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.101 0 C-N-CA 124.554 1.141 . . . . 0.0 109.171 -164.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.401 ' HG3' ' H ' ' A' ' 62' ' ' GLY . 36.3 tp10 173.71 -167.05 0.03 OUTLIER 'General case' 0 N--CA 1.433 -1.32 1 N-CA-C 95.393 -5.78 . . . . 0.0 95.393 178.127 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.401 ' H ' ' HG3' ' A' ' 61' ' ' GLU . . . -125.06 121.15 4.2 Favored Glycine 0 CA--C 1.479 -2.194 1 N-CA-C 94.824 -7.311 . . . . 0.0 94.824 162.826 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -163.72 -61.53 0.04 OUTLIER 'General case' 0 CA--C 1.487 -1.477 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 -164.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -153.4 158.66 41.8 Favored 'General case' 0 N--CA 1.427 -1.621 1 N-CA-C 98.916 -4.475 . . . . 0.0 98.916 -173.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 1.2 t -145.62 154.92 42.66 Favored 'General case' 0 N--CA 1.43 -1.427 1 N-CA-C 94.718 -6.03 . . . . 0.0 94.718 177.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 38.0 p-80 -157.84 177.91 10.82 Favored 'General case' 0 N--CA 1.429 -1.509 1 N-CA-C 99.87 -4.122 . . . . 0.0 99.87 175.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 30.3 m -172.94 175.78 3.21 Favored 'General case' 0 N--CA 1.426 -1.637 1 N-CA-C 96.166 -5.494 . . . . 0.0 96.166 177.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.358 0.948 0 O-C-N 124.405 1.066 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 27.5 m . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 121.11 0.481 . . . . 0.0 110.038 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.31 173.02 9.11 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 106.163 -1.792 . . . . 0.0 106.163 175.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -134.53 140.97 46.54 Favored 'General case' 0 N--CA 1.431 -1.398 1 N-CA-C 95.4 -5.778 . . . . 0.0 95.4 164.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.65 -175.77 33.03 Favored Glycine 0 CA--C 1.475 -2.42 1 N-CA-C 101.56 -4.616 . . . . 0.0 101.56 176.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 48' ' ' TRP . 24.4 m-85 -82.95 136.8 34.43 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 101.16 -3.644 . . . . 0.0 101.16 158.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.414 ' HA ' HG22 ' A' ' 58' ' ' ILE . 13.5 tt -87.29 132.98 31.29 Favored 'Isoleucine or valine' 0 C--O 1.252 1.19 0 N-CA-C 105.612 -1.995 . . . . 0.0 105.612 -174.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.496 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -107.56 -179.68 3.98 Favored 'General case' 0 C--N 1.366 1.314 0 O-C-N 127.691 3.119 . . . . 0.0 108.702 175.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -95.37 135.98 22.87 Favored Pre-proline 0 N--CA 1.433 -1.307 0 N-CA-C 100.508 -3.886 . . . . 0.0 100.508 167.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -78.15 60.42 7.39 Favored 'Trans proline' 0 CA--C 1.514 -0.519 0 C-N-CA 123.836 3.024 . . . . 0.0 112.49 -163.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -118.13 -83.28 0.64 Allowed 'General case' 0 N--CA 1.422 -1.827 1 N-CA-C 96.686 -5.302 . . . . 0.0 96.686 159.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 19.8 t30 -166.17 143.48 5.3 Favored 'General case' 0 N--CA 1.419 -1.976 1 N-CA-C 92.616 -6.809 . . . . 0.0 92.616 159.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 65' ' ' CYS . 7.1 m 176.3 -157.11 0.02 OUTLIER 'General case' 0 CA--C 1.49 -1.333 1 N-CA-C 99.737 -4.172 . . . . 0.0 99.737 178.92 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.505 HG12 HD12 ' A' ' 59' ' ' ILE . 0.8 OUTLIER -120.83 155.95 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.913 1 N-CA-C 97.46 -5.015 . . . . 0.0 97.46 160.592 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -93.64 136.88 33.47 Favored 'General case' 0 CA--C 1.48 -1.724 1 N-CA-C 96.895 -5.224 . . . . 0.0 96.895 162.595 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 79.0 m80 -85.85 176.27 8.19 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 -169.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 12.2 t -140.67 158.23 44.29 Favored 'General case' 0 N--CA 1.413 -2.31 1 N-CA-C 94.056 -6.276 . . . . 0.0 94.056 178.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -124.93 138.69 31.94 Favored Pre-proline 0 N--CA 1.419 -1.986 1 N-CA-C 95.654 -5.684 . . . . 0.0 95.654 177.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_exo -63.53 94.94 0.18 Allowed 'Trans proline' 0 CA--C 1.512 -0.598 0 CA-C-N 124.71 2.718 . . . . 0.0 114.182 -171.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 164.64 -173.51 40.57 Favored Glycine 0 N--CA 1.421 -2.308 1 N-CA-C 97.927 -6.069 . . . . 0.0 97.927 -176.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.1 m -84.49 -32.59 23.88 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 117.333 0.566 . . . . 0.0 110.421 -177.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.5 m -46.7 -59.68 2.88 Favored 'General case' 0 N--CA 1.439 -0.984 0 C-N-CA 127.594 2.358 . . . . 0.0 116.582 -156.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -72.82 -54.69 7.04 Favored Glycine 0 C--N 1.349 1.286 0 N-CA-C 110.179 -1.169 . . . . 0.0 110.179 -174.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 49.1 t -61.29 -48.39 81.62 Favored 'General case' 0 CA--C 1.499 -1.016 0 C-N-CA 125.418 1.487 . . . . 0.0 111.473 -171.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -62.34 -42.78 99.67 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 118.729 0.695 . . . . 0.0 109.543 -175.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.0 m -66.5 -50.86 61.85 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 123.567 0.747 . . . . 0.0 110.639 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 55.7 mt -64.09 -41.83 97.15 Favored 'General case' 0 C--N 1.362 1.124 0 C-N-CA 124.697 1.199 . . . . 0.0 110.35 -175.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 15.9 t -62.35 -46.44 88.65 Favored 'General case' 0 CA--C 1.5 -0.967 0 C-N-CA 123.649 0.779 . . . . 0.0 108.98 177.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -66.82 -45.0 79.68 Favored 'General case' 0 CA--C 1.504 -0.802 0 O-C-N 121.76 -0.587 . . . . 0.0 110.899 -173.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -72.33 -23.58 61.18 Favored 'General case' 0 C--N 1.354 0.774 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -174.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 42.6 mmtm -88.22 -18.82 27.82 Favored 'General case' 0 C--N 1.354 0.772 0 CA-C-N 118.673 0.669 . . . . 0.0 109.393 175.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.35 41.66 1.35 Allowed Glycine 0 CA--C 1.483 -1.952 0 N-CA-C 109.331 -1.507 . . . . 0.0 109.331 161.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -103.79 128.5 9.52 Favored Glycine 0 CA--C 1.486 -1.76 0 N-CA-C 103.56 -3.816 . . . . 0.0 103.56 171.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.7 p -99.87 4.49 45.17 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 122.339 1.066 . . . . 0.0 108.725 -166.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 46.4 m -160.3 165.12 31.92 Favored 'General case' 0 N--CA 1.421 -1.893 1 N-CA-C 98.66 -4.571 . . . . 0.0 98.66 166.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 179.69 -173.72 45.44 Favored Glycine 0 N--CA 1.414 -2.801 1 N-CA-C 99.563 -5.415 . . . . 0.0 99.563 -176.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 10.1 p-80 -171.42 173.65 4.73 Favored 'General case' 0 N--CA 1.43 -1.428 1 N-CA-C 99.463 -4.273 . . . . 0.0 99.463 172.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 49.0 t -94.32 153.92 17.76 Favored 'General case' 0 CA--C 1.502 -0.878 0 N-CA-C 105.361 -2.088 . . . . 0.0 105.361 -176.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.63 -165.3 28.65 Favored Glycine 0 N--CA 1.431 -1.659 0 N-CA-C 104.927 -3.269 . . . . 0.0 104.927 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -148.42 147.58 29.34 Favored 'General case' 0 N--CA 1.429 -1.495 1 N-CA-C 98.012 -4.811 . . . . 0.0 98.012 -170.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -130.17 100.7 5.5 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 102.106 -3.294 . . . . 0.0 102.106 167.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.9 t -70.22 120.08 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 -173.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 141.07 -48.4 0.82 Allowed Glycine 0 CA--C 1.484 -1.865 1 N-CA-C 102.019 -4.433 . . . . 0.0 102.019 -164.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 18.3 m-70 -106.69 -74.93 0.64 Allowed 'General case' 0 CA--C 1.501 -0.934 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 173.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 169.16 -156.53 27.82 Favored Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 105.427 -3.069 . . . . 0.0 105.427 -173.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.78 130.11 42.13 Favored 'General case' 0 C--N 1.358 0.939 0 C-N-CA 127.809 2.443 . . . . 0.0 104.819 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -130.5 174.81 9.53 Favored 'General case' 0 CA--C 1.478 -1.792 0 N-CA-C 104.734 -2.321 . . . . 0.0 104.734 -168.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 19.3 t -121.38 158.16 28.9 Favored 'General case' 0 CA--C 1.492 -1.263 1 N-CA-C 99.575 -4.231 . . . . 0.0 99.575 172.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.423 ' HA ' ' HA ' ' A' ' 5' ' ' TYR . 12.3 t-105 -117.81 150.5 39.04 Favored 'General case' 0 CA--C 1.495 -1.173 0 N-CA-C 102.233 -3.247 . . . . 0.0 102.233 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 59.1 m -147.47 152.01 37.35 Favored 'General case' 0 CA--C 1.492 -1.272 0 N-CA-C 105.057 -2.201 . . . . 0.0 105.057 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -119.79 145.14 46.87 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 104.636 -2.357 . . . . 0.0 104.636 171.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 65.2 53.02 1.38 Allowed 'General case' 0 CA--C 1.49 -1.331 0 C-N-CA 127.283 2.233 . . . . 0.0 110.461 170.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 31.2 mt -91.31 139.95 25.53 Favored Pre-proline 0 CA--C 1.498 -1.028 0 N-CA-C 103.602 -2.74 . . . . 0.0 103.602 175.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -72.17 169.96 20.23 Favored 'Trans proline' 0 N--CA 1.447 -1.233 0 C-N-CA 122.544 2.163 . . . . 0.0 109.456 176.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -83.0 13.65 3.85 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -165.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -103.7 4.28 35.19 Favored 'General case' 0 CA--C 1.501 -0.922 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 177.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.0 t -104.85 154.53 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 N-CA-C 103.181 -2.896 . . . . 0.0 103.181 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -122.94 158.62 17.59 Favored Glycine 0 CA--C 1.483 -1.954 1 N-CA-C 102.731 -4.147 . . . . 0.0 102.731 -175.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.414 HG22 ' HA ' ' A' ' 6' ' ' ILE . 28.4 pt -151.18 -178.81 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.594 0 N-CA-C 102.469 -3.16 . . . . 0.0 102.469 -163.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.505 HD12 HG12 ' A' ' 13' ' ' VAL . 1.5 mm -69.61 131.9 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.045 0 O-C-N 123.974 0.796 . . . . 0.0 109.813 -166.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.6 t -123.93 160.98 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.516 1 N-CA-C 98.98 -4.452 . . . . 0.0 98.98 173.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -157.72 160.61 38.09 Favored 'General case' 0 N--CA 1.426 -1.654 1 N-CA-C 97.429 -5.026 . . . . 0.0 97.429 173.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 114.67 -30.14 7.09 Favored Glycine 0 C--N 1.347 1.171 0 N-CA-C 103.459 -3.857 . . . . 0.0 103.459 -157.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -123.44 -149.82 0.43 Allowed 'General case' 0 N--CA 1.43 -1.435 1 N-CA-C 97.965 -4.828 . . . . 0.0 97.965 164.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.402 ' HG2' ' H ' ' A' ' 65' ' ' CYS . 21.8 ttmt -167.09 -161.94 0.45 Allowed 'General case' 0 N--CA 1.43 -1.448 1 N-CA-C 97.763 -4.903 . . . . 0.0 97.763 -179.32 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 42.3 t -60.71 126.73 28.51 Favored 'General case' 0 CA--C 1.49 -1.349 0 C-N-CA 126.888 2.075 . . . . 0.0 108.201 -178.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 20.4 p-80 -146.81 171.72 14.75 Favored 'General case' 0 CA--C 1.481 -1.685 0 N-CA-C 101.141 -3.652 . . . . 0.0 101.141 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 58.2 m -171.5 173.08 4.86 Favored 'General case' 0 N--CA 1.422 -1.834 1 N-CA-C 95.712 -5.662 . . . . 0.0 95.712 175.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.358 0.958 0 O-C-N 124.229 0.956 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 5.7 m . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 121.811 0.815 . . . . 0.0 111.343 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.411 HH21 HG12 ' A' ' 58' ' ' ILE . 20.5 mtp85 -106.27 147.93 28.56 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 104.834 -2.284 . . . . 0.0 104.834 177.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -129.51 120.1 24.83 Favored 'General case' 0 CA--C 1.489 -1.378 1 N-CA-C 98.044 -4.798 . . . . 0.0 98.044 166.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.78 -170.62 26.76 Favored Glycine 0 CA--C 1.481 -2.058 0 N-CA-C 104.89 -3.284 . . . . 0.0 104.89 -169.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -96.6 140.25 31.5 Favored 'General case' 0 CA--C 1.491 -1.321 0 N-CA-C 101.73 -3.433 . . . . 0.0 101.73 168.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.7 tt -91.07 149.21 4.14 Favored 'Isoleucine or valine' 0 C--O 1.246 0.894 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 178.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.697 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -141.32 173.0 11.9 Favored 'General case' 0 N--CA 1.413 -2.304 1 N-CA-C 99.457 -4.275 . . . . 0.0 99.457 175.42 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -79.97 149.95 71.09 Favored Pre-proline 0 N--CA 1.434 -1.226 0 N-CA-C 103.14 -2.911 . . . . 0.0 103.14 165.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -79.95 -1.87 11.71 Favored 'Trans proline' 0 CA--C 1.499 -1.246 0 CA-C-N 121.113 1.433 . . . . 0.0 112.484 -142.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -96.33 13.79 26.49 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 -177.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 53.5 t30 77.28 44.89 0.09 Allowed 'General case' 0 CA--C 1.5 -0.951 0 C-N-CA 127.693 2.397 . . . . 0.0 108.354 178.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.3 m -122.82 110.73 15.82 Favored 'General case' 0 CA--C 1.482 -1.664 1 N-CA-C 99.42 -4.289 . . . . 0.0 99.42 -176.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 18.0 m -67.22 160.33 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.234 0 CA-C-N 119.652 1.115 . . . . 0.0 112.925 -163.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -101.71 117.49 34.98 Favored 'General case' 0 CA--C 1.479 -1.772 1 N-CA-C 97.341 -5.059 . . . . 0.0 97.341 179.645 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -83.15 125.85 31.97 Favored 'General case' 0 CA--C 1.486 -1.496 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 -158.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 40.4 t -92.24 149.59 21.37 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 104.026 -2.583 . . . . 0.0 104.026 175.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -134.45 140.0 34.41 Favored Pre-proline 0 N--CA 1.416 -2.141 1 N-CA-C 96.977 -5.194 . . . . 0.0 96.977 172.455 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -68.65 67.67 1.16 Allowed 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 124.124 3.216 . . . . 0.0 113.431 174.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -178.13 50.86 0.1 OUTLIER Glycine 0 CA--C 1.487 -1.656 1 N-CA-C 99.41 -5.476 . . . . 0.0 99.41 177.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.0 m -86.25 45.02 1.18 Allowed 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 114.104 -1.048 . . . . 0.0 112.909 -147.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.5 p -72.93 -42.63 63.27 Favored 'General case' 0 N--CA 1.444 -0.756 0 O-C-N 121.372 -0.83 . . . . 0.0 109.379 -175.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -68.97 -43.71 71.67 Favored Glycine 0 C--N 1.349 1.289 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 177.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.7 t -59.73 -44.4 93.79 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 125.455 1.502 . . . . 0.0 111.754 178.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -67.5 -35.32 78.9 Favored 'General case' 0 C--N 1.353 0.737 0 O-C-N 120.974 -1.079 . . . . 0.0 110.596 177.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 40.7 m -70.05 -33.69 72.27 Favored 'General case' 0 N--CA 1.45 -0.448 0 O-C-N 121.052 -1.03 . . . . 0.0 109.955 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 20.3 mt -66.89 -38.38 86.15 Favored 'General case' 0 CA--C 1.496 -1.129 0 O-C-N 121.518 -0.739 . . . . 0.0 109.705 177.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 36.8 t -54.82 -47.89 73.51 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 122.149 -0.344 . . . . 0.0 111.699 170.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.5 mmtm -63.06 -50.32 71.05 Favored 'General case' 0 C--N 1.354 0.784 0 O-C-N 121.394 -0.816 . . . . 0.0 111.276 -178.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -70.71 -8.91 55.53 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 112.897 0.702 . . . . 0.0 112.897 -173.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.9 mmmp? -102.69 2.9 36.44 Favored 'General case' 0 C--N 1.354 0.785 0 O-C-N 121.469 -0.769 . . . . 0.0 111.239 173.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 93.96 29.0 10.17 Favored Glycine 0 C--N 1.35 1.341 0 N-CA-C 111.436 -0.666 . . . . 0.0 111.436 169.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -91.93 140.97 15.42 Favored Glycine 0 C--N 1.354 1.578 0 N-CA-C 106.851 -2.5 . . . . 0.0 106.851 171.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.4 m -99.11 -26.38 14.23 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 -165.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.6 m -147.93 175.64 10.8 Favored 'General case' 0 CA--C 1.482 -1.661 1 N-CA-C 99.92 -4.104 . . . . 0.0 99.92 171.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -171.68 -176.44 40.66 Favored Glycine 0 N--CA 1.42 -2.382 1 N-CA-C 100.579 -5.008 . . . . 0.0 100.579 -173.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.444 ' CE1' ' CD1' ' A' ' 48' ' ' TRP . 16.2 p-80 -177.91 -152.5 0.03 OUTLIER 'General case' 0 N--CA 1.434 -1.254 1 N-CA-C 97.687 -4.931 . . . . 0.0 97.687 173.101 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 24.8 t -149.5 154.77 39.29 Favored 'General case' 0 N--CA 1.425 -1.723 1 N-CA-C 97.904 -4.85 . . . . 0.0 97.904 -173.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 178.76 -179.29 48.82 Favored Glycine 0 N--CA 1.425 -2.092 1 N-CA-C 96.8 -6.52 . . . . 0.0 96.8 -178.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.419 ' CD1' ' HA ' ' A' ' 45' ' ' LEU . 61.3 t80 -158.25 134.34 9.26 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 101.295 -3.595 . . . . 0.0 101.295 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.599 ' H ' HG23 ' A' ' 41' ' ' VAL . 28.7 mmmt -168.72 57.35 0.05 Allowed 'General case' 0 CA--C 1.499 -1.005 1 N-CA-C 97.747 -4.909 . . . . 0.0 97.747 172.545 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.599 HG23 ' H ' ' A' ' 40' ' ' LYS . 13.7 t -134.89 163.94 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.369 1 N-CA-C 99.579 -4.23 . . . . 0.0 99.579 -169.125 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -116.45 89.46 0.49 Allowed Glycine 0 CA--C 1.487 -1.69 1 N-CA-C 101.822 -4.511 . . . . 0.0 101.822 170.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 60.9 m-70 -175.01 -154.63 0.05 Allowed 'General case' 0 N--CA 1.429 -1.507 1 N-CA-C 96.779 -5.267 . . . . 0.0 96.779 -175.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -83.72 -69.86 1.37 Allowed Glycine 0 C--N 1.351 1.395 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -176.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.419 ' HA ' ' CD1' ' A' ' 39' ' ' PHE . 0.1 OUTLIER -167.54 152.7 7.12 Favored 'General case' 0 CA--C 1.489 -1.383 1 N-CA-C 96.363 -5.421 . . . . 0.0 96.363 178.61 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.19 166.06 25.54 Favored 'General case' 0 CA--C 1.486 -1.49 0 N-CA-C 102.521 -3.141 . . . . 0.0 102.521 -167.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 99.6 m -101.84 150.96 22.64 Favored 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 104.318 -2.475 . . . . 0.0 104.318 -178.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.444 ' CD1' ' CE1' ' A' ' 36' ' ' HIS . 44.0 t-105 -93.75 146.33 23.93 Favored 'General case' 0 CA--C 1.496 -1.125 0 N-CA-C 104.327 -2.471 . . . . 0.0 104.327 177.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 60.6 m -133.95 141.14 47.18 Favored 'General case' 0 CA--C 1.48 -1.744 0 N-CA-C 104.651 -2.351 . . . . 0.0 104.651 169.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -113.46 128.63 56.51 Favored 'General case' 0 N--CA 1.427 -1.596 0 N-CA-C 101.843 -3.392 . . . . 0.0 101.843 176.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 63.33 74.1 0.43 Allowed 'General case' 0 N--CA 1.434 -1.245 0 C-N-CA 126.571 1.948 . . . . 0.0 110.823 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 17.8 mt -97.99 141.9 23.71 Favored Pre-proline 0 CA--C 1.496 -1.122 0 N-CA-C 103.006 -2.961 . . . . 0.0 103.006 164.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -72.85 166.43 30.02 Favored 'Trans proline' 0 N--CA 1.443 -1.476 0 C-N-CA 122.382 2.054 . . . . 0.0 109.186 178.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -77.28 1.25 19.22 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -164.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -101.86 5.83 41.2 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 123.855 0.862 . . . . 0.0 109.594 -177.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.9 t -97.6 163.93 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 103.428 -2.804 . . . . 0.0 103.428 178.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -142.98 150.79 22.62 Favored Glycine 0 CA--C 1.475 -2.426 1 N-CA-C 97.247 -6.341 . . . . 0.0 97.247 -178.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.411 HG12 HH21 ' A' ' 2' ' ' ARG . 18.8 pt -153.77 -147.65 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.49 -1.358 0 N-CA-C 101.553 -3.499 . . . . 0.0 101.553 -154.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.697 HD13 ' HB2' ' A' ' 7' ' ' ALA . 7.3 mm -59.51 119.37 3.81 Favored 'Isoleucine or valine' 0 C--N 1.36 1.045 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 174.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -114.52 -15.62 9.92 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.126 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.491 -162.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -173.97 167.68 4.26 Favored 'General case' 0 N--CA 1.434 -1.252 1 N-CA-C 97.49 -5.004 . . . . 0.0 97.49 177.871 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -108.41 83.22 0.32 Allowed Glycine 0 CA--C 1.487 -1.718 1 N-CA-C 102.992 -4.043 . . . . 0.0 102.992 172.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -149.24 -87.07 0.08 Allowed 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 -171.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.486 ' HG2' ' H ' ' A' ' 65' ' ' CYS . 2.4 ttpm? -162.61 -167.13 1.48 Allowed 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 102.647 -3.094 . . . . 0.0 102.647 -173.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.486 ' H ' ' HG2' ' A' ' 64' ' ' LYS . 52.8 t -117.4 152.86 34.1 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 -165.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 45.0 p-80 -116.25 -152.22 0.5 Allowed 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 175.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 31.5 m -171.33 174.57 4.47 Favored 'General case' 0 N--CA 1.424 -1.737 1 N-CA-C 95.7 -5.667 . . . . 0.0 95.7 176.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.354 0.798 0 O-C-N 124.456 1.098 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 24.1 m . . . . . 0 N--CA 1.484 1.263 0 CA-C-O 120.999 0.428 . . . . 0.0 110.455 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.67 173.34 6.92 Favored 'General case' 0 CA--C 1.5 -0.957 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 173.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -130.0 140.08 50.94 Favored 'General case' 0 CA--C 1.488 -1.43 1 N-CA-C 94.563 -6.088 . . . . 0.0 94.563 163.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.72 176.07 38.22 Favored Glycine 0 CA--C 1.476 -2.346 0 N-CA-C 104.901 -3.279 . . . . 0.0 104.901 -178.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -83.62 126.93 33.35 Favored 'General case' 0 CA--C 1.497 -1.067 0 N-CA-C 101.184 -3.636 . . . . 0.0 101.184 157.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.4 tt -90.3 137.39 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 -172.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.68 -150.92 0.34 Allowed 'General case' 0 N--CA 1.427 -1.589 0 C-N-CA 127.605 2.362 . . . . 0.0 107.606 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -119.52 139.54 27.98 Favored Pre-proline 0 N--CA 1.424 -1.769 1 N-CA-C 93.847 -6.353 . . . . 0.0 93.847 165.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -83.0 30.81 0.53 Allowed 'Trans proline' 0 CA--C 1.505 -0.966 0 C-N-CA 122.306 2.004 . . . . 0.0 113.916 -135.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.588 ' HB3' ' CE1' ' A' ' 66' ' ' HIS . 15.4 mm-40 -106.25 -89.45 0.43 Allowed 'General case' 0 N--CA 1.424 -1.727 0 N-CA-C 101.43 -3.544 . . . . 0.0 101.43 177.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -157.16 138.07 13.39 Favored 'General case' 0 N--CA 1.417 -2.091 1 N-CA-C 92.377 -6.898 . . . . 0.0 92.377 164.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 5.5 m 176.59 -163.54 0.03 OUTLIER 'General case' 0 CA--C 1.489 -1.4 1 N-CA-C 97.414 -5.032 . . . . 0.0 97.414 178.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.499 HG12 HD12 ' A' ' 59' ' ' ILE . 15.4 m -119.73 163.08 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.626 1 N-CA-C 99.19 -4.374 . . . . 0.0 99.19 159.975 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -83.44 164.75 19.71 Favored 'General case' 0 CA--C 1.501 -0.925 0 N-CA-C 102.722 -3.066 . . . . 0.0 102.722 162.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 22.8 m80 -90.29 158.12 17.33 Favored 'General case' 0 CA--C 1.484 -1.595 0 N-CA-C 101.538 -3.504 . . . . 0.0 101.538 178.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -160.19 177.48 10.63 Favored 'General case' 0 N--CA 1.41 -2.432 1 N-CA-C 95.92 -5.585 . . . . 0.0 95.92 -174.48 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -147.06 167.29 13.94 Favored Pre-proline 0 N--CA 1.412 -2.331 1 N-CA-C 96.019 -5.548 . . . . 0.0 96.019 -161.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.05 49.67 2.33 Favored 'Trans proline' 0 C--N 1.316 -1.169 0 CA-C-N 124.752 2.733 . . . . 0.0 110.61 169.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -172.68 139.34 5.17 Favored Glycine 0 CA--C 1.478 -2.234 1 N-CA-C 99.702 -5.359 . . . . 0.0 99.702 -177.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.0 m -92.15 11.04 26.88 Favored 'General case' 0 CA--C 1.499 -0.994 0 C-N-CA 123.673 0.789 . . . . 0.0 112.27 -165.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.4 m -51.14 -53.74 31.73 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 126.29 1.836 . . . . 0.0 113.871 -168.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.93 -35.52 27.61 Favored Glycine 0 C--N 1.352 1.427 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -177.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 44.1 t -59.95 -44.61 94.3 Favored 'General case' 0 CA--C 1.499 -0.989 0 C-N-CA 125.379 1.471 . . . . 0.0 110.769 -174.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -59.13 -44.3 92.02 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 124.478 1.111 . . . . 0.0 110.329 178.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -68.87 -38.17 79.54 Favored 'General case' 0 N--CA 1.443 -0.787 0 O-C-N 121.018 -1.051 . . . . 0.0 112.848 175.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 85.8 mt -65.03 -40.33 94.69 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-O 122.29 1.043 . . . . 0.0 109.742 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.6 t -60.14 -46.99 87.78 Favored 'General case' 0 N--CA 1.433 -1.286 0 C-N-CA 123.895 0.878 . . . . 0.0 110.404 -178.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -74.26 -29.34 61.63 Favored 'General case' 0 N--CA 1.444 -0.762 0 O-C-N 121.725 -0.609 . . . . 0.0 112.433 -176.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -79.04 -25.33 43.2 Favored 'General case' 0 C--N 1.357 0.918 0 O-C-N 121.023 -1.048 . . . . 0.0 111.094 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.1 mmmp? -82.53 -29.3 30.51 Favored 'General case' 0 C--N 1.358 0.935 0 O-C-N 121.451 -0.781 . . . . 0.0 109.381 172.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 110.25 43.68 1.06 Allowed Glycine 0 CA--C 1.485 -1.793 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 164.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -104.06 161.3 15.69 Favored Glycine 0 CA--C 1.488 -1.608 0 N-CA-C 103.394 -3.883 . . . . 0.0 103.394 166.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.1 p -71.94 -52.34 17.68 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-O 122.281 1.039 . . . . 0.0 109.924 -168.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 39.3 m -160.85 -176.55 5.59 Favored 'General case' 0 N--CA 1.421 -1.924 1 N-CA-C 98.002 -4.814 . . . . 0.0 98.002 170.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -172.67 -176.17 41.14 Favored Glycine 0 N--CA 1.416 -2.673 1 N-CA-C 98.766 -5.734 . . . . 0.0 98.766 -169.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 39.6 m80 -157.96 169.42 24.62 Favored 'General case' 0 N--CA 1.432 -1.366 1 N-CA-C 99.504 -4.258 . . . . 0.0 99.504 -176.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 64.1 m -84.22 159.92 20.9 Favored 'General case' 0 CA--C 1.499 -0.992 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 172.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -170.02 -178.51 41.05 Favored Glycine 0 N--CA 1.423 -2.19 1 N-CA-C 99.186 -5.566 . . . . 0.0 99.186 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -151.82 -169.33 3.33 Favored 'General case' 0 N--CA 1.422 -1.849 1 N-CA-C 99.224 -4.362 . . . . 0.0 99.224 174.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -154.21 -141.86 0.11 Allowed 'General case' 0 N--CA 1.424 -1.747 1 N-CA-C 93.637 -6.431 . . . . 0.0 93.637 -168.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.2 t -124.95 151.62 30.7 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.293 1 N-CA-C 96.995 -5.187 . . . . 0.0 96.995 149.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 160.49 -137.14 4.84 Favored Glycine 0 N--CA 1.42 -2.398 1 N-CA-C 98.683 -5.767 . . . . 0.0 98.683 -163.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 33.2 m170 -87.49 -35.08 18.41 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -160.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -169.92 -65.14 0.04 OUTLIER Glycine 0 C--N 1.357 1.73 0 C-N-CA 118.031 -2.033 . . . . 0.0 110.692 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.26 -178.08 6.43 Favored 'General case' 0 N--CA 1.434 -1.242 1 N-CA-C 94.784 -6.006 . . . . 0.0 94.784 167.786 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -150.36 171.72 16.54 Favored 'General case' 0 CA--C 1.482 -1.667 0 N-CA-C 102.206 -3.257 . . . . 0.0 102.206 174.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 8.5 t -110.13 155.61 21.69 Favored 'General case' 0 CA--C 1.489 -1.396 1 N-CA-C 99.378 -4.304 . . . . 0.0 99.378 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 6.5 t-105 -118.57 154.45 32.58 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 102.454 -3.165 . . . . 0.0 102.454 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 9.8 m -151.06 154.86 37.81 Favored 'General case' 0 CA--C 1.49 -1.365 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 176.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -117.81 143.42 46.28 Favored 'General case' 0 CA--C 1.495 -1.145 0 N-CA-C 104.689 -2.338 . . . . 0.0 104.689 169.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 65.02 58.27 0.92 Allowed 'General case' 0 CA--C 1.498 -1.023 0 C-N-CA 127.681 2.392 . . . . 0.0 112.507 171.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 31.3 mt -97.03 146.57 31.53 Favored Pre-proline 0 CA--C 1.502 -0.872 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 177.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -64.25 162.51 29.76 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 123.167 2.578 . . . . 0.0 111.244 174.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -68.88 -22.79 64.17 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -169.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 18.5 p-10 -94.66 19.82 9.42 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 124.345 1.058 . . . . 0.0 110.376 -176.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.3 t -106.91 126.2 62.91 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.274 0 N-CA-C 101.596 -3.483 . . . . 0.0 101.596 169.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -90.95 154.55 23.11 Favored Glycine 0 CA--C 1.492 -1.385 0 N-CA-C 107.923 -2.071 . . . . 0.0 107.923 -174.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 45.8 pt -136.68 -171.84 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 -170.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.499 HD12 HG12 ' A' ' 13' ' ' VAL . 2.3 mm -69.77 127.55 31.83 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.275 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 -174.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 42.6 t -113.41 103.57 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.632 0 N-CA-C 101.81 -3.404 . . . . 0.0 101.81 177.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 64.8 -117.25 0.4 Allowed 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 124.686 1.195 . . . . 0.0 108.469 -177.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -168.1 45.46 0.24 Allowed Glycine 0 N--CA 1.431 -1.68 1 N-CA-C 99.542 -5.423 . . . . 0.0 99.542 168.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -84.09 -51.78 6.81 Favored 'General case' 0 CA--C 1.493 -1.235 0 CA-C-O 121.523 0.678 . . . . 0.0 109.416 -164.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 24.8 tptt -149.37 166.37 29.25 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 103.976 -2.601 . . . . 0.0 103.976 -171.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 18.0 t -129.25 136.4 50.05 Favored 'General case' 0 N--CA 1.423 -1.797 1 N-CA-C 93.599 -6.445 . . . . 0.0 93.599 166.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.588 ' CE1' ' HB3' ' A' ' 10' ' ' GLU . 13.6 p-80 -157.09 159.36 37.81 Favored 'General case' 0 CA--C 1.484 -1.579 1 N-CA-C 99.889 -4.115 . . . . 0.0 99.889 -175.324 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 59.2 m -131.78 135.51 46.84 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 100.594 -3.854 . . . . 0.0 100.594 -173.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.36 1.052 0 O-C-N 124.046 0.842 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 15.2 m . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 121.565 0.698 . . . . 0.0 110.515 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 6.1 mmm180 -101.66 141.89 33.84 Favored 'General case' 0 CA--C 1.495 -1.169 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 -178.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -130.19 116.51 18.53 Favored 'General case' 0 CA--C 1.489 -1.403 1 N-CA-C 95.815 -5.624 . . . . 0.0 95.815 158.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.86 -172.2 28.94 Favored Glycine 0 CA--C 1.476 -2.405 1 N-CA-C 100.981 -4.848 . . . . 0.0 100.981 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.446 ' HB2' HD13 ' A' ' 59' ' ' ILE . 40.2 m-85 -76.86 144.87 38.72 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 104.359 -2.46 . . . . 0.0 104.359 161.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.5 tt -91.23 140.99 15.1 Favored 'Isoleucine or valine' 0 C--O 1.249 1.046 0 N-CA-C 104.617 -2.364 . . . . 0.0 104.617 171.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.472 ' HB2' ' CD1' ' A' ' 59' ' ' ILE . . . -141.29 176.99 8.4 Favored 'General case' 0 N--CA 1.41 -2.457 1 N-CA-C 98.875 -4.491 . . . . 0.0 98.875 177.215 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -85.44 153.38 58.8 Favored Pre-proline 0 N--CA 1.431 -1.386 0 N-CA-C 103.705 -2.702 . . . . 0.0 103.705 172.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -68.1 -16.93 45.53 Favored 'Trans proline' 0 CA--C 1.502 -1.121 0 N-CA-C 117.625 2.125 . . . . 0.0 117.625 -149.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.4 mp0 -95.37 18.47 12.48 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-N 119.317 0.962 . . . . 0.0 108.52 -175.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 58.3 t-20 82.06 48.19 0.02 OUTLIER 'General case' 0 C--N 1.356 0.853 0 C-N-CA 125.85 1.66 . . . . 0.0 107.841 168.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.3 m -125.49 122.19 35.9 Favored 'General case' 0 CA--C 1.487 -1.477 0 N-CA-C 101.001 -3.703 . . . . 0.0 101.001 178.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.1 m -56.88 155.16 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.057 0 CA-C-N 120.858 1.663 . . . . 0.0 113.437 -170.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.64 131.84 54.71 Favored 'General case' 0 CA--C 1.468 -2.205 1 N-CA-C 93.344 -6.539 . . . . 0.0 93.344 177.464 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 66.7 m80 -92.83 -156.65 0.49 Allowed 'General case' 0 CA--C 1.49 -1.362 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 -164.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 5.6 t -155.11 168.39 27.17 Favored 'General case' 0 N--CA 1.417 -2.111 1 N-CA-C 94.399 -6.149 . . . . 0.0 94.399 -173.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -122.81 121.45 27.38 Favored Pre-proline 0 N--CA 1.42 -1.935 1 N-CA-C 94.694 -6.039 . . . . 0.0 94.694 175.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -62.45 99.33 0.2 Allowed 'Trans proline' 0 CA--C 1.51 -0.686 0 CA-C-N 123.106 2.145 . . . . 0.0 116.709 -158.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 169.91 -175.6 43.95 Favored Glycine 0 N--CA 1.422 -2.245 1 N-CA-C 96.168 -6.773 . . . . 0.0 96.168 176.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -69.95 -39.03 76.27 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 119.433 1.617 . . . . 0.0 109.124 178.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -45.63 -49.02 14.69 Favored 'General case' 0 N--CA 1.437 -1.122 0 C-N-CA 130.746 3.619 . . . . 0.0 115.566 -171.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.5 -40.88 59.05 Favored Glycine 0 CA--C 1.49 -1.499 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -172.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 43.3 t -70.33 -48.1 58.04 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -52.99 -44.21 67.05 Favored 'General case' 0 C--N 1.354 0.797 0 C-N-CA 124.512 1.125 . . . . 0.0 111.487 -178.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 34.2 m -60.6 -53.84 52.63 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 123.524 0.73 . . . . 0.0 111.142 177.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 83.8 mt -71.86 -40.16 69.17 Favored 'General case' 0 CA--C 1.5 -0.971 0 CA-C-O 122.104 0.955 . . . . 0.0 110.19 -172.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 33.7 t -61.07 -44.28 97.62 Favored 'General case' 0 CA--C 1.5 -0.98 0 C-N-CA 124.932 1.293 . . . . 0.0 109.372 178.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm -68.01 -43.89 77.78 Favored 'General case' 0 CA--C 1.502 -0.892 0 O-C-N 121.986 -0.446 . . . . 0.0 110.1 -173.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -71.67 -13.0 61.61 Favored 'General case' 0 C--N 1.351 0.663 0 O-C-N 121.691 -0.63 . . . . 0.0 112.512 -175.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.4 mmtm -98.43 -2.81 38.18 Favored 'General case' 0 CA--C 1.504 -0.79 0 C-N-CA 123.23 0.612 . . . . 0.0 110.056 176.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.0 32.72 8.73 Favored Glycine 0 CA--C 1.491 -1.416 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 172.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -91.44 142.1 15.95 Favored Glycine 0 C--N 1.354 1.556 0 N-CA-C 106.642 -2.583 . . . . 0.0 106.642 171.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.1 m -98.35 -17.24 18.97 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 -163.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 59.5 m -159.93 167.5 27.87 Favored 'General case' 0 CA--C 1.482 -1.639 1 N-CA-C 99.226 -4.361 . . . . 0.0 99.226 171.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -171.34 174.77 44.99 Favored Glycine 0 CA--C 1.476 -2.365 1 N-CA-C 100.328 -5.109 . . . . 0.0 100.328 -179.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 32.1 p-80 -158.5 159.49 35.68 Favored 'General case' 0 N--CA 1.426 -1.637 1 N-CA-C 98.452 -4.648 . . . . 0.0 98.452 176.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 42.3 t -87.03 159.04 19.1 Favored 'General case' 0 CA--C 1.501 -0.942 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 -173.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -174.68 -172.05 39.39 Favored Glycine 0 N--CA 1.423 -2.221 0 N-CA-C 103.861 -3.696 . . . . 0.0 103.861 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -130.08 148.97 51.98 Favored 'General case' 0 N--CA 1.426 -1.636 1 N-CA-C 97.202 -5.11 . . . . 0.0 97.202 -175.168 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.0 tptm -115.24 112.68 22.83 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 100.61 -3.848 . . . . 0.0 100.61 175.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.7 t -82.06 117.24 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 -173.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 119.79 -13.0 10.78 Favored Glycine 0 C--N 1.347 1.163 0 N-CA-C 107.856 -2.097 . . . . 0.0 107.856 -169.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -128.77 -78.83 0.56 Allowed 'General case' 0 CA--C 1.501 -0.929 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 175.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 168.11 -162.18 35.96 Favored Glycine 0 N--CA 1.427 -1.915 0 N-CA-C 103.808 -3.717 . . . . 0.0 103.808 -168.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 41.1 tp -63.17 131.08 47.28 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 127.448 2.299 . . . . 0.0 107.123 176.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -136.48 -171.72 2.97 Favored 'General case' 0 CA--C 1.492 -1.286 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 -165.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 4.2 t -139.19 156.73 46.9 Favored 'General case' 0 CA--C 1.488 -1.409 0 N-CA-C 100.594 -3.854 . . . . 0.0 100.594 173.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.423 ' HA ' ' HA ' ' A' ' 5' ' ' TYR . 15.6 t-105 -115.06 147.59 39.98 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 103.423 -2.806 . . . . 0.0 103.423 178.018 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 63.4 m -136.44 143.93 44.17 Favored 'General case' 0 CA--C 1.489 -1.384 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 172.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -113.64 131.05 56.28 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 102.309 -3.219 . . . . 0.0 102.309 177.218 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 57.86 71.26 0.59 Allowed 'General case' 0 CA--C 1.498 -1.046 0 C-N-CA 126.877 2.071 . . . . 0.0 110.946 178.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 15.9 mt -96.03 145.94 30.43 Favored Pre-proline 0 CA--C 1.499 -1.005 0 N-CA-C 102.78 -3.045 . . . . 0.0 102.78 164.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.06 166.7 28.33 Favored 'Trans proline' 0 N--CA 1.447 -1.236 0 C-N-CA 122.295 1.997 . . . . 0.0 109.527 172.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -77.86 -9.65 59.16 Favored 'General case' 0 CA--C 1.5 -0.973 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -163.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -85.65 7.33 23.77 Favored 'General case' 0 CA--C 1.506 -0.737 0 C-N-CA 123.996 0.918 . . . . 0.0 109.95 -179.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.0 t -104.35 113.46 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.636 0 N-CA-C 103.877 -2.638 . . . . 0.0 103.877 172.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -84.38 155.5 31.11 Favored Glycine 0 CA--C 1.493 -1.334 0 N-CA-C 104.604 -3.399 . . . . 0.0 104.604 169.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 15.1 pt -144.1 -134.59 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 N-CA-C 102.674 -3.084 . . . . 0.0 102.674 -166.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.472 ' CD1' ' HB2' ' A' ' 7' ' ' ALA . 3.2 mp -74.41 112.35 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 N-CA-C 102.39 -3.189 . . . . 0.0 102.39 168.138 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -130.44 138.71 53.13 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.694 0 N-CA-C 100.8 -3.778 . . . . 0.0 100.8 -158.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 67.85 -70.3 0.13 Allowed 'General case' 0 C--N 1.356 0.883 0 C-N-CA 126.679 1.992 . . . . 0.0 109.015 -165.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 152.52 -53.46 0.47 Allowed Glycine 0 CA--C 1.483 -1.913 0 N-CA-C 104.424 -3.471 . . . . 0.0 104.424 175.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 78.1 tt0 -31.2 -83.24 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.854 0 C-N-CA 129.604 3.161 . . . . 0.0 116.821 -164.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 42.6 tttm -169.26 -167.65 0.74 Allowed 'General case' 0 N--CA 1.426 -1.651 1 N-CA-C 98.056 -4.794 . . . . 0.0 98.056 -175.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 19.6 t -86.96 148.93 25.12 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 -171.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -135.38 -162.34 1.25 Allowed 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 -178.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 18.9 m -174.95 176.98 2.06 Favored 'General case' 0 N--CA 1.427 -1.62 1 N-CA-C 95.771 -5.64 . . . . 0.0 95.771 178.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.359 1.004 0 O-C-N 124.255 0.972 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 28.1 m . . . . . 0 N--CA 1.483 1.176 0 CA-C-O 120.977 0.418 . . . . 0.0 110.528 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -102.16 162.79 12.64 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 172.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -125.19 132.12 53.07 Favored 'General case' 0 CA--C 1.493 -1.217 1 N-CA-C 96.192 -5.484 . . . . 0.0 96.192 158.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.1 -170.13 26.43 Favored Glycine 0 CA--C 1.481 -2.055 0 N-CA-C 103.979 -3.648 . . . . 0.0 103.979 176.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -83.29 135.82 34.6 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 103.765 -2.679 . . . . 0.0 103.765 162.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.8 tt -91.47 147.52 5.21 Favored 'Isoleucine or valine' 0 C--O 1.244 0.814 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 175.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.454 ' HB2' HD12 ' A' ' 59' ' ' ILE . . . -149.3 -169.24 3.32 Favored 'General case' 0 N--CA 1.42 -1.952 0 N-CA-C 104.632 -2.358 . . . . 0.0 104.632 178.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -88.57 150.45 46.32 Favored Pre-proline 0 N--CA 1.432 -1.365 0 N-CA-C 104.624 -2.362 . . . . 0.0 104.624 169.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -70.57 32.47 0.22 Allowed 'Trans proline' 0 CA--C 1.517 -0.347 0 C-N-CA 123.911 3.074 . . . . 0.0 116.029 -174.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -109.54 11.05 25.02 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 106.957 -1.498 . . . . 0.0 106.957 -176.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 50.1 t30 67.66 53.65 0.7 Allowed 'General case' 0 CA--C 1.5 -0.949 0 C-N-CA 127.798 2.439 . . . . 0.0 108.285 -172.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -110.93 -154.72 0.55 Allowed 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -167.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.8 m -135.51 161.35 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.592 1 N-CA-C 98.021 -4.807 . . . . 0.0 98.021 163.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -113.64 130.79 56.34 Favored 'General case' 0 CA--C 1.479 -1.76 1 N-CA-C 96.683 -5.302 . . . . 0.0 96.683 173.918 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 27.7 m80 -82.98 141.88 31.78 Favored 'General case' 0 CA--C 1.493 -1.236 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 -173.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.402 ' H ' ' HG ' ' A' ' 45' ' ' LEU . 1.8 t -91.39 -179.18 5.32 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 -178.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -131.49 126.04 20.97 Favored Pre-proline 0 N--CA 1.412 -2.332 1 N-CA-C 97.073 -5.158 . . . . 0.0 97.073 -174.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_exo -62.96 67.97 0.14 Allowed 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.402 2.735 . . . . 0.0 112.029 164.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 171.96 77.21 0.05 OUTLIER Glycine 0 N--CA 1.423 -2.204 1 N-CA-C 95.346 -7.102 . . . . 0.0 95.346 -172.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.2 m -49.24 -38.1 25.51 Favored 'General case' 0 N--CA 1.438 -1.045 0 C-N-CA 128.532 2.733 . . . . 0.0 113.404 -159.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.5 m -61.05 -17.4 52.19 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 -177.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.8 -52.11 50.81 Favored Glycine 0 C--N 1.35 1.333 0 CA-C-N 119.982 1.265 . . . . 0.0 110.384 173.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -88.23 -20.99 24.77 Favored 'General case' 0 CA--C 1.496 -1.114 0 O-C-N 121.465 -1.021 . . . . 0.0 109.488 -175.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -64.28 -34.66 78.63 Favored 'General case' 0 C--N 1.355 0.818 0 O-C-N 121.232 -0.917 . . . . 0.0 109.515 170.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 33.4 m -64.88 -44.79 88.52 Favored 'General case' 0 C--N 1.354 0.771 0 O-C-N 120.8 -1.188 . . . . 0.0 109.862 172.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 84.1 mt -62.4 -43.33 99.08 Favored 'General case' 0 C--N 1.361 1.109 0 CA-C-O 121.732 0.777 . . . . 0.0 110.897 178.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 41.7 t -54.37 -48.86 71.03 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 125.132 1.373 . . . . 0.0 109.875 173.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.6 tptp -66.13 -40.55 90.74 Favored 'General case' 0 N--CA 1.441 -0.911 0 O-C-N 121.837 -0.539 . . . . 0.0 111.783 -174.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -76.94 -24.57 52.37 Favored 'General case' 0 C--N 1.354 0.773 0 O-C-N 121.772 -0.58 . . . . 0.0 112.455 -177.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -75.43 -39.16 59.24 Favored 'General case' 0 C--N 1.361 1.081 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 171.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 120.7 44.05 0.43 Allowed Glycine 0 CA--C 1.483 -1.963 0 N-CA-C 108.066 -2.014 . . . . 0.0 108.066 166.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -95.84 136.97 13.14 Favored Glycine 0 CA--C 1.486 -1.767 0 N-CA-C 103.159 -3.976 . . . . 0.0 103.159 167.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.0 m -102.38 2.87 37.24 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 -158.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.3 m -160.64 165.42 30.64 Favored 'General case' 0 CA--C 1.488 -1.441 1 N-CA-C 99.517 -4.253 . . . . 0.0 99.517 159.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -175.67 168.85 41.4 Favored Glycine 0 CA--C 1.48 -2.117 0 N-CA-C 103.513 -3.835 . . . . 0.0 103.513 -177.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.472 ' CE1' ' CD1' ' A' ' 48' ' ' TRP . 35.1 p-80 -174.1 -178.86 1.55 Allowed 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 100.619 -3.845 . . . . 0.0 100.619 -176.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 74.4 m -87.47 163.44 16.7 Favored 'General case' 0 CA--C 1.495 -1.157 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -164.07 -177.71 37.03 Favored Glycine 0 N--CA 1.423 -2.209 1 N-CA-C 99.641 -5.384 . . . . 0.0 99.641 176.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -136.35 140.24 43.14 Favored 'General case' 0 N--CA 1.431 -1.403 1 N-CA-C 96.929 -5.211 . . . . 0.0 96.929 177.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.4 tmtt? -108.99 100.68 9.84 Favored 'General case' 0 CA--C 1.492 -1.265 0 N-CA-C 101.625 -3.472 . . . . 0.0 101.625 178.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.1 t -71.42 117.4 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 -178.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 135.46 -38.18 1.83 Allowed Glycine 0 CA--C 1.489 -1.571 0 N-CA-C 105.648 -2.981 . . . . 0.0 105.648 -167.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 30.7 m170 -121.07 -74.41 0.61 Allowed 'General case' 0 CA--C 1.498 -1.033 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 177.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 171.71 -158.82 30.0 Favored Glycine 0 N--CA 1.427 -1.918 0 N-CA-C 104.812 -3.315 . . . . 0.0 104.812 -169.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.402 ' HG ' ' H ' ' A' ' 16' ' ' CYS . 43.8 tp -67.19 129.84 41.19 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 126.67 1.988 . . . . 0.0 106.249 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -137.23 175.27 9.76 Favored 'General case' 0 CA--C 1.484 -1.581 0 N-CA-C 102.006 -3.331 . . . . 0.0 102.006 -167.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 64.0 m -117.95 160.65 21.1 Favored 'General case' 0 CA--C 1.476 -1.884 0 N-CA-C 102.582 -3.118 . . . . 0.0 102.582 174.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.472 ' CD1' ' CE1' ' A' ' 36' ' ' HIS . 30.7 t-105 -117.52 148.52 41.78 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 103.531 -2.766 . . . . 0.0 103.531 -176.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 67.9 m -142.09 148.2 38.0 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 104.602 -2.369 . . . . 0.0 104.602 172.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -112.77 140.28 47.69 Favored 'General case' 0 CA--C 1.492 -1.272 0 N-CA-C 101.499 -3.519 . . . . 0.0 101.499 168.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 66.66 66.12 0.45 Allowed 'General case' 0 CA--C 1.498 -1.035 0 C-N-CA 126.222 1.809 . . . . 0.0 110.691 169.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 14.4 mt -103.74 138.99 19.69 Favored Pre-proline 0 CA--C 1.498 -1.047 0 N-CA-C 104.609 -2.367 . . . . 0.0 104.609 172.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.9 170.05 20.64 Favored 'Trans proline' 0 N--CA 1.447 -1.241 0 C-N-CA 122.542 2.161 . . . . 0.0 110.751 177.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -76.96 -0.45 24.38 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -172.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -87.3 3.35 47.12 Favored 'General case' 0 CA--C 1.505 -0.781 0 O-C-N 121.455 -0.778 . . . . 0.0 110.253 177.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.0 t -103.83 148.08 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.278 0 N-CA-C 102.582 -3.118 . . . . 0.0 102.582 178.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -129.19 144.38 15.37 Favored Glycine 0 CA--C 1.476 -2.372 1 N-CA-C 97.034 -6.426 . . . . 0.0 97.034 174.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 27.4 pt -142.31 -141.7 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.32 0 N-CA-C 104.305 -2.479 . . . . 0.0 104.305 -154.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.454 HD12 ' HB2' ' A' ' 7' ' ' ALA . 1.7 mp -70.25 113.6 6.53 Favored 'Isoleucine or valine' 0 C--N 1.352 0.691 0 N-CA-C 104.548 -2.39 . . . . 0.0 104.548 168.087 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -111.76 -17.71 8.18 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.109 0 CA-C-O 122.655 1.217 . . . . 0.0 108.272 -160.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -170.68 -173.4 1.38 Allowed 'General case' 0 N--CA 1.424 -1.755 1 N-CA-C 96.192 -5.485 . . . . 0.0 96.192 171.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -129.14 73.01 0.47 Allowed Glycine 0 CA--C 1.482 -2.014 1 N-CA-C 101.568 -4.613 . . . . 0.0 101.568 170.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -105.49 -71.48 0.74 Allowed 'General case' 0 CA--C 1.492 -1.288 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 -174.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -165.1 177.67 7.56 Favored 'General case' 0 N--CA 1.426 -1.666 1 N-CA-C 96.575 -5.343 . . . . 0.0 96.575 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 35.9 t -112.49 149.7 32.27 Favored 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 102.433 -3.173 . . . . 0.0 102.433 176.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 14.7 p80 -113.42 62.45 0.65 Allowed 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 176.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.45 67.01 1.94 Allowed 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 126.219 1.808 . . . . 0.0 110.326 -178.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.365 1.262 0 CA-C-N 115.317 -0.856 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 29.8 m . . . . . 0 N--CA 1.484 1.252 0 CA-C-O 121.129 0.49 . . . . 0.0 110.079 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.5 171.97 7.97 Favored 'General case' 0 CA--C 1.493 -1.219 0 N-CA-C 101.116 -3.661 . . . . 0.0 101.116 161.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -129.35 135.25 48.49 Favored 'General case' 0 CA--C 1.485 -1.526 1 N-CA-C 94.007 -6.294 . . . . 0.0 94.007 169.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.81 -177.27 34.73 Favored Glycine 0 CA--C 1.473 -2.556 1 N-CA-C 102.957 -4.057 . . . . 0.0 102.957 -177.014 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -87.97 136.53 32.92 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 101.954 -3.35 . . . . 0.0 101.954 164.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 16.1 tt -90.62 144.26 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.366 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 -177.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -126.26 -148.42 0.39 Allowed 'General case' 0 N--CA 1.423 -1.779 0 C-N-CA 128.674 2.79 . . . . 0.0 106.68 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -133.22 148.78 70.48 Favored Pre-proline 0 N--CA 1.422 -1.857 1 N-CA-C 95.572 -5.714 . . . . 0.0 95.572 166.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -82.01 39.9 0.91 Allowed 'Trans proline' 0 CA--C 1.513 -0.543 0 C-N-CA 123.601 2.867 . . . . 0.0 112.151 -154.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -111.64 17.03 20.32 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 106.557 -1.646 . . . . 0.0 106.557 -178.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.436 ' O ' ' HE1' ' A' ' 43' ' ' HIS . 49.9 t30 64.56 60.23 0.91 Allowed 'General case' 0 CA--C 1.497 -1.063 0 C-N-CA 128.265 2.626 . . . . 0.0 108.583 -172.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -117.9 -158.37 0.71 Allowed 'General case' 0 CA--C 1.493 -1.224 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -166.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.1 m -137.26 156.79 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.687 1 N-CA-C 96.103 -5.517 . . . . 0.0 96.103 167.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -93.73 121.04 34.76 Favored 'General case' 0 CA--C 1.486 -1.51 0 N-CA-C 100.529 -3.878 . . . . 0.0 100.529 170.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -74.88 107.74 7.16 Favored 'General case' 0 CA--C 1.492 -1.26 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 -168.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.3 t -83.65 150.14 26.08 Favored 'General case' 0 CA--C 1.485 -1.54 0 CA-C-N 114.399 -1.273 . . . . 0.0 107.68 -164.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -112.04 112.99 52.38 Favored Pre-proline 0 N--CA 1.428 -1.572 0 N-CA-C 102.046 -3.316 . . . . 0.0 102.046 178.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_exo -59.41 137.59 79.06 Favored 'Trans proline' 0 CA--C 1.503 -1.047 0 C-N-CA 122.625 2.216 . . . . 0.0 110.677 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 119.83 -54.95 0.63 Allowed Glycine 0 CA--C 1.488 -1.607 1 N-CA-C 101.617 -4.593 . . . . 0.0 101.617 -157.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.0 m 91.24 12.04 0.04 OUTLIER 'General case' 0 CA--C 1.496 -1.105 0 C-N-CA 127.518 2.327 . . . . 0.0 111.224 174.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.7 m -56.65 -53.88 52.6 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 124.473 1.109 . . . . 0.0 113.047 -172.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -74.8 -31.81 57.81 Favored Glycine 0 C--N 1.35 1.342 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.7 t -67.03 -51.68 51.79 Favored 'General case' 0 CA--C 1.488 -1.419 0 C-N-CA 124.174 0.99 . . . . 0.0 109.602 -174.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -65.44 -36.74 84.82 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -176.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.8 m -60.33 -50.5 73.38 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 121.52 -0.738 . . . . 0.0 111.137 173.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 32.3 mt -64.5 -42.0 96.09 Favored 'General case' 0 CA--C 1.498 -1.046 0 C-N-CA 123.9 0.88 . . . . 0.0 109.99 -179.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 19.5 t -55.91 -46.0 78.53 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 124.123 0.969 . . . . 0.0 110.82 176.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 37.5 mtmm -63.55 -46.67 84.89 Favored 'General case' 0 C--N 1.356 0.864 0 CA-C-N 118.213 0.461 . . . . 0.0 111.259 -177.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -73.13 -21.95 60.63 Favored 'General case' 0 C--N 1.351 0.636 0 O-C-N 121.666 -0.646 . . . . 0.0 112.267 -175.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 48.9 mmtm -86.14 -10.39 54.91 Favored 'General case' 0 C--N 1.355 0.844 0 O-C-N 121.855 -0.528 . . . . 0.0 110.907 174.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.57 28.85 7.72 Favored Glycine 0 CA--C 1.489 -1.535 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 168.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -94.83 146.46 18.18 Favored Glycine 0 CA--C 1.487 -1.68 0 N-CA-C 105.037 -3.225 . . . . 0.0 105.037 165.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.5 p -72.58 -43.33 63.52 Favored 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 124.483 1.113 . . . . 0.0 110.354 -166.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 34.9 m -160.63 -178.59 6.98 Favored 'General case' 0 N--CA 1.422 -1.863 1 N-CA-C 97.8 -4.889 . . . . 0.0 97.8 165.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -174.7 177.35 46.84 Favored Glycine 0 N--CA 1.417 -2.605 1 N-CA-C 98.947 -5.661 . . . . 0.0 98.947 -167.294 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 81.8 m-70 -164.52 171.28 14.77 Favored 'General case' 0 CA--C 1.492 -1.257 1 N-CA-C 98.621 -4.585 . . . . 0.0 98.621 -171.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 72.5 m -81.16 160.52 24.35 Favored 'General case' 0 CA--C 1.502 -0.881 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 165.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -167.34 171.77 42.1 Favored Glycine 0 CA--C 1.481 -2.084 1 N-CA-C 98.58 -5.808 . . . . 0.0 98.58 173.239 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -156.26 140.38 16.45 Favored 'General case' 0 N--CA 1.426 -1.628 1 N-CA-C 97.82 -4.882 . . . . 0.0 97.82 -176.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -155.42 47.96 0.52 Allowed 'General case' 0 CA--C 1.491 -1.298 1 N-CA-C 99.514 -4.254 . . . . 0.0 99.514 174.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.404 HG12 ' H ' ' A' ' 42' ' ' GLY 0.276 2.1 t 61.68 -147.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 N-CA-C 105.482 -2.044 . . . . 0.0 105.482 -152.271 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.404 ' H ' HG12 ' A' ' 41' ' ' VAL . . . 142.93 -88.11 0.18 Allowed Glycine 0 CA--C 1.48 -2.109 1 N-CA-C 100.853 -4.899 . . . . 0.0 100.853 -178.455 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.436 ' HE1' ' O ' ' A' ' 11' ' ' ASN . 47.0 m170 -150.26 -69.57 0.19 Allowed 'General case' 0 CA--C 1.493 -1.223 1 N-CA-C 98.215 -4.735 . . . . 0.0 98.215 168.179 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -115.01 -159.37 12.29 Favored Glycine 0 N--CA 1.437 -1.267 0 N-CA-C 103.304 -3.918 . . . . 0.0 103.304 168.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -83.18 110.98 18.51 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 -174.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -98.77 175.39 5.98 Favored 'General case' 0 CA--C 1.492 -1.28 0 C-N-CA 124.649 1.18 . . . . 0.0 108.182 -167.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 10.8 t -111.12 148.65 32.24 Favored 'General case' 0 CA--C 1.499 -1.018 0 N-CA-C 102.387 -3.19 . . . . 0.0 102.387 -174.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 70.0 t-105 -100.19 150.64 22.31 Favored 'General case' 0 CA--C 1.492 -1.286 0 N-CA-C 104.355 -2.461 . . . . 0.0 104.355 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 26.1 m -141.01 143.72 34.59 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 101.422 -3.547 . . . . 0.0 101.422 166.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -110.11 23.34 14.45 Favored 'General case' 0 CA--C 1.503 -0.862 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -167.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -177.29 156.44 1.23 Allowed 'General case' 0 N--CA 1.418 -2.037 1 N-CA-C 94.321 -6.177 . . . . 0.0 94.321 170.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 14.8 mt -159.41 154.22 21.15 Favored Pre-proline 0 CA--C 1.488 -1.437 1 N-CA-C 96.128 -5.508 . . . . 0.0 96.128 157.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.18 161.39 46.18 Favored 'Trans proline' 0 N--CA 1.446 -1.287 0 C-N-CA 122.006 1.804 . . . . 0.0 108.328 165.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -77.92 -6.52 54.6 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -165.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -86.91 -1.79 58.1 Favored 'General case' 0 CA--C 1.506 -0.73 0 O-C-N 121.439 -0.788 . . . . 0.0 109.629 -178.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.1 t -94.16 111.01 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.16 0 N-CA-C 104.287 -2.486 . . . . 0.0 104.287 177.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -84.98 143.65 20.59 Favored Glycine 0 CA--C 1.492 -1.382 0 N-CA-C 106.627 -2.589 . . . . 0.0 106.627 176.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 13.6 pt -125.34 -134.65 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.276 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 -162.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.1 mp -76.18 119.45 24.29 Favored 'Isoleucine or valine' 0 C--N 1.354 0.784 0 N-CA-C 102.884 -3.006 . . . . 0.0 102.884 165.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.9 t -104.76 -22.78 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.065 0 C-N-CA 124.954 1.302 . . . . 0.0 109.175 -163.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -171.39 163.58 6.93 Favored 'General case' 0 N--CA 1.431 -1.409 1 N-CA-C 99.188 -4.375 . . . . 0.0 99.188 173.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -92.94 65.17 2.0 Allowed Glycine 0 CA--C 1.496 -1.127 0 N-CA-C 105.52 -3.032 . . . . 0.0 105.52 171.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -104.91 -84.91 0.48 Allowed 'General case' 0 CA--C 1.496 -1.097 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 -172.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -166.98 164.19 16.05 Favored 'General case' 0 N--CA 1.424 -1.735 1 N-CA-C 98.2 -4.741 . . . . 0.0 98.2 -176.253 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 51.4 t -106.33 144.62 32.77 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 176.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 25.1 p-80 -102.53 74.33 1.37 Allowed 'General case' 0 CA--C 1.498 -1.036 0 N-CA-C 105.207 -2.146 . . . . 0.0 105.207 172.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.2 m -69.05 57.63 0.1 Allowed 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 127.077 2.151 . . . . 0.0 114.219 -173.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.358 0.962 0 CA-C-N 116.857 -0.156 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 34.1 m . . . . . 0 N--CA 1.485 1.284 0 CA-C-O 121.17 0.509 . . . . 0.0 109.903 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -106.11 157.95 17.18 Favored 'General case' 0 CA--C 1.499 -0.987 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 171.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -126.44 125.73 42.63 Favored 'General case' 0 CA--C 1.484 -1.589 1 N-CA-C 94.386 -6.153 . . . . 0.0 94.386 156.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.72 178.34 37.64 Favored Glycine 0 CA--C 1.475 -2.41 0 N-CA-C 107.601 -2.2 . . . . 0.0 107.601 -171.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -82.65 129.79 35.01 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 104.446 -2.427 . . . . 0.0 104.446 166.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.444 HG13 HG22 ' A' ' 58' ' ' ILE . 14.0 tt -91.05 144.18 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 -179.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.448 ' HB2' HD12 ' A' ' 59' ' ' ILE . . . -144.85 179.34 7.39 Favored 'General case' 0 N--CA 1.417 -2.078 1 N-CA-C 98.731 -4.544 . . . . 0.0 98.731 -177.405 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -79.64 156.2 75.55 Favored Pre-proline 0 N--CA 1.437 -1.12 0 CA-C-O 116.735 -1.603 . . . . 0.0 106.836 178.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -67.9 -18.82 46.85 Favored 'Trans proline' 0 CA--C 1.504 -0.999 0 CA-C-N 122.989 2.103 . . . . 0.0 116.709 -152.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -101.21 7.12 43.19 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -177.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 86.73 126.62 0.03 OUTLIER 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 128.822 2.849 . . . . 0.0 107.112 176.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 156.9 126.47 0.0 OUTLIER 'General case' 0 CA--C 1.49 -1.345 1 N-CA-C 99.16 -4.385 . . . . 0.0 99.16 172.294 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.0 m -63.36 156.46 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.23 0 CA-C-O 123.011 1.386 . . . . 0.0 112.705 -162.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -100.52 121.16 41.12 Favored 'General case' 0 N--CA 1.42 -1.947 1 N-CA-C 97.317 -5.068 . . . . 0.0 97.317 176.609 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 45.6 m80 -80.83 126.04 30.84 Favored 'General case' 0 CA--C 1.487 -1.472 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 -166.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 9.2 t -94.11 174.05 7.35 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 -176.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -146.31 156.71 49.88 Favored Pre-proline 0 N--CA 1.417 -2.093 1 N-CA-C 97.311 -5.07 . . . . 0.0 97.311 -177.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_exo -69.65 -14.94 37.18 Favored 'Trans proline' 0 CA--C 1.511 -0.653 0 CA-C-N 122.977 2.099 . . . . 0.0 111.715 175.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -113.18 81.84 0.3 Allowed Glycine 0 CA--C 1.486 -1.778 1 N-CA-C 101.162 -4.775 . . . . 0.0 101.162 169.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 m -82.09 29.07 0.42 Allowed 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 125.647 1.579 . . . . 0.0 113.1 -160.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.5 m -56.65 -50.98 70.47 Favored 'General case' 0 N--CA 1.435 -1.193 0 C-N-CA 126.879 2.072 . . . . 0.0 113.737 -161.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.03 -31.87 72.69 Favored Glycine 0 C--N 1.352 1.439 0 N-CA-C 111.374 -0.69 . . . . 0.0 111.374 -176.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.3 t -78.49 -31.8 47.91 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -174.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -62.08 -41.83 98.59 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 123.708 0.803 . . . . 0.0 110.436 174.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.02 -35.31 80.3 Favored 'General case' 0 C--N 1.352 0.707 0 O-C-N 121.048 -1.032 . . . . 0.0 112.196 174.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 92.0 mt -67.45 -41.76 84.21 Favored 'General case' 0 C--N 1.357 0.893 0 CA-C-O 121.938 0.875 . . . . 0.0 109.663 176.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 27.2 t -55.41 -47.57 75.71 Favored 'General case' 0 CA--C 1.507 -0.691 0 C-N-CA 125.027 1.331 . . . . 0.0 110.135 177.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -59.04 -50.79 72.73 Favored 'General case' 0 C--N 1.354 0.797 0 C-N-CA 122.827 0.451 . . . . 0.0 111.697 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -71.16 -23.11 62.0 Favored 'General case' 0 C--N 1.356 0.871 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -174.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.0 mmtp -81.92 -14.8 55.63 Favored 'General case' 0 C--N 1.355 0.805 0 C-N-CA 123.147 0.579 . . . . 0.0 110.713 175.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 110.26 24.39 5.7 Favored Glycine 0 CA--C 1.49 -1.472 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 167.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -97.11 122.31 7.38 Favored Glycine 0 C--N 1.353 1.484 0 N-CA-C 105.899 -2.88 . . . . 0.0 105.899 177.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.7 p -99.57 9.2 43.62 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 122.225 1.012 . . . . 0.0 109.162 -168.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 57.9 m -160.11 164.85 32.69 Favored 'General case' 0 CA--C 1.479 -1.786 1 N-CA-C 97.598 -4.964 . . . . 0.0 97.598 164.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.457 ' HA2' ' HA ' ' A' ' 49' ' ' CYS . . . -158.15 164.95 33.59 Favored Glycine 0 CA--C 1.465 -3.07 1 N-CA-C 99.605 -5.398 . . . . 0.0 99.605 -173.427 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -156.76 -159.18 0.84 Allowed 'General case' 0 N--CA 1.421 -1.88 1 N-CA-C 98.185 -4.746 . . . . 0.0 98.185 -177.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 34.0 t -148.13 166.43 27.88 Favored 'General case' 0 N--CA 1.424 -1.733 1 N-CA-C 97.798 -4.89 . . . . 0.0 97.798 -170.264 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -179.7 -161.83 27.67 Favored Glycine 0 N--CA 1.421 -2.306 1 N-CA-C 100.571 -5.012 . . . . 0.0 100.571 176.149 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -140.55 148.27 40.75 Favored 'General case' 0 N--CA 1.432 -1.358 1 N-CA-C 100.072 -4.047 . . . . 0.0 100.072 -178.035 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.9 mmpt? -123.74 103.06 8.16 Favored 'General case' 0 CA--C 1.491 -1.295 0 N-CA-C 104.027 -2.583 . . . . 0.0 104.027 173.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.7 t -74.06 118.71 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 136.65 -36.72 1.95 Allowed Glycine 0 CA--C 1.487 -1.712 0 N-CA-C 104.131 -3.587 . . . . 0.0 104.131 -165.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 39.1 m170 -125.56 -68.89 0.81 Allowed 'General case' 0 CA--C 1.499 -0.99 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 178.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 162.02 -150.58 20.07 Favored Glycine 0 N--CA 1.429 -1.774 0 N-CA-C 105.297 -3.121 . . . . 0.0 105.297 -175.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -70.78 127.72 33.61 Favored 'General case' 0 C--N 1.353 0.745 0 N-CA-C 103.66 -2.718 . . . . 0.0 103.66 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.67 155.77 49.89 Favored 'General case' 0 CA--C 1.479 -1.759 0 N-CA-C 101.235 -3.617 . . . . 0.0 101.235 -168.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 58.0 m -100.44 177.67 4.96 Favored 'General case' 0 CA--C 1.49 -1.334 0 N-CA-C 103.663 -2.717 . . . . 0.0 103.663 -176.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 3.8 t-105 -140.92 150.08 42.7 Favored 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 101.507 -3.516 . . . . 0.0 101.507 -177.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.457 ' HA ' ' HA2' ' A' ' 35' ' ' GLY . 56.1 m -142.85 154.4 44.12 Favored 'General case' 0 CA--C 1.493 -1.224 0 N-CA-C 104.667 -2.346 . . . . 0.0 104.667 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -123.34 135.47 54.19 Favored 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 175.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 77.7 41.89 0.13 Allowed 'General case' 0 CA--C 1.493 -1.215 0 C-N-CA 127.428 2.291 . . . . 0.0 110.612 169.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 49.2 mt -80.69 135.57 52.47 Favored Pre-proline 0 CA--C 1.502 -0.876 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 177.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -72.02 169.61 20.94 Favored 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 122.416 2.077 . . . . 0.0 109.513 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -76.44 -5.79 48.93 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -163.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -86.17 -7.7 58.37 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 123.432 0.693 . . . . 0.0 110.208 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.0 t -93.17 126.93 45.54 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.045 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 -176.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -97.29 150.89 19.65 Favored Glycine 0 CA--C 1.485 -1.842 0 N-CA-C 104.075 -3.61 . . . . 0.0 104.075 178.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.444 HG22 HG13 ' A' ' 6' ' ' ILE . 20.2 pt -148.25 -143.74 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 N-CA-C 102.032 -3.321 . . . . 0.0 102.032 -166.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.448 HD12 ' HB2' ' A' ' 7' ' ' ALA . 2.9 mp -71.8 119.78 18.89 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 104.881 -2.266 . . . . 0.0 104.881 168.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -152.46 159.78 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.658 0 N-CA-C 102.198 -3.26 . . . . 0.0 102.198 -156.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 80.39 -115.82 0.02 OUTLIER 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 103.093 -2.929 . . . . 0.0 103.093 -170.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -107.19 -60.16 0.57 Allowed Glycine 0 CA--C 1.486 -1.766 1 N-CA-C 101.271 -4.732 . . . . 0.0 101.271 161.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -156.67 159.3 38.27 Favored 'General case' 0 N--CA 1.419 -1.99 1 N-CA-C 95.278 -5.823 . . . . 0.0 95.278 161.007 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.1 tppt? -173.56 -177.2 1.4 Allowed 'General case' 0 N--CA 1.429 -1.524 1 N-CA-C 96.057 -5.534 . . . . 0.0 96.057 -177.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 2.3 t -147.49 145.97 29.34 Favored 'General case' 0 N--CA 1.424 -1.735 1 N-CA-C 95.586 -5.709 . . . . 0.0 95.586 163.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -163.43 173.62 12.94 Favored 'General case' 0 N--CA 1.426 -1.632 1 N-CA-C 98.405 -4.665 . . . . 0.0 98.405 165.033 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.6 m -174.87 172.61 2.89 Favored 'General case' 0 N--CA 1.425 -1.724 1 N-CA-C 96.052 -5.536 . . . . 0.0 96.052 -178.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.358 0.969 0 O-C-N 124.101 0.876 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 25.3 m . . . . . 0 N--CA 1.488 1.459 0 CA-C-O 121.107 0.479 . . . . 0.0 110.962 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.53 166.22 16.43 Favored 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 170.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -130.1 131.81 45.88 Favored 'General case' 0 CA--C 1.492 -1.276 1 N-CA-C 95.173 -5.862 . . . . 0.0 95.173 165.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.86 -173.34 30.4 Favored Glycine 0 CA--C 1.476 -2.372 0 N-CA-C 104.24 -3.544 . . . . 0.0 104.24 178.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -80.04 131.83 35.86 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 102.156 -3.275 . . . . 0.0 102.156 157.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.2 tt -90.72 145.79 6.99 Favored 'Isoleucine or valine' 0 C--O 1.243 0.756 0 N-CA-C 105.52 -2.03 . . . . 0.0 105.52 -177.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.678 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -126.28 -176.17 3.58 Favored 'General case' 0 N--CA 1.424 -1.742 0 C-N-CA 126.165 1.786 . . . . 0.0 106.748 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -82.95 145.31 49.43 Favored Pre-proline 0 N--CA 1.437 -1.119 0 N-CA-C 104.548 -2.389 . . . . 0.0 104.548 157.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_exo -67.28 -22.06 46.87 Favored 'Trans proline' 0 CA--C 1.502 -1.107 0 CA-C-N 122.827 2.045 . . . . 0.0 116.295 -149.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -84.67 38.7 0.71 Allowed 'General case' 0 N--CA 1.438 -1.035 0 C-N-CA 124.825 1.25 . . . . 0.0 110.784 -167.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 50.7 t30 63.85 48.46 3.17 Favored 'General case' 0 C--N 1.354 0.782 0 C-N-CA 127.812 2.445 . . . . 0.0 110.143 -178.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -104.15 -146.68 0.38 Allowed 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 -177.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.557 HG12 HD12 ' A' ' 59' ' ' ILE . 3.1 m -133.11 -166.01 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.338 1 N-CA-C 97.653 -4.943 . . . . 0.0 97.653 164.373 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -120.41 155.41 33.52 Favored 'General case' 0 CA--C 1.491 -1.315 1 N-CA-C 95.704 -5.665 . . . . 0.0 95.704 170.845 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 33.4 m80 -91.1 99.2 12.26 Favored 'General case' 0 CA--C 1.486 -1.481 0 N-CA-C 102.846 -3.02 . . . . 0.0 102.846 175.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 7.2 t -104.94 -176.02 2.96 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 104.273 -2.492 . . . . 0.0 104.273 174.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -137.85 164.55 40.23 Favored Pre-proline 0 N--CA 1.417 -2.084 1 N-CA-C 99.15 -4.389 . . . . 0.0 99.15 -158.266 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.25 55.87 3.65 Favored 'Trans proline' 0 C--N 1.322 -0.863 0 C-N-CA 123.263 2.642 . . . . 0.0 111.063 171.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -173.47 146.31 8.81 Favored Glycine 0 N--CA 1.421 -2.362 1 N-CA-C 99.577 -5.409 . . . . 0.0 99.577 175.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.4 m -93.35 8.77 39.13 Favored 'General case' 0 N--CA 1.438 -1.068 0 C-N-CA 123.92 0.888 . . . . 0.0 110.397 -174.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -50.38 -51.64 44.24 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 128.492 2.717 . . . . 0.0 114.131 -164.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -89.97 -22.01 37.29 Favored Glycine 0 C--N 1.351 1.365 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.9 t -81.28 -12.49 59.06 Favored 'General case' 0 C--N 1.355 0.835 0 O-C-N 121.046 -1.267 . . . . 0.0 109.592 -172.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -51.79 -55.21 21.16 Favored 'General case' 0 C--N 1.352 0.694 0 C-N-CA 124.584 1.154 . . . . 0.0 109.793 166.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.74 -44.98 96.01 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 123.965 0.906 . . . . 0.0 112.131 175.09 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.52 -39.02 93.01 Favored 'General case' 0 C--N 1.361 1.073 0 CA-C-N 118.977 0.808 . . . . 0.0 111.232 -177.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.6 t -68.05 -42.74 80.06 Favored 'General case' 0 N--CA 1.439 -0.987 0 O-C-N 121.301 -0.874 . . . . 0.0 109.51 -178.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -77.89 -26.41 49.13 Favored 'General case' 0 CA--C 1.505 -0.77 0 O-C-N 121.007 -1.058 . . . . 0.0 111.963 -174.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -76.66 -21.55 55.28 Favored 'General case' 0 C--N 1.355 0.815 0 O-C-N 121.243 -0.911 . . . . 0.0 110.988 179.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -79.93 -48.82 12.8 Favored 'General case' 0 CA--C 1.494 -1.174 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 168.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 120.83 48.36 0.3 Allowed Glycine 0 CA--C 1.489 -1.576 0 N-CA-C 108.214 -1.954 . . . . 0.0 108.214 177.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.07 139.29 14.73 Favored Glycine 0 N--CA 1.433 -1.531 0 N-CA-C 103.689 -3.764 . . . . 0.0 103.689 164.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -98.6 2.87 47.77 Favored 'General case' 0 N--CA 1.438 -1.05 0 C-N-CA 124.258 1.023 . . . . 0.0 109.607 -169.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 24.1 m -160.42 159.25 30.76 Favored 'General case' 0 CA--C 1.474 -1.954 0 N-CA-C 100.529 -3.878 . . . . 0.0 100.529 165.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.4 ' HA2' ' HA ' ' A' ' 49' ' ' CYS . . . -165.82 169.79 40.31 Favored Glycine 0 N--CA 1.418 -2.555 1 N-CA-C 101.407 -4.677 . . . . 0.0 101.407 -179.146 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 78.7 m-70 -161.4 -170.16 2.54 Favored 'General case' 0 CA--C 1.491 -1.295 1 N-CA-C 98.558 -4.608 . . . . 0.0 98.558 -174.098 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 73.1 m -145.87 162.57 37.42 Favored 'General case' 0 CA--C 1.485 -1.553 1 N-CA-C 98.852 -4.499 . . . . 0.0 98.852 172.17 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 173.29 179.97 44.31 Favored Glycine 0 N--CA 1.425 -2.049 1 N-CA-C 100.072 -5.211 . . . . 0.0 100.072 -177.099 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -151.1 141.91 22.84 Favored 'General case' 0 N--CA 1.426 -1.674 1 N-CA-C 96.407 -5.405 . . . . 0.0 96.407 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.9 mttp -157.74 58.22 0.49 Allowed 'General case' 0 CA--C 1.488 -1.434 1 N-CA-C 98.303 -4.703 . . . . 0.0 98.303 173.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.732 HG12 ' H ' ' A' ' 42' ' ' GLY 0.272 2.9 t 69.77 -172.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 C-N-CA 127.054 2.142 . . . . 0.0 105.543 -158.264 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.732 ' H ' HG12 ' A' ' 41' ' ' VAL . . . 145.04 -127.96 3.03 Favored Glycine 0 N--CA 1.421 -2.338 1 N-CA-C 97.716 -6.153 . . . . 0.0 97.716 -173.031 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 59.3 m170 -130.37 -39.16 1.33 Allowed 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 104.515 -2.402 . . . . 0.0 104.515 175.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -158.09 -177.0 30.78 Favored Glycine 0 N--CA 1.425 -2.051 1 N-CA-C 95.798 -6.921 . . . . 0.0 95.798 176.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.2 tt -72.25 114.94 10.91 Favored 'General case' 0 C--N 1.351 0.666 0 CA-C-N 118.693 1.247 . . . . 0.0 108.177 -171.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -105.85 -177.81 3.47 Favored 'General case' 0 CA--C 1.485 -1.529 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 -164.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 34.6 t -115.0 161.56 18.17 Favored 'General case' 0 CA--C 1.493 -1.236 0 N-CA-C 102.432 -3.173 . . . . 0.0 102.432 -175.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 33.0 t-105 -117.57 151.75 36.52 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 102.878 -3.008 . . . . 0.0 102.878 178.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.4 ' HA ' ' HA2' ' A' ' 35' ' ' GLY . 15.0 m -148.21 149.79 32.58 Favored 'General case' 0 CA--C 1.495 -1.157 0 N-CA-C 103.428 -2.805 . . . . 0.0 103.428 171.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -111.3 141.99 44.11 Favored 'General case' 0 CA--C 1.495 -1.15 0 N-CA-C 104.212 -2.514 . . . . 0.0 104.212 171.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 66.01 53.28 1.11 Allowed 'General case' 0 CA--C 1.491 -1.298 0 C-N-CA 127.488 2.315 . . . . 0.0 111.164 167.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 40.0 mt -94.81 142.93 25.35 Favored Pre-proline 0 CA--C 1.495 -1.147 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 177.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -72.01 166.74 28.7 Favored 'Trans proline' 0 N--CA 1.447 -1.258 0 C-N-CA 122.61 2.206 . . . . 0.0 110.134 175.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -68.99 -17.07 63.88 Favored 'General case' 0 CA--C 1.506 -0.728 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -167.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -76.48 -6.82 53.45 Favored 'General case' 0 CA--C 1.504 -0.81 0 O-C-N 121.439 -0.788 . . . . 0.0 110.942 -178.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.3 t -94.09 107.96 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 N-CA-C 104.474 -2.417 . . . . 0.0 104.474 178.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -81.63 148.39 27.6 Favored Glycine 0 CA--C 1.489 -1.549 0 N-CA-C 106.393 -2.683 . . . . 0.0 106.393 178.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 41.0 pt -133.66 -160.05 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.303 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 -165.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.678 HD13 ' HB2' ' A' ' 7' ' ' ALA . 0.3 OUTLIER -73.7 121.15 24.07 Favored 'Isoleucine or valine' 0 C--N 1.362 1.146 0 N-CA-C 104.829 -2.286 . . . . 0.0 104.829 176.042 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.4 t -133.06 34.35 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 N-CA-C 101.899 -3.371 . . . . 0.0 101.899 -162.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -72.16 94.28 1.52 Allowed 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 112.782 -2.008 . . . . 0.0 112.875 -169.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -143.42 31.68 1.91 Allowed Glycine 0 N--CA 1.437 -1.234 1 N-CA-C 101.8 -4.52 . . . . 0.0 101.8 155.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 178.48 -178.86 0.29 Allowed 'General case' 0 N--CA 1.432 -1.33 1 N-CA-C 95.093 -5.891 . . . . 0.0 95.093 -170.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 54.5 tttt -127.09 -154.64 0.64 Allowed 'General case' 0 CA--C 1.502 -0.881 0 N-CA-C 105.013 -2.217 . . . . 0.0 105.013 177.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 16.1 t -81.69 152.52 27.03 Favored 'General case' 0 CA--C 1.496 -1.129 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 -169.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 28.0 p-80 -131.05 169.14 16.27 Favored 'General case' 0 CA--C 1.487 -1.451 0 N-CA-C 100.822 -3.77 . . . . 0.0 100.822 174.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.6 m -171.29 174.06 4.68 Favored 'General case' 0 N--CA 1.424 -1.767 1 N-CA-C 96.096 -5.52 . . . . 0.0 96.096 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.357 0.921 0 O-C-N 124.301 1.0 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 33.5 m . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 121.354 0.597 . . . . 0.0 109.629 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -94.24 148.46 22.17 Favored 'General case' 0 CA--C 1.502 -0.879 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 173.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -122.37 118.19 27.84 Favored 'General case' 0 CA--C 1.489 -1.399 1 N-CA-C 94.394 -6.15 . . . . 0.0 94.394 154.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.61 -174.13 31.1 Favored Glycine 0 CA--C 1.479 -2.214 0 N-CA-C 106.196 -2.762 . . . . 0.0 106.196 -171.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 48' ' ' TRP . 92.3 m-85 -86.22 134.96 33.74 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 104.872 -2.27 . . . . 0.0 104.872 167.121 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 16.9 tt -90.63 151.23 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 176.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.513 ' HB2' ' CD1' ' A' ' 59' ' ' ILE . . . -156.3 -177.81 6.86 Favored 'General case' 0 N--CA 1.416 -2.144 1 N-CA-C 98.949 -4.463 . . . . 0.0 98.949 -177.142 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -93.53 156.91 39.31 Favored Pre-proline 0 N--CA 1.435 -1.186 0 N-CA-C 105.419 -2.067 . . . . 0.0 105.419 178.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -77.36 -1.96 12.14 Favored 'Trans proline' 0 CA--C 1.509 -0.745 0 CA-C-N 121.283 1.494 . . . . 0.0 115.254 -155.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -95.13 13.41 25.39 Favored 'General case' 0 C--N 1.358 0.96 0 CA-C-N 121.214 1.825 . . . . 0.0 107.498 176.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 43.4 t30 83.23 43.44 0.02 OUTLIER 'General case' 0 C--N 1.361 1.102 0 C-N-CA 126.081 1.752 . . . . 0.0 107.494 168.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.44 ' O ' ' HB1' ' A' ' 7' ' ' ALA . 0.7 OUTLIER -131.36 132.18 44.25 Favored 'General case' 0 CA--C 1.487 -1.462 0 N-CA-C 102.374 -3.195 . . . . 0.0 102.374 -173.148 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.481 HG12 HD11 ' A' ' 59' ' ' ILE 0.253 1.7 m -60.57 159.25 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 CA-C-O 123.435 1.588 . . . . 0.0 115.228 -173.411 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -114.73 139.97 49.26 Favored 'General case' 0 N--CA 1.416 -2.157 1 N-CA-C 92.687 -6.783 . . . . 0.0 92.687 169.554 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 66.1 m170 -90.42 -162.28 0.88 Allowed 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 178.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 25.4 t -150.06 171.62 16.57 Favored 'General case' 0 N--CA 1.417 -2.121 1 N-CA-C 97.52 -4.993 . . . . 0.0 97.52 -172.244 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -127.28 123.68 23.42 Favored Pre-proline 0 N--CA 1.419 -2.018 1 N-CA-C 95.925 -5.583 . . . . 0.0 95.925 -178.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -55.88 96.6 0.06 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.604 0 CA-C-N 124.224 2.544 . . . . 0.0 116.691 -168.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 159.92 -159.36 30.61 Favored Glycine 0 N--CA 1.422 -2.267 1 N-CA-C 98.07 -6.012 . . . . 0.0 98.07 -178.166 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.8 p -94.25 -43.67 8.33 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 170.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -39.74 -61.95 0.77 Allowed 'General case' 0 N--CA 1.442 -0.875 0 C-N-CA 128.812 2.845 . . . . 0.0 118.243 -150.287 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -72.09 -39.5 58.28 Favored Glycine 0 C--N 1.348 1.227 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -173.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 9.6 t -83.65 -28.45 28.39 Favored 'General case' 0 CA--C 1.5 -0.962 0 O-C-N 121.277 -1.131 . . . . 0.0 109.329 -177.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -60.81 -46.52 90.2 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-N 119.353 0.979 . . . . 0.0 109.679 175.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.9 p -67.06 -39.15 86.83 Favored 'General case' 0 N--CA 1.44 -0.941 0 O-C-N 121.894 -0.504 . . . . 0.0 111.721 179.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 40.7 mt -63.22 -47.61 81.77 Favored 'General case' 0 C--N 1.357 0.899 0 O-C-N 121.032 -1.043 . . . . 0.0 111.127 172.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 3.0 t -66.01 -32.33 73.75 Favored 'General case' 0 CA--C 1.501 -0.911 0 O-C-N 120.155 -1.59 . . . . 0.0 110.827 -175.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -65.41 -35.26 80.41 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 122.943 0.497 . . . . 0.0 111.488 176.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -75.93 -34.18 59.87 Favored 'General case' 0 C--N 1.359 0.999 0 O-C-N 121.559 -0.713 . . . . 0.0 111.108 177.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.2 mmmp? -72.15 -40.23 68.17 Favored 'General case' 0 C--N 1.36 1.026 0 C-N-CA 123.535 0.734 . . . . 0.0 110.519 178.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 128.41 43.57 0.23 Allowed Glycine 0 CA--C 1.492 -1.368 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 162.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -111.12 145.32 17.55 Favored Glycine 0 CA--C 1.491 -1.415 0 N-CA-C 105.512 -3.035 . . . . 0.0 105.512 169.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.4 p -92.23 4.61 52.89 Favored 'General case' 0 C--N 1.352 0.676 0 CA-C-N 118.053 0.926 . . . . 0.0 110.154 -171.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 57.4 m -157.13 156.66 33.09 Favored 'General case' 0 CA--C 1.483 -1.603 0 N-CA-C 100.981 -3.711 . . . . 0.0 100.981 168.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -152.98 141.17 8.16 Favored Glycine 0 N--CA 1.422 -2.278 1 N-CA-C 97.782 -6.127 . . . . 0.0 97.782 -178.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 15.1 t-80 -159.94 175.6 12.84 Favored 'General case' 0 N--CA 1.429 -1.495 1 N-CA-C 99.692 -4.188 . . . . 0.0 99.692 -169.263 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 63.2 m -95.22 -174.93 3.36 Favored 'General case' 0 CA--C 1.491 -1.296 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 176.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 177.13 -166.56 37.25 Favored Glycine 0 N--CA 1.417 -2.604 1 N-CA-C 96.196 -6.762 . . . . 0.0 96.196 179.282 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -144.51 138.82 27.84 Favored 'General case' 0 N--CA 1.43 -1.437 1 N-CA-C 96.098 -5.519 . . . . 0.0 96.098 173.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 26.2 tptp -120.69 100.14 6.94 Favored 'General case' 0 CA--C 1.487 -1.471 0 N-CA-C 102.358 -3.201 . . . . 0.0 102.358 -179.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.5 t -68.45 134.1 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 -175.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 115.67 -36.83 3.69 Favored Glycine 0 CA--C 1.492 -1.387 0 N-CA-C 105.951 -2.86 . . . . 0.0 105.951 -171.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 57.9 m-70 -106.19 -66.85 0.97 Allowed 'General case' 0 CA--C 1.494 -1.177 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 174.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 150.1 -143.26 10.51 Favored Glycine 0 CA--C 1.481 -2.054 0 N-CA-C 103.826 -3.71 . . . . 0.0 103.826 -174.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.9 tp -65.58 135.98 55.78 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 105.124 -2.176 . . . . 0.0 105.124 172.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -155.04 172.6 17.85 Favored 'General case' 0 CA--C 1.475 -1.917 1 N-CA-C 97.98 -4.822 . . . . 0.0 97.98 -168.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 9.1 t -118.34 159.78 22.8 Favored 'General case' 0 CA--C 1.487 -1.444 0 N-CA-C 103.089 -2.93 . . . . 0.0 103.089 -173.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.407 ' HA ' ' HA ' ' A' ' 5' ' ' TYR . 19.0 t-105 -118.83 146.18 45.06 Favored 'General case' 0 CA--C 1.496 -1.116 0 N-CA-C 103.288 -2.856 . . . . 0.0 103.288 -176.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 79.5 m -146.26 157.78 43.83 Favored 'General case' 0 CA--C 1.487 -1.457 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 173.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -118.06 138.88 51.93 Favored 'General case' 0 CA--C 1.495 -1.15 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 176.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 64.62 61.89 0.81 Allowed 'General case' 0 CA--C 1.494 -1.191 0 C-N-CA 128.102 2.561 . . . . 0.0 111.646 173.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 28.6 mt -96.04 133.45 25.2 Favored Pre-proline 0 CA--C 1.502 -0.882 0 N-CA-C 104.015 -2.587 . . . . 0.0 104.015 172.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -75.32 173.97 13.6 Favored 'Trans proline' 0 N--CA 1.447 -1.247 0 CA-C-N 122.057 1.771 . . . . 0.0 109.768 -178.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -74.3 -5.53 42.69 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -169.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -90.61 -0.93 57.86 Favored 'General case' 0 CA--C 1.502 -0.872 0 O-C-N 121.239 -0.913 . . . . 0.0 110.015 -178.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.5 t -97.88 152.01 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 N-CA-C 102.677 -3.083 . . . . 0.0 102.677 178.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -123.01 153.28 16.96 Favored Glycine 0 CA--C 1.481 -2.045 1 N-CA-C 98.767 -5.733 . . . . 0.0 98.767 177.153 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 19.5 pt -152.82 -154.63 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 N-CA-C 101.258 -3.608 . . . . 0.0 101.258 -163.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.513 ' CD1' ' HB2' ' A' ' 7' ' ' ALA . 4.5 mp -73.76 119.28 20.61 Favored 'Isoleucine or valine' 0 C--N 1.362 1.11 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 169.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -149.77 -175.42 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.537 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 -157.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 75.92 -56.54 0.59 Allowed 'General case' 0 CA--C 1.503 -0.852 0 C-N-CA 127.437 2.295 . . . . 0.0 112.702 167.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 108.87 -10.56 34.66 Favored Glycine 0 CA--C 1.492 -1.35 0 N-CA-C 107.309 -2.316 . . . . 0.0 107.309 -175.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -105.36 -165.32 1.11 Allowed 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 103.634 -2.728 . . . . 0.0 103.634 168.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 31.2 tttp -109.97 -149.9 0.45 Allowed 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 -170.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 29.5 t -81.26 153.73 26.97 Favored 'General case' 0 CA--C 1.496 -1.13 0 C-N-CA 124.951 1.301 . . . . 0.0 108.795 -168.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -138.41 179.81 6.24 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 101.961 -3.348 . . . . 0.0 101.961 176.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.4 m -171.99 172.71 4.63 Favored 'General case' 0 N--CA 1.425 -1.72 1 N-CA-C 95.8 -5.63 . . . . 0.0 95.8 179.034 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.358 0.969 0 O-C-N 124.202 0.939 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 27.3 m . . . . . 0 N--CA 1.485 1.29 0 CA-C-O 121.413 0.625 . . . . 0.0 110.646 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -99.25 155.62 17.4 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 105.318 -2.105 . . . . 0.0 105.318 166.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -122.16 126.32 48.06 Favored 'General case' 0 CA--C 1.486 -1.488 1 N-CA-C 94.331 -6.174 . . . . 0.0 94.331 153.19 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.55 179.91 36.65 Favored Glycine 0 CA--C 1.475 -2.466 0 N-CA-C 104.345 -3.502 . . . . 0.0 104.345 -174.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -79.89 134.05 36.28 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 104.461 -2.422 . . . . 0.0 104.461 168.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 16.4 tt -90.36 149.4 4.06 Favored 'Isoleucine or valine' 0 C--N 1.355 0.808 0 N-CA-C 105.62 -1.992 . . . . 0.0 105.62 -178.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.764 ' HB2' HD12 ' A' ' 59' ' ' ILE . . . -139.96 -173.07 3.54 Favored 'General case' 0 N--CA 1.417 -2.113 0 C-N-CA 126.255 1.822 . . . . 0.0 106.898 -170.577 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -95.18 148.33 34.48 Favored Pre-proline 0 N--CA 1.432 -1.36 0 N-CA-C 102.085 -3.302 . . . . 0.0 102.085 163.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_exo -69.62 -26.86 27.8 Favored 'Trans proline' 0 CA--C 1.501 -1.144 0 CA-C-N 123.034 2.119 . . . . 0.0 115.52 -153.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -88.76 53.78 2.81 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-N 119.224 0.92 . . . . 0.0 110.483 -167.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.463 HD21 ' HB3' ' A' ' 61' ' ' GLU . 4.2 t-20 75.32 41.34 0.29 Allowed 'General case' 0 C--N 1.354 0.786 0 C-N-CA 125.793 1.637 . . . . 0.0 110.121 167.095 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 55.6 m -117.05 -154.86 0.57 Allowed 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -168.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.807 HG12 HD11 ' A' ' 59' ' ' ILE . 1.6 m -133.01 175.57 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.4 1 N-CA-C 98.433 -4.655 . . . . 0.0 98.433 166.66 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . 0.31 0.2 OUTLIER -119.62 141.14 49.57 Favored 'General case' 0 CA--C 1.477 -1.861 1 N-CA-C 92.684 -6.784 . . . . 0.0 92.684 170.045 . . . . . . . . 4 3 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 21.5 m80 -90.46 145.66 24.74 Favored 'General case' 0 CA--C 1.491 -1.306 0 N-CA-C 103.558 -2.756 . . . . 0.0 103.558 174.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.7 t -90.48 167.71 12.39 Favored 'General case' 0 CA--C 1.483 -1.606 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 -176.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -114.38 113.44 45.75 Favored Pre-proline 0 N--CA 1.42 -1.952 1 N-CA-C 98.424 -4.658 . . . . 0.0 98.424 168.427 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -57.59 129.59 34.53 Favored 'Trans proline' 0 CA--C 1.507 -0.87 0 CA-C-N 123.154 2.162 . . . . 0.0 111.351 178.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 126.61 -56.98 0.71 Allowed Glycine 0 CA--C 1.49 -1.5 1 N-CA-C 101.853 -4.499 . . . . 0.0 101.853 -157.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.5 m 107.3 -6.1 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.321 0 C-N-CA 129.25 3.02 . . . . 0.0 110.932 174.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.1 m -42.42 -55.36 3.45 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 127.625 2.37 . . . . 0.0 115.275 -166.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -72.26 -45.86 37.2 Favored Glycine 0 C--N 1.351 1.378 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 -176.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.9 m -72.89 -32.59 65.48 Favored 'General case' 0 CA--C 1.492 -1.269 0 O-C-N 121.474 -1.015 . . . . 0.0 112.003 -174.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -65.78 -38.32 88.7 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 174.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 32.2 m -65.29 -43.35 91.42 Favored 'General case' 0 C--N 1.35 0.603 0 O-C-N 120.733 -1.23 . . . . 0.0 110.144 176.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 33.9 mt -63.69 -40.39 96.69 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-O 122.17 0.986 . . . . 0.0 110.474 178.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.4 t -57.14 -43.8 82.77 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 124.6 1.16 . . . . 0.0 110.79 175.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -64.03 -43.61 95.05 Favored 'General case' 0 C--N 1.355 0.84 0 CA-C-N 118.494 0.588 . . . . 0.0 111.633 -178.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -79.04 -30.63 44.23 Favored 'General case' 0 CA--C 1.507 -0.674 0 O-C-N 122.039 -0.413 . . . . 0.0 111.27 -172.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -83.77 -22.11 31.99 Favored 'General case' 0 C--N 1.355 0.843 0 O-C-N 121.774 -0.579 . . . . 0.0 109.847 177.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 108.65 48.27 0.86 Allowed Glycine 0 CA--C 1.491 -1.439 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 159.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.23 154.27 16.9 Favored Glycine 0 C--N 1.35 1.326 0 N-CA-C 106.582 -2.607 . . . . 0.0 106.582 170.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 39.3 p -90.81 -20.53 22.23 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-O 122.341 1.067 . . . . 0.0 109.927 -165.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.9 m -160.22 159.75 31.9 Favored 'General case' 0 N--CA 1.423 -1.818 1 N-CA-C 98.122 -4.77 . . . . 0.0 98.122 179.237 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -178.6 172.52 44.87 Favored Glycine 0 CA--C 1.467 -2.944 1 N-CA-C 100.039 -5.224 . . . . 0.0 100.039 -179.347 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 177.95 -160.07 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 100.262 -3.977 . . . . 0.0 100.262 -174.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 61.6 m -76.77 177.49 7.56 Favored 'General case' 0 CA--C 1.504 -0.821 0 CA-C-O 121.898 0.856 . . . . 0.0 110.704 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -164.05 -179.11 38.1 Favored Glycine 0 N--CA 1.42 -2.426 1 N-CA-C 98.663 -5.775 . . . . 0.0 98.663 178.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -143.7 159.99 41.5 Favored 'General case' 0 N--CA 1.422 -1.833 1 N-CA-C 97.623 -4.955 . . . . 0.0 97.623 -177.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.1 mmmm -148.95 167.08 26.72 Favored 'General case' 0 N--CA 1.421 -1.886 1 N-CA-C 95.995 -5.557 . . . . 0.0 95.995 169.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -133.43 156.77 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.685 1 N-CA-C 94.391 -6.151 . . . . 0.0 94.391 173.228 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.89 -60.53 0.73 Allowed Glycine 0 CA--C 1.492 -1.394 0 N-CA-C 104.771 -3.331 . . . . 0.0 104.771 -170.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 23.4 m170 -90.24 -90.61 0.15 Allowed 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 166.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 163.86 -156.61 28.54 Favored Glycine 0 CA--C 1.479 -2.194 1 N-CA-C 99.399 -5.48 . . . . 0.0 99.399 179.033 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 54.0 tp -43.52 126.73 4.53 Favored 'General case' 0 C--N 1.352 0.712 0 C-N-CA 128.001 2.521 . . . . 0.0 111.646 -179.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -127.67 -171.19 2.38 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 105.416 -2.068 . . . . 0.0 105.416 -168.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 63.7 m -131.23 176.21 8.47 Favored 'General case' 0 CA--C 1.482 -1.641 0 N-CA-C 102.746 -3.057 . . . . 0.0 102.746 171.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 12.5 t-105 -137.58 154.03 49.85 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 -177.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 22.6 m -145.59 152.84 40.34 Favored 'General case' 0 CA--C 1.493 -1.25 0 N-CA-C 104.269 -2.493 . . . . 0.0 104.269 171.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -109.53 143.54 39.05 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 104.31 -2.478 . . . . 0.0 104.31 168.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 55.9 62.48 2.37 Favored 'General case' 0 CA--C 1.499 -1.017 0 C-N-CA 127.871 2.469 . . . . 0.0 113.128 173.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 33.5 mt -95.61 134.74 23.77 Favored Pre-proline 0 CA--C 1.498 -1.021 0 N-CA-C 103.614 -2.735 . . . . 0.0 103.614 171.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -71.53 176.54 7.93 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 CA-C-N 122.375 1.884 . . . . 0.0 111.72 178.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -75.02 -8.76 57.45 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 113.65 0.982 . . . . 0.0 113.65 -167.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.8 p-10 -85.99 -8.24 58.1 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 121.605 -0.684 . . . . 0.0 110.069 -179.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.0 t -92.9 127.78 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 -175.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -97.32 140.69 15.19 Favored Glycine 0 CA--C 1.484 -1.898 0 N-CA-C 104.424 -3.47 . . . . 0.0 104.424 177.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 24.4 pt -139.09 -151.8 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 N-CA-C 104.157 -2.535 . . . . 0.0 104.157 -165.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.807 HD11 HG12 ' A' ' 13' ' ' VAL . 1.8 mp -66.41 118.77 10.27 Favored 'Isoleucine or valine' 0 C--N 1.364 1.209 0 N-CA-C 103.501 -2.778 . . . . 0.0 103.501 168.107 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.4 t -137.86 148.63 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.843 1 N-CA-C 96.95 -5.204 . . . . 0.0 96.95 -168.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.463 ' HB3' HD21 ' A' ' 11' ' ' ASN . 13.7 tp10 60.37 -64.42 0.06 Allowed 'General case' 0 CA--C 1.504 -0.791 0 C-N-CA 130.169 3.388 . . . . 0.0 115.321 173.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.77 58.88 1.56 Allowed Glycine 0 N--CA 1.437 -1.239 0 N-CA-C 104.924 -3.27 . . . . 0.0 104.924 -160.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -102.82 -90.09 0.37 Allowed 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 103.575 -2.75 . . . . 0.0 103.575 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 53.2 tptt -173.76 160.97 3.77 Favored 'General case' 0 N--CA 1.423 -1.801 1 N-CA-C 96.996 -5.187 . . . . 0.0 96.996 176.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 41.4 t -83.21 135.61 34.72 Favored 'General case' 0 CA--C 1.5 -0.955 0 N-CA-C 103.501 -2.777 . . . . 0.0 103.501 178.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 46.6 p-80 -149.59 159.82 44.0 Favored 'General case' 0 CA--C 1.484 -1.59 0 N-CA-C 102.812 -3.033 . . . . 0.0 102.812 -170.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.0 m -80.4 56.72 2.62 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 118.665 0.666 . . . . 0.0 111.258 -177.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.361 1.079 0 CA-C-N 116.223 -0.444 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 27.4 m . . . . . 0 N--CA 1.484 1.265 0 CA-C-O 121.174 0.512 . . . . 0.0 110.26 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -105.03 160.34 15.12 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 106.109 -1.811 . . . . 0.0 106.109 168.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -127.69 126.62 42.24 Favored 'General case' 0 CA--C 1.49 -1.357 1 N-CA-C 96.636 -5.32 . . . . 0.0 96.636 158.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.04 -170.83 27.35 Favored Glycine 0 CA--C 1.477 -2.328 1 N-CA-C 102.084 -4.407 . . . . 0.0 102.084 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -81.08 141.68 34.07 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 103.611 -2.737 . . . . 0.0 103.611 164.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 11.5 tt -90.4 142.14 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.024 0 N-CA-C 104.903 -2.258 . . . . 0.0 104.903 175.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.944 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -130.52 175.65 8.81 Favored 'General case' 0 N--CA 1.414 -2.233 0 N-CA-C 103.919 -2.622 . . . . 0.0 103.919 -175.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -79.6 154.21 76.11 Favored Pre-proline 0 N--CA 1.432 -1.34 0 N-CA-C 105.032 -2.21 . . . . 0.0 105.032 166.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -68.96 0.34 5.18 Favored 'Trans proline' 0 CA--C 1.511 -0.627 0 C-N-CA 121.94 1.76 . . . . 0.0 116.609 -168.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -102.28 9.56 39.85 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 119.773 1.169 . . . . 0.0 108.525 -175.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 66.3 t30 73.34 57.54 0.11 Allowed 'General case' 0 CA--C 1.497 -1.096 0 C-N-CA 126.278 1.831 . . . . 0.0 107.951 -177.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 30.5 m -142.01 135.71 29.55 Favored 'General case' 0 CA--C 1.485 -1.541 1 N-CA-C 99.01 -4.441 . . . . 0.0 99.01 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.462 HG12 HD11 ' A' ' 59' ' ' ILE . 2.7 m -60.95 148.47 9.07 Favored 'Isoleucine or valine' 0 C--N 1.354 0.764 0 CA-C-N 120.463 1.483 . . . . 0.0 112.35 -172.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -98.02 132.09 43.88 Favored 'General case' 0 CA--C 1.483 -1.623 1 N-CA-C 97.97 -4.826 . . . . 0.0 97.97 177.211 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 66.9 m80 -90.38 -175.58 4.52 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 -166.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 5.7 t -147.03 157.55 43.65 Favored 'General case' 0 N--CA 1.413 -2.305 1 N-CA-C 96.392 -5.41 . . . . 0.0 96.392 -175.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -117.34 110.92 40.51 Favored Pre-proline 0 N--CA 1.419 -2.008 1 N-CA-C 96.906 -5.22 . . . . 0.0 96.906 172.405 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_exo -60.1 114.57 2.15 Favored 'Trans proline' 0 CA--C 1.506 -0.899 0 CA-C-N 123.324 2.223 . . . . 0.0 113.811 -162.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 154.45 -42.98 0.59 Allowed Glycine 0 N--CA 1.432 -1.568 1 N-CA-C 100.584 -5.006 . . . . 0.0 100.584 -163.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.6 m 95.84 21.84 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.31 0 C-N-CA 127.329 2.251 . . . . 0.0 111.071 167.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 p -68.13 -52.29 36.47 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 125.493 1.517 . . . . 0.0 110.302 -174.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.62 -38.39 90.17 Favored Glycine 0 C--N 1.347 1.192 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 178.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 41.9 t -66.15 -48.33 71.13 Favored 'General case' 0 CA--C 1.502 -0.872 0 C-N-CA 124.283 1.033 . . . . 0.0 110.013 -177.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -53.34 -49.91 66.11 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 125.539 1.536 . . . . 0.0 109.925 175.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.4 m -60.51 -53.09 61.75 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 124.105 0.962 . . . . 0.0 111.299 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 37.4 mt -65.47 -44.45 87.13 Favored 'General case' 0 CA--C 1.492 -1.257 0 C-N-CA 125.068 1.347 . . . . 0.0 110.234 -175.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.8 t -62.56 -44.97 95.0 Favored 'General case' 0 N--CA 1.435 -1.189 0 C-N-CA 123.021 0.528 . . . . 0.0 109.788 179.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -69.25 -41.94 76.27 Favored 'General case' 0 CA--C 1.503 -0.856 0 O-C-N 122.247 -0.283 . . . . 0.0 110.402 -174.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -74.73 -27.36 60.33 Favored 'General case' 0 CA--C 1.505 -0.777 0 O-C-N 121.715 -0.616 . . . . 0.0 111.621 -176.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.36 -23.53 27.97 Favored 'General case' 0 C--N 1.358 0.966 0 CA-C-O 121.571 0.7 . . . . 0.0 109.331 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.08 43.05 1.23 Allowed Glycine 0 CA--C 1.484 -1.859 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 162.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -98.91 152.09 19.61 Favored Glycine 0 CA--C 1.491 -1.461 0 N-CA-C 104.278 -3.529 . . . . 0.0 104.278 165.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 23.5 p -87.77 -44.53 11.06 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -168.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 18.3 m -129.06 157.23 42.32 Favored 'General case' 0 CA--C 1.485 -1.547 0 N-CA-C 102.14 -3.282 . . . . 0.0 102.14 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -161.26 160.19 31.9 Favored Glycine 0 N--CA 1.416 -2.683 1 N-CA-C 98.473 -5.851 . . . . 0.0 98.473 178.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 9.0 p-80 -164.21 176.53 9.12 Favored 'General case' 0 N--CA 1.427 -1.594 1 N-CA-C 96.719 -5.289 . . . . 0.0 96.719 -178.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 70.3 m -110.58 165.76 11.55 Favored 'General case' 0 CA--C 1.481 -1.69 0 CA-C-N 119.566 1.075 . . . . 0.0 108.256 -173.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -175.6 -169.05 36.83 Favored Glycine 0 N--CA 1.424 -2.154 1 N-CA-C 100.649 -4.981 . . . . 0.0 100.649 -179.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -130.32 138.88 50.67 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 101.605 -3.48 . . . . 0.0 101.605 -172.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -108.1 111.89 24.16 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 102.855 -3.017 . . . . 0.0 102.855 174.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.8 t -80.81 120.66 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 -175.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 119.93 -7.12 12.03 Favored Glycine 0 CA--C 1.494 -1.267 0 N-CA-C 106.838 -2.505 . . . . 0.0 106.838 -166.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.467 ' HE1' ' O ' ' A' ' 64' ' ' LYS . 44.8 m-70 -139.69 -79.56 0.31 Allowed 'General case' 0 CA--C 1.497 -1.067 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 167.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 170.4 -161.52 34.55 Favored Glycine 0 N--CA 1.426 -2.023 0 N-CA-C 104.188 -3.565 . . . . 0.0 104.188 -166.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 30.8 tp -65.57 133.44 51.19 Favored 'General case' 0 CA--C 1.505 -0.77 0 C-N-CA 127.197 2.199 . . . . 0.0 107.275 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.25 -176.41 4.25 Favored 'General case' 0 CA--C 1.491 -1.326 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 -166.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.2 t -125.13 151.16 46.13 Favored 'General case' 0 CA--C 1.491 -1.323 1 N-CA-C 98.631 -4.581 . . . . 0.0 98.631 175.226 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 38.0 t-105 -107.15 152.8 23.58 Favored 'General case' 0 CA--C 1.494 -1.185 0 N-CA-C 103.941 -2.614 . . . . 0.0 103.941 179.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 22.9 m -143.77 150.57 38.78 Favored 'General case' 0 CA--C 1.483 -1.621 0 N-CA-C 104.307 -2.479 . . . . 0.0 104.307 170.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -116.09 140.44 49.28 Favored 'General case' 0 CA--C 1.492 -1.277 0 N-CA-C 102.464 -3.161 . . . . 0.0 102.464 171.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 67.21 56.67 0.62 Allowed 'General case' 0 CA--C 1.496 -1.112 0 C-N-CA 127.103 2.161 . . . . 0.0 111.601 172.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 25.1 mt -93.96 134.04 26.7 Favored Pre-proline 0 CA--C 1.496 -1.12 0 N-CA-C 104.411 -2.44 . . . . 0.0 104.411 174.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -75.06 173.61 14.22 Favored 'Trans proline' 0 N--CA 1.445 -1.327 0 C-N-CA 122.236 1.958 . . . . 0.0 110.236 178.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -64.75 -13.21 54.22 Favored 'General case' 0 CA--C 1.506 -0.744 0 C-N-CA 125.795 1.638 . . . . 0.0 114.477 -173.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -89.88 8.76 30.48 Favored 'General case' 0 CA--C 1.504 -0.807 0 O-C-N 121.503 -0.748 . . . . 0.0 110.247 -176.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.7 t -110.54 141.93 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.339 0 N-CA-C 102.552 -3.129 . . . . 0.0 102.552 177.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -115.79 148.14 18.91 Favored Glycine 0 CA--C 1.479 -2.21 1 N-CA-C 100.3 -5.12 . . . . 0.0 100.3 175.176 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 24.2 pt -147.28 -151.22 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.426 -1.635 0 N-CA-C 102.34 -3.207 . . . . 0.0 102.34 -163.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.944 HD13 ' HB2' ' A' ' 7' ' ' ALA . 7.5 mm -71.65 122.55 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 178.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -142.77 171.41 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.404 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 -163.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 71.67 -57.86 0.6 Allowed 'General case' 0 C--N 1.362 1.115 0 C-N-CA 126.925 2.09 . . . . 0.0 113.161 169.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 155.18 -69.03 0.29 Allowed Glycine 0 N--CA 1.424 -2.142 1 N-CA-C 100.416 -5.074 . . . . 0.0 100.416 -170.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 73.6 tt0 -166.79 153.35 8.64 Favored 'General case' 0 N--CA 1.423 -1.814 1 N-CA-C 97.286 -5.079 . . . . 0.0 97.286 179.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.467 ' O ' ' HE1' ' A' ' 43' ' ' HIS . 18.6 ttmm -179.71 -173.06 0.23 Allowed 'General case' 0 N--CA 1.429 -1.514 1 N-CA-C 95.031 -5.915 . . . . 0.0 95.031 167.07 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 34.9 t -166.0 156.78 13.14 Favored 'General case' 0 N--CA 1.429 -1.484 1 N-CA-C 95.298 -5.816 . . . . 0.0 95.298 160.273 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 29.7 p-80 -162.13 -173.51 3.68 Favored 'General case' 0 CA--C 1.486 -1.509 0 N-CA-C 100.418 -3.919 . . . . 0.0 100.418 173.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 39.0 m -172.72 173.77 3.82 Favored 'General case' 0 N--CA 1.424 -1.727 1 N-CA-C 95.921 -5.585 . . . . 0.0 95.921 179.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.358 0.96 0 O-C-N 124.018 0.824 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.2 m . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 121.164 0.507 . . . . 0.0 110.411 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -109.94 159.26 17.41 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 175.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -126.99 127.13 44.33 Favored 'General case' 0 CA--C 1.488 -1.41 1 N-CA-C 95.21 -5.848 . . . . 0.0 95.21 158.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.82 -169.14 24.73 Favored Glycine 0 CA--C 1.474 -2.53 1 N-CA-C 102.372 -4.291 . . . . 0.0 102.372 -179.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 48' ' ' TRP . 16.4 m-85 -83.71 143.85 29.76 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 103.859 -2.645 . . . . 0.0 103.859 161.27 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.0 tt -90.79 141.49 14.33 Favored 'Isoleucine or valine' 0 C--O 1.25 1.102 0 N-CA-C 105.939 -1.875 . . . . 0.0 105.939 174.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.802 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -140.18 174.41 10.54 Favored 'General case' 0 N--CA 1.42 -1.966 1 N-CA-C 99.915 -4.106 . . . . 0.0 99.915 175.628 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -85.2 160.25 55.02 Favored Pre-proline 0 N--CA 1.432 -1.36 0 C-N-CA 126.983 2.113 . . . . 0.0 106.014 178.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -70.23 -11.98 31.19 Favored 'Trans proline' 0 CA--C 1.505 -0.95 0 CA-C-N 121.4 1.536 . . . . 0.0 116.024 -160.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -99.58 15.02 27.98 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -178.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 63.7 t30 74.43 54.64 0.09 Allowed 'General case' 0 CA--C 1.501 -0.929 0 C-N-CA 125.706 1.603 . . . . 0.0 110.052 172.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.455 ' O ' ' HB1' ' A' ' 7' ' ' ALA . 1.2 m -133.86 136.59 44.47 Favored 'General case' 0 CA--C 1.478 -1.823 1 N-CA-C 98.909 -4.478 . . . . 0.0 98.909 176.692 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -64.35 155.18 6.35 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.932 0 CA-C-N 120.186 1.357 . . . . 0.0 112.224 -172.16 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -104.8 128.2 52.87 Favored 'General case' 0 CA--C 1.473 -1.997 1 N-CA-C 91.416 -7.253 . . . . 0.0 91.416 177.154 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 41.1 m80 -88.5 -150.57 0.19 Allowed 'General case' 0 CA--C 1.491 -1.291 0 N-CA-C 105.41 -2.07 . . . . 0.0 105.41 -167.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 8.0 t -153.19 161.99 41.81 Favored 'General case' 0 N--CA 1.413 -2.303 1 N-CA-C 94.094 -6.262 . . . . 0.0 94.094 -176.006 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -111.73 112.82 53.34 Favored Pre-proline 0 N--CA 1.422 -1.847 1 N-CA-C 95.907 -5.59 . . . . 0.0 95.907 171.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo -60.39 101.06 0.16 Allowed 'Trans proline' 0 CA--C 1.508 -0.811 0 C-N-CA 122.457 2.105 . . . . 0.0 116.449 -157.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 169.16 -178.33 42.42 Favored Glycine 0 N--CA 1.422 -2.247 1 N-CA-C 95.893 -6.883 . . . . 0.0 95.893 178.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.3 m -69.78 -39.24 76.77 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 119.45 1.625 . . . . 0.0 109.234 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -43.87 -53.03 6.39 Favored 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 130.653 3.581 . . . . 0.0 115.607 -173.278 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.71 -39.7 66.29 Favored Glycine 0 C--N 1.353 1.473 0 O-C-N 120.998 -1.064 . . . . 0.0 111.441 -171.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 38.9 t -70.92 -47.24 60.19 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -54.91 -44.14 73.92 Favored 'General case' 0 C--N 1.354 0.769 0 C-N-CA 123.267 0.627 . . . . 0.0 110.845 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 26.6 m -59.92 -50.13 74.97 Favored 'General case' 0 C--N 1.35 0.601 0 C-N-CA 123.193 0.597 . . . . 0.0 111.509 177.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 50.3 mt -67.77 -40.43 84.03 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-O 122.437 1.113 . . . . 0.0 110.43 -176.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.0 t -62.44 -42.75 99.69 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 124.64 1.176 . . . . 0.0 109.419 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 24.0 mtpp -68.44 -42.57 78.65 Favored 'General case' 0 C--N 1.355 0.831 0 C-N-CA 123.072 0.549 . . . . 0.0 111.674 -179.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -75.07 -22.16 58.51 Favored 'General case' 0 C--N 1.354 0.782 0 O-C-N 121.455 -0.778 . . . . 0.0 111.24 -174.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.3 mmtm -79.86 -60.33 2.38 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 170.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 135.39 50.12 0.07 OUTLIER Glycine 0 CA--C 1.489 -1.577 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 171.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.5 141.95 15.57 Favored Glycine 0 CA--C 1.491 -1.442 0 N-CA-C 103.839 -3.704 . . . . 0.0 103.839 164.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.1 p -100.11 3.32 43.85 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 123.813 0.845 . . . . 0.0 110.334 -165.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.4 m -160.1 158.53 30.49 Favored 'General case' 0 CA--C 1.476 -1.894 1 N-CA-C 97.773 -4.899 . . . . 0.0 97.773 168.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -170.76 164.76 37.97 Favored Glycine 0 CA--C 1.469 -2.817 1 N-CA-C 99.56 -5.416 . . . . 0.0 99.56 -176.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 59.9 m80 -155.05 152.98 30.25 Favored 'General case' 0 N--CA 1.43 -1.45 1 N-CA-C 100.049 -4.056 . . . . 0.0 100.049 -175.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 44.9 t -85.1 153.76 22.49 Favored 'General case' 0 CA--C 1.505 -0.778 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 -175.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -174.55 -177.1 43.42 Favored Glycine 0 CA--C 1.482 -2.017 0 N-CA-C 105.061 -3.216 . . . . 0.0 105.061 179.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -119.98 142.61 48.62 Favored 'General case' 0 N--CA 1.431 -1.42 1 N-CA-C 99.547 -4.242 . . . . 0.0 99.547 -179.003 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 24.8 tptp -119.31 103.91 9.91 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 101.457 -3.534 . . . . 0.0 101.457 175.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.9 t -73.07 136.9 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 N-CA-C 105.868 -1.901 . . . . 0.0 105.868 -178.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 113.34 -24.75 12.01 Favored Glycine 0 CA--C 1.491 -1.435 0 N-CA-C 106.23 -2.748 . . . . 0.0 106.23 -168.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 60.8 m-70 -127.98 -81.11 0.59 Allowed 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 174.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 168.17 -151.76 19.14 Favored Glycine 0 N--CA 1.429 -1.798 0 N-CA-C 105.169 -3.172 . . . . 0.0 105.169 -171.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 49.1 tp -65.41 126.14 27.33 Favored 'General case' 0 CA--C 1.506 -0.721 0 C-N-CA 126.634 1.974 . . . . 0.0 106.856 178.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -134.27 -167.99 2.06 Favored 'General case' 0 CA--C 1.489 -1.372 0 N-CA-C 105.369 -2.085 . . . . 0.0 105.369 -166.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.7 t -136.86 148.23 46.97 Favored 'General case' 0 CA--C 1.489 -1.369 0 N-CA-C 100.349 -3.945 . . . . 0.0 100.349 172.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.414 ' HA ' ' HA ' ' A' ' 5' ' ' TYR . 20.3 t-105 -102.89 148.69 25.33 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 104.111 -2.552 . . . . 0.0 104.111 177.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 50.2 m -144.77 149.2 35.1 Favored 'General case' 0 CA--C 1.498 -1.052 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 176.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -113.62 142.84 45.51 Favored 'General case' 0 CA--C 1.495 -1.164 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 172.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 62.69 57.03 1.85 Allowed 'General case' 0 CA--C 1.494 -1.191 0 C-N-CA 127.985 2.514 . . . . 0.0 111.103 172.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 17.8 mt -90.07 137.28 28.09 Favored Pre-proline 0 N--CA 1.44 -0.959 0 N-CA-C 104.899 -2.26 . . . . 0.0 104.899 174.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_exo -69.02 171.88 12.88 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 122.036 1.824 . . . . 0.0 113.047 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -76.25 -13.16 60.17 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 123.39 0.676 . . . . 0.0 112.203 -171.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -91.64 13.3 18.37 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 124.122 0.969 . . . . 0.0 110.426 178.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.3 t -104.22 160.9 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 N-CA-C 101.535 -3.506 . . . . 0.0 101.535 171.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -138.05 150.52 20.97 Favored Glycine 0 CA--C 1.481 -2.09 1 N-CA-C 96.986 -6.446 . . . . 0.0 96.986 178.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 29.4 pt -156.68 -155.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 N-CA-C 101.586 -3.487 . . . . 0.0 101.586 -158.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.802 HD13 ' HB2' ' A' ' 7' ' ' ALA . 3.2 mm -63.08 137.51 24.48 Favored 'Isoleucine or valine' 0 C--N 1.363 1.163 0 C-N-CA 123.943 0.897 . . . . 0.0 109.556 -177.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -149.46 166.71 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.986 1 N-CA-C 96.295 -5.446 . . . . 0.0 96.295 -178.68 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.404 ' HG2' ' H ' ' A' ' 62' ' ' GLY . 28.2 tt0 -170.0 174.55 5.47 Favored 'General case' 0 N--CA 1.428 -1.545 1 N-CA-C 97.686 -4.931 . . . . 0.0 97.686 177.64 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.404 ' H ' ' HG2' ' A' ' 61' ' ' GLU . . . 79.52 35.94 27.78 Favored Glycine 0 C--N 1.349 1.268 0 N-CA-C 104.971 -3.252 . . . . 0.0 104.971 -159.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 178.59 -154.03 0.02 OUTLIER 'General case' 0 N--CA 1.42 -1.948 1 N-CA-C 95.712 -5.662 . . . . 0.0 95.712 -159.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -168.76 -156.69 0.17 Allowed 'General case' 0 N--CA 1.427 -1.61 1 N-CA-C 95.877 -5.601 . . . . 0.0 95.877 -168.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 42.3 t -101.81 157.81 16.57 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 102.948 -2.982 . . . . 0.0 102.948 170.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 9.1 p80 -142.82 -168.46 2.78 Favored 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 102.598 -3.112 . . . . 0.0 102.598 175.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 42.1 m -169.74 171.82 7.14 Favored 'General case' 0 N--CA 1.425 -1.692 1 N-CA-C 96.237 -5.468 . . . . 0.0 96.237 176.361 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.357 0.9 0 O-C-N 124.457 1.098 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 17.3 m . . . . . 0 N--CA 1.481 1.121 0 CA-C-O 121.621 0.724 . . . . 0.0 110.56 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -100.6 174.06 6.25 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 102.654 -3.091 . . . . 0.0 102.654 159.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -119.16 150.17 40.49 Favored 'General case' 0 CA--C 1.487 -1.464 1 N-CA-C 94.262 -6.199 . . . . 0.0 94.262 155.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -160.7 165.12 34.97 Favored Glycine 0 CA--C 1.471 -2.691 0 C-N-CA 116.618 -2.706 . . . . 0.0 108.822 -172.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -87.87 116.24 25.88 Favored 'General case' 0 N--CA 1.429 -1.504 1 N-CA-C 99.51 -4.255 . . . . 0.0 99.51 160.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 13.8 tt -75.72 135.0 27.98 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.419 0 N-CA-C 104.524 -2.399 . . . . 0.0 104.524 -172.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.599 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -125.89 -172.99 2.73 Favored 'General case' 0 N--CA 1.419 -2.01 0 O-C-N 126.309 2.256 . . . . 0.0 107.793 -178.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -101.54 139.52 20.47 Favored Pre-proline 0 N--CA 1.424 -1.753 1 N-CA-C 98.126 -4.768 . . . . 0.0 98.126 164.297 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -76.78 -0.31 10.38 Favored 'Trans proline' 0 CA--C 1.504 -1.008 0 C-N-CA 122.457 2.104 . . . . 0.0 112.501 -152.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 84.5 mt-10 -95.28 45.35 1.1 Allowed 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 124.756 1.222 . . . . 0.0 108.322 -165.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.418 HD21 ' HA ' ' A' ' 61' ' ' GLU . 0.7 OUTLIER 66.49 49.31 1.39 Allowed 'General case' 0 C--N 1.355 0.806 0 C-N-CA 126.555 1.942 . . . . 0.0 108.174 179.788 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -128.29 -160.59 1.03 Allowed 'General case' 0 CA--C 1.492 -1.269 0 O-C-N 120.651 -1.281 . . . . 0.0 110.91 -171.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.551 HG12 HD12 ' A' ' 59' ' ' ILE . 9.7 m -125.37 -171.23 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.435 1 N-CA-C 99.618 -4.216 . . . . 0.0 99.618 167.997 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -126.89 150.44 49.28 Favored 'General case' 0 CA--C 1.477 -1.827 1 N-CA-C 95.338 -5.801 . . . . 0.0 95.338 173.755 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 61.0 m170 -99.08 122.91 42.93 Favored 'General case' 0 CA--C 1.485 -1.535 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 -178.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 41.9 t -83.54 151.08 25.56 Favored 'General case' 0 N--CA 1.427 -1.597 0 N-CA-C 105.95 -1.871 . . . . 0.0 105.95 176.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -98.44 118.41 63.38 Favored Pre-proline 0 N--CA 1.428 -1.528 1 N-CA-C 100.148 -4.019 . . . . 0.0 100.148 175.253 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -62.7 103.15 0.32 Allowed 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.687 2.258 . . . . 0.0 112.849 -165.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 168.59 -52.59 0.22 Allowed Glycine 0 N--CA 1.427 -1.902 1 N-CA-C 100.238 -5.145 . . . . 0.0 100.238 -175.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.8 m 134.11 -42.92 0.01 OUTLIER 'General case' 0 CA--C 1.489 -1.403 0 C-N-CA 128.953 2.901 . . . . 0.0 105.81 174.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.6 m -39.66 -55.53 1.87 Allowed 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 128.311 2.645 . . . . 0.0 117.165 -150.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.89 -34.64 71.64 Favored Glycine 0 C--N 1.346 1.103 0 O-C-N 121.478 -0.764 . . . . 0.0 111.723 -175.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.7 t -86.51 -18.31 31.91 Favored 'General case' 0 CA--C 1.5 -0.953 0 O-C-N 121.46 -1.023 . . . . 0.0 108.4 -176.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -66.1 -44.06 85.45 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 170.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -62.94 -33.3 75.06 Favored 'General case' 0 C--N 1.353 0.758 0 O-C-N 121.123 -0.986 . . . . 0.0 113.019 172.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 86.3 mt -66.76 -41.42 87.79 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-N 119.1 0.864 . . . . 0.0 110.212 175.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 11.4 t -56.41 -50.42 71.66 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 123.763 0.825 . . . . 0.0 110.337 174.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -56.89 -51.48 68.94 Favored 'General case' 0 C--N 1.359 0.979 0 C-N-CA 123.621 0.769 . . . . 0.0 111.888 -179.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -69.57 -19.28 63.68 Favored 'General case' 0 C--N 1.354 0.78 0 O-C-N 121.519 -0.738 . . . . 0.0 112.976 -173.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 48.6 mmtm -96.46 0.44 50.36 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 177.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.11 21.34 23.16 Favored Glycine 0 C--N 1.352 1.428 0 O-C-N 121.416 -0.803 . . . . 0.0 111.582 168.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -88.48 124.02 7.03 Favored Glycine 0 CA--C 1.485 -1.82 0 N-CA-C 106.466 -2.653 . . . . 0.0 106.466 169.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -77.17 -56.39 4.61 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 124.947 1.299 . . . . 0.0 108.435 -173.015 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.2 m -114.17 156.94 23.34 Favored 'General case' 0 CA--C 1.484 -1.584 0 N-CA-C 103.883 -2.636 . . . . 0.0 103.883 178.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -168.13 177.72 42.16 Favored Glycine 0 N--CA 1.416 -2.696 1 N-CA-C 99.926 -5.27 . . . . 0.0 99.926 -177.217 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 31.6 p-80 -171.97 -172.99 1.06 Allowed 'General case' 0 N--CA 1.425 -1.69 1 N-CA-C 95.955 -5.572 . . . . 0.0 95.955 173.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 88.1 m -122.58 158.88 28.96 Favored 'General case' 0 CA--C 1.48 -1.734 0 N-CA-C 102.509 -3.145 . . . . 0.0 102.509 174.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.42 174.42 46.67 Favored Glycine 0 CA--C 1.481 -2.058 1 N-CA-C 100.741 -4.944 . . . . 0.0 100.741 -174.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -146.16 127.7 15.09 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 102.638 -3.097 . . . . 0.0 102.638 -178.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 35.5 mmtm -156.83 82.37 0.95 Allowed 'General case' 0 CA--C 1.493 -1.241 1 N-CA-C 96.417 -5.401 . . . . 0.0 96.417 153.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.8 t -143.57 -178.1 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.071 1 N-CA-C 99.702 -4.184 . . . . 0.0 99.702 -169.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -135.04 26.95 3.21 Favored Glycine 0 C--N 1.349 1.27 0 N-CA-C 108.022 -2.031 . . . . 0.0 108.022 177.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 39.4 m170 -116.22 -75.34 0.58 Allowed 'General case' 0 CA--C 1.5 -0.969 0 N-CA-C 104.346 -2.465 . . . . 0.0 104.346 173.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -171.75 -169.31 34.44 Favored Glycine 0 CA--C 1.478 -2.247 1 N-CA-C 98.312 -5.915 . . . . 0.0 98.312 -175.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . 0.256 0.2 OUTLIER -65.39 147.49 53.34 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 123.817 0.847 . . . . 0.0 111.066 -178.072 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -141.22 175.63 9.49 Favored 'General case' 0 CA--C 1.485 -1.551 0 N-CA-C 101.984 -3.339 . . . . 0.0 101.984 -166.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.5 m -120.05 155.38 33.04 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 104.407 -2.442 . . . . 0.0 104.407 178.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 73.5 t-105 -102.08 148.89 24.84 Favored 'General case' 0 CA--C 1.489 -1.391 0 N-CA-C 104.35 -2.463 . . . . 0.0 104.35 -177.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 69.2 m -140.09 140.91 36.18 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 102.174 -3.269 . . . . 0.0 102.174 168.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -106.73 19.11 20.95 Favored 'General case' 0 C--N 1.352 0.714 0 CA-C-O 121.413 0.625 . . . . 0.0 110.127 -169.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -166.77 144.27 4.95 Favored 'General case' 0 N--CA 1.422 -1.825 1 N-CA-C 93.573 -6.454 . . . . 0.0 93.573 169.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 21.5 mt -150.58 142.11 15.27 Favored Pre-proline 0 CA--C 1.486 -1.518 1 N-CA-C 99.13 -4.396 . . . . 0.0 99.13 153.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -74.06 172.13 16.58 Favored 'Trans proline' 0 N--CA 1.444 -1.402 0 C-N-CA 122.19 1.927 . . . . 0.0 110.14 174.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -75.48 -1.99 26.74 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 -166.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -92.0 -7.73 48.05 Favored 'General case' 0 CA--C 1.505 -0.765 0 O-C-N 121.57 -0.707 . . . . 0.0 109.573 179.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.8 t -101.47 129.71 52.18 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.308 0 N-CA-C 103.748 -2.686 . . . . 0.0 103.748 -174.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -98.45 160.19 20.49 Favored Glycine 0 CA--C 1.485 -1.804 0 N-CA-C 106.133 -2.787 . . . . 0.0 106.133 -178.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 23.2 pt -146.56 -162.67 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.549 0 N-CA-C 103.543 -2.762 . . . . 0.0 103.543 -165.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.599 HD13 ' HB2' ' A' ' 7' ' ' ALA . 2.8 mm -63.51 137.4 24.75 Favored 'Isoleucine or valine' 0 C--N 1.361 1.084 0 C-N-CA 124.074 0.95 . . . . 0.0 109.167 -176.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 55.3 t -118.36 -92.82 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 N-CA-C 103.643 -2.725 . . . . 0.0 103.643 178.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.418 ' HA ' HD21 ' A' ' 11' ' ' ASN 0.343 34.0 tt0 77.8 59.27 0.03 OUTLIER 'General case' 0 CA--C 1.499 -1.01 0 CA-C-O 124.214 1.959 . . . . 0.0 111.009 172.145 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -126.63 43.09 1.38 Allowed Glycine 0 CA--C 1.491 -1.433 1 N-CA-C 100.911 -4.876 . . . . 0.0 100.911 157.388 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 179.92 -158.08 0.03 OUTLIER 'General case' 0 N--CA 1.426 -1.673 1 N-CA-C 96.05 -5.537 . . . . 0.0 96.05 -174.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 35.6 tptt -142.04 178.09 7.77 Favored 'General case' 0 N--CA 1.425 -1.716 1 N-CA-C 96.864 -5.236 . . . . 0.0 96.864 175.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 41.6 t -77.22 150.41 35.42 Favored 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 123.319 0.648 . . . . 0.0 109.347 -168.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -134.89 149.37 50.29 Favored 'General case' 0 N--CA 1.428 -1.545 1 N-CA-C 96.978 -5.193 . . . . 0.0 96.978 165.077 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.7 m 176.42 175.14 0.33 Allowed 'General case' 0 N--CA 1.43 -1.454 1 N-CA-C 96.012 -5.551 . . . . 0.0 96.012 -173.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.359 1.008 0 O-C-N 124.095 0.872 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 34.8 m . . . . . 0 N--CA 1.485 1.303 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.52 165.48 27.46 Favored 'General case' 0 N--CA 1.426 -1.63 1 N-CA-C 100.071 -4.048 . . . . 0.0 100.071 165.753 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -133.41 128.21 35.05 Favored 'General case' 0 N--CA 1.429 -1.522 1 N-CA-C 93.867 -6.345 . . . . 0.0 93.867 166.649 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.03 -175.31 32.93 Favored Glycine 0 CA--C 1.47 -2.748 1 N-CA-C 102.064 -4.414 . . . . 0.0 102.064 176.477 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -75.34 133.1 41.32 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 104.555 -2.387 . . . . 0.0 104.555 163.533 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.9 tt -89.87 137.99 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.315 0 N-CA-C 104.611 -2.366 . . . . 0.0 104.611 -175.436 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.456 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -100.97 -144.81 0.34 Allowed 'General case' 0 N--CA 1.426 -1.674 0 C-N-CA 127.185 2.194 . . . . 0.0 106.717 -178.283 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -128.91 143.03 47.12 Favored Pre-proline 0 N--CA 1.421 -1.895 1 N-CA-C 93.47 -6.493 . . . . 0.0 93.47 163.577 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -82.57 27.27 0.61 Allowed 'Trans proline' 0 CA--C 1.506 -0.917 0 C-N-CA 122.651 2.234 . . . . 0.0 113.731 -141.248 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.558 ' HB3' ' CE1' ' A' ' 66' ' ' HIS . 41.4 mp0 -104.38 -78.52 0.56 Allowed 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 102.589 -3.115 . . . . 0.0 102.589 -178.156 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -161.33 142.97 11.71 Favored 'General case' 0 N--CA 1.425 -1.699 1 N-CA-C 92.464 -6.865 . . . . 0.0 92.464 156.188 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 65' ' ' CYS . 1.0 OUTLIER 176.29 -166.68 0.04 OUTLIER 'General case' 0 CA--C 1.486 -1.513 0 N-CA-C 101.485 -3.524 . . . . 0.0 101.485 179.816 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.554 HG12 HD12 ' A' ' 59' ' ' ILE . 1.0 OUTLIER -121.29 160.56 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.725 1 N-CA-C 99.006 -4.442 . . . . 0.0 99.006 156.929 . . . . . . . . 4 4 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -82.71 -168.87 2.21 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 104.798 -2.297 . . . . 0.0 104.798 161.074 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 42.9 m170 -134.61 177.76 7.53 Favored 'General case' 0 N--CA 1.422 -1.858 1 N-CA-C 95.271 -5.826 . . . . 0.0 95.271 168.291 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 40.9 t -154.89 169.31 24.32 Favored 'General case' 0 N--CA 1.416 -2.148 1 N-CA-C 96.088 -5.523 . . . . 0.0 96.088 -168.275 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -126.3 120.41 23.58 Favored Pre-proline 0 N--CA 1.42 -1.931 1 N-CA-C 98.795 -4.52 . . . . 0.0 98.795 178.768 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 0.8 OUTLIER -55.56 135.2 68.2 Favored 'Trans proline' 0 CA--C 1.505 -0.951 0 C-N-CA 122.568 2.179 . . . . 0.0 112.384 -178.452 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 116.27 -43.55 1.64 Allowed Glycine 0 N--CA 1.438 -1.231 0 N-CA-C 103.989 -3.644 . . . . 0.0 103.989 -158.322 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.0 m 82.56 23.85 0.18 Allowed 'General case' 0 CA--C 1.496 -1.111 0 C-N-CA 128.105 2.562 . . . . 0.0 110.647 175.836 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.7 -61.2 2.68 Favored 'General case' 0 N--CA 1.44 -0.933 0 C-N-CA 126.808 2.043 . . . . 0.0 110.998 -168.995 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.14 -32.23 72.6 Favored Glycine 0 C--N 1.347 1.187 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 -175.468 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 11.5 t -78.45 -21.38 49.22 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-O 119.302 -0.38 . . . . 0.0 110.054 -173.482 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -60.43 -46.96 88.16 Favored 'General case' 0 C--N 1.352 0.692 0 CA-C-N 119.585 1.084 . . . . 0.0 109.409 173.394 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.13 -49.26 75.06 Favored 'General case' 0 N--CA 1.44 -0.934 0 O-C-N 121.537 -0.727 . . . . 0.0 112.521 171.09 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 73.8 mt -63.91 -44.28 93.39 Favored 'General case' 0 C--N 1.358 0.96 0 CA-C-O 121.722 0.772 . . . . 0.0 111.59 -173.882 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 13.7 t -60.0 -42.54 94.47 Favored 'General case' 0 CA--C 1.503 -0.855 0 C-N-CA 123.589 0.756 . . . . 0.0 109.558 179.175 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.6 mtmm -74.47 -35.05 63.28 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-N 119.211 0.914 . . . . 0.0 112.801 -177.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -70.75 -24.71 62.66 Favored 'General case' 0 C--N 1.358 0.941 0 CA-C-N 120.13 1.332 . . . . 0.0 111.536 178.628 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 48.4 mmtm -85.12 -13.58 49.8 Favored 'General case' 0 C--N 1.355 0.822 0 O-C-N 121.882 -0.512 . . . . 0.0 110.067 173.933 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.89 32.0 5.79 Favored Glycine 0 CA--C 1.492 -1.385 0 CA-C-O 119.375 -0.68 . . . . 0.0 111.636 166.718 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.3 138.29 14.29 Favored Glycine 0 CA--C 1.488 -1.653 0 N-CA-C 105.379 -3.089 . . . . 0.0 105.379 174.247 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 18.0 p -100.67 2.76 41.83 Favored 'General case' 0 N--CA 1.44 -0.97 0 O-C-N 122.063 -0.669 . . . . 0.0 110.042 -163.723 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.5 m -160.17 153.41 21.94 Favored 'General case' 0 CA--C 1.483 -1.6 1 N-CA-C 99.225 -4.361 . . . . 0.0 99.225 168.621 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -171.31 161.97 34.56 Favored Glycine 0 CA--C 1.474 -2.526 1 N-CA-C 100.022 -5.231 . . . . 0.0 100.022 178.296 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 14.8 p80 -165.81 170.71 13.61 Favored 'General case' 0 CA--C 1.488 -1.417 0 N-CA-C 100.215 -3.994 . . . . 0.0 100.215 -177.05 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 62.9 m -77.53 147.63 35.68 Favored 'General case' 0 CA--C 1.491 -1.29 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 177.843 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -163.88 173.43 39.93 Favored Glycine 0 CA--C 1.476 -2.404 1 N-CA-C 98.493 -5.843 . . . . 0.0 98.493 179.9 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -168.89 -169.33 0.98 Allowed 'General case' 0 N--CA 1.422 -1.867 1 N-CA-C 97.01 -5.182 . . . . 0.0 97.01 178.142 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.6 mptt 97.65 61.29 0.0 OUTLIER 'General case' 0 CA--C 1.492 -1.251 0 C-N-CA 131.186 3.794 . . . . 0.0 101.753 -164.692 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 19.3 t -143.21 172.92 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.738 1 N-CA-C 96.501 -5.37 . . . . 0.0 96.501 -177.743 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -113.21 89.57 0.52 Allowed Glycine 0 CA--C 1.486 -1.77 0 N-CA-C 104.329 -3.509 . . . . 0.0 104.329 176.643 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 17.4 m170 -172.09 -132.21 0.01 OUTLIER 'General case' 0 N--CA 1.438 -1.041 1 N-CA-C 99.422 -4.288 . . . . 0.0 99.422 172.741 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -110.87 -41.03 1.23 Allowed Glycine 0 C--N 1.358 1.758 0 CA-C-N 120.843 1.656 . . . . 0.0 113.317 -170.32 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 13.6 tp -165.63 177.4 7.35 Favored 'General case' 0 N--CA 1.434 -1.236 1 N-CA-C 95.769 -5.641 . . . . 0.0 95.769 -173.385 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -159.02 -174.86 4.95 Favored 'General case' 0 CA--C 1.478 -1.822 1 N-CA-C 98.288 -4.708 . . . . 0.0 98.288 175.409 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 46.8 t -130.25 164.51 24.4 Favored 'General case' 0 CA--C 1.492 -1.286 1 N-CA-C 99.943 -4.095 . . . . 0.0 99.943 167.872 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 24.9 t-105 -111.99 152.23 28.35 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 104.231 -2.507 . . . . 0.0 104.231 176.997 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 15.3 m -145.55 150.69 36.88 Favored 'General case' 0 C--N 1.36 1.032 0 N-CA-C 104.797 -2.297 . . . . 0.0 104.797 173.73 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -113.15 138.5 49.85 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 104.878 -2.268 . . . . 0.0 104.878 171.178 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 64.79 58.4 0.97 Allowed 'General case' 0 CA--C 1.491 -1.297 0 C-N-CA 127.199 2.2 . . . . 0.0 111.697 166.505 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 20.4 mt -89.11 143.91 31.85 Favored Pre-proline 0 N--CA 1.441 -0.912 0 N-CA-C 104.21 -2.515 . . . . 0.0 104.21 170.788 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -73.11 170.37 19.98 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.574 2.183 . . . . 0.0 109.773 177.573 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -70.47 -12.16 61.39 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -167.293 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -84.61 -9.06 58.63 Favored 'General case' 0 CA--C 1.506 -0.744 0 O-C-N 121.381 -0.825 . . . . 0.0 110.27 -176.469 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.5 t -92.35 133.92 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 -176.39 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -98.2 150.03 19.31 Favored Glycine 0 CA--C 1.487 -1.698 0 N-CA-C 105.193 -3.163 . . . . 0.0 105.193 179.273 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 28.4 pt -135.29 -166.43 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 103.459 -2.793 . . . . 0.0 103.459 -172.707 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.554 HD12 HG12 ' A' ' 13' ' ' VAL . 1.3 mm -66.45 130.06 31.45 Favored 'Isoleucine or valine' 0 C--N 1.362 1.11 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 -173.256 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 77.4 t -110.63 101.4 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.612 0 N-CA-C 102.101 -3.296 . . . . 0.0 102.101 171.477 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 65.59 -114.58 0.29 Allowed 'General case' 0 C--N 1.355 0.832 0 C-N-CA 125.401 1.48 . . . . 0.0 109.626 -179.281 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -173.88 44.49 0.15 Allowed Glycine 0 CA--C 1.491 -1.464 1 N-CA-C 100.15 -5.18 . . . . 0.0 100.15 171.387 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -95.93 -36.68 10.99 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -162.418 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -149.35 160.36 43.49 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 102.993 -2.965 . . . . 0.0 102.993 -174.605 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 29.0 t -139.86 133.52 30.4 Favored 'General case' 0 N--CA 1.423 -1.809 1 N-CA-C 92.895 -6.706 . . . . 0.0 92.895 167.718 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.558 ' CE1' ' HB3' ' A' ' 10' ' ' GLU . 14.7 p80 -160.08 169.05 24.17 Favored 'General case' 0 CA--C 1.48 -1.744 0 N-CA-C 100.972 -3.714 . . . . 0.0 100.972 -173.807 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.3 m -171.43 174.5 4.44 Favored 'General case' 0 N--CA 1.421 -1.893 1 N-CA-C 95.41 -5.774 . . . . 0.0 95.41 177.884 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.356 0.857 0 O-C-N 124.239 0.962 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 27.0 m . . . . . 0 N--CA 1.485 1.285 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -105.41 157.25 17.47 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 171.667 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -131.04 123.8 29.48 Favored 'General case' 0 N--CA 1.431 -1.386 1 N-CA-C 93.459 -6.497 . . . . 0.0 93.459 155.518 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.81 -173.61 30.68 Favored Glycine 0 CA--C 1.478 -2.28 1 N-CA-C 101.705 -4.558 . . . . 0.0 101.705 -177.426 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -79.93 137.69 36.94 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 103.673 -2.714 . . . . 0.0 103.673 166.683 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.2 tt -90.72 150.84 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.976 0 N-CA-C 105.171 -2.159 . . . . 0.0 105.171 179.489 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.858 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -143.88 179.68 7.02 Favored 'General case' 0 N--CA 1.411 -2.386 0 N-CA-C 101.309 -3.589 . . . . 0.0 101.309 -173.093 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -86.08 145.8 41.49 Favored Pre-proline 0 N--CA 1.427 -1.597 0 N-CA-C 102.559 -3.126 . . . . 0.0 102.559 171.33 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.11 5.42 5.76 Favored 'Trans proline' 0 CA--C 1.501 -1.157 0 C-N-CA 122.249 1.966 . . . . 0.0 112.491 -151.27 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -107.99 21.53 17.26 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 -179.919 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.487 HD21 ' HA ' ' A' ' 61' ' ' GLU . 62.4 t30 76.18 52.65 0.05 Allowed 'General case' 0 CA--C 1.496 -1.125 0 C-N-CA 126.903 2.081 . . . . 0.0 109.627 167.512 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.492 ' O ' ' HB1' ' A' ' 7' ' ' ALA . 26.0 m -140.47 138.72 34.86 Favored 'General case' 0 CA--C 1.478 -1.806 0 N-CA-C 100.636 -3.839 . . . . 0.0 100.636 -175.937 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.0 m -66.95 152.19 9.83 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.94 0 CA-C-N 120.544 1.52 . . . . 0.0 111.058 -173.188 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -89.43 122.52 32.71 Favored 'General case' 0 CA--C 1.484 -1.565 1 N-CA-C 100.01 -4.07 . . . . 0.0 100.01 176.018 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 58.6 m80 -86.02 138.34 32.04 Favored 'General case' 0 CA--C 1.478 -1.794 0 N-CA-C 102.427 -3.175 . . . . 0.0 102.427 -174.561 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.0 t -148.53 -179.02 6.65 Favored 'General case' 0 N--CA 1.411 -2.413 1 N-CA-C 93.666 -6.42 . . . . 0.0 93.666 -170.122 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -147.36 171.67 6.07 Favored Pre-proline 0 N--CA 1.412 -2.344 1 N-CA-C 97.515 -4.995 . . . . 0.0 97.515 -157.79 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -66.7 44.58 0.21 Allowed 'Trans proline' 0 C--N 1.324 -0.738 0 C-N-CA 123.307 2.672 . . . . 0.0 116.79 -178.912 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -174.93 148.5 9.69 Favored Glycine 0 N--CA 1.42 -2.427 1 N-CA-C 98.202 -5.959 . . . . 0.0 98.202 172.973 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -78.25 38.12 0.28 Allowed 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 124.813 1.245 . . . . 0.0 112.389 -174.881 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.6 m -54.47 -62.46 1.64 Allowed 'General case' 0 N--CA 1.44 -0.947 0 C-N-CA 127.577 2.351 . . . . 0.0 112.447 -162.816 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -90.16 -19.7 45.31 Favored Glycine 0 C--N 1.35 1.338 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 179.901 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.4 t -80.58 -15.22 57.17 Favored 'General case' 0 N--CA 1.442 -0.837 0 O-C-N 121.679 -0.895 . . . . 0.0 110.462 -167.455 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -54.68 -54.51 40.8 Favored 'General case' 0 C--N 1.353 0.743 0 C-N-CA 125.334 1.454 . . . . 0.0 109.594 172.152 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -61.24 -48.43 81.48 Favored 'General case' 0 N--CA 1.435 -1.184 0 C-N-CA 125.233 1.413 . . . . 0.0 112.111 172.518 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 96.3 mt -65.53 -42.19 92.26 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-O 122.192 0.996 . . . . 0.0 111.368 -171.31 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 14.2 t -61.71 -44.39 97.02 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 124.19 0.996 . . . . 0.0 108.491 179.059 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -68.07 -40.2 82.79 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -179.267 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -72.53 -20.37 61.36 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 120.122 1.328 . . . . 0.0 112.371 -179.114 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.8 mmtm -85.82 -16.34 39.04 Favored 'General case' 0 C--N 1.354 0.783 0 C-N-CA 123.349 0.659 . . . . 0.0 109.947 173.07 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.23 29.63 6.66 Favored Glycine 0 CA--C 1.487 -1.682 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 168.743 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -93.85 142.95 16.25 Favored Glycine 0 N--CA 1.435 -1.386 0 N-CA-C 105.792 -2.923 . . . . 0.0 105.792 172.987 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.1 m -109.84 -3.86 16.39 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 122.866 1.317 . . . . 0.0 108.211 -160.84 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 43.1 m -160.49 165.83 30.25 Favored 'General case' 0 CA--C 1.483 -1.633 1 N-CA-C 98.027 -4.805 . . . . 0.0 98.027 166.232 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -166.33 174.99 41.87 Favored Glycine 0 CA--C 1.473 -2.536 1 N-CA-C 101.561 -4.616 . . . . 0.0 101.561 -176.457 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -166.42 -175.15 3.11 Favored 'General case' 0 N--CA 1.431 -1.415 1 N-CA-C 97.604 -4.961 . . . . 0.0 97.604 -172.505 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 86.4 m -146.06 161.35 40.32 Favored 'General case' 0 CA--C 1.487 -1.468 1 N-CA-C 99.531 -4.248 . . . . 0.0 99.531 172.178 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 179.65 -176.89 47.92 Favored Glycine 0 N--CA 1.426 -1.991 1 N-CA-C 101.837 -4.505 . . . . 0.0 101.837 -177.197 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -99.36 161.14 13.79 Favored 'General case' 0 N--CA 1.436 -1.175 0 N-CA-C 104.829 -2.286 . . . . 0.0 104.829 -178.256 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.26 158.81 40.79 Favored 'General case' 0 N--CA 1.425 -1.707 1 N-CA-C 96.047 -5.538 . . . . 0.0 96.047 163.869 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.4 t -111.7 141.07 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.16 0 N-CA-C 103.505 -2.776 . . . . 0.0 103.505 -170.364 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 145.22 -66.41 0.43 Allowed Glycine 0 CA--C 1.482 -2.024 1 N-CA-C 103.054 -4.018 . . . . 0.0 103.054 179.857 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 60.6 m170 -97.31 -75.86 0.53 Allowed 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 172.49 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 171.46 -158.84 30.23 Favored Glycine 0 CA--C 1.477 -2.287 1 N-CA-C 102.562 -4.215 . . . . 0.0 102.562 -173.901 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.3 tt -69.01 137.16 53.45 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 -173.436 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -137.98 -179.01 5.52 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 104.346 -2.465 . . . . 0.0 104.346 -162.432 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 30.6 t -117.32 169.81 9.19 Favored 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 101.142 -3.651 . . . . 0.0 101.142 179.204 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 7.8 t-105 -131.44 150.42 52.16 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 102.452 -3.166 . . . . 0.0 102.452 -177.842 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 22.2 m -146.64 153.97 40.93 Favored 'General case' 0 CA--C 1.493 -1.25 0 N-CA-C 103.743 -2.688 . . . . 0.0 103.743 176.441 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -121.09 134.6 55.26 Favored 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 104.756 -2.313 . . . . 0.0 104.756 175.331 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 73.08 57.84 0.11 Allowed 'General case' 0 CA--C 1.492 -1.279 0 C-N-CA 126.941 2.096 . . . . 0.0 109.799 170.382 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 31.4 mt -96.32 144.25 27.51 Favored Pre-proline 0 CA--C 1.499 -0.987 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 176.967 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -66.6 164.37 29.19 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.562 2.174 . . . . 0.0 112.552 173.815 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -63.95 -27.58 69.24 Favored 'General case' 0 N--CA 1.442 -0.875 0 C-N-CA 125.224 1.409 . . . . 0.0 113.859 -173.455 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -94.97 17.25 14.23 Favored 'General case' 0 CA--C 1.503 -0.85 0 O-C-N 121.237 -0.915 . . . . 0.0 110.288 -174.796 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 20.4 t -97.21 122.84 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 N-CA-C 102.125 -3.287 . . . . 0.0 102.125 168.758 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -91.87 148.19 19.11 Favored Glycine 0 CA--C 1.488 -1.637 0 N-CA-C 104.817 -3.313 . . . . 0.0 104.817 179.272 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 25.5 pt -140.83 -149.68 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 N-CA-C 103.762 -2.681 . . . . 0.0 103.762 -169.284 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.858 HD13 ' HB2' ' A' ' 7' ' ' ALA . 5.7 mm -71.24 115.42 11.16 Favored 'Isoleucine or valine' 0 C--N 1.357 0.9 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 177.272 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.257 1.2 t -132.14 21.78 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.07 0 N-CA-C 102.519 -3.141 . . . . 0.0 102.519 -166.394 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.487 ' HA ' HD21 ' A' ' 11' ' ' ASN . 43.0 tt0 -65.28 134.85 54.5 Favored 'General case' 0 CA--C 1.498 -1.045 0 C-N-CA 127.034 2.134 . . . . 0.0 109.912 -175.071 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.89 -45.56 0.74 Allowed Glycine 0 N--CA 1.433 -1.566 1 N-CA-C 98.634 -5.787 . . . . 0.0 98.634 -158.426 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.465 ' HG3' ' H ' ' A' ' 64' ' ' LYS . 12.0 tp10 -98.99 -159.18 0.72 Allowed 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 102.73 -3.063 . . . . 0.0 102.73 156.594 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.465 ' H ' ' HG3' ' A' ' 63' ' ' GLU . 9.7 tptm -137.58 -165.55 1.79 Allowed 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 104.532 -2.396 . . . . 0.0 104.532 -170.846 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 37.7 t -82.13 147.85 28.83 Favored 'General case' 0 CA--C 1.496 -1.102 0 C-N-CA 126.465 1.906 . . . . 0.0 107.249 -177.174 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 10.3 p80 -141.96 156.21 45.46 Favored 'General case' 0 N--CA 1.427 -1.607 1 N-CA-C 97.413 -5.032 . . . . 0.0 97.413 165.491 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.4 m 179.53 177.7 0.57 Allowed 'General case' 0 N--CA 1.429 -1.511 1 N-CA-C 96.136 -5.505 . . . . 0.0 96.136 -179.815 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.357 0.901 0 O-C-N 124.429 1.081 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 17.0 m . . . . . 0 N--CA 1.485 1.312 0 CA-C-O 121.709 0.766 . . . . 0.0 110.864 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.5 HH21 HG12 ' A' ' 58' ' ' ILE . 21.1 mtp85 -115.67 159.8 20.87 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 -173.298 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -135.89 134.31 38.63 Favored 'General case' 0 CA--C 1.489 -1.402 1 N-CA-C 96.674 -5.306 . . . . 0.0 96.674 164.071 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.01 -178.22 35.72 Favored Glycine 0 CA--C 1.48 -2.108 0 N-CA-C 106.687 -2.565 . . . . 0.0 106.687 175.558 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -75.36 128.7 35.98 Favored 'General case' 0 CA--C 1.497 -1.076 0 N-CA-C 104.386 -2.45 . . . . 0.0 104.386 158.745 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.469 HG22 ' HB2' ' A' ' 47' ' ' CYS . 5.7 tt -89.85 136.92 22.54 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.975 0 N-CA-C 105.444 -2.058 . . . . 0.0 105.444 -173.733 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.427 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -97.39 -147.11 0.31 Allowed 'General case' 0 N--CA 1.423 -1.806 0 CA-C-N 112.067 -2.333 . . . . 0.0 106.938 174.622 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.404 ' H ' ' HB1' ' A' ' 7' ' ' ALA . 54.2 mt-30 -125.07 141.21 37.85 Favored Pre-proline 0 N--CA 1.42 -1.968 1 N-CA-C 93.575 -6.454 . . . . 0.0 93.575 168.831 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -80.54 23.38 0.71 Allowed 'Trans proline' 0 C--N 1.323 -0.769 0 C-N-CA 122.707 2.271 . . . . 0.0 114.276 -145.443 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.465 ' HB3' ' CE1' ' A' ' 66' ' ' HIS . 17.5 mm-40 -95.48 -82.0 0.39 Allowed 'General case' 0 CA--C 1.489 -1.368 0 N-CA-C 103.043 -2.947 . . . . 0.0 103.043 -179.965 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -165.38 123.78 1.64 Allowed 'General case' 0 N--CA 1.425 -1.698 1 N-CA-C 91.584 -7.191 . . . . 0.0 91.584 169.05 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.3 m -174.59 -166.14 0.24 Allowed 'General case' 0 CA--C 1.496 -1.127 0 N-CA-C 101.825 -3.398 . . . . 0.0 101.825 -179.163 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.419 HG12 HD12 ' A' ' 59' ' ' ILE . 0.9 OUTLIER -125.24 167.32 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.387 1 N-CA-C 96.829 -5.248 . . . . 0.0 96.829 160.039 . . . . . . . . 4 4 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -88.83 -159.01 0.53 Allowed 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 104.718 -2.327 . . . . 0.0 104.718 163.236 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 51.5 m80 -140.46 160.65 39.53 Favored 'General case' 0 N--CA 1.417 -2.112 1 N-CA-C 94.982 -5.932 . . . . 0.0 94.982 168.796 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.4 t -161.23 -153.63 0.31 Allowed 'General case' 0 N--CA 1.415 -2.191 1 N-CA-C 94.188 -6.227 . . . . 0.0 94.188 -178.896 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -147.33 174.2 3.58 Favored Pre-proline 0 N--CA 1.414 -2.238 1 N-CA-C 99.201 -4.37 . . . . 0.0 99.201 -166.069 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_exo -67.82 44.06 0.26 Allowed 'Trans proline' 0 C--N 1.321 -0.883 0 C-N-CA 123.635 2.89 . . . . 0.0 114.245 168.047 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -176.07 147.66 8.78 Favored Glycine 0 N--CA 1.425 -2.094 1 N-CA-C 98.884 -5.686 . . . . 0.0 98.884 179.232 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.3 m -79.36 -16.11 56.8 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -164.182 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.6 m -39.86 -56.75 1.72 Allowed 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 117.264 2.32 . . . . 0.0 117.264 -151.561 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -77.61 -34.59 39.07 Favored Glycine 0 C--N 1.349 1.301 0 O-C-N 121.291 -0.881 . . . . 0.0 111.131 -174.432 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.3 t -84.24 -12.32 54.95 Favored 'General case' 0 CA--C 1.499 -0.999 0 O-C-N 121.695 -0.885 . . . . 0.0 109.065 -172.792 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -62.88 -48.29 79.64 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 172.787 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -58.54 -48.28 81.38 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 123.235 0.614 . . . . 0.0 112.318 171.334 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 90.8 mt -63.97 -42.41 97.26 Favored 'General case' 0 C--N 1.357 0.934 0 CA-C-O 121.895 0.855 . . . . 0.0 111.445 -175.603 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 24.9 t -59.67 -46.97 87.45 Favored 'General case' 0 CA--C 1.5 -0.954 0 C-N-CA 125.304 1.442 . . . . 0.0 108.998 177.253 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 45.3 mttp -70.79 -40.57 72.5 Favored 'General case' 0 N--CA 1.438 -1.064 0 O-C-N 121.683 -0.635 . . . . 0.0 111.405 -173.568 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -71.05 -18.11 62.58 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 118.914 0.779 . . . . 0.0 112.601 -179.111 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -97.57 -1.84 43.03 Favored 'General case' 0 C--N 1.355 0.822 0 O-C-N 121.731 -0.606 . . . . 0.0 110.478 175.152 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.97 33.72 6.51 Favored Glycine 0 C--N 1.352 1.422 0 CA-C-O 119.762 -0.465 . . . . 0.0 112.122 167.209 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -104.79 125.58 8.39 Favored Glycine 0 CA--C 1.49 -1.506 0 N-CA-C 104.826 -3.309 . . . . 0.0 104.826 168.582 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.9 p -100.54 6.08 44.17 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-O 122.139 0.971 . . . . 0.0 109.694 -164.557 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 26.9 m -160.17 159.11 31.25 Favored 'General case' 0 CA--C 1.476 -1.87 1 N-CA-C 98.503 -4.629 . . . . 0.0 98.503 167.289 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -170.89 177.32 43.97 Favored Glycine 0 N--CA 1.418 -2.539 1 N-CA-C 99.421 -5.472 . . . . 0.0 99.421 -176.012 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 52.6 m80 -165.33 -172.96 2.65 Favored 'General case' 0 N--CA 1.431 -1.404 1 N-CA-C 97.18 -5.119 . . . . 0.0 97.18 -177.724 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 100.0 m -140.61 156.51 46.25 Favored 'General case' 0 CA--C 1.477 -1.84 0 N-CA-C 100.503 -3.888 . . . . 0.0 100.503 174.684 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 170.22 -168.74 41.69 Favored Glycine 0 N--CA 1.424 -2.108 1 N-CA-C 98.373 -5.891 . . . . 0.0 98.373 -169.128 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -152.85 -177.95 6.59 Favored 'General case' 0 N--CA 1.427 -1.611 1 N-CA-C 98.921 -4.474 . . . . 0.0 98.921 -177.591 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 25.2 tptp 128.11 63.66 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.149 2 C-N-CA 133.38 4.672 . . . . 0.0 99.372 -179.602 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.5 HG12 ' H ' ' A' ' 42' ' ' GLY . 2.7 t -146.17 -167.08 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.518 1 N-CA-C 97.277 -5.083 . . . . 0.0 97.277 -172.867 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.5 ' H ' HG12 ' A' ' 41' ' ' VAL . . . -139.81 68.77 0.48 Allowed Glycine 0 CA--C 1.487 -1.7 0 N-CA-C 105.616 -2.994 . . . . 0.0 105.616 -176.383 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 21.7 m170 -158.33 -107.43 0.02 OUTLIER 'General case' 0 N--CA 1.434 -1.272 0 N-CA-C 100.894 -3.743 . . . . 0.0 100.894 173.172 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -121.21 -70.39 0.28 Allowed Glycine 0 C--N 1.355 1.587 0 CA-C-N 120.111 1.323 . . . . 0.0 111.932 -170.559 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -149.53 179.78 7.7 Favored 'General case' 0 N--CA 1.434 -1.245 1 N-CA-C 95.328 -5.805 . . . . 0.0 95.328 176.499 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -157.03 -174.48 4.94 Favored 'General case' 0 CA--C 1.486 -1.498 1 N-CA-C 99.936 -4.098 . . . . 0.0 99.936 -179.81 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.469 ' HB2' HG22 ' A' ' 6' ' ' ILE . 1.6 m -116.31 -179.13 3.58 Favored 'General case' 0 CA--C 1.486 -1.484 0 N-CA-C 102.308 -3.219 . . . . 0.0 102.308 165.814 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 32.2 t-105 -122.07 153.53 38.52 Favored 'General case' 0 CA--C 1.496 -1.121 0 N-CA-C 102.885 -3.006 . . . . 0.0 102.885 174.275 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 37.3 m -145.64 147.46 32.04 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 170.457 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -114.08 144.24 43.45 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 105.024 -2.213 . . . . 0.0 105.024 173.572 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 69.7 42.9 1.03 Allowed 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 127.289 2.236 . . . . 0.0 111.602 167.215 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 38.7 mt -84.04 137.95 40.09 Favored Pre-proline 0 CA--C 1.504 -0.825 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 178.391 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -73.6 168.91 23.58 Favored 'Trans proline' 0 N--CA 1.447 -1.208 0 C-N-CA 122.187 1.925 . . . . 0.0 110.333 177.514 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -67.78 -9.22 42.3 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 124.652 1.181 . . . . 0.0 114.054 -171.317 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 -91.15 -0.12 57.64 Favored 'General case' 0 CA--C 1.507 -0.709 0 O-C-N 121.557 -0.715 . . . . 0.0 110.923 -176.946 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.46 HG12 ' H ' ' A' ' 57' ' ' GLY . 2.0 t -99.93 178.12 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 N-CA-C 103.755 -2.683 . . . . 0.0 103.755 179.463 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.46 ' H ' HG12 ' A' ' 56' ' ' VAL . . . -143.61 161.58 27.72 Favored Glycine 0 CA--C 1.479 -2.205 1 N-CA-C 100.086 -5.206 . . . . 0.0 100.086 -176.035 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.5 HG12 HH21 ' A' ' 2' ' ' ARG . 17.8 pt -152.99 -166.94 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.483 -1.627 1 N-CA-C 99.32 -4.326 . . . . 0.0 99.32 -167.655 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.427 HD13 ' HB2' ' A' ' 7' ' ' ALA . 2.9 mm -63.7 134.28 28.79 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 179.146 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.8 t -144.0 169.21 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.822 1 N-CA-C 93.404 -6.517 . . . . 0.0 93.404 -179.183 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 24.6 tp10 -150.43 159.25 44.61 Favored 'General case' 0 N--CA 1.428 -1.556 1 N-CA-C 98.363 -4.681 . . . . 0.0 98.363 171.4 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 136.95 -41.6 1.39 Allowed Glycine 0 CA--C 1.489 -1.582 1 N-CA-C 102.42 -4.272 . . . . 0.0 102.42 -164.527 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -97.04 -106.42 0.17 Allowed 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 174.402 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 19.7 tptm 174.07 -140.63 0.0 OUTLIER 'General case' 0 CA--C 1.491 -1.31 1 N-CA-C 98.629 -4.582 . . . . 0.0 98.629 -167.508 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 43.3 t -110.52 129.17 55.85 Favored 'General case' 0 CA--C 1.485 -1.536 0 N-CA-C 100.515 -3.884 . . . . 0.0 100.515 165.155 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.465 ' CE1' ' HB3' ' A' ' 10' ' ' GLU . 8.2 p-80 -154.28 166.13 34.12 Favored 'General case' 0 CA--C 1.481 -1.704 0 N-CA-C 100.652 -3.833 . . . . 0.0 100.652 -176.677 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 28.7 m -174.38 176.5 2.4 Favored 'General case' 0 N--CA 1.425 -1.705 1 N-CA-C 96.198 -5.482 . . . . 0.0 96.198 175.326 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.356 0.855 0 O-C-N 124.591 1.182 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 19.1 m . . . . . 0 N--CA 1.485 1.295 0 CA-C-O 121.403 0.621 . . . . 0.0 110.424 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -103.97 167.71 9.59 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 104.637 -2.357 . . . . 0.0 104.637 163.551 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -125.86 140.45 52.64 Favored 'General case' 0 CA--C 1.485 -1.556 1 N-CA-C 93.75 -6.389 . . . . 0.0 93.75 156.714 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.79 178.94 37.46 Favored Glycine 0 CA--C 1.474 -2.523 0 C-N-CA 116.904 -2.569 . . . . 0.0 107.513 -178.479 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -73.87 130.16 39.35 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 104.075 -2.565 . . . . 0.0 104.075 155.409 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.8 tt -90.63 137.81 20.86 Favored 'Isoleucine or valine' 0 C--O 1.253 1.275 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 179.247 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.594 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -100.24 -158.38 0.67 Allowed 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 112.755 -2.021 . . . . 0.0 107.484 176.062 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -98.87 142.39 24.52 Favored Pre-proline 0 CA--C 1.49 -1.344 1 N-CA-C 97.422 -5.029 . . . . 0.0 97.422 163.815 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -78.49 26.47 0.52 Allowed 'Trans proline' 0 CA--C 1.509 -0.759 0 C-N-CA 123.07 2.514 . . . . 0.0 114.654 -136.292 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -115.5 -78.95 0.58 Allowed 'General case' 0 N--CA 1.425 -1.704 0 N-CA-C 102.415 -3.18 . . . . 0.0 102.415 177.65 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -165.89 147.83 7.14 Favored 'General case' 0 N--CA 1.429 -1.513 1 N-CA-C 96.544 -5.354 . . . . 0.0 96.544 164.958 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 20.3 m 164.91 -152.73 0.0 OUTLIER 'General case' 0 CA--C 1.499 -1.017 1 N-CA-C 97.308 -5.071 . . . . 0.0 97.308 179.238 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.543 HG12 HD12 ' A' ' 59' ' ' ILE . 0.8 OUTLIER -126.77 163.69 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 1 N-CA-C 98.844 -4.502 . . . . 0.0 98.844 160.111 . . . . . . . . 4 4 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -87.8 -158.87 0.49 Allowed 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 104.79 -2.3 . . . . 0.0 104.79 164.447 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 71.4 m80 -142.82 -178.46 5.82 Favored 'General case' 0 N--CA 1.424 -1.735 1 N-CA-C 97.032 -5.173 . . . . 0.0 97.032 166.739 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.3 t -155.05 166.13 34.56 Favored 'General case' 0 N--CA 1.415 -2.19 1 N-CA-C 96.643 -5.318 . . . . 0.0 96.643 -171.513 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -121.84 125.24 26.78 Favored Pre-proline 0 N--CA 1.42 -1.951 1 N-CA-C 99.841 -4.133 . . . . 0.0 99.841 179.251 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -58.4 111.72 0.96 Allowed 'Trans proline' 0 CA--C 1.503 -1.046 0 C-N-CA 123.327 2.684 . . . . 0.0 112.653 -174.0 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 140.06 -36.79 1.78 Allowed Glycine 0 CA--C 1.49 -1.522 1 N-CA-C 102.739 -4.144 . . . . 0.0 102.739 -166.937 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.3 m 85.23 11.85 0.26 Allowed 'General case' 0 CA--C 1.496 -1.096 0 C-N-CA 128.187 2.595 . . . . 0.0 111.04 172.384 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -48.87 -55.17 12.5 Favored 'General case' 0 N--CA 1.436 -1.148 0 C-N-CA 129.4 3.08 . . . . 0.0 113.526 -169.822 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -85.95 -26.28 35.04 Favored Glycine 0 C--N 1.35 1.359 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 -172.75 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 15.7 t -79.53 -17.09 54.8 Favored 'General case' 0 C--N 1.354 0.78 0 O-C-N 122.238 -0.566 . . . . 0.0 110.187 -172.412 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -62.45 -43.09 99.64 Favored 'General case' 0 C--N 1.354 0.801 0 O-C-N 120.973 -1.079 . . . . 0.0 109.364 174.118 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -56.14 -54.24 47.42 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 124.262 1.025 . . . . 0.0 111.132 169.794 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 91.1 mt -61.75 -45.43 93.93 Favored 'General case' 0 CA--C 1.496 -1.122 0 C-N-CA 123.49 0.716 . . . . 0.0 111.036 -172.739 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.8 t -60.28 -46.5 89.63 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 123.711 0.805 . . . . 0.0 109.407 179.381 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 78.7 mttt -67.31 -43.0 82.74 Favored 'General case' 0 CA--C 1.502 -0.884 0 O-C-N 121.956 -0.465 . . . . 0.0 111.629 -177.329 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -75.26 -21.08 58.8 Favored 'General case' 0 CA--C 1.508 -0.641 0 O-C-N 121.606 -0.684 . . . . 0.0 112.432 -176.5 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -87.94 -15.94 35.19 Favored 'General case' 0 C--N 1.356 0.865 0 CA-C-N 118.971 0.805 . . . . 0.0 109.875 172.822 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.2 34.33 3.98 Favored Glycine 0 CA--C 1.492 -1.366 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 166.655 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -96.83 157.26 21.15 Favored Glycine 0 CA--C 1.491 -1.42 0 N-CA-C 105.535 -3.026 . . . . 0.0 105.535 164.786 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 30.4 m -85.09 -42.38 14.86 Favored 'General case' 0 CA--C 1.497 -1.063 0 CA-C-O 123.119 1.438 . . . . 0.0 107.988 -168.628 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.5 m -158.99 166.59 31.43 Favored 'General case' 0 N--CA 1.417 -2.104 1 N-CA-C 97.083 -5.155 . . . . 0.0 97.083 -178.9 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -175.11 175.6 47.13 Favored Glycine 0 N--CA 1.421 -2.312 1 N-CA-C 98.545 -5.822 . . . . 0.0 98.545 -169.459 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 34.2 p-80 -167.11 -179.35 4.56 Favored 'General case' 0 N--CA 1.428 -1.54 1 N-CA-C 98.575 -4.602 . . . . 0.0 98.575 -173.695 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 80.2 m -74.08 171.29 13.8 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-N 119.476 1.035 . . . . 0.0 111.13 -178.842 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.86 170.34 43.31 Favored Glycine 0 N--CA 1.422 -2.237 1 N-CA-C 99.466 -5.454 . . . . 0.0 99.466 178.525 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -138.39 136.23 36.09 Favored 'General case' 0 N--CA 1.429 -1.489 1 N-CA-C 97.258 -5.09 . . . . 0.0 97.258 177.796 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.5 tmtm? -118.61 102.27 8.75 Favored 'General case' 0 CA--C 1.494 -1.189 0 N-CA-C 102.341 -3.207 . . . . 0.0 102.341 -177.477 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.6 t -73.87 122.28 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 -172.407 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 139.86 -43.26 1.15 Allowed Glycine 0 CA--C 1.484 -1.897 0 N-CA-C 103.115 -3.994 . . . . 0.0 103.115 -171.687 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -113.42 -63.96 1.37 Allowed 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 178.488 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 164.1 -162.65 35.4 Favored Glycine 0 CA--C 1.489 -1.547 0 N-CA-C 108.112 -1.995 . . . . 0.0 108.112 -170.452 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 28.8 tp -63.5 133.96 54.78 Favored 'General case' 0 CA--C 1.501 -0.936 0 C-N-CA 127.768 2.427 . . . . 0.0 105.657 173.515 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -136.59 -158.28 0.85 Allowed 'General case' 0 CA--C 1.483 -1.597 0 N-CA-C 103.289 -2.856 . . . . 0.0 103.289 -167.253 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 52.9 t -138.52 168.72 19.16 Favored 'General case' 0 CA--C 1.49 -1.336 0 N-CA-C 101.683 -3.451 . . . . 0.0 101.683 163.322 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 42.0 t-105 -121.16 145.89 47.34 Favored 'General case' 0 CA--C 1.499 -1.0 0 N-CA-C 103.418 -2.808 . . . . 0.0 103.418 -177.444 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 6.9 m -141.06 146.29 36.96 Favored 'General case' 0 CA--C 1.49 -1.33 0 N-CA-C 105.623 -1.991 . . . . 0.0 105.623 177.159 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -113.51 130.99 56.23 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 179.066 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 65.64 78.65 0.27 Allowed 'General case' 0 CA--C 1.491 -1.318 0 C-N-CA 129.378 3.071 . . . . 0.0 110.422 178.462 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -104.98 125.71 32.98 Favored Pre-proline 0 CA--C 1.496 -1.111 0 N-CA-C 102.216 -3.253 . . . . 0.0 102.216 177.9 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -72.06 170.74 18.25 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 CA-C-N 123.514 2.291 . . . . 0.0 110.126 174.169 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -85.67 18.15 2.99 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -165.64 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -100.92 1.28 39.68 Favored 'General case' 0 CA--C 1.502 -0.885 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 174.045 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.2 t -110.69 133.7 55.32 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.082 0 N-CA-C 103.68 -2.711 . . . . 0.0 103.68 -174.669 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -100.58 148.77 18.41 Favored Glycine 0 CA--C 1.489 -1.579 0 N-CA-C 106.097 -2.801 . . . . 0.0 106.097 178.611 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 25.3 pt -129.83 -146.57 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.492 -1.265 0 N-CA-C 104.222 -2.51 . . . . 0.0 104.222 -169.213 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.594 HD13 ' HB2' ' A' ' 7' ' ' ALA . 3.1 mm -73.03 1.42 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.747 0 CA-C-N 118.904 0.774 . . . . 0.0 112.194 -172.484 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.37 164.69 15.52 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.298 0 O-C-N 119.109 -2.244 . . . . 0.0 105.853 161.353 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -179.22 -62.75 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.274 1 N-CA-C 97.571 -4.974 . . . . 0.0 97.571 -161.544 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -156.36 157.34 27.82 Favored Glycine 0 N--CA 1.424 -2.147 1 N-CA-C 93.655 -7.778 . . . . 0.0 93.655 165.566 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -88.59 95.07 10.1 Favored 'General case' 0 CA--C 1.499 -0.988 0 CA-C-N 119.714 1.757 . . . . 0.0 108.096 -170.37 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -165.66 176.77 7.79 Favored 'General case' 0 N--CA 1.429 -1.49 1 N-CA-C 98.795 -4.52 . . . . 0.0 98.795 174.152 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 1.8 t -128.36 135.23 49.29 Favored 'General case' 0 CA--C 1.487 -1.48 1 N-CA-C 98.754 -4.536 . . . . 0.0 98.754 -179.243 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 3.4 p80 -168.61 146.56 4.04 Favored 'General case' 0 N--CA 1.427 -1.606 1 N-CA-C 98.097 -4.779 . . . . 0.0 98.097 -175.736 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 60.2 m -153.3 158.37 41.5 Favored 'General case' 0 N--CA 1.427 -1.615 1 N-CA-C 95.053 -5.906 . . . . 0.0 95.053 -178.832 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.36 1.028 0 O-C-N 124.258 0.974 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 22.8 m . . . . . 0 N--CA 1.484 1.252 0 CA-C-O 121.202 0.525 . . . . 0.0 110.512 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.46 174.97 5.65 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 103.439 -2.8 . . . . 0.0 103.439 160.798 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -126.22 142.02 51.69 Favored 'General case' 0 CA--C 1.489 -1.399 1 N-CA-C 93.354 -6.535 . . . . 0.0 93.354 162.716 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.28 170.74 37.14 Favored Glycine 0 CA--C 1.47 -2.732 0 N-CA-C 106.446 -2.662 . . . . 0.0 106.446 -174.292 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -88.77 125.22 34.78 Favored 'General case' 0 CA--C 1.488 -1.411 0 N-CA-C 100.708 -3.812 . . . . 0.0 100.708 162.611 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.9 tt -87.84 140.72 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.088 0 N-CA-C 105.58 -2.007 . . . . 0.0 105.58 -174.271 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.625 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -116.41 -158.55 0.69 Allowed 'General case' 0 N--CA 1.424 -1.727 0 C-N-CA 128.12 2.568 . . . . 0.0 107.55 -175.118 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -88.3 144.5 34.16 Favored Pre-proline 0 N--CA 1.44 -0.928 0 N-CA-C 100.493 -3.891 . . . . 0.0 100.493 162.239 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -78.36 27.16 0.5 Allowed 'Trans proline' 0 CA--C 1.511 -0.637 0 C-N-CA 123.322 2.681 . . . . 0.0 113.811 -152.897 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.63 ' HB3' ' CE1' ' A' ' 66' ' ' HIS . 53.6 mp0 -111.37 -82.07 0.58 Allowed 'General case' 0 N--CA 1.425 -1.699 0 N-CA-C 101.912 -3.366 . . . . 0.0 101.912 178.955 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -163.47 143.95 8.92 Favored 'General case' 0 N--CA 1.424 -1.754 1 N-CA-C 93.521 -6.474 . . . . 0.0 93.521 167.496 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 9.1 m 170.66 -156.21 0.01 OUTLIER 'General case' 0 CA--C 1.494 -1.178 1 N-CA-C 98.166 -4.753 . . . . 0.0 98.166 175.203 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.599 HG12 HD12 ' A' ' 59' ' ' ILE . 7.8 m -130.98 168.4 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.531 1 N-CA-C 96.815 -5.254 . . . . 0.0 96.815 160.284 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -89.89 163.55 14.95 Favored 'General case' 0 CA--C 1.499 -1.018 0 N-CA-C 100.957 -3.72 . . . . 0.0 100.957 161.915 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 71.3 m80 -108.13 101.2 10.45 Favored 'General case' 0 CA--C 1.48 -1.727 0 N-CA-C 102.74 -3.059 . . . . 0.0 102.74 -174.654 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.8 t -107.44 -171.51 1.89 Allowed 'General case' 0 N--CA 1.425 -1.7 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 -177.896 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -142.43 167.9 15.02 Favored Pre-proline 0 N--CA 1.416 -2.148 1 N-CA-C 98.552 -4.61 . . . . 0.0 98.552 -160.289 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.94 54.23 2.09 Favored 'Trans proline' 0 C--N 1.327 -0.588 0 C-N-CA 123.259 2.639 . . . . 0.0 110.749 166.497 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -178.51 134.16 2.3 Favored Glycine 0 N--CA 1.425 -2.068 1 N-CA-C 99.403 -5.479 . . . . 0.0 99.403 -178.519 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.98 26.06 9.17 Favored 'General case' 0 N--CA 1.434 -1.249 0 C-N-CA 124.305 1.042 . . . . 0.0 109.722 -168.938 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.5 m -49.68 -48.26 49.67 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 126.73 2.012 . . . . 0.0 115.37 -169.759 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -90.1 -26.35 24.18 Favored Glycine 0 C--N 1.351 1.364 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 -179.374 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -85.88 -14.69 44.12 Favored 'General case' 0 CA--C 1.5 -0.976 0 O-C-N 121.53 -0.982 . . . . 0.0 109.989 -167.946 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -58.9 -49.54 77.4 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 125.724 1.61 . . . . 0.0 108.113 171.979 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.4 -45.25 93.98 Favored 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 124.599 1.16 . . . . 0.0 112.162 174.173 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 95.9 mt -64.34 -41.29 96.84 Favored 'General case' 0 C--N 1.357 0.933 0 CA-C-O 121.69 0.757 . . . . 0.0 111.9 -178.064 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 13.2 t -59.79 -44.72 93.81 Favored 'General case' 0 N--CA 1.443 -0.799 0 O-C-N 121.59 -0.694 . . . . 0.0 109.815 176.776 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 46.1 mttp -63.66 -50.9 67.44 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 123.129 0.571 . . . . 0.0 111.163 -177.581 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -67.71 -23.57 65.29 Favored 'General case' 0 C--N 1.351 0.674 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -175.549 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -91.71 -5.72 53.22 Favored 'General case' 0 C--N 1.357 0.902 0 O-C-N 121.728 -0.607 . . . . 0.0 110.701 177.718 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.25 32.37 5.82 Favored Glycine 0 CA--C 1.492 -1.386 0 N-CA-C 111.579 -0.608 . . . . 0.0 111.579 165.713 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -108.75 140.26 15.51 Favored Glycine 0 CA--C 1.486 -1.735 0 N-CA-C 106.173 -2.771 . . . . 0.0 106.173 170.857 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.78 -76.29 0.34 Allowed 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 -171.814 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.8 m -85.85 151.83 23.48 Favored 'General case' 0 CA--C 1.491 -1.293 0 N-CA-C 105.496 -2.038 . . . . 0.0 105.496 176.706 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -158.41 171.61 35.26 Favored Glycine 0 N--CA 1.414 -2.787 1 N-CA-C 99.246 -5.542 . . . . 0.0 99.246 -175.936 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 52.9 m80 -168.0 -170.38 1.33 Allowed 'General case' 0 N--CA 1.426 -1.662 1 N-CA-C 95.982 -5.562 . . . . 0.0 95.982 -176.156 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 46.8 m -138.09 161.47 36.69 Favored 'General case' 0 N--CA 1.427 -1.579 1 N-CA-C 97.465 -5.013 . . . . 0.0 97.465 167.602 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 178.29 179.49 48.25 Favored Glycine 0 CA--C 1.481 -2.06 1 N-CA-C 100.779 -4.928 . . . . 0.0 100.779 -174.018 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -144.46 138.83 27.93 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 100.228 -3.989 . . . . 0.0 100.228 -170.294 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -148.11 50.39 1.03 Allowed 'General case' 0 CA--C 1.491 -1.302 1 N-CA-C 99.599 -4.223 . . . . 0.0 99.599 170.549 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . 0.275 2.2 t 60.61 -142.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.142 0 C-N-CA 125.84 1.656 . . . . 0.0 106.84 -160.288 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 121.55 -86.09 0.39 Allowed Glycine 0 CA--C 1.484 -1.899 1 N-CA-C 102.894 -4.082 . . . . 0.0 102.894 -176.714 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 26.1 m170 -159.93 -47.9 0.05 Allowed 'General case' 0 CA--C 1.498 -1.033 0 N-CA-C 104.726 -2.324 . . . . 0.0 104.726 -175.486 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -160.07 -176.89 32.65 Favored Glycine 0 N--CA 1.428 -1.878 1 N-CA-C 97.119 -6.393 . . . . 0.0 97.119 -178.508 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.7 tt -73.33 120.63 19.21 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 118.61 1.205 . . . . 0.0 108.689 -169.567 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -105.22 179.01 4.4 Favored 'General case' 0 CA--C 1.491 -1.308 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -162.82 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 58.9 m -109.46 157.13 19.26 Favored 'General case' 0 CA--C 1.486 -1.486 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 179.79 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 65.7 t-105 -109.88 148.93 30.65 Favored 'General case' 0 CA--C 1.487 -1.479 0 N-CA-C 103.717 -2.697 . . . . 0.0 103.717 179.591 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 45.1 m -140.94 141.81 34.45 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 101.72 -3.437 . . . . 0.0 101.72 167.382 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -108.61 17.12 22.33 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-O 121.396 0.617 . . . . 0.0 109.653 -166.679 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -171.0 144.52 2.15 Favored 'General case' 0 N--CA 1.418 -2.042 1 N-CA-C 93.624 -6.436 . . . . 0.0 93.624 172.364 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 17.0 mt -153.48 146.22 17.54 Favored Pre-proline 0 CA--C 1.487 -1.445 1 N-CA-C 97.325 -5.065 . . . . 0.0 97.325 155.61 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.38 170.21 19.8 Favored 'Trans proline' 0 N--CA 1.447 -1.207 0 C-N-CA 122.6 2.2 . . . . 0.0 109.221 173.33 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -65.89 -19.79 66.0 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -167.259 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -83.61 -2.37 55.94 Favored 'General case' 0 CA--C 1.501 -0.923 0 C-N-CA 124.18 0.992 . . . . 0.0 111.289 -172.923 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.8 t -100.09 126.31 53.62 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.303 0 N-CA-C 103.753 -2.684 . . . . 0.0 103.753 -177.67 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -92.68 158.71 24.4 Favored Glycine 0 CA--C 1.485 -1.8 0 N-CA-C 105.324 -3.11 . . . . 0.0 105.324 178.559 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 25.8 pt -144.89 -156.99 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.517 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 -166.491 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.625 HD13 ' HB2' ' A' ' 7' ' ' ALA . 0.7 OUTLIER -71.93 128.03 34.51 Favored 'Isoleucine or valine' 0 C--N 1.365 1.247 0 N-CA-C 104.967 -2.234 . . . . 0.0 104.967 176.085 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.6 t -110.91 109.49 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.596 0 N-CA-C 101.292 -3.596 . . . . 0.0 101.292 176.886 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.517 ' HG3' ' H ' ' A' ' 62' ' ' GLY . 17.4 tp10 60.47 -120.21 0.88 Allowed 'General case' 0 C--N 1.361 1.076 0 C-N-CA 125.712 1.605 . . . . 0.0 106.961 -173.911 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.517 ' H ' ' HG3' ' A' ' 61' ' ' GLU . . . -145.72 50.78 0.61 Allowed Glycine 0 N--CA 1.431 -1.668 1 N-CA-C 98.567 -5.813 . . . . 0.0 98.567 156.655 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -79.82 -58.5 3.14 Favored 'General case' 0 CA--C 1.493 -1.234 0 O-C-N 122.278 -0.542 . . . . 0.0 110.192 -164.854 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 19.9 tttm -147.64 177.91 8.89 Favored 'General case' 0 CA--C 1.489 -1.378 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 -171.781 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 24.8 t -142.72 138.82 30.82 Favored 'General case' 0 N--CA 1.416 -2.13 1 N-CA-C 94.451 -6.129 . . . . 0.0 94.451 175.834 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.63 ' CE1' ' HB3' ' A' ' 10' ' ' GLU . 2.9 p-80 -163.48 157.06 19.28 Favored 'General case' 0 N--CA 1.43 -1.465 1 N-CA-C 97.637 -4.949 . . . . 0.0 97.637 176.907 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.1 m -142.55 143.18 32.37 Favored 'General case' 0 N--CA 1.428 -1.534 1 N-CA-C 98.017 -4.809 . . . . 0.0 98.017 -168.353 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.359 1.01 0 O-C-N 124.448 1.092 . . . . 0.0 . . . . . . . . . . 0 0 . 1 stop_ save_